Citrus Sinensis ID: 024363
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.996 | 0.737 | 0.813 | 1e-122 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.996 | 0.739 | 0.809 | 1e-121 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 1.0 | 0.740 | 0.791 | 1e-121 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.996 | 0.737 | 0.794 | 1e-120 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.996 | 0.739 | 0.783 | 1e-120 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.839 | 0.606 | 0.84 | 1e-112 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.854 | 0.675 | 0.777 | 1e-104 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.854 | 0.675 | 0.772 | 1e-104 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.843 | 0.660 | 0.769 | 1e-102 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.861 | 0.695 | 0.756 | 1e-101 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 437 bits (1125), Expect = e-122, Method: Compositional matrix adjust.
Identities = 218/268 (81%), Positives = 243/268 (90%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS A
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEPK+FRKTIQRIL VQYS+PD IS ECRDLI+RIFVA+PA RI+IPEI
Sbjct: 216 AYPFEDPDEPKNFRKTIQRILGVQYSIPDYVHISPECRDLIARIFVANPATRISIPEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WFLKNLPADL+D+ MSSQYEEP+QPMQS+D IMQI+AEA+IPA G+ G+N ++ +
Sbjct: 276 HPWFLKNLPADLMDDSKMSSQYEEPEQPMQSMDEIMQILAEATIPAAGSGGINQFLN-DG 334
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DDDM+DLDS+ +LD++SSGEI+YA+
Sbjct: 335 LDLDDDMEDLDSDPDLDVESSGEIVYAM 362
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 217/268 (80%), Positives = 240/268 (89%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPA
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EP+D+RKTIQRILSV+YS+PD IS EC LISRIFVADPA RI+IPEI
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WFLKNLPADL++E SQ++EP+QPMQS+D IMQII+EA+IPAV L+ +MT +
Sbjct: 275 HSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT-DN 333
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DDDMDD DSESE+DIDSSGEI+YAL
Sbjct: 334 LDLDDDMDDFDSESEIDIDSSGEIVYAL 361
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 213/269 (79%), Positives = 240/269 (89%), Gaps = 1/269 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 94 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 154 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+FRKTI RIL+VQY++PD IS ECR LISRIFVADPA RI+IPEI
Sbjct: 214 AYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 273
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLPADL+++ TM++Q++E DQP QS++ IMQIIAEA++P GT LN Y+T +L
Sbjct: 274 HEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSL 333
Query: 241 DMDDD-DMDDLDSESELDIDSSGEIIYAL 268
D+DDD + D +LDIDSSGEI+YA+
Sbjct: 334 DIDDDMEEDLESDLDDLDIDSSGEIVYAM 362
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1110), Expect = e-120, Method: Compositional matrix adjust.
Identities = 213/268 (79%), Positives = 237/268 (88%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPA
Sbjct: 96 MEYAAGGELYERICNAGRFSEDEARFFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LLR EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP EP+D+RKTIQRILSV YS+P+ +S ECR LISRIFVADPA RITIPEI
Sbjct: 216 AYPFEDPQEPRDYRKTIQRILSVTYSIPEDLHLSPECRHLISRIFVADPATRITIPEITS 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
+WFLKNLP DL+DE M SQ++EP+QPMQS+D IMQII+EA+IP V L+ +M +
Sbjct: 276 DKWFLKNLPGDLMDENRMGSQFQEPEQPMQSLDTIMQIISEATIPTVRNRCLDDFMA-DN 334
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DDDMDD DSESE+D+DSSGEI+YAL
Sbjct: 335 LDLDDDMDDFDSESEIDVDSSGEIVYAL 362
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-120, Method: Compositional matrix adjust.
Identities = 210/268 (78%), Positives = 244/268 (91%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS A
Sbjct: 95 MEYASGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTA 154
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP++PK+FRKTIQ+IL VQYS+PD IS ECRDLI+RIFV +PA+RIT+PEI
Sbjct: 215 AYPFEDPEDPKNFRKTIQKILGVQYSIPDYVHISPECRDLITRIFVGNPASRITMPEIKN 274
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WF+KN+PADL+D+ +S+QYEEPDQPMQ+++ IMQI+AEA+IPA GT G+N ++T +
Sbjct: 275 HPWFMKNIPADLMDDGMVSNQYEEPDQPMQNMNEIMQILAEATIPAAGTSGINQFLT-DS 333
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DDDM+D+DS+ +LDI+SSGEI+YA+
Sbjct: 334 LDLDDDMEDMDSDLDLDIESSGEIVYAM 361
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1038), Expect = e-112, Method: Compositional matrix adjust.
Identities = 189/225 (84%), Positives = 206/225 (91%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERIC RFSEDEAR+FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPA
Sbjct: 106 MEYASGGELFERICKNVRFSEDEARYFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 165
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGK ADVWSCGVTLYVM+VG
Sbjct: 166 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVG 225
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+FRKTIQRIL+VQYS+P+ IS ECR LISRIFV DP+ RITIPEI
Sbjct: 226 AYPFEDPEEPKNFRKTIQRILNVQYSIPENVDISPECRHLISRIFVGDPSLRITIPEIRS 285
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP 225
H WFLKNLPADL+D+ +MSSQYEEPDQPMQ++D IMQI+ EA+IP
Sbjct: 286 HGWFLKNLPADLMDDDSMSSQYEEPDQPMQTMDQIMQILTEATIP 330
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 377 bits (969), Expect = e-104, Method: Compositional matrix adjust.
Identities = 178/229 (77%), Positives = 195/229 (85%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEP++FRKTI RILSVQY VPD +S ECR L+SRIFVA+P RITIPEI
Sbjct: 197 AYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKN 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGT 229
H WFLKNLP ++ DE MS Q + + P Q ++ IM II EA P G+
Sbjct: 257 HPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKPGDGS 305
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (967), Expect = e-104, Method: Compositional matrix adjust.
Identities = 177/229 (77%), Positives = 195/229 (85%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEP++FRKTI RILSVQY VPD +S ECR L+SRIFVA+P RITIPEI
Sbjct: 197 AYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKN 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGT 229
H WFLKNLP ++ DE MS Q + + P Q ++ IM II EA P G+
Sbjct: 257 HPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKPGDGS 305
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 174/226 (76%), Positives = 192/226 (84%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVT 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPD+P++FRKTI RILSVQYS+PD +S +CR L+SRIFV +P RITIPEI
Sbjct: 197 AYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIFVGNPEQRITIPEIKN 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPA 226
H WFLKNLP ++ DE S Q + + P QS++ +M II EA P
Sbjct: 257 HPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKPG 302
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (944), Expect = e-101, Method: Compositional matrix adjust.
Identities = 177/234 (75%), Positives = 193/234 (82%), Gaps = 3/234 (1%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELF+RICNAGRFSEDE RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS A
Sbjct: 67 MEYASGGELFQRICNAGRFSEDEGRFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVA 126
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 127 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRREYDGKVADVWSCGVTLYVMLVG 186
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEP++FRKTI RILSVQYSVPD +S +C L+SRIFV +P RITIPEI
Sbjct: 187 AYPFEDPDEPRNFRKTITRILSVQYSVPDYVRVSMDCIHLLSRIFVGNPQQRITIPEIKN 246
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP---AVGTHG 231
H WFLK LP ++ DE S Q + + P QS++ M II EA P A+G G
Sbjct: 247 HPWFLKRLPVEMTDEYQRSMQLADMNTPSQSLEEAMAIIQEAQKPGDNALGVAG 300
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| 357518557 | 363 | Serine/threonine protein kinase SAPK3 [M | 0.996 | 0.735 | 0.835 | 1e-130 | |
| 217072176 | 363 | unknown [Medicago truncatula] | 0.996 | 0.735 | 0.832 | 1e-129 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.738 | 0.817 | 1e-128 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 1.0 | 0.738 | 0.813 | 1e-128 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 1.0 | 0.738 | 0.813 | 1e-127 | |
| 224105505 | 362 | predicted protein [Populus trichocarpa] | 0.996 | 0.737 | 0.820 | 1e-127 | |
| 388491244 | 363 | unknown [Medicago truncatula] | 1.0 | 0.738 | 0.805 | 1e-127 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 1.0 | 0.738 | 0.809 | 1e-127 | |
| 359475222 | 371 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.722 | 0.793 | 1e-126 | |
| 255562649 | 362 | Serine/threonine-protein kinase SAPK10, | 0.996 | 0.737 | 0.843 | 1e-126 |
| >gi|357518557|ref|XP_003629567.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|355523589|gb|AET04043.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|388521379|gb|AFK48751.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1208), Expect = e-130, Method: Compositional matrix adjust.
Identities = 224/268 (83%), Positives = 243/268 (90%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERI NAG FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP
Sbjct: 96 MEYASGGELFERISNAGHFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPT 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPKDFRKTIQR+LSVQYS+PD I+ ECR LISRIFV DPA RIT+PEI K
Sbjct: 216 SYPFEDPNEPKDFRKTIQRVLSVQYSIPDNVQITPECRHLISRIFVFDPAERITMPEIWK 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLP DL+DEK M +Q+EEP+QPMQS+D IMQII+EA+IPA GT L+ +M DNL
Sbjct: 276 HKWFLKNLPMDLMDEKIMGNQFEEPEQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DM DD+ DDL+ ESELDIDSSGEI+YA+
Sbjct: 336 DM-DDEFDDLEYESELDIDSSGEIVYAM 362
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217072176|gb|ACJ84448.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1199), Expect = e-129, Method: Compositional matrix adjust.
Identities = 223/268 (83%), Positives = 242/268 (90%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERI NAG FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP
Sbjct: 96 MEYASGGELFERISNAGHFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPT 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPKDFRKTIQR+LSVQYS+PD I+ E R LISRIFV DPA RIT+PEI K
Sbjct: 216 SYPFEDPNEPKDFRKTIQRVLSVQYSIPDNVQITPEGRHLISRIFVFDPAERITMPEIWK 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLP DL+DEK M +Q+EEP+QPMQS+D IMQII+EA+IPA GT L+ +M DNL
Sbjct: 276 HKWFLKNLPMDLMDEKIMGNQFEEPEQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DM DD+ DDL+ ESELDIDSSGEI+YA+
Sbjct: 336 DM-DDEFDDLEYESELDIDSSGEIVYAM 362
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 219/268 (81%), Positives = 241/268 (89%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+F KTIQRIL VQYS+PD IS ECR LISRIFVADPA RITI EI
Sbjct: 216 AYPFEDPEEPKNFHKTIQRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLPADL+DE M +QYEEP+QPMQS+D IM+II EA IPA GT LN Y+T +L
Sbjct: 276 HEWFLKNLPADLMDETKMDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+DD+ +DL+++ +LDIDSSGEI+YA+
Sbjct: 336 DIDDEMEEDLETDPDLDIDSSGEIVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1191), Expect = e-128, Method: Compositional matrix adjust.
Identities = 218/268 (81%), Positives = 247/268 (92%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+FRKTI RIL+VQYS+PD IS EC+ LISRIFVADPA RI+IPEI
Sbjct: 216 AYPFEDPEEPKNFRKTIHRILNVQYSIPDYVHISPECQHLISRIFVADPAKRISIPEIKN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLPADL+D+KT+++Q++EP+QP+QS+D IMQII+EA+IPA GT N Y+T +L
Sbjct: 276 HEWFLKNLPADLMDDKTINNQFDEPEQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+DDD +DL+S+ ELD+DSSGEI+YA+
Sbjct: 336 DIDDDMEEDLESDPELDMDSSGEIVYAM 363
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 218/268 (81%), Positives = 239/268 (89%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGS A
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+F KTIQRIL VQYS+PD IS ECR LISRIFVADPA RITI EI
Sbjct: 216 AYPFEDPEEPKNFHKTIQRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WFLKNLPADL+DE M +QYEEP+QPMQS+D IM+II EA IPA GT LN Y+T +L
Sbjct: 276 HDWFLKNLPADLMDETKMDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+DD+ +DL+++ +LDIDSSGEI+YA+
Sbjct: 336 DIDDEMEEDLETDPDLDIDSSGEIVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 220/268 (82%), Positives = 244/268 (91%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERIC AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFERICIAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEP +FR TI RIL+VQYS+PD IS EC+ LISRIFVADPA RITIPEI
Sbjct: 216 AYPFEDPDEPMNFRNTIHRILNVQYSIPDYVHISPECQHLISRIFVADPAMRITIPEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLPADL+ E TM++++EEPDQPMQS++ IMQII+EA+IPA GT LN Y+T +L
Sbjct: 276 HEWFLKNLPADLMVENTMNNEFEEPDQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+ DDDM+DL+S+ ELD+DSSGEI+YA+
Sbjct: 336 DI-DDDMEDLESDPELDLDSSGEIVYAM 362
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 459 bits (1181), Expect = e-127, Method: Compositional matrix adjust.
Identities = 216/268 (80%), Positives = 242/268 (90%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM+VCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+FRKTI RIL+V YS+PD IS EC+ LISRIFVADPA RI+IPEI
Sbjct: 216 AYPFEDPEEPKNFRKTINRILNVHYSIPDYVHISPECQHLISRIFVADPAKRISIPEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLP DL+D+ ++Q+EEPDQP QSV+ IMQIIAEA++PA GT LN Y+T +L
Sbjct: 276 HEWFLKNLPTDLMDDNGTNNQFEEPDQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+DDD +DLD++ +LDIDSSGEI+YA+
Sbjct: 336 DIDDDMEEDLDTDPDLDIDSSGEIVYAM 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 459 bits (1181), Expect = e-127, Method: Compositional matrix adjust.
Identities = 217/268 (80%), Positives = 240/268 (89%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICN+GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFERICNSGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQP STVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPTSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEP++FR TI RIL+VQYS+PD IS EC+ LISRIFVADPA RITIPEI
Sbjct: 216 AYPFEDPDEPRNFRSTIHRILNVQYSIPDYVHISPECQHLISRIFVADPAKRITIPEIRN 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WFLKN PADL+ E M++Q+EEPDQPMQS+D IMQII EA+IPA GT LN Y+T +L
Sbjct: 276 HDWFLKNFPADLMVENNMNNQFEEPDQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSL 335
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+DD+ +DL+S+ ELD+DSSGEI+YA+
Sbjct: 336 DIDDEMEEDLESDPELDLDSSGEIVYAM 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1175), Expect = e-126, Method: Compositional matrix adjust.
Identities = 219/276 (79%), Positives = 241/276 (87%), Gaps = 8/276 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDE--------ARFFFQQLISGVSYCHAMQVCHRDLKLEN 52
MEYASGGELFERICNAGRFSEDE ARFFFQQL+SGVSYCHAMQVCHRDLKLEN
Sbjct: 96 MEYASGGELFERICNAGRFSEDEVLMQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLEN 155
Query: 53 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112
TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGV
Sbjct: 156 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGV 215
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
TLYVMLVG YPFEDP+EPK+F KTIQRIL VQYS+PD IS ECR LISRIFVADPA R
Sbjct: 216 TLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQYSIPDYVHISPECRHLISRIFVADPATR 275
Query: 173 ITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGL 232
ITI EI H+WFLKNLPADL+DE M +QYEEP+QPMQS+D IM+II EA IPA GT L
Sbjct: 276 ITIAEIRNHEWFLKNLPADLMDETKMDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSL 335
Query: 233 NCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL 268
N Y+T +LD+DD+ +DL+++ +LDIDSSGEI+YA+
Sbjct: 336 NQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIVYAM 371
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-126, Method: Compositional matrix adjust.
Identities = 226/268 (84%), Positives = 242/268 (90%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFE+ICN GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 96 MEYASGGELFEKICNGGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDPDEPKDFRKTIQRILSVQYS+PD IS EC DLISRIF+ DPAARITIP+I
Sbjct: 216 AYPFEDPDEPKDFRKTIQRILSVQYSIPDVVQISPECCDLISRIFIFDPAARITIPQIKT 275
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H+WFLKNLP DL+DE+TM + +EEPDQPMQS+D IMQII+EA+IPA G HGLN +M +
Sbjct: 276 HEWFLKNLPMDLMDERTMGNHFEEPDQPMQSIDTIMQIISEATIPAAGDHGLNRFMA-DN 334
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
DDDM D DSESELD+DSSGEI+YAL
Sbjct: 335 LDMDDDMMDFDSESELDVDSSGEIVYAL 362
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.876 | 0.649 | 0.829 | 6.5e-106 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.847 | 0.628 | 0.845 | 2.5e-104 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.861 | 0.641 | 0.726 | 8.3e-90 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.843 | 0.626 | 0.731 | 2e-88 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.850 | 0.645 | 0.713 | 4.7e-87 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.854 | 0.654 | 0.712 | 6.9e-86 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.847 | 0.661 | 0.711 | 2.4e-85 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.835 | 0.660 | 0.669 | 4.2e-79 | |
| TAIR|locus:2094672 | 512 | KIN11 "SNF1 kinase homolog 11" | 0.675 | 0.353 | 0.497 | 1.6e-40 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.735 | 0.442 | 0.455 | 1.4e-39 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 195/235 (82%), Positives = 215/235 (91%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA
Sbjct: 94 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 153
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 154 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EPK+FRKTI RIL+VQY++PD IS ECR LISRIFVADPA RI+IPEI
Sbjct: 214 AYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 273
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCY 235
H+WFLKNLPADL+++ TM++Q++E DQP QS++ IMQIIAEA++P GT LN Y
Sbjct: 274 HEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
Identities = 192/227 (84%), Positives = 210/227 (92%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPA
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EP+D+RKTIQRILSV+YS+PD IS EC LISRIFVADPA RI+IPEI
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAV 227
H WFLKNLPADL++E SQ++EP+QPMQS+D IMQII+EA+IPAV
Sbjct: 275 HSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAV 321
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
Identities = 170/234 (72%), Positives = 196/234 (83%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCH++Q+CHRDLKLENTLLDGSPA
Sbjct: 77 MEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
P LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK ADVWSCGVTLYVMLVG
Sbjct: 137 PLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
GYPFEDPD+P++FRKTIQRI++VQY +PD ISQECR L+SRIFV + A RIT+ EI K
Sbjct: 197 GYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIFVTNSAKRITLKEIKK 256
Query: 181 HQWFLKNLPADLVDEKTMSSQY--EEPDQPMQSVDVIMQIIAEASIPAVGTHGL 232
H W+LKNLP +L E ++ Y E P +QSV+ IM+I+ EA PA ++ +
Sbjct: 257 HPWYLKNLPKELT-EPAQAAYYKRETPSFSLQSVEDIMKIVGEARNPAPSSNAV 309
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
Identities = 166/227 (73%), Positives = 193/227 (85%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPA
Sbjct: 77 MEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+ADVWSCGVTLYVMLVG
Sbjct: 137 PRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFED ++PK+F+KTIQRI++V+Y +PD ISQ+C+ L+SRIFV + RITI +I K
Sbjct: 197 AYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIFVTNSNKRITIGDIKK 256
Query: 181 HQWFLKNLPADLVD-EKTMSSQYEEPDQPMQSVDVIMQIIAEASIPA 226
H WFLKNLP +L + + + E P +QSV+ IM+I+ EA PA
Sbjct: 257 HPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAKTPA 303
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 164/230 (71%), Positives = 191/230 (83%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCH++Q+CHRDLKLENTLLDGSPA
Sbjct: 77 MEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
P LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK ADVWSCGVTLYVMLVG
Sbjct: 137 PLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP++PK+FRKTIQRI++VQY +PD ISQEC+ L+SRIFV + A RIT+ EI
Sbjct: 197 AYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIFVTNSAKRITLKEIKN 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQ-PMQSVDVIMQIIAEASIPAVGT 229
H W+LKNLP +L+ E ++ Y+ +QSV+ IM+I+ EA PA T
Sbjct: 257 HPWYLKNLPKELL-ESAQAAYYKRDTSFSLQSVEDIMKIVGEARNPAPST 305
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
Identities = 166/233 (71%), Positives = 191/233 (81%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCHAMQ+CHRDLKLENTLLDGSP+
Sbjct: 77 MEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICHRDLKLENTLLDGSPS 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL R EY+GKIADVWSCGVTLYVMLVG
Sbjct: 137 SHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP++P++ R TIQRILSV Y++PD IS EC+ L+SRIFVADP RIT+PEI K
Sbjct: 197 AYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIFVADPDKRITVPEIEK 256
Query: 181 HQWFLKN-LPADLVDEKT---MSSQYEEPDQPMQSVDVIMQIIAEASIPAVGT 229
H WFLK L +EK + + EE ++ QSV+ I++II EA GT
Sbjct: 257 HPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIEEARKGVNGT 309
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 165/232 (71%), Positives = 186/232 (80%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCH++Q+CHRDLKLENTLLDGS A
Sbjct: 77 MEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICHRDLKLENTLLDGSEA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL EYDGKIADVWSCGVTLYVMLVG
Sbjct: 137 PRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIADVWSCGVTLYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP +PKDFRKTI RIL QY++PD +S ECR L+SRIFVA+P RITI EI
Sbjct: 197 AYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIFVANPEKRITIEEIKN 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGL 232
H WFLKNLP ++ + M + P Q+V+ I+ II EA P GL
Sbjct: 257 HSWFLKNLPVEMYEGSLMMNG---PST--QTVEEIVWIIEEARKPITVATGL 303
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 795 (284.9 bits), Expect = 4.2e-79, P = 4.2e-79
Identities = 154/230 (66%), Positives = 180/230 (78%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y HA+Q+CHRDLKLENTLLDGSPA
Sbjct: 77 MEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICHRDLKLENTLLDGSPA 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV R EYDGK DVWSCGV LYVMLVG
Sbjct: 137 PRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSVDVWSCGVALYVMLVG 196
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP +P++FRKT+Q+I++V Y +P IS++CR L+SRIFVA+P R T+ EI
Sbjct: 197 AYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIFVANPLHRSTLKEIKS 256
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPM----QSVDVIMQIIAEA-SIP 225
H WFLKNLP +L E + Y+ + Q V+ IM+I+ EA +IP
Sbjct: 257 HAWFLKNLPREL-KEPAQAIYYQRNVNLINFSPQRVEEIMKIVGEARTIP 305
|
|
| TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 1.6e-40, P = 1.6e-40
Identities = 94/189 (49%), Positives = 114/189 (60%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GELF+ I GR EDEAR FFQQ+ISGV YCH V HRDLK EN LLD
Sbjct: 97 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSRC- 155
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG S K++ G+P Y APEV+ Y G DVWSCGV LY +L G
Sbjct: 156 -NIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 214
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+D + P F+K I Y++P + +S E RDLI R+ + DP RITIPEI +
Sbjct: 215 TLPFDDENIPNLFKKIKGGI----YTLP--SHLSSEARDLIPRMLIVDPVKRITIPEIRQ 268
Query: 181 HQWFLKNLP 189
H+WF +LP
Sbjct: 269 HRWFQTHLP 277
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 1.4e-39, P = 1.4e-39
Identities = 98/215 (45%), Positives = 125/215 (58%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY +GGELF++I GR SE EAR +F QLI GV YCH+ V HRDLK EN LLD
Sbjct: 86 LEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKGVYHRDLKPENLLLDSQG- 144
Query: 61 PRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
LKI DFG S L Q K+T GTP Y+APEVL Y+G +AD+WSCGV LYV
Sbjct: 145 -NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHKGYNGAVADIWSCGVILYV 200
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
++ G PF++ D P + K I ++S P + + LI+RI +P RITI
Sbjct: 201 LMAGYLPFDEMDLPTLYSK----IDKAEFSCPSYFALG--AKSLINRILDPNPETRITIA 254
Query: 177 EIMKHQWFLKNL-PADLVDEK--TMSSQYEEPDQP 208
EI K +WFLK+ P L+D + + Y D P
Sbjct: 255 EIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDP 289
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.7564 | 0.8619 | 0.6957 | N/A | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7772 | 0.8544 | 0.6755 | N/A | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8134 | 0.9962 | 0.7375 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 268 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-73 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-45 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-43 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-41 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-37 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-36 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-33 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-33 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-32 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-32 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-32 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-30 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-28 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-18 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.003 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 9e-73
Identities = 74/185 (40%), Positives = 106/185 (57%), Gaps = 7/185 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+LF+ + GR SEDEARF+ +Q++S + Y H+ + HRDLK EN LLD
Sbjct: 76 MEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED-- 133
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG ++ + + VGTP Y+APEVLL Y + D+WS GV LY +L G
Sbjct: 134 GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV-DIWSLGVILYELLTG 192
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDLISRIFVADPAARITIPEIM 179
PF D+ + ++I + P IS E +DLI ++ V DP R+T E +
Sbjct: 193 KPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEAL 249
Query: 180 KHQWF 184
+H +F
Sbjct: 250 QHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 5e-64
Identities = 79/187 (42%), Positives = 108/187 (57%), Gaps = 6/187 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+LF+ + G SEDEA+ Q++ G+ Y H+ + HRDLK EN LLD +
Sbjct: 77 MEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN-- 134
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG +K + S +T VGTP Y+APEVLL G DVWS GV LY +L
Sbjct: 135 GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194
Query: 120 GGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
G PF + D + I+RIL +++ P + S+E +DLI + DP+ R T E
Sbjct: 195 GKPPFSGENIL-DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 178 IMKHQWF 184
I++H WF
Sbjct: 254 ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 9e-52
Identities = 77/190 (40%), Positives = 103/190 (54%), Gaps = 17/190 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+EYA GGELF + GRFSE+ ARF+ +++ + Y H++ + +RDLK EN LLD G
Sbjct: 72 LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG- 130
Query: 59 PAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG +K S+ + GTP Y+APEVLL Y GK D WS GV LY M
Sbjct: 131 ---HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEM 186
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT--- 174
L G PF D + ++IL P+ +S E RDLIS + DP R+
Sbjct: 187 LTGKPPFYAEDRK----EIYEKILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGSGG 240
Query: 175 IPEIMKHQWF 184
EI H +F
Sbjct: 241 AEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 8e-45
Identities = 65/183 (35%), Positives = 89/183 (48%), Gaps = 40/183 (21%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY GG L + + N G+ SEDE Q++ G+ Y H+ + HRDLK EN LLD S
Sbjct: 70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD-SD 128
Query: 60 APRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++K+ DFG SK + S K+ VGTPAY+APEVLL Y + +D+WS GV LY +
Sbjct: 129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL- 187
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
E +DLI ++ DP R + EI
Sbjct: 188 ------------------------------------PELKDLIRKMLQKDPEKRPSAKEI 211
Query: 179 MKH 181
++H
Sbjct: 212 LEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-44
Identities = 70/191 (36%), Positives = 103/191 (53%), Gaps = 20/191 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
MEY GGELF + +GRF E ARF+ Q++ + Y H++ + +RDLK EN LLD G
Sbjct: 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY 139
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG++K + + + GTP Y+APE++L Y GK D W+ G+ +Y ML
Sbjct: 140 ----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEML 192
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF D D P + ++IL + P + S + +DLI + D R+
Sbjct: 193 AGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKN 246
Query: 174 TIPEIMKHQWF 184
+ +I H WF
Sbjct: 247 GVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-44
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EYA GEL + I G E RF+ +++ + Y H+ + HRDLK EN LLD
Sbjct: 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-- 138
Query: 61 PRLKICDFGYSK---------------------SSVLHSQPKSTVGTPAYIAPEVLLRHE 99
+KI DFG +K + S VGT Y++PE LL +
Sbjct: 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE-LLNEK 197
Query: 100 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159
GK +D+W+ G +Y ML G PF +E T Q+IL ++YS P P + +D
Sbjct: 198 PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTFQKILKLEYSFPPNFP--PDAKD 251
Query: 160 LISRIFVADPAARITI----PEIMKHQWF 184
LI ++ V DP R+ + E+ H +F
Sbjct: 252 LIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY SGG L + G+ E R + +Q++ G++Y H+ + HRD+K N L+D
Sbjct: 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-- 137
Query: 61 PRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG +K S GTP ++APEV +R E G+ AD+WS G T+ M
Sbjct: 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEYGRAADIWSLGCTVIEM 196
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITI 175
G P+ + P + +I S +P+ +S+E +D + + DP R T
Sbjct: 197 ATGKPPWSELGNPMAA---LYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRPTA 251
Query: 176 PEIMKHQWF 184
E+++H +
Sbjct: 252 DELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-41
Identities = 73/196 (37%), Positives = 101/196 (51%), Gaps = 19/196 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + N G ED AR + +++ + Y H+ + HRDLK +N L+D +
Sbjct: 72 MEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-- 129
Query: 61 PRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 111
LK+ DFG SK + + K VGTP YIAPEV+L + K D WS G
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLG 188
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171
LY LVG PF + P + Q IL+ + P+ +S E DLIS++ V DP
Sbjct: 189 CILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEK 244
Query: 172 RI---TIPEIMKHQWF 184
R+ +I EI H +F
Sbjct: 245 RLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-37
Identities = 77/202 (38%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELF + FSED ARF+ +++S + Y H+ V +RDLKLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-- 131
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + T GTP Y+APEVL ++Y G+ D W GV +Y M+
Sbjct: 132 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF + D K F + IL + P T +S E + L++ + DP R+
Sbjct: 191 GRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPED 244
Query: 175 IPEIMKHQWFLKNLPADLVDEK 196
EIM+H++F D+V +K
Sbjct: 245 AKEIMEHRFFASINWQDVVQKK 266
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 63/187 (33%), Positives = 101/187 (54%), Gaps = 17/187 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
MEYA GG+L ++I + F E++ +F QL + Y H+ ++ HRD+K +N L
Sbjct: 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 57 GSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
+K+ DFG SK S+V + K+ VGTP Y++PE+ Y+ K +D+WS G
Sbjct: 138 --SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCV 192
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY + +PFE ++ + +IL QY P + S E R+L+S + DP R
Sbjct: 193 LYELCTLKHPFEG----ENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERP 247
Query: 174 TIPEIMK 180
+I +I++
Sbjct: 248 SIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 67/189 (35%), Positives = 98/189 (51%), Gaps = 10/189 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GGEL+ + + G F E ARF+ ++ Y H + +RDLK EN LLD +
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-- 129
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K + + GTP Y+APE++L YD D WS G+ LY +L G
Sbjct: 130 GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTG 188
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TI 175
PF + DE D + IL + N I + +DLI ++ +P R+ I
Sbjct: 189 RPPFGEDDE--DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGI 246
Query: 176 PEIMKHQWF 184
+I KH+WF
Sbjct: 247 KDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-36
Identities = 71/215 (33%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + F E+ ARF+ +L+ + H + HRD+K +N L+D
Sbjct: 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG- 138
Query: 61 PRLKICDFGYSK--------------------------SSVLHSQPK----STVGTPAYI 90
+K+ DFG K H Q + STVGTP YI
Sbjct: 139 -HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI 197
Query: 91 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150
APEVL Y + D WS GV LY ML G PF + + K I S+++ P
Sbjct: 198 APEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF--PPD 254
Query: 151 NPISQECRDLISRIFVADPAARIT-IPEIMKHQWF 184
P+S E DLI R + DP R+ EI H +F
Sbjct: 255 PPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-35
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 1 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
MEY GG L + + G SE EA F Q++S + Y H+ + HRD+K EN LLD
Sbjct: 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD- 135
Query: 58 SPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL--RHEYDGKIADVW 108
+K+ DFG +K +S + + P ++VGTP Y+APEVLL Y +D+W
Sbjct: 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195
Query: 109 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------QYSVPDTNPISQECRDLI 161
S G+TLY +L G PFE +T++ IL + S + IS+ DL+
Sbjct: 196 SLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL 255
Query: 162 SRIFVADPAARITIPEIMKHQWF 184
++ DP R++ + H
Sbjct: 256 KKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 31/200 (15%)
Query: 1 MEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEY SGG L E + GR DE R + QL+ G++Y H+ + HRD+K N LD +
Sbjct: 78 MEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135
Query: 59 PAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI--ADVWSCG 111
+K+ DFG + ++ + + +S GTPAY+APEV+ + G AD+WS G
Sbjct: 136 GV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--------PDTNPISQECRDLISR 163
+ M G P+ + D + + V PD+ +S E +D + R
Sbjct: 194 CVVLEMATGKRPWSELDNE----------FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR 243
Query: 164 IFVADPAARITIPEIMKHQW 183
+DP R T E+++H +
Sbjct: 244 CLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 73/191 (38%), Positives = 106/191 (55%), Gaps = 21/191 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RDLKL+N LLD
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ ST GTP YIAPE+L +Y+ + D WS GV LY ML+
Sbjct: 133 GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEMLI 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARIT 174
G PF DE + F S+ + P IS+E +D +S++F DP R+
Sbjct: 192 GQSPFHGEDEDELF-----------DSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG 240
Query: 175 IP-EIMKHQWF 184
+ +I +H +F
Sbjct: 241 VDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 74/196 (37%), Positives = 104/196 (53%), Gaps = 18/196 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+ + N G SED ARF+ ++ V H + HRDLK EN L+D S
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-- 137
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG SK V + S VG+P Y+APEVL YD + D WS G LY L G
Sbjct: 138 GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTV-DYWSLGCMLYEFLCG 194
Query: 121 GYPF--EDPDEP----KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI- 173
PF P+E K +++T+QR + P N +S E DLI+++ + DP+ R
Sbjct: 195 FPPFSGSTPNETWENLKYWKETLQRPVYDD---PRFN-LSDEAWDLITKL-INDPSRRFG 249
Query: 174 TIPEIMKHQWFLKNLP 189
++ +I H +F K +
Sbjct: 250 SLEDIKNHPFF-KEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 85/259 (32%), Positives = 129/259 (49%), Gaps = 26/259 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GGELF + FSED RF+ +++S + Y H+ ++ +RDLKLEN +LD
Sbjct: 74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-- 131
Query: 61 PRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W GV +Y M+
Sbjct: 132 GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF + D K F + IL P T +S + + L+S + + DP R+
Sbjct: 191 GRLPFYNQDHEKLF----ELILMEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDD 244
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNC 234
EIM+H +F D+ D+K + P +P + + + E T
Sbjct: 245 AKEIMRHSFFTGVNWQDVYDKKLVP-----PFKPQVTSETDTRYFDEEFTAQTIT----- 294
Query: 235 YMTDNLDMDDDDMDDLDSE 253
+T D+D MD +D+E
Sbjct: 295 -ITPPEKYDEDGMDCMDNE 312
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 72/212 (33%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ + +GGELF + GRF ARF+ +L+ + H V +RDLK EN LLD
Sbjct: 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD--YQ 129
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ +CDFG K ++ +T GTP Y+APE+LL H Y K D W+ GV LY ML
Sbjct: 130 GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLT 188
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---P 176
G PF D + + +RK +Q L PD ++ +DL+ + DP R+
Sbjct: 189 GLPPFYDENVNEMYRKILQEPL----RFPDG--FDRDAKDLLIGLLSRDPTRRLGYNGAQ 242
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 208
EI H +F + L +K + + P +P
Sbjct: 243 EIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDLKL+N LLD
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K +L ST GTP YIAPE+L Y G D W+ GV LY ML
Sbjct: 133 GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLA 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP--- 176
G PFE DE + F Q IL + P +S+E + ++ +P R+
Sbjct: 192 GQSPFEGDDEDELF----QSILEDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTG 245
Query: 177 --EIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPM 209
+I H +F + + D ++ K + + P +P
Sbjct: 246 EQDIKGHPFF-REIDWDKLERKEI----KPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 77/203 (37%), Positives = 112/203 (55%), Gaps = 16/203 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSP 59
MEYA+GGELF + FSED ARF+ +++S + Y H+ V +RDLKLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD- 132
Query: 60 APRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W GV +Y M+
Sbjct: 133 -GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 190
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF + D K F + IL + P T +S E + L+S + DP R+
Sbjct: 191 CGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPD 244
Query: 174 TIPEIMKHQWFLKNLPADLVDEK 196
EIM+H++F + D+ ++K
Sbjct: 245 DAKEIMQHKFFAGIVWQDVYEKK 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + F+E E R + +++ + + H + + +RD+KLEN LLD
Sbjct: 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-- 141
Query: 61 PRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVM 117
+ + DFG SK + + + S GT Y+APEV+ K D WS GV + +
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---T 174
L G PF E + +RIL + P T +S E RD I ++ DP R+
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGANG 259
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQY 202
EI H F + + D + K + + +
Sbjct: 260 ADEIKNHP-FFQGIDWDDLAAKRIPAPF 286
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-32
Identities = 73/202 (36%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+KLEN +LD
Sbjct: 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-- 131
Query: 61 PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + + K+ GTP Y+APEVL ++Y G+ D W GV +Y M+
Sbjct: 132 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMC 190
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF + D + F + IL + P T +S E + L++ + DP R+
Sbjct: 191 GRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSD 244
Query: 175 IPEIMKHQWFLKNLPADLVDEK 196
E+M+H++FL D+V +K
Sbjct: 245 AKEVMEHRFFLSINWQDVVQKK 266
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 1 MEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
M+Y GGELF + SE+ ARF+ +++ + Y H + + +RDLK EN LL S
Sbjct: 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 59 -----------------PAPRLKICDFGYSKSSVLHSQP-----------KSTVGTPAYI 90
P P K G +SSV S VGT YI
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 91 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150
APEV+ + + D W+ G+ LY ML G PF+ + +T IL + + P +
Sbjct: 200 APEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNRDETFSNILKKEVTFPGS 254
Query: 151 NPISQECRDLISRIFVADPAARI----TIPEIMKHQWF 184
P+S RDLI ++ V DP+ R+ EI +H +F
Sbjct: 255 PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 18/190 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GGELF + N+GRFS F+ +++ + Y H+ ++ +RDLK EN LLD
Sbjct: 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-- 137
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K L + + GTP Y+APEV+ + K D W+ G+ +Y MLVG
Sbjct: 138 GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVG 194
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDT-NPISQECRDLISRIFVADPAARI-----T 174
PF D D P ++IL+ + P + + +DLI ++ V D R+
Sbjct: 195 YPPFFD-DNPFGI---YEKILAGKLEFPRHLDLYA---KDLIKKLLVVDRTRRLGNMKNG 247
Query: 175 IPEIMKHQWF 184
++ H+WF
Sbjct: 248 ADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-31
Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 11/186 (5%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
ME+ SGG L + + + + +E + + ++L+ G+ Y H+ + HRD+K N LL DG
Sbjct: 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG S + VGTP ++APEV+ YD K AD+WS G+T +
Sbjct: 136 E----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIEL 190
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
G P+ + K K + + + S E +D + + +P R T +
Sbjct: 191 AEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
Query: 178 IMKHQW 183
++KH +
Sbjct: 248 LLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 12/190 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ +GG+L I + GRF A F+ +++ G+ + H+ + +RDLKL+N +LD
Sbjct: 75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K +V ST GTP YIAPE+L +Y + D WS GV LY ML+
Sbjct: 133 GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLI 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIPEI 178
G PF DE + F S++ P I++E +D++ ++F DP R+ +
Sbjct: 192 GQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGN 244
Query: 179 MKHQWFLKNL 188
++ F K +
Sbjct: 245 IRGHPFFKTI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 70/214 (32%), Positives = 114/214 (53%), Gaps = 24/214 (11%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I + +F A F+ ++I G+ + H+ + +RDLKL+N LLD
Sbjct: 75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++L T GTP YIAPE+LL +Y+ + D WS GV LY ML+
Sbjct: 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DWWSFGVLLYEMLI 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARIT 174
G PF DE + F+ S+ NP +++E +D++ ++FV +P R+
Sbjct: 192 GQSPFHGHDEEELFQ-----------SIRMDNPCYPRWLTREAKDILVKLFVREPERRLG 240
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 208
+ ++ F + + ++E+ + E P +P
Sbjct: 241 VKGDIRQHPFFREIDWSALEER----EIEPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 66/190 (34%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY SGGELF + G F ED A F+ ++ + + H + +RDLK EN LLD
Sbjct: 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-- 136
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG K S+ T GT Y+APE+L+R + GK D WS G +Y ML
Sbjct: 137 GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLT 195
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF + +KTI +IL + ++P ++ E RDL+ ++ +P++R+
Sbjct: 196 GAPPFTAENR----KKTIDKILKGKLNLPPY--LTPEARDLLKKLLKRNPSSRLGAGPGD 249
Query: 175 IPEIMKHQWF 184
E+ H +F
Sbjct: 250 AAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 68/191 (35%), Positives = 95/191 (49%), Gaps = 19/191 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+ I G ED A+ + +++ GV H + HRD+K EN L+D
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--T 133
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LK+ DFG S++ + K VGTP Y+APE +L D K++D WS G ++ L G
Sbjct: 134 GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFG 189
Query: 121 GYPF--EDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARI--- 173
PF E PD ILS + + P+ S E DLI+R+ DPA R+
Sbjct: 190 YPPFHAETPDA------VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
Query: 174 TIPEIMKHQWF 184
EI H +F
Sbjct: 244 GYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 66/189 (34%), Positives = 100/189 (52%), Gaps = 16/189 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+ GGELF + AGRF D A+F+ +L+ Y H+ + +RDLK EN LLD
Sbjct: 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-- 154
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K + + + GTP Y+APEV ++ + GK D W+ GV LY + G
Sbjct: 155 GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEFIAG 211
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIP--- 176
PF D D P FR ++IL+ + P N RDL+ + D R+ T+
Sbjct: 212 YPPFFD-DTP--FR-IYEKILAGRLKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGV 265
Query: 177 -EIMKHQWF 184
++ H +F
Sbjct: 266 ADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 17/193 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
MEY GG L + I N R +E + + ++++ G+ Y H+ V HRD+K +N LL DG
Sbjct: 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG 153
Query: 58 SPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
S +K+ DFG++ + + S+ S VGTP ++APEV+ R +Y K+ D+WS G+
Sbjct: 154 S----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMCIE 208
Query: 117 MLVGGYP--FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
M G P +P F T + I ++ + S E +D +++ V DP R +
Sbjct: 209 M-AEGEPPYLREPPLRALFLITTKGIPPLK----NPEKWSPEFKDFLNKCLVKDPEKRPS 263
Query: 175 IPEIMKHQWFLKN 187
E+++H FLK
Sbjct: 264 AEELLQHP-FLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 64/191 (33%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
M +GG+L I N G F E A F+ Q+I G+ + H ++ +RDLK EN LLD
Sbjct: 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH 131
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
R I D G + + K GTP Y+APEVL YD D ++ G TLY M+
Sbjct: 132 GNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMI 188
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF E + + +R L + PD S E +DL + DP R+
Sbjct: 189 AGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF--SPEAKDLCEALLQKDPEKRLGCRGG 246
Query: 174 TIPEIMKHQWF 184
+ E+ +H F
Sbjct: 247 SADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDLK EN LLD
Sbjct: 75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH 134
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
L DFG K + HS+ ST GTP Y+APEVL + YD + D W G LY ML
Sbjct: 135 VVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----TI 175
G PF D + + + + L ++ + IS R L+ + D R+
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQKDRTKRLGAKDDF 245
Query: 176 PEIMKHQWFLKNLPADLVDEK 196
EI H +F DLV++K
Sbjct: 246 LEIKNHVFFSSINWDDLVNKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-28
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 61
+Y SGGELF + GRFSED A+F+ +L+ + + H + +RDLK EN LLD +
Sbjct: 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT--G 133
Query: 62 RLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+ +CDFG SK+++ ++ +T GT Y+APEVLL + K D WS GV ++ M G
Sbjct: 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---PE 177
PF D + +R I + P N +S E R + + +P R+
Sbjct: 194 WSPFYAEDTQQMYRN----IAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYE 203
+K F ++ DL+ +K ++ ++
Sbjct: 249 ELKEHPFFADIDWDLLSKKQITPPFK 274
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 71/230 (30%), Positives = 101/230 (43%), Gaps = 56/230 (24%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG++ + F+E+E RF+ + I + H + HRD+K +N LLD
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG- 138
Query: 61 PRLKICDFGYSK---------------------SSVLHSQPK------------------ 81
+K+ DFG S+P
Sbjct: 139 -HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQR 139
STVGTP YIAPEV L+ Y K D WS GV +Y MLVG PF ++P E T ++
Sbjct: 198 STVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQE------TYRK 250
Query: 140 ILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIP---EIMKHQWF 184
I++ + ++ PD P+S E +DLI R + R+ EI H +F
Sbjct: 251 IINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y SGGE+F + FSEDE RF+ ++I + + H + + +RD+KLEN LLD
Sbjct: 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-- 141
Query: 61 PRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+ + DFG SK + + + S GT Y+APE++ GK D WS G+ ++ +L
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF E + +RIL P I E +DL+ ++ DP R+
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 174 TIPEIMKHQWF 184
EI +H +F
Sbjct: 260 GASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-28
Identities = 66/190 (34%), Positives = 98/190 (51%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I G+F E A F+ ++ G+ + H+ + +RDLKL+N +LD
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-- 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ + T GTP YIAPE++ Y GK D W+ GV LY ML
Sbjct: 138 GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---- 175
G PF+ DE + F Q I+ S P + +S+E + + PA R+
Sbjct: 197 GQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTG 250
Query: 176 -PEIMKHQWF 184
+I +H +F
Sbjct: 251 ERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-28
Identities = 64/190 (33%), Positives = 106/190 (55%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+++ GG+LF R+ F+E++ +F+ +L + + H++ + +RDLK EN LLD
Sbjct: 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134
Query: 61 PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG SK S+ H + S GT Y+APEV+ R + + AD WS GV ++ ML
Sbjct: 135 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLT 193
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF+ KD ++T+ IL + +P +S E + L+ +F +PA R+
Sbjct: 194 GSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDG 247
Query: 175 IPEIMKHQWF 184
+ EI +H +F
Sbjct: 248 VEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 12/188 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ GG+L + +FSE++ +F+ +++ + Y H+ + HRD+K +N LLD
Sbjct: 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-- 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+ I DF + + ST GTP Y+APEVL R Y D WS GVT Y L G
Sbjct: 137 GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRG 195
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI--SQECRDLISRIFVADPAARI--TIP 176
P+ R +I + Q + P S E D I+++ DP R+ +
Sbjct: 196 KRPYRGHS-----RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLK 250
Query: 177 EIMKHQWF 184
++ H +F
Sbjct: 251 DLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 60/211 (28%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74
G S + + QL+ G++YCH+ ++ HRDLK +N L++ LK+ DFG +++
Sbjct: 91 RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD--GVLKLADFGLARA- 147
Query: 75 VLHSQPKST----VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG--------- 120
P T V T Y APE+LL Y + D+WS G M+ G
Sbjct: 148 --FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSE 204
Query: 121 -----------GYPFED--PD--------------EPKDFRKTIQRILSVQYSVPDTNPI 153
G P E+ P PKD K + R +
Sbjct: 205 IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR-------------L 251
Query: 154 SQECRDLISRIFVADPAARITIPEIMKHQWF 184
E DL+S++ +PA RI+ E +KH +F
Sbjct: 252 DPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-27
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+ + N G D AR +F + + + Y H + HRDLK +N L+ +
Sbjct: 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI--TSM 137
Query: 61 PRLKICDFGYSKSSVLHS----------------QPKSTVGTPAYIAPEVLLRHEYDGKI 104
+K+ DFG SK ++ K GTP YIAPEV+LR Y GK
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKP 196
Query: 105 ADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPDTN-PISQECRDLI 161
D W+ G+ LY LVG PF + P+E F + I S P+ + + + +DLI
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI----SDDIEWPEGDEALPADAQDLI 250
Query: 162 SRIFVADPAARITIP---EIMKHQWFL 185
SR+ +P R+ E+ +H++FL
Sbjct: 251 SRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 61/188 (32%), Positives = 91/188 (48%), Gaps = 12/188 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLL--DG 57
+EY GG L + + G+ E + +Q++ G+ Y H + HRD+K N L+ G
Sbjct: 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG 137
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
KI DFG SK +T VGT Y++PE ++ E AD+WS G+TL
Sbjct: 138 EV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLE 192
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITI 175
+G +PF P +P F + +Q I S+P S E RD IS DP R +
Sbjct: 193 CALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRDFISACLQKDPKKRPSA 250
Query: 176 PEIMKHQW 183
E+++H +
Sbjct: 251 AELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 62/183 (33%), Positives = 91/183 (49%), Gaps = 9/183 (4%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEYA GG L E I ED FF Q++ + + H + HRDLK +N LLD
Sbjct: 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG SK S+ + VGTP YI+PE+ Y+ K +D+W+ G LY +
Sbjct: 138 KMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELA 195
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
FE + P + +I+S ++ P ++ S + R LI + DP+ R + +I
Sbjct: 196 SLKRAFEAANLP----ALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
Query: 179 MKH 181
M
Sbjct: 251 MAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + +++ G +E R + +Q++ GV Y H+ + HRD+K N L D A
Sbjct: 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--A 140
Query: 61 PRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG SK + S KS GTP +++PEV+ Y G+ ADVWS G T+
Sbjct: 141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVE 199
Query: 117 MLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
ML P+ + E F+ Q +P +S + R+ + R FV + R +
Sbjct: 200 MLTEKPPWAEF-EAMAAIFKIATQ---PTNPQLPSH--VSPDARNFLRRTFVENAKKRPS 253
Query: 175 IPEIMKHQWF 184
E+++H +
Sbjct: 254 AEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 65/190 (34%), Positives = 96/190 (50%), Gaps = 16/190 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +RDLKL+N LLD
Sbjct: 81 MEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD--TE 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + ST GTP ++APEVL Y + D W GV +Y MLV
Sbjct: 138 GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLV 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF DE + F I++ + P +S+E ++ R+ +P R+
Sbjct: 197 GESPFPGDDEEEVF----DSIVNDEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKD 250
Query: 175 IPEIMKHQWF 184
++ K +F
Sbjct: 251 AEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-26
Identities = 68/190 (35%), Positives = 99/190 (52%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L +I GRF E A F+ ++ G+ + H+ + +RDLKL+N +LD
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-- 137
Query: 61 PRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ K+ GTP YIAPE++ Y GK D W+ GV LY ML
Sbjct: 138 GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-PE- 177
G PFE DE + F Q I+ + P + +S+E + + P R+ PE
Sbjct: 197 GQAPFEGEDEDELF----QSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEG 250
Query: 178 ---IMKHQWF 184
I +H +F
Sbjct: 251 ERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 28/197 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY GG + + G+ E F ++++ G+ Y H HRD+K N LL +G
Sbjct: 78 MEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD 136
Query: 59 PAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG S + S+ + VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 137 ----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIEL 191
Query: 118 LVGGYPFEDPDE-------PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 170
G P D PK+ +++ N S+ +D +S DP
Sbjct: 192 AKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NKFSKPFKDFVSLCLNKDPK 240
Query: 171 ARITIPEIMKHQWFLKN 187
R + E++KH+ F+K
Sbjct: 241 ERPSAKELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-26
Identities = 62/174 (35%), Positives = 91/174 (52%), Gaps = 10/174 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I G+F E +A F+ ++ G+ + H + +RDLKL+N +LD
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-- 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ T GTP YIAPE++ Y GK D W+ GV LY ML
Sbjct: 138 GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLA 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
G PF+ DE + F Q I+ S P + +S+E + + P+ R+
Sbjct: 197 GQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ +GG+L I + RF E ARF+ ++ S + + H + +RDLKL+N LLD
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K + + + ST GTP YIAPE+L Y G D W+ GV LY ML
Sbjct: 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLC 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---- 175
G PFE +E F + IL+ + P +SQ+ D++ +P R+
Sbjct: 192 GHAPFEAENEDDLF----EAILNDEVVYPTW--LSQDAVDILKAFMTKNPTMRLGSLTLG 245
Query: 176 --PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 208
I++H +F K L + ++ + Q E P +P
Sbjct: 246 GEEAILRHPFF-KELDWEKLNRR----QIEPPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 57/186 (30%), Positives = 91/186 (48%), Gaps = 16/186 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E GG L + + G F E R + +Q++ G+ Y H HRD+K N L+D +
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV 140
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG +K V S KS G+P ++APEV+ + G AD+WS G T+ M G
Sbjct: 141 --VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYS-----VPDTNPISQECRDLISRIFVADPAARITI 175
P+ + + + + S +PD +S E +D I + DP+ R T
Sbjct: 199 KPPWSQLEG-------VAAVFKIGRSKELPPIPDH--LSDEAKDFILKCLQRDPSLRPTA 249
Query: 176 PEIMKH 181
E+++H
Sbjct: 250 AELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 1 MEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEYA+GG L+++I F E+ ++ Q++S VSY H + HRD+K N L +
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--T 135
Query: 59 PAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
A +K+ DFG SK S ++ + VGTP Y++PE+ +Y+ K +D+W+ G LY
Sbjct: 136 KAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLY 192
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
+L F+ + K +Q + P + S E L+ + DP R T
Sbjct: 193 ELLTLKRTFDATNPLNLVVKIVQGNYT-----PVVSVYSSELISLVHSLLQQDPEKRPTA 247
Query: 176 PEIMKHQWFL 185
E++ Q L
Sbjct: 248 DEVLD-QPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 63/193 (32%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
+EYA G L + I G F E + Q++ G++Y H V HRD+K N L DG
Sbjct: 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137
Query: 59 PAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG + K + + S VGTP ++APEV+ +D+WS G T+ +
Sbjct: 138 ----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIEL 192
Query: 118 LVGGYPFEDPDE-PKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAA 171
L G P+ D + FR I V D +P IS E +D + + F DP
Sbjct: 193 LTGNPPYYDLNPMAALFR--I---------VQDDHPPLPEGISPELKDFLMQCFQKDPNL 241
Query: 172 RITIPEIMKHQWF 184
R T +++KH W
Sbjct: 242 RPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-25
Identities = 68/194 (35%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + N E ARF+ +++ + H+M HRD+K +N LLD S
Sbjct: 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-- 178
Query: 61 PRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVT 113
LK+ DFG + ++ + VGTP YI+PEVL Y G+ D WS GV
Sbjct: 179 GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY MLVG PF + K + S+ + PD IS++ +DLI F+ D R+
Sbjct: 237 LYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIEISKQAKDLI-CAFLTDREVRL 293
Query: 174 ---TIPEIMKHQWF 184
+ EI H +F
Sbjct: 294 GRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-25
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
MEYA G+L + I + E E F QL+ G+ H ++ HRDLK N LL
Sbjct: 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL- 136
Query: 57 GSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+KI D G SK VL K+ +GTP Y+APEV Y K +D+WS G LY
Sbjct: 137 -VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLY 192
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVADPAARIT 174
M PF E + + ++ +Y +P SQ+ ++ I + P R
Sbjct: 193 EMATFAPPF----EARSMQDLRYKVQRGKYPPIPPIY--SQDLQNFIRSMLQVKPKLRPN 246
Query: 175 IPEIMKH 181
+I+
Sbjct: 247 CDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-24
Identities = 52/134 (38%), Positives = 75/134 (55%), Gaps = 4/134 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L +I + +F E +RF+ ++ + + H V +RDLKL+N LLD
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K +L+ +T GTP YIAPE+L EY + D W+ GV +Y M+
Sbjct: 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-DWWALGVLMYEMMA 191
Query: 120 GGYPFEDPDEPKDF 133
G PFE +E F
Sbjct: 192 GQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-24
Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLE 51
MEY GG+L + I E+ QL+ + CH V HRDLK
Sbjct: 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSC 110
N LD + +K+ DFG +K S T VGTP Y++PE L YD K +D+WS
Sbjct: 140 NIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSL 196
Query: 111 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI----SQECRDLISRIFV 166
G +Y + PF ++ + +I ++ I S E ++I +
Sbjct: 197 GCLIYELCALSPPF----TARNQLQLASKIKEGKFR-----RIPYRYSSELNEVIKSMLN 247
Query: 167 ADPAARITIPEIMKHQ 182
DP R + E+++
Sbjct: 248 VDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 71/233 (30%), Positives = 100/233 (42%), Gaps = 57/233 (24%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M+Y GG++ + G F ED ARF+ +L + H M HRD+K +N L+D
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG- 138
Query: 61 PRLKICDFG-------------YSK---------------SSVLHSQPK----------- 81
+K+ DFG Y K S + + K
Sbjct: 139 -HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQ 197
Query: 82 -----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 136
S VGTP YIAPEVLLR Y ++ D WS GV LY MLVG PF P + T
Sbjct: 198 RCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAD-TPAE---T 252
Query: 137 IQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 184
++++ + + +P +S+E DLI R+ R+ EI H +F
Sbjct: 253 QLKVINWETTLHIPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA GG + + AG +E ++++ + Y H + V HRD+K N L+ +
Sbjct: 81 MEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV--TNT 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVML 118
+K+CDFG + +S +ST VGTP ++APEV+ YD K AD+WS G+T+Y M
Sbjct: 138 GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK-ADIWSLGITIYEMA 196
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRDLISRIFVADPAA 171
G P+ D D +P + P S+ R+ ++ +P
Sbjct: 197 TGNPPYSDVDA-----------FRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKE 245
Query: 172 RITIPEIMKHQW 183
R++ E++K +W
Sbjct: 246 RLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY GG+L + +F ED A+F+ +L+ + H M HRD+K EN L+D +
Sbjct: 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT- 138
Query: 60 APRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA-----DVWSCGV 112
+K+ DFG + ++ K VGTP YIAPEVL DGK D WS GV
Sbjct: 139 -GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPA 170
Y M+ G PF + KT I++ Q + P+ +S + DLI + +
Sbjct: 198 IAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL-LCGQK 252
Query: 171 ARITIPEIMKHQWF-------LKNLPADLV-----DEKTMSSQYEEPDQ 207
R+ + H +F ++N V D+ T S ++EP++
Sbjct: 253 ERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDT--SNFDEPEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 73/213 (34%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
MEY SGG+L ++I + F E E F Q++ + H+ ++ HRDLK N L
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL- 202
Query: 57 GSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
P +K+ DFG+SK SV S GTP Y+APE+ R Y K AD+WS GV
Sbjct: 203 -MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVI 260
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY +L PF+ P + R+ +Q++L +Y P P+S + L+ + +PA R
Sbjct: 261 LYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRP 315
Query: 174 TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 206
T +++ H FLK + A+L + S+ P
Sbjct: 316 TTQQLL-HTEFLKYV-ANLFQDIVRHSETISPH 346
|
Length = 478 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-24
Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY GG + + N G F E R F +Q++ G++Y H + HRD+K N L+D
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG 144
Query: 61 PRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
+KI DFG SK S+ + S G+ ++APEV+ + Y K AD+WS G
Sbjct: 145 --IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCL 201
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPD-TNPISQECRDLISRIFVADPAA 171
+ ML G +PF D + +Q I + + + P+ + IS E D + + F D
Sbjct: 202 VVEMLTGKHPFPDCTQ-------LQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNK 254
Query: 172 RITIPEIMKH 181
R T E++KH
Sbjct: 255 RPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 4e-24
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 31/193 (16%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
E + + QL+ G+++CH+ + HRDLK EN L++ LK+ DFG ++S S
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARS--FGS 150
Query: 79 QPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------ 129
+ V T Y APE+LL + D+WS G +L F E
Sbjct: 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210
Query: 130 ---------PKDFRKTIQRILSVQYSVPDTNPI---------SQECRDLISRIFVADPAA 171
P+ + K + ++S P + S + DL+S++ DP
Sbjct: 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
Query: 172 RITIPEIMKHQWF 184
RIT + + H +F
Sbjct: 271 RITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-24
Identities = 62/189 (32%), Positives = 101/189 (53%), Gaps = 12/189 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
ME+ GG L + I R +E++ ++ +S+ HA V HRD+K ++ LL DG
Sbjct: 95 MEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG- 152
Query: 59 PAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y G D+WS G+ + M
Sbjct: 153 ---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEM 208
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
+ G P+ + + P K I+ L + + + + +S R + R+ V DPA R T E
Sbjct: 209 VDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265
Query: 178 IMKHQWFLK 186
++ H + K
Sbjct: 266 LLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-24
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + RF E E + + +++ + + H + + +RD+KLEN LLD +
Sbjct: 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-- 141
Query: 61 PRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYV 116
+ + DFG SK + S GT Y+AP+++ + +D K D WS GV +Y
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD-KAVDWWSMGVLMYE 200
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDLISRIFVADPAARI-- 173
+L G PF E + +RIL + P + + ++ +D+I R+ + DP R+
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA---KDIIQRLLMKDPKKRLGC 257
Query: 174 ---TIPEIMKHQWFLKNLPADLVDEK 196
EI KH +F K DL +K
Sbjct: 258 GPSDADEIKKHPFFQKINWDDLAAKK 283
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 6e-24
Identities = 65/195 (33%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 1 MEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-- 55
M Y SGG L + G E ++++ G+ Y H+ HRD+K N LL
Sbjct: 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137
Query: 56 DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVL-LRHEYDGKIADVWS 109
DGS +KI DFG S S K+ VGTP ++APEV+ H YD K AD+WS
Sbjct: 138 DGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWS 192
Query: 110 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 169
G+T + G P+ K T+Q + D S+ R +IS DP
Sbjct: 193 FGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDP 252
Query: 170 AARITIPEIMKHQWF 184
+ R T E++KH++F
Sbjct: 253 SKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 39/199 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+F+E + + + +QL+ G+ Y H+ + HRD+K N L++ LK+ DFG ++
Sbjct: 96 KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKR 153
Query: 78 SQPKST--VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 120
+ T V T Y PE+LL Y ++ D+WS G L + +G
Sbjct: 154 NSADYTNRVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLE 212
Query: 121 ------GYP----FEDPDEPKDF-----RKTIQRILSVQYSVPDTNPISQECRDLISRIF 165
G P + + F +K +R L + + I DL+ ++
Sbjct: 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK----HLIDPSALDLLDKLL 268
Query: 166 VADPAARITIPEIMKHQWF 184
DP RI+ + ++H++F
Sbjct: 269 TLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-23
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 17/192 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M+Y G+LF+ + G+ SE E + +QL+ ++ H + H D+KLEN L D +
Sbjct: 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-K 146
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
R+ +CD+G K P GT Y +PE + H YD D W+ GV Y +L G
Sbjct: 147 DRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTG 202
Query: 121 GYPFE-DPDE---PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR-ITI 175
+PF+ D DE + K Q+ +P +S+ D + + + R
Sbjct: 203 KHPFKEDEDEELDLESLLKRQQK------KLPFIKNVSKNANDFVQSMLKYNINYRLTNY 256
Query: 176 PEIMKHQWFLKN 187
EI+KH FLK
Sbjct: 257 NEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDLK EN LLD
Sbjct: 75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ + DFG K ++ H+ ST GTP Y+APEVL + YD + D W G LY ML
Sbjct: 133 GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----TI 175
G PF + + + + + L ++ P+ I+ R L+ + D R+
Sbjct: 192 GLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLLQKDRTKRLGAKDDF 245
Query: 176 PEIMKHQWFLKNLPADLVDEK 196
EI H +F DL+++K
Sbjct: 246 MEIKNHIFFSPINWDDLINKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 6e-23
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY +L E + + R E + + + + L+ GV+Y HA + HRDLK N L+ S
Sbjct: 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--SA 134
Query: 60 APRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYV 116
LKI DFG ++ S V T Y APE+L +YD + D+W+ G
Sbjct: 135 DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV-DLWAVGCIFAE 193
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDTNPI--------------- 153
+L G P + + + R L S+PD N I
Sbjct: 194 LL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP 252
Query: 154 --SQECRDLISRIFVADPAARITIPEIMKHQWF 184
S E DL+ + V DP+ R++ E ++H +F
Sbjct: 253 DASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 9e-23
Identities = 55/149 (36%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDLK EN LLD
Sbjct: 75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ + DFG K V + ST GTP Y+APEVL + YD + D W G LY ML
Sbjct: 133 GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLY 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148
G PF +D + IL +P
Sbjct: 192 GLPPFYS----RDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-22
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 22/193 (11%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY GG + + GRF E RFF +Q++ G++Y H+ + HRDLK +N L+D
Sbjct: 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI 146
Query: 61 PRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLY 115
KI DFG SK S + Q S G+ ++APEV Y K+ D+WS G +
Sbjct: 147 --CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV-DIWSLGCVVL 203
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRI--LSVQYSVP----DTNP-ISQECRDLISRIFVAD 168
M G P+ D + I + L + S P D + +S D ++ F +
Sbjct: 204 EMFAGRRPWSD-------EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTIN 256
Query: 169 PAARITIPEIMKH 181
P R T E+++H
Sbjct: 257 PDNRPTARELLQH 269
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-22
Identities = 57/188 (30%), Positives = 105/188 (55%), Gaps = 21/188 (11%)
Query: 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-- 55
M+Y GG+L+++I NA R F ED+ +F Q+ + + H ++ HRD+K +N L
Sbjct: 78 MDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112
DG+ +K+ DFG ++ VL+S ++ +GTP Y++PE+ Y+ K +D+W+ G
Sbjct: 137 DGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICENRPYNNK-SDIWALGC 189
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
LY M + F E + + + +I+ Y P ++ S + R+L+S++F +P R
Sbjct: 190 VLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDR 244
Query: 173 ITIPEIMK 180
++ I++
Sbjct: 245 PSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 5e-22
Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 15/193 (7%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDG 57
MEY GG L + GR E ++ G++Y H ++ HRD+K N L++
Sbjct: 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
++K+CDFG S V +S K+ VGT +Y+APE + ++Y K +D+WS G++L +
Sbjct: 137 RG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIEL 192
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILS--VQYSVP--DTNPISQECRDLISRIFVADPAARI 173
G +P+ ++P D I +L V P + S + +D ++ + DP R
Sbjct: 193 ATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
Query: 174 TIPEIMKHQWFLK 186
+ E+++H + K
Sbjct: 250 SYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-22
Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 15/177 (8%)
Query: 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEYA G+L + + ED+ FF Q++ G+++ H+ ++ HRD+K N LD
Sbjct: 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137
Query: 59 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+KI D G +K +L + VGTP Y++PE+ Y+ K +DVW+ GV LY
Sbjct: 138 --DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLY 192
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
G +PF+ ++ K I+ + P + SQ+ LI + D R
Sbjct: 193 ECCTGKHPFDANNQGALILKIIRGVFP-----PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-21
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 10/178 (5%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
M +GG+L I N F E A F+ Q+ISG+ + H ++ +RDLK EN LLD
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD 131
Query: 57 GSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
++I D G + + S+ K GTP ++APE+L EYD + D ++ GVTLY
Sbjct: 132 N--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLY 188
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
M+ PF E + ++ QRIL+ + PD S + + DP R+
Sbjct: 189 EMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-21
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 12/191 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+ +GG + + G F E + +QL+ G+SY H Q+ HRD+K N L+D S
Sbjct: 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID-STG 140
Query: 61 PRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
RL+I DFG ++ L ++ +GT A++APEV LR E G+ DVWS G
Sbjct: 141 QRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGEQYGRSCDVWSVGCV 197
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
+ M P+ + ++ + I +I S + +S RD+ R P R
Sbjct: 198 IIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
Query: 174 TIPEIMKHQWF 184
E++KH F
Sbjct: 257 PSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 59/189 (31%), Positives = 96/189 (50%), Gaps = 16/189 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+ GGE F + RF D F+ Q++ Y ++ + +RDLK EN LLD
Sbjct: 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+K+ DFG++K V+ ++ + GTP YIAPE+LL + GK AD W+ G+ +Y +LVG
Sbjct: 170 --IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVG 224
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TI 175
PF + ++K ++ I+ + D N C+ L+ ++ D R
Sbjct: 225 CPPFYANEPLLIYQKILEGIIYFPKFL-DNN-----CKHLMKKLLSHDLTKRYGNLKKGA 278
Query: 176 PEIMKHQWF 184
+ +H WF
Sbjct: 279 QNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-21
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+++ +GGELF + F E ARF+ ++ S + Y H++ + +RDLK EN LLD
Sbjct: 75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ + DFG K + S +T GTP Y+APEV+ + YD + D W G LY ML
Sbjct: 133 GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DWWCLGAVLYEMLY 191
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN-PISQECRDLISRIFVADPAARITIPEI 178
G PF D + + + + L ++ T I +E L+ + A+ EI
Sbjct: 192 GLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEE---LLEKDRQRRLGAKEDFLEI 248
Query: 179 MKHQWFLKNLPADLVDEK 196
+H +F DL +K
Sbjct: 249 QEHPFFESLSWTDLEQKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 25/197 (12%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
+E+ GG L + R +E + R+ +Q++ +++ H+ +V HRDLK N LL DG
Sbjct: 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG 140
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-----RHEYDGKIADVWSCG 111
+K+ DFG S + Q + T +GTP ++APEV+ + YD K AD+WS G
Sbjct: 141 D----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLG 195
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----NPISQECRDLISRIFVA 167
+TL + P + + ++ +L + S P T + S D + V
Sbjct: 196 ITLIELAQMEPPHHELN-------PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVK 248
Query: 168 DPAARITIPEIMKHQWF 184
DP R T E++KH +
Sbjct: 249 DPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-21
Identities = 60/188 (31%), Positives = 100/188 (53%), Gaps = 14/188 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG + +++ + G +E+ R + +Q++ GVSY H+ + HRD+K N L D
Sbjct: 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--V 142
Query: 61 PRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG SK + + KS GTP +++PEV+ Y G+ AD+WS G T+
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVE 201
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARITI 175
ML P+ + + K ++ Q + P P +S CRD + RIFV + R +
Sbjct: 202 MLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSA 255
Query: 176 PEIMKHQW 183
E+++H +
Sbjct: 256 DELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 7e-21
Identities = 56/180 (31%), Positives = 99/180 (55%), Gaps = 17/180 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
++YA+ G+L + I + + F E EA F Q++ V + H+ + HRD+K N LL
Sbjct: 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC 177
Query: 57 GSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
+ +K+ DFG+SK ++V ++ GTP Y+APE+ R Y K AD++S GV
Sbjct: 178 SNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVL 234
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVADPAAR 172
LY +L PF+ ++ + + + L+ +Y +P + IS E +++++ + +DP R
Sbjct: 235 LYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPPS--ISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-21
Identities = 59/187 (31%), Positives = 98/187 (52%), Gaps = 12/187 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + +++ G +E R + +Q++ G+SY H+ + HRD+K N L D A
Sbjct: 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--A 142
Query: 61 PRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG SK ++ S +S GTP +++PEV+ Y G+ ADVWS G T+
Sbjct: 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVE 201
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
ML P+ + + I +I + + + IS+ RD + IFV + R +
Sbjct: 202 MLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFLGCIFV-EARHRPSAE 256
Query: 177 EIMKHQW 183
E+++H +
Sbjct: 257 ELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+ SGG+L + + E+ ARF+ ++ +++ H + +RDLKL+N LLD
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L +Y + D W+ GV ++ M+
Sbjct: 133 GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DWWALGVLMFEMMA 191
Query: 120 GGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
G PF ++PD+ +D+ Q IL Q +P + +S + ++ DP R
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDY--LFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKER 247
Query: 173 I------TIPEIMKHQWFLKNLPADLVDEKTMSSQYE 203
+ +I H +F +N+ DL+++K + Y+
Sbjct: 248 LGCHPQTGFRDIKSHPFF-RNIDWDLLEQKQVLPPYK 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-20
Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 20/188 (10%)
Query: 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-- 55
MEY GG+L +RI N R FSED+ +F Q+ G+ + H ++ HRD+K +N L
Sbjct: 78 MEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK 136
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112
+G A K+ DFG ++ L+ + VGTP Y++PE+ Y+ K D+WS G
Sbjct: 137 NGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGC 190
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
LY + +PFE + + + +I ++ P + S++ R LIS++F P R
Sbjct: 191 VLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDR 245
Query: 173 ITIPEIMK 180
+I I+K
Sbjct: 246 PSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 70/194 (36%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + N E ARF+ +++ + H+M HRD+K +N LLD S
Sbjct: 122 MEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG- 179
Query: 61 PRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVT 113
LK+ DFG +K ++ + VGTP YI+PEVL Y G+ D WS GV
Sbjct: 180 -HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY MLVG PF + K + S+ + PD N IS+E ++LI F+ D R+
Sbjct: 237 LYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDISKEAKNLIC-AFLTDREVRL 293
Query: 174 ---TIPEIMKHQWF 184
+ EI +H +F
Sbjct: 294 GRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG++ + SE+ +F+ + + + H + HRD+K +N LLD
Sbjct: 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG- 138
Query: 61 PRLKICDFGYSKS-----------SVLHSQPK-------------------------STV 84
+K+ DFG ++ H+ P STV
Sbjct: 139 -HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144
GTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF + +RK + ++
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV 256
Query: 145 YSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 184
+ P PIS++ +DLI R F D RI + EI H +F
Sbjct: 257 F--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 5e-20
Identities = 57/203 (28%), Positives = 83/203 (40%), Gaps = 52/203 (25%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
FSE R Q++ G+++ H HRDLK EN L+ S +KI DFG ++ + S
Sbjct: 96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRS 151
Query: 79 QPKST--VGTPAYIAPEVLLRH-EYDGKIADVWSCG------VTLYVMLVGGYPFEDPDE 129
+P T V T Y APE+LLR Y + D+W+ G TL + G + D+
Sbjct: 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPV-DIWALGCIMAELYTLRPLFPGS---SEIDQ 207
Query: 130 PKDFRKTIQRILSV-------------------QYSVPDTNPI---------SQECRDLI 161
+ +I SV + P P S E DLI
Sbjct: 208 -------LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLI 260
Query: 162 SRIFVADPAARITIPEIMKHQWF 184
+ DP R T + ++H +F
Sbjct: 261 KDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 6e-20
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 24/195 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + + AG F E + ++++ G+ Y H+ + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQ 137
Query: 61 PRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS G+T + L
Sbjct: 138 GDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITA-IEL 194
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAAR 172
G P P + V + +P NP S+ ++ I DP+ R
Sbjct: 195 AKGEPPNSDMHP----------MRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244
Query: 173 ITIPEIMKHQWFLKN 187
T E++KH++ +KN
Sbjct: 245 PTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+ GG L +F D AR Q++SG++Y H + HRD+K N L++ A
Sbjct: 151 LEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINS--A 204
Query: 61 PRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL---LRH-EYDGKIADVWSCGVTLY 115
+KI DFG S+ P S+VGT AY++PE + L H YDG D+WS GV++
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARI 173
+G +PF + D+ + I S P P S+E R IS +PA R
Sbjct: 265 EFYLGRFPFGVGRQ-GDWASLMCAIC---MSQPPEAPATASREFRHFISCCLQREPAKRW 320
Query: 174 TIPEIMKHQWFLKNLPA 190
+ ++++H + L+ P
Sbjct: 321 SAMQLLQHPFILRAQPG 337
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 9e-20
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 36/207 (17%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67
EL E + G D R + QL+ ++YCH+ + HRD+K EN L+ S + LK+CD
Sbjct: 88 ELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV--SESGVLKLCD 143
Query: 68 FGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-- 121
FG++++ L ++P S V T Y APE+L+ GK DVW+ G + +L G
Sbjct: 144 FGFARA--LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201
Query: 122 YPFE-DPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRDLISRIFVA------ 167
+P + D D+ +K + + + +NP + + R +
Sbjct: 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA 261
Query: 168 ----------DPAARITIPEIMKHQWF 184
DP R+T E+++H +F
Sbjct: 262 LDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 44/234 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG++ + +E+E +F+ + + + H + HRD+K +N LLD
Sbjct: 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG- 138
Query: 61 PRLKICDFGYSKS-----------SVLHSQPK-------------------------STV 84
+K+ DFG ++ HS P STV
Sbjct: 139 -HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144
GTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF + ++K + ++
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI 256
Query: 145 YSVPDTNPISQECRDLISRIFVADPAARITIP--EIMKHQWFLKNLPADLVDEK 196
+ P PIS++ +DLI R F + RI P E +K F + + + + E+
Sbjct: 257 F--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRER 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 55/198 (27%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79
++D ++F Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDED 158
Query: 80 PKST----VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG-------------- 120
K V T Y APE+LL Y I D+WS G +L
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 121 ------GYPFEDPDEPKDFRKTIQRILSVQYS--------VPDTNPISQECRDLISRIFV 166
G P E+ + K + S+ P +P E DL+ ++ V
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP---EAIDLLEKMLV 274
Query: 167 ADPAARITIPEIMKHQWF 184
DP RIT E + H +
Sbjct: 275 FDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY +GG+L + + E+ ARF+ ++ ++Y H + +RDLKL+N LLD
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L +Y G D W+ GV ++ M+
Sbjct: 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMA 191
Query: 120 GGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
G PF ++PD+ +D+ Q IL Q +P + +S + ++ DP R
Sbjct: 192 GRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKER 247
Query: 173 I-TIPE-----IMKHQWFLKNLPADLVDEKTM 198
+ P+ I H +F +N+ DL+++K +
Sbjct: 248 LGCHPQTGFADIQGHPFF-RNVDWDLMEQKQV 278
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 18/188 (9%)
Query: 1 MEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEY G + + +I N +E+E Q + G+ Y H+ + HRD+K N LL+
Sbjct: 77 MEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE 135
Query: 59 PAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
K+ DFG S + + ++ + +GTP ++APEV+ Y+ K AD+WS G+T M
Sbjct: 136 GQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEM 192
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NP--ISQECRDLISRIFVADPAARI 173
G P+ D ++ I + P T +P S E D + + V DP R
Sbjct: 193 AEGKPPYSD-------IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
Query: 174 TIPEIMKH 181
+ ++++H
Sbjct: 246 SAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 57/235 (24%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG+L + FSED RF+ + + + H + HRD+K +N L+D
Sbjct: 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG- 138
Query: 61 PRLKICDFG-------------YSK----------------------SSVLHSQPK---- 81
+K+ DFG Y K + + S+ +
Sbjct: 139 -HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATW 197
Query: 82 ---------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 132
STVGTP YIAPE+ L+ Y G+ D WS G ++ L+G PF + +
Sbjct: 198 KKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHET 256
Query: 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF 184
+RK I ++ + PD +S E DLI R+ + + R+ EI H +F
Sbjct: 257 YRKIINWRETLYF--PDDIHLSVEAEDLIRRL-ITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 23/202 (11%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGS 58
ME+ GG L + I + R +E++ + ++ + Y H+ V HRD+K ++ L LDG
Sbjct: 97 MEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG- 154
Query: 59 PAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y ++ D+WS G+ + M
Sbjct: 155 ---RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWSLGIMVIEM 210
Query: 118 LVGGYPFEDPDEPKDFRKT-IQRILSVQYSVP----DTNPISQECRDLISRIFVADPAAR 172
+ G EP F + +Q + ++ S P + + IS RD + R+ +P R
Sbjct: 211 VDG--------EPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262
Query: 173 ITIPEIMKHQWFLK-NLPADLV 193
T E++ H + L+ LP LV
Sbjct: 263 ATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-19
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
R+ + + ++F Q++ G+ Y H+ V HRDLK N L++ + LKICDFG +
Sbjct: 98 RLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN--CDLKICDFGLA 155
Query: 72 KSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFEDP- 127
+ + Q V T Y APE++L +YD ++ D+WS G ML G +P +D
Sbjct: 156 R--IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHV 212
Query: 128 -----------DEPKDFRKTI--QRILSVQYSVPDTN--PISQ-------ECRDLISRIF 165
P D TI + L S+P P S+ DL+ ++
Sbjct: 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 166 VADPAARITIPEIMKHQWF-LKNLPADL-VDEKTMSSQYEEPDQPMQSVDVIM 216
V DP RI+ E + H + + P D V E+ + + D P+ + V+M
Sbjct: 273 VFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMM 325
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 43/202 (21%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 74
F + E + QL+SGV++ H + HRDLK N LL + LKICDFG ++ S
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGS 158
Query: 75 VLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCG------VTLYVMLVG------- 120
L + V T Y APE+LL EY I D+WS G +T + G
Sbjct: 159 PLKPYTQLVV-TLWYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQL 216
Query: 121 -------GYPFED--PDEPKDFRKTIQRILSVQYSVPDTNPISQECR---------DLIS 162
G P E P F + + ++ N + ++ DL++
Sbjct: 217 NKIFKLLGTPTEKIWP----GFSE-LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLN 271
Query: 163 RIFVADPAARITIPEIMKHQWF 184
R+ DPA RI+ + +KH +F
Sbjct: 272 RLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-19
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ +GG+L + G FSE E RF+ ++I G+ + H V +RDLK N LLD
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH 135
Query: 61 PRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
R+ CDF K P ++VGT Y+APEVL + AD +S G L+
Sbjct: 136 VRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI- 175
+L G PF + KD + + L+V +PD+ S E + L+ + D + R+
Sbjct: 189 LLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPDS--FSPELKSLLEGLLQRDVSKRLGCL 245
Query: 176 ----PEIMKHQWF 184
E+ +H +F
Sbjct: 246 GRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-18
Identities = 60/185 (32%), Positives = 96/185 (51%), Gaps = 12/185 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY GG + +++ G +E+ R + +Q++ GVSY H+ + HRD+K N L D A
Sbjct: 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--A 142
Query: 61 PRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG SK ++ S KS GTP +++PEV+ Y G+ ADVWS T+
Sbjct: 143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVE 201
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
ML P+ + + K + +PD +S CRD + +IFV + R T
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTKPM--LPDG--VSDACRDFLKQIFVEE-KRRPTAE 256
Query: 177 EIMKH 181
+++H
Sbjct: 257 FLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
ME+ GG L + I R +E++ ++ +S HA V HRD+K ++ LL DG
Sbjct: 96 MEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG- 153
Query: 59 PAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
R+K+ DFG+ ++ S + KS VGTP ++APE++ R Y G D+WS G+ + M
Sbjct: 154 ---RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEM 209
Query: 118 LVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
+ G P F +P P K I+ L + + + + +S + + R+ V DPA R T
Sbjct: 210 VDGEPPYFNEP--PLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
Query: 177 EIMKHQWFLKNLP 189
E++KH + K P
Sbjct: 266 ELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 16/178 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ +GG+L + G FSE E RF+ ++I G+ + H V +RDLK N LLD
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 135
Query: 61 PRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLY 115
R+ CDF K P ++VGT Y+APEVL + YD AD +S G L+
Sbjct: 136 VRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLF 187
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
+L G PF + KD + + L++ +PD+ S E R L+ + D R+
Sbjct: 188 KLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 24/195 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + + G E + ++++ G+ Y H+ + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL--SEH 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS G+T + L
Sbjct: 138 GEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITA-IEL 194
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAAR 172
G P P + V + +P NP S+ ++ + +P+ R
Sbjct: 195 AKGEPPHSELHP----------MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 244
Query: 173 ITIPEIMKHQWFLKN 187
T E++KH++ ++
Sbjct: 245 PTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-18
Identities = 59/185 (31%), Positives = 95/185 (51%), Gaps = 17/185 (9%)
Query: 1 MEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEY GG+L ++I G+ F ED +F Q+ GV + H +V HRD+K +N L +
Sbjct: 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL--T 134
Query: 59 PAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
++K+ DFG S+ L + P + VGTP Y+ PE+ Y+ K +D+WS G L
Sbjct: 135 QNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCIL 190
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
Y + +PF + ++ I ++ Y P + S E R LI ++F +P +R +
Sbjct: 191 YELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPS 245
Query: 175 IPEIM 179
I+
Sbjct: 246 ATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 46/215 (21%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSS 74
+E+ R+F QL+ G+ Y H+ V HRDLK N L++ L+I DFG S S
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSP 161
Query: 75 VLHSQ-PKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-K 131
H V T Y APE+LL EY I D+WS G ML F P K
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGK 215
Query: 132 DFRKTIQRILSV------------------QY--SVPDTNPI---------SQECRDLIS 162
++ ++ ILSV +Y ++P P+ S E DL+S
Sbjct: 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLS 275
Query: 163 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 197
++ DP RIT+ + ++H FL D DE T
Sbjct: 276 QMLQFDPEERITVEQALQHP-FLAQYH-DPDDEPT 308
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N LLD +
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG 139
Query: 60 APRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVLLRHEYDGK-----IADVW 108
RL DFG S L T VGTP YI+PE+L E DGK D W
Sbjct: 140 HIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISPEILQAME-DGKGRYGPECDWW 192
Query: 109 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 168
S GV +Y ML G PF + + K + Q+ PD +S+E +DLI R+ +
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP-PDVTDVSEEAKDLIRRL-ICS 250
Query: 169 PAARI---TIPEIMKHQWF-------LKNLPADLVDE 195
P R+ + + H +F ++N A V E
Sbjct: 251 PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPE 287
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY +GG+L + + E+ ARF+ ++ +++ H + +RDLKL+N LLD
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-- 132
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ D+G K + ST GTP YIAPE+L EY G D W+ GV ++ M+
Sbjct: 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMA 191
Query: 120 GGYPF----EDPD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI- 173
G PF ++PD +D+ Q IL +P +S + ++ DP R+
Sbjct: 192 GRSPFDIITDNPDMNTEDY--LFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLG 247
Query: 174 ----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 213
T +K F +++ DL+++K Q P +P + D
Sbjct: 248 CQPQTGFSDIKSHTFFRSIDWDLLEKK----QVTPPFKPQITDD 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-18
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 59
ME+ G L G + ++ G++Y + ++ HRD+K N L++
Sbjct: 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-- 139
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
++K+CDFG S +++S + VGT Y++PE + +Y K +DVWS G+++ + +
Sbjct: 140 RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELAL 197
Query: 120 GGYPFEDPDEPKDFRKTIQRILS-VQYSVPDTNP------ISQECRDLISRIFVADPAAR 172
G +PF + D + IL +Q V + P ++ RD + + DP R
Sbjct: 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
Query: 173 ITIPEIMKHQWFLKNLPADLVD 194
T ++ F++ L A VD
Sbjct: 258 PTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + N E A+F+ +++ + H+M + HRD+K +N LLD
Sbjct: 122 MEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD--KH 178
Query: 61 PRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVT 113
LK+ DFG ++ ++ + VGTP YI+PEVL Y G+ D WS GV
Sbjct: 179 GHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
L+ MLVG PF + K + S+ + P+ IS+ ++LI F+ D R+
Sbjct: 237 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEISKHAKNLIC-AFLTDREVRL 293
Query: 174 ---TIPEIMKHQWF 184
+ EI +H +F
Sbjct: 294 GRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-18
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 24 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 82
+ F QL+ G+++CH +V HRDLK +N L++ LK+ DFG +++ + + +
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSN 159
Query: 83 TVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-----GYPFED---------- 126
V T Y AP+VLL Y I D+WS G + M+ G G ED
Sbjct: 160 EVVTLWYRAPDVLLGSRTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
Query: 127 -PDE---------PKDFRKTIQRI--LSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
P E P+ ++ T R +Q P +P+ DL+ R+ +P RI+
Sbjct: 219 TPTESTWPGISQLPE-YKPTFPRYPPQDLQQLFPHADPLGI---DLLHRLLQLNPELRIS 274
Query: 175 IPEIMKHQWF 184
+ ++H WF
Sbjct: 275 AHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 69/236 (29%), Positives = 97/236 (41%), Gaps = 59/236 (25%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGS 58
M+Y GG++ + F E ARF+ +L + H M HRD+K +N L LDG
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG- 138
Query: 59 PAPRLKICDFG-------------YSKSSVLHS---QPK--------------------- 81
+K+ DFG Y K S + +P
Sbjct: 139 ---HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQR 195
Query: 82 -----------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130
S VGTP YIAPEVLLR Y ++ D WS GV L+ MLVG PF P
Sbjct: 196 ATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPT 254
Query: 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA--DPAARITIPEIMKHQWF 184
+ K I ++ +P +S E DLI+++ + + R +I H +F
Sbjct: 255 ETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 61/201 (30%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 1 MEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 55
MEY GG L + I GR E + ++ G+SY H+ ++ HRD+K N LL
Sbjct: 80 MEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL 138
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+K+CDFG S V S + GT Y+APE + Y +DVWS G+TL
Sbjct: 139 TRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLL 194
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI-----------SQECRDLISRI 164
+ +PF P + + I + Y V NP S+E +D I +
Sbjct: 195 EVAQNRFPF-----PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQC 249
Query: 165 FVADPAARITIPEIMKHQWFL 185
DP R T ++++H W
Sbjct: 250 LEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 16/185 (8%)
Query: 2 EYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
EY G +L ++ SE++ +F QL+ GV Y H ++ HRDLK +N L
Sbjct: 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+ LKI DFG S+ + +T GTP Y++PE L YD K +D+WS G LY
Sbjct: 142 N---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYE 197
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISRIFVADPAARITI 175
M + FE ++F + RI+ S+P+T ++ ++ + DP+ R +
Sbjct: 198 MCCLAHAFEG----QNFLSVVLRIVEGPTPSLPETYS--RQLNSIMQSMLNKDPSLRPSA 251
Query: 176 PEIMK 180
EI++
Sbjct: 252 AEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 40/195 (20%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL 76
+ + +QL+ GV + H+ ++ HRDLK +N L+ DG ++KI DFG ++
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSF 159
Query: 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML------------------ 118
S V T Y APEVLL+ Y + D+WS G +
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218
Query: 119 --VGGYPFEDPDEPKD-------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 169
V G P E+ + P++ F R S + VP+ I +E DL+ ++ +P
Sbjct: 219 FDVIGLPSEE-EWPRNVSLPRSSFPSYTPR--SFKSFVPE---ICEEGLDLLKKMLTFNP 272
Query: 170 AARITIPEIMKHQWF 184
RI+ E ++H +F
Sbjct: 273 HKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 36/195 (18%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHS 78
S+D ++F QL+ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ +S
Sbjct: 106 SDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGD 163
Query: 79 QPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCG---------------------VTLYV 116
V T Y APE+LL EY I DVWS G + L
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222
Query: 117 MLVGG-----YPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADP 169
L+G F ++ + + +++ ++ P NP++ DL+ ++ V DP
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAI---DLLEKMLVFDP 279
Query: 170 AARITIPEIMKHQWF 184
+ RIT+ E + H +
Sbjct: 280 SKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 21/193 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
ME+ GG L + I R +E++ ++ +SY H V HRD+K ++ LL DG
Sbjct: 98 MEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG- 155
Query: 59 PAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y G D+WS G+ + M
Sbjct: 156 ---RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEM 211
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVP----DTNPISQECRDLISRIFVADPAARI 173
+ G P+ +EP +Q + ++ ++P D++ +S R + + V +P+ R
Sbjct: 212 IDGEPPYF--NEPP-----LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA 264
Query: 174 TIPEIMKHQWFLK 186
T E+++H FLK
Sbjct: 265 TAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-17
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 18/187 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
+E A G+L I + + E +F QL S + + H+ ++ HRD+K N +
Sbjct: 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140
Query: 57 GSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 111
+ +K+ D G SK++ HS VGTP Y++PE + + Y+ K +D+WS G
Sbjct: 141 ATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPERIHENGYNFK-SDIWSLG 193
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171
LY M PF + + ++I Y + S+E RDL+SR DP
Sbjct: 194 CLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEK 251
Query: 172 RITIPEI 178
R I +
Sbjct: 252 RPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 34/189 (17%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STV 84
+ G+ Y H+ + HRDLK N L+ LK+ DFG ++S P V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQV 163
Query: 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-- 142
T Y APE+L + G D+WS G ++ L+ PF D D I L
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGC-IFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 143 ------VQYSVPDTNPI---------------SQECRDLISRIFVADPAARITIPEIMKH 181
S+PD S + DL+ R+ +P RIT + ++H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 182 QWFLKNLPA 190
+F N PA
Sbjct: 283 PYF-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-17
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 42/207 (20%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 69
F + + QL+ G+++CH+ +V HRDLK +N L++ A +K+ DFG
Sbjct: 88 FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFG 145
Query: 70 YSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML------- 118
+++ + P T V T Y APE+LL +Y D+WS G M+
Sbjct: 146 LARAFGV---PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202
Query: 119 -------------VGGYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157
G P E PD F K ++ VP P+ ++
Sbjct: 203 GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQ--DFSKVVP---PLDEDG 257
Query: 158 RDLISRIFVADPAARITIPEIMKHQWF 184
RDL+S++ DP RI+ + H +F
Sbjct: 258 RDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-17
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N L+D +
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139
Query: 60 APRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGK-----IADVWSCGV 112
RL DFG + +S+ VGTP YI+PE+L E DGK D WS GV
Sbjct: 140 HIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DGKGKYGPECDWWSLGV 196
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP--A 170
+Y ML G PF + + K + Q+ T+ +S++ +DLI R+ +
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-VSEDAKDLIRRLICSREHRL 255
Query: 171 ARITIPEIMKHQWF 184
+ I + +H +F
Sbjct: 256 GQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-16
Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 17/187 (9%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEY GG+L + R S + F Q+ G+ Y + HRDL N L+ +
Sbjct: 80 MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN 139
Query: 59 PAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
+KI DFG Y K + ++APE L ++ K +DVWS GV
Sbjct: 140 --LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESLKEGKFTSK-SDVWSFGVL 193
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
L+ + G + + +++ Y +P E L+ + + DP R
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKG----YRLPKPPNCPPELYKLMLQCWAEDPEDRP 249
Query: 174 TIPEIMK 180
T E+++
Sbjct: 250 TFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 70/236 (29%), Positives = 96/236 (40%), Gaps = 59/236 (25%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---- 56
M+Y GG++ + G F ED ARF+ +L V H M HRD+K +N L+D
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH 139
Query: 57 ----------------------GSPAPRLKICDFGYS------------------KSSVL 76
R DF +++
Sbjct: 140 IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199
Query: 77 HSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKD 132
H + S VGTP YIAPEVLLR Y ++ D WS GV LY MLVG PF + P E
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLE--- 255
Query: 133 FRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVA--DPAARITIPEIMKHQWF 184
T ++++ Q S +P +S E DLI ++ D + EI H +F
Sbjct: 256 ---TQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
M+Y GG+L + R ED ARF+ +++ + H + HRD+K +N LLD +
Sbjct: 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139
Query: 60 APR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD----GKIADVW 108
R LK+ G +SSV VGTP YI+PE+L E G D W
Sbjct: 140 HIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYISPEILQAMEDGMGKYGPECDWW 192
Query: 109 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 168
S GV +Y ML G PF + + K + Q+ T+ +S+E +DLI R+ +
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD-VSEEAKDLIQRLICSR 251
Query: 169 PA--ARITIPEIMKHQWF-------LKNLPADL---VDEKTMSSQYEEPDQPMQSVDVI 215
+ I + KH +F ++NL A V + +S ++ D +++ ++
Sbjct: 252 ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIA 310
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 59/196 (30%), Positives = 81/196 (41%), Gaps = 41/196 (20%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79
S D ++F Q++ G+ Y H+ V HRDLK N LL+ LKICDFG ++ +
Sbjct: 104 SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHD 161
Query: 80 PKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFR 134
V T Y APE++L + K D+WS G L ML F P KD+
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-----PGKDYL 216
Query: 135 KTIQRILSV--QYSVPDTNPI-SQECR--------------------------DLISRIF 165
+ IL V S D N I S R DL+ ++
Sbjct: 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKML 276
Query: 166 VADPAARITIPEIMKH 181
+P RIT+ E + H
Sbjct: 277 TFNPHKRITVEEALAH 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-16
Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 13/187 (6%)
Query: 1 MEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K +N L++
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN- 142
Query: 58 SPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLY 115
+ + +KI DFG SK + ++ ++ GT Y+APEV+ + G AD+WS G T+
Sbjct: 143 TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202
Query: 116 VMLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
M G PF + EP+ F+ + +I +P++ +S E ++ I R F DP R
Sbjct: 203 EMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPES--LSAEAKNFILRCFEPDPDKRA 257
Query: 174 TIPEIMK 180
+ ++++
Sbjct: 258 SAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 43/208 (20%)
Query: 9 LFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67
L+E I R E + + QL+ + + H + HRD+K EN L+ LK+ D
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD---ILKLAD 142
Query: 68 FGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML------- 118
FG + ++S+P T + T Y APE LL Y G D+W+ G + +L
Sbjct: 143 FGSCRG--IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 119 -------------VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI---------SQE 156
V G P D + K FRK+ Y+ P S E
Sbjct: 201 GTNELDQIAKIHDVLGTP--DAEVLKKFRKSRHM----NYNFPSKKGTGLRKLLPNASAE 254
Query: 157 CRDLISRIFVADPAARITIPEIMKHQWF 184
DL+ ++ DP RIT + ++H +F
Sbjct: 255 GLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-16
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG + + G E + +Q++ GV+Y H V HRD+K N +L P
Sbjct: 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML--MPN 138
Query: 61 PRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
+K+ DFG ++ HS KS GTP ++APEV+ Y G+ +D+WS G T
Sbjct: 139 GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCT 197
Query: 114 LYVMLVGGYPFEDPD 128
++ M G P D
Sbjct: 198 VFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 58/199 (29%), Positives = 81/199 (40%), Gaps = 44/199 (22%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
FSED + F +QL+ G++YCH HRD+K N LL+ ++K+ DFG ++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEE 170
Query: 79 QPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML------------------ 118
T V T Y PE+LL E G DVWSCG L +
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 119 --VGGYPFED--PD----------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164
+ G P PD +PK K +R L ++S I DL+ +
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPK---KQYRRRLREEFSF-----IPTPALDLLDHM 282
Query: 165 FVADPAARITIPEIMKHQW 183
DP+ R T E + W
Sbjct: 283 LTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 44/207 (21%)
Query: 1 MEYASGG---ELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL- 55
ME GG +L + + G R E+ + ++ + G++Y H +V HRD+K +N LL
Sbjct: 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT 147
Query: 56 -DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVL-----LRHEYDG 102
+ +K+ DFG S +Q ST +GTP ++APEV+ YD
Sbjct: 148 KNA----EVKLVDFGVS------AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDA 197
Query: 103 KIADVWSCGVTLYVMLVGGYPFED--PDEPKDFRKTIQRILSVQYSVPDT----NPISQE 156
+ +DVWS G+T + G P D P + + +I + P T S++
Sbjct: 198 R-SDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR---NPPPTLKSPENWSKK 247
Query: 157 CRDLISRIFVADPAARITIPEIMKHQW 183
D IS + + R + E+++H +
Sbjct: 248 FNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 1 MEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLD 56
MEY G +L+ ED R ++ G+ + + HRD+K N L++
Sbjct: 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI-----ADVWSCG 111
G+ ++K+CDFG S +++ S K+ +G +Y+APE + + +DVWS G
Sbjct: 138 GNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADP 169
+++ M +G YP+ P+ + ++ ++ P T P S + +D +++ P
Sbjct: 195 LSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP 250
Query: 170 AARITIPEIMKHQWFLKNLPAD 191
R T ++++H W +K AD
Sbjct: 251 NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-16
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
M +GG+L I N G + R + Q+ G+ + H+M + +RD+K EN LLD
Sbjct: 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ 131
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
RL D G + GT Y+APE+L Y + D ++ G ++Y M+
Sbjct: 132 GNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-DWFAMGCSIYEMV 188
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
G PF+D E + +R L + N ++E +D+ P R+ E
Sbjct: 189 AGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN-FTEESKDICRLFLAKKPEDRLGSREK 247
Query: 179 ----MKHQWF----LKNLPADLVD 194
KH++F L A L+
Sbjct: 248 NDDPRKHEFFKTINFPRLEAGLIP 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-16
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + + G E ++++ G+ Y H+ + HRD+K N LL S
Sbjct: 81 MEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL--SEQ 137
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 138 GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAK 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARI 173
G P D + V + +P +P S+ ++ + DP R
Sbjct: 197 GEPPNSDLHP-----------MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 174 TIPEIMKHQWFLK 186
T E++KH++ +
Sbjct: 246 TAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-16
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 17/191 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY +GG L + + E + ++ + + + H+ QV HRD+K +N LL DGS
Sbjct: 95 MEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 153
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG+ +ST VGTP ++APEV+ R Y K+ D+WS G+ M
Sbjct: 154 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 208
Query: 118 LVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
+ G P+ E+P R + + + +S RD ++R D R +
Sbjct: 209 VEGEPPYLNENP-----LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 263
Query: 176 PEIMKHQWFLK 186
E+++H FLK
Sbjct: 264 KELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 6e-16
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 16/186 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY GG+L + N + S + F Q+ G+ Y + HRDL N L+ +
Sbjct: 80 MEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN- 138
Query: 60 APRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
+KI DFG Y K + ++APE L ++ K +DVWS GV L
Sbjct: 139 -LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLKEGKFTSK-SDVWSFGVLL 193
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
+ + G ++ + ++ Y +P E DL+ + + DP R T
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEYLKNG----YRLPQPPNCPPELYDLMLQCWAEDPEDRPT 249
Query: 175 IPEIMK 180
E+++
Sbjct: 250 FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-16
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
MEY GG L + G SE + + ++ + G++Y H HRD+K N LL DG
Sbjct: 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG 138
Query: 58 SPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL---LRHEYDGKIADVWSCG 111
+K+ DFG S +++ ++ KS +GTP ++APEV + YDGK D+W+ G
Sbjct: 139 D----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALG 191
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---DTNPISQECRDLISRIFVAD 168
+T + P D P + + I + P D S D I + D
Sbjct: 192 ITAIELAELQPPMFDLH-P---MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247
Query: 169 PAARITIPEIMKHQ 182
P R T ++++H
Sbjct: 248 PKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 34/186 (18%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 83
+ QL+ G++YCH+ +V HRDLK +N L+D A LK+ DFG +++ P T
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTH 158
Query: 84 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGY 122
V T Y APE+LL D+WS G M+ G
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT 218
Query: 123 PFED--PD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
P ED P D++ T + S N + ++ DL+S++ V DPA RI+
Sbjct: 219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAA 277
Query: 179 MKHQWF 184
++H +F
Sbjct: 278 LQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-16
Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 56/245 (22%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-S 74
++ + F Q++ G+ Y H+ V HRDLK N L D LKICDFG ++ S
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFS 156
Query: 75 VLH--SQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---ED- 126
+ T V T Y APE++L + K DVWS G L L+G P +D
Sbjct: 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVFKGKDY 215
Query: 127 -------------PDEPKDFRKTIQRILS-----------------VQYSVPDTNPISQE 156
PDE +T+ RI S + P+ NP
Sbjct: 216 VDQLNQILQVLGTPDE-----ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP---L 267
Query: 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIM 216
DL+ ++ DP RI++ E ++H + + D DE ++ + S++ +
Sbjct: 268 ALDLLEKLLAFDPTKRISVEEALEHPYL--AIWHDPDDEPVCQKPFDFSFESEDSMEELR 325
Query: 217 QIIAE 221
+I E
Sbjct: 326 DMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-15
Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 17/191 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY +GG L + + E + ++ + + + H+ QV HRD+K +N LL DGS
Sbjct: 96 MEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154
Query: 59 PAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG+ ++ + S+ + VGTP ++APEV+ R Y K+ D+WS G+ M
Sbjct: 155 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 209
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITI 175
+ G P+ + + + +++ + NP +S RD ++R D R +
Sbjct: 210 IEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSA 264
Query: 176 PEIMKHQWFLK 186
E+++HQ FLK
Sbjct: 265 KELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 5 SGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62
+GG+L I N G F E+ A F+ ++ G+ H ++ +RDLK EN LLD
Sbjct: 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY--GH 140
Query: 63 LKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 121
++I D G + + + + VGT Y+APEV+ Y D W G +Y M+ G
Sbjct: 141 IRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGK 198
Query: 122 YPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQECRDLISRIFVADPAARI-----T 174
PF E + +R+ Q YS S+ R + ++ DP R+
Sbjct: 199 SPFRQRKEKVKREEVERRVKEDQEEYS----EKFSEAARSICRQLLTKDPGFRLGCRGEG 254
Query: 175 IPEIMKHQWF----LKNLPADLVD 194
E+ H +F K L A +++
Sbjct: 255 AEEVKAHPFFRTANFKRLEAGMLE 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-15
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 21/193 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDLKLENTLL--D 56
MEY +GG L + + DEA+ ++ + + + HA QV HRD+K +N LL D
Sbjct: 95 MEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
GS +K+ DFG+ +ST VGTP ++APEV+ R Y K+ D+WS G+
Sbjct: 152 GS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAI 206
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARI 173
M+ G P+ + + + +++ + NP +S RD ++R D R
Sbjct: 207 EMVEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRG 261
Query: 174 TIPEIMKHQWFLK 186
+ E+++H FLK
Sbjct: 262 SAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-15
Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 17/191 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY +GG L + + E + ++ + + + H+ QV HRD+K +N LL DGS
Sbjct: 95 MEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS 153
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG+ +ST VGTP ++APEV+ R Y K+ D+WS G+ M
Sbjct: 154 ----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEM 208
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITI 175
+ G P+ + + + +++ + NP +S RD ++R D R +
Sbjct: 209 VEGEPPYLNENPLRAL-----YLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSA 263
Query: 176 PEIMKHQWFLK 186
E+++H FLK
Sbjct: 264 KELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73
CN G + + F QL+ G+++CH+ V HRDLK +N L++ + LK+ DFG +++
Sbjct: 92 CN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARA 148
Query: 74 -SVLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 131
+ + V T Y P+VL + Y I D+WS G + G P ++
Sbjct: 149 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 132 DFRKTIQRILSVQ--------YSVPDTNP----------------ISQECRDLISRIFVA 167
D K I R+L +PD P ++ RDL+ + V
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267
Query: 168 DPAARITIPEIMKHQWF 184
+P RI+ E ++H +F
Sbjct: 268 NPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
FSE + + QL+ G+ Y H + HRDLK+ N LL LKI DFG +++ L +
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPA 162
Query: 79 QPKS-TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 137
+P + V T Y APE+LL D+W+ G L +L E + I
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
Query: 138 Q-------RI--------LSVQYSVPDTNP----------ISQECRDLISRIFVADPAAR 172
Q I L ++++P P +S+ L++ + + DP R
Sbjct: 223 QLLGTPNESIWPGFSDLPLVGKFTLPK-QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281
Query: 173 ITIPEIMKHQWFLKN-LPAD 191
T E ++ +F + LP +
Sbjct: 282 ATAEEALESSYFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-15
Identities = 41/117 (35%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74
+ D+A +Q++ G+ Y HA ++ HRD+K EN ++ ++ I D G ++
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207
Query: 75 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPD 128
V+ GT APEVL R +Y+ K AD+WS G+ L+ ML YP FEDP
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-15
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL----L 96
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 135 GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 97 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN-PISQ 155
+YD + ADVWS G++L + G +P+++ +F + + +IL + N S
Sbjct: 192 NPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGFSP 247
Query: 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 191
+ + D R E+++H + + A+
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 53/191 (27%), Positives = 76/191 (39%), Gaps = 44/191 (23%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 85
F QL+ GV++CH V HRDLK +N L+D LKI D G ++ S+ +
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-- 143
T Y APEVLL + D+WS G M F E +Q++L +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFK 226
Query: 144 ------------------------------QYSVPDTNPISQECRDLISRIFVADPAARI 173
+VPD +S E DL+ ++ DPA RI
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRI 283
Query: 174 TIPEIMKHQWF 184
+ + H +F
Sbjct: 284 SAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 11/190 (5%)
Query: 5 SGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62
+GG+L I N G F E+ A F+ +++ G+ H +RDLK EN LLD
Sbjct: 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY--GH 140
Query: 63 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 122
++I D G + + VGT Y+APEVL Y D W G +Y M+ G
Sbjct: 141 IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQS 199
Query: 123 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE----I 178
PF E + +R+L + + S+E + + + DP R+ E
Sbjct: 200 PFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257
Query: 179 MKHQWFLKNL 188
+K F +N+
Sbjct: 258 VKRHPFFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 12/182 (6%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGS 58
+E A GE F + RF+E+ F Q++ + Y H ++ HRDL N +L
Sbjct: 91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--G 148
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++ I DFG +K S+ S VGT Y PE++ Y G+ ADVW+ G LY M
Sbjct: 149 EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMC 207
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
PF + +I+ Y S++ D+I+ D AR P+I
Sbjct: 208 TLQPPFYS----TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR---PDI 260
Query: 179 MK 180
++
Sbjct: 261 IQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 83
+ Q++ G++YCH+ +V HRDLK +N L+D LK+ DFG +++ + P T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTH 162
Query: 84 -VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 142
V T Y APE+LL + D+WS G ++ +V P D D I RIL
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 143 VQY--------SVPD---TNP-------------ISQECRDLISRIFVADPAARITIPEI 178
S+PD P + DL+S++ DP+ RIT
Sbjct: 222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 179 MKHQWF 184
++H++F
Sbjct: 282 LEHEYF 287
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 31 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 90
++ G++Y ++++ HRD+K N L++ ++K+CDFG S V +S K+ VGT AY+
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 91 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150
APE + +Y G +DVWS G++ + +G +P+ + + +Q + + P
Sbjct: 161 APERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 151 NPI---SQECRDLISRIFVADPAARITIPEIMKH 181
P+ S++ I++ P R +M H
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ SED +F Q++ G+ Y HA + HRDLK N L + LKI DFG ++ +
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--D 169
Query: 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------- 129
S+ V T Y APEV+L + + D+WS G + ML G F+ D
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229
Query: 130 ------PKDFRKTIQRILSVQYS--------------VPDTNPISQECRDLISRIFVADP 169
K+F + +Q + Y +P+ NP++ +++ ++ V D
Sbjct: 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAV---NVLEKMLVLDA 286
Query: 170 AARITIPEIMKHQWFLK-NLPADLVDEKTMSSQYEEPDQPMQ 210
+RIT E + H +F + + P D + ++E DQ ++
Sbjct: 287 ESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLE 328
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSP 59
ME+ GG L + + AGR E +I G++Y ++ HRD+K N L++
Sbjct: 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 141
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M +
Sbjct: 142 --EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAI 197
Query: 120 GGYPFEDPD---------------------EPK-------------DFRKTIQRILSVQY 145
G YP PD P+ D R + + Y
Sbjct: 198 GRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDY 257
Query: 146 SVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 194
V + P E +D +++ + +PA R + ++M H F+K A+ VD
Sbjct: 258 IVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA-FIKRSEAEEVD 311
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-14
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 21/191 (10%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLE 51
+EY GG+L + R S +++ + L+S G+ Y + + HRDL
Sbjct: 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAAR 134
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVW 108
N L+ +KI DFG S+ + G I APE L + K +DVW
Sbjct: 135 NCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVW 191
Query: 109 SCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
S GV L+ + +G P+ + ++ + Y +P E +L+ +
Sbjct: 192 SFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQL 246
Query: 168 DPAARITIPEI 178
DP R T E+
Sbjct: 247 DPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 31 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 89
++ + Y H+ + V HRD+K N L++ ++K+CDFG S V G Y
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 90 IAPE----VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 145
+APE L + YD K +DVWS G+T+ + G +P++ P F++ Q +
Sbjct: 170 MAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSP 226
Query: 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184
+P S E +D +++ + R PE+++H +F
Sbjct: 227 QLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 11/173 (6%)
Query: 5 SGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62
+GG+L I + G F E A F+ ++ G+ H ++ +RDLK EN LLD
Sbjct: 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH--GH 140
Query: 63 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 122
++I D G + K VGT Y+APEV+ Y D W+ G LY M+ G
Sbjct: 141 IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQS 199
Query: 123 PFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARI 173
PF+ + K R+ ++R++ V + + S + R L + DP R+
Sbjct: 200 PFQQ-RKKKIKREEVERLVK---EVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 35/206 (16%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67
EL E + N ++ R + QLI + +CH + HRD+K EN L+ S LK+CD
Sbjct: 88 ELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCD 143
Query: 68 FGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 125
FG++++ S T V T Y +PE+LL Y GK D+WS G L L G P
Sbjct: 144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILG-ELSDGQPLF 201
Query: 126 DPDEPKDFRKTIQRIL--------SVQYSVPD---------TNPISQECR---------- 158
+ D TIQ++L + YS P +P S E R
Sbjct: 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL 261
Query: 159 DLISRIFVADPAARITIPEIMKHQWF 184
DL+ + +P R + + H F
Sbjct: 262 DLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-14
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 59
ME+ GG L + + AGR E+ ++ G++Y ++ HRD+K N L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG 137
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M +
Sbjct: 138 --EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAI 193
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQ--------------YSVPDTNP------------- 152
G YP PD K ++ + PD+
Sbjct: 194 GRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248
Query: 153 ----------ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186
S E +D + + +P R + E+ KH + +
Sbjct: 249 EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 57/190 (30%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 24 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 83
R F QL+ G++YCH +V HRDLK +N L+ S LK+ DFG +++ + S+ S
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSN 162
Query: 84 -VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 141
V T Y P+VLL EY + D+W G Y M G F + +D I R+L
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
Query: 142 S----------------VQYSVPDTNP-----------ISQECRDLISRIFVADPAARIT 174
YS P P +L + +P RI+
Sbjct: 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
Query: 175 IPEIMKHQWF 184
E MKH +F
Sbjct: 282 AAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 51/195 (26%), Positives = 77/195 (39%), Gaps = 36/195 (18%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
S D + F Q++ G+ Y H+ + HRD+K N L++ + LKICDFG ++
Sbjct: 99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPD 156
Query: 78 SQPKST--VGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFE-------- 125
T V T Y APE+L+ RH Y + D+WS G +L F+
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRH-YTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQL 214
Query: 126 --------DPDEPKDFRK----TIQRILSVQYSVPDTN-------PISQECRDLISRIFV 166
P + R IL + P + E L+ R+ V
Sbjct: 215 DLITDLLGTPSL-EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 167 ADPAARITIPEIMKH 181
DP RI+ + + H
Sbjct: 274 FDPDKRISAADALAH 288
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (171), Expect = 1e-13
Identities = 51/153 (33%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-------VCHRDLK 49
ME+ G+L I G+ E +QL+ ++YCH ++ V HRDLK
Sbjct: 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLK 152
Query: 50 LENTLLDG---------------SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 94
+N L + P KI DFG SK+ + S S VGTP Y +PE+
Sbjct: 153 PQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPEL 212
Query: 95 LLRHE---YDGKIADVWSCGVTLYVMLVGGYPF 124
LL HE YD K +D+W+ G +Y + G PF
Sbjct: 213 LL-HETKSYDDK-SDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 25/194 (12%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
+E+ GG + + R +E + + +Q++ + Y H+M++ HRDLK N LL DG
Sbjct: 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG 147
Query: 58 SPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL-----RHEYDGKIADVWSCG 111
+K+ DFG S +V Q + S +GTP ++APEV++ YD K AD+WS G
Sbjct: 148 D----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLG 202
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----NPISQECRDLISRIFVA 167
+TL M + P ++ +L + S P T + S E RD +
Sbjct: 203 ITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDK 255
Query: 168 DPAARITIPEIMKH 181
P R + ++++H
Sbjct: 256 HPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 18/184 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
+E A G+L + I + E +F QL S V + H+ +V HRD+K N +
Sbjct: 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140
Query: 57 GSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 111
+ +K+ D G SK++ H S VGTP Y++PE + + Y+ K +D+WS G
Sbjct: 141 ATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHENGYNFK-SDIWSLG 193
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171
LY M PF + + Q+I Y T S++ R+L+S DP
Sbjct: 194 CLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQ 251
Query: 172 RITI 175
R I
Sbjct: 252 RPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 7/171 (4%)
Query: 5 SGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62
+GG+L I N G F E A F+ +L G+ ++ +RDLK EN LLD
Sbjct: 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR--GH 140
Query: 63 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 122
++I D G + + VGT Y+APEV+ +Y D W G +Y M+ G
Sbjct: 141 IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQS 199
Query: 123 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
PF E + +R+ Q + S++ + + + +P R+
Sbjct: 200 PFRKRKERVKREEVDRRVKEDQEEY--SEKFSEDAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 15/188 (7%)
Query: 1 MEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
M + GG+L+ ++ G+ E++ +F Q+ + Y H + HRDLK +N L +
Sbjct: 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138
Query: 59 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+K+ D G ++ VL +Q + +GTP Y++PE+ Y+ K +DVW+ G +Y
Sbjct: 139 NI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVY 193
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
M + F KD + RI+ + P S E +LI+ + P R ++
Sbjct: 194 EMATLKHAF----NAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSV 248
Query: 176 PEIMKHQW 183
I++ +
Sbjct: 249 KSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 54/205 (26%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS----- 82
Q+++GV Y H+ V HRDLK N L+ +G +KI D G ++ + ++ K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLD 173
Query: 83 -TVGTPAYIAPEVLL--RHEYDGKIADVWSCG------VTLY------------------ 115
V T Y APE+LL RH Y I D+W+ G +TL
Sbjct: 174 PVVVTIWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 116 -----VMLVGGYPFED--PD-----EPKDFRKTIQRILSVQYSVPD----TNPISQECRD 159
+ V G P E PD E K + S+ + D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 160 LISRIFVADPAARITIPEIMKHQWF 184
L+ ++ DP RIT E ++H +F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 29/201 (14%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
+ G SE+ AR F QL+ G+ Y H+ V HRDLK N ++ + LKI DFG +
Sbjct: 104 NVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLA 162
Query: 72 KSSVLHSQPKS----TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 127
+ H K + T Y +P +LL K D+W+ G ML G F
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222
Query: 128 DEPKDF--------------RKTIQRILSVQYSVPDTNP----------ISQECRDLISR 163
E + R + ++ P ++ E D + +
Sbjct: 223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ 282
Query: 164 IFVADPAARITIPEIMKHQWF 184
I +P R+T E + H +
Sbjct: 283 ILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 37/190 (19%)
Query: 21 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80
E E + G++Y H+ + HRD+K N LL + +K+ DFG S+ L S
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPA 168
Query: 81 KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVT----------LYVM--LVGGYPFE 125
S VGTP ++APEV+L +YDGK DVWS G+T L+ M + Y
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
Query: 126 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185
D P T+ +N S R+ + P R + E++KH++ L
Sbjct: 228 QNDSP-----TLS-----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
Query: 186 KNLPADLVDE 195
+ P ++ +
Sbjct: 272 RERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 43/129 (33%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSP 59
ME+ GG L + + A R E+ ++ G++Y Q+ HRD+K N L++
Sbjct: 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG 141
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L + +
Sbjct: 142 --EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAI 197
Query: 120 GGYPFEDPD 128
G YP PD
Sbjct: 198 GRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 35/194 (18%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
SED+ ++ Q++ G+ Y H+ + HRDLK N L + LKI DFG ++ + +
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DA 169
Query: 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---------- 128
+ V T Y APEV+L + + D+WS G + ML G F+ D
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
Query: 129 ----------------EPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPA 170
K + K++ + +S P +P + DL+ ++ D
Sbjct: 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV---DLLEKMLELDVD 286
Query: 171 ARITIPEIMKHQWF 184
R+T E ++H +F
Sbjct: 287 KRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-12
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 32 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 91
+ G++Y H+ + HRD+K N LL + ++K+ DFG S+ + S S VGTP ++A
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMA 189
Query: 92 PEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 148
PEV+L +YDGK+ DVWS G+T + L P P + + I +
Sbjct: 190 PEVILAMDEGQYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPTL 244
Query: 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189
+N S R+ + P R T E++KH + L+ P
Sbjct: 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 11/134 (8%)
Query: 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
ME+ G + + + N ED + ++++ G+++ HA +V HRD+K +N LL +
Sbjct: 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL--T 155
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE-----YDGKIADVWSCGV 112
+K+ DFG S ++T +GTP ++APEV+ E YD + +D+WS G+
Sbjct: 156 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGI 214
Query: 113 TLYVMLVGGYPFED 126
T M G P D
Sbjct: 215 TAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 42/187 (22%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKST 83
Q++ G+ +CH+ +V HRDLK +N L+D +K+ DFG +++ H
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE----- 161
Query: 84 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRIL 141
V T Y APEVLL D+WS G T++ + P D D FR I RIL
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRIL 218
Query: 142 SVQ--------YSVPD---TNP-------------ISQECRDLISRIFVADPAARITIPE 177
S+PD T P + ++ DL+ ++ + DPA RI+ +
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 178 IMKHQWF 184
+ H +F
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 32/201 (15%)
Query: 11 ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70
E+ N E R + Q++ G+ +CH+ + HRD+K EN L+ S + +K+CDFG+
Sbjct: 91 EKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGF 146
Query: 71 SKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---E 125
++ ++ T V T Y APE+L+ G+ D+W+ G + ML G F
Sbjct: 147 AR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
Query: 126 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECR----------------------DLISR 163
D D+ K + ++ + NP+ R DL +
Sbjct: 206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ 265
Query: 164 IFVADPAARITIPEIMKHQWF 184
DP R + +++ H++F
Sbjct: 266 CLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 83
+ F QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYSNE 164
Query: 84 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGG--YPFEDPDEPKDF------- 133
V T Y P++LL +Y +I D+W G Y M G +P +E F
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT 223
Query: 134 --RKTIQRILS----VQYSVPDTNP---------ISQECRDLISRIFVADPAARITIPEI 178
+T ILS Y+ P + + +L+S++ + RI+ E
Sbjct: 224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283
Query: 179 MKHQWFL 185
MKH +F
Sbjct: 284 MKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 83
+ F Q++ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNE 164
Query: 84 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 142
V T Y P+VLL EY +I D+W G + M G P +D I R+L
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQI-DMWGVGCIFFEM-ASGRPLFPGSTVEDELHLIFRLLG 222
Query: 143 V----------------QYSVPDTNP---------ISQECRDLISRIFVADPAARITIPE 177
Y+ P P + E +L+++ + RI+ E
Sbjct: 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282
Query: 178 IMKHQWF 184
MKH +F
Sbjct: 283 AMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ S+D +F Q++ G+ Y H+ + HRDLK N ++ LKI DFG ++ H
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----H 167
Query: 78 SQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG--YPFED------- 126
+ + T V T Y APE++L + + D+WS G + +L G +P D
Sbjct: 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227
Query: 127 -------PDEPKDFRKTIQ--RILSVQYSVPDT------------NPISQECRDLISRIF 165
PDE + + I + S+P NP++ DL+ ++
Sbjct: 228 IMNLVGTPDE--ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI---DLLEKML 282
Query: 166 VADPAARITIPEIMKHQWF 184
V DP RIT E + H +
Sbjct: 283 VLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 25/194 (12%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LDG 57
+E+ +GG + + R +E + R +Q + ++Y H ++ HRDLK N L LDG
Sbjct: 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140
Query: 58 SPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL-----RHEYDGKIADVWSCG 111
+K+ DFG S + Q + S +GTP ++APEV++ YD K ADVWS G
Sbjct: 141 D----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLG 195
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----NPISQECRDLISRIFVA 167
+TL M + P ++ +L + S P T + S E +D + +
Sbjct: 196 ITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEK 248
Query: 168 DPAARITIPEIMKH 181
+ AR T ++++H
Sbjct: 249 NVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-12
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 33/188 (17%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 83
R+ QL+ + Y H+ V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENP 167
Query: 84 -----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE------------- 125
V T Y APE+LL K D+WS G L ML+G F
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 126 --DPDEPKD-------FRKTIQRILSV--QYSVPDTNP-ISQECRDLISRIFVADPAARI 173
P +D F T+ L + + + P S + DL+ ++ V +P R+
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 174 TIPEIMKH 181
T E ++H
Sbjct: 288 TAEEALEH 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-12
Identities = 51/207 (24%), Positives = 81/207 (39%), Gaps = 51/207 (24%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 75
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 76 LHSQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCG------------------- 111
L K V T Y PE+LL G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230
Query: 112 --VTLYVMLVGG-----YP-------FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157
+TL L G +P F+ + P+ ++ ++ L
Sbjct: 231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK-------DPHA 283
Query: 158 RDLISRIFVADPAARITIPEIMKHQWF 184
DLI ++ V DPA RI + H +F
Sbjct: 284 LDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-12
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 32/189 (16%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 83
R F QL+ G++Y H + HRDLK +N L+ S LK+ DFG +++ + SQ S+
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 84 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 142
V T Y P+VLL +Y + D+W G ML G F + + + I +L
Sbjct: 164 VVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222
Query: 143 VQYS--------VPDTNP-----------------ISQ--ECRDLISRIFVADPAARITI 175
V +P+ P +S+ + DL S++ + P RI+
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282
Query: 176 PEIMKHQWF 184
+ + H +F
Sbjct: 283 QDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 50/228 (21%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66
G I + ++D +F Q++ G+ Y H+ + HRDLK N L + LKI
Sbjct: 105 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDCELKIL 162
Query: 67 DFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124
DFG ++ H+ + T V T Y APE++L + + D+WS G + +L G F
Sbjct: 163 DFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
Query: 125 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR-------------------------- 158
D D K I R++ + S+ R
Sbjct: 219 PGTDH-IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277
Query: 159 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 206
DL+ ++ V D RIT + + H +F +QY +PD
Sbjct: 278 DLLEKMLVLDSDKRITAAQALAHAYF---------------AQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70
+C D R + Q++ G+ + H+ + HRDLK N ++ LKI DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 169
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130
++++ + V T Y APEV+L Y + D+WS G + ++ G F+ D
Sbjct: 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 131 KDFRKTIQRI---------------------------LSVQYSVPD---------TNPIS 154
+ K I+++ +S + PD +
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQW 183
+ RDL+S++ V DP RI++ E ++H +
Sbjct: 289 SQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 29/186 (15%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 83
+ F QL+ G+SYCH ++ HRDLK +N L++ LK+ DFG +++ + ++ S
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNE 163
Query: 84 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GY 122
V T Y P+VLL EY I D+W G LY M G G
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPI-DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT 222
Query: 123 PFEDP----DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
P E+ ++FR + Q + + + DL+S + + + +RI+
Sbjct: 223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282
Query: 179 MKHQWF 184
++H +F
Sbjct: 283 LRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 81
+F QL S + + H+ +V HRD+K N + + +K+ D G SK++ H
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 141
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + + ++I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIE 221
Query: 142 SVQYSVPDTNPISQECRDLISRIFVADPAAR 172
Y ++ S+E R L++ DP R
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
ME+ G + + I N E+ + ++++ G+S+ H +V HRD+K +N LL +
Sbjct: 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL--T 145
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE-----YDGKIADVWSCGV 112
+K+ DFG S ++T +GTP ++APEV+ E YD K +D+WS G+
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGI 204
Query: 113 TLYVMLVGGYPFEDPDEPKDF----RKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 168
T M G P D + R R+ S ++ S++ + I V +
Sbjct: 205 TAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--------SKKFQSFIESCLVKN 256
Query: 169 PAARITIPEIMKH 181
+ R T ++MKH
Sbjct: 257 HSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 34/184 (18%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGT 86
Q + V++CH HRD+K EN L+ + ++K+CDFG+++ +L V T
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVAT 163
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF----EDPDEPKDFRKTI----- 137
Y APE+L+ G DVW+ G ++ L+ G P D D+ RKT+
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGC-VFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222
Query: 138 --QRILSVQ-----YSVP---DTNPISQECRDLISR-------IFVADPAARITIPEIMK 180
Q+I S S+P P+ + ++ S DP R++ E+++
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 181 HQWF 184
H +F
Sbjct: 283 HPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 50/213 (23%)
Query: 28 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------YS 71
F ++ + + Y H+ V HRDLK +N LL + I D+G
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 72 KSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML +P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR-- 233
Query: 129 EPKDFRKTIQRILSVQYSVPDTNPIS--QECRDLISRI----FVADPAARIT-----IPE 177
K RK +S + + ++ +E +S+I DPA R + +
Sbjct: 234 --KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286
Query: 178 IMKH-----QWFLKNLPADLVDEKTMSSQYEEP 205
+ H +W +K A L+ +K ++ EP
Sbjct: 287 LEPHLQGSPEWTVK---ATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 2e-11
Identities = 36/147 (24%), Positives = 62/147 (42%), Gaps = 15/147 (10%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY GG+L F R + + + + Q+ G+ Y + HRDL N L+ +
Sbjct: 80 TEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN 138
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVT 113
+KI DFG S+ ++ + APE L ++ K +DVWS GV
Sbjct: 139 --LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK-SDVWSFGVL 193
Query: 114 LYVMLVGGY-PFEDPDEPKDFRKTIQR 139
L+ + G P+ ++ + ++
Sbjct: 194 LWEIFTLGEQPYPGMS-NEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 38/116 (32%), Positives = 64/116 (55%), Gaps = 5/116 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG L + G SE + + ++ + G++Y H+ HRD+K N LL +
Sbjct: 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--TDN 142
Query: 61 PRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVT 113
+K+ DFG +K + ++ KS +GTP ++APEV + G ++ D+W+ G+T
Sbjct: 143 GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ GG L + G SE + + ++ + G+ Y H+ HRD+K N LL +
Sbjct: 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL--TDN 142
Query: 61 PRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVT 113
+K+ DFG S + ++ KS +GTP ++APEV G ++ D+W+ G+T
Sbjct: 143 GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 37/207 (17%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
G + + F QL+ G+SY H + HRDLK +N L+ S LK+ DFG +++ +
Sbjct: 98 GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLARAKSV 155
Query: 77 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 135
S S V T Y P+VLL D+W G M+ G F KD +
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM---KDIQD 212
Query: 136 TIQRILSVQ-----------YSVPDTNP------ISQECR-------------DLISRIF 165
++RI V +S+P P + R DL S++
Sbjct: 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 166 VADPAARITIPEIMKHQWFLKNLPADL 192
P R++ + H++F +LP L
Sbjct: 273 QCFPKNRLSAQAALSHEYF-SDLPPRL 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 36/85 (42%), Positives = 53/85 (62%), Gaps = 9/85 (10%)
Query: 32 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 91
+ G++Y H+ + HRD+K N LL + ++K+ DFG S+ S S VGTP ++A
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMA 185
Query: 92 PEVLL---RHEYDGKIADVWSCGVT 113
PEV+L +YDGK+ DVWS G+T
Sbjct: 186 PEVILAMDEGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 13/167 (7%)
Query: 32 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 91
+ G++Y H+ + HRD+K N LL S +K+ DFG S+ + + VGTP ++A
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMA 179
Query: 92 PEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 148
PEV+L +YDGK+ DVWS G+T + P + + + I +
Sbjct: 180 PEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPAL 234
Query: 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 195
+ S+ R+ + P R T ++KH++ L+ P ++ +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70
+C + D R + Q++ G+ + H+ + HRDLK N ++ LKI DFG
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 172
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130
++++ V T Y APEV+L Y + D+WS G + M+ GG F D
Sbjct: 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHI 231
Query: 131 KDFRKTIQRI---------------------------LSVQYSVPDT--------NPI-S 154
+ K I+++ S + PD N + +
Sbjct: 232 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQW 183
+ RDL+S++ V D + RI++ E ++H +
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 36/190 (18%)
Query: 22 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 81
+ + +Q + G+ + HA + HRDLK EN L+ + ++K+ DFG ++
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALT 165
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGG 121
V T Y APEVLL+ Y + D+WS G M + G
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224
Query: 122 YPFEDPDEPKD-------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
P ED D P+D F R VQ VP+ I + L+ + +P RI+
Sbjct: 225 LPPED-DWPRDVTLPRGAFSPRGPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRIS 278
Query: 175 IPEIMKHQWF 184
++H +F
Sbjct: 279 AFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 58/232 (25%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66
G I + S++ +F QL+ G+ Y H+ + HRDLK N ++ L+I
Sbjct: 103 GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED--CELRIL 160
Query: 67 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 126
DFG ++ + + V T Y APE++L + + D+WS G + +L G F
Sbjct: 161 DFGLARQA--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
Query: 127 PDEPKDFRKTIQRILSV------------------QY--SVP------------DTNPIS 154
D+ ++RI+ V +Y S+P NP++
Sbjct: 219 ----NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLA 274
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 206
DL+ ++ V D RI+ E + H +F SQY +P+
Sbjct: 275 I---DLLEKMLVLDSDKRISASEALAHPYF---------------SQYHDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 23 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 82
+ R +QL+ V Y H ++ HRD+KLEN L+ L DFG + +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFD 325
Query: 83 T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
VGT A +PE+L Y +I D+WSCG+ L ML
Sbjct: 326 YGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 44/200 (22%)
Query: 26 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 85
+ Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++ V
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 179
Query: 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR------ 139
T Y APEV+L Y + D+WS G + M+ G F D + K I++
Sbjct: 180 TRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 140 --ILSVQYSV-------------------PDTN-PISQE---------CRDLISRIFVAD 168
+ +Q +V PD P E RDL+S++ V D
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298
Query: 169 PAARITIPEIMKH----QWF 184
P RI++ + ++H W+
Sbjct: 299 PEKRISVDDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 54/198 (27%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPK 81
+ + QL ++Y H+ +CHRDLK +N L+D P LK+CDFG +K+ + +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------G 121
S + + Y APE++L D+WS G + M++G G
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288
Query: 122 YPFED--------------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 166
P ED PD +PKD +K P P + + IS+
Sbjct: 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVF----------PKGTP--DDAINFISQFLK 336
Query: 167 ADPAARITIPEIMKHQWF 184
+P R+ E + +F
Sbjct: 337 YEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 13 ICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70
+C + D R + Q++ G+ + H+ + HRDLK N ++ LKI DFG
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGL 165
Query: 71 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130
++++ V T Y APEV+L Y + D+WS G + M+ F D
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 131 KDFRKTIQRI---------------------------LSVQYSVPDT--------NPI-S 154
+ K I+++ L+ PD+ N + +
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQW 183
+ RDL+S++ V DPA RI++ E ++H +
Sbjct: 285 SQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 8/132 (6%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L + + + + + F Q+ G+ Y + + HRDL N L++
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE- 145
Query: 60 APRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
+KI DFG +K K +P + APE L ++ +DVWS GVTLY
Sbjct: 146 -DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLY 203
Query: 116 VMLVGGYPFEDP 127
+ G P + P
Sbjct: 204 ELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 52/210 (24%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ +E + + + QL+ G++Y H + HRD+K N L+D LKI DFG ++
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYD 166
Query: 78 SQPK--------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--- 120
P + V T Y PE+LL D+W G M
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
Query: 121 -----------------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPIS 154
G P E+ P E R L ++ +
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-----KLG 281
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQWF 184
E DL+S++ DP R+T + ++H +F
Sbjct: 282 PEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 14/173 (8%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSV 75
R E + + + G+ + H + HRD+K N LL + +K+ DFG S +S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTST 177
Query: 76 LHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130
+ ++VGTP ++APEV+ L YD + DVWS G+T + G P D
Sbjct: 178 RLRR-NTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPM 235
Query: 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 183
+ K I R P+ S E D I + D R T+ ++++H +
Sbjct: 236 RALFK-IPRNPPPTLHQPEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 38/204 (18%)
Query: 5 SGGELFE--RICNAGRFSE------------DEA--RFFFQQLISGVSYCHAMQVCHRDL 48
GG+L+ +CN G +E DEA + + G+ + H ++ HRD+
Sbjct: 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV 154
Query: 49 KLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVL-----LRHEYDG 102
K N LL +K+ DFG S + + ++VGTP ++APEV+ + YD
Sbjct: 155 KGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212
Query: 103 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD- 159
+ DVWS G+T D D P ++ + + + P T +P + CR
Sbjct: 213 R-CDVWSLGIT-------AIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP-EKWCRSF 263
Query: 160 --LISRIFVADPAARITIPEIMKH 181
IS+ + D AR ++ +++H
Sbjct: 264 NHFISQCLIKDFEARPSVTHLLEH 287
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQP 80
F Q+ G+ Y M++ HRDL N L+ + ++KI DFG S+ S V S+
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 139
+ V ++A E L H Y + +DVWS GV L+ ++ +GG P+ P + +
Sbjct: 190 RIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY-----PGIAPERLFN 240
Query: 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
+L Y + S+E +L+ + +P R T +I K
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 52/225 (23%), Positives = 80/225 (35%), Gaps = 66/225 (29%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 76
R +E + + Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYP 172
Query: 77 ----------HSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-- 120
Q + S V T Y APE+L+ E D+WS G +L G
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 121 ------------------GYPFED---------------PDEPKDFRKTIQRILSVQYSV 147
G P ED P +PKD +
Sbjct: 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN-------- 284
Query: 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPAD 191
S + DL+ + +P RI+ E +KH++F + LP D
Sbjct: 285 -----ASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCD 324
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 41/199 (20%)
Query: 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--- 81
+FF QL+ + Y H V HRDLK +N L + +LKICDFG ++ + +
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFW 163
Query: 82 -STVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVG------------------ 120
V T Y APE+ +Y I D+WS G +L G
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
Query: 121 --GYPFEDP------DEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPA 170
G P + ++ + + ++++ V +S P+ +P++ L+ R+ DP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL---RLLERLLAFDPK 279
Query: 171 ARITIPEIMKHQWFLKNLP 189
R T E + +F K L
Sbjct: 280 DRPTAEEALADPYF-KGLA 297
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKST 83
F QQ+ G++Y H+ HRDL N LLD +KI DFG +K+ + + +
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVRED 169
Query: 84 VGTPAY-IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ---- 138
+P + A E L +++ +DVWS GVTLY +L + P PK F + I
Sbjct: 170 GDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIGPKQG 226
Query: 139 --------RILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
+L +P QE L+ + + R T
Sbjct: 227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 35/88 (39%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL--- 96
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 127 LKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSA 183
Query: 97 RHEYDGKIADVWSCGVTLYVMLVGGYPF 124
R YD + +DVWS G+TLY + G +P+
Sbjct: 184 RDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 44/234 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M Y S +L + G E F + +++ + Y H+ HR +K + LL G
Sbjct: 81 MAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-- 137
Query: 61 PRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSC 110
++ + YS + V+H PKS+V +++PEVL + Y+ K D++S
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS-DIYSV 196
Query: 111 GVTLYVMLVGGYPFEDPDEPK----DFRKTIQRIL-----------SVQYSVPDTNPISQ 155
G+T + G PF+D + R T+ +L Q + +P ++
Sbjct: 197 GITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR 256
Query: 156 ECRDLIS-RIFVA------------DPAARITIPEIMKHQWF--LKNLPADLVD 194
+ D R F DP +R + +++ H +F K L+D
Sbjct: 257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 3/89 (3%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 89
QL+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 90 IAPEVLLRHEYDGKIADVWSCGVTLYVML 118
APEVLL+ Y + D+WS G M
Sbjct: 176 RAPEVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 21/148 (14%)
Query: 2 EYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTL 54
EY S G C E RF QL+ G++Y + Q HRDL N L
Sbjct: 79 EYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCL 132
Query: 55 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIADVWSCG 111
+D +K+ DFG S+ VL + S+VG+ + PEVLL ++ K +DVW+ G
Sbjct: 133 VDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFG 188
Query: 112 VTLY-VMLVGGYPFEDPDEPKDFRKTIQ 138
V ++ V +G P+E + + K Q
Sbjct: 189 VLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME+ G L E + N + + + + Q+ G+ Y + Q HRDL N L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 60 APRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLRHEYDGKIADVWSCGVTLY 115
++KI DFG +K+ + K + +P + APE L++ ++ +DVWS GVTLY
Sbjct: 147 --QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLY 203
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQ------------RILSVQYSVPDTNPISQECRDLISR 163
+L Y + F K I R+L +P +E L+ +
Sbjct: 204 ELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK 261
Query: 164 IFVADPAARITIPEIMK 180
+ P+ R T +++
Sbjct: 262 CWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-08
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 53/205 (25%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP------- 80
Q++ G+ Y HA V HRDLK N L+ +G R+KI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML---------------------- 118
V T Y APE+LL + K D+W+ G +L
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 119 -------VGGYP----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRD 159
V G+P +ED P+ P KDFR+T S ++Y +
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292
Query: 160 LISRIFVADPAARITIPEIMKHQWF 184
L+ ++ DP RIT + ++ +F
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 53/205 (25%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP------- 80
Q++ G+ Y HA V HRDLK N L+ +G R+KI D G+++ L + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADL 172
Query: 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML---------------------- 118
V T Y APE+LL + K D+W+ G +L
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 119 -------VGGYP----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRD 159
V G+P +ED P+ KDFR+ S ++Y +
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 160 LISRIFVADPAARITIPEIMKHQWF 184
L+ ++ DP RIT + M+ +F
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 86 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 140
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
+ + + P+ I C + DP R T +++
Sbjct: 297 RAPENATPEIYRIMLAC-------WQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 40/129 (31%), Positives = 56/129 (43%), Gaps = 15/129 (11%)
Query: 8 ELFERIC-------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E E C G+ S+D Q + G+ Y HRDL N L+ S
Sbjct: 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV--SST 136
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIADVWSCGVTLY-V 116
+K+ DFG ++ VL + S+ G + PEV +Y K +DVWS GV ++ V
Sbjct: 137 GVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEV 194
Query: 117 MLVGGYPFE 125
G PFE
Sbjct: 195 FTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGT 86
Q+ G+SY H V H+D+ N ++D ++KI D S+ H +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 128
++A E L+ EY +DVWS GV L+ +M +G P+ + D
Sbjct: 183 VKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 88
+ + Y + HRDL N L+ +K+ DFG ++ VL Q S+ GT
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKF 163
Query: 89 YI---APEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFE 125
+ PEV + K +DVWS GV ++ + G P+E
Sbjct: 164 PVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP 87
Q+ G+SY ++ HRDL N L+ +P +KI DFG +K V + + G P
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 88 -AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 126
++A E +L Y K +DVWS GVT++ +M G P+E
Sbjct: 175 IKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 10/128 (7%)
Query: 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A 60
EY G L E + G E Q++ ++ H + HRDLK +N ++ +
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 61 PRLKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGV 112
P K+ DFG + T +GTP Y APE LR E +D+++ G+
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGL 177
Query: 113 TLYVMLVG 120
L G
Sbjct: 178 IFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 42/134 (31%), Positives = 62/134 (46%), Gaps = 16/134 (11%)
Query: 2 EYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E A G L +R+ +A G F + Q+ +G+ Y + + HRDL N LL +
Sbjct: 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL--AS 132
Query: 60 APRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLLRHEYDGKIADVWSCGVT 113
++KI DFG ++ + + V P A+ APE LR +DVW GVT
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES-LRTRTFSHASDVWMFGVT 189
Query: 114 LYVMLVGGYPFEDP 127
L+ M G E+P
Sbjct: 190 LWEMFTYG---EEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG++ + G F E+ A + ++ + Y H + HRDLK +N L+ S
Sbjct: 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI--SNE 140
Query: 61 PRLKICDFGYSK 72
+K+ DFG SK
Sbjct: 141 GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 84
F Q+ G+++ + HRDL N LL + +KICDFG ++ + S K
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 85 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD--FRKTIQRI 140
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 204 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKE- 259
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
+ + P+ P E D++ + ADP R T +I
Sbjct: 260 -GYRMAQPEHAP--AEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 84
F Q+ G+S+ + HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 85 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKD--FRKTIQ-- 138
P ++APE + Y + +DVWS G+ L+ + +G P+ P P D F K I+
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIKEG 333
Query: 139 -RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
R+LS + + + I + C D ADP R T +I++
Sbjct: 334 YRMLSPECAPSEMYDIMKSCWD-------ADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 86 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 140
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181
+ Y+ P+ +C + +P+ R T E+++H
Sbjct: 302 RAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 34 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYI 90
G++Y + V HRDL N L+ + +K+ DFG ++ VL Q S+ GT +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 91 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 126
+PEV +Y K +DVWS GV ++ V G P+E+
Sbjct: 169 SPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 31/101 (30%), Positives = 43/101 (42%), Gaps = 11/101 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVG 85
Q+ G++Y HRDL N L+ K+ DFG + K V L S K
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY- 168
Query: 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 125
+ APE + K +DVWS G+ LY + G P+
Sbjct: 169 --KWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 86
F Q+ G+ + + HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 87 P----AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRIL 141
++APE + + Y ++DVWS G+ L+ + +GG P+ F I+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355
Query: 142 SVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+ + PD QE D++ + + ++P R
Sbjct: 356 GYRMAKPDHAT--QEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 84 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 143
+GTP Y+APE+LL + G D W+ GV L+ L G PF D + F Q IL+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVF----QNILNR 595
Query: 144 QYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 184
P+ +S ++ I + DP R + E+ +H F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 80
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK--DFRKTI 137
TV T APEVL Y + D+WS G+ ++ V F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 138 QRILSVQYSVPDTNPISQECRDLISR 163
RI+ D P R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 85
Q+ G+ + + + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 86 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 140
P ++APE + Y + +DVWS GV L+ + +G P+ ++F + ++ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181
+ +Y+ P+ I +C +P R T E+++
Sbjct: 296 RAPEYATPEIYSIMLDCWH-------NNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 8/131 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME A G L + + + + Q+ G++Y + HRDL N LL
Sbjct: 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131
Query: 61 PRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+ KI DFG S++ ++T P + APE + ++ K +DVWS GVTL+
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWE 190
Query: 117 ML-VGGYPFED 126
G P+ +
Sbjct: 191 AFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 83
F Q+ +G+ + + HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 84 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 139
++APE + + Y ++DVWS G+ L+ + +GG P+ + + F I+R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 12/119 (10%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74
+ G FS + + + +G+ Y M HRDL N L++ + K+ DFG S+
Sbjct: 100 HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSR-- 155
Query: 75 VLHSQPKSTVGTPA------YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 126
VL P+ T T + APE + ++ +DVWS G+ ++ VM G P+ D
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 21 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 79
+D RF Q + G+ + + HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 80 --PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRK 135
K P ++APE + Y + +DVWS G+ L+ + +G P+ F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 136 TIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEI 178
++R Q S PD P I + C +L +P R T +I
Sbjct: 327 MVKR--GYQMSRPDFAPPEIYSIMKMCWNL-------EPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 6/120 (5%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L D
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--D 228
Query: 68 FGYSKSSVLHS-QPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124
FG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 22/158 (13%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 87
++ G++Y A + HRDL N ++ +KI DFG ++ + P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 88 A-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDF---RKTIQRI 140
++APE L + K +DVWS GV L+ M Y +E F +
Sbjct: 185 VRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL- 242
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
P+ P + +L+ + +P R T EI
Sbjct: 243 -------PENCP--DKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 15/176 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
ME S G L + GR + F + G+ Y + ++ HRDL N L+ S
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV--S 134
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-V 116
K+ DFG ++ + S P + APE L ++ K +DVWS GV L+ V
Sbjct: 135 EDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEV 190
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
G P+ PK K ++ + Y + + L++ + +P R
Sbjct: 191 FSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG--TP 87
Q+ SG+ Y ++ HRDL N L+ +KI DFG S++ L+S V P
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSDYYRVQGRAP 193
Query: 88 AYI---APEVLLRHEYDGKIADVWSCGVTLY--VMLVGGYPFED-PDEP------KDFRK 135
I A E +L ++ K +DVW+ GVTL+ + L P+E D+ FR
Sbjct: 194 LPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD 252
Query: 136 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187
++I +P ++ +L+ + D R T EI H FL+
Sbjct: 253 DGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HL-FLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME GG+ + G R E + +G+ Y + HRDL N L+
Sbjct: 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN 131
Query: 60 APRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY- 115
LKI DFG S+ +++ P + APE L Y + +DVWS G+ L+
Sbjct: 132 V--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWE 188
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+G P+ + + R+ I++ V+ P+ P L+ R + DP R
Sbjct: 189 AFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPELCP--DAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 2 EYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
EY G L F R + G+F+ + + + SG+ Y M HRDL N L++ +
Sbjct: 85 EYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL 143
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHEYDGKIADVWSCGVT 113
K+ DFG S+ VL P++ T + APE + ++ +DVWS G+
Sbjct: 144 V--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIV 198
Query: 114 LY-VMLVGGYPFED 126
++ VM G P+ +
Sbjct: 199 MWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPK--STV 84
+ ++ + Y H ++ HRD+K EN ++ P +C DFG + V + K
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DVCLGDFGAACFPVDINANKYYGWA 244
Query: 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
GT A APE+L R Y G D+WS G+ L+ M
Sbjct: 245 GTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 17/184 (9%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY + G L + + + GR + + F + G+ Y HRDL N L+
Sbjct: 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138
Query: 59 PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-V 116
K+ DFG +K + K V + APE L ++ K +DVWS G+ L+ +
Sbjct: 139 LVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVWSFGILLWEI 192
Query: 117 MLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
G P+ P P KD +++ + P+ P E ++ + DPA R T
Sbjct: 193 YSFGRVPY--PRIPLKDVVPHVEK--GYRMEAPEGCP--PEVYKVMKDCWELDPAKRPTF 246
Query: 176 PEIM 179
++
Sbjct: 247 KQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 25/145 (17%)
Query: 1 MEYASGGELFERICNAGR-----FSEDEAR-----FFFQQLIS-------GVSYCHAMQV 43
+EYAS G L E + A R +S D AR F+ L+S G+ Y + +
Sbjct: 100 VEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC 158
Query: 44 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPA-YIAPEVLLRHEY 100
HRDL N L+ + +KI DFG ++ +++ + + + P ++APE L Y
Sbjct: 159 IHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 101 DGKIADVWSCGVTLY-VMLVGGYPF 124
+ +DVWS GV ++ + +GG P+
Sbjct: 217 THQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 16/110 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
F+ D A G+ Y Q HRDL N L+ + KI DFG S+ ++
Sbjct: 116 HFAADVA--------RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVY 165
Query: 78 SQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
K T+G P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 166 V--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 35/137 (25%), Positives = 55/137 (40%), Gaps = 26/137 (18%)
Query: 2 EYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHAMQVCHRDLKLENT 53
EY S G L + + E + QL+ G++Y + HRDL N
Sbjct: 81 EYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134
Query: 54 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLLRHEYDGKIADVWS 109
L+ + KI DFG ++ ++ + P + APE + K +DVWS
Sbjct: 135 LVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK-SDVWS 189
Query: 110 CGVTLYVMLVGG---YP 123
G+ L ++ G YP
Sbjct: 190 FGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74
N R + + Q+ G+SY +++ HRDL N L+ SP +KI DFG ++
Sbjct: 102 NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLL 159
Query: 75 VLHSQPKSTVGTPA---YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 125
+ G ++A E +L + + +DVWS GVT++ +M G P++
Sbjct: 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 38/123 (30%), Positives = 55/123 (44%), Gaps = 14/123 (11%)
Query: 1 MEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L + + R + + Q+ G+ Y + + HRDL N L++
Sbjct: 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN 145
Query: 60 APRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLRHEYDGKIADVWSCGV 112
R+KI DFG +K + Q K V P + APE L ++ +DVWS GV
Sbjct: 146 --RVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGV 199
Query: 113 TLY 115
LY
Sbjct: 200 VLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 37/131 (28%), Positives = 57/131 (43%), Gaps = 9/131 (6%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME ASGG L + + + Q+ G+ Y HRDL N LL
Sbjct: 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH 132
Query: 60 APRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYDGKIADVWSCGVTLY 115
KI DFG SK+ + + +S P + APE + ++ + +DVWS G+T++
Sbjct: 133 YA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMW 189
Query: 116 VML-VGGYPFE 125
G P++
Sbjct: 190 EAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 26/142 (18%)
Query: 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL--LD 56
M Y S +L IC SE + Q ++ + Y H M HR +K + L +D
Sbjct: 81 MAYGSAKDL---ICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137
Query: 57 GSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKI 104
G K+ G + V+H PK +V +++PEVL ++ YD K
Sbjct: 138 G------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK- 190
Query: 105 ADVWSCGVTLYVMLVGGYPFED 126
+D++S G+T + G PF+D
Sbjct: 191 SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 42/142 (29%), Positives = 62/142 (43%), Gaps = 30/142 (21%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLE 51
EY G L F R E++ +F QL+ SG+ Y M HRDL
Sbjct: 84 TEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-YIAPEVLLRHEYDGKIA 105
N L++ + K+ DFG S+ L ++T T P + APE + + +
Sbjct: 136 NILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRWTAPEA-IAYRKFTSAS 189
Query: 106 DVWSCGVTLY-VMLVGGYPFED 126
DVWS G+ ++ VM G P+ D
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 38/154 (24%), Positives = 64/154 (41%), Gaps = 17/154 (11%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 81
F Q+ G+++ HRDL+ N L+ S + KI DFG ++ K
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRI 140
+ + APE + + K +DVWS G+ L ++ G P+ P+ + R
Sbjct: 165 FPI---KWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRA 215
Query: 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
L Y +P +E +++ R + P R T
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 36/117 (30%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 2 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
EY + G L + + + GR D F + + Y A HRDL N L+ S
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV--SE 137
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
K+ DFG +K + S + T P + APE L ++ K +DVWS G+ L+
Sbjct: 138 DNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-05
Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 13/121 (10%)
Query: 2 EYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ + G L + + R + + Q+ S + Y HRDL N L+
Sbjct: 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GE 139
Query: 60 APRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
+K+ DFG S+ + H+ K + + APE L +++ K +DVW+ GV L
Sbjct: 140 NHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SDVWAFGVLL 195
Query: 115 Y 115
+
Sbjct: 196 W 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 16/110 (14%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+F+ D A +G+ Y Q HRDL N L+ + A KI DFG S+ ++
Sbjct: 123 QFASDVA--------TGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVY 172
Query: 78 SQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
K T+G P ++A E L Y K +DVWS GV L+ ++ +GG P+
Sbjct: 173 V--KKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 35/119 (29%), Positives = 52/119 (43%), Gaps = 7/119 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME A G L + + +E Q+ G+ Y HRDL N LL
Sbjct: 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--VTQ 131
Query: 61 PRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
KI DFG SK + + + K+ P + APE + +++ K +DVWS GV ++
Sbjct: 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 20/163 (12%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 81
F + G+ Y HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 138
+IA E L Y K +DVW+ GVT++ + G YP + E D+ +
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 139 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181
R+ P+ E DL+ + ADP R T ++ +
Sbjct: 233 RL-----KQPEDCL--DELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 86
Q+ SG+ Y ++ HRDL N L+ +KI DFG S+ S + V
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLP 194
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
++A E +L ++ +DVW+ GVTL+ M
Sbjct: 195 IRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 51/200 (25%), Positives = 78/200 (39%), Gaps = 43/200 (21%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLENT 53
ME GG L + + + R ++L+ +G+ Y + HRDL N
Sbjct: 71 MELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124
Query: 54 LLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGK 103
L+ + LKI DFG Y+ S L P K T APE L Y +
Sbjct: 125 LVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------APEALNYGRYTSE 175
Query: 104 IADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160
+DVWS G+ L+ G YP + ++ ++ R+ P P +E L
Sbjct: 176 -SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-----PAPQLCP--EEIYRL 227
Query: 161 ISRIFVADPAARITIPEIMK 180
+ + + DP R + EI
Sbjct: 228 MLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG- 85
Q+ G+ + + + HRDL N L+ + +KI DFG ++ +H K+T G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYYRKTTNGR 195
Query: 86 TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
P ++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 196 LPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 48/177 (27%), Positives = 72/177 (40%), Gaps = 33/177 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLENT 53
ME GG+ + R +DE + +QL+ +G++Y + HRDL N
Sbjct: 71 MELVPGGDFLSFL----RKKKDELKT--KQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 54 LLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 105
L+ + LKI DFG S+ SS L P + APE L Y + +
Sbjct: 125 LVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNYGRYSSE-S 175
Query: 106 DVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159
DVWS G+ L+ G YP + ++ + R+ Q D + Q C D
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ G++Y ++ HRDL N L+ +KI DFG +K +L + K
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGK 172
Query: 89 ----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 125
++A E +L Y + +DVWS GVT++ +M G P++
Sbjct: 173 VPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 89
Q+ SG++Y A HRDL N L+ + K+ DFG ++ + ++ G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFP 167
Query: 90 I---APEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 123
I APE L + + K +DVWS G+ L ++ G YP
Sbjct: 168 IKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 25/145 (17%)
Query: 1 MEYASGGELFERICNAGR-----FSED-----EARFFFQQLIS-------GVSYCHAMQV 43
+EYAS G L E + A R +S D E + F+ L+S G+ Y + +
Sbjct: 97 VEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC 155
Query: 44 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG--TPAYIAPEVLLRHEY 100
HRDL N L+ +KI DFG ++ + K+T G ++APE L Y
Sbjct: 156 IHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213
Query: 101 DGKIADVWSCGVTLY-VMLVGGYPF 124
+ +DVWS GV L+ + +GG P+
Sbjct: 214 THQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 8/112 (7%)
Query: 16 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75
A S + F + G+ Y Q HRDL N L+ + KI DFG S+
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQE 175
Query: 76 LHSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
++ K T+G P ++A E L Y +DVWS GV L+ ++ +GG P+
Sbjct: 176 VYV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG--T 86
Q+ G+ Y + + HRDL N L+ +KI DFG ++ + K+T G
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
++APE L Y + +DVWS GV L+ + +GG P+
Sbjct: 206 VKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 30/193 (15%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENT 53
ME GG+L + +A ++L+ G Y M HRDL N
Sbjct: 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNC 137
Query: 54 LLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI--- 104
L+ G A R +KI DFG ++ S + + + ++APE LL DGK
Sbjct: 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL----DGKFTTQ 193
Query: 105 ADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 161
+DVWS GV ++ +L G YP + E R+ P+ P + L+
Sbjct: 194 SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK-----PENCP--DKIYQLM 246
Query: 162 SRIFVADPAARIT 174
+ + DP+ R T
Sbjct: 247 TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 86
Q+ +G+ Y + HRDL N L+ +KI DFG S+ S+ + ++
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
++ PE +L ++ + +D+WS GV L+
Sbjct: 190 VRWMPPEAILYGKFTTE-SDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 13/122 (10%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 81
F + SG+ Y + HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGR 172
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 138
+IA E L Y K +DVWS GVT++ + G YP + E D+ +
Sbjct: 173 IAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 139 RI 140
R+
Sbjct: 232 RL 233
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 42/135 (31%), Positives = 63/135 (46%), Gaps = 18/135 (13%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHS 78
F Q+ G+ Y + + HRDL N +LD S +K+ DFG Y K S H+
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHT 160
Query: 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRK 135
K V ++A E L ++ K +DVWS GV L+ ++ G YP D + +
Sbjct: 161 GAKLPV---KWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216
Query: 136 TIQRILSVQYSVPDT 150
+R+L +Y PD
Sbjct: 217 QGRRLLQPEY-CPDP 230
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 17/136 (12%)
Query: 2 EYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ G L F R N G+F+ + + + +G+ Y M HRDL N L++ +
Sbjct: 85 EFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL 143
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLLRHEYDGKIADVWSCG 111
K+ DFG S+ L T + + APE + ++ +DVWS G
Sbjct: 144 V--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYG 198
Query: 112 VTLY-VMLVGGYPFED 126
+ ++ VM G P+ D
Sbjct: 199 IVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTP 87
Q+ G+ Y + + HRDL N L+ +KI DFG ++ + + + S P
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 88 A-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
++APE L Y + +DVWS G+ ++ + +GG P+
Sbjct: 200 VKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 20/189 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+++A GG+L+ I E+ + + +++ + H + RDL N LLD
Sbjct: 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH 123
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+L +S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 124 IQLTY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TI 175
E P I ++P+ +S+E R L+ ++ +P R+ +
Sbjct: 179 KTLVE--CHPSG----INT--HTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGV 228
Query: 176 PEIMKHQWF 184
+I H +F
Sbjct: 229 EDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 86
Q+ SG+ Y + HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 87 PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ-RILSVQ 144
++ PE ++ ++ + +DVWS GV L+ + G P+ + Q R+L
Sbjct: 189 IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
P +E D++ + +P R+ I EI K
Sbjct: 248 RVCP------KEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 13/92 (14%)
Query: 38 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 95
A++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 96 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 127
Y K AD++S G+TLY L P+ +
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEALDYELPYNEE 107
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 16/170 (9%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
G + + Q+ SG+ Y + HRDL N L+ +KI DFG S+ +
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--V 172
Query: 77 HSQPKSTVGTPA-----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEP 130
++ VG ++ PE ++ ++ + +DVWS GV L+ + G P+
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNE 231
Query: 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
+ Q L + P T P E D++ + DP RI I +I +
Sbjct: 232 EVIECITQGRLLQR---PRTCP--SEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 85
QQ+ +G+ Y + HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 121
++ PE ++ ++ + +DVWS GV L+ + G
Sbjct: 185 PIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYG 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ SG+ Y ++ HRDL N L+ + +KI DFG S++ L++ + A
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAV 201
Query: 89 ----YIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++A E +L ++ +DVW+ GVTL+ +L
Sbjct: 202 LPIRWMAWECILMGKFT-TASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 35/160 (21%), Positives = 64/160 (40%), Gaps = 22/160 (13%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTV 84
Q+ G+ + + HRDL N L+ L Y+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL 182
Query: 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED-PDEPKDFRKTIQRILS 142
++APE + ++ K +DVWS GV ++ V G PF DE + + R+ +
Sbjct: 183 ---RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQA 233
Query: 143 --VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
++ VP+ P L++R + +P R + E++
Sbjct: 234 GKLELPVPEGCPSR--LYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 21/153 (13%)
Query: 29 QQLISGVSYCHAMQVCHRDLKLENTLL-----DGSPAPRLKICDFGYSKSSVLHSQPKST 83
+QL S + Y ++ H ++ +N L+ + P +K+ D G + + +
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 84 VGTPAYIAPEVLLRHEYDGKIA-DVWSCGVTLYVMLVGG-YPFE--DPDEPKDFRKTIQR 139
+ +IAPE + + IA D WS G TL + G P E + F + R
Sbjct: 168 I---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+ +PD ++ LI++ + DP R
Sbjct: 225 L-----PMPDCAELAN----LINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 88
Q+ SG+ Y ++ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTM 185
Query: 89 ----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 121
++ PE +L ++ + +D+WS GV L+ + G
Sbjct: 186 LPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYG 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 86
F Q+ G++Y HRDL+ N L+ S + KI DFG ++ + ++ + G
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGA 164
Query: 87 P---AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILS 142
+ APE + + K +DVWS G+ LY ++ G P+ P + L
Sbjct: 165 KFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPY-----PGMSNSDVMSALQ 218
Query: 143 VQYSVPDTNPISQECRDLISRIFVADPAARIT 174
Y +P E D++ + R T
Sbjct: 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 14/105 (13%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 86
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ L + T
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQ 161
Query: 87 PA-----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 123
A + APE L + K +DVWS G+ L + G YP
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 13/164 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M Y S L + G SE + G++Y H HR++K + L+ G
Sbjct: 81 MAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL 139
Query: 61 PRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGV 112
L YS K+ V++ P+ + +++PE+L + + Y+ K +D++S G+
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK-SDIYSVGI 198
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156
T + G PF+D + +Q++ YS D E
Sbjct: 199 TACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTFPCE 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.004
Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVG 85
Q+ G+ Y ++ HR+L N LL S + ++I DFG + +L+ K S
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHK 172
Query: 86 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRIL 141
TP ++A E +L Y + +DVWS GVT++ M+ G Y P E D + +R+
Sbjct: 173 TPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA 231
Query: 142 SVQYSVPDTNPISQEC 157
Q D + +C
Sbjct: 232 QPQICTIDVYMVMVKC 247
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP-- 87
Q+ G+ Y ++ HRDL N L+ SP +KI DFG ++ + + G
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 88 -AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 125
++A E + ++ + +DVWS GVT++ +M GG P++
Sbjct: 175 IKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.62 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.57 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.54 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.41 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.29 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.28 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.22 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.86 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.74 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.39 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.54 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.48 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.23 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.93 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.7 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.42 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.08 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.89 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 91.96 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.9 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 91.69 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 91.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.16 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.96 | |
| PLN02236 | 344 | choline kinase | 90.92 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.83 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.21 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 89.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 89.44 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 87.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.4 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 85.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 83.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 83.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 83.05 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.66 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=327.35 Aligned_cols=184 Identities=38% Similarity=0.635 Sum_probs=160.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|++++-.++.+.|...+.+++|++.|+.|||++||+||||||+|||++.+ ....+||+|||+|+.......
T Consensus 255 lE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf 334 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF 334 (475)
T ss_pred EEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence 7999999999999999999999999999999999999999999999999999999766 334589999999998877788
Q ss_pred CCCCcCCCCcccchhhccCc--cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCH
Q 024363 80 PKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQ 155 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~ 155 (268)
.++.+|||.|.|||++...+ ++..++|+||+|||+|.+++|.+||.+......+ .+++....+. .+.+..+|.
T Consensus 335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl---~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL---KEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH---HHHHhcCcccccChhhhhhhH
Confidence 89999999999999997644 3444589999999999999999999876654433 3344445543 356778999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++++||.+||..||++|||+.++|+||||+..
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999999999999999999999999754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=318.09 Aligned_cols=185 Identities=30% Similarity=0.532 Sum_probs=160.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||||.+++.+.++++|.....++.++++||.|||+ ++||||||||+||||+..+. |||||||.|+..... .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-h
Confidence 8999999999999999999999999999999999999995 99999999999999977665 999999999865444 6
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhccc-ccCCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQ-YSVPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~ 157 (268)
..+.+||..|||||.+.+..|+.+ +||||||++++|+++|++||... .....+...+..++... ...|.. .+|+++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef 311 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEF 311 (364)
T ss_pred cccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHH
Confidence 688899999999999999999888 99999999999999999999875 22334556666666533 333332 489999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++||..||++||.+|+++.|+++|||+++....
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 999999999999999999999999999865443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=310.39 Aligned_cols=214 Identities=34% Similarity=0.598 Sum_probs=170.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
+||+.||.|+.+|++.+.|+|..++.+++.|+.||.|||++|||||||||+|||++.+| +++|+|||+++..... ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCc
Confidence 58999999999999999999999999999999999999999999999999999997665 4999999999965544 34
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
+.+.+||+.|||||++.+.+|+.. +|+||||+++|+|++|.+||.+.+......+ +...+.. ..+.-++.++++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~----I~~~k~~-~~p~~ls~~ard 255 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDK----ILKGKLP-LPPGYLSEEARD 255 (357)
T ss_pred cccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHH----HhcCcCC-CCCccCCHHHHH
Confidence 556699999999999999988766 9999999999999999999998776544443 4333311 112228999999
Q ss_pred HHHHccccCCCCCC----CHHHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHHHhC
Q 024363 160 LISRIFVADPAARI----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEAS 223 (268)
Q Consensus 160 li~~~l~~dp~~R~----s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (268)
||+++|+.+|.+|. .+.++.+||||. ...+..+..+...+++.+..........+...+....
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~-~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~ 322 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFK-GINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYT 322 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcccc-cCCHHHHHhcCCCCCeecCCCCccccccccHHHHhcc
Confidence 99999999999996 688999999995 4555555555555555544443333444444444443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=320.20 Aligned_cols=180 Identities=51% Similarity=0.874 Sum_probs=163.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC-CCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~~~ 79 (268)
||||.||+|+++|.+.++++|.+++.+++|++.|++|||++||+||||||+|||++.+. +.+||+|||++... .....
T Consensus 99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~~~ 177 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGEDGL 177 (370)
T ss_pred EEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCCCc
Confidence 89999999999999999999999999999999999999999999999999999998773 45999999999877 46667
Q ss_pred CCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
..+.+||+.|+|||++.+.. |.++++||||+||++|.|++|+.||...+... ....+....+.+|.... |.+++
T Consensus 178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S~~~~ 252 (370)
T KOG0583|consen 178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-SPEAR 252 (370)
T ss_pred ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-CHHHH
Confidence 78899999999999999988 99999999999999999999999999855443 34446677777777633 99999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+|+.+||..+|.+|+|+.+++.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=298.75 Aligned_cols=190 Identities=34% Similarity=0.656 Sum_probs=164.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||.|++++++.++|+|..++.++.||+.||+|||+++|++|||||+|||++++|. +||+|||+|+..... +
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence 899999999999999999999999999999999999999999999999999999987765 999999999865433 6
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+|||.|+|||++...+|+.. +|+|||||++|||++|.+||...+. .++..+++.....+|.. +++++++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~--fs~~~kdL 271 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY--FSSDAKDL 271 (355)
T ss_pred EEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc--cCHHHHHH
Confidence 78899999999999998888654 9999999999999999999998776 45667777888877776 89999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCCCCCCcccchhhhcccC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQY 202 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~~~~~~~~~~~~~~~~~ 202 (268)
|+++|+.|-.+|. ...++.+||||. ...+.....+....++
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~-~v~W~~i~~r~ie~P~ 317 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFK-GVDWEAILQRKIEPPF 317 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCcccc-cccHHHHhhccccCCC
Confidence 9999999999995 567999999996 4444443333333333
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=320.63 Aligned_cols=182 Identities=35% Similarity=0.659 Sum_probs=163.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
+|+|..|+|..++++.+.++|.+|+.++.||+.||.|||+++|+|||||..|+|++.+.. |||+|||+|...... ..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccc
Confidence 599999999999999999999999999999999999999999999999999999987765 999999999876654 66
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+|||.|+|||++...+..-. +||||+|||||-|+.|++||.... +.++..++....+.+|.. +|.++++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~----vkety~~Ik~~~Y~~P~~--ls~~A~d 247 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKT----VKETYNKIKLNEYSMPSH--LSAEAKD 247 (592)
T ss_pred cceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccch----HHHHHHHHHhcCcccccc--cCHHHHH
Confidence 778899999999999998777655 999999999999999999997643 566677777788888774 9999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCCc
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPAD 191 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~ 191 (268)
||.+||..+|.+|||++++|.|+||++..-+.
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 99999999999999999999999997655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.22 Aligned_cols=177 Identities=37% Similarity=0.655 Sum_probs=154.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++||+|.++|++.+.|+|..++.++.+|+.||+|||++|||||||||+|||++.++. +||+|||.|+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence 699999999999999999999999999999999999999999999999999999977664 999999998742221
Q ss_pred -----------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 78 -----------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 78 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
....+.+||-.|.+||++...... ..+|+|+||||+|.|+.|.+||.+.+.-. +.++++...+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Neyl----iFqkI~~l~y~ 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYL----IFQKIQALDYE 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHH----HHHHHHHhccc
Confidence 111457899999999999876654 44999999999999999999999887643 55566677777
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+|.. +++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus 306 fp~~--fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 306 FPEG--FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCC--CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 7665 7899999999999999999999999999999953
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.17 Aligned_cols=182 Identities=42% Similarity=0.815 Sum_probs=167.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
+||++||.|++++-++|+|+|.++.++++||+.|+.|+|..+|+||||||+|+|++.... +||+|||+|.........
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccc
Confidence 589999999999999999999999999999999999999999999999999999987665 999999999988888888
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+|+|+|.|||++.+.+|.+.++||||.|||+|.|++|+.||.+.+ ++.++.++..+.+.+|.. +|.++++|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLlKV~~G~f~MPs~--Is~eaQdL 242 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLLKVQRGVFEMPSN--ISSEAQDL 242 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHHHHHcCcccCCCc--CCHHHHHH
Confidence 999999999999999999999999999999999999999999998644 456677777888888755 99999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|.+||..||++|+|.+++++|||+.+....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 999999999999999999999999775433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=303.56 Aligned_cols=184 Identities=33% Similarity=0.528 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
||||+||+|.+++.+.+ +|+|..++.+.+||++||.|||++|+|||||||+|||++.. .+.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCccccccccccc
Confidence 89999999999999876 89999999999999999999999999999999999999873 23499999999886542
Q ss_pred -CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 77 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 77 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
........||+.|||||++.......+++|||||||++.||+||+.||... ..... +..+.......+.+..+|
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~----~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA----LLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH----HHHHhccCCCCCCCcccC
Confidence 223446789999999999986434444599999999999999999999863 22221 112222222223445599
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.++++||.+||..+|.+||||.++|.|||..+..+
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999999976554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=303.10 Aligned_cols=185 Identities=28% Similarity=0.438 Sum_probs=160.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+- +|+++++.+ ..|++..++.||.||++||+|+|++|+.|||+||+|||+.... .+||+|||+||.......
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCC
Confidence 789976 999999765 4599999999999999999999999999999999999997544 499999999999888888
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (268)
.+.++.|.||+|||++++..+++.++||||+|||++|+.+-++.|.|.++.+++.++..-+-.. +
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 8999999999999999988877777999999999999999999999999888877665433221 2
Q ss_pred ccCCCC---------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 145 YSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 145 ~~~~~~---------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+++|.. ...+.++.+||.+||.+||.+||||.++|+||||+-..
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 333332 22689999999999999999999999999999997543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=286.52 Aligned_cols=182 Identities=36% Similarity=0.615 Sum_probs=158.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
+|.|+.|.|++++.+.-.++|...+.+|+|++.|++|||.++||||||||+|||++.+.. +||+|||+|+........
T Consensus 102 Fdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~GekL 179 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPGEKL 179 (411)
T ss_pred hhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccCCchhH
Confidence 578999999999999999999999999999999999999999999999999999987765 999999999998888888
Q ss_pred CCCcCCCCcccchhhccC-----ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 81 KSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
...+|||+|.|||.+... +-+++.+|+||+|||||-|+.|++||........++.+++. +..+..|.+..+|.
T Consensus 180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG--kyqF~speWadis~ 257 (411)
T KOG0599|consen 180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG--KYQFRSPEWADISA 257 (411)
T ss_pred HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc--ccccCCcchhhccc
Confidence 899999999999998643 22345599999999999999999999876544434333332 33445677888999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
..++||.+||+.||.+|+|++|+|.||||.+
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999999999999954
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=303.35 Aligned_cols=180 Identities=37% Similarity=0.631 Sum_probs=155.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
|||++||++.++|.+.+.|+|..++.++.+++.|++-||+.|+|||||||+|+||+..| ++||+|||+++....
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhh
Confidence 89999999999999999999999999999999999999999999999999999997665 599999999752100
Q ss_pred ------------------C-CC-------------------------CCCCcCCCCcccchhhccCccCCcccchhhhhH
Q 024363 77 ------------------H-SQ-------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112 (268)
Q Consensus 77 ------------------~-~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (268)
. .. ..+.+|||.|||||++.+.+|.-. +|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHH
Confidence 0 00 023579999999999999997655 99999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHhcccccCC
Q 024363 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 113 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
||||||.|.+||.+.+....+.+++... ..+.+|....+++++++||.+||. ||.+|+ +++||..||||+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999998888777776543 234667777789999999999999 999999 4899999999964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=276.75 Aligned_cols=182 Identities=36% Similarity=0.688 Sum_probs=157.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
+|++.||+|..-|-..-.++|..+-.+++||++||.|+|.+||||||+||+|+++.+.. ..-+||+|||+|........
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 58899999988887767799999999999999999999999999999999999996433 33589999999987776666
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~ 157 (268)
....+|||.|||||++...+|..+ +|||+.|||+|-|+.|++||.+.+....+..+ ....+. .|.+..+++++
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I----~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQI----KAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHH----hccccCCCCcccCcCCHHH
Confidence 677899999999999998888655 99999999999999999999987665544444 444443 34677899999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=280.51 Aligned_cols=187 Identities=38% Similarity=0.623 Sum_probs=160.9
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||+++||.|++.|+.++. |+|.++..++.||..|+.|||+.+|.||||||+|+|..... +..+||+|||+|+.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 899999999999988665 99999999999999999999999999999999999996443 445899999999987777
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~ 155 (268)
....+.+.||+|.|||++...+|. +.+|+||+||++|-|++|.+||........-.....++....+.+| .+..+|+
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 777888999999999999777764 5599999999999999999999876543222233445666667665 4567899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+++++|+++|..+|.+|+|+.+++.|||+.+..
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 999999999999999999999999999997754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=299.86 Aligned_cols=180 Identities=28% Similarity=0.524 Sum_probs=153.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||++||+|.+.+.. ..++|.++..+++.++.||+|||.+||+|||||.+|||++.++. +||+|||++...... ..
T Consensus 349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCc
Confidence 899999999888855 45999999999999999999999999999999999999977665 999999998764443 36
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+|||+|||||++.+..|..+ +||||||++++||+.|.+||...+.-..+ ..-.......+..+..+|+.+++
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAl---yLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred cccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHH---HHHhhcCCCCcCCccccCHHHHH
Confidence 778899999999999998888766 99999999999999999999875543322 22122333455566679999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|+.+||+.|+.+|+++.+||+||||...
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=282.49 Aligned_cols=185 Identities=30% Similarity=0.453 Sum_probs=152.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---~ 77 (268)
+|+|+ -+|.+.|+.++.+++..++.+++|||.||.|+|+.+|+||||||.|+|++.+.. +||+|||+|+.... .
T Consensus 105 ~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 105 FELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFED 181 (359)
T ss_pred hhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCcc
Confidence 46664 489999988888999999999999999999999999999999999999988776 99999999997653 4
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------------
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------------- 142 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 142 (268)
...+.++.|.||+|||++.....+++++||||+|||+.||++|++.|.|.+...++..++.-+..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 45578899999999999987655566799999999999999999999998776665433321111
Q ss_pred -----ccccC--C---CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 143 -----VQYSV--P---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 143 -----~~~~~--~---~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..... + ..+..++.+.+|+.+||+.||.+|+|++|+|.|||+....
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00000 0 1234689999999999999999999999999999997654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=288.33 Aligned_cols=183 Identities=36% Similarity=0.624 Sum_probs=157.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CC---CCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~---~~~kl~Dfg~a~~~~~ 76 (268)
||||.||+|..+|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. .. ..+||+|||+|+....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 8999999999999999999999999999999999999999999999999999999765 22 4689999999998877
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC-CCCCCCH
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQ 155 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~ 155 (268)
.....+.+|+|.|||||++....|+.+ +|+||+|+|+|++++|+.||...+..+.+. .+.......+ .+..++.
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccC
Confidence 777788899999999999998999887 899999999999999999998877654433 2222222222 2334678
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+.+|+...|..+|..|.+..+-+.|++...+.
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 888999999999999999999999999986554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=274.70 Aligned_cols=182 Identities=23% Similarity=0.460 Sum_probs=151.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~ 78 (268)
+|||+. ++...+.+ ...++++.++.+++|++.|+.|+|++++|||||||+||||+.++. +||||||+|+... ...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcc
Confidence 589987 55566655 456999999999999999999999999999999999999987765 9999999999766 555
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (268)
..+.++.|.||+|||.+.+...+++.+||||+||++.||++|.+.|.+.+..+++..+...+-..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 56778999999999999996556777999999999999999999999999888776555432111
Q ss_pred cccCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 144 QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 144 ~~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
..++|. .+.++.-+.+|+++||..||.+|++.++++.|+||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 112222 233678899999999999999999999999999993
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.65 Aligned_cols=212 Identities=31% Similarity=0.545 Sum_probs=173.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (268)
|||+.||++ .+++..+.|+|..++.|++.|+.||.|||++||||||||.+|||++..| ++||+|||+++... ....
T Consensus 448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccccCCCCCc
Confidence 899999994 5556678999999999999999999999999999999999999997665 59999999999766 4455
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
+.+.+|||.|||||++.+..|+.. +|+|||||+||||+.|..||.+.+..+.+.. ++......|.. +|.++.+
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~~--ls~ea~~ 597 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPRF--LSKEAIA 597 (694)
T ss_pred cccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCCc--ccHHHHH
Confidence 667899999999999999998766 9999999999999999999999888665554 44455555554 8999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHHHhC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEAS 223 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (268)
+++++|.++|++|+. +.++..||||+ ...+.....+...++|.+.......++..-+.++...
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr-~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~ 665 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFR-SIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEK 665 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhCCccc-cCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCC
Confidence 999999999999995 58999999995 4556666666666666655555445555555544443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=271.91 Aligned_cols=184 Identities=28% Similarity=0.385 Sum_probs=157.2
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+. +|.+++.+.+ +|...+++.++.|+|+||.|||.+.|+||||||+|+|++..|. +||+|||+|+.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcc
Confidence 899998 9999998765 8999999999999999999999999999999999999977665 9999999999765553
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY------------- 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 145 (268)
..+..+.|.||+|||++.+...++.++|+||+|||+.||+++++.|.+.....++.++++..-...-
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 3566789999999999999776666699999999999999999999999998888887765432211
Q ss_pred --cCCC-----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 --SVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 --~~~~-----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.++. ...++....+|+..+|.+||.+|.||+++|+|.||...
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 1110 01145889999999999999999999999999999764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=278.04 Aligned_cols=184 Identities=33% Similarity=0.594 Sum_probs=155.7
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC--
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-- 76 (268)
||||+||+|..+.+++ +.|++..++.++..++.||+|||-.|||+|||||+||||.++| +|.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCC
Confidence 8999999999999874 4699999999999999999999999999999999999997665 599999988642100
Q ss_pred ---------------------------------C----------------------CCCCCCcCCCCcccchhhccCccC
Q 024363 77 ---------------------------------H----------------------SQPKSTVGTPAYIAPEVLLRHEYD 101 (268)
Q Consensus 77 ---------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 101 (268)
. ....+.+||-.|.|||++.+.+..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 001234689999999999998876
Q ss_pred CcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC----HHH
Q 024363 102 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT----IPE 177 (268)
Q Consensus 102 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s----~~e 177 (268)
.. +|+|+||+++|||+.|..||.+.++...+.+ ++.....+|....+|..+++||+++|.+||.+|+. +.|
T Consensus 314 sA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 314 SA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred ch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 65 9999999999999999999999998665555 55666777877789999999999999999999997 999
Q ss_pred HhcccccCCCCCCcc
Q 024363 178 IMKHQWFLKNLPADL 192 (268)
Q Consensus 178 ~l~h~~~~~~~~~~~ 192 (268)
|.+||||. ...|.+
T Consensus 389 IK~HpFF~-gVnWaL 402 (459)
T KOG0610|consen 389 IKRHPFFE-GVNWAL 402 (459)
T ss_pred hhcCcccc-CCChhh
Confidence 99999994 455543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=275.84 Aligned_cols=188 Identities=27% Similarity=0.451 Sum_probs=160.2
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++. +|...++. +.+++.-.++-+++||++||.|||+.||+||||||.|+|++.+ .+.+||||||.|+....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeecc
Confidence 789987 99999873 6789999999999999999999999999999999999999854 45799999999998888
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
.....+++.|..|+|||.+.+...++.+.||||.|||+.||+.|++.|.|.+...++..+++-+-...
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 88888999999999999999876666669999999999999999999999888888777665432111
Q ss_pred -ccCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 145 -YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 145 -~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
...| .....++++.+|+.++|+++|.+|.++.+++.||||......
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0111 223468999999999999999999999999999999765433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=283.07 Aligned_cols=177 Identities=41% Similarity=0.715 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCc
Confidence 799999999999998889999999999999999999999999999999999999976554 99999999875322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..... ..+......++ ..++.++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~ 224 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKS 224 (323)
T ss_pred ccceecCccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHH
Confidence 345679999999999988777655 99999999999999999999876543322 22333333333 448999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
||.+||..||.+|| ++.++++||||..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=280.83 Aligned_cols=183 Identities=28% Similarity=0.468 Sum_probs=155.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
+|||+. +|.-++.+ .-+|++.+++.+|.||+.||+|||++||+|||||.+||||+.++. +||+|||+|+.....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence 589998 99888876 347999999999999999999999999999999999999977665 999999999954443
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc------cCCC--
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY------SVPD-- 149 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~-- 149 (268)
...++.+.|+||+|||++++...++.++|+||+||||.||++|++.|.+.+..+++.++..-.-.... .+|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 35788899999999999999877777799999999999999999999999988888776654322111 1111
Q ss_pred ---------------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 150 ---------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 150 ---------------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
...++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1226788999999999999999999999999999943
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.53 Aligned_cols=181 Identities=27% Similarity=0.439 Sum_probs=148.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC
Confidence 6899999999888643 36999999999999999999999999999999999999976554 9999999987644333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+..... .....++.++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~ 233 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAK 233 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHH
Confidence 3455679999999999988777665 89999999999999999999876553333333333322222 23345889999
Q ss_pred HHHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 159 DLISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
+||.+||+.||.+||+ ++++++||||..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999999997 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=265.24 Aligned_cols=168 Identities=30% Similarity=0.462 Sum_probs=140.8
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~--~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||.+|+|...|+. +..++|..+|.++.|++.||..+|+ .+ |+||||||.|||++.++. +||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence 899999999999953 4569999999999999999999999 45 999999999999986664 9999999998
Q ss_pred CCCCC-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 73 SSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 73 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
..... ....+.+|||.||+||++.+.+|+.+ +||||+||++|||+.-..||.+.+ +.....++....+..-...
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n----~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDN----LLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCccccc----HHHHHHHHHcCCCCCCcHH
Confidence 64433 33467899999999999999999877 999999999999999999999874 3344444544444311124
Q ss_pred CCCHHHHHHHHHccccCCCCCCCH
Q 024363 152 PISQECRDLISRIFVADPAARITI 175 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~ 175 (268)
.+|.++..||..|+..||.+||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 488999999999999999999985
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=279.75 Aligned_cols=181 Identities=29% Similarity=0.558 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+++++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCc
Confidence 79999999999998888999999999999999999999999999999999999997655 499999999874222 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhcccccCCCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||....... ......+.+.......| ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~ 229 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCC
Confidence 345679999999999988777655 899999999999999999996322111 11112233333333444 3488
Q ss_pred HHHHHHHHHccccCCCCCCC------HHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARIT------IPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s------~~e~l~h~~~~~ 186 (268)
..+.++|.+||+.||.+|++ +.++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999997 789999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=258.47 Aligned_cols=184 Identities=26% Similarity=0.402 Sum_probs=152.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
+||++- +|...|+.. -.|+..+++.++.++++||+|||++.|+||||||.|+||+.++. +||+|||+|+.......
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNR 156 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCc
Confidence 478876 898888654 45999999999999999999999999999999999999976654 99999999997554433
Q ss_pred -CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cCCC--------
Q 024363 80 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD-------- 149 (268)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------- 149 (268)
....+.|.||+|||.+.|...++..+||||+|||+.||+.|.+.|.|.+..+++..+.+.+-.... .+|.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 344589999999999998776677799999999999999999999999988887776665433321 1111
Q ss_pred -------------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 150 -------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 150 -------------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....+.++.+|+.+||.+||.+|+|+.|+++|+||+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 12357889999999999999999999999999999763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=278.87 Aligned_cols=177 Identities=35% Similarity=0.626 Sum_probs=148.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKT 152 (320)
T ss_pred EcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCc
Confidence 799999999999998889999999999999999999999999999999999999976654 99999999875322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.... ...+.......+ ..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ 225 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYP--TWLSQDAVD 225 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHH
Confidence 344579999999999987777655 8999999999999999999987665333 233333333333 348899999
Q ss_pred HHHHccccCCCCCCCH------HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI------PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~------~e~l~h~~~~~ 186 (268)
||++||+.||.+|+++ +++++||||..
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999998 99999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=280.66 Aligned_cols=182 Identities=34% Similarity=0.593 Sum_probs=148.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCccccccCCC
Confidence 79999999999999888999999999999999999999999999999999999997665 4999999998753322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+..... +.+..++..+.
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEAQ 239 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence 2234579999999999976543345599999999999999999999754332222233333333332 23344889999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+||.+||+.||.+|| ++.++++||||..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=277.43 Aligned_cols=178 Identities=35% Similarity=0.651 Sum_probs=149.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 72 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDK 149 (312)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCc
Confidence 799999999999998889999999999999999999999999999999999999976654 999999998753222 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...+......++ ..+++.+.+
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 222 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEPLRFP--DGFDRDAKD 222 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCCCCCC--CcCCHHHHH
Confidence 344579999999999988777665 8999999999999999999987654333 333344433333 348899999
Q ss_pred HHHHccccCCCCCC---CHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARI---TIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~---s~~e~l~h~~~~~~ 187 (268)
||.+||..||.+|| ++.+++.||||.+.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.74 Aligned_cols=183 Identities=37% Similarity=0.627 Sum_probs=159.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC--CCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (268)
||+|.||+|++.|... .++|..+..++.|++.|+.|||+.||+||||||+|+|+..... +.+|++|||+|.......
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 7999999999999877 4999999999999999999999999999999999999975533 469999999999777666
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
.....+||+.|+|||++.+..|... +||||+||++|.|++|..||.+.+....+.++..... .+..+.+..+|..++
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISESAK 270 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHHHH
Confidence 6778899999999999988888766 8999999999999999999999887666554443322 334456677999999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+||.+||..||.+|+|+.++|+|||+...
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=277.38 Aligned_cols=181 Identities=30% Similarity=0.566 Sum_probs=146.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 75 ~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCc
Confidence 799999999999988889999999999999999999999999999999999999976654 99999999875322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-----hHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----PKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ........+.+.......| ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~ 229 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCC
Confidence 344679999999999988777655 8999999999999999999953211 1111112233333333344 3488
Q ss_pred HHHHHHHHHccccCCCCCCC------HHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARIT------IPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s------~~e~l~h~~~~~ 186 (268)
..+.+||++||+.||.+||+ +.++++||||..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999998 589999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=273.51 Aligned_cols=175 Identities=35% Similarity=0.661 Sum_probs=147.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||+++.... ..
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RT 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Cc
Confidence 79999999999999988999999999999999999999999999999999999997655 499999999875432 22
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....... ..+......++ ..++..+++|
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~l 228 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIY----EKILAGKLEFP--RHLDLYAKDL 228 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcCCC--ccCCHHHHHH
Confidence 34579999999999988777655 89999999999999999999876643333 33333333333 3378999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
|++||+.||.+|++ +.+++.||||..
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=277.08 Aligned_cols=177 Identities=38% Similarity=0.701 Sum_probs=148.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
|||++||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 74 ~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAAT 151 (328)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccc
Confidence 799999999999988889999999999999999999999999999999999999976554 99999999875322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.... ...+......+| ..++.++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~p--~~~~~~~~~ 224 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEDIKFP--RTLSADAKS 224 (328)
T ss_pred cccccCCcCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccCCccCC--CCCCHHHHH
Confidence 344579999999999987777655 8999999999999999999987654332 222333333333 448999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
||.+||..||.+|+ ++.++++||||..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999997 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=279.89 Aligned_cols=184 Identities=36% Similarity=0.611 Sum_probs=155.0
Q ss_pred CCCCCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
+|||.+|.+...= ..+. +++.+++.+++.++.||+|||.+|||||||||.|+|++.++ ++||+|||.+.....
T Consensus 189 ley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsDFGVs~~~~~~~~ 265 (576)
T KOG0585|consen 189 LEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISDFGVSNEFPQGSD 265 (576)
T ss_pred EEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeeccceeeecccCCc
Confidence 5899999885432 2334 99999999999999999999999999999999999997665 599999999864422
Q ss_pred ---CCCCCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 77 ---HSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 77 ---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
.......+|||.|+|||.+.+ ..+.+.+.||||+||++|-|+.|+.||.+... .++..++......+|..
T Consensus 266 ~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~KIvn~pL~fP~~ 341 (576)
T KOG0585|consen 266 EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFDKIVNDPLEFPEN 341 (576)
T ss_pred cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHHHHhcCcccCCCc
Confidence 122345789999999999987 55778889999999999999999999987655 34555666777788888
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCCc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 191 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~ 191 (268)
..+...+++||++||.+||.+|+++.++..|||..+.....
T Consensus 342 pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 342 PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 77899999999999999999999999999999998875444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.33 Aligned_cols=177 Identities=32% Similarity=0.623 Sum_probs=155.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
.|||.| +|+.+|...++++|++++.++.+++.||.|||+++|+|||+||.|||+..++. +|+||||+|+...... .
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCcee
Confidence 489998 99999999999999999999999999999999999999999999999976654 9999999998654432 3
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.++..|||.|||||+..+..|+.. +|+||+|||+||++.|++||.. ..+...+..+......+|. ..|..+..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~n 229 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVN 229 (808)
T ss_pred eeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHH
Confidence 345679999999999998888777 8999999999999999999975 3345566667766665555 48999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|+..+|.+||.+|+++.+++.|||++..
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999999753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.38 Aligned_cols=179 Identities=27% Similarity=0.470 Sum_probs=151.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||.||++.+.++.++.+.|..+..++++++.||.|||+++.+|||||+.|||+...+. +||+|||++...... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhc
Confidence 899999999999998888899999999999999999999999999999999999987754 999999998754333 33
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+|||.|||||++.+..|+.+ +||||||++.+||++|.+|+........+ .-+.+. ........+|+.+++
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvl----flIpk~-~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVL----FLIPKS-APPRLDGDFSPPFKE 241 (467)
T ss_pred cccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEE----EeccCC-CCCccccccCHHHHH
Confidence 478899999999999998899888 89999999999999999999887762211 111111 111122358999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
||..||.+||+.||+|.++|+|+|+++.
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999999999763
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=278.06 Aligned_cols=175 Identities=34% Similarity=0.614 Sum_probs=148.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence 799999999999999889999999999999999999999999999999999999976654 99999999875432 22
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...+.......+ ..++..+++|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~l 245 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRLKFP--NWFDGRARDL 245 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCcCCC--CCCCHHHHHH
Confidence 34579999999999988777655 9999999999999999999987654332 233333333333 3378999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
|.+||+.||.+|++ +.+++.||||..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999996 799999999975
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.70 Aligned_cols=177 Identities=38% Similarity=0.689 Sum_probs=148.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++.+.+.+++.++..++.||+.||.|||++|++||||||+||+++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVT 152 (318)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCc
Confidence 799999999999998889999999999999999999999999999999999999976654 99999999864322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+..... ..+.......+ ..++..+.+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~ 225 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKS 225 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHH
Confidence 334569999999999988877665 89999999999999999999876543322 22333333333 347899999
Q ss_pred HHHHccccCCCCCCCH-----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI-----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-----~e~l~h~~~~~ 186 (268)
||++||..||.+||++ .+++.||||..
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999 99999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=280.18 Aligned_cols=179 Identities=35% Similarity=0.611 Sum_probs=147.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKT 152 (330)
T ss_pred EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCC
Confidence 799999999999998889999999999999999999999999999999999999976654 99999999875322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+...... ...+......++. ..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~-~~~~~~~~~ 227 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRFPK-NVLSDEGRQ 227 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCCCC-ccCCHHHHH
Confidence 34567999999999987654334459999999999999999999987654332 2233333333332 237899999
Q ss_pred HHHHccccCCCCCC----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~----s~~e~l~h~~~~~ 186 (268)
||++||..+|.+|| ++.++++||||..
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 99999999999998 7999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=266.75 Aligned_cols=184 Identities=25% Similarity=0.388 Sum_probs=150.7
Q ss_pred CCCCCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+.- +|.+++...+ .++...++.+++||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+....
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFGLARAFSI 172 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccchHHHhcC
Confidence 467765 8999997654 588899999999999999999999999999999999998755 499999999986553
Q ss_pred C-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------
Q 024363 77 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------- 145 (268)
Q Consensus 77 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 145 (268)
. ...+..++|.||+|||++.+...++..+||||+|||++||++++..|.+.+...++..+.+.+-....
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 3 34677899999999999999855555599999999999999999999999987777766654432211
Q ss_pred ----cCCCC----------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 ----SVPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 ----~~~~~----------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.++.+ +..+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111 1123589999999999999999999999999999754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.47 Aligned_cols=180 Identities=31% Similarity=0.566 Sum_probs=145.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCcccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997655 49999999986422110
Q ss_pred ----------------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCC
Q 024363 79 ----------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124 (268)
Q Consensus 79 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 124 (268)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCC
Confidence 0124579999999999988877665 99999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCC---CCCCHHHHhcccccCC
Q 024363 125 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA---ARITIPEIMKHQWFLK 186 (268)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~---~R~s~~e~l~h~~~~~ 186 (268)
.+........++... .....+|...++++++++||.+|+. +|. .||+++++++||||..
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 237 CSETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 876654443333221 1223345445689999999999765 444 4689999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.58 Aligned_cols=174 Identities=30% Similarity=0.489 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~-ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||+++|+|..++.+ ...++...+..++.+|++||+|||+++ ||||||||+|||++... .++||+|||+++.....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVIS 197 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccc
Confidence 799999999999987 678999999999999999999999999 99999999999998765 25999999999865443
Q ss_pred -CCCCCCcCCCCcccchhhc--cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 78 -SQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
...+...||+.|||||++. ...|+.+ +||||||+++|||+||+.||.+..... ....+.....+.+.+..++
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQ----VASAVVVGGLRPPIPKECP 272 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCccCC
Confidence 3445578999999999999 4577766 999999999999999999999887632 2222333333344444488
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+..||.+||..||.+||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999998875
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=272.94 Aligned_cols=177 Identities=38% Similarity=0.702 Sum_probs=147.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+...+++.+++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAK 152 (316)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCc
Confidence 799999999999988888999999999999999999999999999999999999976654 99999999874322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+ +.+.......+ ..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~ 225 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELF----QSIRMDNPCYP--RWLTREAKD 225 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--ccCCHHHHH
Confidence 345579999999999988777665 89999999999999999999876643322 22222222223 337899999
Q ss_pred HHHHccccCCCCCCCHH-HHhcccccCC
Q 024363 160 LISRIFVADPAARITIP-EIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~-e~l~h~~~~~ 186 (268)
||.+||..+|.+||++. +++.||||..
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 99999999999999996 8999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.02 Aligned_cols=177 Identities=40% Similarity=0.714 Sum_probs=147.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGK 152 (316)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCc
Confidence 79999999999998888999999999999999999999999999999999999997665 499999999875322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...... .+....... +..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~--~~~~~~~~~~ 225 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILNDRPHF--PRWISKEAKD 225 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCC--CCCCCHHHHH
Confidence 345579999999999988777665 899999999999999999998766533322 233322222 3347899999
Q ss_pred HHHHccccCCCCCCCH-HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI-PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-~e~l~h~~~~~ 186 (268)
||.+||..+|.+||++ .+++.||||..
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 9999999999999986 58889999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=272.53 Aligned_cols=192 Identities=30% Similarity=0.498 Sum_probs=152.9
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|-||.+||+.++++.. ..|+|..+..+++++++||.|||.+|.||||||+.||||+.+|. |||+|||.+......+
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSG 180 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccC
Confidence 6689999999999763 45999999999999999999999999999999999999987766 9999999875433222
Q ss_pred C----C-CCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----cccC
Q 024363 79 Q----P-KSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----QYSV 147 (268)
Q Consensus 79 ~----~-~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 147 (268)
. . ++.+||++|||||++.. .+|+.+ +||||||++..||.+|..||........+...++.-... ....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 1 1 45689999999999543 577777 899999999999999999998877655544433322110 0111
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCCcccch
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 195 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~ 195 (268)
.....++..++.+|..||++||.+|||++++|+|+||++.........
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~ 307 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVK 307 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcch
Confidence 223457789999999999999999999999999999987766554433
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.14 Aligned_cols=177 Identities=35% Similarity=0.616 Sum_probs=147.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred EcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCc
Confidence 799999999999998889999999999999999999999999999999999999976654 999999998753222 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..... ..+....... ...++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~--~~~~~~~~~~ 225 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMY----DNILNKPLRL--KPNISVSARH 225 (323)
T ss_pred cccccCChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCC--CCCCCHHHHH
Confidence 344579999999999988777655 89999999999999999999876543332 2333333332 2347899999
Q ss_pred HHHHccccCCCCCCCH----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~----~e~l~h~~~~~ 186 (268)
+|.+||+.+|.+||++ .+++.||||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999987 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.61 Aligned_cols=181 Identities=29% Similarity=0.550 Sum_probs=146.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCc
Confidence 799999999999988889999999999999999999999999999999999999976654 99999999874322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .......+.+.......| ..++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~ 229 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVK 229 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHH
Confidence 345679999999999988777655 89999999999999999999643211 111112222333333333 348899
Q ss_pred HHHHHHHccccCCCCCCC------HHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARIT------IPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s------~~e~l~h~~~~~ 186 (268)
+.++|.+||+.||.+|++ +.+++.||||..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 999999999999999997 579999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=277.38 Aligned_cols=175 Identities=32% Similarity=0.581 Sum_probs=147.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~~--~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVDT--RT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecCC--Cc
Confidence 79999999999999988999999999999999999999999999999999999997655 499999999875422 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+..... +.+.......| ..+++.+.++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~l 258 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIY----QKILEGIIYFP--KFLDNNCKHL 258 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHH
Confidence 45679999999999987776555 89999999999999999999876653332 33333333333 3478999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
|++||+.+|.+|+ +++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999964
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.90 Aligned_cols=178 Identities=37% Similarity=0.663 Sum_probs=147.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||.||+|..++.+.+.+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNR 152 (316)
T ss_pred ECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCc
Confidence 79999999999998888999999999999999999999999999999999999997665 499999999874322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ ..+.......+ ..++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~ 225 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELF----ESIRVDTPHYP--RWITKESKD 225 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHH
Confidence 345679999999999988777655 89999999999999999999876543322 22222222233 337899999
Q ss_pred HHHHccccCCCCCCCH-HHHhcccccCCC
Q 024363 160 LISRIFVADPAARITI-PEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-~e~l~h~~~~~~ 187 (268)
||.+||..||.+|+++ .++++||||...
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 9999999999999997 588899999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=265.12 Aligned_cols=210 Identities=34% Similarity=0.601 Sum_probs=169.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
|||++||.|+-++++...|+|..++.+-..|+.||.|||+++||+||||.+|+|++.++. +||+|||+.+.... ...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence 899999999999999999999999999999999999999999999999999999977665 99999999986443 445
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+|||.|.|||++....|... +|+|.+||+||||+||+.||...++...+.-++ -...++| ..+|++++.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----~ed~kFP--r~ls~eAkt 397 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----MEDLKFP--RTLSPEAKT 397 (516)
T ss_pred eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHHH----hhhccCC--ccCCHHHHH
Confidence 677899999999999998888555 999999999999999999999888765544333 3333444 449999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHH
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIA 220 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (268)
|+..+|.+||.+|+ .+.++.+|+||. ...++..-.+...+++++..........+...|+
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~-~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT 462 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA-SVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFT 462 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhc-cCCHHHHHHhccCCCCCCCcccccchhhhhhhhh
Confidence 99999999999998 588999999995 3445444445555555544433333333333333
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=278.73 Aligned_cols=179 Identities=31% Similarity=0.492 Sum_probs=158.5
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|+||+||+|.+.|.+. ..|+|+.+..|+.|++.|++|||+++|+|||||+.|||++.+.. |||+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 7999999999999654 46999999999999999999999999999999999999987776 8999999999766665
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
...+.+|||.||+||++.+.+|..+ +|||||||++|||++-+.+|...+......++.+.. ..|.+..+|.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YSPLPSMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CCCCCccccHHH
Confidence 6678899999999999999999888 899999999999999999999877665555544443 345666699999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.+|+.||..+|..||++.++|.+|.....
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999999999888643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.07 Aligned_cols=177 Identities=38% Similarity=0.714 Sum_probs=148.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCc
Confidence 799999999999988889999999999999999999999999999999999999976654 999999998753222 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...... .+......++ ..+++++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~p--~~~~~~~~~ 224 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP--RTLSPEAKS 224 (323)
T ss_pred cccccCCcCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCC--CCCCHHHHH
Confidence 334579999999999987777655 899999999999999999998765433322 2233333333 348999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
||.+||..||.+|+ ++.++++|+||..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 99999999999998 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.52 Aligned_cols=202 Identities=29% Similarity=0.463 Sum_probs=169.1
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|..|+||+|.-+|.+.+ .|+|..++.++.+|+.||++||+.+||+|||||+|||+|..+ +++|+|+|+|.......
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--hvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--HVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--CeEeeccceEEecCCCC
Confidence 45789999999998876 799999999999999999999999999999999999997665 49999999998877777
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
.....+||.+|||||++....|+.. +|+|||||++|||+.|+.||.......-..++-+.+.......+ ..+|++++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eak 418 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAK 418 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHH
Confidence 7777899999999999998888766 89999999999999999999876554433344455555544444 55999999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCCCCCCcccchhhhcccCCCCCCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 208 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (268)
+|.+.+|++||++|+ ++.++.+||||+. ..+..+......+++.++...
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~-lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD-LNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCccccc-CCHhHHhccCCCCCCCCCccc
Confidence 999999999999998 5679999999964 666666666666666655443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.97 Aligned_cols=177 Identities=36% Similarity=0.650 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCc
Confidence 799999999999988889999999999999999999999999999999999999976654 99999999875332 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+......+| ..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~ 230 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYP--KSMSKEAVA 230 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CcCCHHHHH
Confidence 345679999999999988877655 89999999999999999999876654333 33333333333 348999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
++.+||+.+|.+|++ ..++++||||..
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999997 489999999954
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.27 Aligned_cols=177 Identities=35% Similarity=0.670 Sum_probs=148.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCc
Confidence 79999999999998888999999999999999999999999999999999999997655 499999999864322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+........ .+.......+ ..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~ 230 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYP--KSLSKEAVS 230 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHH
Confidence 334579999999999988777655 899999999999999999998766543332 3333333333 348899999
Q ss_pred HHHHccccCCCCCCCH-----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI-----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-----~e~l~h~~~~~ 186 (268)
++.+||..+|.+|++. .++++||||..
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999976 89999999965
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.68 Aligned_cols=177 Identities=34% Similarity=0.603 Sum_probs=148.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVT 152 (321)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcc
Confidence 79999999999998888999999999999999999999999999999999999997665 499999999875322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+. .+.......| ..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~ 225 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFE----SILHDDVLYP--VWLSKEAVS 225 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHH
Confidence 344579999999999987777665 899999999999999999998776544333 3333333333 337899999
Q ss_pred HHHHccccCCCCCC-------CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-------TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-------s~~e~l~h~~~~~ 186 (268)
||.+||+.+|.+|+ ++.++++||||..
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.51 Aligned_cols=177 Identities=41% Similarity=0.703 Sum_probs=147.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||+||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA 151 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCc
Confidence 7999999999999888899999999999999999999998 79999999999999976654 99999999874322 22
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...+.......+ ..+++++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~ 224 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLSPEAK 224 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHH
Confidence 2344579999999999987777655 9999999999999999999987654332 222233333333 34889999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+||.+||+.||.+|+ ++.++++||||..
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 999999999999997 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=274.64 Aligned_cols=179 Identities=35% Similarity=0.553 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCccccc--cc
Confidence 79999999999999888999999999999999999999999999999999999997655 499999999875433 33
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC----CCCCHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----NPISQE 156 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~ 156 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+..+.... .....+.. ..++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred CCcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHH
Confidence 55679999999999988877665 899999999999999999998766544333322211 11111211 246899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+||.+||..+|.+||++.++++||||..
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.80 Aligned_cols=180 Identities=38% Similarity=0.641 Sum_probs=150.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCcc
Confidence 799999999999998889999999999999999999999999999999999999976654 9999999987543322
Q ss_pred ----------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh
Q 024363 79 ----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130 (268)
Q Consensus 79 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 130 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHH
Confidence 2334579999999999988877665 89999999999999999999887654
Q ss_pred HHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC-HHHHhcccccCC
Q 024363 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWFLK 186 (268)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-~~e~l~h~~~~~ 186 (268)
....++... ......+....+++++.+||.+||. +|.+|++ +.++++||||..
T Consensus 237 ~~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 433332221 1233445555579999999999997 9999999 999999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=272.36 Aligned_cols=178 Identities=35% Similarity=0.623 Sum_probs=149.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCc
Confidence 79999999999999988999999999999999999999999999999999999997655 4999999998743222 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...+.... +..+.......+ ..+++.+.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 229 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLNLP--PYLTPEARD 229 (323)
T ss_pred ccccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHH
Confidence 344579999999999987776555 8999999999999999999987665433 333333333333 347899999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~~ 187 (268)
||.+||+.+|.+|| ++.+++.||||...
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999 89999999999653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=276.91 Aligned_cols=180 Identities=37% Similarity=0.662 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceeccccccc
Confidence 799999999999998889999999999999999999999999999999999999976654 9999999986421110
Q ss_pred -------------------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC
Q 024363 79 -------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 121 (268)
Q Consensus 79 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 121 (268)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCC
Confidence 1113469999999999988777665 89999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHhcccccCC
Q 024363 122 YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLK 186 (268)
Q Consensus 122 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~e~l~h~~~~~ 186 (268)
.||.+.+......+++.. ......+....+++++.+||.+||. +|.+|++ +.+++.||||..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 237 PPFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999876654333322211 1122334444579999999999996 9999998 999999999965
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=268.51 Aligned_cols=177 Identities=41% Similarity=0.735 Sum_probs=161.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||..||.|+++|.+.+.|+|.+++.+++||+.|+.|+|+++++|||||.+|||++.+++ +||+|||++..+......
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 899999999999999999999999999999999999999999999999999999988776 999999999876666677
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
++.+|+|-|.+||++.+.+|.++.+|-|||||++|-|+.|..||.+.+. ...++++....+..|. -+.++.-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHH
Confidence 8899999999999999999999999999999999999999999998765 4456667777776665 46789999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
|+.||-.||.+|.|+.++..|=|+.-
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeec
Confidence 99999999999999999999977753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=284.29 Aligned_cols=185 Identities=24% Similarity=0.391 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+|+....
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLA 223 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccC
Confidence 789986 7777664 356799999999999999999999999999999999999997543 2499999999986554
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+.++++......
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 44455678999999999987654334459999999999999999999998876666555544321110
Q ss_pred -ccCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 -YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 -~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..++ .+...+.++.+||.+||+++|.+|||+.+++.||||..-
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0111 112367899999999999999999999999999999653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=266.25 Aligned_cols=180 Identities=27% Similarity=0.404 Sum_probs=146.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+. |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 88 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~ 164 (290)
T cd07862 88 FEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQM 164 (290)
T ss_pred EccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccccceEeccCCc
Confidence 68887 5999998753 4589999999999999999999999999999999999997665 49999999997654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccCC---------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP--------- 148 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------- 148 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+.+++....... ..++
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (290)
T cd07862 165 ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243 (290)
T ss_pred ccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchh
Confidence 4456679999999999987777665 8999999999999999999998776655555443221100 0000
Q ss_pred -----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 149 -----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 149 -----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
....++..+.+||.+||+.||++|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=251.29 Aligned_cols=177 Identities=40% Similarity=0.690 Sum_probs=157.3
Q ss_pred CCCCCCCchhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
+||..+|+|+..|+ ..++|+|..++.++.|++.||.|+|.++|+||||||+|+|++..+. +||+|||.+.... ..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CC
Confidence 69999999999998 6778999999999999999999999999999999999999976554 9999999998765 56
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
...+.+||..|.|||+..+..++.+ +|+|++|++.||++.|.+||..... .+..+++......+| ..+|..++
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p--~~is~~a~ 250 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFP--STISGGAA 250 (281)
T ss_pred CceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCC--cccChhHH
Confidence 6678899999999999998888777 9999999999999999999987663 345556666666666 44999999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++|.+||.++|.+|++..+++.|||....
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 99999999999999999999999998643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=272.37 Aligned_cols=177 Identities=32% Similarity=0.567 Sum_probs=147.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCC
Confidence 799999999999998889999999999999999999999999999999999999976654 99999999875322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+.. +....... ....+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~ 225 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPLVL--RPGASLTAWS 225 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCccC--CCCCCHHHHH
Confidence 345579999999999988777665 8999999999999999999987665443333 33322222 2347899999
Q ss_pred HHHHccccCCCCCCCH----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~----~e~l~h~~~~~ 186 (268)
+|.+||..+|.+||++ .+++.||||..
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 9999999999999976 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=264.83 Aligned_cols=181 Identities=33% Similarity=0.497 Sum_probs=146.5
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCC
Confidence 799999999888743 35699999999999999999999999999999999999997655 499999999865332
Q ss_pred C-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .......||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...............+..... ..+..++.
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 226 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV--TYPDKFSP 226 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--CCcccCCH
Confidence 2 22334578999999999988777655 89999999999999999999865543332333333333322 22344889
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
.+.+++.+||+.||.+|| +++++++||||..
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999999999999999 8899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=276.34 Aligned_cols=180 Identities=38% Similarity=0.625 Sum_probs=146.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccc
Confidence 799999999999988888999999999999999999999999999999999999976654 999999997521100
Q ss_pred ---------------------------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhH
Q 024363 78 ---------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112 (268)
Q Consensus 78 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (268)
....+.+||+.|+|||++.+..++.+ +|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechH
Confidence 00123469999999999988888765 99999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC---HHHHhcccccCC
Q 024363 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLK 186 (268)
Q Consensus 113 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~e~l~h~~~~~ 186 (268)
++|+|++|+.||.+.+......++.. .......|....+++++.++|.+|+ .+|.+|++ +.++++||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999999987665443333221 1122334445568999999999976 59999997 999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=271.27 Aligned_cols=177 Identities=33% Similarity=0.587 Sum_probs=147.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCC
Confidence 79999999999999888999999999999999999999999999999999999997655 499999999875322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+ ...... ....++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~~~~~~--~~~~~~~~~~~ 225 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI----LNKPLQ--LKPNITNSARH 225 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHH----HhCCcC--CCCCCCHHHHH
Confidence 345679999999999988777655 89999999999999999999876654433332 222222 22348899999
Q ss_pred HHHHccccCCCCCCCHH----HHhcccccCC
Q 024363 160 LISRIFVADPAARITIP----EIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~----e~l~h~~~~~ 186 (268)
+|.+||+.+|.+|+++. ++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999865 8999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.94 Aligned_cols=181 Identities=35% Similarity=0.576 Sum_probs=145.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997655 5999999987531100
Q ss_pred ---------------------------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhH
Q 024363 78 ---------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112 (268)
Q Consensus 78 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (268)
....+.+||+.|+|||++.+..++.+ +|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhh
Confidence 00123579999999999988777655 89999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHcc--ccCCCCCCCHHHHhcccccCC
Q 024363 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF--VADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 113 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l--~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++|+|++|+.||..........+++. .......+....+++++.+||.+|+ ..+|..|+++.+++.||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999999987665443333221 1222344555568999999999955 445556999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.53 Aligned_cols=181 Identities=26% Similarity=0.397 Sum_probs=142.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||++|.|..+....+.+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccc
Confidence 79999988866655566799999999999999999999999999999999999997655 49999999987543221
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------c---
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------V--- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------~--- 143 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+...... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2234578999999999988777655 89999999999999999999876654433222111000 0
Q ss_pred cccCCC-----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 144 QYSVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 144 ~~~~~~-----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
....+. ...+|..+.+||++||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000111 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=265.58 Aligned_cols=181 Identities=28% Similarity=0.506 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... .
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCc
Confidence 689985 9999987644 5899999999999999999999999999999999999976654 999999998753322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------- 144 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (268)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 234557899999999987644334459999999999999999999987765554433332211100
Q ss_pred -ccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 -YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 -~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+. ...++.++++||++||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 12467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=273.32 Aligned_cols=180 Identities=33% Similarity=0.582 Sum_probs=146.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKM 157 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCc
Confidence 7999999999999876 6899999999999999999999999999999999999997655 499999999875432221
Q ss_pred --CCCCcCCCCcccchhhcc------CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 80 --PKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
.....||+.|+|||++.. ..++ .++|||||||++|+|++|+.||........+.++... ......+...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 234 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDP 234 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCC
Confidence 233479999999999863 3343 4489999999999999999999877665444433321 1122344455
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.++.++.+||.+||. +|.+|||+.+++.||||..
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 689999999999997 9999999999999999965
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.32 Aligned_cols=184 Identities=26% Similarity=0.465 Sum_probs=140.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||. |+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCc
Confidence 68996 588887765 45799999999999999999999999999999999999997655 499999999864322 22
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------- 144 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (268)
......+|+.|+|||++.+......++||||+||++|+|++|..||.+........+.+.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987654444558999999999999999999987655433222222111110
Q ss_pred ----ccC--C-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 ----YSV--P-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 ----~~~--~-------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.. + .....+..+.+||.+||+.||.+|||+.++++||||..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 0 001245789999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=275.90 Aligned_cols=180 Identities=34% Similarity=0.589 Sum_probs=145.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997655 49999999985211100
Q ss_pred ----------------------------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhH
Q 024363 79 ----------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112 (268)
Q Consensus 79 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 112 (268)
.....+||+.|+|||++.+..++.+ +|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecch
Confidence 0012469999999999988777655 99999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCC---CCHHHHhcccccCC
Q 024363 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFLK 186 (268)
Q Consensus 113 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R---~s~~e~l~h~~~~~ 186 (268)
++|+|++|..||.+......+..+... .....++....++.++.+||.+||. +|.+| +++.+++.||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999876654433332221 1223344445689999999999997 67765 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.54 Aligned_cols=177 Identities=35% Similarity=0.661 Sum_probs=148.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCcc
Confidence 799999999999998889999999999999999999999999999999999999976654 9999999987533222 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+....... +.+.......| ..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~ 230 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYP--KSLSKEAVS 230 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--ccCCHHHHH
Confidence 334569999999999987777655 89999999999999999999876643333 33333333333 347899999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
++.+||+.+|.+|++ ..++++||||..
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999999999997 579999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=274.95 Aligned_cols=180 Identities=34% Similarity=0.612 Sum_probs=146.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997655 5999999998632110
Q ss_pred ---------------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCC
Q 024363 78 ---------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124 (268)
Q Consensus 78 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 124 (268)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCC
Confidence 00123579999999999988887765 89999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHhcccccCC
Q 024363 125 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
.+.+......++... .....++....++.++++||.+|+ .+|.+|+ ++.+++.||||..
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 877654443333211 122234444458999999999977 5999998 5899999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.67 Aligned_cols=183 Identities=27% Similarity=0.502 Sum_probs=145.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cc
Confidence 79999999999999888899999999999999999999986 5999999999999976654 99999999875432 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHH---------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ--------------------- 138 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--------------------- 138 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... +...+.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccc
Confidence 345679999999999988777665 899999999999999999997544321 111110
Q ss_pred ----------------------HHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 139 ----------------------RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 139 ----------------------~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+............+++++++||.+||++||++|||+.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 01110000011123688999999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.34 Aligned_cols=181 Identities=36% Similarity=0.584 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCcc
Confidence 799999999998865 46899999999999999999999999999999999999976654 9999999987543222
Q ss_pred CCCCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+....+.+++.. .....++....+|.
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~ 276 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISK 276 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCH
Confidence 223567999999999986532 2344599999999999999999999887654443333221 12234455556899
Q ss_pred HHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
++.+||.+||..+|.+ |+++.++++||||..
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999988 999999999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=276.28 Aligned_cols=179 Identities=27% Similarity=0.477 Sum_probs=150.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~~ 78 (268)
+|||.||-...++-. ...|++.++..+++|++.||.|||+++|||||||..|||++.+|. ++|+|||++... ....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHh
Confidence 489999999887765 557999999999999999999999999999999999999987776 999999997543 3334
Q ss_pred CCCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
...+.+|||+|||||++. ..+|..+ +||||||+++.||..+.+|....+....+.++.. ..+.....+..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqPS~W 261 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQPSHW 261 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCcchh
Confidence 456789999999999975 3577777 8999999999999999999887665444443332 233344556779
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
+..+.+|+++||.+||..||++.++|+||||.
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 99999999999999999999999999999995
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=281.99 Aligned_cols=184 Identities=26% Similarity=0.387 Sum_probs=142.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCC--------------CCEEE
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA--------------PRLKI 65 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~--------------~~~kl 65 (268)
||++ ||+|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++..+. ..+||
T Consensus 211 ~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl 289 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289 (467)
T ss_pred Eecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence 4566 77999999888899999999999999999999998 59999999999999975432 24899
Q ss_pred eecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--
Q 024363 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-- 143 (268)
Q Consensus 66 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 143 (268)
+|||.+.... ......+||+.|+|||++.+..+..+ +|||||||++|||++|+.||.+......+..+. .....
T Consensus 290 ~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~-~~~g~~p 365 (467)
T PTZ00284 290 CDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME-KTLGRLP 365 (467)
T ss_pred CCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHcCCCC
Confidence 9999876422 22345689999999999988887665 899999999999999999998766543332221 11100
Q ss_pred ------------------ccc-CCC----------------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 144 ------------------QYS-VPD----------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 144 ------------------~~~-~~~----------------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
... .+. ....+..+.+||.+||++||.+|||+.|+|+||||.+..
T Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 366 SEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred HHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 000 000 000145678999999999999999999999999998755
Q ss_pred C
Q 024363 189 P 189 (268)
Q Consensus 189 ~ 189 (268)
+
T Consensus 446 ~ 446 (467)
T PTZ00284 446 P 446 (467)
T ss_pred C
Confidence 4
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.23 Aligned_cols=181 Identities=28% Similarity=0.473 Sum_probs=148.6
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||.||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCC
Confidence 7999999999888653 4699999999999999999999999999999999999997654 49999999987644333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......|++.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.............+....... +..++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 233 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAAR 233 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHH
Confidence 3345679999999999987777655 8999999999999999999987665443333333333222222 234889999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+||.+||..||.+|| ++.+++.||||..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999999 8999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=270.30 Aligned_cols=177 Identities=35% Similarity=0.651 Sum_probs=148.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... ..
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKK 154 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCc
Confidence 799999999999988888999999999999999999999999999999999999976654 999999998754333 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+.......+ ..++..+.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~ 227 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETM----TMILKAKLGMP--QFLSPEAQS 227 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHH
Confidence 345679999999999987777655 89999999999999999999876543332 33333333333 347899999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
||++||+.||.+||+ +.+++.||||..
T Consensus 228 li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999999999999 788999999965
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=274.95 Aligned_cols=180 Identities=37% Similarity=0.623 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997655 4999999997421100
Q ss_pred -----------------------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHH
Q 024363 78 -----------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116 (268)
Q Consensus 78 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 116 (268)
......+||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeee
Confidence 00123479999999999988777655 899999999999
Q ss_pred HHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHhcccccCC
Q 024363 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 117 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
|++|+.||.+.........+.. .......+....+++++.++|.+|+ .+|.+|+ ++.++++||||..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999987765433322211 1122334444568999999999976 5999999 9999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=267.15 Aligned_cols=176 Identities=36% Similarity=0.632 Sum_probs=146.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|..++.+ +.+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||+++.... ...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 799999999988754 57999999999999999999999999999999999999977654 99999999874322 222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.+...... .+.......+ ..++..+.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYP--RFLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHH
Confidence 345679999999999988777655 899999999999999999998766543332 2333333333 347899999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+|.+||+.||.+|| ++.++++||||..
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999999999 6999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.12 Aligned_cols=183 Identities=26% Similarity=0.393 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 83 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 83 FELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCccccccccccCc
Confidence 78995 69999998888999999999999999999999999999999999999997655 49999999987532221
Q ss_pred --CCCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHH----------------
Q 024363 79 --QPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ---------------- 138 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~---------------- 138 (268)
......||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1234579999999999865 44544 48999999999999999999987654322211110
Q ss_pred -------HHhcccc-cC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 139 -------RILSVQY-SV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 139 -------~~~~~~~-~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....... .. .....+++.+.++|.+||..+|.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000000 00 0112367889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.92 Aligned_cols=216 Identities=29% Similarity=0.550 Sum_probs=180.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||.||+|..+|++-++|.|..+..++..|+-||=|||++||++||||.+||+++..+ ++||+|||+++..... ..
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcc
Confidence 89999999999999999999999999999999999999999999999999999997655 5999999999865444 34
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
+.+.+|||.|+|||++...+|. +++|+||+||++|||+.|++||.+.+....+..++... ...|. .+|.++.+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----vsyPK--slSkEAv~ 579 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----VSYPK--SLSKEAVA 579 (683)
T ss_pred eeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----CcCcc--cccHHHHH
Confidence 5677999999999999988884 55999999999999999999999998877766665543 33343 48999999
Q ss_pred HHHHccccCCCCCCCH-----HHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHHHhCCCC
Q 024363 160 LISRIFVADPAARITI-----PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPA 226 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-----~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (268)
+++.+|.+.|.+|+.+ .++-.||||+ ...+...+.....+++++...-....+.....++......
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR-~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~l 650 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFR-RIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDL 650 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchh-hccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCC
Confidence 9999999999999954 6899999994 5666666666667777666656667777777777655433
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.43 Aligned_cols=182 Identities=33% Similarity=0.566 Sum_probs=145.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEEecccceecccCCce
Confidence 7999999999998654 699999999999999999999999999999999999997665 49999999987543222
Q ss_pred CCCCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+.. +.+.++||||+||++|+|++|+.||.+.+....+.+++.. .....++....++.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~ 276 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISK 276 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCH
Confidence 223567999999999987543 2344599999999999999999999877654444333321 12234455556899
Q ss_pred HHHHHHHHccccCCCC--CCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~~ 187 (268)
.++++|.+||..++.+ |+++.++++||||...
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999999865544 8899999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=260.73 Aligned_cols=180 Identities=25% Similarity=0.372 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.+ +|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 86 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~ 162 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM 162 (288)
T ss_pred Eccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcc
Confidence 688885 898988764 35999999999999999999999999999999999999976654 9999999997654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccCC---------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP--------- 148 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------- 148 (268)
......||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+......+.++........ ..++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07863 163 ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241 (288)
T ss_pred cCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc
Confidence 4455678999999999987777665 8999999999999999999987766555444433221100 0000
Q ss_pred -----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 149 -----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 149 -----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.47 Aligned_cols=177 Identities=34% Similarity=0.576 Sum_probs=146.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCc
Confidence 79999999999998888999999999999999999999999999999999999997665 499999999875322 223
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.... ...+.......+ ...+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ 225 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLP--GGKTVAACD 225 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHH
Confidence 344579999999999987777665 8999999999999999999987654332 233333333333 347899999
Q ss_pred HHHHccccCCCCCCCH----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~----~e~l~h~~~~~ 186 (268)
+|.+||+.+|.+|+++ .++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9999999999999975 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=267.28 Aligned_cols=181 Identities=27% Similarity=0.458 Sum_probs=144.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.+ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 108 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~ 182 (364)
T cd07875 108 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 182 (364)
T ss_pred EeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeCCCccccCCCCcc
Confidence 689975 77777753 589999999999999999999999999999999999997655 4999999999865544444
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++..+...
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (364)
T cd07875 183 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261 (364)
T ss_pred cCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHh
Confidence 56689999999999988777665 899999999999999999998877655554443321110
Q ss_pred -ccc--------------C----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 -QYS--------------V----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 -~~~--------------~----~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
... . ......+..+++||.+||+.||.+|||+.++|+||||...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 0 0011135678999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=266.83 Aligned_cols=183 Identities=27% Similarity=0.483 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 105 ~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~ 179 (359)
T cd07876 105 MELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTACTNFMM 179 (359)
T ss_pred EeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEecCCCccccccCccC
Confidence 689876 6766664 3589999999999999999999999999999999999997665 4999999999765444444
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH------------------hc
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI------------------LS 142 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~------------------~~ 142 (268)
....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.+....+...+... ..
T Consensus 180 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (359)
T cd07876 180 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258 (359)
T ss_pred CCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHh
Confidence 56689999999999988877766 899999999999999999998776544333222211 00
Q ss_pred ccccC--------------C----CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 143 VQYSV--------------P----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 143 ~~~~~--------------~----~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
..... + .....++.+++||.+||..||.+|||+.|++.||||.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00000 0 01124678999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=258.08 Aligned_cols=182 Identities=26% Similarity=0.437 Sum_probs=145.4
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCc
Confidence 79999999998886543 5899999999999999999999999999999999999976554 9999999987544333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||.......................+ ...++.+++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 227 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESK 227 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHH
Confidence 3344578999999999988776655 89999999999999999999765433222223333332222221 234789999
Q ss_pred HHHHHccccCCCCCCCH----HHHhcccccCC
Q 024363 159 DLISRIFVADPAARITI----PEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~----~e~l~h~~~~~ 186 (268)
+||.+||+.||.+||++ .+++.||||..
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999999999 67889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=265.93 Aligned_cols=180 Identities=37% Similarity=0.746 Sum_probs=159.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
+|+=.||+|+++|-++ ..+.|..+++|++||+.|+.|+|+..+|||||||+|+.+-.. -|-|||+|||++........
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcch
Confidence 3666789999999765 469999999999999999999999999999999999887533 34599999999998888888
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.++.+|+..|-|||++++..|.-+++||||||||+|-|+||++||...+..+.+.. +...++..|.- +|.+|++
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----ImDCKYtvPsh--vS~eCrd 248 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----IMDCKYTVPSH--VSKECRD 248 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----hhcccccCchh--hhHHHHH
Confidence 89999999999999999999999999999999999999999999998887665544 44556666554 8999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
||..||+.||.+|.+.++|..|+|++..
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCC
Confidence 9999999999999999999999999754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=268.34 Aligned_cols=182 Identities=36% Similarity=0.596 Sum_probs=144.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCcc
Confidence 799999999999865 4689999999999999999999999999999999999997655 49999999987543222
Q ss_pred CCCCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+....+.+++.. .....++....++.
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~ 276 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISK 276 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCH
Confidence 223567999999999987543 2344599999999999999999999876654443333321 12234455556899
Q ss_pred HHHHHHHHccccCCCC--CCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAA--RITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~~ 187 (268)
.+++||.+||..++.+ |+++.++++|+||...
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999844433 7899999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.36 Aligned_cols=182 Identities=27% Similarity=0.436 Sum_probs=143.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.+ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 101 ~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 175 (355)
T cd07874 101 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 175 (355)
T ss_pred hhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeCcccccCCCcccc
Confidence 789976 67777643 589999999999999999999999999999999999997655 4999999999865544444
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+.+.+..+...
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T cd07874 176 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_pred CCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHh
Confidence 56689999999999988777666 899999999999999999998766544443333221100
Q ss_pred -cc-----c---------C----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 144 -QY-----S---------V----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 144 -~~-----~---------~----~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.. . . ......+..+++||.+||..||.+|||+.++++||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00 0 0 00112357889999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.69 Aligned_cols=195 Identities=31% Similarity=0.571 Sum_probs=167.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||-|-||.|++.+..++.|.+..++.++.++++|++|||++|||+|||||+|++++..+. +||.|||+|+.......+
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCce
Confidence 788999999999999999999999999999999999999999999999999999987665 999999999999999999
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
++.+|||.|.|||+++..+.... +|.||||+++|||++|.+||.+.+.......++..+ -.+..+..++..+.+|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi----d~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI----DKIEFPRRITKTATDL 651 (732)
T ss_pred eeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh----hhhhcccccchhHHHH
Confidence 99999999999999998887666 899999999999999999999988755554444433 3333446689999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCCCCCCcccchhhhcccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYE 203 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~~~~~~~~~~~~~~~~~~ 203 (268)
|+++...+|.+|+. +.++.+|.|| ..+.+.-.......+++.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf-~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWF-EGFDWEGLRSRTLPPPII 698 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhh-hcCChhhhhhccCCCCcc
Confidence 99999999999995 8899999999 456665544444444443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=271.65 Aligned_cols=182 Identities=29% Similarity=0.408 Sum_probs=147.9
Q ss_pred CCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 2 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|... -+|+++|+.++ .|+...++.++.||+.||.+||+.||||+||||+|||+.......|||+|||.|+......
T Consensus 268 ELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v- 345 (586)
T KOG0667|consen 268 ELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV- 345 (586)
T ss_pred hhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc-
Confidence 4444 49999998754 5899999999999999999999999999999999999987766689999999998654333
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-----------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------------- 142 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------- 142 (268)
.+++.++.|+|||++++.+|..+ .||||||||++||++|.+.|.|.+..+++..++.-+-.
T Consensus 346 -ytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 346 -YTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred -eeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 38899999999999999999887 89999999999999999999998877766544432100
Q ss_pred c-------------------------------cccCC-CCC--------CCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 143 V-------------------------------QYSVP-DTN--------PISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 143 ~-------------------------------~~~~~-~~~--------~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
. ....| ... .-...+.+||++||.+||.+|+|+.++|+||
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 0 00011 000 0125679999999999999999999999999
Q ss_pred ccCCC
Q 024363 183 WFLKN 187 (268)
Q Consensus 183 ~~~~~ 187 (268)
||...
T Consensus 504 fl~~~ 508 (586)
T KOG0667|consen 504 FLTGT 508 (586)
T ss_pred ccccc
Confidence 99853
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=255.06 Aligned_cols=244 Identities=26% Similarity=0.479 Sum_probs=190.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
.||++||+|.-+++++.+++|+.++.+...|..||+|||++||++||||.+|+|++..+ ++||+|+|+.+.......
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCcc
Confidence 48999999999999999999999999999999999999999999999999999997655 599999999987555444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCC--CCChHH--HHHHHHHHhcccccCCCCCCCCH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED--PDEPKD--FRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
+.+.+|||.|+|||++.+..|.-. +|+|+|||+|+||+.|+.||.- .+++.. -.-..+-++....++|.. +|-
T Consensus 408 tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsv 484 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSV 484 (593)
T ss_pred cccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eeh
Confidence 456789999999999998887544 9999999999999999999952 222211 111234445555555554 888
Q ss_pred HHHHHHHHccccCCCCCC------CHHHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHHHhCCCCCCC
Q 024363 156 ECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGT 229 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~------s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (268)
.+..+++..|++||.+|+ .+.++..|+||+ ...+.....+...++|.+.....--++.+...|+.
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr-~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~-------- 555 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR-SIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTS-------- 555 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh-hCCHHHHhhcccCCCCCCccccccCcccccccccc--------
Confidence 899999999999999998 468999999996 77888887777777776554433333322222222
Q ss_pred cCccccccCCCCCCCccccccccccccccCCCCcccc
Q 024363 230 HGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIY 266 (268)
Q Consensus 230 ~~~~~~~~~~~~~~~~d~d~~~~~~~~d~~~~g~~~~ 266 (268)
.-.....||+|...-.|+.+.+|+.+||+
T Consensus 556 --------e~~qltpdd~d~i~ridqsefegfeyinp 584 (593)
T KOG0695|consen 556 --------EPVQLTPDDEDAIKRIDQSEFEGFEYINP 584 (593)
T ss_pred --------CCcccCCCCHHHHHhcchhhcCcceecch
Confidence 12233457778888889999999999986
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.72 Aligned_cols=181 Identities=28% Similarity=0.483 Sum_probs=144.8
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCCc
Confidence 7999999999998653 3599999999999999999999999999999999999997655 49999999987544333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......|++.|+|||++.+..++.+ +|+||+||++|+|++|+.||........... ....... ........+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKE-VQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhh-hhhhcCccCCHHHH
Confidence 3345679999999999987777655 8999999999999999999986543221111 1111111 11112334789999
Q ss_pred HHHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 159 DLISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
+|+.+||+.||.+||| +.++++||||.+
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.92 Aligned_cols=184 Identities=34% Similarity=0.593 Sum_probs=154.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++||+|..++.+.++++|.-+++|+..|+.||.-||+.|+|||||||+||||+..| ++||+|||.+-.....+
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcE
Confidence 89999999999999988999999999999999999999999999999999999997665 59999999765443333
Q ss_pred CCCCCcCCCCcccchhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....+|||.|++||++.. .+.+++.+|+||+||++|||+.|..||...+-...+.+++.. ...+.+|....+|
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDVS 309 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCcccccC
Confidence 3456689999999999852 245577799999999999999999999977666666666544 2345667666699
Q ss_pred HHHHHHHHHccccCCCCCCC---HHHHhcccccCCCCCC
Q 024363 155 QECRDLISRIFVADPAARIT---IPEIMKHQWFLKNLPA 190 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s---~~e~l~h~~~~~~~~~ 190 (268)
.++++||.+++ .+|..|+. ++++..||||. +.+|
T Consensus 310 eeakdLI~~ll-~~~e~RLgrngiedik~HpFF~-g~~W 346 (1317)
T KOG0612|consen 310 EEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFE-GIDW 346 (1317)
T ss_pred HHHHHHHHHHh-cChhhhcccccHHHHHhCcccc-CCCh
Confidence 99999999987 56999997 99999999994 3444
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=256.00 Aligned_cols=184 Identities=27% Similarity=0.434 Sum_probs=152.9
Q ss_pred CCCCCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||..|++.+.+. ++++++|.++..+++..++||+|||-..-+|||||..|||++..+ ..||+|||+|-.... -.
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHH
Confidence 89999999999996 466799999999999999999999999999999999999996655 489999999865332 34
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
..++.+|||.|||||++..-+|++. +||||||++..||..|++||........ +.----+....+..+..+|.++.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred hhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCChHhhhhHHH
Confidence 5678899999999999999999888 8999999999999999999987665221 11000112223344455899999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
+||++||.++|++|.|+.++++|||++.....
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 99999999999999999999999999655443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=261.32 Aligned_cols=182 Identities=29% Similarity=0.521 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..+..++.|++.||.|||++ +++||||||+|||++.++. +||+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hc
Confidence 79999999999999888899999999999999999999985 7999999999999976554 99999999864322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHH----------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---------------------- 137 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---------------------- 137 (268)
.....||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||........ ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccc
Confidence 234578999999999987776655 8999999999999999999975443211 1111
Q ss_pred -------------------HHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 138 -------------------QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 138 -------------------~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..+............++.++++||.+||++||.+|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00111000000112367899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=266.06 Aligned_cols=182 Identities=20% Similarity=0.304 Sum_probs=139.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (268)
|||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++..+. +||+|||+|+..... .
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINAN 238 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccc
Confidence 57775 699999988888999999999999999999999999999999999999976554 999999998642221 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHh----------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRIL---------- 141 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~---------- 141 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ...+..++....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2334579999999999988777655 9999999999999999988754321 111111111110
Q ss_pred ------------cccccCCC-------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 142 ------------SVQYSVPD-------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 142 ------------~~~~~~~~-------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
......+. ...++.++.+||.+||+.||.+|||+.++|+||||..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000010 1124678999999999999999999999999999965
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.16 Aligned_cols=182 Identities=30% Similarity=0.506 Sum_probs=140.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
||||.||+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceeccccccc
Confidence 799999998643 3567888999999999999999999999999999999997665 49999999987543222 2
Q ss_pred CCCCcCCCCcccchhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .+...+..+.. .........++.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~ 302 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICM-SQPPEAPATASR 302 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhc-cCCCCCCCccCH
Confidence 345679999999998743 233444589999999999999999999743322 22222222221 112223345789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++++||.+||..+|.+|||+.++++||||.+....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 99999999999999999999999999999876443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=265.83 Aligned_cols=184 Identities=26% Similarity=0.425 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (268)
|||+. ++|.+.+.+.+.+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++..... .
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESK 159 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCccc
Confidence 68886 58999998888899999999999999999999999999999999999997665 4999999998753322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH-------------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR------------------- 139 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~------------------- 139 (268)
......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 2234568999999999987554445589999999999999999999877654443332211
Q ss_pred HhcccccC-------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 140 ILSVQYSV-------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 140 ~~~~~~~~-------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+....... ......+.++.+||.+||+.||.+|||+.+++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00111111 1123357899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.50 Aligned_cols=178 Identities=31% Similarity=0.521 Sum_probs=146.7
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++....
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAA 195 (496)
T ss_pred EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEecccCeeccc
Confidence 799999999999864 34699999999999999999999999999999999999997655 499999999875332
Q ss_pred C---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 77 H---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 77 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.... +........ .+.+..+
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~----~~~~~~~~~-~~~~~~~ 269 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEV----MHKTLAGRY-DPLPPSI 269 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCCC-CCCCCCC
Confidence 2 22345679999999999988777655 8999999999999999999987654332 233332222 2334458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++++.+++.+||+.+|.+||++.++++|||++.
T Consensus 270 ~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999854
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.05 Aligned_cols=175 Identities=30% Similarity=0.470 Sum_probs=154.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||..|.|+..|+...+++......|..+|+.|++|||.++|||||||.-||||+.+.. |||+|||-++........
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTK 268 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhh
Confidence 899999999999999999999999999999999999999999999999999999987665 999999998865555555
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
-+..||..|||||++...+.+.+ +||||||||||||+||..||.+.+.. .++-.+-......|.+..++.-++=|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHH
Confidence 56789999999999999888877 99999999999999999999876653 23444444555677777799999999
Q ss_pred HHHccccCCCCCCCHHHHhccc
Q 024363 161 ISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~ 182 (268)
|+.||+..|.+||++.+++.|-
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHH
Confidence 9999999999999999999984
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=273.65 Aligned_cols=178 Identities=34% Similarity=0.562 Sum_probs=145.8
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSD 221 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCC
Confidence 799999999988753 45699999999999999999999999999999999999997655 499999999975432
Q ss_pred CC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 77 HS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 77 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
.. .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... +..+..... .+.+..+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~----~~~~~~~~~-~~~~~~~ 295 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREI----MQQVLYGKY-DPFPCPV 295 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCC-CCCCccC
Confidence 21 2344579999999999987777655 8999999999999999999987654332 333332222 1233458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.++.+||.+||..+|.+||++.+++.|+|+..
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999853
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=253.91 Aligned_cols=179 Identities=32% Similarity=0.529 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||++...... ..
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KP 152 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-Cc
Confidence 799999999999988889999999999999999999999999999999999999976654 999999998643322 22
Q ss_pred CCCcCCCCcccchhhcc-CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....|++.|+|||.+.. ..++. ++|+||+||++|+|++|..||........ ........... ...+..++.++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVN--VELPDSFSPELKS 228 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCc-hhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCC--cCCccccCHHHHH
Confidence 34579999999999864 33444 48999999999999999999975433221 11111112222 2223448899999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+|.+||..||.+|+ ++.++++||||+.
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=261.14 Aligned_cols=182 Identities=30% Similarity=0.581 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCc
Confidence 799999999999977 46799999999999999999999999999999999999997655 49999999986532222
Q ss_pred -CCCCCcCCCCcccchhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC-CCC
Q 024363 79 -QPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNP 152 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 152 (268)
......||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+......++.... ....++. ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~ 235 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD 235 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence 1233579999999999863 2223444999999999999999999998766544433332211 1112222 234
Q ss_pred CCHHHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
++.++++||++||..++.+ |+++.++++||||..
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 7999999999999765554 689999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=251.52 Aligned_cols=178 Identities=29% Similarity=0.545 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+...+++.+++.++.|+++||.|||+.|++||||||+||+++.++ +.++|+|||+++.... .
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~---~ 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGT---P 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCC---C
Confidence 79999999999998888999999999999999999999999999999999999997665 2599999999865432 2
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....++..|+|||++.+..++.+ +|+||+||++|+|++|+.||........-...+..... ...+....+++.+.+|
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSKNANDF 240 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCHHHHHH
Confidence 33468999999999988777655 89999999999999999999855432211111211111 1223334589999999
Q ss_pred HHHccccCCCCCCC-HHHHhcccccC
Q 024363 161 ISRIFVADPAARIT-IPEIMKHQWFL 185 (268)
Q Consensus 161 i~~~l~~dp~~R~s-~~e~l~h~~~~ 185 (268)
|.+||+.+|.+|++ ++++++||||.
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999996 69999999995
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=259.30 Aligned_cols=182 Identities=31% Similarity=0.599 Sum_probs=141.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGT 157 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCC
Confidence 799999999999976 56799999999999999999999999999999999999997655 499999999865332222
Q ss_pred --CCCCcCCCCcccchhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC-CCCC
Q 024363 80 --PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNP 152 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 152 (268)
.....||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.........+... ......+ ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 235 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTD 235 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCC
Confidence 223469999999999863 222344589999999999999999999876554433332221 1111222 2234
Q ss_pred CCHHHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
++..+++||++||..++.+ |+++.+++.||||..
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 7899999999998764443 789999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=257.47 Aligned_cols=183 Identities=26% Similarity=0.386 Sum_probs=134.8
Q ss_pred CCCCCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC--CCCCEEEeecC
Q 024363 1 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~--~~~~~kl~Dfg 69 (268)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 578864 888887532 258999999999999999999999999999999999999532 23469999999
Q ss_pred CCCCCCCCC----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---------HHHHHH
Q 024363 70 YSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKT 136 (268)
Q Consensus 70 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~ 136 (268)
+++...... ......||+.|+|||++.+....+.++||||+||++|+|++|++||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 997543221 2235678999999999987554455599999999999999999999754321 111111
Q ss_pred HHHH------------------------hcccccC--------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 137 IQRI------------------------LSVQYSV--------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 137 ~~~~------------------------~~~~~~~--------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.... ....... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100 0000000 0011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=266.31 Aligned_cols=172 Identities=38% Similarity=0.580 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||++.||-|.+.+.....+. .++..|+++|+.|+.|||++|||||||||+|||++ +..++++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--h
Confidence 78999999999987776666 88889999999999999999999999999999996 33446999999999865444 3
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+-|..|.|||++....|+.. +||||||+++|+|++|+.||...... .++...+....+. ..+|..+++|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdL 542 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDL 542 (612)
T ss_pred cccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHH
Confidence 45567889999999998888766 99999999999999999999877665 3344444444333 4599999999
Q ss_pred HHHccccCCCCCCCHHHHhccccc
Q 024363 161 ISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
|++||+.||.+|+++.+++.||||
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=250.31 Aligned_cols=177 Identities=28% Similarity=0.452 Sum_probs=141.5
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
|||+.+|+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc
Confidence 6999999999999763 46899999999999999999999999999999999999976654 999999998753322
Q ss_pred CCCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 78 SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.......|++.|+|||++.+ ..++.+ +|+||+||++|+|++|+.||........... .............
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 240 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKK 240 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCC
Confidence 22344578999999999863 234444 8999999999999999999976543222211 1122222223345
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++..+.+||.+||..+|.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=259.51 Aligned_cols=182 Identities=25% Similarity=0.430 Sum_probs=140.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||++ |++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.... ..
T Consensus 99 ~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~--~~ 172 (343)
T cd07878 99 TNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD--EM 172 (343)
T ss_pred eecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC--Cc
Confidence 4555 779987764 457999999999999999999999999999999999999976654 99999999875432 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.......
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence 456799999999998774434455999999999999999999998765443333222111000
Q ss_pred --cccCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 144 --QYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 144 --~~~~~~------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
....+. ....++.+.+||.+||+.||.+|||+.+++.||||.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000000 123567789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=263.61 Aligned_cols=183 Identities=24% Similarity=0.368 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+. +||+|||+++.......
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDT 241 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccc
Confidence 67886 589999987888999999999999999999999999999999999999976554 99999999875433221
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhcccc---------
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQY--------- 145 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~--------- 145 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..++..+.....
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 234579999999999988777665 89999999999999999999765432 222222221111100
Q ss_pred ----------------cCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 ----------------SVPD---TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 ----------------~~~~---~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..+. ...++.++.+||++||..+|.+|||+.++|.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0010 01246789999999999999999999999999999664
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=252.79 Aligned_cols=182 Identities=29% Similarity=0.480 Sum_probs=148.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCC
Confidence 6899999999888653 3699999999999999999999999999999999999997655 49999999986543333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......|++.|+|||++.+..++.+ +|+||+||++|+|++|..||.+.................... ....++..+.
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--YSAKFSEEAK 233 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--cCccCCHHHH
Confidence 3345679999999999987777655 899999999999999999998765543333333333332222 2334789999
Q ss_pred HHHHHccccCCCCCCC-----HHHHhcccccCCC
Q 024363 159 DLISRIFVADPAARIT-----IPEIMKHQWFLKN 187 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s-----~~e~l~h~~~~~~ 187 (268)
+|+.+||+.+|.+||+ +.+++.|+||..-
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8899999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=248.57 Aligned_cols=177 Identities=31% Similarity=0.526 Sum_probs=145.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||+++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceeccccccc
Confidence 68999999999999888899999999999999999999999999999999999997655 4999999998643222111
Q ss_pred ----CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 81 ----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 81 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
....++..|+|||++.+..++.+ +|||||||++|+|++|+.||.......... ...........+..++..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPQLPSHVSPD 235 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHH----HHhccCCCCCCCccCCHH
Confidence 23467889999999987776555 899999999999999999997655433222 222222223334458899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+.++|.+||..+|.+|||+.++++|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=255.36 Aligned_cols=183 Identities=26% Similarity=0.473 Sum_probs=142.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... .
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcc
Confidence 789986 888888654 45899999999999999999999999999999999999976654 999999998753322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (268)
......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 23345689999999998765444455999999999999999999998776544433332211100
Q ss_pred cccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 144 QYSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 144 ~~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....+ ....++.++++||.+||+.||.+|||+.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00011 11246889999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.01 Aligned_cols=171 Identities=22% Similarity=0.234 Sum_probs=141.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..+..++.|++.||.|||+. +++||||||+||+++.++. +||+|||+++.... .
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~ 176 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--P 176 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--c
Confidence 79999999999999888999999999999999999999984 9999999999999987654 99999999875322 2
Q ss_pred CCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....|++.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+...... .+.......+.+..++..+
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~l 251 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEI 251 (283)
T ss_pred cccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCCcCcHHH
Confidence 235678999999999876 456555 999999999999999999998766433322 2322333334444588999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+||.+||+.||.+|||+.+++.
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999986
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.54 Aligned_cols=183 Identities=31% Similarity=0.517 Sum_probs=150.7
Q ss_pred CCCCCCCchhHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l--~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~ 76 (268)
||-++||+|.+++.. -|++ +|..+..+.+||++||.|||.+.|||||||-+|+||+. ..|.+||+|||-++... .
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccC
Confidence 899999999999964 5777 89999999999999999999999999999999999974 34569999999987533 3
Q ss_pred CCCCCCCcCCCCcccchhhccC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
...+.+..||..|||||++..+ .-+++++|||||||++.||.||++||....++...+ -++--.+...|.+..+|.
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmyKvHP~iPeelsa 806 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMYKVHPPIPEELSA 806 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhcceecCCCCcHHHHH
Confidence 4455677899999999999653 334677999999999999999999998766654322 122112223445556889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+++.||.+|+..+|..||++.++|..||++.+
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999999999754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.82 Aligned_cols=180 Identities=31% Similarity=0.523 Sum_probs=145.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.||+|.+++.+.+.+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++..... ..
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KP 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCcc-CC
Confidence 79999999999998888899999999999999999999999999999999999997655 4999999998743222 23
Q ss_pred CCCcCCCCcccchhhccC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....|+..|+|||++.+. .++. ++|+||+||++|+|++|+.||........ .............. +..+|..+.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~-~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~--~~~~s~~~~~ 228 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL--PDSFSPELRS 228 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCc-ccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCC--CCcCCHHHHH
Confidence 455799999999998754 4544 48999999999999999999986533221 11112222222222 3347899999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~~ 187 (268)
++.+||..+|.+|| ++.++++||||...
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=255.75 Aligned_cols=156 Identities=22% Similarity=0.427 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (268)
.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......+++.|+|||+
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 478889999999999999999999999999999999997655 49999999997532221 1223456788999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |..||.+......+...+. .......+..+++.+.+|+.+||..+|.+||
T Consensus 248 ~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 248 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK----DGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred hhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 988777666 899999999999997 9999987654333322221 1122223345789999999999999999999
Q ss_pred CHHHHhc
Q 024363 174 TIPEIMK 180 (268)
Q Consensus 174 s~~e~l~ 180 (268)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=258.45 Aligned_cols=171 Identities=26% Similarity=0.438 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++.|+|.++|+. ++.+...+...++.||++|++||+++++|||||.+.||||+.+.. +||+|||+|+.....
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~- 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDD- 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCC-
Confidence 799999999999986 567999999999999999999999999999999999999977664 999999999943222
Q ss_pred CCCCC---cCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 QPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
..+.. --...|.|||.+....++.+ +|||||||+|||++| |+.||.+.++.+.+. .+..+++.|.+..+|
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCP 430 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCC
Confidence 22222 23457999999999999888 999999999999998 999999888755443 345677888888899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.++.+++..||..+|++|||++.+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 99999999999999999999986653
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.68 Aligned_cols=182 Identities=27% Similarity=0.438 Sum_probs=137.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+. |+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++..+. +||+|||+++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcc
Confidence 57885 588888865 457999999999999999999999999999999999999976554 99999999875443344
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCC-CCCCCh---------HHHHHHHHHHhcccccCC-
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEP---------KDFRKTIQRILSVQYSVP- 148 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~---------~~~~~~~~~~~~~~~~~~- 148 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|+++..|+ ...... ..+.+++.........++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 445679999999999988777666 89999999999999855444 332211 111111111110000001
Q ss_pred ---------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 149 ---------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 149 ---------------------------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11235678888999999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.81 Aligned_cols=179 Identities=27% Similarity=0.481 Sum_probs=150.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.+ +|...+. -.+.-..+..++.|++.|+.|||+.||+||||||+||++..++. +||.|||+|+........
T Consensus 100 ~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~m 174 (369)
T KOG0665|consen 100 MELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMM 174 (369)
T ss_pred HHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCccccc
Confidence 678865 8888887 35788899999999999999999999999999999999987776 999999999987776667
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (268)
+.++.|..|+|||++.+.+|..+ +||||+||++.||++|+..|.+.+...++.+++...-....
T Consensus 175 tpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred CchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 78899999999999999888777 99999999999999999999998887777666654322110
Q ss_pred ------------cCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 146 ------------SVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 146 ------------~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.+|. ...-+..+++++.+||..+|++|.++.++|+|||++
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0110 111235689999999999999999999999999997
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=246.03 Aligned_cols=181 Identities=36% Similarity=0.630 Sum_probs=148.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+...+++..+..++.||+.||.|||+++++|+||+|.||+++.++ .+||+|||+++........
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 72 MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred EecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCccccc
Confidence 68999999999999888899999999999999999999999999999999999997655 4999999998765443333
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||....... .+....+.........+...+.+++++
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred ccccCCcCccChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 45578999999999877776655 899999999999999999998765211 222233332222223333358999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
|.+||..+|.+||+ +.++++||||..
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999999999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=250.98 Aligned_cols=180 Identities=37% Similarity=0.646 Sum_probs=143.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC-CCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~~~ 79 (268)
||||.+|+|.+++.+.+.+++..++.++.|++.||.+||++|++||||||+||+++.++. ++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 689999999999998889999999999999999999999999999999999999985554 999999998642 22334
Q ss_pred CCCCcCCCCcccchhhc-cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--cCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 156 (268)
.....+++.|+|||++. +.... .++|+||+|+++|+|++|..||........ ...+........ ........+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYT-RKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBS-THHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHH
Confidence 45667899999999987 45554 449999999999999999999987632222 222222222111 11111123489
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+.++|.+||+.+|++||++.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=246.98 Aligned_cols=178 Identities=35% Similarity=0.565 Sum_probs=144.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+.+++||||+|.||+++.++ .+||+|||+++.... .
T Consensus 76 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~ 150 (260)
T cd05611 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---N 150 (260)
T ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---c
Confidence 69999999999998888999999999999999999999999999999999999997655 499999999875332 2
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+....+........ .+.......++..+.++
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 227 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI--NWPEEVKEFCSPEAVDL 227 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--CCCCcccccCCHHHHHH
Confidence 34568899999999887765544 9999999999999999999987665433322221111 11112223478999999
Q ss_pred HHHccccCCCCCC---CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
|.+||+.+|.+|| ++++++.||||.+
T Consensus 228 i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 228 INRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 9999999999999 4579999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=272.86 Aligned_cols=176 Identities=32% Similarity=0.557 Sum_probs=148.3
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||.||+|.+++.+ ..+|+|.+|++|++++++|+.+||..+ |||||||-|||||+.++. .||||||.|.....
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKIL 198 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccC
Confidence 899999999999963 456999999999999999999999998 999999999999976664 99999999875333
Q ss_pred CCCCC----------CCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 024363 77 HSQPK----------STVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 77 ~~~~~----------~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
..... ....|+.|+|||++. +.....+ +|||||||+||.|+....||+.... ..|+..
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~--------laIlng 269 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGK--------LAILNG 269 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEec
Confidence 32111 235799999999984 4455555 9999999999999999999987633 236788
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+.+|...++|..+.+||+.||+.||.+||++-+++.+-+-..+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 89999988999999999999999999999999998876554433
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=244.09 Aligned_cols=176 Identities=25% Similarity=0.491 Sum_probs=143.4
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||+||+|.+++.. ...+++.+++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQC 156 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccC
Confidence 799999999999975 34599999999999999999999999999999999999997655 4999999998754322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.......+++.|+|||++.+..++.+ +|+||+||++++|++|+.||...+....... +..... .+.+..+++.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~ 230 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPEL 230 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHH
Confidence 22334568999999999987777655 8999999999999999999986554332222 222211 12234588999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+++.+||+.+|.+||++.++++||||
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=256.42 Aligned_cols=181 Identities=31% Similarity=0.592 Sum_probs=141.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCc
Confidence 799999999999987 56899999999999999999999999999999999999997655 499999999875433222
Q ss_pred --CCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC-CC
Q 024363 80 --PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TN 151 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 151 (268)
.....||+.|+|||++.+ ..+. .++|||||||++|+|++|+.||...+......++... .....++. ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~ 234 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHIT 234 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCccc
Confidence 123569999999999865 2343 4489999999999999999999876654433332221 11112222 23
Q ss_pred CCCHHHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 152 PISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
.++.++++||.+||...+.+ |++++++++||||..
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 47899999999999876554 568999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.52 Aligned_cols=181 Identities=34% Similarity=0.536 Sum_probs=147.2
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+.+ .+++..++.++.|++.||.|||++|++||||+|+||+++.++. +||+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGK 149 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCC
Confidence 69999999999997765 7999999999999999999999999999999999999976654 9999999987544333
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......++..|+|||++.+..++.+ +|+||+||++|+|++|+.||...........+........ ...+..+++.+.
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 226 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA--VEYPDKFSPEAK 226 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc--ccCCccCCHHHH
Confidence 4445678899999999887776555 8999999999999999999977654222222222222222 223334789999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
++|.+||+.+|.+|| ++.+++.||||.+
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999999999 8899999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=246.08 Aligned_cols=179 Identities=25% Similarity=0.435 Sum_probs=140.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++...+.+++.+++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccc
Confidence 79999999999998888999999999999999999999999999999999999997655 4999999998643222 22
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....|++.|+|||++. ...++. ++|+|||||++|+|++|..||.................. .........++..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQ-LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKWSNS 240 (267)
T ss_pred cccccCcccccChhhhccccCCCCCc-hhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC-CCcccccCCCCHH
Confidence 23457899999999974 233444 489999999999999999998765433222111111000 0111122347889
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
+.++|.+||..+|++||++.+++.|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=247.19 Aligned_cols=182 Identities=25% Similarity=0.426 Sum_probs=143.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||+++++|..++.....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccc
Confidence 69999999988887777899999999999999999999999999999999999997665 49999999987543332 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (268)
.....++..|+|||++.+....+.++|+|||||++|+|++|+.||.+.........+....... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 3345688999999998764433445899999999999999999998766544333222211100 0
Q ss_pred ccCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 ~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+. ...++..+.+||.+||..+|++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00111 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=244.92 Aligned_cols=176 Identities=35% Similarity=0.538 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++|++|.+++.+.+.+++..++.++.|++.||+|||++|++||||+|+||+++.++. +||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06628 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLS 162 (267)
T ss_pred EEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccccccc
Confidence 689999999999988888999999999999999999999999999999999999976554 9999999987543211
Q ss_pred -----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......|++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||..........+ .... .....+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~ 236 (267)
T cd06628 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IGEN-ASPEIPSNI 236 (267)
T ss_pred CCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hhcc-CCCcCCccc
Confidence 1123458889999999987776655 8999999999999999999987654332222 1111 112223447
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+..+.++|++||+.+|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=245.76 Aligned_cols=181 Identities=32% Similarity=0.489 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||++|++|.+++.+. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADG 155 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccC
Confidence 6899999999999764 4699999999999999999999999999999999999998655 4999999998654332
Q ss_pred CC-----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC-CCCC
Q 024363 78 SQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV-PDTN 151 (268)
Q Consensus 78 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 151 (268)
.. .....|+..|+|||++......+.++|+|||||++|+|++|+.||........+.+..... ...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccc
Confidence 22 2344689999999998766333444899999999999999999998766544433333221 111111 1123
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+++.+.+++.+||..+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 578999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=247.63 Aligned_cols=177 Identities=27% Similarity=0.447 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||.+|+|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV 175 (282)
T ss_pred EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc
Confidence 799999999999975 345899999999999999999999999999999999999976554 999999998753321
Q ss_pred CCCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 78 SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.......|++.|+|||++.. ..++.+ +|+|||||++|+|++|+.||........... .............
T Consensus 176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 250 (282)
T cd06636 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSKK 250 (282)
T ss_pred cCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcccc
Confidence 22344678999999999752 344444 8999999999999999999976543222211 1111111122234
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.++.+||.+||..+|.+||++.++++||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=251.45 Aligned_cols=179 Identities=36% Similarity=0.640 Sum_probs=147.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhcccccc
Confidence 6899999999999764 5799999999999999999999999999999999999997655 49999999876432111
Q ss_pred ------------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Q 024363 79 ------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128 (268)
Q Consensus 79 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 128 (268)
.....+||..|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1123468899999999987776555 899999999999999999998776
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC----HHHHhcccccCC
Q 024363 129 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT----IPEIMKHQWFLK 186 (268)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s----~~e~l~h~~~~~ 186 (268)
....+.+.. ......+....++..+.++|.+||..+|.+||| +.+++.||||..
T Consensus 237 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNIL----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHHh----cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 654443332 333334444447899999999999999999999 999999999965
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=246.21 Aligned_cols=181 Identities=28% Similarity=0.453 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||++||+|..++.+ .+.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEcccccccccccccc
Confidence 689999999888765 56799999999999999999999999999999999999997665 4999999998653222 2
Q ss_pred CCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......+++.|+|||++.. ..++. ++|+||+||++|+|++|+.||..........+... ......+.+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRW 234 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCc-cchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCcccc
Confidence 2334568999999999842 23433 48999999999999999999987654333222221 111222334457
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.++.+||.+||+.+|.+||++.++++||||+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 8999999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=247.00 Aligned_cols=175 Identities=37% Similarity=0.684 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|.||+++.++ .+||+|||+++..... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCC--C
Confidence 79999999999999889999999999999999999999999999999999999997665 4999999998764333 3
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....+++.|+|||.+.+...+.+ +|+||||+++|+|++|+.||........ .+.+.......+ ..++..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~l~~l 228 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQI----YEKILEGKVRFP--SFFSPDAKDL 228 (290)
T ss_pred CCCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCccCC--ccCCHHHHHH
Confidence 44578999999999877665544 8999999999999999999987663222 222333333333 3478999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
|.+||..+|.+|+ ++.++++||||..
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 9999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=246.60 Aligned_cols=181 Identities=25% Similarity=0.484 Sum_probs=137.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||.+ +|.+++.+ .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++..... .
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCC
Confidence 689975 88888765 56799999999999999999999999999999999999997665 4999999998754322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcc------------cc
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV------------QY 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~------------~~ 145 (268)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...... ..+..+....... ..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567899999999877554445599999999999999998886443332 2222221111000 00
Q ss_pred -cC----------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 146 -SV----------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 146 -~~----------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.. .....+++++++||.+||..||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=249.18 Aligned_cols=183 Identities=26% Similarity=0.474 Sum_probs=142.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+. |+|.+++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCC
Confidence 68997 599888865 456999999999999999999999999999999999999976654 9999999987533222
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (268)
......+++.|+|||++.+....+.++|||||||++|+|++|++||...+.......+.......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22345678999999998765544455899999999999999999998776544433322211100
Q ss_pred cccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 144 QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 144 ~~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....+. ...+++.+++||.+||+.||.+|||+.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 001111 1246889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.39 Aligned_cols=179 Identities=25% Similarity=0.472 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
.|.+..|+|+.|+++.++.+...++.|++|||+||.|||++. |+|||||.+||||+++ .|.|||+|+|+|+.....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhhcc-
Confidence 378999999999999999999999999999999999999996 9999999999999754 567999999999854433
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
...+.+|||-|||||+.. ..|+.. +||||||++|.||+|+.+||....++.++.+.+ ..+........--.++++
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---TSGIKPAALSKVKDPEVR 274 (632)
T ss_pred ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---HcCCCHHHhhccCCHHHH
Confidence 345589999999999986 677766 999999999999999999999888876654433 222111111111358999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+||.+||.. .+.|+|+.|+|.||||...
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999 9999999999999999764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=253.03 Aligned_cols=183 Identities=22% Similarity=0.414 Sum_probs=137.9
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||++|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHG 155 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccc
Confidence 699999999999965 345999999999999999999999999999999999999976654 9999998654321111
Q ss_pred --------CCCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---- 144 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 144 (268)
......++..|+|||++.+. .++.+ +|||||||++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence 11223567789999998753 35444 8999999999999999999986554332222211100000
Q ss_pred ------------------------------------ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 ------------------------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ------------------------------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
...+....+++.+.+||.+||+.||++|||+.++++||||.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000111235788999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=246.04 Aligned_cols=181 Identities=25% Similarity=0.429 Sum_probs=139.5
Q ss_pred CCCCCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||++ |+|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 154 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIP 154 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCC
Confidence 68997 5898888643 56999999999999999999999999999999999999976654 999999998743322
Q ss_pred C-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 024363 78 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 143 (268)
Q Consensus 78 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (268)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 22344678999999998765433445899999999999999999998765443332222111000
Q ss_pred ------cc----cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 144 ------QY----SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 144 ------~~----~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+ .......++++++++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 000123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.13 Aligned_cols=177 Identities=30% Similarity=0.494 Sum_probs=141.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCcccccccccc
Confidence 68999999999998888899999999999999999999999999999999999997655 4999999998743221
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......++..|+|||.+.+..++.+ +|+||+||++|+|++|+.||.......... ...........+..++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQPTNPQLPSHISEH 237 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCCCCCCCchhcCHH
Confidence 11223458889999999987766555 899999999999999999998664433222 222221122222346788
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
+.+++ +||..+|.+||++.++++||||.
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99999 57778999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=253.39 Aligned_cols=179 Identities=27% Similarity=0.407 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||= .-+|..+|++... ++...++.+..|+|.|+.++|..||||.||||.|+|+-. |++||+|||+|.....+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccCcccc
Confidence 4543 3589999987665 444689999999999999999999999999999999853 459999999998654433
Q ss_pred --CCCCCcCCCCcccchhhccCccC----------CcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
...+.+||+.||+||.+....+. +.++||||||||+|+|+.|+.||....+ +...+..+......
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNHE 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCcc
Confidence 23567899999999998643332 3348999999999999999999964322 22333444444443
Q ss_pred CCCCCCC-CHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 VPDTNPI-SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 ~~~~~~~-s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++.+..- ..++.++++.||..||.+|+++.++|+|||+.-
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3322212 234999999999999999999999999999854
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.24 Aligned_cols=182 Identities=21% Similarity=0.320 Sum_probs=137.5
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+. |+|..++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccc
Confidence 57775 6898888654 56999999999999999999999999999999999999976554 9999999987533221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhccc-----
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRILSVQ----- 144 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~----- 144 (268)
......||+.|+|||++.+..++.+ +|||||||++|||++|..|+..... ...+.++++......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1224569999999999988777655 8999999999999998765433211 122333332211100
Q ss_pred ---------------------cc---CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 ---------------------YS---VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ---------------------~~---~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+. +.....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0111235678999999999999999999999999999964
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=243.51 Aligned_cols=178 Identities=26% Similarity=0.430 Sum_probs=144.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
|||++||+|.+++.+.+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHhhhhcccc
Confidence 69999999999998888899999999999999999999999999999999999997655 499999998864321
Q ss_pred ---CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 77 ---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 77 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
........++..|+|||++.+..++.+ +|+|||||++|+|++|..||............. .......+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hccCCCCCCCCCC
Confidence 112234568999999999987776655 899999999999999999998665433222111 1111112233458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+..+.++|.+||..+|.+||++.+++.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=247.29 Aligned_cols=183 Identities=30% Similarity=0.554 Sum_probs=146.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||++||+|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... ..
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhccccccc
Confidence 799999999998754 5799999999999999999999999999999999999997665 4999999998643222 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||........... +.... ....+....++..+.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNL--PPRVKDSHKVSSVLRG 250 (292)
T ss_pred CceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcC--CCccccccccCHHHHH
Confidence 234578999999999977776655 8999999999999999999987654333222 21111 1222333457899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++.+||..+|.+|||+.++++||||....++
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999999765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=281.98 Aligned_cols=181 Identities=29% Similarity=0.459 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+.+..++-.+|...+.+..|++.|++|||+.|||||||||.||+++.++- +|++|||.|.....+.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhc
Confidence 899999999999988888999999999999999999999999999999999999987764 9999999987544332
Q ss_pred ---CCCCCcCCCCcccchhhccCcc--CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
..+...||+.|||||++.+..- ...+.||||||||+.||+||+.||...++.-+ ++..+. ..-..+.+..+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~V~-~gh~Pq~P~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYHVA-AGHKPQIPERL 1466 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhHHh-ccCCCCCchhh
Confidence 2346789999999999976432 23348999999999999999999987766432 333332 22233334449
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|++.++||.+||+.||.+|-++.|++.|.|-...
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999999999999999999999886543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=275.36 Aligned_cols=181 Identities=31% Similarity=0.513 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEEcCC-----------
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-------QVCHRDLKLENTLLDGS----------- 58 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~-------~ivHrdlkp~Nili~~~----------- 58 (268)
||||.+|+|.++|.. .+.+++..++.++.||+.||.|||+. +||||||||+||||+..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 799999999999965 35799999999999999999999985 49999999999999642
Q ss_pred ----CCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH
Q 024363 59 ----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 132 (268)
Q Consensus 59 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 132 (268)
+.+.+||+|||+++............||+.|+|||++.+. .+. .++||||||||+|+|++|..||........
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s-~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred cccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCC-chhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 2334899999999865444444566899999999998643 344 448999999999999999999987665443
Q ss_pred HHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+...+.. ....+ ....+.++.+||..||..+|.+||++.++|.|+|+...
T Consensus 252 li~~lk~----~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISELKR----GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhc----CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 3332221 11222 12368999999999999999999999999999999644
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=252.21 Aligned_cols=183 Identities=25% Similarity=0.378 Sum_probs=133.7
Q ss_pred CCCCCCCchhHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC--CCCCEEEeecC
Q 024363 1 MEYASGGELFERICN---------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~---------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~--~~~~~kl~Dfg 69 (268)
|||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 588875 78787742 1248999999999999999999999999999999999999432 23469999999
Q ss_pred CCCCCCCCC----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---------HHHHHH
Q 024363 70 YSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKT 136 (268)
Q Consensus 70 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~ 136 (268)
+++...... ......||+.|+|||++.+....+.++|||||||++|+|++|++||...... ......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 997543221 2234578999999999877554455599999999999999999999754321 111111
Q ss_pred HHHHh------------------------ccccc--------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 137 IQRIL------------------------SVQYS--------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 137 ~~~~~------------------------~~~~~--------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..... ..... .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 10000 00000 00011245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=238.21 Aligned_cols=190 Identities=33% Similarity=0.559 Sum_probs=156.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~-- 77 (268)
||-+.||+|.++|+++..|+|.++..++..|+.||.|||.+||.||||||+|||-.... ...+|||||.+.......
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 68899999999999999999999999999999999999999999999999999985332 234899999886532111
Q ss_pred ------CCCCCCcCCCCcccchhhc----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-----------hHHHHHH
Q 024363 78 ------SQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKT 136 (268)
Q Consensus 78 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~ 136 (268)
....+.+|+-.|||||+.. ...++.+++|.||||||+|-|++|.+||.+.-. ..-..+.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1224557888999999863 345567779999999999999999999976422 1223456
Q ss_pred HHHHhcccccCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 137 IQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 137 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
...+....+.+|. +..+|.+.+++|+.+|..++.+|.++.++++|||+..-.+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 6677788888874 56799999999999999999999999999999999765544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.25 Aligned_cols=181 Identities=27% Similarity=0.466 Sum_probs=145.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.+ +.+++.++..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccc
Confidence 799999999999864 4689999999999999999999999999999999999997665 49999999987533221 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||............ ........+.+..++..+.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHH
Confidence 234578999999999887666555 89999999999999999999876543322211 11111222334457899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+|.+||..+|.+||++.+++.||||....
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=244.63 Aligned_cols=180 Identities=27% Similarity=0.447 Sum_probs=141.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++| +|.+.+.+ .+.+++..++.++.|++.||+|||++|++||||||.||+++. +.+||+|||+++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCC
Confidence 689975 88888876 457999999999999999999999999999999999999986 4699999999976544444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc--------------ccc
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------------VQY 145 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~ 145 (268)
.....+++.|+|||++......+.++||||+||++|+|++|..||.+.+....+......... ..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 445568999999998765554455699999999999999999999876654433222211100 011
Q ss_pred cCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 146 SVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 146 ~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..+. ...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 12368999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.68 Aligned_cols=178 Identities=28% Similarity=0.474 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.|++|.+++.. ...+++..++.++.|++.||.|||+.+++||||+|.||+++.++. +||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcc
Confidence 689999999999975 457899999999999999999999999999999999999976654 9999999987543332
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......++..|+|||++.+..++.+ +|||||||++|+|++|+.||............. ............++..+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHH
Confidence 2334568899999999987777655 899999999999999999998655432221110 011111222334778999
Q ss_pred HHHHHccccCCCCCCCHHHHhccccc
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++|.+||+.+|.+|||+.+++.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=246.22 Aligned_cols=181 Identities=30% Similarity=0.570 Sum_probs=142.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++. +||+|||++..... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-cc
Confidence 7999999999999988899999999999999999999998 58999999999999976554 99999999864322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH--------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------------------- 139 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-------------------- 139 (268)
.....+++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.. ........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCC
Confidence 345678999999999877666555 89999999999999999999754421 11111110
Q ss_pred -------------Hhccc-ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 140 -------------ILSVQ-YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 140 -------------~~~~~-~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..... ...+ ...++.++++||.+||..+|++||++.+++.||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 0001 11267889999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=256.78 Aligned_cols=181 Identities=29% Similarity=0.459 Sum_probs=151.9
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||-| |-.+++.- .+++.|.++..|..+.+.||+|||+.+.||||||..|||++..+ .|||+|||.|... ..
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi~---~P 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASIM---AP 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhhc---Cc
Confidence 899986 88888854 45799999999999999999999999999999999999997655 4999999988643 44
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.++.+|||+|||||++. .+.|+++ +||||||+++.||...++|+.+.+....+..+.+. ....-..+.+|..
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----esPtLqs~eWS~~ 253 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEWSDY 253 (948)
T ss_pred hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----CCCCCCCchhHHH
Confidence 57889999999999986 4678888 99999999999999999999887765444443332 2222234558999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCCCcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 192 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~ 192 (268)
++.|+..||++-|..|||.+++|+|+|+.+..+...
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV 289 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence 999999999999999999999999999998877654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=244.72 Aligned_cols=180 Identities=25% Similarity=0.387 Sum_probs=141.3
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.. ...+++..++.++.|++.||+|||+.+++||||||+||+++.++. +||+|||++.....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~ 180 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS 180 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhccc
Confidence 689999999998853 457999999999999999999999999999999999999976554 99999999875332
Q ss_pred CC-CCCCCcCCCCcccchhhccCcc----CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEY----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
.. ......|+..|+|||++..... .+.++|||||||++|+|++|+.||...........+. ...........
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 257 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPPPTLLHPE 257 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cCCCCCCCccc
Confidence 22 2234568999999999754321 2344899999999999999999998765433322211 11112222333
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.++..+.+||.+||+.+|.+||++.+++.||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=241.51 Aligned_cols=181 Identities=31% Similarity=0.496 Sum_probs=141.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+.||+|.+++.+.+.+++..++.++.|++.||.|||+++++||||+|+||+++.++ .++|+|||+++......
T Consensus 87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~ 164 (272)
T cd06629 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSDDIYDN 164 (272)
T ss_pred EecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeeccccccccccccc
Confidence 69999999999998888999999999999999999999999999999999999997655 49999999987532211
Q ss_pred -CCCCCcCCCCcccchhhccCc--cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......++..|+|||++.... ++. ++|+||||+++|++++|..||..........+.................++.
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCc-cchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCH
Confidence 123346889999999987654 444 4899999999999999999997554432222211111111111111234689
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+.++|.+||..+|.+||++.++++||||
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 244 VALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.90 Aligned_cols=179 Identities=35% Similarity=0.650 Sum_probs=143.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||.||+++.++ .+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCccc
Confidence 79999999999998888899999999999999999999999999999999999997655 49999999886321110
Q ss_pred --------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 024363 79 --------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144 (268)
Q Consensus 79 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (268)
......++..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~----~~~~~~ 232 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDD 232 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcc
Confidence 0112357889999999887776655 899999999999999999998765433222 222222
Q ss_pred ccCCC-CCCCCHHHHHHHHHccccCCCCCCC---HHHHhcccccCC
Q 024363 145 YSVPD-TNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLK 186 (268)
Q Consensus 145 ~~~~~-~~~~s~~~~~li~~~l~~dp~~R~s---~~e~l~h~~~~~ 186 (268)
...+. ...++.++.++|.+||+.+|.+||+ +.+++.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 22222 1247899999999999999999997 799999999955
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.10 Aligned_cols=182 Identities=30% Similarity=0.477 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++. .+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccccccccccccccc
Confidence 689999999999988889999999999999999999999999999999999999965432 48999999986543221
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......++..|+|||.+.+..++.+ +|+||+||++|+|++|..||.......... .+............+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhCH
Confidence 1123468899999999877666555 899999999999999999997554332222 22222222222223334789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
++.+++.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=240.15 Aligned_cols=169 Identities=23% Similarity=0.347 Sum_probs=138.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+...+++..+..++.|++.||+|||++|++||||||+||+++.++. ++++|||.+...... .
T Consensus 64 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~ 139 (237)
T cd05576 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--C 139 (237)
T ss_pred EecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--c
Confidence 799999999999988888999999999999999999999999999999999999976654 999999987543322 2
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....++..|+|||.+.+..++.+ +|+||+||++|+|++|+.|+...... ... ...... +..++..++++
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~------~~~--~~~~~~--~~~~~~~~~~l 208 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEETEA-CDWWSLGAILFELLTGKTLVECHPSG------INT--HTTLNI--PEWVSEEARSL 208 (237)
T ss_pred ccCCcCccccCCcccCCCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh------ccc--ccccCC--cccCCHHHHHH
Confidence 34456778999999877666555 89999999999999999887543211 000 111122 23478999999
Q ss_pred HHHccccCCCCCCCH-----HHHhccccc
Q 024363 161 ISRIFVADPAARITI-----PEIMKHQWF 184 (268)
Q Consensus 161 i~~~l~~dp~~R~s~-----~e~l~h~~~ 184 (268)
|.+||+.||.+|+++ .+++.||||
T Consensus 209 i~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.48 Aligned_cols=182 Identities=41% Similarity=0.741 Sum_probs=164.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.||.+++++.+.+++.+..++.++.|+++|++|||+++|||||||++|||++.+.. +||+|||++.........
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccc
Confidence 799999999999999999999999999999999999999999999999999999987765 999999999988777778
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+|++.|.|||++.+..|.+..+|+||+|+++|.|++|..||.+.+- ...-...+..++++|.+ ++.+|.++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~~--ms~dce~l 285 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPFY--MSCDCEDL 285 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccce--eechhHHH
Confidence 8999999999999999999999999999999999999999999998654 22334455666777776 89999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|+++|..+|.+|+++++++.|.|.......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999998655443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=244.12 Aligned_cols=182 Identities=27% Similarity=0.440 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+ |++|.+++.. .+.+++.+++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCC
Confidence 6899 9999999865 45699999999999999999999999999999999999997654 49999999987543332
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------- 144 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 144 (268)
......++..|+|||++.+......++||||+||++|+|++|.+||.+......+...........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 234457899999999987655444559999999999999999888877665544443333211110
Q ss_pred --ccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 145 --YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 145 --~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
...+ .....+..+.+||.+||..+|.+|||+++++.||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 0123578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=239.92 Aligned_cols=178 Identities=30% Similarity=0.510 Sum_probs=147.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.|++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccc
Confidence 689999999999988788999999999999999999999999999999999999976654 999999998765444344
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...... ............ ....+..++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETA--DVLYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccc--cccCcccCcHHHHHH
Confidence 55678899999999987776555 89999999999999999999876642 111222222212 222334478999999
Q ss_pred HHHccccCCCCCCCH--HHHhccccc
Q 024363 161 ISRIFVADPAARITI--PEIMKHQWF 184 (268)
Q Consensus 161 i~~~l~~dp~~R~s~--~e~l~h~~~ 184 (268)
|.+||..+|.+||++ .+++.||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=242.07 Aligned_cols=184 Identities=27% Similarity=0.482 Sum_probs=143.6
Q ss_pred CCCCCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|..++.+. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC
Confidence 7999999999988763 379999999999999999999997 5999999999999997654 599999999865422
Q ss_pred CCCCCCCcCCCCcccchhhccCcc-----CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
.......+++.|+|||++.+... .+.++|+|||||++|+|++|+.||......... ..+..+..... ...+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~~~~~ 232 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDP-PTLPS 232 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCC-CCCCc
Confidence 22344568899999999854332 234489999999999999999999765433322 22222222211 12223
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.++.++.+||.+||+.+|.+||++.+++.||||.....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 38899999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=242.83 Aligned_cols=182 Identities=30% Similarity=0.556 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||+.|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCcc
Confidence 689999999999877 6799999999999999999999999999999999999997655 49999999876433221 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+........... ..........++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPKLKNLHKVSPRLRS 247 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCCCcccccCCHHHHH
Confidence 234568999999999987776665 89999999999999999999775543332221111 11112222337899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||..+|.+||++.+++.||||.+..+
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 999999999999999999999999977554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=242.45 Aligned_cols=182 Identities=30% Similarity=0.500 Sum_probs=146.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||++||+|.+++... ++++..++.++.|++.||.|||+++++||||+|+||+++.++. ++|+|||+++..... ..
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeecccccc
Confidence 5899999999999765 8999999999999999999999999999999999999977654 999999998754433 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+.... ...+............++.++.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRV----LFLIPKNNPPSLEGNKFSKPFKD 229 (274)
T ss_pred cccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHH----HHHhhhcCCCCCcccccCHHHHH
Confidence 344578899999999987776555 9999999999999999999976553222 11222211111111227889999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++.+||..+|.+|||++++++||||.+....
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 9999999999999999999999999765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=248.28 Aligned_cols=185 Identities=29% Similarity=0.474 Sum_probs=140.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+.+ +|.+++. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 87 ~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 87 QELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDH 162 (336)
T ss_pred ehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccc
Confidence 578865 8888774 457999999999999999999999999999999999999976554 9999999987533221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 143 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (268)
......||+.|+|||.+.+....+.++||||+||++|+|++|+.||.+......+..... ....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG-VLGTPSQEDLNCIISLR 241 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCCHHHHHHhhchh
Confidence 123357899999999876543334558999999999999999999976553332221111 1100
Q ss_pred --------cc--cCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 144 --------QY--SVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 144 --------~~--~~~---~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
.. ..+ .....+.++.+||.+||+.+|.+|||+.+++.||||.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00 000 012357889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=238.34 Aligned_cols=176 Identities=30% Similarity=0.482 Sum_probs=143.2
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCcc
Confidence 6899999999999764 5799999999999999999999999999999999999997655 49999999987543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......|++.|+|||++.+..++.+ +|+|||||++++|++|+.||.......... .+..... .+....++..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVF-PPVSQMYSQQL 229 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCC-CCCccccCHHH
Confidence 2234468899999999987776655 899999999999999999998766433222 2222211 12222578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.++|.+||+.+|++||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=244.89 Aligned_cols=181 Identities=27% Similarity=0.466 Sum_probs=145.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|..++.+ ..+++.++..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhccccccc
Confidence 689999999998865 4699999999999999999999999999999999999997655 49999999987533222 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||.+.+.......... ........+..++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPIFRD 247 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHHHHH
Confidence 234568999999999887766655 8999999999999999999987665433222111 111122334457899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||..+|.+||++.+++.||||....
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=244.37 Aligned_cols=185 Identities=24% Similarity=0.381 Sum_probs=144.5
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+ +|+|.+++.+.. .+++..++.++.||++||.|||++|++||||||+||+++.++ .+||+|||+++..... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence 7899 899999998766 799999999999999999999999999999999999998665 4999999998754332 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------c-
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------Y- 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~- 145 (268)
......+++.|+|||.+.+......++|+|||||++|+|++|.+||.+......+.++........ +
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223446788999999986544444559999999999999999888887665544433332211000 0
Q ss_pred c----CC-----CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 S----VP-----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ~----~~-----~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
. .+ .....+..+.+||.+||..+|.+|||+.+++.|+||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 00 0123578899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=242.89 Aligned_cols=183 Identities=28% Similarity=0.397 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLGRAFS 162 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeecccceecC
Confidence 689986 898888642 358999999999999999999999999999999999999762 2359999999987543
Q ss_pred CC-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-c-------
Q 024363 76 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S------- 146 (268)
Q Consensus 76 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------- 146 (268)
.. .......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+......++...+..... .
T Consensus 163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence 22 22234467899999999876443344599999999999999999999877665554444332211100 0
Q ss_pred -----CC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 147 -----VP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 147 -----~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.+ ....++..+.+||.+||..+|.+||++.+++.||||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0123788999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=242.12 Aligned_cols=180 Identities=29% Similarity=0.492 Sum_probs=143.5
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||++||+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccccc
Confidence 7999999999999764 56999999999999999999999999999999999999976554 999999988643222 2
Q ss_pred CCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNP 152 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 152 (268)
......+++.|+|||++.. ..++ .++|+|||||++|+|++|+.||..........+ +.... .....+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 233 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSK 233 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCccc
Confidence 2234568999999999753 2233 348999999999999999999987654332222 22221 12223345
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++.++.++|.+||..+|.+||++.++++||||...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 78999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=237.78 Aligned_cols=177 Identities=35% Similarity=0.514 Sum_probs=145.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.+. ..+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKS 156 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCc
Confidence 6899999999999763 3589999999999999999999999999999999999997543 348999999987655444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+......... ... ..+....++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~l~ 230 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIM----SGT-FAPISDRYSPDLR 230 (256)
T ss_pred cccccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHH----hcC-CCCCCCCcCHHHH
Confidence 4445678999999999987666555 899999999999999999998766543332222 111 1122334789999
Q ss_pred HHHHHccccCCCCCCCHHHHhccccc
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+++.+||..+|.+|||+.+++.||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=248.99 Aligned_cols=183 Identities=27% Similarity=0.457 Sum_probs=144.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++........
T Consensus 100 ~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~ 174 (353)
T cd07850 100 MELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 174 (353)
T ss_pred EeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCccceeCCCCCCC
Confidence 688865 888888654 99999999999999999999999999999999999997665 4999999999765444334
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....+++.|+|||++.+..+..+ +|||||||++|+|++|+.||...+....+.+++..+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T cd07850 175 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253 (353)
T ss_pred CCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhh
Confidence 45678999999999988777665 899999999999999999998776544444332211100
Q ss_pred -ccc--------------CCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 144 -QYS--------------VPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 144 -~~~--------------~~~-----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
... .+. ....+..+++||.+||+.||.+|||+.++|.||||.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred cCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 000 1124567899999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.61 Aligned_cols=182 Identities=30% Similarity=0.575 Sum_probs=144.4
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHH
Confidence 6899999999999876 789999999999999999999999 9999999999999998755 49999999986543222
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhcccc-cCCCCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRILSVQY-SVPDTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~s~~ 156 (268)
. ....++..|+|||.+.+..+..+ +|+|||||++|+|++|+.||..... .......++....... ..+. ..++..
T Consensus 156 ~-~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPD 232 (265)
T ss_pred h-hcccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHH
Confidence 1 22678899999999987766655 8999999999999999999975421 1112222333222211 1111 127889
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.++|.+||..+|.+|||+.+++.||||++.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=239.82 Aligned_cols=176 Identities=32% Similarity=0.544 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||+|||+++++|+||||+||+++.++ .+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCcccccccccccc
Confidence 68999999999998888899999999999999999999999999999999999997655 4999999998743221
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......++..|+|||++.+..++.+ +|+|||||++|+|++|+.||......... ............+..++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHH----HHHhcCCCCCCCchhhCHH
Confidence 12234568899999999887666554 89999999999999999999865443322 2222222222233447788
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+.++|.+||. +|.+||+++++++|||+
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 9999999994 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=239.90 Aligned_cols=179 Identities=29% Similarity=0.461 Sum_probs=142.5
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||++|++|.+++... .++++.+++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhh
Confidence 7999999999999776 78999999999999999999999999999999999999986654 9999999987543322
Q ss_pred CCCCCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......++..|+|||.+.+. .++.+ +|+|||||++|+|++|+.||.................. .........++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKWSP 234 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CccccchhhhhH
Confidence 22345788999999998765 56554 89999999999999999999876543332221111001 111112234678
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
++.+||.+||..+|.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=238.73 Aligned_cols=178 Identities=40% Similarity=0.671 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+.||+|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++. +||+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 72 MEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCccc
Confidence 689999999999988889999999999999999999999999999999999999977654 9999999987533321
Q ss_pred -------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 79 -------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 79 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
......++..|+|||.+.....+.+ +|+||||+++|++++|..||........+ ..+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~ 224 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDV 224 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccc
Confidence 2233468889999999887765544 89999999999999999999876643332 22333333444443
Q ss_pred CCCHHHHHHHHHccccCCCCCCCH---HHHhcccccC
Q 024363 152 PISQECRDLISRIFVADPAARITI---PEIMKHQWFL 185 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~---~e~l~h~~~~ 185 (268)
.++..+.+++.+||+.+|.+|||+ .++++||||.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 458999999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=242.02 Aligned_cols=179 Identities=26% Similarity=0.467 Sum_probs=140.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|..+ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++. +||+|||++...... ..
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cc
Confidence 699999999654 36889999999999999999999999999999999999976654 999999998754322 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhcccccCCCCCCCCHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
....||..|+|||++.+..++.+ +|+|||||++|+|++|+.||........ .......+.............++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 44679999999999987777655 8999999999999999999965322111 1111222222111111223478899
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.++|.+||+.+|.+||++.+++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=247.74 Aligned_cols=186 Identities=28% Similarity=0.408 Sum_probs=146.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+++ +|.+++.+...+++..++.++.||+.||+|||++|++||||||.||+++.++ .++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 83 TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDEDE 159 (330)
T ss_pred ecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccccc
Confidence 688874 8999998888999999999999999999999999999999999999997664 59999999987644432
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----------
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------- 145 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 145 (268)
......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.........+.........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2344578999999999987733344599999999999999999999877655444333322111000
Q ss_pred -----------c---CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 146 -----------S---VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 146 -----------~---~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
. ......++..+.+||.+||+.+|.+||++.+++.||||.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 0011236789999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=248.47 Aligned_cols=186 Identities=27% Similarity=0.418 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||+. |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTE 163 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcC
Confidence 68996 599999988888999999999999999999999999999999999999976654 99999999865332211
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-------------- 141 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-------------- 141 (268)
.....++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 12347899999999986644344559999999999999999999977654332221111100
Q ss_pred -----c-ccccCCC-----CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 142 -----S-VQYSVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 142 -----~-~~~~~~~-----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
. .....+. ....+.++.++|++||+.+|.+||++.+++.||||.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0 0000000 1336899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=241.79 Aligned_cols=179 Identities=25% Similarity=0.419 Sum_probs=139.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccc
Confidence 699999999999988889999999999999999999999999999999999999976554 9999999987543221 2
Q ss_pred CCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....|++.|+|||.+.. ..++ .++|+||+||++|+|++|+.||................. .....+....++..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKDKTKWSST 240 (267)
T ss_pred cCccccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCCccccccCHH
Confidence 234568899999998753 2343 448999999999999999999965443221111111000 00111222347899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
+.+||.+||..+|++|||++++++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=231.99 Aligned_cols=169 Identities=25% Similarity=0.419 Sum_probs=138.3
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchh
Q 024363 16 AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 94 (268)
Q Consensus 16 ~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 94 (268)
.++++|..+-++...+++||.||-. ++|+|||+||+|||++..+. +||||||+|-........+...|.+.|||||.
T Consensus 185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPER 262 (391)
T KOG0983|consen 185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPER 262 (391)
T ss_pred cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccccccCCccccCccc
Confidence 5679999999999999999999986 58999999999999987765 99999999976655556667789999999999
Q ss_pred hcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCC
Q 024363 95 LLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171 (268)
Q Consensus 95 ~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 171 (268)
+.- ..|... +||||||+.++||+||++||.+.+-.-.....+.. ......+....+|+.+++|+..||.+|+.+
T Consensus 263 idp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 263 IDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLPGHMGFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred cCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCCcccCcCHHHHHHHHHHhhcCccc
Confidence 853 356555 89999999999999999999986544333222222 222344555559999999999999999999
Q ss_pred CCCHHHHhcccccCCCCC
Q 024363 172 RITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 172 R~s~~e~l~h~~~~~~~~ 189 (268)
||...++|+|||++....
T Consensus 340 RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 340 RPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CcchHHHhcCcceeecch
Confidence 999999999999976543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=236.99 Aligned_cols=177 Identities=32% Similarity=0.526 Sum_probs=144.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccc
Confidence 68999999999998888899999999999999999999999999999999999997655 4999999998754443334
Q ss_pred CCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+++.|+|||.+.... ++. ++|+|||||++|+|++|+.||..........+ ..........+..++..+.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGL-AADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCc-hhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHH
Confidence 5567899999999987655 444 48999999999999999999976553222211 11111111223347899999
Q ss_pred HHHHccccCCCCCCCHHHHhccccc
Q 024363 160 LISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.+||..+|.+||++.+++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=244.91 Aligned_cols=184 Identities=29% Similarity=0.422 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+.+ +|.+++.. ...+++.+++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPAK 163 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCccC
Confidence 689975 88888865 46799999999999999999999999999999999999997655 4999999998754432 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (268)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+.......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22334568899999998764444455999999999999999999998776655444433321100
Q ss_pred cccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 ~~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....+. ....++.+.+||.+||+.||++|||+.+++.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 000000 01257889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=241.79 Aligned_cols=179 Identities=28% Similarity=0.481 Sum_probs=141.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||++||+|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceecccccc
Confidence 799999999888754 45799999999999999999999999999999999999997654 4999999988643222 2
Q ss_pred CCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-cccCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNP 152 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 152 (268)
......+++.|+|||++.+ ..++. ++|+|||||++|+|++|..||...+......+ .... ......+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 240 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEPPTLSQPSK 240 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCc-hhhhHhHHHHHHHHhcCCCCCccccHHHHHHH----HhcCCCccCCCCcc
Confidence 2234568899999999853 23333 48999999999999999999976554322222 2211 112233445
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++.++.++|.+||..+|.+||++.++++||||..
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 7899999999999999999999999999999954
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=236.83 Aligned_cols=179 Identities=32% Similarity=0.529 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCc
Confidence 68999999999998888899999999999999999999999999999999999997755 499999999875433222
Q ss_pred ----CCCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.....+++.|+|||++.+.. ...+ +|||||||++|++++|+.||............+ ........+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV--GAGHKPPIPDSLQ 232 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHHHHH--hcCCCCCCCcccc
Confidence 12346788999999987654 4444 899999999999999999997654332221111 1122233444444
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++..+.++|.+||+.+|.+||++.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 68999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=236.92 Aligned_cols=176 Identities=31% Similarity=0.488 Sum_probs=144.2
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH-----~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
|||+++|+|.+++.+ .+++++..++.++.||+.||.||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEeccccc
Confidence 799999999999965 467999999999999999999999 99999999999999997655 4999999998
Q ss_pred CCCCCCCC-CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 72 KSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 72 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
........ .....+++.|+|||++....++.+ +|+||||+++|+|++|+.||...... .+ ...+..... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~-~~~~ 231 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQL-QL---ASKIKEGKF-RRIP 231 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH-HH---HHHHhcCCC-CCCc
Confidence 86544332 344578999999999987766555 89999999999999999999876532 22 222222221 1223
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..++..+.+++.+||..+|.+||++.++++|||+
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 3478999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=241.54 Aligned_cols=178 Identities=26% Similarity=0.437 Sum_probs=139.6
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||+++++||||||+||+++.++. +||+|||+++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~ 176 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS 176 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeeccc
Confidence 799999999988752 356899999999999999999999999999999999999976654 99999999875432
Q ss_pred C-CCCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 77 H-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 77 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
. .......|++.|+|||++.. ..++. ++||||+||++|+|++|+.||..........+.. .........+
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 252 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLHQP 252 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccc-hhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCcccCC
Confidence 2 22334579999999998753 23444 4899999999999999999998765433222111 1111112223
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..++..+.+||.+||+.+|.+|||+.++++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 3367899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=240.71 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=139.6
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||++||+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~ 164 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--TVK 164 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--cEE
Confidence 6899999999999764 4588899999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++..... .......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....... ..+
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~----~~i 239 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----EMI 239 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHH
Confidence 9999998743222 12234467889999999887777655 899999999999998 99999876654322 222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
... ...+.+..++.++.+|+.+||+.+|.+||++.+++++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222 1223344588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=241.26 Aligned_cols=181 Identities=30% Similarity=0.425 Sum_probs=141.6
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+.+ +|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||+++..... .
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCcc
Confidence 689975 9999987644 5999999999999999999999999999999999999976654 999999998754433 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 143 (268)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||..........++.......
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 23345688999999998765543455999999999999999999998776554444333221100
Q ss_pred --c--------ccCCCCCC-CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 144 --Q--------YSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 144 --~--------~~~~~~~~-~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
. .....+.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 00001111 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=240.00 Aligned_cols=181 Identities=29% Similarity=0.541 Sum_probs=142.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCccc
Confidence 689999999999865 4899999999999999999999999999999999999997654 59999999987543322 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....|+..|+|||.+.+....+.++|+|||||++|+|++|..||.+........ .+............++.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCCcccCCHHHHH
Confidence 2345689999999998654443445999999999999999999997655422211 111111111111227789999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++.+||..+|.+||++.+++.|+||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999996654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=226.61 Aligned_cols=222 Identities=23% Similarity=0.351 Sum_probs=161.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
|.+|+. +|+-++.+. .+|+..+++.+|.+++.||.|+|.+.|+|||+||.|+||+.++. +||+|||+++.....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n 179 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKN 179 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccc
Confidence 356765 888888765 67999999999999999999999999999999999999976665 999999999743322
Q ss_pred ---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--ccCCCC--
Q 024363 78 ---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDT-- 150 (268)
Q Consensus 78 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~-- 150 (268)
...+.++.|.+|++||.+.+...++++.|||..|||+.+|+++.+.+.+.++..++.- +..++..- -.+|..
T Consensus 180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~-Is~LcGs~tkevWP~~d~ 258 (376)
T KOG0669|consen 180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL-ISQLCGSITKEVWPNVDN 258 (376)
T ss_pred cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH-HHHHhccCCcccCCCccc
Confidence 2345677899999999999987777779999999999999999999988776655432 22222110 001110
Q ss_pred --------------------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCCcccc----hhhhcc
Q 024363 151 --------------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD----EKTMSS 200 (268)
Q Consensus 151 --------------------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~~~----~~~~~~ 200 (268)
-.-.+++.+|+.++|..||.+|+.++++++|.||.+..-+...- .....+
T Consensus 259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml~t~~~s 338 (376)
T KOG0669|consen 259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDMLSTHLQS 338 (376)
T ss_pred chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHHHHhHHH
Confidence 00135789999999999999999999999999997654332111 112234
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhCCCC
Q 024363 201 QYEEPDQPMQSVDVIMQIIAEASIPA 226 (268)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (268)
.|+-..++..+.+..+..-+....+.
T Consensus 339 ~fey~~~~~~~~~~~~~q~~~q~~nq 364 (376)
T KOG0669|consen 339 MFEYLAQPRRSNQMRNYQQQLQTMNQ 364 (376)
T ss_pred HHHHhcCcchhhhhhhHHHHhcCCCc
Confidence 44444455555555555444444333
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=245.18 Aligned_cols=185 Identities=22% Similarity=0.414 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||++|+|.+++.+. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHG 155 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeecccc
Confidence 6999999999999753 4689999999999999999999999999999999999997655 49999999876432211
Q ss_pred --------CCCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---- 144 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 144 (268)
......++..|+|||++.+. .++.+ +|+||+||++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 12334578899999998653 34444 8999999999999999999987654433222211100000
Q ss_pred ------------------------ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 145 ------------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 145 ------------------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
........++.++.+|+.+||..+|++|||+.++++||||.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00011112457889999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=236.81 Aligned_cols=176 Identities=31% Similarity=0.540 Sum_probs=144.6
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. +||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEY 155 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEccccc
Confidence 6999999999999764 56999999999999999999999999999999999999976654 9999999987543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......+++.|+|||++.+..++.+ +|+|||||++|+|++|..||.......... .+....+. +....++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 229 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVV----KIVQGNYT-PVVSVYSSEL 229 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCC-CCccccCHHH
Confidence 2345678999999999887766555 899999999999999999998755433332 23233222 2234578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.++|.+||..+|.+||++.++++|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.47 Aligned_cols=185 Identities=26% Similarity=0.406 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~ 161 (332)
T cd07857 85 EELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSENPGE 161 (332)
T ss_pred Eeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCCceeccccccc
Confidence 46675 69999998888999999999999999999999999999999999999997665 49999999987533211
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-------------
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------- 142 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------- 142 (268)
......||+.|+|||++.+....+.++|+||+||++|+|++|+.||...+....+...+.....
T Consensus 162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (332)
T cd07857 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241 (332)
T ss_pred ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence 1234578999999998866433344589999999999999999999876543332222211100
Q ss_pred ----------cc-ccC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 143 ----------VQ-YSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 143 ----------~~-~~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.. ..+ ......+..+.+|+.+||+.+|.+|||+.+++.|||+.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 000 01123578999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=239.35 Aligned_cols=184 Identities=25% Similarity=0.451 Sum_probs=145.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+.+.+++..++.++.+++.||.|||+ .+++||||||+||+++.++ .++|+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hc
Confidence 7999999999999888889999999999999999999997 5899999999999997655 499999999864322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-------HHHHHHHHHHhcccccCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------KDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.....|+..|+|||++.+..++.+ +|+|||||++|+|++|+.||...... ..+...................
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 234578999999999887766655 89999999999999999999764432 1112223332222111111223
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++..+.+|+.+||+.||.+|||+.++++|+||.+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 678999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=235.87 Aligned_cols=173 Identities=26% Similarity=0.455 Sum_probs=142.4
Q ss_pred CCCCCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
|||++||+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccc
Confidence 6899999999999875 7899999999999999999999999999999999999997765 4999999998
Q ss_pred CCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccC
Q 024363 72 KSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV 147 (268)
Q Consensus 72 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (268)
...... .......+++.|+|||.+....++.+ +||||+||++|+|++ |..||........... +.. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~ 226 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRL 226 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCC
Confidence 764433 22334567889999999887766555 899999999999999 6999987754332222 222 2333
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4445578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=240.27 Aligned_cols=182 Identities=25% Similarity=0.464 Sum_probs=142.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||+++++|..+....+.+++.+++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccCCccc
Confidence 68999999988887777799999999999999999999999999999999999997655 4999999998753322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (268)
.....++..|+|||++.+....+.++|||||||++|+|++|++||...........+....... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2345688999999998764444455999999999999999999997665433333222111000 0
Q ss_pred ccCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 ~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+ ....++..+.+|+.+||..+|.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=237.50 Aligned_cols=181 Identities=32% Similarity=0.562 Sum_probs=146.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+...+++..++.++.|++.||+|||+ ++++||||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLD 155 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCC
Confidence 6899999999999888899999999999999999999999 9999999999999997655 499999999875443332
Q ss_pred C-CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC-CCHHH
Q 024363 80 P-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQEC 157 (268)
Q Consensus 80 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~ 157 (268)
. ....++..|+|||.+....++.+ +|+||||+++|+|++|..||...... ........+.... ....... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGP-PPSLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCC-CCCCCcccCCHHH
Confidence 2 24568899999999887766555 89999999999999999999776521 1222233332221 1222333 78999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.++|.+||..+|.+||++.+++.|||++.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=249.58 Aligned_cols=156 Identities=24% Similarity=0.417 Sum_probs=122.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC---CCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~ 94 (268)
++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... .....+++.|+|||+
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 285 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 285 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCCCccceeCHHH
Confidence 478889999999999999999999999999999999997654 499999999875432221 112335678999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |+.||........+.+.+ ......+.+..+++++.++|.+||+.+|.+||
T Consensus 286 ~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 360 (374)
T cd05106 286 IFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360 (374)
T ss_pred hcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 987777665 899999999999997 999998765433332222 22223333344789999999999999999999
Q ss_pred CHHHHhc
Q 024363 174 TIPEIMK 180 (268)
Q Consensus 174 s~~e~l~ 180 (268)
|+.++++
T Consensus 361 s~~~l~~ 367 (374)
T cd05106 361 TFSQISQ 367 (374)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=242.35 Aligned_cols=180 Identities=28% Similarity=0.540 Sum_probs=143.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++....... .
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhccccccc
Confidence 689999999987754 57999999999999999999999999999999999999976654 9999999986432221 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.......... .+.... .........++..+.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSP--PPKLKNAHKISPVLRD 249 (297)
T ss_pred ccceecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccC--CCCccccCCCCHHHHH
Confidence 234578999999999987776555 899999999999999999998655433222 111111 1112223347889999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+|.+||+.+|.+||++.+++.||||.+.
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=239.12 Aligned_cols=178 Identities=27% Similarity=0.469 Sum_probs=140.1
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~ 165 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQLDS 165 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceeccc
Confidence 699999999998865 35799999999999999999999999999999999999997655 499999998864322
Q ss_pred -CCCCCCCcCCCCcccchhhccC-----ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 77 -HSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 77 -~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
........|++.|+|||++... .++. ++|||||||++|+|++|+.||..........++.. .........
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 241 (275)
T cd06608 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDA-RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKSP 241 (275)
T ss_pred chhhhcCccccccccCHhHhcccccccCCccc-cccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCch
Confidence 2223445689999999987542 2333 48999999999999999999976544333222211 111122222
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..++..+.+||.+||..||++|||+.+++.|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3377899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=231.62 Aligned_cols=188 Identities=28% Similarity=0.414 Sum_probs=144.3
Q ss_pred CCCCCCCchhHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~~ 73 (268)
+||++. +|...|+ +...++...++.++.||+.|++|||++=|+||||||.||||..++ .|+|||+|||+|+.
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 578887 8988884 234699999999999999999999999999999999999996552 36799999999986
Q ss_pred CCCCC----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHH
Q 024363 74 SVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKTIQRI 140 (268)
Q Consensus 74 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~ 140 (268)
..... .....+.|.||+|||++.+...+++++||||+|||+.||++-.+.|.+.... .++.+++. +
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~-v 264 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE-V 264 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH-H
Confidence 54432 2345678999999999999888888899999999999999999888764321 12222221 1
Q ss_pred hcccc--cCCC------------------C------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 141 LSVQY--SVPD------------------T------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 141 ~~~~~--~~~~------------------~------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+..+- .+|. . ..-++...+|+.+||++||.+|+|++++|+|+||+...
T Consensus 265 LG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 265 LGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred cCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 11100 0110 0 01245588999999999999999999999999998764
Q ss_pred CC
Q 024363 189 PA 190 (268)
Q Consensus 189 ~~ 190 (268)
.+
T Consensus 345 lp 346 (438)
T KOG0666|consen 345 LP 346 (438)
T ss_pred CC
Confidence 43
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.79 Aligned_cols=181 Identities=27% Similarity=0.461 Sum_probs=140.7
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
|||+. ++|.+++.. .+.+++..++.++.|++.||+|||+++++||||+|+||+++.++. +||+|||+++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPV 154 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCc
Confidence 68996 589998865 456899999999999999999999999999999999999976654 999999998754322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------- 144 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 144 (268)
.......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......+.........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1223445788999999887655444559999999999999999999987665444333332111000
Q ss_pred -ccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 -YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 -~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..++ ....++.+++++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 012367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=245.57 Aligned_cols=184 Identities=29% Similarity=0.433 Sum_probs=142.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||+. ++|.+++.+.+.+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++..... ..
T Consensus 88 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~ 164 (337)
T cd07858 88 YELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDF 164 (337)
T ss_pred EeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCccccccCCCccc
Confidence 68886 69999998888999999999999999999999999999999999999997655 4999999998754333 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH-------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI------------------- 140 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~------------------- 140 (268)
.....++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.......+....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence 3445689999999998753333445999999999999999999997654322221111100
Q ss_pred hcc---ccc---CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 141 LSV---QYS---VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 141 ~~~---~~~---~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
... ... ......++.++.+||++||+.+|.+|||+.++++||||..-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 000 00123478999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=239.15 Aligned_cols=182 Identities=27% Similarity=0.477 Sum_probs=142.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++++.|..++.+...+++.+++.++.|++.||.|||+++++||||+|+||+++.++ .+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccc
Confidence 68999988877776777799999999999999999999999999999999999997655 49999999987644433
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------c-
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------Y- 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~- 145 (268)
......++..|+|||++.+....+.++|+||||+++|+|++|+.||.+.................. +
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 334467889999999998773334459999999999999999999987655433322221110000 0
Q ss_pred --cC-----------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 146 --SV-----------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 146 --~~-----------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.. .....++.++++||++||..+|++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 0112248899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=241.93 Aligned_cols=183 Identities=26% Similarity=0.468 Sum_probs=144.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccC
Confidence 799999999999865 5689999999999999999999999999999999999997655 49999999986533222 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|+|||||++|++++|+.||.+.+........ ..........+..++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHH
Confidence 234568999999999987766555 89999999999999999999765542221111 01111112223447889999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|+.+||..+|.+||++.+++.||||....+.
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 9999999999999999999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=254.01 Aligned_cols=180 Identities=35% Similarity=0.587 Sum_probs=148.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----- 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~----- 75 (268)
|||++||++.++|-+.+-|.|..+++++..+..|+++.|+.|+|||||||+||||+.++. +||+|||+.+...
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 899999999999999999999999999999999999999999999999999999987665 9999999964100
Q ss_pred ---CCC-----------------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHH
Q 024363 76 ---LHS-----------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117 (268)
Q Consensus 76 ---~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 117 (268)
... .....+||+.|+|||++...+|+.. ||+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 000 0023469999999999999998766 9999999999999
Q ss_pred HhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC---CHHHHhcccccCC
Q 024363 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 118 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
+.|++||...+......+++.- ..-..++....+|.++.++|.++. -+++.|+ .++++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw--~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINW--RNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeeh--hhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999999887765544333321 222345666779999999998864 6788888 4778999999964
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=234.27 Aligned_cols=172 Identities=24% Similarity=0.290 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||+++|+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||.||+++.++ .+||+|||+++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENY 151 (257)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCe
Confidence 68999999999998888899999999999999999999999999999999999997654 499999999875433221
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+++.|+|||.+....++.+ +|+|||||++|+|++ |..||........ ...+ ... ...+.+..+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~i---~~~-~~~~~~~~~~~ 225 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQMI---ESG-ERMECPQRCPP 225 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH---HCC-CCCCCCCCCCH
Confidence 122234678999999876666554 899999999999998 9999986554322 2222 221 22333445889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.++|.+||+.+|.+||++.++..
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHH
Confidence 9999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=239.17 Aligned_cols=183 Identities=33% Similarity=0.571 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (268)
|||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++ ++||+|||+++..... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceeccccccc
Confidence 69999999999998888899999999999999999999999999999999999997654 5999999998754322 1
Q ss_pred CCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......|+..|+|||.+.+.. ....++|||||||++|+|++|..||...............+..... +.+..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 239 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALA 239 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHH
Confidence 223456899999999986532 2234489999999999999999999754333333333333333322 2234478999
Q ss_pred HHHHHHccccCCCCCC-----CHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARI-----TIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~-----s~~e~l~h~~~~~~ 187 (268)
.+++.+||..+|.+|| ++.+++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.97 Aligned_cols=184 Identities=25% Similarity=0.417 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+ |++|.+++.. +++++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 99 ~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~--~ 172 (343)
T cd07851 99 THLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDDE--M 172 (343)
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEcccccccccccc--c
Confidence 5777 6699998865 5799999999999999999999999999999999999997655 4999999998754322 3
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 144 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (268)
....++..|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI 252 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence 4557889999999986543334458999999999999999999987665444333322110000
Q ss_pred ---ccC------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 145 ---YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 145 ---~~~------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
... ......+..+.+||.+||+.+|.+|||+.+++.||||.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 000 0012368899999999999999999999999999999875444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=240.07 Aligned_cols=180 Identities=24% Similarity=0.392 Sum_probs=137.4
Q ss_pred CCCCCCCchhHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFER---IC--NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~---l~--~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
|||+.+ +|.++ +. ..+.+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||+++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHh
Confidence 577764 54443 32 246799999999999999999999975 9999999999999976554 999999998754
Q ss_pred CCCCCCCCCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccC--C
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSV--P 148 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~ 148 (268)
..........|++.|+|||++.+. .++. ++||||+||++|+|++|+.||..... ....+....... ... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDV-RSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcc-hhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCc
Confidence 443333455789999999998765 3444 48999999999999999999976542 112222222111 111 1
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....++.++.+||.+||+.+|.+|||+.+++.||||.+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 223478999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=237.94 Aligned_cols=184 Identities=30% Similarity=0.505 Sum_probs=142.2
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++. ++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeeccccccccc
Confidence 699999999888753 456899999999999999999999999999999999999976654 99999999865432
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhccc-ccC----CCC
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQ-YSV----PDT 150 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~----~~~ 150 (268)
.. .....++..|+|||.+.+..++.+ +|||||||++|+|++|+.||...... ....+....+.... ... ...
T Consensus 158 ~~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 158 SL-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cc-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 22 223457889999999987777666 89999999999999999999765221 01111222222111 111 111
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+++.+++||.+||..+|.+|||+.+++.||||++..
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 23578999999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=237.19 Aligned_cols=182 Identities=33% Similarity=0.571 Sum_probs=144.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||+.||+|.+++.+.+.+++..++.++.|++.||.|||+.+++||||||.||+++.++ .++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECcccccccccccc
Confidence 69999999999998888899999999999999999999999999999999999997654 499999999875333221
Q ss_pred -CCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 80 -PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 80 -~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....|++.|+|||.+.+.. ....++|+||||+++|+|++|..||.............+....... +.+..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 239 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEA 239 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHH
Confidence 22346899999999986543 2234489999999999999999999654332222333333333322 3334478999
Q ss_pred HHHHHHccccCCCCCCC---HHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARIT---IPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s---~~e~l~h~~~~~ 186 (268)
.++|.+||+.+|++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 567899999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=231.51 Aligned_cols=175 Identities=42% Similarity=0.706 Sum_probs=145.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 72 LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSR 149 (250)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCc
Confidence 689999999999998888999999999999999999999999999999999999976654 999999998754332 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||.+.+...+.+ +|+||||+++|++++|..||....... ....+.... .+.+..++..+.+
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~--~~~~~~~~~~l~~ 222 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDP--LRFPEFLSPEARD 222 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCC--CCCCCCCCHHHHH
Confidence 345578899999999877665544 899999999999999999997665422 222233322 3334446899999
Q ss_pred HHHHccccCCCCCCCH---HHHhccccc
Q 024363 160 LISRIFVADPAARITI---PEIMKHQWF 184 (268)
Q Consensus 160 li~~~l~~dp~~R~s~---~e~l~h~~~ 184 (268)
+|++||..+|.+||++ .+++.||||
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=215.22 Aligned_cols=184 Identities=26% Similarity=0.454 Sum_probs=150.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
+|||.. +|.++..+ ++.+..+.++.++.|+++||.|+|++++.||||||.|++|+.++. +|++|||+|+......
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceE
Confidence 478865 88888865 677999999999999999999999999999999999999987766 9999999998655443
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc-cCC------CC
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY-SVP------DT 150 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------~~ 150 (268)
.....+.|.||++|.++.+.+.++...|+||.|||+.|+.. |++.|.+.+-..++.++...+-.... .+| ..
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 34556789999999999998776666899999999999986 88889888777777766654432211 111 11
Q ss_pred ----------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 151 ----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 151 ----------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.++...++|++++|.-+|.+|++++++++||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1134567899999999999999999999999999754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=232.96 Aligned_cols=178 Identities=31% Similarity=0.534 Sum_probs=146.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||++|++|.+++.+...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEeccccccc
Confidence 68999999999998888999999999999999999999999999999999999997654 499999999875444432
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....++..|+|||.+.+.....+ +|+||||+++|+|++|..||........ ....+.........+..++..+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHH
Confidence 345678999999999877766555 8999999999999999999987663222 2222222122222334468999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.++|.+||..+|.+||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=246.11 Aligned_cols=157 Identities=27% Similarity=0.434 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC---CCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~ 94 (268)
.+++..+..++.||+.||.|||++||+||||||+|||++.+. .+||+|||+++....... .....++..|+|||+
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 287 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPES 287 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccccCCCCCCcceeChhH
Confidence 478889999999999999999999999999999999997654 499999999875433221 112335667999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |..||........+.+.+. .......+...+.++.+||.+||+.||++||
T Consensus 288 ~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 362 (375)
T cd05104 288 IFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPSEMYDIMKSCWDADPLKRP 362 (375)
T ss_pred hcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCHHHHHHHHHHccCChhHCc
Confidence 988777665 899999999999998 8899987655443333322 2222223334688999999999999999999
Q ss_pred CHHHHhcc
Q 024363 174 TIPEIMKH 181 (268)
Q Consensus 174 s~~e~l~h 181 (268)
|+.++++.
T Consensus 363 s~~eil~~ 370 (375)
T cd05104 363 TFKQIVQL 370 (375)
T ss_pred CHHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.40 Aligned_cols=180 Identities=26% Similarity=0.464 Sum_probs=139.3
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
|||++ |+|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||+++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccc
Confidence 68997 588877754 34699999999999999999999998 999999999999997655 49999999987543
Q ss_pred CCCCCCCCcCCCCcccchhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcccccCCCC
Q 024363 76 LHSQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 150 (268)
.........++..|+|||++.+ ..++. ++|+|||||++|+|++|+.||...... ....... .......+ .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-~ 230 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDV-KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV---EEPSPQLP-A 230 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCc-cccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---hcCCCCCC-c
Confidence 3333334568999999998864 23344 489999999999999999999754332 2221111 11111222 2
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+|.++.++|.+||..+|.+||++.+++.||||.+..
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 23789999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=236.02 Aligned_cols=180 Identities=27% Similarity=0.443 Sum_probs=144.1
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.+ +|.+++.+.. .+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++.......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 85 FEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIYSFEM 161 (287)
T ss_pred ehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceeccCCc
Confidence 688875 8999887643 599999999999999999999999999999999999998764 59999999987654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccCC---------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP--------- 148 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------- 148 (268)
......++..|+|||++.+..++.+ +|+|||||++|+|++|.+||.+........++........ ..++
T Consensus 162 ~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07838 162 ALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240 (287)
T ss_pred ccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh
Confidence 4445568899999999987776665 8999999999999999999988776655555444321100 0000
Q ss_pred --C---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 149 --D---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 149 --~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
. ...++..+.++|.+||+.||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01246788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=230.97 Aligned_cols=177 Identities=29% Similarity=0.519 Sum_probs=143.4
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccc
Confidence 6899999999999776 6899999999999999999999999999999999999997654 499999999876544332
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||.+.+...+.+ +|+||||+++|+|++|+.||...+.......... ......+....++..+.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHH
Confidence 345678999999999877665555 8999999999999999999987643332222111 112222333335899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccc
Q 024363 160 LISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
+|.+||+.+|++|||+.+++.|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=235.94 Aligned_cols=172 Identities=20% Similarity=0.393 Sum_probs=137.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDET 164 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeecccccc
Confidence 689999999999976 45699999999999999999999999999999999999997655 499999999875432222
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....+ ......+....++.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~ 238 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL----EKGERLPQPPICTI 238 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCcCCCCccCCH
Confidence 122345678999999987777665 899999999999998 899987654322 22222 22223334455889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.+++.+||..||++||++.+++.
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=235.72 Aligned_cols=181 Identities=29% Similarity=0.443 Sum_probs=142.5
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|.||+++.++. ++|+|||+++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRP 153 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCC
Confidence 6899 789999997754 7899999999999999999999999999999999999976554 9999999987654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------------c
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---------------V 143 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 143 (268)
......++..|+|||++.+....+.++|+||||+++++|++|+.||..........+....... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 4455678999999998865443344599999999999999999999877654444332221100 0
Q ss_pred cccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 144 QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 144 ~~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
....+. ....+..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000 11236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=236.78 Aligned_cols=181 Identities=27% Similarity=0.430 Sum_probs=141.0
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
|||++ ++|.+++.... .+++..++.++.|++.||+|||+++++||||+|+||+++.++ .++|+|||+++.....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPV 153 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCc
Confidence 68985 69999997765 799999999999999999999999999999999999997754 5999999998753322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------- 144 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 144 (268)
.......+++.|+|||++.+......++|+|||||++|+|++|+.||...+......+..+......
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 2223446788999999887654334458999999999999999999987665444333322111000
Q ss_pred -ccC---------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 -YSV---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 -~~~---------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
... .....++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 1123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=238.69 Aligned_cols=180 Identities=26% Similarity=0.447 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+ +|.+.+.+.+ .+++.+++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 98 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~ 174 (310)
T cd07865 98 FEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLARAFSLSKN 174 (310)
T ss_pred EcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcccccCCcc
Confidence 689875 8888886543 799999999999999999999999999999999999997655 499999999875332221
Q ss_pred -----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------
Q 024363 80 -----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------- 144 (268)
Q Consensus 80 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 144 (268)
.....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+........ .+..+....
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (310)
T cd07865 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEVWPGVDK 253 (310)
T ss_pred cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhcccccc
Confidence 1234678899999988765433445999999999999999999998765433222 222221100
Q ss_pred ------ccCCC-----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 ------YSVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 ------~~~~~-----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+. ....+..+.+||.+||..||.+|||+++++.||||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 254 LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 01135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=233.13 Aligned_cols=176 Identities=28% Similarity=0.539 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTV 155 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcch
Confidence 6899999999999754 35899999999999999999999999999999999999976554 9999999987543222
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......|++.|+|||++.+...+.+ +|+|||||++++|++|+.||..........+ +..... .+.+..++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~ 229 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSY-PPVSSHYSYDL 229 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCC-CCCcccCCHHH
Confidence 1223468899999999887766555 8999999999999999999976554333322 222221 22334578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=238.44 Aligned_cols=173 Identities=25% Similarity=0.393 Sum_probs=136.9
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++. +|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 68999999999997542 4889999999999999999999999999999999999976554 99
Q ss_pred EeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+|||++..............+..|+|||++.+..++.+ +|||||||++|+|++ |..||..........+. . .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~-~ 233 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----P-Q 233 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----h-c
Confidence 999999864322222222233557999999887776655 999999999999997 99999876654433322 1 1
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+..++..+.+||.+||..+|.+|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22233344588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=242.16 Aligned_cols=157 Identities=22% Similarity=0.418 Sum_probs=125.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (268)
.+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++...... ......++..|+|||+
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 578999999999999999999999999999999999998655 49999999997543221 1223456778999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |..||.+......+...+.. ......+...++++.+++.+||+.+|.+||
T Consensus 247 ~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 247 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred hcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 988887776 899999999999998 99999875544433332221 112222344789999999999999999999
Q ss_pred CHHHHhcc
Q 024363 174 TIPEIMKH 181 (268)
Q Consensus 174 s~~e~l~h 181 (268)
++.++++|
T Consensus 322 s~~ell~~ 329 (337)
T cd05054 322 TFSELVEI 329 (337)
T ss_pred CHHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=237.38 Aligned_cols=181 Identities=31% Similarity=0.542 Sum_probs=136.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.+ +|.+++.+. +.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCc
Confidence 689985 999988764 46899999999999999999999999999999999999976654 9999999986532221
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------- 144 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (268)
......++..|+|||++.+....+.++||||+||++|+|++|+.||..........+.+.......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 222345788999999987644334448999999999999999999976653322222221111100
Q ss_pred --ccCC---------CCCCCC--HHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 --YSVP---------DTNPIS--QECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 --~~~~---------~~~~~s--~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+ ....++ .++.++|.+||+.+|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 001234 888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=240.14 Aligned_cols=173 Identities=25% Similarity=0.407 Sum_probs=136.8
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||++||+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~k 164 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 164 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cEE
Confidence 68999999999997543 578999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+|||+++............++..|+|||++.+..++.+ +|||||||++|+|++ |..||........... . ..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~-~~ 238 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQ 238 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHHH----H-hc
Confidence 999999864322222222334678999999877666554 999999999999998 9999976654332222 1 22
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
......+..+++++.+||.+||+.+|.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22233334478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=240.25 Aligned_cols=173 Identities=21% Similarity=0.367 Sum_probs=139.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
+||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEK 164 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCCc
Confidence 6899999999999764 46899999999999999999999999999999999999976554 99999999986443222
Q ss_pred C---CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 P---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. ....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.... .+.. +.......+.+..++.
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~~~~~ 238 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS-EISS----ILEKGERLPQPPICTI 238 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHhCCCCCCCCCCCCH
Confidence 1 22234678999999987777665 899999999999997 99999765432 2222 2223334444555789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++.+++.+||..+|.+||++.+++.+
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=235.34 Aligned_cols=175 Identities=20% Similarity=0.337 Sum_probs=138.3
Q ss_pred CCCCCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (268)
|||+.||+|.+++.+.+ .+++..+..++.||+.||+|||+++++||||||+||+++..+ ...+||+|||+++
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 69999999999997653 489999999999999999999999999999999999997654 2348999999987
Q ss_pred CCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 73 SSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 73 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
....... ......+..|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ .+. ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~----~~~-~~~~~~ 241 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME----FVT-GGGRLD 241 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHH-cCCcCC
Confidence 5422111 112234568999999987777665 999999999999997 999998766543221 111 112223
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+..++..+.+++.+||+.+|.+||++.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 344578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=233.79 Aligned_cols=180 Identities=30% Similarity=0.494 Sum_probs=138.1
Q ss_pred CCCCCCCchhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l--~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||++||+|.+++... +.+ ++..+..++.||+.||+|||++||+||||||+||+++... +.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccC
Confidence 6899999999999764 456 8899999999999999999999999999999999997532 35999999988643221
Q ss_pred -CCCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.......+++.|+|||++.+.. ....++|+||+|+++|+|++|+.||............ ....... ...+..++.
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~ 239 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIH--PEIPESLSA 239 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccC--CCCCcccCH
Confidence 2223346889999999986533 1234489999999999999999999765432211110 1111111 122334789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.+|+.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=235.11 Aligned_cols=175 Identities=37% Similarity=0.667 Sum_probs=144.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCcccc
Confidence 79999999999999888999999999999999999999999999999999999997655 49999999986433221
Q ss_pred -------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 024363 79 -------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 139 (268)
Q Consensus 79 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 139 (268)
......++..|+|||++.....+.+ +|+|||||+++++++|+.||........+ +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTF----QK 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH
Confidence 1123457889999999877665555 89999999999999999999876643332 22
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCH----HHHhccccc
Q 024363 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWF 184 (268)
Q Consensus 140 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~e~l~h~~~ 184 (268)
.....+..+ ..+++.+.+||.+||+.+|.+||++ .++++||||
T Consensus 234 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 333333333 3478999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=236.74 Aligned_cols=178 Identities=31% Similarity=0.523 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.. +++++.++..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCccc
Confidence 699999999999865 5799999999999999999999999999999999999997655 49999999986543322 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||++.+...+.+ +|+|||||++|+|++|..||.......... .+ ...........++..+.+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LI-PKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred cccccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hh-hcCCCCCCchhhhHHHHH
Confidence 233468889999999887766555 899999999999999999998655432211 11 111111222346789999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++.+||..+|.+||++.+++.|+||...
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=236.44 Aligned_cols=172 Identities=24% Similarity=0.415 Sum_probs=137.3
Q ss_pred CCCCCCCchhHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEee
Q 024363 1 MEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~D 67 (268)
|||+++|+|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~d 163 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIGD 163 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEecc
Confidence 68999999999997543 489999999999999999999999999999999999997655 499999
Q ss_pred cCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 68 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 68 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
||+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||........... +...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~----i~~~ 238 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQG 238 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC
Confidence 99987543221 1223345778999999987766655 899999999999998 8999977664433222 2222
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
. ..+....++.++.+|+.+||+.+|.+|||+.+++.
T Consensus 239 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2 12233457899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=254.44 Aligned_cols=184 Identities=23% Similarity=0.324 Sum_probs=134.6
Q ss_pred CCCCCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
||++. ++|..++... ......+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 242 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--~vkL~DFGla~~~~ 318 (501)
T PHA03210 242 TQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--KIVLGDFGTAMPFE 318 (501)
T ss_pred Eeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEeCCCceecC
Confidence 45664 5777777542 2345678889999999999999999999999999999997655 49999999997543
Q ss_pred CCC--CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC---ChHHHHHHHHHHhcccccCC--
Q 024363 76 LHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---EPKDFRKTIQRILSVQYSVP-- 148 (268)
Q Consensus 76 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~-- 148 (268)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..++.... ....+.+++..+......++
T Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 397 (501)
T PHA03210 319 KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDP 397 (501)
T ss_pred cccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCc
Confidence 322 2234579999999999988877665 899999999999999876443222 12223332221110000000
Q ss_pred ------------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 149 ------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 149 ------------------------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
....++.++.++|.+||++||.+|||+.|+|.||||....
T Consensus 398 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 398 PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 0123567888999999999999999999999999997653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=237.15 Aligned_cols=177 Identities=28% Similarity=0.466 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchh
Confidence 699999999998854 57999999999999999999999999999999999999976554 9999999987543322 1
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||.+.+..++.+ +|+|||||++|+|++|+.||.......... .+... ........++..+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~ 231 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKN-SPPTLEGQYSKPFKE 231 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcC-CCCCCCcccCHHHHH
Confidence 223468899999999987776655 899999999999999999997654322211 11111 111122347789999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+|.+||..+|.+||++.++++||||..
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 999999999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=238.35 Aligned_cols=179 Identities=30% Similarity=0.493 Sum_probs=141.0
Q ss_pred CCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC------------------CCCEEE
Q 024363 6 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP------------------APRLKI 65 (268)
Q Consensus 6 gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~------------------~~~~kl 65 (268)
|-|+++++.+++ +|+-.+++.+.+|++++++|||+.+++|.||||+|||+-++. ...|||
T Consensus 174 G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~v 253 (415)
T KOG0671|consen 174 GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKV 253 (415)
T ss_pred ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEE
Confidence 448999998765 589999999999999999999999999999999999984211 124899
Q ss_pred eecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--
Q 024363 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-- 143 (268)
Q Consensus 66 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 143 (268)
.|||.|+... ....+.+.|..|+|||++++-+++.+ +||||+|||++||.+|...|...++.+.+ ..++.++..
T Consensus 254 IDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlGp~P 329 (415)
T KOG0671|consen 254 IDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILGPIP 329 (415)
T ss_pred EecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhCCCc
Confidence 9999987432 33367789999999999999999888 99999999999999999999887765543 333333221
Q ss_pred ----------------cccCCC-------------CCC----------CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 144 ----------------QYSVPD-------------TNP----------ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 144 ----------------~~~~~~-------------~~~----------~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...++. +.+ --.++.+||++||.+||.+|+|+.|+|.||||
T Consensus 330 ~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 330 SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHh
Confidence 111111 000 11458899999999999999999999999999
Q ss_pred CCCC
Q 024363 185 LKNL 188 (268)
Q Consensus 185 ~~~~ 188 (268)
....
T Consensus 410 ~~~~ 413 (415)
T KOG0671|consen 410 ARLT 413 (415)
T ss_pred hcCC
Confidence 7643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=234.10 Aligned_cols=172 Identities=24% Similarity=0.398 Sum_probs=138.3
Q ss_pred CCCCCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEe
Q 024363 1 MEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~ 66 (268)
|||++||+|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~kl~ 164 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVKIG 164 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEEEC
Confidence 7999999999999754 2488999999999999999999999999999999999997665 49999
Q ss_pred ecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 024363 67 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 142 (268)
Q Consensus 67 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (268)
|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||........... +..
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~----~~~ 239 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC----ITQ 239 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc
Confidence 999987432211 1233456788999999988777665 899999999999998 9999987665443222 222
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
... ...+..++..+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 222 2223458899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=232.64 Aligned_cols=176 Identities=32% Similarity=0.533 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcccccccccccccc
Confidence 68999999999998888899999999999999999999999999999999999997655 4999999998753221
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......++..|+|||++.+...+.+ +|+|||||++|+|++|+.||......... ............+..++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccCHH
Confidence 11233568999999999987666555 89999999999999999999865443322 2222222222234458899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+.++|.+||+ +|..||++.+++.|||+
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999998 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=236.80 Aligned_cols=182 Identities=31% Similarity=0.544 Sum_probs=144.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++|++|.+++. .+++++..++.++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 96 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred EecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceeccccccc
Confidence 79999999998774 45789999999999999999999999999999999999997665 49999999876433221 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|+||+||++|+|++|..||.+........ .+..... ........++..+.+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~ 248 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLP--PKLKNLHKVSPSLKG 248 (292)
T ss_pred ccccccCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhCC--cccCCcccCCHHHHH
Confidence 234568999999999877666554 899999999999999999998655433222 2221111 122233347899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
++.+||..+|.+||++.+++.||||.+..+
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=237.10 Aligned_cols=177 Identities=23% Similarity=0.342 Sum_probs=135.1
Q ss_pred CCCCCCCchhHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC
Q 024363 1 MEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 61 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~ 61 (268)
||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~-- 175 (304)
T cd05096 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-- 175 (304)
T ss_pred EecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCc--
Confidence 79999999999986532 367888999999999999999999999999999999997655
Q ss_pred CEEEeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh--CCCCCCCCCChHHHHHH
Q 024363 62 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPKDFRKT 136 (268)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~~~ 136 (268)
.+||+|||+++...... ......++..|+|||++.+..++.+ +|||||||++|+|++ +..||............
T Consensus 176 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254 (304)
T ss_pred cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHH
Confidence 49999999987532221 1223345788999999887777655 899999999999986 56788776544333322
Q ss_pred HHHHhcc--cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 137 IQRILSV--QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 137 ~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
....... ......+..++..+.+||.+||..+|.+|||+.++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 255 GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 2211111 1111223457899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=233.41 Aligned_cols=172 Identities=20% Similarity=0.338 Sum_probs=137.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+. +.+++..++.++.|++.||+|||++|++||||||+||+++.++ .+|++|||.+........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence 7999999999999764 5799999999999999999999999999999999999997655 499999998764322211
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....++..|+|||++.+..++.+ +|||||||++|++++ |..||.+......... + ......+.+..++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~ 236 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----V-EDGFRLPAPRNCPNL 236 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----H-HCCCCCCCCCCCCHH
Confidence 112345678999999987777665 899999999999775 9999987665432222 1 222233445558899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=236.93 Aligned_cols=172 Identities=24% Similarity=0.401 Sum_probs=137.5
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||++||+|.+++... +.+++..++.++.||+.||+|||++|++||||||+||+++.++ .+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~~ 163 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LVK 163 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEE
Confidence 7999999999999754 2489999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |+.||........... +
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~----~ 238 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC----I 238 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H
Confidence 99999987533221 1234456889999999987776655 899999999999998 9999977655432222 2
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
... .........+..+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221 112223347899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=234.00 Aligned_cols=172 Identities=26% Similarity=0.410 Sum_probs=135.6
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++.+.. .+++.+++.++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~k 152 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 152 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEE
Confidence 78999999999997543 478999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+|||++..............+..|+|||++....++.+ +|||||||++|+|++ |..||.+......+.. + ..
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~-~~ 226 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQ 226 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----H-hC
Confidence 999999864322222222334667999999877666555 899999999999997 9999977654332222 2 12
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
....+.+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2233334457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=234.64 Aligned_cols=181 Identities=29% Similarity=0.449 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+++ +|.+++.. ...+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.......
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVR 153 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcc
Confidence 689975 88888866 45799999999999999999999999999999999999997655 49999999886543332
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------- 144 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 144 (268)
......++..|+|||.+.+....+.++|+|||||++|+|++|+.||...+....+.++........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223456888999999987663334459999999999999999999987766554444332211110
Q ss_pred -ccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 -YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 -~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+ ....++.++.+||.+||..+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000 012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=235.02 Aligned_cols=181 Identities=28% Similarity=0.472 Sum_probs=134.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+. ++|.+.+.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++..... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCC
Confidence 68996 577777654 45689999999999999999999999999999999999997655 4999999998753322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------c
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------Y 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~ 145 (268)
......+++.|+|||++.+....+.++|+|||||++|+|++|+.||.................... +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 223456799999999987643223448999999999999999999986554322111111100000 0
Q ss_pred --c-C----C-------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 146 --S-V----P-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 146 --~-~----~-------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
. . + .....+..+.+++.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0 011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=230.60 Aligned_cols=172 Identities=25% Similarity=0.374 Sum_probs=138.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||.++++||||||+||+++.++. +||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDY 151 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcc
Confidence 689999999999998888999999999999999999999999999999999999976654 999999998754332211
Q ss_pred ----CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 81 ----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 81 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
....++..|+|||.+.+..++.+ +|||||||++|++++ |..||....... +.+.+. .....+.+..++.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~ 225 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLE----SGERLPRPEECPQ 225 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHH----cCCcCCCCCCCCH
Confidence 11223567999999987777655 999999999999998 999997665432 222221 1222344455889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.++++|.+||..+|.+||++.+++.
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=240.19 Aligned_cols=184 Identities=24% Similarity=0.379 Sum_probs=144.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
|||+. |+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||+++....
T Consensus 99 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--~~kl~dfg~~~~~~~~~~~ 175 (335)
T PTZ00024 99 MDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFGLARRYGYPPYS 175 (335)
T ss_pred Eeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC--CEEECCccceeeccccccc
Confidence 68997 59999998888899999999999999999999999999999999999997665 499999999864331
Q ss_pred -----------CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 024363 77 -----------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 145 (268)
Q Consensus 77 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (268)
........+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.........+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~ 255 (335)
T PTZ00024 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255 (335)
T ss_pred ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch
Confidence 111223457889999999876544345599999999999999999999877765544433332211100
Q ss_pred c-CC---------------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 S-VP---------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 ~-~~---------------------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
. ++ .....+..+.++|.+||..+|++|||+++++.||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 0 00 012357889999999999999999999999999999765
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=235.32 Aligned_cols=184 Identities=27% Similarity=0.426 Sum_probs=140.6
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
|||++ ++|.+++..... +++..++.++.||+.||+|||++|++||||+|+||+++..+ +.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPV 157 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCc
Confidence 68996 588888865443 58899999999999999999999999999999999997543 34899999998753322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------- 144 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 144 (268)
.......+++.|+|||++.+......++||||+||++|+|++|+.||..........+.........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 2223456789999999987654334459999999999999999999987665544444332111100
Q ss_pred -ccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 -YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 -~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
...+ ....++..+.++|.+||+.+|.+||++.+++.||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0000 01246889999999999999999999999999999964
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=234.85 Aligned_cols=180 Identities=29% Similarity=0.540 Sum_probs=144.8
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||++|++|.+++...+ .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccchh
Confidence 68999999999998876 899999999999999999999999999999999999997655 49999999876432221
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......+++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.............. ......+....++..+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---KGIPPLKNPEKWSPEFK 247 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCCCcchhhCCHHHH
Confidence 2233457889999999887776655 9999999999999999999976554332222111 11112222333789999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++|.+||+.+|.+||++.+++.|+||.+
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=234.19 Aligned_cols=181 Identities=27% Similarity=0.474 Sum_probs=141.6
Q ss_pred CCCCCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||+.| +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~ 153 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIP 153 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCC
Confidence 689985 898888654 35899999999999999999999999999999999999976554 999999998643322
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
.......+++.|+|||++.+......++|+|||||++|+|++|+.||.+.+......++........
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1223456789999999987654444559999999999999999999988776655544433211000
Q ss_pred --ccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 --YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 --~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+. ...++..+.++|.+||+.+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=242.32 Aligned_cols=183 Identities=20% Similarity=0.342 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.+|+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+|++||+.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccC
Confidence 6899999999999764 3589999999999999999999999999999999999997655 49999997543211111
Q ss_pred C--------CCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------
Q 024363 79 Q--------PKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL------- 141 (268)
Q Consensus 79 ~--------~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------- 141 (268)
. .....++..|+|||++.+. .+. .++||||+||++|+|++|+.||............+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 0 1112345679999998764 233 448999999999999999999987654433222211000
Q ss_pred ----------------------------------cccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 142 ----------------------------------SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 142 ----------------------------------~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
......+....++..+.+||++||+.||.+|||+.++++||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000011112235678999999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=232.33 Aligned_cols=172 Identities=19% Similarity=0.326 Sum_probs=137.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++++||||||+||+++.++ .+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCCc
Confidence 689999999999976 45799999999999999999999999999999999999997654 49999999987533221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......++..|+|||.+.+..++.+ +|||||||++|++++ |+.||.+..... ..+.+ ......+.+...+.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~ 238 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL----EKGERLAQPQICTI 238 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH----HCCCcCCCCCCCCH
Confidence 1223456778999999987777655 899999999999998 999997764322 22222 22222333344678
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++..++.+||..+|.+|||+.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=238.91 Aligned_cols=183 Identities=26% Similarity=0.359 Sum_probs=135.6
Q ss_pred CCCCCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~~ 73 (268)
|||+++ +|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++ .+.+||+|||+++.
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 689875 777776431 3689999999999999999999999999999999999997611 34599999999875
Q ss_pred CCCCC----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH---------HHHHHHHHH
Q 024363 74 SVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------DFRKTIQRI 140 (268)
Q Consensus 74 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~~~~~~ 140 (268)
..... ......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+..... .+.+++..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (316)
T cd07842 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241 (316)
T ss_pred cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence 43222 22345688999999988765433455999999999999999999997654322 111111100
Q ss_pred h----------------------cccccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 141 L----------------------SVQYSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 141 ~----------------------~~~~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
. ......+ .....+..+.++|.+||+.+|++|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0000000 001467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=233.43 Aligned_cols=176 Identities=26% Similarity=0.380 Sum_probs=135.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||+++|+|.+++.+ ..+++.+++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCCcchh
Confidence 799999999999876 4699999999999999999999999999999999999997654 499999999875432211
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH-H---------HHHHHHHhccccc
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-F---------RKTIQRILSVQYS 146 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~---------~~~~~~~~~~~~~ 146 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++|+.||........ . .............
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 122345667999999877766655 8999999999999999999865432100 0 0001111111222
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+..++..+.+++.+||+.+|++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3334557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=238.93 Aligned_cols=183 Identities=30% Similarity=0.419 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+. ++|.+++.+. .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 88 ~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 88 FEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEEN 163 (337)
T ss_pred ecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccccc
Confidence 68997 4999998765 8899999999999999999999999999999999999976654 9999999987533221
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 140 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-------------- 140 (268)
......|++.|+|||++.+....+.++|+|||||++|+|++|+.||.+........+.....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 22335689999999988665444455999999999999999999998765544332221111
Q ss_pred -----hc----cccc--CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 141 -----LS----VQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 141 -----~~----~~~~--~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.. .... ......++.++.++|.+||+.+|.+|||+.++++||||.+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 0000 00112268899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=229.58 Aligned_cols=176 Identities=34% Similarity=0.548 Sum_probs=144.2
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++|++|.+++.+. +.+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~ 155 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSS 155 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeeccc
Confidence 6899999999999764 6799999999999999999999999999999999999997654 499999999875433
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ......|++.|+|||.+.+..++.+ +|+||+|+++++|++|+.||......... ....... ..+.+..++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~ 229 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELA----LKILKGQ-YPPIPSQYSS 229 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHH----HHHhcCC-CCCCCCCCCH
Confidence 32 2234578999999999887776655 89999999999999999999776533222 2222222 1222335789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+.+++.+||..+|.+|||+.+++.||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=255.58 Aligned_cols=186 Identities=17% Similarity=0.250 Sum_probs=130.3
Q ss_pred CCCCCCCchhHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC
Q 024363 1 MEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--------------------l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~ 60 (268)
|||+.+|+|.+++..... ..+..+..++.||+.||+|||+++|+||||||+|||++.. .
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~-~ 292 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG-S 292 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC-C
Confidence 689999999999875421 1244577899999999999999999999999999999743 2
Q ss_pred CCEEEeecCCCCCCCC--CCCCCCCcCCCCcccchhhccCccC---------------------CcccchhhhhHHHHHH
Q 024363 61 PRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRHEYD---------------------GKIADVWSCGVTLYVM 117 (268)
Q Consensus 61 ~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG~il~el 117 (268)
+.+||+|||+|+.... ........+++.|+|||.+...... ..++|||||||++|+|
T Consensus 293 ~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el 372 (566)
T PLN03225 293 GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372 (566)
T ss_pred CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHH
Confidence 3599999999974322 2233456899999999976432211 1226999999999999
Q ss_pred HhCCCCCCCCCChHHHHHHHHHH----------hccccc------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 118 LVGGYPFEDPDEPKDFRKTIQRI----------LSVQYS------VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 118 ~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+++..++.. ....+...+... ...... +......+..+++||.+||++||.+|||+.++|+|
T Consensus 373 ~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 373 AFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 997665432 222222222110 000000 00001123456799999999999999999999999
Q ss_pred cccCCCCC
Q 024363 182 QWFLKNLP 189 (268)
Q Consensus 182 ~~~~~~~~ 189 (268)
|||.....
T Consensus 451 pff~~~~~ 458 (566)
T PLN03225 451 PYFDREGL 458 (566)
T ss_pred cCcCCCCc
Confidence 99976543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=229.52 Aligned_cols=172 Identities=23% Similarity=0.347 Sum_probs=135.9
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDS 150 (257)
T ss_pred EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCcc
Confidence 799999999999975 55799999999999999999999999999999999999997655 499999999874322211
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....+++.|+|||++....++.+ +|||||||++|++++ |..||......... ..+ . .....+.+...+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~~~ 224 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFI---E-QGKRLDCPAECP 224 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHH---H-CCCCCCCCCCCC
Confidence 112233578999999887766555 899999999999996 99999876543322 212 1 112223334578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+++.++|.+||..+|++||++.++.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=236.66 Aligned_cols=181 Identities=26% Similarity=0.461 Sum_probs=143.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||++||+|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccc
Confidence 689999999999865 4689999999999999999999999999999999999997655 49999999876433222 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....+++.|+|||.+.+..++.+ +|+|||||++|++++|+.||...+........ ........+....++..+.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred cccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHH
Confidence 234468899999999877766555 89999999999999999999765442221111 01111222333447889999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+|.+||..+|.+||++.+++.|+||....
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=231.81 Aligned_cols=173 Identities=21% Similarity=0.328 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++..
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~ 162 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGLSKKI 162 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCccccc
Confidence 689999999988742 23489999999999999999999999999999999999997655 4999999998754
Q ss_pred CCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
..... .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |+.||.+...... ...+.. ....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~ 236 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYLRQ-GNRLKQP 236 (272)
T ss_pred CcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHc-CCCCCCC
Confidence 33221 122346778999999887776655 899999999999999 8899976554322 222222 2222334
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..++..+.++|.+||+.+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=240.24 Aligned_cols=183 Identities=28% Similarity=0.428 Sum_probs=139.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++ ++|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++..+ +.+||+|||+++.....
T Consensus 95 ~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~~~~ 171 (342)
T cd07854 95 QEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPHYSH 171 (342)
T ss_pred eeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceecCCcccc
Confidence 68997 599888754 5799999999999999999999999999999999999997433 34899999998643221
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc--------------
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-------------- 142 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 142 (268)
.......++..|+|||++.+....+.++|||||||++|+|++|+.||.+................
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07854 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP 251 (342)
T ss_pred ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence 11123467889999998765444445599999999999999999999876654433332221100
Q ss_pred -----ccc--cCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 143 -----VQY--SVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 143 -----~~~--~~~---~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
... ..+ ....++.++.+||.+||+.||.+|||+.+++.||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 252 SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 000 01237789999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=229.43 Aligned_cols=172 Identities=23% Similarity=0.393 Sum_probs=137.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCce
Confidence 799999999999975 45689999999999999999999999999999999999997655 499999999875432221
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....++..|+|||++.+..++.+ +|+|||||++|+|++ |+.||...+.......+. .. .....+...+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~----~~-~~~~~~~~~~~~ 229 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----RG-FRLYRPKLASMT 229 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CC-CCCCCCCCCCHH
Confidence 122345668999999887776655 999999999999999 899998766544333322 21 122233346789
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+++.+||..+|.+||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=229.33 Aligned_cols=172 Identities=22% Similarity=0.351 Sum_probs=137.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccce
Confidence 6899999999999753 3589999999999999999999999999999999999997655 49999999987543322
Q ss_pred CC--CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.......... ......+.+..++.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 232 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKGYRMERPEGCPP 232 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----HCCCCCCCCCCCCH
Confidence 11 12234668999999887777655 899999999999998 99999876543332221 12223334455889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.++|.+||..+|++||++.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=231.92 Aligned_cols=173 Identities=20% Similarity=0.315 Sum_probs=135.3
Q ss_pred CCCCCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
|||+++|+|.+++.+.. .++...+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCCCC
Confidence 69999999999997532 357788999999999999999999999999999999997655 499999999
Q ss_pred CCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ ...... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~~-~ 239 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVMEGG-L 239 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC-c
Confidence 87432211 1122355788999999987776555 899999999999998 788997765433222 112211 1
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+..++..+.+++.+||+.+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22234478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.89 Aligned_cols=177 Identities=33% Similarity=0.530 Sum_probs=142.4
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++|++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||||.||+++.++. .+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSM 156 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCc
Confidence 68999999999997643 5899999999999999999999999999999999999976543 37999999887543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......|++.|+|||++.+..++.+ +|+|||||++++|++|..||........... ..... ..+....++..+
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~ 230 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDL 230 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHH
Confidence 1223468999999999877766655 8999999999999999999976554333222 22221 122234478999
Q ss_pred HHHHHHccccCCCCCCCHHHHhccccc
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.++|.+||..+|++|||+.++++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=230.59 Aligned_cols=181 Identities=30% Similarity=0.480 Sum_probs=141.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||++ ++|.+++.+. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||+++......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLR 153 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCcc
Confidence 68998 4999999876 5799999999999999999999999999999999999997655 49999999987543322
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------c
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------Q 144 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~ 144 (268)
......++..|+|||.+.+....+.++|+|||||++|++++|+.||..........++....... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 22344567889999998766333445899999999999999999998766544443333211100 0
Q ss_pred ccCCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 145 YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 145 ~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
...+. ...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 11247889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=227.82 Aligned_cols=176 Identities=32% Similarity=0.531 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCccc
Confidence 68999999999998888999999999999999999999999999999999999997644 599999999875433222
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||.+.+.....+ +|+||+|+++|+|++|+.||..........+ ... ....+.+..++..+.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 229 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IVQ-DDHPPLPEGISPELKD 229 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhc-cCCCCCCCCCCHHHHH
Confidence 234568899999999877665444 8999999999999999999976553222222 111 1122233457899999
Q ss_pred HHHHccccCCCCCCCHHHHhccccc
Q 024363 160 LISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.+||..+|++||++.+++.||||
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=229.71 Aligned_cols=173 Identities=23% Similarity=0.392 Sum_probs=137.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+|+|.+++.+. ..+++..++.++.||+.||+|||+.|++||||||.||+++.++ .+||+|||.++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCce
Confidence 7999999999999764 4699999999999999999999999999999999999997655 499999999875432221
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |..||...........+. .. ...+.....+..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~ 229 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS----QG-LRLYRPHLASEK 229 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh----cC-CCCCCCCCCCHH
Confidence 112345678999999987766655 899999999999998 999998766543333222 21 122223346899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+++++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=222.69 Aligned_cols=175 Identities=28% Similarity=0.447 Sum_probs=139.6
Q ss_pred CCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 2 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 2 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
.|...|||.+.|.. +..++|.++..++.+|++||.+||+.. ..||||||.||+++.++ .++|.|||.++...
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~--~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG--LPVLMDLGSATQAP 180 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--ceEEEeccCccccc
Confidence 47778999999964 346999999999999999999999999 99999999999997654 48999999887544
Q ss_pred CCCCCC----------CCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 024363 76 LHSQPK----------STVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 142 (268)
Q Consensus 76 ~~~~~~----------~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 142 (268)
...... ....|..|+|||.+.-. ..+.+ +|||||||++|.|+.|..||+..-.. -..+...+.+
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~--GgSlaLAv~n 257 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQ--GGSLALAVQN 257 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhc--CCeEEEeeec
Confidence 332221 23579999999998643 34445 89999999999999999999632110 0011122455
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+|...++|+.+.+||+.||+.||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 677888888899999999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=232.49 Aligned_cols=181 Identities=27% Similarity=0.476 Sum_probs=140.5
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+++ +|.+++.+. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS 155 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCc
Confidence 689975 899988765 57999999999999999999999999999999999999976554 9999999987543332
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccCCC-------
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPD------- 149 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~------- 149 (268)
......++..|+|||.+.+....+.++|||||||++|+|++|+.||...........+........ ..++.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 223456788999999876544334459999999999999999999987765444443332211100 00000
Q ss_pred ----------------CCC-CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 150 ----------------TNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 150 ----------------~~~-~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
... ++..+.++|.+||..+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=228.08 Aligned_cols=173 Identities=24% Similarity=0.377 Sum_probs=139.8
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+.+.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccc
Confidence 68999999999997754 689999999999999999999999999999999999997664 49999999987543321
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......++..|+|||.+....++.+ +|||||||++|+|++ |..||...+.......+ .......+.+...
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEAC 226 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccC
Confidence 1123457788999999887777665 899999999999998 99999766554332222 2222233334457
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=228.63 Aligned_cols=170 Identities=23% Similarity=0.374 Sum_probs=135.5
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST- 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceecccc-
Confidence 68999999999997644 489999999999999999999999999999999999997665 4999999998743222
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||......... ..+. ..........+++.+
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~ 228 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVE-KGYKMDAPDGCPPVV 228 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHh-cCCCCCCCCCCCHHH
Confidence 123345678999999887766655 899999999999997 99999765432222 1111 122222334578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+++.+||..+|.+|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=266.57 Aligned_cols=177 Identities=15% Similarity=0.206 Sum_probs=132.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-----------------CCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----------------SPAPR 62 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-----------------~~~~~ 62 (268)
|||+ +++|.++|.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+. +..+.
T Consensus 59 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~ 137 (793)
T PLN00181 59 LECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDAT 137 (793)
T ss_pred hccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCc
Confidence 5776 5699999975 456999999999999999999999999999999999999953 22334
Q ss_pred EEEeecCCCCCCCCC-----------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCC
Q 024363 63 LKICDFGYSKSSVLH-----------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 125 (268)
Q Consensus 63 ~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 125 (268)
+|++|||+++..... .......||++|||||++.+..+..+ +|||||||++|||++|..|+.
T Consensus 138 ~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 138 TKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCA-SDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCch-hhhhhHHHHHHHHhhCCCchh
Confidence 788888887642110 00112468999999999988888655 999999999999999988875
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 126 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.... .+........ .+...........++.+||..+|.+||++.++++||||..
T Consensus 217 ~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 217 EKSR--TMSSLRHRVL-----PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hHHH--HHHHHHHhhc-----ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 3221 1111111111 1111113456789999999999999999999999999975
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=233.46 Aligned_cols=173 Identities=24% Similarity=0.422 Sum_probs=137.2
Q ss_pred CCCCCCCchhHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----------------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+|
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--~~k 172 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--VMK 172 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--eEE
Confidence 699999999999964 24689999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+..........
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 247 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 247 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH----
Confidence 99999987543221 1122235678999999877777655 899999999999997 99999876543332221
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
........+...+..+.+|+.+||..+|.+|||+.+++++
T Consensus 248 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 -KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1222223334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=228.44 Aligned_cols=171 Identities=21% Similarity=0.274 Sum_probs=133.4
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC------CEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~------~~kl~Dfg~a~~ 73 (268)
||||++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.. .++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 79999999999997644 58999999999999999999999999999999999999765432 379999998864
Q ss_pred CCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 74 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
... .....+++.|+|||++.+....+.++|||||||++|+|++|. .||........ .. ........+ ..
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~~~~~~--~~ 227 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYEDRHQLP--AP 227 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHccccCC--CC
Confidence 332 233568889999999976443344489999999999999985 66654433221 11 112222223 23
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.++.+||.+||+.+|.+|||+.++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 67899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=229.09 Aligned_cols=171 Identities=25% Similarity=0.300 Sum_probs=132.6
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC-----CCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~-----~~~kl~Dfg~a~~~ 74 (268)
|||+++|+|..++.+ .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++. ..+|++|||++...
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 83 EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 799999999988875 456999999999999999999999999999999999999975432 13899999988643
Q ss_pred CCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
. ......++..|+|||++......+.++|||||||++|+|+ .|..||....... .. ....... ....+.
T Consensus 163 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~----~~~~~~~--~~~~~~ 232 (262)
T cd05077 163 L---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KE----RFYEGQC--MLVTPS 232 (262)
T ss_pred c---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HH----HHHhcCc--cCCCCC
Confidence 2 2234568889999999874443344599999999999998 5888887544321 11 1111211 222335
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++.+||.+||+.||.+||++.+++++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 6889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=225.81 Aligned_cols=175 Identities=33% Similarity=0.452 Sum_probs=143.2
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++|++|.+++.+ ...+++..++.++.|++.||+|||++|++||||+|.||+++.++ .+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~ 155 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKK 155 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhcc
Confidence 689999999999866 45699999999999999999999999999999999999998654 499999999876544
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
. ......+++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...+..... ..+....+ .+....++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 228 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLR----YKVQRGKY-PPIPPIYSQD 228 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCC-CCCchhhCHH
Confidence 3 3344678999999999987776555 89999999999999999999876543221 12222221 1222357899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+++++.+||+.+|.+||++.+++.||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=228.26 Aligned_cols=173 Identities=20% Similarity=0.376 Sum_probs=137.6
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccc
Confidence 689999999999976 457899999999999999999999999999999999999976654 99999999875432211
Q ss_pred C--CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 P--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
. ....++..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||........... + ......+.+..++..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~ 229 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----V-SAGYRLYRPKLAPTE 229 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----H-HcCCcCCCCCCCCHH
Confidence 1 11224457999999987777655 899999999999998 8999976654332222 1 122233344458999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+++.+||..+|.+|||+.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=234.47 Aligned_cols=181 Identities=24% Similarity=0.408 Sum_probs=136.9
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+ +|...+.. ...+++..++.++.|+++||.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 94 ~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 170 (311)
T cd07866 94 TPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPP 170 (311)
T ss_pred EecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCc
Confidence 578765 67777654 457999999999999999999999999999999999999976654 99999999874322111
Q ss_pred ------------CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cc
Q 024363 80 ------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YS 146 (268)
Q Consensus 80 ------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 146 (268)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+........ ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T cd07866 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250 (311)
T ss_pred ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 12345788999999887654334458999999999999999999987665444333322111000 00
Q ss_pred ------------------CC-----CCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 147 ------------------VP-----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 147 ------------------~~-----~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.+ ....+++.+.+||.+||..+|.+|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 012345789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=230.68 Aligned_cols=177 Identities=21% Similarity=0.335 Sum_probs=137.5
Q ss_pred CCCCCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
|||+.||+|.+++.+. ..++...+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Dfg~ 165 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDFGM 165 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcCCc
Confidence 7999999999999753 2356778899999999999999999999999999999997655 499999999
Q ss_pred CCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
++....... .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+....... ..+.... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~-~ 239 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGG-Y 239 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-C
Confidence 874322211 122345778999999887776655 899999999999998 78899765543322 2222221 1
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc------ccccC
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK------HQWFL 185 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~------h~~~~ 185 (268)
.+.+...+..+.+++.+||+.+|.+|||+.++++ ||||.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 2223346799999999999999999999999987 77774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=227.97 Aligned_cols=172 Identities=22% Similarity=0.349 Sum_probs=139.1
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.+ ...+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcc
Confidence 799999999999975 346899999999999999999999999999999999999976654 9999999987543221
Q ss_pred C-CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 Q-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
. .....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||........+.... .....+.+..++..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 232 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQE 232 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHH
Confidence 1 223345678999999887766655 899999999999998 899998766443333222 22334445568899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.++|.+||+.+|.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=231.26 Aligned_cols=172 Identities=22% Similarity=0.390 Sum_probs=136.9
Q ss_pred CCCCCCCchhHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEE
Q 024363 1 MEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 65 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl 65 (268)
|||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~kL 163 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVKI 163 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEEE
Confidence 68999999999997643 488999999999999999999999999999999999997654 4999
Q ss_pred eecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHh
Q 024363 66 CDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 141 (268)
Q Consensus 66 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~ 141 (268)
+|||+++...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||............ .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~ 238 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI----T 238 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----H
Confidence 9999986432221 1223345788999999987777665 899999999999998 89999766544332222 1
Q ss_pred cccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 142 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 142 ~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.. .....+..+++.+.+||.+||+.+|.+||++.+++.
T Consensus 239 ~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 122333458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=233.04 Aligned_cols=173 Identities=26% Similarity=0.446 Sum_probs=138.3
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++.+.. .+++.++..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDS 195 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCC
Confidence 69999999999997643 389999999999999999999999999999999999997554 49999999987543222
Q ss_pred C---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 Q---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
. .....+++.|+|||.+.+..++.+ +||||+||++|+|++ |..||........+.+.. ........+...+
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 270 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEGYRMAQPEHAP 270 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcCCcCCCCCCCC
Confidence 1 122346788999999887776655 899999999999998 999998766544333322 2222333334478
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+|+.+||..+|++|||+.+++.
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=237.99 Aligned_cols=182 Identities=25% Similarity=0.428 Sum_probs=139.2
Q ss_pred CCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCC
Q 024363 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 81 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~ 81 (268)
|++ |++|.+++.. +.+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||+++.... ...
T Consensus 102 ~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~--~~~ 175 (345)
T cd07877 102 HLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD--EMT 175 (345)
T ss_pred hhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccccc--ccc
Confidence 444 7899887754 46999999999999999999999999999999999999976654 99999999875422 233
Q ss_pred CCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-------------------
Q 024363 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------------- 142 (268)
Q Consensus 82 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------------- 142 (268)
...+++.|+|||++.+....+.++|||||||++|+|++|+.||...........+......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (345)
T cd07877 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255 (345)
T ss_pred ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHH
Confidence 4578999999999876433344589999999999999999999776554433322221100
Q ss_pred ccccCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 143 VQYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 143 ~~~~~~~------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.....+. ....++++.+||.+||+.+|.+||++.+++.||||.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000000 1135788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=229.31 Aligned_cols=173 Identities=22% Similarity=0.347 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
|||+++|+|..++... ..+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++..
T Consensus 86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~ 163 (273)
T cd05035 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKI 163 (273)
T ss_pred EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCccceeec
Confidence 5899999999998542 3689999999999999999999999999999999999997654 4999999998754
Q ss_pred CCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
..... .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....... ..+... .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~ 237 (273)
T cd05035 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHG-NRLKQP 237 (273)
T ss_pred cccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC-CCCCCC
Confidence 32221 112335678999999877666655 999999999999999 88999776543322 222221 222334
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..++..+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=238.30 Aligned_cols=181 Identities=27% Similarity=0.404 Sum_probs=137.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.+ +|..++ ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++.... ..
T Consensus 99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~~--~~ 171 (342)
T cd07879 99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHADA--EM 171 (342)
T ss_pred eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCCC--CC
Confidence 466653 676654 34799999999999999999999999999999999999997655 499999999875322 22
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL------------------- 141 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------------- 141 (268)
....+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.+....+..++....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHH
Confidence 3456889999999987643334459999999999999999999987654443333222100
Q ss_pred cccccCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 142 SVQYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 142 ~~~~~~~------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
......+ .....+..+.+||.+||+.||.+||++.+++.||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 0123678899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=227.77 Aligned_cols=172 Identities=23% Similarity=0.374 Sum_probs=137.5
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+ ...+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNE 157 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCc
Confidence 689999999999965 35689999999999999999999999999999999999997655 49999999987543221
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........... + ......+....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~ 231 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----L-QRGYRMPRMENCPD 231 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCH
Confidence 1 122345678999999887766555 899999999999998 9999977654332222 1 12233444455889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.+++.+||..+|++||+++++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=232.69 Aligned_cols=181 Identities=29% Similarity=0.458 Sum_probs=138.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+++ +|...+.+. ..+++..++.++.|++.||+|||++||+||||||.||+++.++. +||+|||++.......
T Consensus 95 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~ 171 (302)
T cd07864 95 FEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEES 171 (302)
T ss_pred EcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcc
Confidence 689986 777777653 46999999999999999999999999999999999999976654 9999999987543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cC---------
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV--------- 147 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--------- 147 (268)
......++..|+|||.+.+......++|||||||++|+|++|++||........+..+......... .+
T Consensus 172 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T cd07864 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYF 251 (302)
T ss_pred cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccc
Confidence 1223456888999998865443344599999999999999999999876554443333322111100 00
Q ss_pred --------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 148 --------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 148 --------------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 252 NTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122368999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=232.74 Aligned_cols=167 Identities=17% Similarity=0.199 Sum_probs=130.0
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--------C
Q 024363 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------Q 79 (268)
Q Consensus 8 ~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~--------~ 79 (268)
++.+.+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||+|+...... .
T Consensus 112 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~DFGla~~~~~~~~~~~~~~~~ 189 (294)
T PHA02882 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYIIDYGIASHFIIHGKHIEYSKEQ 189 (294)
T ss_pred CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEEEcCCceeeccCCccccccccc
Confidence 6667776666688999999999999999999999999999999999997654 49999999987532211 1
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHH-----HHHHHhcccccCCCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK-----TIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~s 154 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......... .+..+...... ....+
T Consensus 190 ~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 265 (294)
T PHA02882 190 KDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK---IKNAN 265 (294)
T ss_pred ccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc---cCCCC
Confidence 223469999999999988777655 9999999999999999999987743322211 11222222222 22367
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+++..||..+|.+||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 266 KFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 89999999999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=229.10 Aligned_cols=172 Identities=23% Similarity=0.340 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++. +||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~dfg~ 165 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCccc
Confidence 7999999999999643 24688899999999999999999999999999999999977654 99999999
Q ss_pred CCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
++...... ......++..|+|||.+.+..++.+ +|||||||++|++++ |..||...+..... +. +. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~---~~-~~~~ 239 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KF---VI-DGGH 239 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHH-HH---Hh-cCCC
Confidence 87533221 2233456789999999877766655 899999999999998 99999766543322 22 22 2222
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+..++..+.++|.+||+.+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2334447899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=229.44 Aligned_cols=177 Identities=19% Similarity=0.305 Sum_probs=131.5
Q ss_pred CCCCCCCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccc
Confidence 79999999999997643 2567888999999999999999999999999999999976654 9999999986432
Q ss_pred CCC---CCCCCcCCCCcccchhhccC------ccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 024363 76 LHS---QPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 145 (268)
Q Consensus 76 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (268)
... ......+++.|+|||++... ...+.++|||||||++|+|++ |..||............+........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC
Confidence 221 11233467789999997532 122445899999999999999 78888776554433333222111111
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.......++..+.+++..|+ .+|.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11122357889999999998 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=233.70 Aligned_cols=173 Identities=25% Similarity=0.393 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||++|+|.+++...+ .++..+++.++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~k 180 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMK 180 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC--cEE
Confidence 69999999999997642 488899999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.+... ..+.+.+
T Consensus 181 L~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~--- 255 (307)
T cd05098 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLL--- 255 (307)
T ss_pred ECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH---
Confidence 99999987543211 1122234578999999987766555 899999999999998 8888876543 2222222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
......+.+..++.++.+|+.+||..+|.+||++.+++++
T Consensus 256 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 -KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred -HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 2222233344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=231.44 Aligned_cols=177 Identities=25% Similarity=0.360 Sum_probs=138.8
Q ss_pred CCCCCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecC
Q 024363 1 MEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg 69 (268)
|||+.+|+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~--~~~l~dfg 175 (296)
T cd05051 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFG 175 (296)
T ss_pred EecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC--ceEEcccc
Confidence 68999999999997765 699999999999999999999999999999999999997664 49999999
Q ss_pred CCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhc--
Q 024363 70 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPKDFRKTIQRILS-- 142 (268)
Q Consensus 70 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~~~~~~~~~-- 142 (268)
+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ +..||........+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05051 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254 (296)
T ss_pred ceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc
Confidence 987533221 1223456788999999887666655 899999999999998 77888766554443333222111
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.....+....++.++.+++.+||+.+|.+|||+.+++.
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11112233446799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=236.75 Aligned_cols=183 Identities=27% Similarity=0.407 Sum_probs=141.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++..... ..
T Consensus 99 ~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~--~~ 172 (343)
T cd07880 99 MPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDS--EM 172 (343)
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccccc--Cc
Confidence 5777 7799888754 5799999999999999999999999999999999999997655 499999999875432 22
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+........+++......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence 345678999999998764333455899999999999999999998766544333322211000
Q ss_pred --c--ccC----CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 144 --Q--YSV----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 144 --~--~~~----~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
. ... .....++..+.++|.+||+.||.+|||+.+++.||||.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 000 011346788999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=226.23 Aligned_cols=172 Identities=24% Similarity=0.411 Sum_probs=134.3
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVY 149 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccc
Confidence 6999999999999764 4689999999999999999999999999999999999997655 499999999874322111
Q ss_pred C---CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 P---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....+..|+|||.+.+..++.+ +|+|||||++|+|++ |..||........ ...+. .....+.+..++.
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~~----~~~~~~~~~~~~~ 223 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIE----QGVRLPCPELCPD 223 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHHH----cCCCCCCcccCCH
Confidence 1 11123456999999987777665 899999999999997 8889876554322 11111 1222233445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+|+.+||+.+|.+|||+.++++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=227.73 Aligned_cols=173 Identities=32% Similarity=0.515 Sum_probs=139.0
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.. ...+++..++.++.|++.||.|||++|++|+||||.||+++.++. ++|+|||+++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPG 154 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccc
Confidence 699999999999864 345899999999999999999999999999999999999976554 9999999987543222
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+.... ...+..... .+.+..++..+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~ 228 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYEL 228 (255)
T ss_pred cccccccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHH
Confidence 2234568999999999987776555 8999999999999999999986553222 222222222 22334578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcc
Q 024363 158 RDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+||.+||+.+|.+||++.+++.-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=231.75 Aligned_cols=181 Identities=28% Similarity=0.452 Sum_probs=139.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+. ++|.+++.. .+.+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .+||+|||++.......
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCC
Confidence 67875 477777755 4579999999999999999999997 5999999999999997655 49999999987543333
Q ss_pred CCCCCcCCCCcccchhhccCc----cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-cccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 153 (268)
......+++.|+|||.+.+.. ++.+ +|+|||||++|+|++|+.||........ ........ ....+....+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCCCCC
Confidence 333446788999999986543 4444 8999999999999999999976433211 12222221 1223333347
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+.++.+||.+||..+|.+||++.+++.||||....
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 89999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=227.22 Aligned_cols=172 Identities=23% Similarity=0.352 Sum_probs=137.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.+. ..+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||.++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeeccccc
Confidence 7899999999999763 4589999999999999999999999999999999999997655 49999999987543222
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||++.+..++.+ +|+|||||++|+|++ |..||.+......... +. .....+....++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 230 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VE-RGYRMPCPPECPE 230 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hh-cCCCCCCccccCH
Confidence 1 123346678999999877777655 899999999999999 8889977654333222 21 1222333445889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=216.38 Aligned_cols=164 Identities=21% Similarity=0.240 Sum_probs=126.3
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcC
Q 024363 7 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 85 (268)
Q Consensus 7 g~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 85 (268)
|||.+++.+ ++.+++.+++.++.|++.||.|||+++ ||+|||++.++. +|+ ||+++.... ....|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCC
Confidence 799999987 456999999999999999999999998 999999976554 888 998875332 22368
Q ss_pred CCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHH-HHHHHHHhccccc-CCCCCCCCH--HHHHHH
Q 024363 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF-RKTIQRILSVQYS-VPDTNPISQ--ECRDLI 161 (268)
Q Consensus 86 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~s~--~~~~li 161 (268)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ............. .+....++. .+.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 999999999988887665 99999999999999999999765433222 2222221111100 011122333 699999
Q ss_pred HHccccCCCCCCCHHHHhcccccC
Q 024363 162 SRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 162 ~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.+||..+|.+||++.+++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=227.67 Aligned_cols=174 Identities=23% Similarity=0.364 Sum_probs=130.8
Q ss_pred CCCCCCCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
|||++||+|.+++.+.. .+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCcccccccc
Confidence 79999999999996532 457778889999999999999999999999999999997654 49999999986432
Q ss_pred CCC---CCCCCcCCCCcccchhhccCc------cCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 024363 76 LHS---QPKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY 145 (268)
Q Consensus 76 ~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (268)
... ......+++.|+|||++.+.. ..+.++|+|||||++|+|++ |+.||............+. ....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~ 228 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQL 228 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccC
Confidence 221 112345778899999986421 12344899999999999996 9999987665443222221 1111
Q ss_pred cCCC---CCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPD---TNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~---~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+. ....+..+.+++.+|+ .+|.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1111 2246788999999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=229.68 Aligned_cols=173 Identities=19% Similarity=0.362 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCE
Q 024363 1 MEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 63 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~ 63 (268)
|||+++|+|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.+.. +
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--~ 163 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--V 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--E
Confidence 7999999999998532 24789999999999999999999999999999999999976654 9
Q ss_pred EEeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 024363 64 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR 139 (268)
Q Consensus 64 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~ 139 (268)
||+|||+++...... ......++..|+|||++.+..++.+ +|+|||||++|+|++ |..||.+..... ..+ .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~---~ 238 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIE---M 238 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---H
Confidence 999999987543221 1233446778999999987776555 999999999999998 999997755322 222 2
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 140 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.. ....+.+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 211 22233444578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=232.28 Aligned_cols=179 Identities=29% Similarity=0.453 Sum_probs=139.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.| +|.+++.. .+.+++..+..++.|++.||.|||++|++||||+|.||+++.++. +||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~--- 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP--- 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---
Confidence 688874 77777754 567999999999999999999999999999999999999976654 99999998864322
Q ss_pred CCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....+++.|+|||++.+ ..++.+ +||||||+++|+|++|+.||.+......... +............++..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDY 242 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHH
Confidence 234568899999998742 334444 8999999999999999999976654332221 11111111112336789
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
+.++|.+||..+|.+||++.+++.||||.+..+.
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=227.07 Aligned_cols=173 Identities=23% Similarity=0.393 Sum_probs=138.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||++||+|.+++.. .+.+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--CEEECccchhhccccccc
Confidence 689999999999976 35799999999999999999999999999999999999997655 49999999988653111
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.......... .+. .....+....++.
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 235 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIK----AVE-DGYRLPPPMDCPS 235 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCH
Confidence 1 112335678999999887776655 899999999999997 999997665433222 221 2223344455789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=227.09 Aligned_cols=175 Identities=28% Similarity=0.430 Sum_probs=137.3
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~ 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhcccc
Confidence 689999999998863 45689999999999999999999999999999999999997655 499999998865432
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.+.... .......+............++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence 22 2234568999999999987776655 89999999999999999999764432 11222222222222112234788
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.++|.+||..+|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=229.79 Aligned_cols=177 Identities=24% Similarity=0.399 Sum_probs=135.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccCcc
Confidence 7999999999999765 3589999999999999999999999999999999999997655 499999999875433221
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhccc
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKTIQRILSVQ 144 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~ 144 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++++.|+..... ......... .....
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLEEG 242 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HHHcC
Confidence 123456778999999887766655 8999999999999998766532111 001111111 11222
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
...+....++..+.+|+.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2334445588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=231.60 Aligned_cols=172 Identities=24% Similarity=0.398 Sum_probs=135.3
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~--~~k 174 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN--VMK 174 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC--cEE
Confidence 6999999999999753 3488999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+. .+.
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~-- 250 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFK-LLR-- 250 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHH--
Confidence 99999997543211 1122234568999999987766655 899999999999999 889997655433222 221
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
. ......+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 251 -~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 -E-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 1222233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=231.38 Aligned_cols=173 Identities=24% Similarity=0.384 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++.+. ..++...+..++.||+.||.|||++|++||||||+||+++.++ .+|
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~--~~k 177 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN--VMK 177 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC--cEE
Confidence 7999999999999763 2477888999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ .+
T Consensus 178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~ 252 (304)
T cd05101 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LL 252 (304)
T ss_pred ECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HH
Confidence 99999987543221 1223346778999999987777666 899999999999998 788887655332222 22
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
........+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 253 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 253 -KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred -HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1222223344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=256.84 Aligned_cols=176 Identities=31% Similarity=0.476 Sum_probs=136.3
Q ss_pred CCCCCCCchhHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---- 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l-~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~---- 75 (268)
||||+.-+|.+++.++... ....+|.++++|+.||.|+|++|||||||||.|||++.+.. |||+|||+|+...
T Consensus 675 MEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~ 752 (1351)
T KOG1035|consen 675 MEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLE 752 (1351)
T ss_pred HhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhh
Confidence 8999998887777665544 47889999999999999999999999999999999986655 9999999987410
Q ss_pred ---------------CCCCCCCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 024363 76 ---------------LHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 137 (268)
Q Consensus 76 ---------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 137 (268)
.....++.+||-.|+|||++.+.. |+.+ +|+||||+|++||+. ||...-. -..++
T Consensus 753 ~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGIVlFEM~y---PF~TsME---Ra~iL 825 (1351)
T KOG1035|consen 753 SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK-IDMYSLGIVLFEMLY---PFGTSME---RASIL 825 (1351)
T ss_pred hHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch-hhhHHHHHHHHHHhc---cCCchHH---HHHHH
Confidence 112345678999999999998755 6665 999999999999985 6754322 23344
Q ss_pred HHHhcccccCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 138 QRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 138 ~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
..+.+.....+ ...+--+.-+.+|++||+.||++||||.|+|++.||-
T Consensus 826 ~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 826 TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 44444433333 0111234567999999999999999999999999885
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=226.15 Aligned_cols=172 Identities=23% Similarity=0.360 Sum_probs=136.6
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+. ..+++..++.++.|++.||.|||+++++||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNE 156 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCcc
Confidence 7899999999999763 4589999999999999999999999999999999999997655 49999999986533222
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+......... +. .....+.+...+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 230 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE-RGYRMPCPQDCPI 230 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCH
Confidence 1 122345668999999877666555 899999999999999 8999977654332222 21 2223334445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+|+.+||..+|.+|||+.++..
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=228.99 Aligned_cols=173 Identities=20% Similarity=0.326 Sum_probs=136.3
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
+||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +|
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~k 164 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VK 164 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--eE
Confidence 5899999999998532 34888999999999999999999999999999999999976544 99
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+...... ...+
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~i 239 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV----IEMI 239 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHH
Confidence 99999987543221 1223456789999999987776655 899999999999998 8889877654332 2222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.... ..+.+..++..+.+|+.+||+.+|.+||++.+++..
T Consensus 240 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2222 222334588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=225.30 Aligned_cols=172 Identities=23% Similarity=0.346 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDI 157 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCc
Confidence 79999999999997654 6999999999999999999999999999999999999976654 9999999987543221
Q ss_pred CC--CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. .....+..|+|||++.+..++.+ +|+|||||++|+|++ |+.||.+.........+ ......+....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 231 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-----DQGYRMPCPPGCPK 231 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCH
Confidence 11 11223457999999887776655 899999999999999 99999876543322221 12223334445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=225.52 Aligned_cols=172 Identities=23% Similarity=0.344 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCc
Confidence 7999999999999753 34899999999999999999999999999999999999976554 9999999986533222
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+.......... . .....+.+...+.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~ 230 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQV----E-RGYRMPCPQGCPE 230 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCcccCH
Confidence 1 122346678999999877666555 899999999999999 89999876554332221 1 1222333445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++++||..+|.+||++.++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=225.35 Aligned_cols=177 Identities=20% Similarity=0.309 Sum_probs=132.5
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++++||||||+|||++.++ .+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCc
Confidence 7999999999999753 3467778899999999999999999999999999999997655 499999999864221
Q ss_pred C---CCCCCCcCCCCcccchhhccCc------cCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 77 H---SQPKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 77 ~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
. .......+++.|+|||++.... ..+.++|||||||++|+|++ |..||........+...+.........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence 1 1223456889999999875321 11334899999999999997 577887666544444433322111112
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
......++..+.+++..|| .+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 2223347899999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=225.21 Aligned_cols=175 Identities=31% Similarity=0.507 Sum_probs=140.0
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 689999999988853 4569999999999999999999999999999999999999642 399999999865432
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||........ ........ ....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 231 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIVEGP-TPSLPETYSR 231 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCC-CCCCcchhcH
Confidence 22 2234468899999999877666655 8999999999999999999975543222 22222211 1112334789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.++|.+||..+|.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=227.69 Aligned_cols=171 Identities=25% Similarity=0.350 Sum_probs=133.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-----CCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----APRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-----~~~~kl~Dfg~a~~~ 74 (268)
||||+||+|..++.+ .+.+++..+..++.||+.||+|||+++|+||||||.||+++..+ .+.+|++|||++...
T Consensus 95 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 95 EEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence 799999999999865 56799999999999999999999999999999999999997533 224899999987643
Q ss_pred CCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
.. .....++..|+|||.+.+....+.++|||||||++|+++ +|..||........ ... .......+ ...
T Consensus 175 ~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~----~~~~~~~~--~~~ 244 (274)
T cd05076 175 LS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERF----YEKKHRLP--EPS 244 (274)
T ss_pred cc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHH----HHhccCCC--CCC
Confidence 22 233467888999998876443345599999999999995 68999976654322 111 11222222 235
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+..+.++|.+||+.+|.+|||+.+++++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 6789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=228.79 Aligned_cols=172 Identities=27% Similarity=0.432 Sum_probs=136.3
Q ss_pred CCCCCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 024363 1 MEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~ 56 (268)
|||+.||+|.+++.+. ..+++..++.++.|++.||.|||+++++||||||+||+++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~ 161 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence 6899999999998642 2478899999999999999999999999999999999997
Q ss_pred CCCCCCEEEeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHH
Q 024363 57 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 132 (268)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 132 (268)
.++ .+||+|||+++....... .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+......
T Consensus 162 ~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 162 EGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred CCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 655 499999999875322211 122345678999999877766655 899999999999998 9999976654322
Q ss_pred HHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+. .......+.+..++.++.+++.+||+.+|.+||++.++++
T Consensus 239 -~~~----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 -FNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -HHH----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 222 2222333444558899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=223.94 Aligned_cols=170 Identities=24% Similarity=0.394 Sum_probs=136.6
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc
Confidence 68999999999997765 7999999999999999999999999999999999999976554 9999999987652221
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....+..|+|||.+....+..+ +|+|||||++|++++ |..||....... ....+. ..+....+..+++.+
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~ 228 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHVE----KGYRMEAPEGCPPEV 228 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh----cCCCCCCccCCCHHH
Confidence 23345667999999877666555 899999999999997 999997665332 222111 122223334578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.++|.+||..+|.+||++.+++.
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=226.71 Aligned_cols=176 Identities=30% Similarity=0.426 Sum_probs=137.1
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~ 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence 689999999988853 345899999999999999999999999999999999999976554 99999998875332
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ......+++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...... .......+............++.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCH
Confidence 22 1234568899999999987776555 89999999999999999999654321 11222222222221111234678
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.++|.+||..+|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=230.42 Aligned_cols=178 Identities=28% Similarity=0.448 Sum_probs=139.9
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||. |+|.+++.. ...+++.+++.++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++.... .
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKSS---P 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCcccC---C
Confidence 68996 478777755 45799999999999999999999999999999999999997655 49999999886432 2
Q ss_pred CCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....|+..|+|||++.. ..++. ++|||||||++|+|++|..||.............. ..........++..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 248 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEWTDS 248 (313)
T ss_pred CCCccccccccChhhccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccccCHH
Confidence 234578999999999742 33444 48999999999999999999987654333332221 11111122346788
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
+.+|+.+||+.+|.+||++.+++.||||.....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=230.64 Aligned_cols=172 Identities=32% Similarity=0.511 Sum_probs=133.2
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||++|+|.++|... ..+++.++..++.||+.||.|||+++++|++|++.||+++.++. +||+|||+++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKS 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 6999999999999886 67999999999999999999999999999999999999987664 9999999987542211
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
..........|+|||.+.+..++.+ +||||||+++||+++ |+.||........ ...+ ......+.+..++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~----~~~~-~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEI----IEKL-KQGQRLPIPDNCP 231 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHH----HHHH-HTTEETTSBTTSB
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccc----cccc-cccccceeccchh
Confidence 1233457778999999987776555 999999999999999 7899987754332 2222 2222333444589
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=224.21 Aligned_cols=169 Identities=24% Similarity=0.272 Sum_probs=133.2
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC-----CEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~-----~~kl~Dfg~a~~~ 74 (268)
|||++||+|.+++.+.+ .+++..+..++.||+.||.|||++|++||||||+||+++..+.. .+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 69999999999998766 79999999999999999999999999999999999999765521 4999999998754
Q ss_pred CCCCCCCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
.. .....++..|+|||++.+. .++. ++|||||||++|+|++ |..||....... ...... .....+.
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~-~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~-- 227 (259)
T cd05037 159 LS---REERVERIPWIAPECIRNGQASLTI-AADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ----DQHRLPM-- 227 (259)
T ss_pred cc---ccccccCCCccChhhhcCCCCCcch-hhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh----cCCCCCC--
Confidence 32 2345577889999998765 4444 4899999999999999 577886654321 111111 1111222
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+..+.++|.+||..+|.+|||+.++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 23489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=224.59 Aligned_cols=174 Identities=30% Similarity=0.469 Sum_probs=136.6
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||++||+|.+++.+ ...+++.+++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeeccC
Confidence 799999999999864 34589999999999999999999999999999999999997655 499999999864332
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC-CCCC
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-NPIS 154 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s 154 (268)
.. ......+++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||...... .......+..... .+.+ ..++
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~ 234 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDY-PPLPADHYS 234 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCC-CCCChhhcC
Confidence 21 2234568899999999987777655 89999999999999999999654321 1122222222211 1122 2477
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.++|.+||..+|.+|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=226.59 Aligned_cols=174 Identities=21% Similarity=0.392 Sum_probs=139.9
Q ss_pred CCCCCCCchhHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++..+. ++++|||++
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~ 164 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLS 164 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccccc
Confidence 69999999999997655 6999999999999999999999999999999999999976654 999999998
Q ss_pred CCCCCCC--CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 72 KSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 72 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
+...... ......+++.|+|||.+.+.....+ +|||||||++|+|++ |..||....... ...........++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~~~ 239 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLELP 239 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcCCC
Confidence 6432221 2234456788999999877666544 899999999999998 788997654433 2223333333344
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....++..+.+++.+||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 445688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=227.84 Aligned_cols=178 Identities=28% Similarity=0.490 Sum_probs=141.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||+.||+|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||.||+++.++ .++|+|||++....... .
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccchhh
Confidence 689999999998864 5799999999999999999999999999999999999997655 49999999986433221 1
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....++..|+|||.+.+...+.+ +|+|||||++|+|++|..||........ ...+.... .......++.++.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~ 231 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKV----LFLIPKNN-PPTLEGNYSKPLKE 231 (277)
T ss_pred hccccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHH----HHHHhcCC-CCCCCcccCHHHHH
Confidence 233468889999999877666555 8999999999999999999976543221 11121111 11122347899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++.+||..+|.+||++.++++||||.+.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=243.23 Aligned_cols=171 Identities=25% Similarity=0.464 Sum_probs=134.9
Q ss_pred CCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 2 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 2 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
-+|+|-+|+.+|+- ..+|.....+.|++||++|+.|||.++|||||||..|||+.+++. |||+|||++......
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccc
Confidence 48999999999964 457999999999999999999999999999999999999976654 999999998754333
Q ss_pred CCCCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC----C
Q 024363 78 SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD----T 150 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~ 150 (268)
.......|...|||||++.. .+|+.. +||||||||+|||++|..||. ..+.+++. - .....+-.+. .
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~q-SDVYaFGiV~YELltg~lPys-i~~~dqIi---f-mVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQ-SDVYAFGIVWYELLTGELPYS-IQNRDQII---F-MVGRGYLMPDLSKIR 618 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcc-cchhhhhHHHHHHHhCcCCcC-CCChhheE---E-EecccccCccchhhh
Confidence 22344568889999999964 345444 899999999999999999998 44433321 1 1122221121 2
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+.++++|+..||.+++++||.+.+||.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 335679999999999999999999999886
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=223.82 Aligned_cols=173 Identities=23% Similarity=0.330 Sum_probs=133.4
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.+|+|.+++.+. ..+++..+..++.|++.||+|||+++++||||||+|||++.++ .+||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEY 153 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcc
Confidence 6899999999999764 4578888899999999999999999999999999999997655 49999999987432211
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......++..|+|||.+.+..++.+ +|||||||++|+|++| .+||........ ...+... ...+....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~ 227 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDI----TVYLLQG-RRLLQPEYC 227 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHhcC-CCCCCCCcC
Confidence 1123346778999999887777655 8999999999999995 566665443221 2222211 122223346
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+..+.+++.+||..+|++||++.+++..
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=228.62 Aligned_cols=173 Identities=18% Similarity=0.355 Sum_probs=137.7
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCccc
Confidence 68999999999997644 6899999999999999999999999999999999999976554 99999999975432221
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+... ......+ ......+.+...+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~~ 238 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPICTI 238 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCCCCH
Confidence 123345778999999887776555 899999999999997 8899976542 2222222 22233344445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+++.+||..+|.+||++.+++..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=229.59 Aligned_cols=178 Identities=28% Similarity=0.423 Sum_probs=139.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+. |+|.+.+.. ...+++..++.++.|++.||.|||+++++||||||.||+++.++ .+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---
Confidence 68997 588777754 55699999999999999999999999999999999999997654 499999998864322
Q ss_pred CCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....+++.|+|||.+.+ ..++. ++|||||||++|+|++|+.||........... .............++..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEY 242 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCc-ccchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcCCCCcCcccccHH
Confidence 234568899999999753 33444 48999999999999999999976544322222 11111111223347889
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
+.+||.+||..+|.+||++.++++|||+....+
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999999999999999999999977543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=237.90 Aligned_cols=156 Identities=25% Similarity=0.465 Sum_probs=122.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (268)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++...... ......+++.|+|||+
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 310 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES 310 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence 4788889999999999999999999999999999999976554 9999999987533221 1223456788999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |..||........+... .......+.+..++..+.+++.+||+.+|++||
T Consensus 311 ~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 311 IFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK----IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred hcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH----HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 987777655 899999999999997 89999765443322222 222233344455889999999999999999999
Q ss_pred CHHHHhc
Q 024363 174 TIPEIMK 180 (268)
Q Consensus 174 s~~e~l~ 180 (268)
++.++.+
T Consensus 386 t~~~l~~ 392 (400)
T cd05105 386 SFLHLSD 392 (400)
T ss_pred CHHHHHH
Confidence 9998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=221.12 Aligned_cols=172 Identities=23% Similarity=0.379 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++........
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIY 148 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceecccccc
Confidence 799999999999865 346899999999999999999999999999999999999976554 99999999864322211
Q ss_pred C--CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 P--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
. ....+++.|+|||++.+..++.+ +|||||||++|++++ |..||........... + ........+..++..
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~ 222 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQ----V-EKGYRMSCPQKCPDD 222 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHH
Confidence 1 12234667999999987766655 899999999999998 9999987654332221 1 112222333457899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+++.+||..+|.+||++.++++
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=222.45 Aligned_cols=170 Identities=22% Similarity=0.377 Sum_probs=136.3
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMG- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceecccc-
Confidence 79999999999997643 589999999999999999999999999999999999997655 4999999998753221
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......+..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||......... ..+ ......+....++..+
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~ 226 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECV----EKGYRMEPPEGCPADV 226 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHH----hCCCCCCCCCcCCHHH
Confidence 223345678999999877766555 899999999999997 99999876543322 111 2223333344578999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+++.+||..+|.+||++.+++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=224.58 Aligned_cols=172 Identities=23% Similarity=0.394 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+++|+|.+++.+ .+.+++.++..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence 799999999999976 45799999999999999999999999999999999999997655 499999999864332211
Q ss_pred C----CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 P----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
. .....++.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... .+. .....+....++
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~----~i~-~~~~~~~~~~~~ 236 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMK----AIN-DGFRLPAPMDCP 236 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH----HHh-cCCCCCCCCCCC
Confidence 1 11223457999999987777655 899999999999997 999997765433222 222 223444455578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=241.06 Aligned_cols=182 Identities=35% Similarity=0.647 Sum_probs=154.1
Q ss_pred CCCCCCCchhHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l--~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~ 77 (268)
||-+.| +..+.| ++.++++|...+.++.||+.||.|||-++|+|+||||+|||+.+. ..+++||||||+|+.....
T Consensus 642 MEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 566654 666666 357889999999999999999999999999999999999999643 4467999999999988888
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~ 155 (268)
....+.+|||.|.|||++...+|+.. -|+||+|||+|.-++|..||...... -.++.+..+..| .+..+|.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdI------ndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDI------NDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccch------hHHhhccccccCCCchhhcCH
Confidence 88889999999999999999999876 79999999999999999999765442 223344444443 4566899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
.+.+||..+|+..-.+|.|.+..+.|||++...-+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w 828 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTW 828 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcchHH
Confidence 99999999999999999999999999999765443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=223.30 Aligned_cols=172 Identities=22% Similarity=0.358 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+.+|+|.+++.+. ..+++.++..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCC
Confidence 6899999999998653 46899999999999999999999999999999999999976654 9999999986543221
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||++....++.+ +|||||||++|++++ |+.||.+.+........ ......+.+...+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 230 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPE 230 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCH
Confidence 1 123345678999999887766555 899999999999998 99999876654332221 22223344455789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.++|.+||..+|++||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=224.72 Aligned_cols=173 Identities=22% Similarity=0.335 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccc
Confidence 69999999999997644 5899999999999999999999999999999999999976554 99999999875332221
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....+++.|+|||.+....++.+ +|||||||++|++++ |..||...........+ . .....+.+..++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----E-NGERLPMPPNCPPT 236 (270)
T ss_pred eecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----H-cCCcCCCCCCCCHH
Confidence 112234568999999877766655 899999999999986 99999877654333221 1 12223344557899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=228.48 Aligned_cols=179 Identities=30% Similarity=0.467 Sum_probs=140.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.| +|.+.+.. ..++++.++..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++.... .
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~ 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---P 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---C
Confidence 689975 78777754 56799999999999999999999999999999999999997654 49999999876432 2
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....|++.|+|||.+. ...++.+ +|||||||++|+|++|+.||........... +............++..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDY 252 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHH
Confidence 23456899999999974 2334444 8999999999999999999977554332222 22222222223347889
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++++|.+||+.+|.+||++.++++|+|+....+.
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999999999999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=231.34 Aligned_cols=174 Identities=24% Similarity=0.386 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
|||+++|+|.+++.+.. .++...+..++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~--~~k 174 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN--VMK 174 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEE
Confidence 68999999999997532 377888999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~ 249 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL----L 249 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----H
Confidence 99999987533221 1122334568999999987777666 899999999999998 8889977654332221 1
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
......+.+...+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 250 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 250 -KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 12223333445789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=226.44 Aligned_cols=177 Identities=24% Similarity=0.364 Sum_probs=134.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+. +.+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCCCc
Confidence 6899999999999764 5699999999999999999999999999999999999997655 499999999875432221
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhccc
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKTIQRILSVQ 144 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~ 144 (268)
.....++..|+|||++.+..++.+ +|||||||++|+|++|..|+....... .....+.......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 111233456999999987766555 899999999999999877654332110 0001111222233
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+....++.++.+||.+||..+|++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 344445568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=226.18 Aligned_cols=177 Identities=23% Similarity=0.348 Sum_probs=135.9
Q ss_pred CCCCCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecC
Q 024363 1 MEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg 69 (268)
|||+.||+|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg 175 (296)
T cd05095 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY--TIKIADFG 175 (296)
T ss_pred EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC--CEEeccCc
Confidence 68999999999997643 367789999999999999999999999999999999997654 49999999
Q ss_pred CCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhc--
Q 024363 70 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPKDFRKTIQRILS-- 142 (268)
Q Consensus 70 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~~~~~~~~~-- 142 (268)
+++....... .....+++.|+|||+..+..++.+ +|+|||||++|+|++ |..||..................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05095 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG 254 (296)
T ss_pred ccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc
Confidence 9875332211 122334678999998877777655 899999999999998 77898766554433322211111
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.....+.+..++..+.+|+.+||+.+|.+||++.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 255 RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11123344457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=225.46 Aligned_cols=172 Identities=23% Similarity=0.366 Sum_probs=136.8
Q ss_pred CCCCCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
+||+.+|+|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~~~ 165 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSR 165 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCCcc
Confidence 4789999999999653 4589999999999999999999999999999999999997654 49999999997
Q ss_pred CCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 73 SSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 73 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
...... ......++..|+|||++.+..++.+ +|||||||++|++++ |+.||...... .+... .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~----~~~~~~~~ 239 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAY----LKDGYRLA 239 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHH-HHHHH----HHcCCCCC
Confidence 532221 1123346778999999987777655 899999999999998 99999765432 22221 22223333
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
....++..+.+++.+||..+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 44457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=221.09 Aligned_cols=172 Identities=27% Similarity=0.454 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++..... +++..+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceeccccc
Confidence 789999999999976554 99999999999999999999999999999999999997665 49999999987543332
Q ss_pred CCC--CCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 QPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
... ...+++.|+|||.+.+..++.+ +|+||+||++|+|++ |..||........... +... ...+....++.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 231 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKG-YRLPKPENCPP 231 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCCCcCCH
Confidence 111 2336789999999866666555 999999999999998 7888876544332222 2221 22233444789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=231.41 Aligned_cols=157 Identities=22% Similarity=0.428 Sum_probs=121.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchh
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 94 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 94 (268)
.++...+..++.|++.||+|||++||+||||||.||+++.++ .+||+|||+++...... ......+++.|+|||+
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 252 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 252 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCCcceECcHH
Confidence 367888899999999999999999999999999999997655 49999999987532221 1122345678999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+.+..++.+ +|||||||++|+|++ |..||........+...+. .....+.+...++++.+++.+||+.+|.+||
T Consensus 253 ~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp 327 (343)
T cd05103 253 IFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 327 (343)
T ss_pred hcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----ccCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 887777665 899999999999997 8999976544333222221 1122222334678999999999999999999
Q ss_pred CHHHHhcc
Q 024363 174 TIPEIMKH 181 (268)
Q Consensus 174 s~~e~l~h 181 (268)
|+.++++|
T Consensus 328 s~~eil~~ 335 (343)
T cd05103 328 TFSELVEH 335 (343)
T ss_pred CHHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=225.76 Aligned_cols=177 Identities=24% Similarity=0.334 Sum_probs=135.3
Q ss_pred CCCCCCCchhHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeec
Q 024363 1 MEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 68 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Df 68 (268)
||||.||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+||
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~--~~kl~df 173 (295)
T cd05097 96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY--TIKIADF 173 (295)
T ss_pred EecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC--cEEeccc
Confidence 79999999999996532 368899999999999999999999999999999999997655 4999999
Q ss_pred CCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 69 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 69 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+++...... ......+++.|+|||++.+..++.+ +|+|||||++|+|++ +..||...................
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd05097 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252 (295)
T ss_pred ccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc
Confidence 9987532221 1122345678999999887776555 999999999999988 667887765544333322211111
Q ss_pred --cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 --QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 --~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.........+++.+.+|+.+||..+|.+||++.++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 253 GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1112223347899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=223.13 Aligned_cols=172 Identities=23% Similarity=0.366 Sum_probs=136.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+++|+|.+++.+. +.+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEK 164 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCccc
Confidence 6899999999999764 56999999999999999999999999999999999999976554 99999999875433222
Q ss_pred CC---CCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 PK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ...++..|+|||.+....++.+ +|+|||||++|++++ |+.||.+..... +.. .+. .....+.+...+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE-IPD---LLE-KGERLPQPPICTI 238 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---HHh-CCCCCCCCCCCCH
Confidence 11 1223567999999877666655 899999999999998 999998765432 222 222 2223344445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++.+||..+|..||++.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=221.93 Aligned_cols=174 Identities=24% Similarity=0.413 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC---CCCEEEeecCC
Q 024363 1 MEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~---~~~~kl~Dfg~ 70 (268)
|||++||+|.+++.+. ..+++.++..++.|++.||.|||+++++|+||||+||+++.+. ...+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 6899999999999642 3478999999999999999999999999999999999997654 12599999999
Q ss_pred CCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
++...... ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........... + .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~----~-~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQH----V-TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH----H-hcCCc
Confidence 87533221 1123346788999999987776555 899999999999998 9999976554332221 1 12222
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
......++..+.++|.+||..+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3334457899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=250.96 Aligned_cols=175 Identities=27% Similarity=0.389 Sum_probs=133.3
Q ss_pred CCCCCCCchhHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecC
Q 024363 1 MEYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg 69 (268)
||||+||+|.+++.+. ..++...+..++.||+.||+|||++||+||||||+||+++.++. +||+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence 7999999999998641 23556778899999999999999999999999999999976654 9999999
Q ss_pred CCCCCCCC-------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh
Q 024363 70 YSKSSVLH-------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 130 (268)
Q Consensus 70 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 130 (268)
+++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 98754110 01123469999999999988777655 89999999999999999999764432
Q ss_pred HHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.... ...............+++.+.+++.+||..||.+|++..+.+.+
T Consensus 238 ki~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2111 11111111222234578999999999999999999977665543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=220.85 Aligned_cols=172 Identities=24% Similarity=0.381 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++..+ .+||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNE 156 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCC
Confidence 6899999999999763 4578899999999999999999999999999999999997654 59999999886433221
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||++....++.+ +|+|||||++|++++ |..||.+.+....... ....+..+.....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 230 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGYRMPRPENCPE 230 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HhCCCCCCCcccCCH
Confidence 1 122345678999999977666555 899999999999998 9999987654433222 122233344455889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=219.63 Aligned_cols=172 Identities=25% Similarity=0.400 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.|++|.+++.+ ...+++..+..++.+++.||.|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIY 148 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcc
Confidence 689999999999965 45689999999999999999999999999999999999997655 499999999875432111
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||........... .......+.+..++.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 222 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----IESGYRMPAPQLCPE 222 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----HhcCCCCCCCccCCH
Confidence 112234567999999877766555 899999999999998 8889977654332221 122223334445789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=221.59 Aligned_cols=172 Identities=23% Similarity=0.342 Sum_probs=137.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDE 157 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchh
Confidence 6899999999999764 36999999999999999999999999999999999999976654 9999999987543211
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
. .....++..|+|||.+.+..++.+ +|+||+||++|+|++ |+.||.+........+. . ..+..+.+...+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~ 231 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----E-RGYRMPRPPNCPE 231 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCCCCH
Confidence 1 112234578999999987766555 899999999999998 99999876544333322 1 2223344444689
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+++.+||..+|.+||++.+++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=220.54 Aligned_cols=173 Identities=23% Similarity=0.413 Sum_probs=136.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++... +.+++..++.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcc
Confidence 6899999999999764 5689999999999999999999999999999999999997655 499999999864322211
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....++..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||.......... .+. .......+...+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~ 229 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----TIN-AGFRLYKPRLASQS 229 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----HHh-CCCCCCCCCCCCHH
Confidence 122335678999999887766555 899999999999998 999997655433222 221 11222223346899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+|+.+||+.+|.+||++.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=221.99 Aligned_cols=172 Identities=23% Similarity=0.393 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.. .+.+++.+++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence 699999999999975 45689999999999999999999999999999999999997654 499999999864332211
Q ss_pred C---CCCc---CCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 80 P---KSTV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 80 ~---~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
. .... .+..|+|||.+.+..++.+ +||||+||++|++++ |..||........... + ......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~----i-~~~~~~~~~~~ 235 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINA----I-EQDYRLPPPMD 235 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH----H-HcCCcCCCccc
Confidence 1 1111 2457999999987777655 899999999999886 9999987654332222 2 12234444455
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=222.24 Aligned_cols=174 Identities=29% Similarity=0.455 Sum_probs=139.1
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||+|.||+++.++ .+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~ 165 (269)
T cd08528 88 MDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDFGLAKQKQ 165 (269)
T ss_pred EecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEecccceeecc
Confidence 699999999988743 4569999999999999999999996 7899999999999997655 49999999987644
Q ss_pred CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 76 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.........|+..|+|||.+.+..++.+ +|+||||+++|+|++|+.||......... ..+....+.......++.
T Consensus 166 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 166 PESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLA----TKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred cccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHH----HHHhhccCCcCCcccCCH
Confidence 4433445678999999999987666555 89999999999999999999765443222 222222222222235789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.++|.+||+.||.+||++.++..+
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 99999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=223.99 Aligned_cols=172 Identities=22% Similarity=0.358 Sum_probs=134.8
Q ss_pred CCCCCCCchhHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC
Q 024363 1 MEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~ 58 (268)
|||+++|+|.+++.... .+++..++.++.|++.||.|||+++++||||||.||+++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN 166 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC
Confidence 68999999999997432 47888999999999999999999999999999999999765
Q ss_pred CCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHH
Q 024363 59 PAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR 134 (268)
Q Consensus 59 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 134 (268)
+ .+||+|||+++...... .......++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.......
T Consensus 167 ~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~~~- 242 (288)
T cd05050 167 M--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI- 242 (288)
T ss_pred C--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 5 49999999987432221 1122345678999999887777665 899999999999997 88899766543322
Q ss_pred HHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 135 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.... ..+.+..++..+.+||.+||+.+|.+|||+.++++
T Consensus 243 ---~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 ---YYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---HHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2222222 12223347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=222.03 Aligned_cols=172 Identities=22% Similarity=0.380 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+. +.+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence 7999999999999764 5689999999999999999999999999999999999997655 499999999875432211
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||........... +. .....+....++
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~ 235 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IE-EGYRLPAPMDCP 235 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----Hh-CCCcCCCCCCCC
Confidence 111223568999999987776655 899999999999886 9999987654332222 22 123344445578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=243.62 Aligned_cols=172 Identities=26% Similarity=0.404 Sum_probs=143.6
Q ss_pred CCCCCCCchhHHHHhc----------CC----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEe
Q 024363 1 MEYASGGELFERICNA----------GR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------~~----l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~ 66 (268)
+|||..|||.++|... .. |+..+.+.++.||+.|++||-++.+|||||...|+||+.+.. |||+
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIs 645 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKIS 645 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEec
Confidence 5999999999999642 12 889999999999999999999999999999999999976655 9999
Q ss_pred ecCCCCCCCCCCCCC---CCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 024363 67 DFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 142 (268)
Q Consensus 67 Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (268)
|||+++........+ ...-.++|||||.+...+++++ +||||+||++||+++ |+.||.+.++.+. ++.+..
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EV----Ie~i~~ 720 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEV----IECIRA 720 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHH----HHHHHc
Confidence 999998644332221 2334679999999999999888 899999999999998 9999999888654 333444
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
... ++.+..+|.++.+|+..||+.+|.+||++++|-.
T Consensus 721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 721 GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 443 5666669999999999999999999999998743
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=245.51 Aligned_cols=179 Identities=28% Similarity=0.474 Sum_probs=150.4
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC-CCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~-~~~ 77 (268)
||||.|||..+++++ +.++.|..+..+++.++.||.+||.+.++|||||-.|||++.++. |||+|||++... .+.
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTV 177 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeeccc
Confidence 899999999999975 567999999999999999999999999999999999999987665 999999998753 344
Q ss_pred CCCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 78 SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
....+.+|||.|||||++.. ..|+.. +|+||||++..||.-|.+|+-+......+ +.-....+.....+..
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchhh
Confidence 55678899999999999864 334454 89999999999999999999877654322 2222233333444566
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
++.++.+||..||.+|..+||+..++|.|||.+
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 899999999999999999999999999999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=223.98 Aligned_cols=177 Identities=25% Similarity=0.416 Sum_probs=138.1
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccccCCc
Confidence 69999999999997654 699999999999999999999999999999999999997664 499999999875432211
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH----------HHHHHHHHHhcccc
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------DFRKTIQRILSVQY 145 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------~~~~~~~~~~~~~~ 145 (268)
.....++..|+|||.+....++.+ +|+|||||++|+|++|+.||....... .....+........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 112345567999999877766555 899999999999999999986543221 01122222233333
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 44444557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=215.22 Aligned_cols=178 Identities=42% Similarity=0.720 Sum_probs=146.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+.+|+|.+++.....+++..++.++.+++.++.|||+.+++|+||+|.||+++.++ .++|+|||.+.........
T Consensus 66 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~ 143 (244)
T smart00220 66 MEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLL 143 (244)
T ss_pred EeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeecccccc
Confidence 68999999999998777799999999999999999999999999999999999997664 5999999998765544445
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC-CCHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRD 159 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ 159 (268)
....++..|+|||.+.+..++.+ +|+||+|++++++++|..||.......... ............... ++.++.+
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELF---KKIGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhccCCCCccccccCCHHHHH
Confidence 56678999999999987777664 899999999999999999997744333222 222222222222221 7899999
Q ss_pred HHHHccccCCCCCCCHHHHhccccc
Q 024363 160 LISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++.+||..+|.+||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=237.16 Aligned_cols=173 Identities=27% Similarity=0.406 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.+.. +||+|||+++.......
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcceee
Confidence 79999999999999877 4999999999999999999999999999999999999976554 79999999986542222
Q ss_pred CC-CCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 80 PK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 80 ~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.. ..--...|+|||.+....|+.+ +|||||||++||+.+ |..||.+..... +...+....++.+.+...+.++
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred ccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHH----HHHHHHhcCccCCCCCCCHHHH
Confidence 22 2235678999999998877776 999999999999998 788999887643 3444545666666666788999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..++.+||..+|++||++.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=236.18 Aligned_cols=185 Identities=19% Similarity=0.287 Sum_probs=135.8
Q ss_pred CCCCCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 024363 1 MEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~ 56 (268)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~ 343 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC
Confidence 6899999999988642 1235677899999999999999999999999999999997
Q ss_pred CCCCCCEEEeecCCCCCCCCCCCCC--CCcCCCCcccchhhccCcc--------------------C-CcccchhhhhHH
Q 024363 57 GSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEY--------------------D-GKIADVWSCGVT 113 (268)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~--------------------~-~~~~DiwslG~i 113 (268)
.++ .+||+|||+++......... ...+|+.|+|||++..... . ...+||||+||+
T Consensus 344 ~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvi 421 (507)
T PLN03224 344 VDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVL 421 (507)
T ss_pred CCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHH
Confidence 655 49999999986533222222 2345889999998754221 1 112699999999
Q ss_pred HHHHHhCCC-CCCCCCChHHH-------HHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCC---CCCCCHHHHhccc
Q 024363 114 LYVMLVGGY-PFEDPDEPKDF-------RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP---AARITIPEIMKHQ 182 (268)
Q Consensus 114 l~el~~g~~-pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp---~~R~s~~e~l~h~ 182 (268)
+|+|++|.. ||.....-... .+..+......+.++.....++.+++|+.+||..+| .+|+|+.|+|+||
T Consensus 422 l~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 422 LMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 999999875 76542211110 111222233344555556688999999999999866 6899999999999
Q ss_pred ccCCC
Q 024363 183 WFLKN 187 (268)
Q Consensus 183 ~~~~~ 187 (268)
||...
T Consensus 502 ~f~~~ 506 (507)
T PLN03224 502 FFLPE 506 (507)
T ss_pred CcCCC
Confidence 99643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=227.97 Aligned_cols=181 Identities=29% Similarity=0.486 Sum_probs=137.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+ +++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|.||+++.++ .+||+|||+++.... ..
T Consensus 89 ~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~--~~ 162 (328)
T cd07856 89 TELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDP--QM 162 (328)
T ss_pred eehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccCC--Cc
Confidence 6888 5689887754 5689999999999999999999999999999999999997655 499999999874322 22
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 140 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-------------------- 140 (268)
....+++.|+|||.+.+....+.++|+|||||++|+|++|+.||........+..+....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 345678899999988663333455999999999999999999997665422221111100
Q ss_pred hccc--ccCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 141 LSVQ--YSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 141 ~~~~--~~~~---~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.... ...+ ....++..++++|++||+.+|++|||+.+++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000 0001 012367899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=249.68 Aligned_cols=171 Identities=24% Similarity=0.413 Sum_probs=142.9
Q ss_pred CCCCCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
+|||+||+|.++|++. ..++..+...++.+|++|+.||+++++|||||...|+|++... .+||+|||+|+.
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlArD 851 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLARD 851 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhHh
Confidence 6999999999999875 3589999999999999999999999999999999999997664 599999999983
Q ss_pred CCCCCCCCCC----cCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 74 SVLHSQPKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 74 ~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
..... .... .-...|||||.+....++++ +|||||||++||+++ |..||.+.++.+.+. ...... +.+
T Consensus 852 iy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~----~~~~gg-RL~ 924 (1025)
T KOG1095|consen 852 IYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL----DVLEGG-RLD 924 (1025)
T ss_pred hhhch-heeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH----HHHhCC-ccC
Confidence 22211 1111 22358999999999888888 899999999999998 899999888755433 233333 666
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+..++..+.++|..||+.+|++||++..+++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 67779999999999999999999999999987
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=231.88 Aligned_cols=156 Identities=24% Similarity=0.433 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchhh
Q 024363 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 95 (268)
Q Consensus 19 l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 95 (268)
+++..++.++.||+.||.|||+++++||||||+|||++..+ .+||+|||+++...... ......+++.|+|||++
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC--EEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 67778899999999999999999999999999999997654 49999999987532211 12234578899999999
Q ss_pred ccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC
Q 024363 96 LRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174 (268)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 174 (268)
.+..+..+ +|||||||++|+|++ |..||..........+.+ ......+.+..++.++.+|+.+||..+|.+||+
T Consensus 314 ~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 314 FNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred cCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 87766555 899999999999998 889997655433322222 222233334457899999999999999999999
Q ss_pred HHHHhcc
Q 024363 175 IPEIMKH 181 (268)
Q Consensus 175 ~~e~l~h 181 (268)
+.++++.
T Consensus 389 ~~ell~~ 395 (401)
T cd05107 389 FSQLVHL 395 (401)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=226.85 Aligned_cols=187 Identities=28% Similarity=0.431 Sum_probs=150.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEc-CCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
+|||+|-+|.-+|+.+..++|.+++.|+.||+.||.||.+.. |||-||||.|||+- ....|.+||+|||+++.....
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 699999999999999999999999999999999999999875 99999999999984 444567999999999864433
Q ss_pred C--------CCCCCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 78 S--------QPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 78 ~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
+ .+....||.||++||++.-. +.-+.++||||+|||+|..+.|+.||........+...---+......
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVq 706 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQ 706 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceecc
Confidence 2 22345799999999998533 222344999999999999999999997654433322211112233446
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+|.-+.+++++++||++||++.-+.|....++..||||...
T Consensus 707 FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 707 FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 67777799999999999999999999999999999999754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=247.12 Aligned_cols=98 Identities=30% Similarity=0.570 Sum_probs=78.1
Q ss_pred cCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC-CCCCCHHHHHHHH
Q 024363 84 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLIS 162 (268)
Q Consensus 84 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~ 162 (268)
+||+.|+|||++.+..+..+ +|||||||++|||++|+.||.+......+..++ .....++. ...++..+.+++.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~-~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il----~~~~~~p~~~~~~~~~~~~~l~ 615 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL----NRDIPWPEGEEKLSVNAQNAIE 615 (669)
T ss_pred eeCccccCHHHcCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hcCCCCCcccccCCHHHHHHHH
Confidence 46889999999998887655 899999999999999999998766544443333 22222221 2347889999999
Q ss_pred HccccCCCCCCCHHHHhcccccCC
Q 024363 163 RIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 163 ~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+||..+|.+||++.++++||||..
T Consensus 616 ~lL~~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 616 ILLTMDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred HHcccChhHCcCHHHHHhCHhhcC
Confidence 999999999999999999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=215.73 Aligned_cols=177 Identities=27% Similarity=0.492 Sum_probs=138.8
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC--CCCCcC
Q 024363 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 85 (268)
Q Consensus 8 ~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~g 85 (268)
+|.++|-+-+.++.+.++-+++||++||.|||+.+|+||||||.|+|++++.. +||||||+|+....... .+..+.
T Consensus 142 DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTqEVV 219 (449)
T KOG0664|consen 142 DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTHEVV 219 (449)
T ss_pred hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhhhhHHHHH
Confidence 66666667778999999999999999999999999999999999999987775 99999999997554432 344578
Q ss_pred CCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH-------------------Hhccccc
Q 024363 86 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------------------ILSVQYS 146 (268)
Q Consensus 86 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-------------------~~~~~~~ 146 (268)
|.+|+|||++.+...++.++||||+|||+.||+..+..|...+...++.-+..- ++....+
T Consensus 220 TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k 299 (449)
T KOG0664|consen 220 TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLR 299 (449)
T ss_pred HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCC
Confidence 999999999998766666699999999999999999999876665544322211 1111111
Q ss_pred CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 ~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.|. +..-.-+...++.++|..||.+|.+..+++.|++.-+
T Consensus 300 ~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 300 APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 111 1112356788999999999999999999999999854
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=217.71 Aligned_cols=173 Identities=19% Similarity=0.366 Sum_probs=133.8
Q ss_pred CCCCCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
+||+.+|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg~~~~~ 163 (273)
T cd05074 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFGLSKKI 163 (273)
T ss_pred EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECcccccccc
Confidence 4789999998887432 2478999999999999999999999999999999999997654 4999999998754
Q ss_pred CCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
.... ......+++.|++||.+....++.+ +|||||||++|+|++ |+.||.+........ .+.... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~ 237 (273)
T cd05074 164 YSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN-RLKQP 237 (273)
T ss_pred cCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH----HHHcCC-cCCCC
Confidence 3221 1223345678999999887776655 899999999999999 889987655432222 122211 12223
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
...+..+.+++.+||..+|.+|||+.+++.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=235.10 Aligned_cols=173 Identities=29% Similarity=0.426 Sum_probs=135.3
Q ss_pred CCCCCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC--EEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~--~kl~Dfg~a~~~~ 75 (268)
||||.||||...+.+ ...|+|.+++.++..+..||.|||++||+||||||.||++-.+..++ .||+|||.|+...
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 899999999999964 45699999999999999999999999999999999999985444333 5999999999988
Q ss_pred CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-------------
Q 024363 76 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------- 142 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------- 142 (268)
......+.+||+.|.+||+..+..+++..+|.|||||++|+.+||..||.....+.....++..+..
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~ 255 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEE 255 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecc
Confidence 8888899999999999999986444455599999999999999999999654444221222222111
Q ss_pred ------ccccCCCCCCCCHH----HHHHHHHccccCCCCCC
Q 024363 143 ------VQYSVPDTNPISQE----CRDLISRIFVADPAARI 173 (268)
Q Consensus 143 ------~~~~~~~~~~~s~~----~~~li~~~l~~dp~~R~ 173 (268)
....+|.+..+++. +-.++..+|..+|.+|-
T Consensus 256 eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 256 ENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11234444445544 44677788899999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=204.80 Aligned_cols=182 Identities=23% Similarity=0.448 Sum_probs=141.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
+||+++.+...+. +.|+...++.++.++++||.|+|++||.|||+||.|++|+... ..++|+|+|+|...-.....
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCcee
Confidence 3566665554433 4588999999999999999999999999999999999998544 35999999999876666666
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCC-CCCCChHHHHHHHHHHhc---------------c-
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTIQRILS---------------V- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~---------------~- 143 (268)
+-.+.+..|--||.+.......-+-|+|||||++..|++.+-|| .|.++..++.++..-+-. .
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 67788999999999987655545479999999999999988876 455666665554432110 0
Q ss_pred -----------cc-cC--CC-CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 144 -----------QY-SV--PD-TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 144 -----------~~-~~--~~-~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.| ++ +. ..-+++++.+|+.++|.+|..+|+|+.|++.||||..
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 00 01 1125699999999999999999999999999999954
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=226.44 Aligned_cols=174 Identities=25% Similarity=0.377 Sum_probs=132.8
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~---ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
+||+++|+|.++|.... .++|.....|+.++++||+|||+.. ||||||||+|||++.+.. .||+|||+|+...
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGP 228 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCC
Confidence 59999999999997655 8999999999999999999999865 999999999999987665 8999999997654
Q ss_pred C-CCCCCCC-cCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC--ChHHHHH----HHH-----HHhc
Q 024363 76 L-HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--EPKDFRK----TIQ-----RILS 142 (268)
Q Consensus 76 ~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~----~~~-----~~~~ 142 (268)
. .....+. .||.+|+|||.+.....+.+ +|||||||++.||++|+.+..... ....+.. .+. .++.
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 4 3332333 89999999999987666666 999999999999999998876432 1111111 111 1111
Q ss_pred ccccCCCCCCCC-----HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 143 VQYSVPDTNPIS-----QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 143 ~~~~~~~~~~~s-----~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..... ...+ ..+..+..+|+..+|..||++.++++
T Consensus 308 ~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11110 1122 23567888999999999999999765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=225.97 Aligned_cols=177 Identities=28% Similarity=0.439 Sum_probs=139.3
Q ss_pred CchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCC
Q 024363 7 GELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 83 (268)
Q Consensus 7 g~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 83 (268)
-+|.+.|++-| .|....++.|+.|+..||..|-..||+|.||||+|||++.+.. .+||||||.|...... ..+.+
T Consensus 518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~en-eitPY 595 (752)
T KOG0670|consen 518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASEN-EITPY 595 (752)
T ss_pred chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccc-cccHH
Confidence 47788887754 4889999999999999999999999999999999999986554 5899999988654333 23556
Q ss_pred cCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc--------ccc---------c
Q 024363 84 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------VQY---------S 146 (268)
Q Consensus 84 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~---------~ 146 (268)
..+..|.|||++++..|... .|+||+||++|||.||+..|.|.++...+.-.+.-.-+ ..+ .
T Consensus 596 LVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~n 674 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLN 674 (752)
T ss_pred HHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccc
Confidence 67889999999999999888 89999999999999999999998876654332211000 000 0
Q ss_pred -----------------CCC--C------------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 -----------------VPD--T------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 -----------------~~~--~------------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.. + ..+-..+++|+.+||..||++|.|+.++|.||||+.
T Consensus 675 f~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 675 FLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred eEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 000 0 001256899999999999999999999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=210.70 Aligned_cols=167 Identities=24% Similarity=0.399 Sum_probs=134.4
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchh
Q 024363 16 AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 94 (268)
Q Consensus 16 ~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 94 (268)
+..++|.-+-.+....+.||.||-. .+|||||+||+|||++..|. +||||||++-........+...|...|||||.
T Consensus 161 ~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT~daGCrpYmAPER 238 (361)
T KOG1006|consen 161 KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKTVDAGCRPYMAPER 238 (361)
T ss_pred hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHHhhhccCCccccChhc
Confidence 5679999999999999999999985 58999999999999987776 99999999876555555566789999999999
Q ss_pred hcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cCCC---CCCCCHHHHHHHHHccccC
Q 024363 95 LLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD---TNPISQECRDLISRIFVAD 168 (268)
Q Consensus 95 ~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~s~~~~~li~~~l~~d 168 (268)
+.. .+|..+ +|+||||+++||+.||+.||.+-++ +...+..+..... .... ...+|..+..+|..||.+|
T Consensus 239 i~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd 314 (361)
T KOG1006|consen 239 IDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKD 314 (361)
T ss_pred cCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcc
Confidence 853 456666 8999999999999999999986543 2233333332222 1211 2347899999999999999
Q ss_pred CCCCCCHHHHhcccccCCCC
Q 024363 169 PAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 169 p~~R~s~~e~l~h~~~~~~~ 188 (268)
.+.||+..+++++||++...
T Consensus 315 ~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 315 RSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccCcchhhhhcCchhhhhh
Confidence 99999999999999997643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=234.92 Aligned_cols=176 Identities=31% Similarity=0.484 Sum_probs=133.0
Q ss_pred CCCCCCCchhHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC---CCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~---~~~~~~kl~Dfg~a~~ 73 (268)
+|.|.- +|.+++..... ......+.++.|+++||++||+.+||||||||.||||+. .+..+++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 477865 99999976411 112456889999999999999999999999999999976 4556789999999986
Q ss_pred CCCCCC----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 74 SVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 74 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
...... ..+..||-+|+|||++....... ++||+|+|||+|+.++| ..||......+ .+ ++...+...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R~--~N----Il~~~~~L~ 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLERQ--AN----ILTGNYTLV 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHHhh--hh----hhcCcccee
Confidence 444322 34567999999999998765544 49999999999999985 88997543211 12 223332221
Q ss_pred CCCC-CCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 149 DTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 149 ~~~~-~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.-.+ ...++.+||.+||+.+|..||+|.++|.||+|
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 1100 11289999999999999999999999999999
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=225.04 Aligned_cols=172 Identities=23% Similarity=0.388 Sum_probs=145.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||+|+-|.|..+++.+ ..++......++.||..||+|||+.++|||||...|||+.+... +||+|||+++.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAY 546 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccch
Confidence 8999999999999764 46999999999999999999999999999999999999987665 99999999997655544
Q ss_pred CCCCcC--CCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.+...| .+-|||||.+.-..++.. +|||-|||++||++. |..||.+..+.+.+.. +..+-+.|.+..+++.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----IENGERLPCPPNCPPA 620 (974)
T ss_pred hhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEE-----ecCCCCCCCCCCCChH
Confidence 433333 457999999988888776 899999999999886 9999998877554322 3344567888889999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+..|+.+||.++|.+||++.++..
T Consensus 621 LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999998876543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=230.52 Aligned_cols=173 Identities=23% Similarity=0.407 Sum_probs=148.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
.|||++|+|.++|.+ .+.|+..+...+++.|+.|+.||-..|.|||||...|||++.+-. +|++|||+++......
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCC
Confidence 389999999999965 567999999999999999999999999999999999999987664 9999999998654333
Q ss_pred CCCCCc-C--CCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 QPKSTV-G--TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~~~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
...+.. | ..+|.|||.+...++++. +||||+|+||||.++ |..||...++.+.+..+ ...++.|.+..++
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-----e~gyRLPpPmDCP 860 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-----EQGYRLPPPMDCP 860 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHH-----HhccCCCCCCCCc
Confidence 222222 2 458999999999999877 899999999999776 99999999987665543 4457888888899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+..|+..||++|-.+||++.+|+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999998874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=224.92 Aligned_cols=173 Identities=28% Similarity=0.517 Sum_probs=142.2
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
+|||..|+|.+++.... .++..+...++.||+.|++||+++++|||||-..|||+..+.. +|
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--~k 458 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--IK 458 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--EE
Confidence 58999999999997654 3889999999999999999999999999999999999987654 99
Q ss_pred EeecCCCCCCCCCCCCC--CCcC--CCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHSQPK--STVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR 139 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~ 139 (268)
|+|||+|+......... ...+ ...|||||.+....|+.+ +||||||+++||+.+ |..||.+......+ +.
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l---~~- 533 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEEL---LE- 533 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHH---HH-
Confidence 99999998543333221 2222 346999999998888777 899999999999998 88999875433322 22
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 140 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+....+...+..++.++.++++.||+.+|.+||++.++..
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 45556666677778999999999999999999999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=215.23 Aligned_cols=175 Identities=23% Similarity=0.372 Sum_probs=145.8
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||+|+.|+|.+.|.+ +..|.......|+.||+.||.||.++++|||||...|+|+.... .|||+|||+.+......
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCC
Confidence 699999999999987 44588999999999999999999999999999999999997644 49999999998765555
Q ss_pred CCCCC----cCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKST----VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
..... -...-|+|||.+....++.+ +|||++||++|||++ |..||.+......+ +. +...-+.+.+..+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL----~~-iD~~erLpRPk~c 340 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----KN-IDAGERLPRPKYC 340 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHH----Hh-ccccccCCCCCCC
Confidence 44433 23457999999998888777 999999999999998 88999988764332 22 2345566777779
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
|+++.++++.||..+|.+|||+..|...-+
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 999999999999999999999998865433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=214.53 Aligned_cols=183 Identities=25% Similarity=0.391 Sum_probs=150.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||.||+|.+.-+-.+.++|.++..+.+..++||+|||++|-+|||||-.||+++..++ +|++|||.+..... -.+
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhh
Confidence 899999999999888999999999999999999999999999999999999999987776 99999999865333 345
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.++.+||+.|||||+.. ..+|+.. +|||++|+...|+-.-++|-..... ......+-+-............+++.
T Consensus 169 rksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhp-mr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHP-MRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccch-HHHHHHhhccCCCCCcccCCccchHH
Confidence 67789999999999863 3456555 9999999999999888777654443 22222332222222334455668999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.+|++.+|.++|.+||+++-+|.|||+.+.
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999999765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=209.66 Aligned_cols=170 Identities=23% Similarity=0.383 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
.|||..|+|.++|.+.. .++.-..+.++.||..|++||..+++|||||...|+|+..+.- +|++|||+++......
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDT 419 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCc
Confidence 38999999999997654 4777788889999999999999999999999999999976544 9999999998643322
Q ss_pred CCCCCcC---CCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 QPKSTVG---TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.+...| .+-|.|||-+....++.+ +|||+|||++||+.| |--||.+.+. ..+..++...+++..+..++
T Consensus 420 -YTAHAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 420 -YTAHAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred -eecccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhccccccCCCCCC
Confidence 222233 457999999998888888 899999999999998 8889988764 34556677788888888899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHh
Q 024363 155 QECRDLISRIFVADPAARITIPEIM 179 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l 179 (268)
+...+|+..||+++|..||++.++-
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHH
Confidence 9999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=200.57 Aligned_cols=181 Identities=25% Similarity=0.453 Sum_probs=131.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC-------
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~------- 73 (268)
|||.+.-+-.++.. .++-.+++.+++.++.||.++|++|||||||||.|+|.+.. .++-.|.|||+|..
T Consensus 114 lp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~-t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR-TQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc-cCCceEEechhHHHHHhhhhh
Confidence 57777766666653 37799999999999999999999999999999999999754 34578999999751
Q ss_pred ----------CCC-C---------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHH
Q 024363 74 ----------SVL-H---------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115 (268)
Q Consensus 74 ----------~~~-~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 115 (268)
... . .......||++|+|||++...+-.+.++||||.|||+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 000 0 00012469999999999988766666699999999999
Q ss_pred HHHhCCCCCCCCCChH-HHHHHH--------HHH-------------------------hcc----ccc--------CCC
Q 024363 116 VMLVGGYPFEDPDEPK-DFRKTI--------QRI-------------------------LSV----QYS--------VPD 149 (268)
Q Consensus 116 el~~g~~pf~~~~~~~-~~~~~~--------~~~-------------------------~~~----~~~--------~~~ 149 (268)
-+++++.||......- .+.+++ .+. ... -.. ...
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 9999999996432211 111000 000 000 000 000
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 150 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 150 ~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
..-.+..+.+|+.+||..||.+|+|++++|+||||.
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 111345789999999999999999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=207.96 Aligned_cols=177 Identities=22% Similarity=0.342 Sum_probs=139.4
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+++|+|.+++.++. .+.-.....++.||+.||+||.+.++|||||.+.|+|++.+.. +||+|||+|+......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCC
Confidence 69999999999998863 3345566779999999999999999999999999999976554 9999999998543322
Q ss_pred CC---CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHH--hCCCCCCCCCChHHHHHHHHHHhcccc---cCCCC
Q 024363 79 QP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--VGGYPFEDPDEPKDFRKTIQRILSVQY---SVPDT 150 (268)
Q Consensus 79 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~ 150 (268)
.. ...+-.++|||+|.+.-.+++++ +|+|+||+++||++ +...||...+......+ ...+...+. -.+.+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCC
Confidence 21 12245679999999998899877 89999999999976 47789988776544433 333322221 23445
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..++..+.++|.+||..+..+||+++++-.|
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 5688999999999999999999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=221.74 Aligned_cols=183 Identities=37% Similarity=0.621 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
||||++ +|+.++...+.++..++..++.|++.|+.|+|+.||.||||||+|+++..++. +||+|||.+........
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcch
Confidence 899999 99999999889999999999999999999999999999999999999987664 99999999875433322
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc-----CCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-----VPDT 150 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 150 (268)
....+|+..|+|||++.+..|....+||||.|+++..|++|+.||.............. ...... ....
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--YSDQRNIFEGPNRLL 554 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--cccccccccChHHHH
Confidence 34567999999999999999999999999999999999999999976544322110000 000000 1112
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..++...+.+|.+||+.+|.+|.|+++|++.+||+.-.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 33678899999999999999999999999999997644
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=200.33 Aligned_cols=121 Identities=29% Similarity=0.485 Sum_probs=83.1
Q ss_pred EEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC------hHHHHHH
Q 024363 63 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE------PKDFRKT 136 (268)
Q Consensus 63 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~ 136 (268)
|||+|||-|+.... ..+..+.|..|+|||++.+.+|... +||||++|++|||+||.+.|...+. ...+..+
T Consensus 393 vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 56666666654322 2345678999999999999999887 8999999999999999999864321 1112111
Q ss_pred HHHH--------hccccc------------CCCCCC----------------CCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 137 IQRI--------LSVQYS------------VPDTNP----------------ISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 137 ~~~~--------~~~~~~------------~~~~~~----------------~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.-+ +...+. +..... -..++.+||.-||+.+|++||||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111 011100 000000 1256889999999999999999999999
Q ss_pred ccccCC
Q 024363 181 HQWFLK 186 (268)
Q Consensus 181 h~~~~~ 186 (268)
|||+..
T Consensus 550 hPwLn~ 555 (590)
T KOG1290|consen 550 HPWLNP 555 (590)
T ss_pred CccccC
Confidence 999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=227.47 Aligned_cols=171 Identities=20% Similarity=0.248 Sum_probs=124.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH---~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++.+.. .++. ||.+....
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~-- 833 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC-- 833 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc--
Confidence 79999999999995 3899999999999999999999 679999999999999986665 4443 55543221
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhc---------cccc-
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILS---------VQYS- 146 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~---------~~~~- 146 (268)
......+|+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ....+..+.... ....
T Consensus 834 -~~~~~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 834 -TDTKCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -cCCCccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1233478999999999988777666 99999999999999999998542211 111111111110 0000
Q ss_pred -CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 147 -VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 147 -~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.......++.+++.+||+.+|.+|||+.++++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000112357789999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=180.12 Aligned_cols=116 Identities=31% Similarity=0.509 Sum_probs=96.7
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCccc
Q 024363 13 ICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 91 (268)
Q Consensus 13 l~~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a 91 (268)
+.+++.++|..+-+++..++.||.|||++ .++|||+||+||||+..+ ++|+||||++-.....-..+...|...|||
T Consensus 139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dSiAkt~daGCkpYma 216 (282)
T KOG0984|consen 139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDSIAKTMDAGCKPYMA 216 (282)
T ss_pred HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhhhHHHHhcCCCccCC
Confidence 34577899999999999999999999975 899999999999997655 599999999865444444344678899999
Q ss_pred chhhcc----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChH
Q 024363 92 PEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 131 (268)
Q Consensus 92 PE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 131 (268)
||.+.. .+|+-+ +||||||++++||.+++.||.....+-
T Consensus 217 PEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 217 PERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred hhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHH
Confidence 999853 467666 899999999999999999998765543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.36 Aligned_cols=172 Identities=21% Similarity=0.366 Sum_probs=144.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
.+|+++|+|.++++. ++.+..+..+.|..||++||.|||.+++|||||...|||+..-. ++||+|||+|+.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccCcccc
Confidence 379999999999976 45799999999999999999999999999999999999996544 599999999987655544
Q ss_pred CCCC---cCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 PKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
..+. ...+-|||-|.+....|+.. +|||||||++||++| |..|+.+.... .+..++....+.+.+..++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~-----eI~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAE-----EIPDLLEKGERLSQPPICTI 927 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHH-----HhhHHHhccccCCCCCCccH
Confidence 3332 23567999999988888777 899999999999998 99999887643 33444555556777888999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.-++.+||..|+..||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=181.92 Aligned_cols=181 Identities=25% Similarity=0.413 Sum_probs=132.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+-|+|.+-+.. ..+.|...+.++.|+++|+.|+|++++||||||.+||||-.....++||||||+++.....-
T Consensus 101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-- 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-- 177 (378)
T ss_pred eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee--
Confidence 799999999988744 46899999999999999999999999999999999999965555589999999987543222
Q ss_pred CCCcCCCCcccchhhccC----ccCCcccchhhhhHHHHHHHhCCCCCCCCCChH-HHHHHHHHHhcccccCC-CCCCCC
Q 024363 81 KSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-DFRKTIQRILSVQYSVP-DTNPIS 154 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~s 154 (268)
...-.+..|.+||++... -...+.+|+|.||+++|..++|++||....... ...+.++-........| ..+++|
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 122345678999987432 122344799999999999999999997432211 11122222222222333 346689
Q ss_pred HHHHHHHHHccccCCCCCC---CHHHHhccccc
Q 024363 155 QECRDLISRIFVADPAARI---TIPEIMKHQWF 184 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~ 184 (268)
+.+..+.++-|..+|++|- ++.......|.
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 9999999999999999994 44444445555
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=185.41 Aligned_cols=170 Identities=19% Similarity=0.304 Sum_probs=140.4
Q ss_pred CCCCCchhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 3 YASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 3 y~~gg~L~~~l~~--------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
+..-|+|..++.. .+.++-.+...++.|++.|++|||+.||||.||...|++|+..- ++||+|=.+++..
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsaLSRDL 446 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSALSRDL 446 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccchhcccc
Confidence 4556899999962 12477888899999999999999999999999999999997664 5999999988743
Q ss_pred CC---CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
.. +....+..-...||+||.+....|++. +|+|||||++|||++ |+.|+...+.. .+...++.+++..++
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPf-----Em~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPF-----EMEHYLKDGYRLAQP 520 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHH-----HHHHHHhccceecCC
Confidence 22 122222334568999999998888877 899999999999998 89999877653 344566777888888
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+++++..++..||...|++||+++|+..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 889999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=191.55 Aligned_cols=173 Identities=23% Similarity=0.270 Sum_probs=124.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~---------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
+||.+.|+|.++|+. ..+++....+++..+++||+|||+. .|+|||||..||||.++.. +.|+|||+|
T Consensus 287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeecccee
Confidence 578999999999965 5799999999999999999999973 4999999999999977766 999999999
Q ss_pred CCCCC---CCCCCCCcCCCCcccchhhccCccC-----CcccchhhhhHHHHHHHhCCCCCC-CCCChH-----------
Q 024363 72 KSSVL---HSQPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFE-DPDEPK----------- 131 (268)
Q Consensus 72 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~el~~g~~pf~-~~~~~~----------- 131 (268)
..... .......+||.+|||||++.+.... -+..||||+|.|+||+++...-+. +.....
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 75432 2334457999999999999764322 244799999999999998543221 110000
Q ss_pred HHHHHHHHHhcccccCCCC------CCCCHHHHHHHHHccccCCCCCCCHH
Q 024363 132 DFRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAARITIP 176 (268)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~l~~dp~~R~s~~ 176 (268)
.-...++.........|.. ..-..-+++.+..||..||+.|+|+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 0011122221111111111 11346688999999999999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=187.30 Aligned_cols=176 Identities=24% Similarity=0.368 Sum_probs=130.7
Q ss_pred CCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~--------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
+|.+.|||+++|.+ ..++-....+++..++.||++||.. .|.|||||..||||..++. +.|+|+|+|..
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~ 365 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 365 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEE
Confidence 79999999999987 6899999999999999999999953 3999999999999977765 99999999853
Q ss_pred CC-----CCCCCCCCcCCCCcccchhhccCc-----cCCcccchhhhhHHHHHHHhC----------CCCCCCCCChHHH
Q 024363 74 SV-----LHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVG----------GYPFEDPDEPKDF 133 (268)
Q Consensus 74 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g----------~~pf~~~~~~~~~ 133 (268)
.. .....+..+||.+|||||++...- .+.+.+||||||.|+||++.. ++||.+....+.-
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 22 223456789999999999986421 123458999999999999852 4788665433322
Q ss_pred HHHHHHHhc-ccccCCCCCCCC-----HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 134 RKTIQRILS-VQYSVPDTNPIS-----QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 134 ~~~~~~~~~-~~~~~~~~~~~s-----~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.++++.- .+.+...++.++ ..+.++++.||..+|.-|.|+--+.+
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 333333222 222222222222 45678899999999999999866654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=171.10 Aligned_cols=144 Identities=43% Similarity=0.715 Sum_probs=121.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.|++|.+++... ..++...++.++.+++.+|.+||++|++|+||+|.||+++.. .++++|+|||.+.......
T Consensus 70 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcc
Confidence 6899999999999776 579999999999999999999999999999999999999762 2359999999886433222
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......+...|++||.+.........+|+|++|++++++ ..+.
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~ 191 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELK 191 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHH
Confidence 133456888999999987652333448999999999999 6789
Q ss_pred HHHHHccccCCCCCCCHHHHhccc
Q 024363 159 DLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
+++.+||..+|.+||++.++++|+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-24 Score=189.71 Aligned_cols=168 Identities=34% Similarity=0.612 Sum_probs=142.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
++|..||.|+..+.+...+.+..++.+...++.|++++|+.+++|||+|++||+++..| ++++.|||+++.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G--hi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC--ccccCCchhhhHhHhhhh-
Confidence 47889999999999999999999999999999999999999999999999999997665 499999999985433322
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+||.-|||||++.+ .. .++|.||+|+++++|++|..||.. .++..+++.....|.. ++..++++
T Consensus 153 --~cgt~eymApEI~~g--h~-~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~~--l~~~a~~~ 217 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIING--HL-SAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPRE--LSAEARSL 217 (612)
T ss_pred --cccchhhhhhHhhhc--cC-CcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCchh--hhHHHHHH
Confidence 289999999999973 22 338999999999999999999976 3455556655555544 88999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
+..++..+|.+|.. +.++++|+||..
T Consensus 218 ~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 99999999999984 479999999953
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=183.84 Aligned_cols=119 Identities=34% Similarity=0.580 Sum_probs=108.0
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCc
Q 024363 5 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 84 (268)
Q Consensus 5 ~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 84 (268)
+|-+|+++|..+..++|.+++.+++|++.|+++||++||||||||-+|+.+++++. +||+|||.|.. ...+.....+
T Consensus 653 ~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~-~ksgpfd~f~ 729 (772)
T KOG1152|consen 653 EGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAY-TKSGPFDVFV 729 (772)
T ss_pred CCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhh-hcCCCcceee
Confidence 46799999999999999999999999999999999999999999999999987766 99999998753 2344456778
Q ss_pred CCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCC
Q 024363 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 126 (268)
Q Consensus 85 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 126 (268)
||..|.|||++.+.+|-++.-|||++|+++|-++....||.+
T Consensus 730 gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 730 GTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=164.10 Aligned_cols=127 Identities=41% Similarity=0.713 Sum_probs=107.4
Q ss_pred CCCCCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.+++|.+++..... +++..++.++.+++.+|.+||+.+++|+||+|.||+++.. +.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~--~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD--GLVKLADFGLARFIHRDLA 153 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEeeCceeeEecCccc
Confidence 689999999999988776 8999999999999999999999999999999999999765 459999999887544332
Q ss_pred -CCCCCcCCCCcccchhh-ccCccCCcccchhhhhHHHHHHHhCCCCCCC-CCCh
Q 024363 79 -QPKSTVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFED-PDEP 130 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~ 130 (268)
......++..|++||.+ ....++. ++|+|+||+++++|++|+.||.. ....
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 33456788899999998 4455555 48999999999999999999976 4433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=188.52 Aligned_cols=166 Identities=34% Similarity=0.600 Sum_probs=130.3
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--------
Q 024363 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------- 78 (268)
Q Consensus 7 g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-------- 78 (268)
|+-.+.++..++++..- +.+++|||+.||+|||+||+|.+|+.-+ ++|++|||+++......
T Consensus 136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhcc
Confidence 34555555555555543 7899999999999999999999996554 59999999986422111
Q ss_pred --------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
..+..+|||.|+|||++...+| ++.+|+|++|+|+|+.+-|+.||.+.+.++.+...+...+...- ..
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE---~d 281 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE---ED 281 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc---cC
Confidence 1234589999999999999888 45599999999999999999999999887766665554433222 23
Q ss_pred CCCCHHHHHHHHHccccCCCCCC---CHHHHhcccccCC
Q 024363 151 NPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK 186 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~---s~~e~l~h~~~~~ 186 (268)
..++++++++|.++|..+|..|. .+-++.+|+||+.
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 44789999999999999999997 5678999999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=161.90 Aligned_cols=185 Identities=35% Similarity=0.593 Sum_probs=140.5
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||+.|++|.+++.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++.... .++++|||.++.....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDP 155 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCC
Confidence 58999999997877665 7999999999999999999999999999999999999976542 4899999998743332
Q ss_pred C-------CCCCCcCCCCcccchhhccC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhcccc
Q 024363 78 S-------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PKDFRKTIQRILSVQY 145 (268)
Q Consensus 78 ~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 145 (268)
. ......||..|+|||.+.+. .......|+||+|++++++++|..||..... .......+........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 34667899999999999873 3444458999999999999999999877654 2232332222211101
Q ss_pred cCCCCCCC----CHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 146 SVPDTNPI----SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 146 ~~~~~~~~----s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
........ ...+.+++.+++..+|..|.+......+++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11111111 257899999999999999999999888866644
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=170.84 Aligned_cols=170 Identities=25% Similarity=0.326 Sum_probs=129.0
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|++|..++|.++|.... ..+....+.++.|+..|+.| ++.+|||+||.||+...+. .+||+|||+.......
T Consensus 335 Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 335 MNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVTSQDKD 409 (516)
T ss_pred hhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhheeecccC
Confidence 78999999999996433 46778899999999999999 9999999999999997665 4899999998754444
Q ss_pred C-------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCC
Q 024363 78 S-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD 149 (268)
Q Consensus 78 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (268)
. ..+..+||.+||+||.+.+..|..+ +||||||++++||+. -...|. ....+..+....+....
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGIIPPEF 481 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCCCChHH
Confidence 3 4456789999999999999999777 999999999999997 222222 11222333333222101
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 150 TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 150 ~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
.. --+.-..|+.+||...|.+||++.+.-.|+|.
T Consensus 482 ~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11 11345699999999999999988877777664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=169.27 Aligned_cols=168 Identities=24% Similarity=0.372 Sum_probs=119.7
Q ss_pred CCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC--
Q 024363 3 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 80 (268)
Q Consensus 3 y~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~-- 80 (268)
|+.. +|++.|..+.-+...+.+.++.||+.||..+|+.||+|+|||.+||||++= + .+.|+||..-+........
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-N-W~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-N-WLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-c-hhhhhcccccCCccCCCCCcc
Confidence 4444 899999888889999999999999999999999999999999999999742 2 4899999754433222211
Q ss_pred ------CCCcCCCCcccchhhccCc----------cCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 81 ------KSTVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 81 ------~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
.+..-..+|+|||.+.... .-.++.||+|+||+++||++ |++||.-. ++ ......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL----~aYr~~ 250 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QL----LAYRSG 250 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HH----HhHhcc
Confidence 1122344799999886422 12345799999999999998 78888521 11 111111
Q ss_pred cccCC---CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 144 QYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 144 ~~~~~---~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+ ...--+..++.||..|++.||++|.+|++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000 000023478999999999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-18 Score=147.27 Aligned_cols=173 Identities=22% Similarity=0.186 Sum_probs=127.8
Q ss_pred CCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-C--CCEEEeecCCCC--CCCCCC
Q 024363 6 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK--SSVLHS 78 (268)
Q Consensus 6 gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~--~~~kl~Dfg~a~--~~~~~~ 78 (268)
|.+|.++.... ++|+...+..++.|++.+|++||+.|++||||||.|+++.... . ..+.|.|||+|+ ......
T Consensus 104 G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~ 183 (322)
T KOG1164|consen 104 GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDS 183 (322)
T ss_pred CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCC
Confidence 67898887543 5799999999999999999999999999999999999997553 1 358999999998 311111
Q ss_pred --------C-CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC
Q 024363 79 --------Q-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 149 (268)
Q Consensus 79 --------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (268)
. .....||..|+++.+..+...... -|+||++.++.++..|..||.+........+..+........ ..
T Consensus 184 ~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-~~ 261 (322)
T KOG1164|consen 184 GGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-RF 261 (322)
T ss_pred CcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-cc
Confidence 1 123459999999999888777555 899999999999999999997766433322222221111111 12
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 150 TNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 150 ~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
....+..+..+...+-..+...+|....+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 262 GDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred cCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2224577888888887788999998776655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-20 Score=152.12 Aligned_cols=133 Identities=24% Similarity=0.350 Sum_probs=90.3
Q ss_pred HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccC------
Q 024363 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH------ 98 (268)
Q Consensus 25 ~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------ 98 (268)
..+..|+++.+++||+.|+||+||||+|++++.+|. ++|+||+.......... ....+..|.|||.....
T Consensus 148 l~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~ 223 (288)
T PF14531_consen 148 LSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQN 223 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHS
T ss_pred HHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcc
Confidence 445689999999999999999999999999987655 99999986543222211 13455789999987442
Q ss_pred --ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCC
Q 024363 99 --EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172 (268)
Q Consensus 99 --~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 172 (268)
.++ .+.|.|+||+++|.|+|+..||........ ..+.+.....+|+.++.||..+|+.+|.+|
T Consensus 224 ~~~~t-~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 224 NAPYT-FATDAWQLGITLYSLWCGRLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp EEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cceee-eccCHHHHHHHHHHHHHccCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 233 347999999999999999999986543211 111333344689999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=145.88 Aligned_cols=164 Identities=27% Similarity=0.354 Sum_probs=117.1
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE--cCCCCCCEEEeecCCCCCCCC-------CC
Q 024363 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HS 78 (268)
Q Consensus 8 ~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili--~~~~~~~~kl~Dfg~a~~~~~-------~~ 78 (268)
+|..++..+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+ +.++.+.+.|+|||.+--... .+
T Consensus 328 tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S 406 (598)
T KOG4158|consen 328 TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYES 406 (598)
T ss_pred hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccccc
Confidence 667776553 56788888899999999999999999999999999999 445556789999996532111 11
Q ss_pred CCCCCcCCCCcccchhhccC-----ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
.....-|.-..||||+.... ..+..++|.|+.|.+.||++....||.+....-.-....++ .+ -.+.+..+
T Consensus 407 ~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---~q-LPalp~~v 482 (598)
T KOG4158|consen 407 DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---SQ-LPALPSRV 482 (598)
T ss_pred ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---hh-CCCCcccC
Confidence 12233477788999997532 12223389999999999999999999873321100011111 11 12334558
Q ss_pred CHHHHHHHHHccccCCCCCCCHH
Q 024363 154 SQECRDLISRIFVADPAARITIP 176 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~ 176 (268)
++.+++++..+|+.||++|++..
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCcc
Confidence 89999999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=139.15 Aligned_cols=168 Identities=21% Similarity=0.326 Sum_probs=131.8
Q ss_pred CCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 2 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
.|++.|+|+..++.+.. ....++.+++..+++|++|||+.. |..--|....++|+.+...++..+|--++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 58999999999987654 678899999999999999999975 334468888999998887667777754442
Q ss_pred CCCCCCcCCCCcccchhhccCcc--CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
+.......|.||+||.+...+. +..++|+|||++++|||.|...||......+--.++ .-...+...++.+|.
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~ 416 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISR 416 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccH
Confidence 2345567899999999976543 344589999999999999999999887764433333 233344455566999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHh
Q 024363 156 ECRDLISRIFVADPAARITIPEIM 179 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l 179 (268)
.+..|+.-|++.||.+||.+..++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=152.32 Aligned_cols=177 Identities=25% Similarity=0.318 Sum_probs=131.5
Q ss_pred CCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 2 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQV-CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 2 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~i-vHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
+||.-|+|.+.+.. .-+++.-....+++.|+.||+|||+-.| +|+.|+..|++++.... +||+|||+......
T Consensus 27 ~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~--lklt~~Gl~~~~~~~~~ 104 (484)
T KOG1023|consen 27 EYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWV--LKLTDFGLNSLLEETAE 104 (484)
T ss_pred eeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEE--EEechhhhccccccccc
Confidence 68999999999987 4568888899999999999999998766 99999999999976654 99999998764321
Q ss_pred CCCCCCCcCCCCcccchhhccCcc------CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----- 145 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 145 (268)
........-...|.|||++..... -.++.|+||+|++++|+++...||..........+++..+.+...
T Consensus 105 ~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP 184 (484)
T KOG1023|consen 105 PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP 184 (484)
T ss_pred ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCc
Confidence 111122234557999999876421 244589999999999999999999875443332344444333111
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.........+++..++..||..+|..||+++++-.
T Consensus 185 ~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 185 SIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred chhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 11111135568999999999999999999987754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-19 Score=163.47 Aligned_cols=184 Identities=34% Similarity=0.571 Sum_probs=148.3
Q ss_pred CCCCCCCchhHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-
Q 024363 1 MEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l-~~~~-~l~e~~~~~~~~qil~~L~~LH-~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~- 76 (268)
+||..||+++..+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++.++. .+|++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence 4789999999998 5554 6888899999999999999999 999999999999999987773 499999999986544
Q ss_pred CC---CCCCCcC-CCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 77 HS---QPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 77 ~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.. .....+| ++.|+|||...+..+..+..|+||.|+++..+++|..|+................. .......+..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNS 257 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCcccc
Confidence 22 2234568 99999999998877777779999999999999999999976654332111111111 1222444566
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++....+++.+++..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-16 Score=125.03 Aligned_cols=119 Identities=16% Similarity=0.157 Sum_probs=87.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdl-kp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.|++|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|........
T Consensus 77 meyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 77 RSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcch
Confidence 789999999764422 1 2357889999999999999999999 79999997554 499999999975433221
Q ss_pred C--------------CCCcCCCCcccchhhccC-ccCCcccchhhhhHHHHHHHhCCCCCCCCC
Q 024363 80 P--------------KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128 (268)
Q Consensus 80 ~--------------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~ 128 (268)
. .-...++.|+.|+...-- ..+-...++++.|+-+|.++|+..++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 011268888888854321 222233588899999999999998886544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=137.14 Aligned_cols=88 Identities=17% Similarity=0.190 Sum_probs=67.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdl-kp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++ ++||+|||+|+.......
T Consensus 97 mE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 97 RGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccCcc
Confidence 79999999963 211 11 1467899999999999999999999 99999996554 599999999985433321
Q ss_pred ---------CCCCcCCCCcccchhhcc
Q 024363 80 ---------PKSTVGTPAYIAPEVLLR 97 (268)
Q Consensus 80 ---------~~~~~gt~~y~aPE~~~~ 97 (268)
..+..+++.|+|||.+.-
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCCh
Confidence 134567888999998853
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.1e-16 Score=123.29 Aligned_cols=70 Identities=24% Similarity=0.264 Sum_probs=62.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~L-H~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
||||+|++|...+.+.+.+++..+..++.|++.+|.|| |+.||+||||||+||+++. +.++|+|||+|..
T Consensus 96 mE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~v~LiDFG~a~~ 166 (190)
T cd05147 96 MEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GKLYIIDVSQSVE 166 (190)
T ss_pred EEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---CcEEEEEcccccc
Confidence 89999988876655567899999999999999999999 7999999999999999973 3599999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.2e-15 Score=121.97 Aligned_cols=123 Identities=25% Similarity=0.368 Sum_probs=101.6
Q ss_pred CCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC---CCEEEeecCCCCCCCCCC---
Q 024363 6 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS--- 78 (268)
Q Consensus 6 gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~---~~~kl~Dfg~a~~~~~~~--- 78 (268)
|-||-+++.= +.+|+...+..++.|++.-++|+|++.+|+|||||+|+||...+. ..|.+.|||+|+......
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 5677666643 457999999999999999999999999999999999999965332 248999999998644332
Q ss_pred -----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC
Q 024363 79 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 129 (268)
Q Consensus 79 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 129 (268)
..++..||-.||+--...+...+.. -|+-|||-++.+.+.|..||.+...
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 2345679999999988888777655 7999999999999999999998664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=118.83 Aligned_cols=180 Identities=19% Similarity=0.247 Sum_probs=127.7
Q ss_pred CCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCC-----
Q 024363 6 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS----- 78 (268)
Q Consensus 6 gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~----- 78 (268)
|.||-+++.- ...|+...++-++-|++.-++|+|.+++|||||||+|+|..-+. ..++.++|||+|+......
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 5677666642 34699999999999999999999999999999999999985332 2358999999998533221
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC---CCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---DTNP 152 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 152 (268)
..+...||..|.+--...+...+.. -|+-|+|.++.++..|..||.+....... +...++...+.+.+ ....
T Consensus 174 pyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~s~~ie~LC~G 251 (341)
T KOG1163|consen 174 PYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKMSTPIEVLCKG 251 (341)
T ss_pred ccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhcCCCHHHHhCC
Confidence 2234569999988777666555444 79999999999999999999987654322 22223333332222 2344
Q ss_pred CCHHHHHHHHHccccCCCCCCCH---HHHhcccccCCC
Q 024363 153 ISQECRDLISRIFVADPAARITI---PEIMKHQWFLKN 187 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~---~e~l~h~~~~~~ 187 (268)
+|.++.-.+.-|-..--.+-|.. .++.+--|+..+
T Consensus 252 ~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 252 FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 78888888888877777777753 455554444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.8e-16 Score=144.58 Aligned_cols=180 Identities=31% Similarity=0.506 Sum_probs=145.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC-CCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~-~~~~--- 76 (268)
|+|.+||+|...+++.+..++.-++.++..+..+++|||+..+.|||++|.|+++...+. .++++||... ....
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCc
Confidence 578899999999999999999999999999999999999999999999999999976654 8999998322 1000
Q ss_pred --C--------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Q 024363 77 --H--------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128 (268)
Q Consensus 77 --~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 128 (268)
. .......||+.|.+||...+...... +|+|++|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 00123468999999999987766555 899999999999999999998877
Q ss_pred ChHHHHHHHHHHhcccccCCC-CCCCCHHHHHHHHHccccCCCCCCCHH---HHhcccccCCC
Q 024363 129 EPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKN 187 (268)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~dp~~R~s~~---e~l~h~~~~~~ 187 (268)
....+ +.+.+....++. ....+..+.+++.+.|..+|.+|..+. ++..|+||+..
T Consensus 1040 pq~~f----~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1040 PQQIF----ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhh----hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 75554 344444444443 334789999999999999999999887 89999999653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.5e-15 Score=118.43 Aligned_cols=70 Identities=19% Similarity=0.188 Sum_probs=60.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|+++.........+++..+..++.|++.+|.++|+ +||+||||||+||+++ + ++++|+|||+++.
T Consensus 96 mE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~~~~liDFG~a~~ 166 (190)
T cd05145 96 MEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--GKPYIIDVSQAVE 166 (190)
T ss_pred EEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--CCEEEEEccccee
Confidence 7999998765544455678999999999999999999999 9999999999999997 3 4599999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-15 Score=121.81 Aligned_cols=95 Identities=20% Similarity=0.269 Sum_probs=69.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++|.+|.+.. .+++. .+.+++.+|..||..|++|||+||+||+++.++ ++|+|||.++........
T Consensus 122 mEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~ 190 (232)
T PRK10359 122 IEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK 190 (232)
T ss_pred EEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH
Confidence 7999999997763 23432 456999999999999999999999999997544 999999977543211110
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 118 (268)
........+..+ +|+||||+++..+.
T Consensus 191 -----------d~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 191 -----------DRIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred -----------HHHHHHhHhccc-ccccceeEeehHHH
Confidence 113334455544 89999999977654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=137.45 Aligned_cols=121 Identities=29% Similarity=0.335 Sum_probs=104.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-----CCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-----~~~~~kl~Dfg~a~~~~ 75 (268)
+||.+.|+|.+++...+.+++..+..++.|++.-++.||..+|||+||||+|+||... +..-++|+|||.|.-..
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 5899999999999988889999999999999999999999999999999999999532 22348999999886322
Q ss_pred C---CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCC
Q 024363 76 L---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 122 (268)
Q Consensus 76 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 122 (268)
. ....+..++|-.+-.+|+..+..++.. +|.|.|+.+++.||+|++
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 2 223455678999999999999999888 899999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.1e-13 Score=107.74 Aligned_cols=68 Identities=21% Similarity=0.211 Sum_probs=54.7
Q ss_pred CCC--CCCCchhHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEEcCC--CCCCEEEeecCCC
Q 024363 1 MEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy--~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L-~~LH~~~ivHrdlkp~Nili~~~--~~~~~kl~Dfg~a 71 (268)
||| +.+|+|.+++++ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +..+++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 688 558999999966 457766 36688888888 99999999999999999999753 3346999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-13 Score=112.16 Aligned_cols=70 Identities=20% Similarity=0.217 Sum_probs=60.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~-ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|.........+.+..+..++.|++.+|.+||++| ++||||||+||+++ . +.++|+|||.+..
T Consensus 127 ~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~--~~i~LiDFg~a~~ 197 (237)
T smart00090 127 MEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D--GKVVIIDVSQSVE 197 (237)
T ss_pred EEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C--CCEEEEEChhhhc
Confidence 799999998776545566778888999999999999999999 99999999999997 3 3599999998763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.8e-13 Score=109.39 Aligned_cols=174 Identities=17% Similarity=0.284 Sum_probs=117.5
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCC-C
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK-S 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~-~ 73 (268)
.||+..|+|.++|++. ..+....-++|+-||+.||.|||+-. |+|+++....|++..++ -+|++--.-.. .
T Consensus 151 teymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng--LIkig~~ap~s~h 228 (458)
T KOG1266|consen 151 TEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG--LIKIGSVAPDSTH 228 (458)
T ss_pred EecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc--eEEecccCccccc
Confidence 3899999999999753 45888889999999999999999875 99999999999997544 36664322111 0
Q ss_pred ----CCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC
Q 024363 74 ----SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 149 (268)
Q Consensus 74 ----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (268)
...........+-++|.+||.=.....++. +|||++|....+|..+..--............+... ......
T Consensus 229 ~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~---i~~len 304 (458)
T KOG1266|consen 229 PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV---IIGLEN 304 (458)
T ss_pred hhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh---eeeccC
Confidence 000011122346789999995433444455 899999999999998765322222211111111111 111111
Q ss_pred CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 150 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 150 ~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.--+.++.+||+-.|..||++..++.||...
T Consensus 305 -----~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 305 -----GLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred -----ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 1235789999999999999999999999764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.5e-12 Score=103.70 Aligned_cols=66 Identities=26% Similarity=0.382 Sum_probs=54.8
Q ss_pred CCCCCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++| ++|.+++.+ ..+++.. +.+|+.+|.+||.+||+||||||.|||++.++ .++|+|||.++.
T Consensus 125 ~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~~ 191 (239)
T PRK01723 125 IERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGEL 191 (239)
T ss_pred EEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCccc
Confidence 588997 689888755 4566654 56899999999999999999999999997654 599999998763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.8e-12 Score=101.54 Aligned_cols=66 Identities=27% Similarity=0.382 Sum_probs=58.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||+++ . +.++|+|||.++.
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~--~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G--GKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C--CCEEEEECCcccC
Confidence 799999999999865432 8888999999999999999999999999999997 3 3499999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=5e-12 Score=101.49 Aligned_cols=65 Identities=23% Similarity=0.336 Sum_probs=54.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|...... .....++.+++.++.++|+.|++||||||.||+++.++ .++|+|||++..
T Consensus 110 ~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDfg~~~~ 174 (198)
T cd05144 110 MEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDWPQMVS 174 (198)
T ss_pred EEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--cEEEEECCcccc
Confidence 789999999765321 45667889999999999999999999999999997644 599999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.3e-12 Score=100.47 Aligned_cols=63 Identities=27% Similarity=0.395 Sum_probs=54.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ + +.+++.|||+++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence 799999999988755322 7889999999999999999999999999997 3 4599999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.1e-12 Score=112.05 Aligned_cols=176 Identities=18% Similarity=0.167 Sum_probs=131.4
Q ss_pred CCCCCCCchhHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qil~----~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
.|+|. .+|.++...... +++..++..+.+... ||..+|+.+++|-|+||.||++..+. ..++++|||+.....
T Consensus 197 tE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKIS 274 (524)
T ss_pred ecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEEcc
Confidence 36675 688888876555 899999999999999 99999999999999999999997663 348999999876433
Q ss_pred CCCC------CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCC--CChHHHHHHHHHHhcccccC
Q 024363 76 LHSQ------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP--DEPKDFRKTIQRILSVQYSV 147 (268)
Q Consensus 76 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~ 147 (268)
.... ....-|...|++||+..+. .....|++++|.++.+..++..++... ..+..+.. .....
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-------~~ip~ 345 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-------GYIPL 345 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-------ccCch
Confidence 3221 1122577889999987543 345589999999999999887666554 22222111 11111
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
......+..+...+..|+..+|-.|+++..+++|++....
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2223467788889999999999999999999999988643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.8e-12 Score=113.97 Aligned_cols=157 Identities=18% Similarity=0.304 Sum_probs=110.1
Q ss_pred HHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC----------CCCCcCCCCcccchh
Q 024363 26 FFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----------PKSTVGTPAYIAPEV 94 (268)
Q Consensus 26 ~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~ 94 (268)
.=+.+++.||.|+|. .++||++|.|++|.++..+. +||+.|+++........ .....-...|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 344556689999995 68999999999999977766 89999998654332111 111234568999999
Q ss_pred hccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCC
Q 024363 95 LLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173 (268)
Q Consensus 95 ~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 173 (268)
+....... ++|++|+||++|.+.. |+..+......... ..... ...-........+++++++-+.+++..++..||
T Consensus 181 ~~~~~~~~-~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~-~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 181 LLGTTNTP-ASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRN-LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred hccccccc-cccceeeeeEEEEEecCCcchhhccCCcchh-hhhhc-ccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 98755444 4899999999999984 55555443322111 11111 111112223356899999999999999999999
Q ss_pred CHHHHhcccccCCC
Q 024363 174 TIPEIMKHQWFLKN 187 (268)
Q Consensus 174 s~~e~l~h~~~~~~ 187 (268)
++..++..|||...
T Consensus 258 ~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 258 TLDLLLSIPFFSDP 271 (700)
T ss_pred chhhhhcccccCCc
Confidence 99999999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.8e-12 Score=112.23 Aligned_cols=172 Identities=21% Similarity=0.214 Sum_probs=123.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
.|||+||++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..++ +..+++|||..+.... ..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~-~~- 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAF-SS- 421 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccce-ec-
Confidence 38999999987776566799999999999999999999999999999999999998754 4479999998764111 11
Q ss_pred CCCcCCCCcc--cchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 81 KSTVGTPAYI--APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 81 ~~~~gt~~y~--aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
....+.-++. ++.......+..+ +|++|||..+.+.+++...-....... . +... ..+.....+..+.
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~~---~----i~~~--~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQSL---T----IRSG--DTPNLPGLKLQLQ 491 (524)
T ss_pred ccccccccccccchhhccccccccc-cccccccccccccccCcccCcccccce---e----eecc--cccCCCchHHhhh
Confidence 1122233344 4444444455444 899999999999999875433322211 1 1111 2233333457888
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.+.+.++..++..|+.+.++..|.-|.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 999999999999999999998887653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-11 Score=113.46 Aligned_cols=62 Identities=27% Similarity=0.386 Sum_probs=55.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ ++ .++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 79999999999885 4567899999999999999999999999999994 33 499999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-11 Score=94.99 Aligned_cols=68 Identities=21% Similarity=0.321 Sum_probs=52.7
Q ss_pred CCCCCCCchhH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~-~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++||++.. .+... .. ..+++.++.+++.++.++|. .||+||||||+||+++ + +.++|+|||.+..
T Consensus 94 ~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~--~~~~liDfg~a~~ 163 (187)
T cd05119 94 MEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D--GKVYIIDVPQAVE 163 (187)
T ss_pred EEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C--CcEEEEECccccc
Confidence 68888854422 12111 11 16788999999999999999 9999999999999998 3 3599999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.3e-10 Score=88.48 Aligned_cols=70 Identities=16% Similarity=0.221 Sum_probs=55.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~L-H~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||+.|+.+..-.-+...+++.++..+..+++.+|..| |+.|+||+||++.||++.. + .+.|+|||.|..
T Consensus 103 ME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~--~v~iIDF~qav~ 173 (197)
T cd05146 103 MSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G--KVWFIDVSQSVE 173 (197)
T ss_pred EEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C--cEEEEECCCcee
Confidence 78998765533222334567777888899999999998 8999999999999999963 2 499999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.1e-09 Score=81.20 Aligned_cols=63 Identities=27% Similarity=0.383 Sum_probs=53.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|-.|.+.+... ...++..+-.-+.-||.+||+|+||.++||+++... +.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence 8999998888888665 255677777888889999999999999999997543 89999999863
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.8e-09 Score=80.00 Aligned_cols=63 Identities=35% Similarity=0.483 Sum_probs=52.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~---~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
|||+.|+++..+ +......++.+++.+|.+||.. +++|+|++|.||+++.. +.+++.|||.++
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~--~~~~l~Df~~~~ 137 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--KILGIIDWEYAG 137 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC--cEEEEEeccccc
Confidence 577877777543 5567777899999999999985 69999999999999763 359999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.9e-08 Score=84.03 Aligned_cols=156 Identities=13% Similarity=0.140 Sum_probs=106.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhc-
Q 024363 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 96 (268)
Q Consensus 18 ~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~- 96 (268)
.+.+..+.++.+.++.+.+-||..|.+-+|+.++|+|++..+. +.|.|-..-............+|.+.|.+||...
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~ 190 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTL 190 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccCCceEecccCccccCCHHHhcc
Confidence 4778889999999999999999999999999999999976655 7777643222222333445668999999999865
Q ss_pred ----cCccCCcccchhhhhHHHHHHHhC-CCCCCCCCChH----HHH-HHHHHH------hcccc----cCCCCCCCCHH
Q 024363 97 ----RHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPK----DFR-KTIQRI------LSVQY----SVPDTNPISQE 156 (268)
Q Consensus 97 ----~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~----~~~-~~~~~~------~~~~~----~~~~~~~~s~~ 156 (268)
+...+.. .|.+.||+++++++.| +.||.+..... ... .+.... ....+ ..+....++++
T Consensus 191 ~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~ 269 (637)
T COG4248 191 PSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD 269 (637)
T ss_pred ccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence 2233334 7999999999999986 89998743211 111 011000 00111 11112336789
Q ss_pred HHHHHHHccccC--CCCCCCHH
Q 024363 157 CRDLISRIFVAD--PAARITIP 176 (268)
Q Consensus 157 ~~~li~~~l~~d--p~~R~s~~ 176 (268)
+..|..+|+... +.-|||++
T Consensus 270 vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 270 VQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred HHHHHHHHhcccCCCCCCCCHH
Confidence 999999999753 56799875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-08 Score=82.85 Aligned_cols=72 Identities=18% Similarity=0.180 Sum_probs=59.9
Q ss_pred CCCCCCC-chhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-----CCCCCEEEeecCCCC
Q 024363 1 MEYASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg-~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-----~~~~~~kl~Dfg~a~ 72 (268)
||+++|- +|.+++.. ....++.....++.+++..+.-||.+||+|+|+++.|||++. .+...+.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 5788875 78888854 345677888899999999999999999999999999999974 234569999999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-08 Score=90.99 Aligned_cols=68 Identities=18% Similarity=0.176 Sum_probs=51.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~-~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++|++|.+..... ..+. ...++..++. .+..+|..|++|+|+||.||+++.++ +++++|||++..
T Consensus 237 mE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g--~i~liDfG~~~~ 306 (437)
T TIGR01982 237 MEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG--KIIALDFGIVGR 306 (437)
T ss_pred EEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC--cEEEEeCCCeeE
Confidence 8999999998876432 1222 2345555555 47889999999999999999996554 599999998864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-08 Score=78.50 Aligned_cols=61 Identities=28% Similarity=0.437 Sum_probs=48.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~i-----vHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
|||++|.++... .......+.+++.+|+.||+.++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 688898887543 11123456799999999999985 9999999999997 33 48999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.6e-08 Score=77.39 Aligned_cols=72 Identities=19% Similarity=0.265 Sum_probs=61.4
Q ss_pred CCCCCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCC
Q 024363 1 MEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (268)
+|+++| -+|.+++.....++......++.+++..+.-||.+||+|+|+++.|||++... ...+.++||+.++
T Consensus 96 te~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 96 TEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred EEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 467777 47999988766688888999999999999999999999999999999997664 3458999998665
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-07 Score=73.81 Aligned_cols=73 Identities=26% Similarity=0.304 Sum_probs=57.0
Q ss_pred CCCCCC-CchhHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC-CEEEeecCCCCC
Q 024363 1 MEYASG-GELFERICNAG-RFSEDEA-RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~g-g~L~~~l~~~~-~l~e~~~-~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~-~~kl~Dfg~a~~ 73 (268)
|||++| -++.+++.... .-.+... ..++.+|-+.+.-||.++++|+||..+||++...+.. .+.+.|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 789987 57788886532 2233333 7889999999999999999999999999999765542 248999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.6e-08 Score=87.77 Aligned_cols=66 Identities=29% Similarity=0.403 Sum_probs=49.9
Q ss_pred CCCCCCCchhHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCC
Q 024363 1 MEYASGGELFER--ICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~--l~~~~----~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~ 72 (268)
||||.|+.|.++ +...+ .+.+..+..++.|++ ..|++|+|+||.||+++.++ .+++++.|||+..
T Consensus 240 mE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 240 MERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred EeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 899999999764 33333 355666666666665 58999999999999997654 2369999999875
Q ss_pred C
Q 024363 73 S 73 (268)
Q Consensus 73 ~ 73 (268)
.
T Consensus 313 ~ 313 (537)
T PRK04750 313 S 313 (537)
T ss_pred E
Confidence 4
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.6e-07 Score=80.75 Aligned_cols=96 Identities=16% Similarity=0.269 Sum_probs=70.5
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-CCCCcCCCCcccchhhcc
Q 024363 20 SEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLR 97 (268)
Q Consensus 20 ~e~~~~~~~~qil~~L~~LH-~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~ 97 (268)
+...+..-+.||+.||.||| ..+++|++|.-..|+++..+. .||++|-+......... .....---.|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 36677888999999999998 568999999999999977665 99999987653322221 122222335677775533
Q ss_pred CccCCcccchhhhhHHHHHHHhC
Q 024363 98 HEYDGKIADVWSCGVTLYVMLVG 120 (268)
Q Consensus 98 ~~~~~~~~DiwslG~il~el~~g 120 (268)
..+ ..|.|-|||++++++.|
T Consensus 180 s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc---chhhhhHHHHHHHHhCc
Confidence 332 26999999999999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-06 Score=84.34 Aligned_cols=170 Identities=21% Similarity=0.258 Sum_probs=120.1
Q ss_pred CCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE-cCCCCCCEEEe--ecCCCCCCCCCC
Q 024363 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKIC--DFGYSKSSVLHS 78 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili-~~~~~~~~kl~--Dfg~a~~~~~~~ 78 (268)
|||.+-++...++..+..+...++.+..++++||.|+|+....|.-|......- +..+.+.+.++ ||+.++......
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~ 345 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE 345 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence 689999999999999999999999999999999999999966665554442221 11233334555 888777655555
Q ss_pred CCCCCcCCCCcccchhhccCccCCc-ccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGK-IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.......+..+.+||.......... ..|+|.+|.....+..|..+-.... ....++... .....
T Consensus 346 ~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~-------~~~~~l~~~--------~~~~~ 410 (1351)
T KOG1035|consen 346 KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA-------VPVSLLDVL--------STSEL 410 (1351)
T ss_pred cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc-------chhhhhccc--------cchhh
Confidence 5555667778888887765443222 2599999999999988764422111 111111110 11267
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+++.+|+.-++++|+++.+++.|+|...
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchhccc
Confidence 88999999999999999999999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.4e-07 Score=73.43 Aligned_cols=68 Identities=26% Similarity=0.389 Sum_probs=46.2
Q ss_pred CCCCC--CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~--gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~-LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++ |..+..+... .++......++.+++..+.. +|+.|++|+||.+.||+++.+ .+.++|||.+..
T Consensus 85 ME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~qav~ 155 (188)
T PF01163_consen 85 MEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFGQAVD 155 (188)
T ss_dssp EE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GTTEEE
T ss_pred EEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecCccee
Confidence 88998 6666544322 22355667788888886555 579999999999999999765 399999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-06 Score=69.88 Aligned_cols=61 Identities=25% Similarity=0.349 Sum_probs=47.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
|||++|..|.+.. .+++. +...+.+++.-||+.|++|+|..|.|++++.++ +++.||+..+
T Consensus 122 ~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 122 MEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred EEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 7999998886653 23332 445677889999999999999999999997543 8999997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.9e-07 Score=88.49 Aligned_cols=177 Identities=12% Similarity=0.102 Sum_probs=121.6
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~-----ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
|+||.+|.+++.|-++ ..+.+..+.....+.+.+..-+|+.. .+|++||+-|.+|..+. ++|++++|+.
T Consensus 1310 ~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny--~v~~gk~gLd 1387 (2724)
T KOG1826|consen 1310 SLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY--NVKLGKGGLD 1387 (2724)
T ss_pred HHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC--cccccccccc
Confidence 5789999999999653 34566667767777678888877642 78999999999996554 4999999999
Q ss_pred C-CCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 72 K-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 72 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
+ ...........++++.|+.|++...-.++.+ +|+|+.|+.+|.+..|..+|. ......++.+..........
T Consensus 1388 KIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe 1461 (2724)
T KOG1826|consen 1388 KIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIE 1461 (2724)
T ss_pred cccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCccccccccccc
Confidence 8 3333344456678999999999887777665 899999999999988876652 22222233322222222222
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
...|.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1462 ~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1462 KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 22345555555566666667788877777766653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.8e-06 Score=65.90 Aligned_cols=71 Identities=23% Similarity=0.341 Sum_probs=52.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------- 40 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~---------------------------------------- 40 (268)
|||++|++|.+.+.. ..+++.+...++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 578888877665432 456777777777778777777773
Q ss_pred ----------------cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ----------------~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|++|.||+++.+..+.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999976323347899998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=3e-05 Score=62.21 Aligned_cols=66 Identities=8% Similarity=0.100 Sum_probs=54.6
Q ss_pred CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 7 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 7 g~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
-+|.+++.+. .+.++.+...++.+++..+.-||..|+.|+|+-+.||+++..+...++++||--++
T Consensus 111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 5777777553 35678888899999999999999999999999999999975554459999997554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.7e-06 Score=77.42 Aligned_cols=153 Identities=20% Similarity=0.226 Sum_probs=105.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccC
Q 024363 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 98 (268)
Q Consensus 19 l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 98 (268)
|.+-+.....+.-+++|+++|+.-=+||| ||+.++.. .|.++|+...........++..+++.|+|||+....
T Consensus 333 ~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~ 405 (829)
T KOG0576|consen 333 LEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQEN 405 (829)
T ss_pred hhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCCCCCCCCCchhhccc
Confidence 44445566667777899999998889998 88876533 699999988765555566778899999999999888
Q ss_pred ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---cCCCCCCCCHHHH-HHHHHccccCCCCCCC
Q 024363 99 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---SVPDTNPISQECR-DLISRIFVADPAARIT 174 (268)
Q Consensus 99 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~-~li~~~l~~dp~~R~s 174 (268)
.+... .|.|++|+-..++.-|.+|-....... . ...... ........+.... ++...|+..-|..|+.
T Consensus 406 ~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~~------~-~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv 477 (829)
T KOG0576|consen 406 TIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAVL------P-MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV 477 (829)
T ss_pred ccccC-CCccCCCcchhhcCCCCCCCCCCcccc------C-CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc
Confidence 88777 799999987778877776654311100 0 000000 0000001111122 4677899999999999
Q ss_pred HHHHhcccccCC
Q 024363 175 IPEIMKHQWFLK 186 (268)
Q Consensus 175 ~~e~l~h~~~~~ 186 (268)
...++.|.+|..
T Consensus 478 ~mgacfsKvfng 489 (829)
T KOG0576|consen 478 HMGACFSKVFNG 489 (829)
T ss_pred hhhHHHHHHhcc
Confidence 999999988854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00024 Score=63.62 Aligned_cols=134 Identities=18% Similarity=0.252 Sum_probs=91.1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhc
Q 024363 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 96 (268)
Q Consensus 17 ~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 96 (268)
.+.+|..+|.++.|+..||.++|+.|+.-+=|.|.+|++.+.. +++|+.-|+........ + +.+.
T Consensus 388 ~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~------~-------~~le 452 (655)
T KOG3741|consen 388 LKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP------T-------EPLE 452 (655)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC------C-------cchh
Confidence 3578999999999999999999999999999999999996554 58887766543222111 1 1112
Q ss_pred cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHH
Q 024363 97 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176 (268)
Q Consensus 97 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 176 (268)
+. +.-|.=.||.+++.|.||..--...+..... .+..+ ...+|.+++++|.-+...++.. -++.
T Consensus 453 ~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~ 516 (655)
T KOG3741|consen 453 SQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQ 516 (655)
T ss_pred HH----hhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence 21 1258889999999999985321111111111 01111 1127889999999998888886 5777
Q ss_pred HHhcc
Q 024363 177 EIMKH 181 (268)
Q Consensus 177 e~l~h 181 (268)
+++.+
T Consensus 517 ~llp~ 521 (655)
T KOG3741|consen 517 DLLPM 521 (655)
T ss_pred HHHHH
Confidence 77765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=6.8e-05 Score=62.01 Aligned_cols=65 Identities=22% Similarity=0.336 Sum_probs=50.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
|||++|-.|... +++...+..++..|+.-+.-+-..|+||+|+.+-||+++.++. +.++||-.+.
T Consensus 186 Me~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 186 MEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred eehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 888888766532 2345666667777777777777999999999999999987665 9999996543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00049 Score=56.35 Aligned_cols=52 Identities=17% Similarity=0.192 Sum_probs=43.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 19 FSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 19 l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
+...++..+..++++.+.-|-. .++||+||+.-|||+. .+ .+.++|||.|..
T Consensus 163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~--~p~iID~~QaV~ 215 (268)
T COG1718 163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG--EPYIIDVSQAVT 215 (268)
T ss_pred cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC--eEEEEECccccc
Confidence 3444788889999999998887 9999999999999997 33 389999997753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.002 Score=58.83 Aligned_cols=71 Identities=15% Similarity=0.129 Sum_probs=50.3
Q ss_pred CCCCCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC--CCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~--~~~~~kl~Dfg~a~~ 73 (268)
||||.|..+.+.-. +...++...+...+.++.. +.|-..|++|+|=.|.||+++.+ +..++.+.|||+...
T Consensus 281 ME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 281 MEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred EEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 89999988865532 2345666655554444432 33446789999999999999853 355799999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0044 Score=56.70 Aligned_cols=68 Identities=18% Similarity=0.213 Sum_probs=47.2
Q ss_pred CCCCCCCchhHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l--~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||+.|-.+.+.. +. ..++...+.....++. +..+-..|++|.|.+|.||+++.++ ++-+.|||+...
T Consensus 245 mE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g--~i~~lDfGi~g~ 314 (517)
T COG0661 245 MEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDG--RIVLLDFGIVGR 314 (517)
T ss_pred EEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCC--cEEEEcCcceec
Confidence 8999999887774 33 4455443333222221 2334448999999999999997664 599999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.015 Score=46.15 Aligned_cols=69 Identities=16% Similarity=0.104 Sum_probs=51.4
Q ss_pred CCCCCCchhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 2 EYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 2 Ey~~gg~L~~~---l~~~~~l~e~~~~~~~~qil~~L~~LH~---~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||...+++... +..--..++..+..++.++++.+++|+. ..+.-.|++|+|+-++.++. +|+.|.....
T Consensus 36 E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 36 EYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 55665555321 1122246899999999999999999997 34677999999999986554 9999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.14 Score=41.06 Aligned_cols=56 Identities=21% Similarity=0.228 Sum_probs=38.9
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC--EEEee
Q 024363 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICD 67 (268)
Q Consensus 7 g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~--~kl~D 67 (268)
-+|.+++.+ +.+++ .....+ -.-..||-..+|+.+||+|.||++.....+. +.|.|
T Consensus 108 ~TL~~~l~~-~~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 108 PTLEDYLKE-GGLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccHHHHHHc-CCccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 467777744 45666 333333 3445688999999999999999997655443 66776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.096 Score=44.73 Aligned_cols=28 Identities=32% Similarity=0.641 Sum_probs=23.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
.+++|+|+.+.||+++. + .+.|.||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECccc
Confidence 57899999999999975 3 3899999854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.044 Score=44.97 Aligned_cols=30 Identities=27% Similarity=0.264 Sum_probs=23.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.|.||+++.+. ..-|.||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 4589999999999997432 24699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.089 Score=45.04 Aligned_cols=30 Identities=33% Similarity=0.453 Sum_probs=24.9
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.+.||+++.++ .+.|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 6899999999999997654 25899998653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.11 Score=44.64 Aligned_cols=30 Identities=30% Similarity=0.392 Sum_probs=24.0
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.|.||+++.+. ..-|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 4899999999999997432 24799998764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.065 Score=46.05 Aligned_cols=52 Identities=25% Similarity=0.268 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHHHHHHH----cCCeecCCCCCcEEEcCCCC----------------CCEEEeecCCCCC
Q 024363 22 DEARFFFQQLISGVSYCHA----MQVCHRDLKLENTLLDGSPA----------------PRLKICDFGYSKS 73 (268)
Q Consensus 22 ~~~~~~~~qil~~L~~LH~----~~ivHrdlkp~Nili~~~~~----------------~~~kl~Dfg~a~~ 73 (268)
+-++.++.||+.-.-.+-+ .+.+|-||||+||||-.+.. -+++|.||.+|+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3466677788665444433 46999999999999943321 1345777777654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.15 Score=43.52 Aligned_cols=31 Identities=35% Similarity=0.614 Sum_probs=24.5
Q ss_pred CCeecCCCCCcEEEcCC--CCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~--~~~~~kl~Dfg~a~ 72 (268)
+++|+|+.|.||+++.+ ..+.++++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999753 01248999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.077 Score=43.35 Aligned_cols=31 Identities=26% Similarity=0.543 Sum_probs=24.7
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.+.||+++.. .+.+.+.||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~-~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEE-KNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCC-CCCEEEEEcccCC
Confidence 369999999999999752 1248999997664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.18 Score=40.20 Aligned_cols=32 Identities=22% Similarity=0.264 Sum_probs=25.3
Q ss_pred cCCeecCCCCCcEEEcCCCCC---CEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~---~~kl~Dfg~a~ 72 (268)
..++|||+.+.||++..++.+ .+.+.||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 468999999999999754432 48999998664
|
subfamily of choline kinases |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.027 Score=51.13 Aligned_cols=84 Identities=15% Similarity=0.159 Sum_probs=55.3
Q ss_pred cccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC-------CCCCCCHHHHHHHHHccccCCCCCCCH
Q 024363 103 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-------DTNPISQECRDLISRIFVADPAARITI 175 (268)
Q Consensus 103 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~l~~dp~~R~s~ 175 (268)
+++||||+|.++.++..|...+......+... .+.++........ ..-.++..+..+..+|+...|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~-~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLE-ILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHH-HHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 35999999999999998876665444333222 2222211111000 001145678899999999999999999
Q ss_pred HHHhcccccCCC
Q 024363 176 PEIMKHQWFLKN 187 (268)
Q Consensus 176 ~e~l~h~~~~~~ 187 (268)
.++.+++-|...
T Consensus 189 ~~~~k~~i~~ev 200 (725)
T KOG1093|consen 189 MELSKRCSFTEV 200 (725)
T ss_pred hHHhcCccHHHH
Confidence 999999888543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.066 Score=46.24 Aligned_cols=51 Identities=27% Similarity=0.317 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHHHHHH----HcCCeecCCCCCcEEEcCCCC----------------CCEEEeecCCCCCC
Q 024363 24 ARFFFQQLISGVSYCH----AMQVCHRDLKLENTLLDGSPA----------------PRLKICDFGYSKSS 74 (268)
Q Consensus 24 ~~~~~~qil~~L~~LH----~~~ivHrdlkp~Nili~~~~~----------------~~~kl~Dfg~a~~~ 74 (268)
++.++.|++.-.--+- ..+.+|-||||+||||-.+.. -+++|.||.+|+..
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 5556666644321122 346999999999999943222 13578888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.15 Score=43.34 Aligned_cols=30 Identities=33% Similarity=0.442 Sum_probs=24.1
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.|.||+++.+. .+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence 4799999999999997543 25799998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.1 Score=41.25 Aligned_cols=29 Identities=24% Similarity=0.393 Sum_probs=24.1
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
..+|+|+.|.||+++.++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 369999999999996543 89999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.18 Score=40.46 Aligned_cols=40 Identities=25% Similarity=0.290 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 25 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 25 ~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
..-+.+|++-|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---C----CEEEecccC
Confidence 344567888899999999999999999975 2 299999854
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.86 E-value=0.065 Score=43.26 Aligned_cols=30 Identities=37% Similarity=0.429 Sum_probs=19.0
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
..++|+|+.|.||+++..+ +++.|.||+.+
T Consensus 166 ~~~~HgD~~~~Nil~~~~~-~~i~iID~e~a 195 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSD-GRIGIIDFEDA 195 (239)
T ss_dssp EEEE-SS-SGGGEEEESST-TEEEE--GTT-
T ss_pred cEEEEeccccccceeeecc-ceeEEEecccc
Confidence 5699999999999998222 23579999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=91.96 E-value=0.15 Score=42.43 Aligned_cols=28 Identities=25% Similarity=0.388 Sum_probs=23.9
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++|+|+.|.||+++.++ +.|.||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 589999999999997644 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.90 E-value=0.31 Score=41.00 Aligned_cols=49 Identities=24% Similarity=0.295 Sum_probs=34.8
Q ss_pred HHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 22 DEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 22 ~~~~~~~~qil~~L~~LH~~--~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..+...+..+-.++.-++.. -++|+|+.|+|++.+..+ .++|+||-.|.
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~--~l~LIDWEyAg 182 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG--GLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC--cEEEEecccCC
Confidence 33444555555555555554 589999999999997634 49999998764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.16 Score=41.57 Aligned_cols=28 Identities=21% Similarity=0.283 Sum_probs=23.3
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++|+|+.|.||+++.++ +.+.||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 478999999999996533 7899998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=91.59 E-value=0.16 Score=41.80 Aligned_cols=30 Identities=27% Similarity=0.289 Sum_probs=24.0
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|+.|.||+++.+. .+.|.||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~--~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGK--FSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCc--EEEEEEccccc
Confidence 3589999999999997643 36799998663
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.44 E-value=0.33 Score=42.06 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=23.8
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
+||+|+.|.||+++.... .+.+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 999999999999976543 36899998654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.51 Score=41.36 Aligned_cols=52 Identities=29% Similarity=0.376 Sum_probs=42.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 19 FSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 19 l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
-..+++..++.+.+..+.-+.++ ..-||++...||+|+ .| +|.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G--nvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG--NVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC--ceEEEEeeeeec
Confidence 35778888888888877777655 588999999999997 34 499999999874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.42 Score=40.95 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=24.4
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
+++|+|+.+.|++++.++. +.+.||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 7999999999999976544 8899997664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.96 E-value=0.32 Score=48.54 Aligned_cols=33 Identities=24% Similarity=0.294 Sum_probs=25.6
Q ss_pred HcCCeecCCCCCcEEEcCCCCCC---EEEeecCCCC
Q 024363 40 AMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSK 72 (268)
Q Consensus 40 ~~~ivHrdlkp~Nili~~~~~~~---~kl~Dfg~a~ 72 (268)
..++||+|+.+.||+++.+..+. .-|.|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 46899999999999997653222 3799999764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=90.92 E-value=0.34 Score=42.35 Aligned_cols=31 Identities=29% Similarity=0.689 Sum_probs=24.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|+++.||+++... +.+.+.||..|.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 3589999999999997432 359999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.39 Score=48.10 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEE-EeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~k-l~Dfg~a~ 72 (268)
.++||+|+.+.||+++.+...++. |.|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 579999999999999866433455 99999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.21 E-value=0.21 Score=40.23 Aligned_cols=30 Identities=33% Similarity=0.682 Sum_probs=18.5
Q ss_pred cCCeecCCCCCcEEE-cCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili-~~~~~~~~kl~Dfg~a~ 72 (268)
..+.|+|+.|.||++ +.++ .++++||-.|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~--~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDG--EVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSS--CEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCC--eEEEecHHHHh
Confidence 358999999999999 4343 49999998663
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.08 E-value=0.54 Score=39.82 Aligned_cols=47 Identities=15% Similarity=0.275 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHHHHH------cCCeecCCCCCcEEEcCCCCC---CEEEeecCCCC
Q 024363 26 FFFQQLISGVSYCHA------MQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 72 (268)
Q Consensus 26 ~~~~qil~~L~~LH~------~~ivHrdlkp~Nili~~~~~~---~~kl~Dfg~a~ 72 (268)
.+...+...+..+.. +-++|+|+++.|||+..++.+ .+++.||.+++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 194 ALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred HHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 334444444444441 239999999999999766543 58999997654
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=89.95 E-value=0.74 Score=39.85 Aligned_cols=43 Identities=14% Similarity=0.237 Sum_probs=33.2
Q ss_pred HHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 26 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 26 ~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
.+...+..-+.-|...|+||+|..--||++..++. ++++||-.
T Consensus 206 ~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQ 248 (465)
T KOG2268|consen 206 TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQ 248 (465)
T ss_pred HHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeechH
Confidence 34444455556688999999999999999976554 99999953
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=89.44 E-value=0.3 Score=41.24 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.5
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++|+|++|.||+++.++. ..-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999975322 24699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.96 E-value=0.5 Score=38.60 Aligned_cols=36 Identities=25% Similarity=0.236 Sum_probs=29.7
Q ss_pred HHHHHHHHH--cCCeecCCCCCcEEEcCCCCCCEEEeecC
Q 024363 32 ISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFG 69 (268)
Q Consensus 32 l~~L~~LH~--~~ivHrdlkp~Nili~~~~~~~~kl~Dfg 69 (268)
+++|.-.|+ .+.+|+|..|+||+-+..+. +||.|-+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChh
Confidence 467888884 46999999999999976665 9999875
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.77 E-value=0.48 Score=40.79 Aligned_cols=31 Identities=16% Similarity=0.290 Sum_probs=26.2
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
.++|+|+++.|++|+.... +=|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP--TGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCe--eEEEeccccccC
Confidence 5899999999999976554 889999988643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.40 E-value=2 Score=37.13 Aligned_cols=28 Identities=18% Similarity=0.213 Sum_probs=22.9
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+.+.||+++ + . +.+.||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~--~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G--PHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-C--cEEEeCCCCC
Confidence 4689999999999994 3 2 6899998653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=85.94 E-value=1.6 Score=37.80 Aligned_cols=29 Identities=31% Similarity=0.500 Sum_probs=23.7
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
++|+|+.+.||+++.++ +.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 79999999999996432 249999998764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.88 E-value=0.68 Score=41.27 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=24.4
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 40 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 40 ~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
...++|||+.+.||+++.+. ++++||-++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~~---~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEEE---TKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCCC---cEEEeccccc
Confidence 34699999999999997553 8999997654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=83.60 E-value=0.83 Score=40.63 Aligned_cols=29 Identities=17% Similarity=0.290 Sum_probs=24.1
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+||.|.|||++.+. .|+.|.-+|.
T Consensus 227 ~aLlHGDlHtGSI~v~~~~---~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKNDS---TKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCCc---eEEEcccccc
Confidence 4599999999999997654 7999987664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=83.36 E-value=0.76 Score=40.30 Aligned_cols=30 Identities=20% Similarity=0.247 Sum_probs=24.2
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 40 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 40 ~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
...++|+|+.+.||+++... +++.|+..+.
T Consensus 191 ~~~llHGDl~~gNi~~~~~~---~~~iD~e~~~ 220 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE---TKVIDPEFAF 220 (370)
T ss_pred cceeeeccCCcccEEEcCCC---CEEEcCcccc
Confidence 35699999999999996543 6899997654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=83.05 E-value=2.2 Score=37.65 Aligned_cols=53 Identities=26% Similarity=0.261 Sum_probs=43.1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 17 GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 17 ~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
-.++...+..+-.|++.-+.-|.+ .++||.||.--|+|+.. |.+.++|.+.|.
T Consensus 259 ~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd---G~lyiIDVSQSV 312 (520)
T KOG2270|consen 259 ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD---GKLYIIDVSQSV 312 (520)
T ss_pred ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC---CEEEEEEccccc
Confidence 357788888888899888888765 57999999999999953 248999987654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.66 E-value=5.4 Score=35.83 Aligned_cols=56 Identities=14% Similarity=0.070 Sum_probs=38.4
Q ss_pred CCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEEcCC
Q 024363 2 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGS 58 (268)
Q Consensus 2 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~-LH~~~ivHrdlkp~Nili~~~ 58 (268)
+|..|-++..+++. ...+|..++.++.--..||-- |--.+++|.|+.|.||++.-.
T Consensus 325 ~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 325 TYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 46777777777743 345666666666655565443 445689999999999999543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 268 | ||||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-118 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-117 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-117 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-116 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-116 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-111 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-39 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-37 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-37 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-36 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-36 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-36 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-36 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-36 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-35 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-35 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-34 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-34 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-34 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-30 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-30 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-30 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-30 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-30 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-30 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-30 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-30 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-30 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-30 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-30 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-30 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-30 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-30 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-30 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-30 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-30 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-30 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-30 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-30 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-30 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-30 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-30 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-30 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-30 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-30 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-30 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-30 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-30 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-30 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-30 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-30 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-30 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-30 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-30 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-30 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-30 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-30 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-30 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-29 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-28 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-28 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-28 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-28 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-28 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-28 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-28 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-28 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-27 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-27 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-27 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-27 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-27 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-27 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-27 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-27 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-27 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-27 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-27 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-27 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-27 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-27 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-26 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-26 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-26 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-26 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-25 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-25 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-25 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-24 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-23 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-23 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-23 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-23 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-23 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-23 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-23 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-23 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-23 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-23 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-23 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-23 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-23 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-23 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-23 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-23 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-23 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-23 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-23 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-23 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-23 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-23 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-23 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-23 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-21 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-20 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-20 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-20 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-20 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-20 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-20 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-20 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-20 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-20 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-20 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-20 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-20 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-20 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-20 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-20 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-19 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-17 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-04 |
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-155
Identities = 221/268 (82%), Positives = 244/268 (91%), Gaps = 1/268 (0%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPA
Sbjct: 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
YPFEDP+EP+D+RKTIQRILSV+YS+PD IS EC LISRIFVADPA RI+IPEI
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240
H WFLKNLPADL++E SQ++EP+QPMQS+D IMQII+EA+IPAV L+ +MTDNL
Sbjct: 275 HSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNL 334
Query: 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268
D+ DDDMDD DSESE+DIDSSGEI+YAL
Sbjct: 335 DL-DDDMDDFDSESEIDIDSSGEIVYAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-109
Identities = 78/235 (33%), Positives = 115/235 (48%), Gaps = 12/235 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY SGGELF+RI E +A+ FF QL++GV Y H + + HRD+K EN LLD
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-- 141
Query: 61 PRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
LKI DFG + +++ GT Y+APE+L R E+ + DVWSCG+ L M
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
L G P++ P + + + + I L+ +I V +P+ARITIP+
Sbjct: 202 LAGELPWDQPSDSC---QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEEP----DQPMQSVDVIMQIIAEASIPAVG 228
I K +W+ K L + S E + +QS + + + P G
Sbjct: 259 IKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSG 313
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-105
Identities = 72/196 (36%), Positives = 107/196 (54%), Gaps = 10/196 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY SGGELF+RI E +A+ FF QL++GV Y H + + HRD+K EN LLD
Sbjct: 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-- 141
Query: 61 PRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
LKI DFG + +++ GT Y+APE+L R E+ + DVWSCG+ L M
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 118 LVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
L G P++ P + +++ ++ + + I L+ +I V +P+ARITIP
Sbjct: 202 LAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPLALLHKILVENPSARITIP 257
Query: 177 EIMKHQWFLKNLPADL 192
+I K +W+ K L
Sbjct: 258 DIKKDRWYNKPLKKGA 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 3e-86
Identities = 83/195 (42%), Positives = 109/195 (55%), Gaps = 8/195 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY SGGELF+ IC GR E EAR FQQ++S V YCH V HRDLK EN LLD
Sbjct: 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-- 147
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
KI DFG S +++ G+P Y APEV+ Y G D+WSCGV LY +L G
Sbjct: 148 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+D P F+K I + +P+ +++ L+ + DP R TI +I +
Sbjct: 208 TLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMHMLQVDPLKRATIKDIRE 261
Query: 181 HQWFLKNLPADLVDE 195
H+WF ++LP+ L E
Sbjct: 262 HEWFKQDLPSYLFPE 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 7e-85
Identities = 79/217 (36%), Positives = 112/217 (51%), Gaps = 12/217 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYASGGE+F+ + GR E EAR F+Q++S V YCH ++ HRDLK EN LLD
Sbjct: 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-- 150
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG+S + + + G P Y APE+ +YDG DVWS GV LY ++ G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+ + + + +L +Y +P +S +C +L+ R V +P R T+ +IMK
Sbjct: 211 SLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMK 264
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQ 217
+W D + E D Q IM
Sbjct: 265 DRWINAGHEEDELK----PFVEPELDISDQKRIDIMV 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-84
Identities = 85/216 (39%), Positives = 111/216 (51%), Gaps = 8/216 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY SGGELF+ IC GR E E+R FQQ++SGV YCH V HRDLK EN LLD
Sbjct: 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-- 152
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
KI DFG S +++ G+P Y APEV+ Y G D+WS GV LY +L G
Sbjct: 153 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+D P F+K I + P ++ L+ + DP R TI +I +
Sbjct: 213 TLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIM 216
H+WF ++LP L E S D+ ++ V
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 8e-84
Identities = 72/193 (37%), Positives = 101/193 (52%), Gaps = 18/193 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E + G + E + SED+ARF+FQ LI G+ Y H ++ HRD+K N L+
Sbjct: 117 FELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-- 173
Query: 61 PRLKICDFGYS-----KSSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVT 113
+KI DFG S ++L +TVGTPA++APE L R + GK DVW+ GVT
Sbjct: 174 GHIKIADFGVSNEFKGSDALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY + G PF D K I S PD I+++ +DLI+R+ +P +RI
Sbjct: 230 LYCFVFGQCPFMDERIMCLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI 285
Query: 174 TIPEIMKHQWFLK 186
+PEI H W +
Sbjct: 286 VVPEIKLHPWVTR 298
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-82
Identities = 92/207 (44%), Positives = 118/207 (57%), Gaps = 9/207 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EYA GGELF+ I R +EDE R FFQQ+I + YCH ++ HRDLK EN LLD +
Sbjct: 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-- 144
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG S + K++ G+P Y APEV+ Y G DVWSCG+ LYVMLVG
Sbjct: 145 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+D P F+K + S Y +PD +S + LI R+ VADP RITI EI +
Sbjct: 205 RLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRRMIVADPMQRITIQEIRR 258
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQ 207
WF NLP L + + Y +
Sbjct: 259 DPWFNVNLPDYLRPMEEVQGSYADSRI 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-82
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E GE+ + N FSE+EAR F Q+I+G+ Y H+ + HRDL L N LL +
Sbjct: 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN- 148
Query: 60 APRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG + + + T+ GTP YI+PE+ R + + +DVWS G Y +L
Sbjct: 149 -MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLL 206
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
+G PF+ K ++ Y +P +S E +DLI ++ +PA R+++ +
Sbjct: 207 IGRPPFDTDTVKNTLNK----VVLADYEMPSF--LSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 179 MKHQWFLKNLPADLVDE 195
+ H + +N DE
Sbjct: 261 LDHPFMSRNSSTKSKDE 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-82
Identities = 66/194 (34%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E L E +E EAR++ +Q++ G Y H +V HRDLKL N L+
Sbjct: 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-- 151
Query: 61 PRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG + + K + GTP YIAPEVL + + + DVWS G +Y +LV
Sbjct: 152 LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLV 210
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G PFE + + + I +YS+P I+ LI ++ DP AR TI E++
Sbjct: 211 GKPPFETSCLKETYLR----IKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELL 264
Query: 180 KHQWFLKN-LPADL 192
++F +PA L
Sbjct: 265 NDEFFTSGYIPARL 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 4e-82
Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 16/225 (7%)
Query: 1 MEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
MEY G E+ + + RF +A +F QLI G+ Y H+ + H+D+K N LL
Sbjct: 87 MEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145
Query: 59 PAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTL 114
LKI G +++ + +++ G+PA+ PE+ + G D+WS GVTL
Sbjct: 146 --GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
Y + G YPFE + K F I Y++P DL+ + +PA R +
Sbjct: 204 YNITTGLYPFEGDNIYKLFEN----IGKGSYAIPGD--CGPPLSDLLKGMLEYEPAKRFS 257
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSS-QYEEPDQPMQSVDVIMQI 218
I +I +H WF K P S ++ + M V + +
Sbjct: 258 IRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 7e-82
Identities = 62/189 (32%), Positives = 97/189 (51%), Gaps = 10/189 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E+A GEL++ + GRF E + F ++L + YCH +V HRD+K EN L+
Sbjct: 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-- 150
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG+S + + ++ GT Y+ PE++ +D K D+W GV Y LVG
Sbjct: 151 GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVG 208
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PF+ P + R+ I++V P +S +DLIS++ P R+ + +M+
Sbjct: 209 MPPFDSPSHTETHRR----IVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVME 262
Query: 181 HQWFLKNLP 189
H W N
Sbjct: 263 HPWVKANSR 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-81
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EYA G ++ + +F E + +L + +SYCH+ +V HRD+K EN LL +
Sbjct: 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-- 145
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG+S S+ GT Y+ PE++ +D K D+WS GV Y LVG
Sbjct: 146 GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 203
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PFE +T +RI V+++ PD +++ RDLISR+ +P+ R + E+++
Sbjct: 204 KPPFEANTYQ----ETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 181 HQWFLKNLPADLVDEKTMSSQYEEPDQ 207
H W N + + E +
Sbjct: 258 HPWITANSS-----KPSNCQNKESASK 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 4e-81
Identities = 68/194 (35%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+E L E +E EAR++ +Q++ G Y H +V HRDLKL N L+
Sbjct: 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-- 177
Query: 61 PRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG + + K + GTP YIAPEVL + + + DVWS G +Y +LV
Sbjct: 178 LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLV 236
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G PFE ++T RI +YS+P I+ LI ++ DP AR TI E++
Sbjct: 237 GKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAASLIQKMLQTDPTARPTINELL 290
Query: 180 KHQWFLKN-LPADL 192
++F +PA L
Sbjct: 291 NDEFFTSGYIPARL 304
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-79
Identities = 68/211 (32%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 1 MEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E +LF+ I G E+ AR FF Q++ V +CH V HRD+K EN L+D +
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186
Query: 60 APRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
LK+ DFG K +V GT Y PE + H Y G+ A VWS G+ LY
Sbjct: 187 G-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
M+ G PFE + I+ Q +S EC+ LI P+ R T
Sbjct: 242 MVCGDIPFEHDE----------EIIRGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFE 289
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 207
EI H W L E + S P +
Sbjct: 290 EIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-78
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 1 MEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E +LF+ I G E +R FF Q+++ + +CH+ V HRD+K EN L+D
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 60 APRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
K+ DFG GT Y PE + RH+Y A VWS G+ LY
Sbjct: 177 G-CAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
M+ G PFE Q IL + P +S +C LI R P++R ++
Sbjct: 232 MVCGDIPFER----------DQEILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 177 EIMKHQWFLKNLPADLVD 194
EI+ W ++
Sbjct: 280 EILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-75
Identities = 50/222 (22%), Positives = 79/222 (35%), Gaps = 39/222 (17%)
Query: 1 MEYASGGELFERICNAG--------RFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLE 51
EY + + + + +++ SY H +CHRD+K
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 52 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADV 107
N L+D + R+K+ DFG S+ + + GT ++ PE Y+G D+
Sbjct: 182 NILMDKNG--RVKLSDFGESEYMVDKKIKG----SRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 108 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--------------- 152
WS G+ LYVM PF + I + P
Sbjct: 236 WSLGICLYVMFYNVVPFSLKI---SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 153 --ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 192
+S E D + +PA RIT + +KH+W DL
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-75
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 1 ME-YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME + SG +LF I R E A + F+QL+S V Y + HRD+K EN ++
Sbjct: 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED- 166
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + + GT Y APEVL+ + Y G ++WS GVTLY ++
Sbjct: 167 -FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
PF + +E + P +S+E L+S + P R T+ +++
Sbjct: 226 EENPFCELEE----------TVEAAIHPP--YLVSKELMSLVSGLLQPVPERRTTLEKLV 273
Query: 180 KHQWFLK--NLPADLVDEKTMSSQYEEPD 206
W + NL +E + +P+
Sbjct: 274 TDPWVTQPVNLADYTWEEVF---RVNKPE 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-70
Identities = 71/193 (36%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
ME +GGELFER+ + F E +A + ++S V+YCH + V HRDLK EN L SP
Sbjct: 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LK+ DFG + ++ VGTP Y++P+VL Y G D WS GV +YV+L
Sbjct: 145 DSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLC 202
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF P + + K I ++ P+ +S + LI R+ P RIT +
Sbjct: 203 GYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQ 258
Query: 178 IMKHQWFLKNLPA 190
++H+WF K L +
Sbjct: 259 ALEHEWFEKQLSS 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-69
Identities = 64/189 (33%), Positives = 94/189 (49%), Gaps = 8/189 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
+E GGELF+++ R E + +F Q++ V Y H + HRDLK EN LL
Sbjct: 93 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVM 117
+KI DFG+SK S ++ GTP Y+APEVL+ + D WS GV L++
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 175
L G PF + +I S +Y+ +S++ DL+ ++ V DP AR T
Sbjct: 213 LSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 269
Query: 176 PEIMKHQWF 184
E ++H W
Sbjct: 270 EEALRHPWL 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-68
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
+ +GGELFE I +SE +A QQ++ ++YCH+ + HR+LK EN LL +
Sbjct: 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + GTP Y++PEVL + Y K D+W+CGV LY++LV
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLV 202
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF D D+ + + + I + Y P + ++ E + LI + +P RIT +
Sbjct: 203 GYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 178 IMKHQWFLKNLPAD 191
+K W
Sbjct: 259 ALKVPWICNRERVA 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-68
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
+E GGELF+++ R E + +F Q++ V Y H + HRDLK EN LL
Sbjct: 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVM 117
+KI DFG+SK S ++ GTP Y+APEVL+ + D WS GV L++
Sbjct: 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 175
L G PF + + +I S +Y+ +S++ DL+ ++ V DP AR T
Sbjct: 338 LSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 394
Query: 176 PEIMKHQWF----LKNLPADLVDEK 196
E ++H W +K DL+ E+
Sbjct: 395 EEALRHPWLQDEDMKRKFQDLLSEE 419
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-67
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 1 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
ME GGEL ERI SE +Q+++ ++Y H+ V H+DLK EN L
Sbjct: 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158
Query: 57 G-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
SP +KI DFG ++ + GT Y+APEV + + K D+WS GV +Y
Sbjct: 159 DTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FKRDVTFK-CDIWSAGVVMY 216
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVADPAARIT 174
+L G PF + +K + + + P++ + DL+ ++ DP R +
Sbjct: 217 FLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
Query: 175 IPEIMKHQWF 184
+++ H+WF
Sbjct: 273 AAQVLHHEWF 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-67
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ GELF+ + SE E R + L+ + H + + HRDLK EN LLD
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-- 160
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLY 115
+K+ DFG+S + + GTP+Y+APE++ D GK D+WS GV +Y
Sbjct: 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARI 173
+L G PF + R I+S Y + S +DL+SR V P R
Sbjct: 221 TLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 174 TIPEIMKHQWFLKNLPADL 192
T E + H +F + + ++
Sbjct: 277 TAEEALAHPFFQQYVVEEV 295
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-66
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 21/213 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME +L + E + +++ ++ V H + H DLK N L+
Sbjct: 107 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 163
Query: 61 PRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYD----------GKIADV 107
LK+ DFG + S VGT Y+ PE + +DV
Sbjct: 164 -MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 108 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
WS G LY M G PF+ + I+ + + + ++ +D++
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 168 DPAARITIPEIMKHQWFLKNL-PADLVDEKTMS 199
DP RI+IPE++ H + P + + + T
Sbjct: 280 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-66
Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 13/193 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ GELF+ + SE E R + L+ VS+ HA + HRDLK EN LLD +
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-M 237
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLY 115
+++ DFG+S + + GTP Y+APE+L + GK D+W+CGV L+
Sbjct: 238 Q-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARI 173
+L G PF + R I+ QY + S +DLISR+ DP AR+
Sbjct: 297 TLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
Query: 174 TIPEIMKHQWFLK 186
T + ++H +F +
Sbjct: 353 TAEQALQHPFFER 365
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-66
Identities = 43/223 (19%), Positives = 84/223 (37%), Gaps = 35/223 (15%)
Query: 1 MEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
ME+ G L+ + NA E E + ++ G+++ + HR++K N +
Sbjct: 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 58 SPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-------GKIADVW 108
+ K+ DFG ++ Q S GT Y+ P++ R G D+W
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 109 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-------------------VPD 149
S GVT Y G PF + P+ ++ + +I++ + S +P
Sbjct: 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267
Query: 150 TNPISQECRD----LISRIFVADPAARITIPEIMKHQWFLKNL 188
+ +S+ + +++ I AD + + +
Sbjct: 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-66
Identities = 46/226 (20%), Positives = 82/226 (36%), Gaps = 20/226 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME +L + E + +++ ++ V H + H DLK N L+
Sbjct: 88 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 144
Query: 61 PRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYD----------GKIADV 107
LK+ DFG + S VGT Y+ PE + +DV
Sbjct: 145 -MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203
Query: 108 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
WS G LY M G PF+ + I+ + + + ++ +D++
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 260
Query: 168 DPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 213
DP RI+IPE++ H + K + + + + ++
Sbjct: 261 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN 306
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-66
Identities = 70/195 (35%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
M+ SGGELF+RI G ++E +A QQ++S V Y H + HRDLK EN L
Sbjct: 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE 144
Query: 60 APRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++ I DFG SK + + + GTP Y+APEVL + Y K D WS GV Y++L
Sbjct: 145 NSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILL 201
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIP 176
G PF + E K F K I Y + IS+ +D I + DP R T
Sbjct: 202 CGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCE 257
Query: 177 EIMKHQWFLKNLPAD 191
+ + H W N
Sbjct: 258 KALSHPWIDGNTALH 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 2e-65
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+E SGGELF+ + SE+EA F +Q++ GV+Y H ++ H DLK EN +L
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P P +K+ DFG + + K+ GTP ++APE++ G AD+WS GV Y++L
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 212
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIP 176
G PF + ++T+ I SV Y + + S+ +D I ++ V + R+TI
Sbjct: 213 SGASPFLGDTK----QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYE 203
E ++H W + + E
Sbjct: 269 EALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-65
Identities = 71/190 (37%), Positives = 102/190 (53%), Gaps = 9/190 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
E +GGELF+ I RFSE +A +Q+ SG++Y H + HRDLK EN LL+
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG S +++ K +GT YIAPEVL YD K DVWS GV LY++L
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLS 217
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF +E ++ + + +Y+ IS + +DLI ++ P+ RIT +
Sbjct: 218 GTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273
Query: 178 IMKHQWFLKN 187
++H W K
Sbjct: 274 CLEHPWIQKY 283
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-65
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
+ +GGELFE I +SE +A QQ++ ++YCH+ + HR+LK EN LL +
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 166
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + GTP Y++PEVL + Y K D+W+CGV LY++LV
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLV 225
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF D D+ + + + I + Y P + ++ E + LI + +P RIT +
Sbjct: 226 GYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 281
Query: 178 IMKHQWFLKNLPAD 191
+K W
Sbjct: 282 ALKVPWICNRERVA 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-65
Identities = 71/197 (36%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
ME +GGELFERI FSE EA + ++L+S VS+ H + V HRDLK EN L D +
Sbjct: 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND 144
Query: 60 APRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG+++ +QP K+ T Y APE+L ++ YD + D+WS GV LY ML
Sbjct: 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTML 203
Query: 119 VGGYPFEDPDEPKDFRKTI---QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARI 173
G PF+ D + ++I +S +SQE +DLI + DP R+
Sbjct: 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
Query: 174 TIPEIMKHQWFLKNLPA 190
+ + ++W
Sbjct: 264 KMSGLRYNEWLQDGSQL 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-65
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+E SGGELF+ + SE+EA F +Q++ GV+Y H ++ H DLK EN +L
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P P +K+ DFG + + K+ GTP ++APE++ G AD+WS GV Y++L
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 212
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIP 176
G PF + ++T+ I +V Y + + S+ +D I ++ V + R+TI
Sbjct: 213 SGASPFLGDTK----QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYE 203
E ++H W + + E
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-65
Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
+E +GGELF+ + +E+EA F +Q+++GV Y H++Q+ H DLK EN +L
Sbjct: 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 152
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P PR+KI DFG + ++ K+ GTP ++APE++ G AD+WS GV Y++L
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 211
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIP 176
G PF + ++T+ + +V Y D + S +D I R+ V DP R+TI
Sbjct: 212 SGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYEE 204
+ ++H W + K + E+
Sbjct: 268 DSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-65
Identities = 45/226 (19%), Positives = 82/226 (36%), Gaps = 20/226 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME +L + E + +++ ++ V H + H DLK N L+
Sbjct: 135 MECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-- 191
Query: 61 PRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYD----------GKIADV 107
LK+ DFG + + S VG Y+ PE + +DV
Sbjct: 192 -MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 108 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
WS G LY M G PF+ + I+ + + + ++ +D++
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 168 DPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 213
DP RI+IPE++ H + K + + + + ++
Sbjct: 308 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN 353
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-64
Identities = 65/188 (34%), Positives = 101/188 (53%), Gaps = 9/188 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+E SGGELF+ + +EDEA F +Q++ GV Y H+ ++ H DLK EN +L
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNV 146
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P PR+K+ DFG + ++ K+ GTP ++APE++ G AD+WS GV Y++L
Sbjct: 147 PNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILL 205
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIP 176
G PF + + I +V Y + + S+ +D I R+ V DP R+TI
Sbjct: 206 SGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIA 261
Query: 177 EIMKHQWF 184
+ ++H W
Sbjct: 262 QSLEHSWI 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-64
Identities = 69/190 (36%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP- 59
E GGEL ++I FSE EA + V Y HA V HRDLK N L
Sbjct: 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154
Query: 60 -APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
++ICDFG++K + T T ++APEVL R YD D+WS GV LY M
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTM 213
Query: 118 LVGGYPFEDPDEPKDFRKTI-QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARIT 174
L G PF + P D + I RI S ++S+ N +S +DL+S++ DP R+T
Sbjct: 214 LTGYTPFA--NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 175 IPEIMKHQWF 184
+++H W
Sbjct: 272 AALVLRHPWI 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 5e-64
Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
+E +GGELF+RI G +SE +A +Q++ V+Y H + HRDLK EN L +P
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LKI DFG SK K+ GTP Y APE+L Y G D+WS G+ Y++L
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLC 245
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF D + +RIL+ +Y + +S +DL+ ++ V DP R+T +
Sbjct: 246 GFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 178 IMKHQWFLKNLPADLVDEKTMS 199
++H W + +
Sbjct: 303 ALQHPWVTGKAANFVHMDTAQK 324
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-64
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 1 MEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DG 57
+EYA+GGE+F A SE++ +Q++ GV Y H + H DLK +N LL
Sbjct: 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
P +KI DFG S+ + + +GTP Y+APE+L D+W+ G+ Y++
Sbjct: 168 YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYML 226
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 175
L PF D + + I V + + +SQ D I + V +P R T
Sbjct: 227 LTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSS 200
+ H W + +L + SS
Sbjct: 283 EICLSHSWLQQWDFENLFHPEETSS 307
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-64
Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 8/207 (3%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY GGELF+RI + +E + F +Q+ G+ + H M + H DLK EN L
Sbjct: 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
A ++KI DFG ++ + K GTP ++APEV + +++ D+WS GV Y++L
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLS 283
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF ++ +T+ IL+ ++ + D IS+E ++ IS++ + + + RI+ E
Sbjct: 284 GLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASE 339
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEE 204
+KH W + + + ++ +
Sbjct: 340 ALKHPWLSDHKLHSRLSAQKKKNRGSD 366
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-64
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DG 57
ME GGELF RI G F+E EA + + + + + H+ + HRD+K EN L
Sbjct: 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK 164
Query: 58 SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
LK+ DFG++K ++ TP Y+APEVL +YD K D+WS GV +Y+
Sbjct: 165 EKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYI 221
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARIT 174
+L G PF +RI QY P+ + +S++ + LI + DP R+T
Sbjct: 222 LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQ 217
I + M H W +++ P P+ + V+ +
Sbjct: 282 ITQFMNHPWINQSMVV--------------PQTPLHTARVLQE 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-63
Identities = 44/256 (17%), Positives = 94/256 (36%), Gaps = 35/256 (13%)
Query: 1 MEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
ME+ G L+ + NA E E + ++ G+++ + HR++K N +
Sbjct: 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 58 SPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-------GKIADVW 108
+ K+ DFG ++ Q S GT Y+ P++ R G D+W
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 109 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-------------------VPD 149
S GVT Y G PF + P+ ++ + +I++ + S +P
Sbjct: 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267
Query: 150 TNPISQECRD----LISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 205
+ +S+ + +++ I AD + + + V + ++
Sbjct: 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIY 327
Query: 206 DQPMQSVDVIMQIIAE 221
+ + +++ +
Sbjct: 328 IHSYNTATIFHELVYK 343
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-63
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 1 MEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L++ I + DE F+Q++ +SY H+ + HRDLK N +D S
Sbjct: 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES- 152
Query: 60 APRLKICDFGYSKS---------------SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 104
+KI DFG +K+ S +GT Y+A EVL + +
Sbjct: 153 -RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLIS 162
D++S G+ + M+ YPF E ++++ SV P + + + +I
Sbjct: 212 IDMYSLGIIFFEMI---YPFSTGMERV---NILKKLRSVSIEFPPDFDDNKMKVEKKIIR 265
Query: 163 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 199
+ DP R ++ W +++ E S
Sbjct: 266 LLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKS 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-62
Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 52/235 (22%)
Query: 1 MEYASGGELFERICNAGR----------------------------------------FS 20
ME GG L +++
Sbjct: 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166
Query: 21 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80
E +Q+ S + Y H +CHRD+K EN L + + +K+ DFG SK +
Sbjct: 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 81 -----KSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 134
+ GTP ++APEVL G D WS GV L+++L+G PF ++
Sbjct: 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS 286
Query: 135 KTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187
+ +L+ + + N +S RDL+S + + R ++H W +
Sbjct: 287 Q----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-62
Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 8/187 (4%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ SG ++FERI + +E E + Q+ + + H+ + H D++ EN +
Sbjct: 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ +KI +FG ++ + P Y APEV D+WS G +YV+L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLS 198
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF ++ I+ I++ +Y+ + IS E D + R+ V + +R+T E
Sbjct: 199 GINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 178 IMKHQWF 184
++H W
Sbjct: 255 ALQHPWL 261
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-62
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DG 57
ME GGELF RI + G F+E EA + + + Y H++ + HRD+K EN L
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 197
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
P LK+ DFG++K + H+ + TP Y+APEVL +YD K D+WS GV +Y++
Sbjct: 198 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYIL 256
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 175
L G PF RI QY P+ + +S+E + LI + +P R+TI
Sbjct: 257 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 176 PEIMKHQWFLKNLPA 190
E M H W +++
Sbjct: 317 TEFMNHPWIMQSTKV 331
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-62
Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 5/202 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
E +GGELF+ I RFSE +A +Q+ SG++Y H + HRDLK EN LL+
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG S +++ K +GT YIAPEVL YD K DVWS GV LY++L
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLS 217
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G PF +E ++ ++ + +P IS + +DLI ++ P+ RIT + +
Sbjct: 218 GTPPFYGKNEYDILKR-VETG-KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 180 KHQWFLKNLPADLVDEKTMSSQ 201
+H W K S +
Sbjct: 276 EHPWIQKYSSETPTISDLPSLE 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-62
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 8/193 (4%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E+ SGGELF+RI + SE E + +Q G+ + H + H D+K EN + +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
A +KI DFG + K T T + APE++ R G D+W+ GV YV+L
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLS 245
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF D+ +T+Q + + + + +S E +D I + +P R+T+ +
Sbjct: 246 GLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 178 IMKHQWFLKNLPA 190
++H W +
Sbjct: 302 ALEHPWLKGDHSN 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-62
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
E+ GGELFE+I N +F E +A +Q++SG+ Y H + HRD+K EN LL + +
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG S + + +GT YIAPEVL + Y+ K DVWSCGV +Y++L
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEK-CDVWSCGVIMYILLC 242
Query: 120 GGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
G PF ++ + I+++ + D IS E ++LI + D R T E
Sbjct: 243 GYPPFGGQND----QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQ 201
+ +W K ++
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLCG 322
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-62
Identities = 71/198 (35%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----D 56
+ +GGELFE I +SE +A QQ++ V +CH M V HR+LK EN LL
Sbjct: 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148
Query: 57 GSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
G+ +K+ DFG + Q GTP Y++PEVL + Y GK D+W+CGV LY
Sbjct: 149 GAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILY 204
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARI 173
++LVG PF D D+ + +++ I + Y P + ++ E +DLI+++ +P+ RI
Sbjct: 205 ILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI 260
Query: 174 TIPEIMKHQWFLKNLPAD 191
T E +KH W
Sbjct: 261 TAAEALKHPWISHRSTVA 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-62
Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 5/202 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
ME GGELF+ I + +F+E +A +Q++SGV+Y H + HRDLK EN LL
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG S + K +GT YIAPEVL + YD K DVWS GV L+++L
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-YDEK-CDVWSIGVILFILLA 232
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G PF + + RK +++ + P+ +S+ +DLI ++ D RI+ + +
Sbjct: 233 GYPPFGGQTDQEILRK-VEKG-KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290
Query: 180 KHQWFLKNLPADLVDEKTMSSQ 201
+H W + + S
Sbjct: 291 EHPWIKEMCSKKESGIELPSLA 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SP 59
E +GGELF+ I + RFSE +A +Q++SG++Y H ++ HRDLK EN LL+ S
Sbjct: 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 164
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
++I DFG S + K +GT YIAPEVL YD K DVWS GV LY++L
Sbjct: 165 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEK-CDVWSTGVILYILLS 222
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF +E ++++ +Y+ +S+ +DLI ++ P+ RI+ +
Sbjct: 223 GCPPFNGANE----YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARD 278
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQ 201
+ H+W + +
Sbjct: 279 ALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-61
Identities = 58/256 (22%), Positives = 93/256 (36%), Gaps = 33/256 (12%)
Query: 1 MEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD- 56
MEY GG+L + + N E R + S + Y H ++ HRDLK EN +L
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQP 156
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
G KI D GY+K VGT Y+APE+L + +Y D WS G +
Sbjct: 157 GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFE 215
Query: 117 MLVGGYPFEDPDEPKDFRKTIQR--------------ILSVQYSVPDTNPISQECRDLIS 162
+ G PF +P + ++ + +P N +S +
Sbjct: 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE 275
Query: 163 RIF----VADPAARITIPEIMKHQWF--------LKNLPADLVDEKTMSSQYEEPDQPMQ 210
R + R T P+ F LK L + + + ++ +Q
Sbjct: 276 RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQ 335
Query: 211 SVDVIMQIIAEASIPA 226
++ + + IP
Sbjct: 336 --NLKSWLQQDTGIPE 349
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-60
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 14/195 (7%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
E+ G +L I +SE A + +Q++ + YCH + HRD+K LL
Sbjct: 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164
Query: 57 G-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
+ +K+ FG + VGTP ++APEV+ R Y GK DVW CGV L
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVIL 223
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAAR 172
+++L G PF E + + I+ +Y + + IS+ +DL+ R+ + DPA R
Sbjct: 224 FILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278
Query: 173 ITIPEIMKHQWFLKN 187
IT+ E + H W +
Sbjct: 279 ITVYEALNHPWLKER 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-59
Identities = 61/190 (32%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ SGGELFE++ + + SEDEA + +Q+ G+ + H H DLK EN +
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 292
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ LK+ DFG + K T GT + APEV G D+WS GV Y++L
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLS 351
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPE 177
G PF ++ +T++ + S +++ D+ + IS++ +D I ++ +ADP R+TI +
Sbjct: 352 GLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 178 IMKHQWFLKN 187
++H W
Sbjct: 408 ALEHPWLTPG 417
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-59
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
E GG + I F+E EA Q + S + + H + HRDLK EN L +
Sbjct: 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ 149
Query: 59 PAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLLRHEYD----GKIAD 106
+P +KICDF S + + + G+ Y+APEV+ + K D
Sbjct: 150 VSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 107 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-----------QRILSVQYSVPDT--NPI 153
+WS GV LY++L G PF + I +Y PD I
Sbjct: 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268
Query: 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 194
S +DLIS++ V D R++ ++++H W P + +
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-56
Identities = 47/203 (23%), Positives = 79/203 (38%), Gaps = 21/203 (10%)
Query: 1 MEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
+ + G L+ I +ED+ + + G+ HA HRDLK N LL
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKST----------VGTPAYIAPEV--LLRHEYDGKI 104
+ + D G + +H + T +Y APE+ + H +
Sbjct: 169 DE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164
DVWS G LY M+ G P++ + D ++ + Q S+P + S L++ +
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQLSIPQSPRHSSALWQLLNSM 283
Query: 165 FVADPAARITIPEIMKHQWFLKN 187
DP R IP ++ L+
Sbjct: 284 MTVDPHQRPHIPLLLSQLEALQP 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-56
Identities = 25/189 (13%), Positives = 49/189 (25%), Gaps = 25/189 (13%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 65
G L Q+I ++ H + H L+ + +LD + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFL 247
Query: 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLY 115
F V + + + PE+ R D W+ G+ +Y
Sbjct: 248 TGFE---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
+ P + + I Q R L+ R+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSCKN----------IPQPVRALLEGFLRYPKEDRLLP 354
Query: 176 PEIMKHQWF 184
+ M+ +
Sbjct: 355 LQAMETPEY 363
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-56
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ YA GEL + I G F E RF+ +++S + Y H + HRDLK EN LL+
Sbjct: 109 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-- 166
Query: 61 PRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
++I DFG +K S+ VGT Y++PE+L K +D+W+ G +Y +
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQL 225
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP- 176
+ G PF +E Q+I+ ++Y P+ + RDL+ ++ V D R+
Sbjct: 226 VAGLPPFRAGNE----YLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEE 279
Query: 177 -----EIMKHQWF 184
+ H +F
Sbjct: 280 MEGYGPLKAHPFF 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-54
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 30/231 (12%)
Query: 1 MEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLL 55
+ G+L E + G S D F Q V + H + + HRDLK+EN LL
Sbjct: 112 LTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQPKST-------------VGTPAYIAPEV--LLRHEY 100
+K+CDFG + + + + TP Y PE+ L +
Sbjct: 172 SNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 101 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160
G+ D+W+ G LY++ +PFED RI++ +YS+P + L
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPFEDG--------AKLRIVNGKYSIPPHDTQYTVFHSL 281
Query: 161 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 211
I + +P R++I E++ + + +
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSAT 332
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-54
Identities = 64/222 (28%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DG 57
ME GGELF RI + G F+E EA + + + Y H++ + HRD+K EN L
Sbjct: 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 153
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
P LK+ DFG A E +YD K D+WS GV +Y++
Sbjct: 154 RPNAILKLTDFG--------------------FAKET-TGEKYD-KSCDMWSLGVIMYIL 191
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITI 175
L G PF RI QY P+ + +S+E + LI + +P R+TI
Sbjct: 192 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 251
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQ 217
E M H W +++ P P+ + V+ +
Sbjct: 252 TEFMNHPWIMQSTKV--------------PQTPLHTSRVLKE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-54
Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 15/191 (7%)
Query: 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
ME+ G L + I + + A F+Q+ GV Y H+ ++ +RDLK N L +
Sbjct: 99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++KI DFG S + + GT Y++PE + +Y + D+++ G+ L +L
Sbjct: 159 --KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELL 215
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
+ K + S + ++ + L+ ++ P R EI
Sbjct: 216 HVCDT------AFETSKFFTDLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 179 MKHQWFLKNLP 189
++ K P
Sbjct: 266 LRTLTVWKKSP 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-53
Identities = 58/261 (22%), Positives = 100/261 (38%), Gaps = 44/261 (16%)
Query: 1 MEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSYCHAMQVCHRDLKLENT 53
+E L + + + E+ +Q+ SGV++ H++++ HRDLK +N
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 54 LLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLR 97
L+ S R+ I DFG K S + + GT + APE+L
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
Query: 98 HEYD------GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQRILSVQYSVPDT 150
+ D++S G Y +L G PF D I+ +S+ +
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------RESNIIRGIFSLDEM 260
Query: 151 NP-----ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE-E 204
+ E DLIS++ DP R T ++++H F L +S + E E
Sbjct: 261 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF-WPKSKKLEFLLKVSDRLEIE 319
Query: 205 PDQPMQSVDVIMQIIAEASIP 225
P ++ + ++ IP
Sbjct: 320 NRDPPSALLMKFDAGSDFVIP 340
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-53
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLE 51
MEY GG+L I + E+ QL + CH V HRDLK
Sbjct: 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 52 NTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 110
N LDG +K+ DFG ++ + S K+ VGTP Y++PE + R Y+ K +D+WS
Sbjct: 146 NVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSL 202
Query: 111 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 170
G LY + PF ++ +I ++ S E ++I+R+
Sbjct: 203 GCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDY 257
Query: 171 ARITIPEIMKHQWFLKNL 188
R ++ EI+++ L++
Sbjct: 258 HRPSVEEILENPLILEHH 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-52
Identities = 63/192 (32%), Positives = 106/192 (55%), Gaps = 19/192 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+++ GG+LF R+ F+E++ +F+ +L + + H++ + +RDLK EN LLD G
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG- 163
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG SK S+ H + + GT Y+APEV+ R + + AD WS GV ++ M
Sbjct: 164 ---HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEM 219
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---- 173
L G PF+ D ++T+ IL + +P +S E + L+ +F +PA R+
Sbjct: 220 LTGTLPFQGKDR----KETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGP 273
Query: 174 -TIPEIMKHQWF 184
+ EI +H +F
Sbjct: 274 DGVEEIKRHSFF 285
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 9e-52
Identities = 33/197 (16%), Positives = 55/197 (27%), Gaps = 16/197 (8%)
Query: 1 MEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 54
M AS L G QLI + + + H +N
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 55 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGV 112
+ RL + D + P AP L + W G+
Sbjct: 227 IMPD--GRLMLGDVS---ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 113 TLYVMLVGGYPFEDPDEPKDF---RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 169
++Y + PF R +++ + + P+ + LI R D
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
Query: 170 AARITIPEIMKHQWFLK 186
R+ E M+ FL+
Sbjct: 342 RRRLLPLEAMETPEFLQ 358
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-52
Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 19/192 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+EY SGGELF ++ G F ED A F+ ++ + + H + +RDLK EN +L+ G
Sbjct: 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG- 158
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG K S+ T GT Y+APE+L+R + + D WS G +Y M
Sbjct: 159 ---HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDM 214
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---- 173
L G PF + +KTI +IL + ++P ++QE RDL+ ++ + A+R+
Sbjct: 215 LTGAPPFTGENR----KKTIDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGP 268
Query: 174 -TIPEIMKHQWF 184
E+ H +F
Sbjct: 269 GDAGEVQAHPFF 280
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-51
Identities = 58/233 (24%), Positives = 111/233 (47%), Gaps = 17/233 (7%)
Query: 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
M+Y GG+LF+RI F ED+ +F Q+ + + H ++ HRD+K +N L
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161
Query: 59 PAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+++ DFG ++ + ++ +GTP Y++PE+ Y+ K +D+W+ G LY +
Sbjct: 162 --GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYEL 218
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
+ FE + + +I+S + P + S + R L+S++F +P R ++
Sbjct: 219 CTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNS 273
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTH 230
I++ + K + EK +S Q + +++ A PA G +
Sbjct: 274 ILEKGFIAKRI------EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 46/196 (23%), Positives = 76/196 (38%), Gaps = 17/196 (8%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---D 56
+E L E + E QQ SG+++ H++ + HRDLK N L+ +
Sbjct: 97 IELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 57 GSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSC 110
+ I DFG K S+ GT +IAPE+L + D++S
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 111 GVTLYVMLVGGY-PFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVAD 168
G Y ++ G PF + R+ + + R+LI ++ D
Sbjct: 216 GCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 169 PAARITIPEIMKHQWF 184
P R + ++KH +F
Sbjct: 272 PQKRPSAKHVLKHPFF 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
++Y +GGELF + RF+E E + + +++ + + H + + +RD+KLEN LLD G
Sbjct: 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG- 196
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLY 115
+ + DFG SK V ++ GT Y+AP+++ + K D WS GV +Y
Sbjct: 197 ---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-- 173
+L G PF E + +RIL + P +S +DLI R+ + DP R+
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGC 311
Query: 174 ---TIPEIMKHQWF 184
EI +H +F
Sbjct: 312 GPRDADEIKEHLFF 325
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-50
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
++ GG+L + F E+ + F +L+ + Y ++ HRD+K +N LLD G
Sbjct: 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG- 152
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVTLYV 116
+ I DF + +Q + GT Y+APE+ + G D WS GVT Y
Sbjct: 153 ---HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TI 175
+L G P+ ++ + + + P SQE L+ ++ +P R +
Sbjct: 210 LLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFSQL 266
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSSQY 202
++ + ++ D V +K + +
Sbjct: 267 SDVQNFPYM-NDINWDAVFQKRLIPGF 292
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-50
Identities = 68/188 (36%), Positives = 99/188 (52%), Gaps = 15/188 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
MEY +GG+L I + +F A F+ ++I G+ + H+ + +RDLKL+N LLD G
Sbjct: 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG- 155
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+KI DFG K ++L +T GTP YIAPE+LL +Y D WS GV LY M
Sbjct: 156 ---HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEM 211
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-TIP 176
L+G PF DE + I P + +E +DL+ ++FV +P R+
Sbjct: 212 LIGQSPFHGQDE----EELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRG 265
Query: 177 EIMKHQWF 184
+I +H F
Sbjct: 266 DIRQHPLF 273
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-50
Identities = 69/192 (35%), Positives = 104/192 (54%), Gaps = 19/192 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
MEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+KLEN +LD G
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG- 142
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+KI DFG K + T GTP Y+APEVL ++Y G+ D W GV +Y M
Sbjct: 143 ---HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEM 198
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---- 173
+ G PF + D + + IL + P T +S E + L++ + DP R+
Sbjct: 199 MCGRLPFYNQDH----ERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 174 -TIPEIMKHQWF 184
E+M+H++F
Sbjct: 253 SDAKEVMEHRFF 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 65/191 (34%), Positives = 99/191 (51%), Gaps = 20/191 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
M+Y GGELF + + RF A+F+ ++ + Y H+ + +RDLK EN LLD G
Sbjct: 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG- 143
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG++K + + GTP YIAPEV+ Y K D WS G+ +Y ML
Sbjct: 144 ---HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEML 197
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF D + KT ++IL+ + P +++ +DL+SR+ D + R+
Sbjct: 198 AGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQN 251
Query: 174 TIPEIMKHQWF 184
++ H WF
Sbjct: 252 GTEDVKNHPWF 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDLK EN LLD G
Sbjct: 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 176
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+ + DFG K ++ H+ ST GTP Y+APEVL + Y + D W G LY M
Sbjct: 177 ---HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEM 232
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP- 176
L G PF + + IL+ + I+ R L+ + D R+
Sbjct: 233 LYGLPPFYSRNT----AEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKD 286
Query: 177 ---EIMKHQWF 184
EI H +F
Sbjct: 287 DFMEIKSHVFF 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-49
Identities = 63/191 (32%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME+ +GG+L I + RF E ARF+ ++IS + + H + +RDLKL+N LLD
Sbjct: 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-- 160
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
K+ DFG K + + +T GTP YIAPE+L Y G D W+ GV LY ML
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLC 219
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI------ 173
G PFE +E F IL+ + P + ++ ++ +P R+
Sbjct: 220 GHAPFEAENEDDLFEA----ILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQG 273
Query: 174 TIPEIMKHQWF 184
I++H +F
Sbjct: 274 GEHAILRHPFF 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-49
Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 13/185 (7%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E G L + G E + + + + +++ H+ + H D+K N L P
Sbjct: 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG--P 192
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
R K+ DFG + G P Y+APE+ L+ Y ADV+S G+T+ +
Sbjct: 193 RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSYGTA-ADVFSLGLTILEVAC 250
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
P + +++ Q L ++ T +S E R ++ + DP R T ++
Sbjct: 251 NMEL---PHGGEGWQQLRQGYLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALL 303
Query: 180 KHQWF 184
Sbjct: 304 ALPVL 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-49
Identities = 65/192 (33%), Positives = 95/192 (49%), Gaps = 19/192 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
MEY +GG+L I GRF E A F+ ++ G+ + + + +RDLKL+N +LD G
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG- 158
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+KI DFG K ++ T GTP YIAPE++ Y GK D W+ GV LY M
Sbjct: 159 ---HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEM 214
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---- 173
L G PFE DE + Q I+ + P + +S+E + + P R+
Sbjct: 215 LAGQAPFEGEDE----DELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGP 268
Query: 174 -TIPEIMKHQWF 184
+I +H +F
Sbjct: 269 EGERDIKEHAFF 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-49
Identities = 30/209 (14%), Positives = 58/209 (27%), Gaps = 19/209 (9%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 65
G L Q+I ++ H + H L+ + +LD + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFL 252
Query: 66 CDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLV 119
F + + S P A +L ++ + D W+ G+ +Y +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
P D I Q R L+ R+ + M
Sbjct: 313 ADLPNTDDAALGGSEWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
Query: 180 KHQWFLKNLPADLVDEKTMSSQYEEPDQP 208
+ + + L +L + EP +
Sbjct: 363 ETPEY-EQLRTELSAALPLYQTDGEPTRE 390
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 20/191 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
MEY +GGE+F + GRFSE ARF+ Q++ Y H++ + +RDLK EN L+D G
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG- 178
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+++ DFG++K + + + GTP +APE++L Y K D W+ GV +Y M
Sbjct: 179 ---YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMA 232
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF + + K I+S + P S + +DL+ + D R
Sbjct: 233 AGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 174 TIPEIMKHQWF 184
+ +I H+WF
Sbjct: 287 GVNDIKNHKWF 297
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-48
Identities = 74/191 (38%), Positives = 103/191 (53%), Gaps = 16/191 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSP 59
MEYA+GGELF + FSED ARF+ +++S + Y H+ + V +RDLKLEN +LD
Sbjct: 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD- 285
Query: 60 APRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+KI DFG K + T GTP Y+APEVL ++Y G+ D W GV +Y M+
Sbjct: 286 -GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 343
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF + D K F IL + P T + E + L+S + DP R+
Sbjct: 344 CGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 174 TIPEIMKHQWF 184
EIM+H++F
Sbjct: 398 DAKEIMQHRFF 408
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-48
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+EY +GG+L + + E+ ARF+ ++ ++Y H + +RDLKL+N LLD G
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 147
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ D+G K + ST GTP YIAPE+L +Y G D W+ GV ++ M
Sbjct: 148 ---HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEM 203
Query: 118 LVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+ G PF+ Q IL Q +P + +S + ++ DP R
Sbjct: 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKER 261
Query: 173 I------TIPEIMKHQWF 184
+ +I H +F
Sbjct: 262 LGCHPQTGFADIQGHPFF 279
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-47
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 15/191 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
++ +GG+L + G FSE + RF+ ++I G+ + H V +RDLK N LLD G
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++I D G + +P ++VGT Y+APEVL + AD +S G L+ +L
Sbjct: 331 ----VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF + KD + + L++ +PD+ S E R L+ + D R+
Sbjct: 386 RGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGR 442
Query: 174 TIPEIMKHQWF 184
E+ + +F
Sbjct: 443 GAQEVKESPFF 453
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+EY +GG+L + + E+ ARF+ ++ ++Y H + +RDLKL+N LLD G
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 190
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ D+G K + ST GTP YIAPE+L +Y G D W+ GV ++ M
Sbjct: 191 ---HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEM 246
Query: 118 LVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+ G PF+ Q IL Q +P + +S + ++ DP R
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKER 304
Query: 173 I------TIPEIMKHQWF 184
+ +I H +F
Sbjct: 305 LGCHPQTGFADIQGHPFF 322
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 69/194 (35%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG+L + + E ARF+ +++ + H+M HRD+K +N LLD S
Sbjct: 148 MEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-- 204
Query: 61 PRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYD---GKIADVWSCGVTLY 115
LK+ DFG + VGTP YI+PEVL D G+ D WS GV LY
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARI 173
MLVG PF T +I++ + S+ PD N IS+E ++LI F+ D R+
Sbjct: 265 EMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRL 319
Query: 174 T---IPEIMKHQWF 184
+ EI +H +F
Sbjct: 320 GRNGVEEIKRHLFF 333
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-46
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
+E A G+L I + + E +F QL S + + H+ +V HRD+K N +
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 170
Query: 57 GSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+ +K+ D G + S + S VGTP Y++PE + + Y+ K +D+WS G LY
Sbjct: 171 AT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLY 227
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
M PF + + ++I Y ++ S+E R L++ DP R +
Sbjct: 228 EMAALQSPFY--GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 176 PEIMKHQWFLKNLPADLVDEKTMS 199
+ + A ++
Sbjct: 286 TYVYDVAKRMHACTASSLEHHHHH 309
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 6e-46
Identities = 64/190 (33%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I GRF E A F+ ++ G+ + + + +RDLKL+N +LD
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--SE 478
Query: 61 PRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++ T GTP YIAPE++ Y GK D W+ GV LY ML
Sbjct: 479 GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLA 537
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PFE DE + Q I+ + P + +S+E + + P R+
Sbjct: 538 GQAPFEGEDE----DELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEG 591
Query: 175 IPEIMKHQWF 184
+I +H +F
Sbjct: 592 ERDIKEHAFF 601
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
M +GG++ I N F E A F+ Q++SG+ + H + +RDLK EN LLD
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323
Query: 57 --GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
G ++I D G + GTP ++APE+LL EY D ++ GVT
Sbjct: 324 DDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVT 378
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
LY M+ PF E + ++ QR+L + PD S +D + DP R+
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRL 436
Query: 174 -----TIPEIMKHQWF 184
+ + H F
Sbjct: 437 GFRDGSCDGLRTHPLF 452
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
M+Y GG+L + R E+ ARF+ +++ + H + HRD+K +N L+D +
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN- 211
Query: 60 APRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYD----GKIADVWSCGVT 113
+++ DFG + +S+ VGTP YI+PE+L E G D WS GV
Sbjct: 212 -GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---DTNPISQECRDLISRIFVADPA 170
+Y ML G PF +T +I++ + +S+ +DLI R +
Sbjct: 271 MYEMLYGETPFYAESL----VETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSRE 325
Query: 171 ARIT---IPEIMKHQWF-------LKNLPA 190
R+ I + KH +F ++N A
Sbjct: 326 HRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 12/191 (6%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
+ +GG+L I + G+ F E A F+ ++ G+ H ++ +RDLK EN LLD
Sbjct: 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH 322
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++I D G + K VGT Y+APEV+ Y D W+ G LY M+
Sbjct: 323 --GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMI 379
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----- 173
G PF+ + + + + V + S + R L S++ DPA R+
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGG 437
Query: 174 TIPEIMKHQWF 184
+ E+ +H F
Sbjct: 438 SAREVKEHPLF 448
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 16/196 (8%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY GG+L + G R + ARF+ +++ + H + HRD+K +N LLD
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC- 198
Query: 60 APRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYD------GKIADVWSCG 111
+++ DFG +S VGTP Y++PE+L G D W+ G
Sbjct: 199 -GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171
V Y M G PF + + K + + + D + +E RD I R + P
Sbjct: 258 VFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG-VPEEARDFIQR-LLCPPET 315
Query: 172 RIT---IPEIMKHQWF 184
R+ + H +F
Sbjct: 316 RLGRGGAGDFRTHPFF 331
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-43
Identities = 42/213 (19%), Positives = 78/213 (36%), Gaps = 27/213 (12%)
Query: 1 MEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
M+ L + + C F Q+ V + H+ + HRDLK N
Sbjct: 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153
Query: 58 SPAPRLKICDFGYSK-------------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 104
+K+ DFG +++ VGT Y++PE + + Y K
Sbjct: 154 D--DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK- 210
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164
D++S G+ L+ +L YPF E +T+ + ++++ P ++ +
Sbjct: 211 VDIFSLGLILFELL---YPFSTQMERV---RTLTDVRNLKFP-PLFTQKYPCEYVMVQDM 263
Query: 165 FVADPAARITIPEIMKHQWFLK-NLPADLVDEK 196
P R I+++ F + P V +
Sbjct: 264 LSPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-41
Identities = 33/211 (15%), Positives = 68/211 (32%), Gaps = 37/211 (17%)
Query: 1 MEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 55
E S G L I + F +++ + H ++ H D+K +N +L
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205
Query: 56 DGSPAPR---------LKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVLLRHEYD 101
+ L + D G S + PK T+ T + E+L ++
Sbjct: 206 GNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 102 GKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160
+I D + T+Y ML G Y ++ +R+ P +
Sbjct: 264 YQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL-----------PHLDMWNEF 311
Query: 161 ISRIFVADPAARITIPEIMKH---QWFLKNL 188
+ + ++++ + F ++
Sbjct: 312 FHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-41
Identities = 38/200 (19%), Positives = 75/200 (37%), Gaps = 26/200 (13%)
Query: 1 MEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
M+ L + + C+ F Q+ V + H+ + HRDLK N
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKST-------------VGTPAYIAPEVLLRHEYDGKI 104
+K+ DFG + + ++ VGT Y++PE + + Y K
Sbjct: 200 D--DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK- 256
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164
D++S G+ L+ +L Y F E + I + ++++ + ++ +
Sbjct: 257 VDIFSLGLILFELL---YSFSTQMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDM 309
Query: 165 FVADPAARITIPEIMKHQWF 184
P R +I+++ F
Sbjct: 310 LSPSPTERPEATDIIENAIF 329
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 34/208 (16%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56
EY +GG L + I R F E E + Q+ G+ Y H+M + H D+K N +
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 57 -----------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RH 98
S KI D G+ S P+ G ++A EVL +
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQVEEGDSRFLANEVLQENY 206
Query: 99 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158
+ K AD+++ +T+ + D+ + R+ + SQE
Sbjct: 207 THLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVL--------SQEFT 257
Query: 159 DLISRIFVADPAARITIPEIMKHQWFLK 186
+L+ + DP R + ++KH L
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 15/214 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME GG L + I G ED A ++ Q + G+ Y H ++ H D+K +N LL
Sbjct: 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD-G 187
Query: 61 PRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
R +CDFG++ GT ++APEV++ D K D+WS +
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMM 246
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARI 173
ML G +P+ +I S + + P + I +P R
Sbjct: 247 LHMLNGCHPWTQYFRG----PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
Query: 174 TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 207
+ E+ + L + +Y+EP
Sbjct: 303 SAMELRRKVGKALQEVGGL--KSPWKGEYKEPRG 334
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 1 MEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K +N L++
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN- 156
Query: 58 SPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTL 114
+ + LKI DFG SK + ++ ++ GT Y+APE++ + Y AD+WS G T+
Sbjct: 157 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTI 215
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRDLISRIFVA 167
M G PF + EP + + V +S E + I + F
Sbjct: 216 IEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 168 DPAARITIPEIMKHQW 183
DP R +++ ++
Sbjct: 266 DPDKRACANDLLVDEF 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-32
Identities = 43/189 (22%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGS 58
E + G L + R + +Q++ G+ + H + HRDLK +N + G
Sbjct: 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG- 166
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P +KI D G + S K+ +GTP ++APE+ +YD DV++ G+ + M
Sbjct: 167 PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMA 223
Query: 119 VGGYPFEDPDEPKD-FRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITI 175
YP+ + +R+ + P + E +++I + R +I
Sbjct: 224 TSEYPYSECQNAAQIYRRVTSGVK------PASFDKVAIPEVKEIIEGCIRQNKDERYSI 277
Query: 176 PEIMKHQWF 184
+++ H +F
Sbjct: 278 KDLLNHAFF 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-30
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 24/228 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHAMQ---VCHRDLKLENTL 54
MEYA GG L+ + A A + GV+Y H+MQ + HRDLK N L
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 55 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
L LKICDFG + + + + G+ A++APEV Y K DV+S G+ L
Sbjct: 138 LVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIIL 193
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVADP 169
+ ++ PF+ + RI+ + + P + L++R + DP
Sbjct: 194 WEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLP--KPIESLMTRCWSKDP 245
Query: 170 AARITIPEIMKH-QWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIM 216
+ R ++ EI+K ++ P + P + + +
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVD 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 43/225 (19%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSP 59
ME+ GG L + + AGR E +I G++Y ++ HRD+K N L++
Sbjct: 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S + S S VGT +Y++PE L Y + +D+WS G++L M V
Sbjct: 170 --EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAV 225
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI-------------------------- 153
G YP PD + ++ P
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 154 ------------SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186
S E +D +++ + +PA R + ++M H + +
Sbjct: 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY GG + + G E + ++++ G+ Y H+ + HRD+K N LL
Sbjct: 99 MEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-- 155
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS G+T +
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAR 214
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARI 173
G P + P + V + +P NP S+ ++ + +P+ R
Sbjct: 215 GEPPHSELH-P----------MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263
Query: 174 TIPEIMKHQWFLKNLP-----ADLVDEKTMSSQYEEPDQ 207
T E++KH++ L+N +L+D + D
Sbjct: 264 TAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDD 302
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 29/198 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
ME+ GG L + I + R +E++ + ++ ++Y HA V HRD+K ++ LL DG
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG- 178
Query: 59 PAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
R+K+ DFG+ + S + KS VGTP ++APEV+ R Y + D+WS G+ + M
Sbjct: 179 ---RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEM 234
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--------ISQECRDLISRIFVADP 169
+ G P+ D P + + D+ P +S RD + R+ V DP
Sbjct: 235 VDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 170 AARITIPEIMKHQWFLKN 187
R T E++ H FL
Sbjct: 284 QERATAQELLDHP-FLLQ 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-27
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY +GG L + + E + ++ + + + H+ QV HRD+K +N LL DG
Sbjct: 96 MEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG- 153
Query: 59 PAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG+ + + S+ + VGTP ++APEV+ R Y K D+WS G+ M
Sbjct: 154 ---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEM 209
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--------ISQECRDLISRIFVADP 169
+ G P+ + + P L Y + +S RD ++R D
Sbjct: 210 IEGEPPYLN-ENP----------LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 258
Query: 170 AARITIPEIMKHQWFLKN 187
R + E+++HQ FLK
Sbjct: 259 EKRGSAKELLQHQ-FLKI 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 1 MEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD 56
ME + ++++ + ED ++ + + H+ + V HRD+K N L++
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL----RHEYDGKIADVWSCG 111
++K+CDFG S V K G Y+APE + + Y K +D+WS G
Sbjct: 145 ALG--QVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLG 200
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLISRIFVADP 169
+T+ + + +P++ P ++++ V+ P + S E D S+ +
Sbjct: 201 ITMIELAILRFPYDSWGTPFQ---QLKQV--VEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 170 AARITIPEIMKHQWFLK 186
R T PE+M+H +F
Sbjct: 256 KERPTYPELMQHPFFTL 272
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 23/194 (11%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDG 57
ME+ G+L+ R+ + + G+ Y + HRDL+ N L
Sbjct: 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159
Query: 58 ---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RHE-YDGKIADVWSCGV 112
+ K+ DFG S+ +G ++APE + E Y K AD +S +
Sbjct: 160 LDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAM 216
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVA 167
LY +L G PF++ K I+ I ++ ++P+ P R++I +
Sbjct: 217 ILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTIPEDCP--PRLRNVIELCWSG 269
Query: 168 DPAARITIPEIMKH 181
DP R I+K
Sbjct: 270 DPKKRPHFSYIVKE 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 13/198 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSP 59
ME + G E ++ + Y V HRD+K N LLD
Sbjct: 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 162
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTL 114
++K+CDFG S V + G AY+APE + + +YD + ADVWS G++L
Sbjct: 163 --QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISL 219
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPISQECRDLISRIFVADPAARI 173
+ G +P+++ + + ++L + +P S + + + D R
Sbjct: 220 VELATGQFPYKNCKTD---FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
Query: 174 TIPEIMKHQWFLKNLPAD 191
++++H + + +
Sbjct: 277 KYNKLLEHSFIKRYETLE 294
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 57/243 (23%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ + QL+ ++Y H++ +CHRD+K +N LLD LK+ DFG +K +L
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILI 193
Query: 78 SQPKST--VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG-------------- 120
+ + + + Y APE++ Y I D+WS G + ++ G
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 121 ------GYPFED------PD---------EPKDFRKTIQRILSVQYSVPDTNPISQECRD 159
G P + P+ P F K + P T P + D
Sbjct: 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFR---------PRTPP---DAID 300
Query: 160 LISRIFVADPAARITIPEIMKHQWF--LKNLPADLVDEKTMSSQYE-EPDQPMQSVDVIM 216
LISR+ P+AR+T E + H +F L+ A + + + + + ++ D+I
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLIS 360
Query: 217 QII 219
+++
Sbjct: 361 RLV 363
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 31/204 (15%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---LKICDFGYS 71
S + F QLI+GV++CH+ + HRDLK +N LL S A LKI DFG +
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 72 KSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------- 120
++ + + + + T Y PE+LL Y + D+WS ML+
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSE 243
Query: 121 -----------GYPFED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 165
G P + P D++++ + + E DL++ +
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303
Query: 166 VADPAARITIPEIMKHQWFLKNLP 189
DP RI+ ++H +F +
Sbjct: 304 EMDPVKRISAKNALEHPYF-SHND 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 43/202 (21%), Positives = 83/202 (41%), Gaps = 21/202 (10%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
++ G L+ + + +F + +Q G+ Y HA + HRDLK N L
Sbjct: 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED- 156
Query: 60 APRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVT 113
+KI DFG + Q + G+ ++APEV+ + Y + +DV++ G+
Sbjct: 157 -NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAFGIV 214
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC----RDLISRIFVADP 169
LY ++ G P+ + + + + R PD + + C + L++
Sbjct: 215 LYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRMKRLMAECLKKKR 270
Query: 170 AARITIPEIMKHQWFLKNLPAD 191
R + P I+ ++ L +
Sbjct: 271 DERPSFPRILAE---IEELARE 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 34/203 (16%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
+ ++F QL+ G+++CH ++ HRDLK +N L++ +LK+ DFG +++ +
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGI 160
Query: 77 HSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 120
S+ V T Y AP+VL+ Y I D+WSCG L M+ G
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLK 219
Query: 121 ------GYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 166
G P E P + ++ R L P+ D + +
Sbjct: 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279
Query: 167 ADPAARITIPEIMKHQWFLKNLP 189
+P R++ + + H WF
Sbjct: 280 LNPDMRLSAKQALHHPWF-AEYY 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 53/196 (27%), Positives = 78/196 (39%), Gaps = 36/196 (18%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ + QL ++Y H+ +CHRD+K +N LLD A LK+CDFG +K L
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLV 208
Query: 78 SQPKST--VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVM--LVGGYPFEDPDEPKD 132
+ + + Y APE++ +Y I DVWS G V+ L+ G P D D
Sbjct: 209 RGEPNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGC---VLAELLLGQPIFPGDSGVD 264
Query: 133 FRKTIQRIL--------------SVQYSVPDTNPI----------SQECRDLISRIFVAD 168
I ++L ++ P E L SR+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 169 PAARITIPEIMKHQWF 184
P AR+T E H +F
Sbjct: 325 PTARLTPLEACAHSFF 340
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
MEY G + + I +EDE Q + G+ Y H M+ HRD+K N LL +G
Sbjct: 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG 162
Query: 58 SPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
K+ DFG + + + ++ + +GTP ++APEV+ Y+ AD+WS G+T
Sbjct: 163 ----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIE 217
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--------ISQECRDLISRIFVAD 168
M G P+ D P + + +P P S D + + V
Sbjct: 218 MAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKS 266
Query: 169 PAARITIPEIMKHQWFLKNLP-----ADLVDEKTMSSQYEEPDQP 208
P R T ++++H F+++ DL++E + Q
Sbjct: 267 PEQRATATQLLQHP-FVRSAKGVSILRDLINEAMDVKLKRQESQQ 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 1 MEYASGGELF--------ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 52
M+ SGG + + +G E ++++ G+ Y H HRD+K N
Sbjct: 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151
Query: 53 TLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIA 105
LL + ++I DFG S + K+ VGTP ++APEV+ + YD K A
Sbjct: 152 ILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-A 208
Query: 106 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ----RILSVQYSVPDTNPISQECRDLI 161
D+WS G+T + G P+ K T+Q + + + R +I
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMI 268
Query: 162 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEK 196
S DP R T E+++H++F K + + EK
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 46/214 (21%), Positives = 90/214 (42%), Gaps = 44/214 (20%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
++ + RF+ +++ + YCH+M + HRD+K N ++D +L++ D+G ++ H
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--H 182
Query: 78 SQPKST--VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPF---ED----- 126
+ V + + PE+L+ YD + D+WS G L M+ PF D
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 127 --------PDEPKDFRKTIQRILSVQYS--------------VPDTNP--ISQECRDLIS 162
++ D+ L +++ V N +S E D +
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 301
Query: 163 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEK 196
++ D +R+T E M+H +F +V ++
Sbjct: 302 KLLRYDHQSRLTAREAMEHPYF-----YTVVKDQ 330
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 1e-24
Identities = 51/198 (25%), Positives = 82/198 (41%), Gaps = 38/198 (19%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
G A+ F QL++G++YCH +V HRDLK +N L++ LKI DFG +++ +
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGI 152
Query: 77 HSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 120
+ + + T Y AP+VL+ +Y I D+WS G M+ G
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 121 ------GYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 166
G P P +F + + DL+S++
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK-----GLDESGIDLLSKMLK 266
Query: 167 ADPAARITIPEIMKHQWF 184
DP RIT + ++H +F
Sbjct: 267 LDPNQRITAKQALEHAYF 284
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 40/204 (19%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ +
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGI 171
Query: 77 HSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 120
+ + V T Y AP+VL+ +Y + D+WS G M+ G
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLP 230
Query: 121 ------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 165
G P P + + F+ ++ S QE DL+S +
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNML 285
Query: 166 VADPAARITIPEIMKHQWFLKNLP 189
DP RI+ + M H +F K+L
Sbjct: 286 CFDPNKRISARDAMNHPYF-KDLD 308
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 1 MEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--D 56
ME+ G + + + E+ + ++++ G+S+ H +V HRD+K +N LL +
Sbjct: 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE-----YDGKIADVWSC 110
+K+ DFG S ++T +GTP ++APEV+ E YD K +D+WS
Sbjct: 166 A----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSL 220
Query: 111 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRDLISR 163
G+T M G P D P + + +P S++ + I
Sbjct: 221 GITAIEMAEGAPPLCDMH-P----------MRALFLIPRNPAPRLKSKKWSKKFQSFIES 269
Query: 164 IFVADPAARITIPEIMKHQWFLKNLP 189
V + + R ++MKH F+++ P
Sbjct: 270 CLVKNHSQRPATEQLMKHP-FIRDQP 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 56/197 (28%), Positives = 80/197 (40%), Gaps = 30/197 (15%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDG 57
ME+A GG L + R D + Q+ G++Y H + HRDLK N L+
Sbjct: 85 MEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143
Query: 58 SPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 111
LKI DFG ++ + S G A++APEV+ + +DVWS G
Sbjct: 144 KVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYG 201
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN---PISQEC----RDLISRI 164
V L+ +L G PF D L+V Y V PI C L+
Sbjct: 202 VLLWELLTGEVPFRGIDG-----------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDC 250
Query: 165 FVADPAARITIPEIMKH 181
+ DP +R + I+
Sbjct: 251 WNPDPHSRPSFTNILDQ 267
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
+ + F QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ +
Sbjct: 95 NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSI 152
Query: 77 HSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 120
++ V T Y P++LL +Y +I D+W G Y M G
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLH 211
Query: 121 ------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 165
G P E+ + + ++ K L + + DL++++
Sbjct: 212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP-----RLDSDGADLLTKLL 266
Query: 166 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQ 210
+ RI+ + MKH +F +L + +S + + +Q
Sbjct: 267 QFEGRNRISAEDAMKHPFF-LSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-24
Identities = 47/203 (23%), Positives = 76/203 (37%), Gaps = 36/203 (17%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73
+ + +Q + G+ + HA + HRDLK EN L+ +K+ DFG ++
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI 169
Query: 74 SVLHSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG---------- 120
+S V T Y APEVLL+ Y + D+WS G M
Sbjct: 170 ---YSYQMALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEA 225
Query: 121 ----------GYPFED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 166
G P ED P + + VQ VP+ + + L+ +
Sbjct: 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE---MEESGAQLLLEMLT 282
Query: 167 ADPAARITIPEIMKHQWFLKNLP 189
+P RI+ ++H + K+
Sbjct: 283 FNPHKRISAFRALQHSYLHKDEG 305
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-24
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 27/194 (13%)
Query: 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLL 55
EY S G L+ + +G E + G++Y H + HR+LK N L+
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGV 112
D +K+CDFG S+ + S KS GTP ++APEVL + K +DV+S GV
Sbjct: 173 DKKY--TVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGV 227
Query: 113 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVPDTNPISQECRDLISRIFVA 167
L+ + P+ + + Q + +V + +P + +I +
Sbjct: 228 ILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLEIPRNLN--PQVAAIIEGCWTN 278
Query: 168 DPAARITIPEIMKH 181
+P R + IM
Sbjct: 279 EPWKRPSFATIMDL 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 16/224 (7%)
Query: 1 MEYASGG--ELFERICNA--GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLL 55
ME S + ++ + + E+ + +++ +++ HRD+K N LL
Sbjct: 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL 159
Query: 56 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCG 111
D S +K+CDFG S V G Y+APE + R YD + +DVWS G
Sbjct: 160 DRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLG 216
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 171
+TLY + G +P+ + D + + Q S + S + ++ D +
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESK 276
Query: 172 RITIPEIMKHQWFL--KNLPADLVD--EKTMSSQYEEPDQPMQS 211
R E++KH + L + ++ K + P PM
Sbjct: 277 RPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYV 320
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 30/193 (15%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ + QL V + H++ +CHRD+K +N L++ LK+CDFG +K +
Sbjct: 137 SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLIPS 195
Query: 78 SQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFED-------- 126
+ + + Y APE++L EY I D+WS G +++G + E
Sbjct: 196 EPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRI 254
Query: 127 ------PDE-------PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAA 171
P + P + + + +P+ P DL+ +I +P
Sbjct: 255 IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP--SLAIDLLEQILRYEPDL 312
Query: 172 RITIPEIMKHQWF 184
RI E M H +F
Sbjct: 313 RINPYEAMAHPFF 325
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-24
Identities = 36/187 (19%), Positives = 66/187 (35%), Gaps = 16/187 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VCHRDLKLENTLLD 56
+ G L+ + F D+++ F + G+++ H ++ + L + ++D
Sbjct: 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID 147
Query: 57 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI--ADVWSCGVTL 114
+I S Q + PA++APE L + D AD+WS V L
Sbjct: 148 EDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
+ ++ PF D + ++ IS L+ DPA R
Sbjct: 202 WELVTREVPFAD----LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPK 257
Query: 175 IPEIMKH 181
I+
Sbjct: 258 FDMIVPI 264
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 6e-24
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
G + + F QL+ G+ +CH+ V HRDLK +N L++ + LK+ +FG +++ +
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGI 153
Query: 77 HSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPF------ED-- 126
+ S V T Y P+VL Y I D+WS G + G P +D
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 127 ---------PDE---P--------KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 166
P E P K + S+ VP ++ RDL+ +
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT-SLVNVVPK---LNATGRDLLQNLLK 268
Query: 167 ADPAARITIPEIMKHQWFLKNLPA 190
+P RI+ E ++H +F +
Sbjct: 269 CNPVQRISAEEALQHPYF-SDFCP 291
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-24
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 31/215 (14%)
Query: 17 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
+ + Q+I+G+ +CH+ + HRD+K EN L+ S +K+CDFG++++
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAA 176
Query: 77 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 135
+ V T Y APE+L+ GK DVW+ G L + G P D D
Sbjct: 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGEPLFPGDSDIDQLY 235
Query: 136 TIQRIL----------------SVQYSVPDTNP----------ISQECRDLISRIFVADP 169
I L +P+ +S+ DL + DP
Sbjct: 236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295
Query: 170 AARITIPEIMKHQWFLK-NLPADLVDEKTMSSQYE 203
R E++ H +F E + Q +
Sbjct: 296 DKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 38/209 (18%), Positives = 79/209 (37%), Gaps = 35/209 (16%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
G L+ + +A ++ R Q+++ G+ Y HA + H+DLK +N D
Sbjct: 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG- 166
Query: 60 APRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL---------LRHEYDGKI 104
++ I DFG + + + G ++APE++ + +
Sbjct: 167 --KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH- 223
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----SVPDTNPISQECRDL 160
+DV++ G Y + +PF+ I + ++ + +E D+
Sbjct: 224 SDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMGTGMKPNLSQIG-MGKEISDI 275
Query: 161 ISRIFVADPAARITIPEIMKHQWFLKNLP 189
+ + + R T ++M L+ LP
Sbjct: 276 LLFCWAFEQEERPTFTKLMDM---LEKLP 301
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 35/172 (20%), Positives = 60/172 (34%), Gaps = 22/172 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G L + EA + +++ +SY H++ + + DLK EN +L
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-- 218
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+LK+ D G + GTP + APE++ D+++ G TL + +
Sbjct: 219 -QLKLIDLGAVSR---INSFGYLYGTPGFQAPEIVRTGPTVA--TDIYTVGRTLAALTLD 272
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR 172
+ + L+ R DP R
Sbjct: 273 LPTRNG-RYVDGLPEDDPVL-----------KTYDSYGRLLRRAIDPDPRQR 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 49/220 (22%), Positives = 73/220 (33%), Gaps = 52/220 (23%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSK 72
+ Q++ G+ Y HA V HRDLK N L+ G R +KI D G ++
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 73 SSVLHSQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG---------- 120
+ V T Y APE+LL RH Y I D+W+ G +L
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTSEPIFHCRQED 242
Query: 121 -------------------GYPFED------------PDEPKDFRKTIQRILSVQYSVPD 149
G+P + R T ++Y
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 150 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189
+ L+ ++ DP RIT + M+ +F P
Sbjct: 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF-LEDP 341
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 46/215 (21%), Positives = 76/215 (35%), Gaps = 39/215 (18%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
E + Q + V++CH HRD+K EN L+ +K+CDFG+++ L
Sbjct: 99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTG 154
Query: 79 QPKS-T--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------- 120
V T Y +PE+L+ G DVW+ G +L G
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214
Query: 121 -----GYPFED----PDEPKDFRKT----IQRILSVQYSVPDTNPISQECRDLISRIFVA 167
G + F + + ++ P+ IS L+
Sbjct: 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN---ISYPALGLLKGCLHM 271
Query: 168 DPAARITIPEIMKHQWFLK-NLPADLVDEKTMSSQ 201
DP R+T +++ H +F DL E ++
Sbjct: 272 DPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAE 306
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 27/185 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G L + + G + A +++ H + HRD+K N ++ S
Sbjct: 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SAT 152
Query: 61 PRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG + S +Q + +GT Y++PE D + +DV+S G LY
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYE 211
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQY--------SVPDTNP-ISQECRDLISRIFVA 167
+L G PF D P +SV Y + +S + ++ +
Sbjct: 212 VLTGEPPFTG-DSP----------VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260
Query: 168 DPAAR 172
+P R
Sbjct: 261 NPENR 265
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 42/211 (19%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKS 73
+F+ E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLA 177
Query: 74 SVLHSQP-KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG----------- 120
+ V T Y PE+LL +Y I D+W G + M
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQH 236
Query: 121 ---------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 162
G + E + K +R + + DLI
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLID 293
Query: 163 RIFVADPAARITIPEIMKHQWFLKN-LPADL 192
++ V DPA RI + + H +F + +P+DL
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-23
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 35/202 (17%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73
+ + QL+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI 169
Query: 74 SVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------- 120
Q T V T Y APEVLL+ Y + D+WS G M
Sbjct: 170 --YSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVD 226
Query: 121 ---------GYPFED--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
G P E+ P + + ++ V D I + +DL+ +
Sbjct: 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDLLLKCLTF 283
Query: 168 DPAARITIPEIMKHQWFLKNLP 189
+PA RI+ + H +F ++L
Sbjct: 284 NPAKRISAYSALSHPYF-QDLE 304
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 18/179 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M +G +L + G + A +Q+ S + HA HRD+K EN L+ S
Sbjct: 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV--SAD 170
Query: 61 PRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
+ DFG + + +Q +TVGT Y+APE + AD+++ LY L
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECL 229
Query: 119 VGGYPFEDPDEPKDFRKTIQRILS-VQYSVP---DTNP-ISQECRDLISRIFVADPAAR 172
G P++ + + + + ++P P I +I+R +P R
Sbjct: 230 TGSPPYQG--------DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G L E I + G S D A F Q++ G+ + H M++ HRD+K +N L+D
Sbjct: 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID--SN 147
Query: 61 PRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
LKI DFG +K S +Q +GT Y +PE D D++S G+ LY ML
Sbjct: 148 KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEML 206
Query: 119 VGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAAR 172
VG PF + K + ++ + + D I Q ++I R D A R
Sbjct: 207 VGEPPFNG-ETAVSIAIKHIQDSVPNVTT------DVRKDIPQSLSNVILRATEKDKANR 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DG 57
+E+ GG + + +E + + +Q++ +++ H+ ++ HRDLK N L+ +G
Sbjct: 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG 154
Query: 58 SPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCG 111
+++ DFG S K+ + S +GTP ++APEV++ YD K AD+WS G
Sbjct: 155 D----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLG 209
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--------ISQECRDLISR 163
+TL M P + P + V + ++P S E RD +
Sbjct: 210 ITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258
Query: 164 IFVADPAARITIPEIMKHQWFLKNLP----ADLVDEK 196
+P R + ++++H + +LV E
Sbjct: 259 ALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEA 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 46/208 (22%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK 72
N+ + + + + G+ Y H + HRDLK N LLD G LK+ DFG +K
Sbjct: 105 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAK 160
Query: 73 SSVLHSQPKST-VGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG--------- 120
S ++ + V T Y APE+L R Y + D+W+ G L +L+
Sbjct: 161 SFGSPNRAYTHQVVTRWYRAPELLFGARM-YGVGV-DMWAVGCILAELLLRVPFLPGDSD 218
Query: 121 -----------GYPFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 161
G P E+ PD F+ + + + + DLI
Sbjct: 219 LDQLTRIFETLGTPTEEQWPDMCSLPDY-VTFKS--FPGIPLHHIFSA---AGDDLLDLI 272
Query: 162 SRIFVADPAARITIPEIMKHQWFLKNLP 189
+F+ +P ARIT + +K ++F N P
Sbjct: 273 QGLFLFNPCARITATQALKMKYF-SNRP 299
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-22
Identities = 56/233 (24%), Positives = 80/233 (34%), Gaps = 58/233 (24%)
Query: 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78
FS R F ++ + H ++ H DLK EN LL +K+ DFG SS
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEH 253
Query: 79 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 120
Q T + + Y APEV+L Y I D+WS G L +L G
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312
Query: 121 ---GYP--------------FEDPDEPKDFRKTIQRILSVQYS-----------VPDTNP 152
G P P+ T SV + P++
Sbjct: 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 153 ISQECR--------DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 197
+ D + + DPA R+T + ++H W + LP EKT
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 9e-22
Identities = 43/249 (17%), Positives = 82/249 (32%), Gaps = 57/249 (22%)
Query: 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
+ + G + IC +E + Q ++ + Y H M HR +K + L+
Sbjct: 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 59 PAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVW 108
+ + + + V+H PK +V +++PEVL + YD K +D++
Sbjct: 165 GK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIY 221
Query: 109 SCGVTLYVMLVGGYPFED----------------------------------------PD 128
S G+T + G PF+D
Sbjct: 222 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281
Query: 129 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF--LK 186
T + S P S + + +P AR + ++ H +F +K
Sbjct: 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341
Query: 187 NLPADLVDE 195
++ + E
Sbjct: 342 RRASEALPE 350
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-22
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 35/233 (15%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGS 58
MEY G + E E + G++Y H+ + HRD+K N LL G
Sbjct: 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG- 191
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLY 115
+K+ DFG + + S VGTP ++APEV+L +YDGK DVWS G+T
Sbjct: 192 ---LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCI 244
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRDLISRIFVAD 168
+ P + +S Y + S+ R+ +
Sbjct: 245 ELAERKPPLFN-MNA----------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 169 PAARITIPEIMKHQWFLKNLP----ADLVDEKTMSSQYEEPDQPMQSVDVIMQ 217
P R T ++KH++ L+ P DL+ + + + Q + ++ Q
Sbjct: 294 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 346
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 33/231 (14%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
EY GG L I + + + F + + SG++Y H+M + HRDL N L+ +
Sbjct: 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN- 144
Query: 60 APRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 104
+ + DFG ++ + + VG P ++APE++ YD K
Sbjct: 145 -KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK- 202
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC----RDL 160
DV+S G+ L ++ D + C +
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYL-------PRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 161 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 211
R DP R + ++ +L+ L L + Q E+ D+
Sbjct: 256 TVRCCDLDPEKRPSFVKLE---HWLETLRMHLAGHLPLGPQLEQLDRGFWE 303
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 51/205 (24%), Positives = 79/205 (38%), Gaps = 37/205 (18%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
+ G E+ AR F QL+ G+ Y H+ V HRDLK N ++ + LKI DFG +
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLA 168
Query: 72 KSSVLHSQPKST----VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFED 126
+ H K + T Y +P +LL + Y I D+W+ G ML G F
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAG 227
Query: 127 PDE--------------PKDFRKTIQR-----ILSVQYS--------VPDTNPISQECRD 159
E ++ R+ + I + +P + E D
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR---EAVD 284
Query: 160 LISRIFVADPAARITIPEIMKHQWF 184
+ +I P R+T E + H +
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYM 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 43/246 (17%), Positives = 80/246 (32%), Gaps = 63/246 (25%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPR----LKICDFG 69
+ +QL+ G+ Y H + H D+K EN L++ +P +KI D G
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 70 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 129
+ +++ T Y +PEVLL + D+WS ++ ++ G + FE +
Sbjct: 184 --NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEG 240
Query: 130 --------------------------------------------PKDFRKTIQRILSVQY 145
K ++ +L+ +Y
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 205
++E D +S + DP R ++ H W L + P
Sbjct: 301 KFSKDE--AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG---------MEEIRVP 349
Query: 206 DQPMQS 211
D+ +
Sbjct: 350 DRELYG 355
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 37/199 (18%)
Query: 18 RFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75
+ F QLI + H ++ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183
Query: 76 LHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFED------ 126
+ + + Y APE++ Y + D+WS G M++G + ++
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 127 --------PDE-------PKDFRKTIQRILSVQYS------VPDTNPISQECRDLISRIF 165
P P + + +S E DL+S +
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK---EAYDLLSALL 299
Query: 166 VADPAARITIPEIMKHQWF 184
P R+ E + H +F
Sbjct: 300 QYLPEERMKPYEALCHPYF 318
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 51/249 (20%), Positives = 80/249 (32%), Gaps = 62/249 (24%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA------ 60
FE + + R QL + + H Q+ H DLK EN L S
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167
Query: 61 -----------PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVW 108
+++ DFG S+ + +T V T Y PEV+L + DVW
Sbjct: 168 HKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILELGWAQPC-DVW 223
Query: 109 SCGVTLYVMLVG--------------------GYP-------------FED-----PDEP 130
S G L+ G G F +
Sbjct: 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283
Query: 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190
D R + ++ + + + DL+ R+ DPA RIT+ E + H +F P
Sbjct: 284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343
Query: 191 DLVDEKTMS 199
+ + +
Sbjct: 344 ERSFHTSRN 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 45/235 (19%), Positives = 85/235 (36%), Gaps = 36/235 (15%)
Query: 14 CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73
S ++F ++ G+ H V HRDL N LL + + ICDF ++
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLARE 183
Query: 74 SVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---- 128
+ V Y APE+++ + + D+WS G + M F
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 129 ---------EPKDFRKTIQRILS------VQYSVPDTNPI---------SQECRDLISRI 164
PK + + S ++ S+ + DLI+++
Sbjct: 243 LNKIVEVVGTPKI--EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 165 FVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 219
+P RI+ + ++H + ++L D +D S+ D+ + V + +I
Sbjct: 301 LEFNPQRRISTEQALRHP-YFESL-FDPLDLTEGLSERFHFDESVTDVYDMHKIF 353
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 35/201 (17%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
++ + ED +F Q++ G+ Y HA + HRDLK N ++ LKI DFG +
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLA 175
Query: 72 KSSVLHSQPKST--VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128
+ + + T V T Y APEV+L Y + D+WS G + M+ G F+ D
Sbjct: 176 RQ----ADSEMTGYVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSD 230
Query: 129 E--------------PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISR 163
P +F + +Q + Y +P+ S +L+ +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 164 IFVADPAARITIPEIMKHQWF 184
+ V D R+T E + H +F
Sbjct: 291 MLVLDAEQRVTAGEALAHPYF 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 42/215 (19%), Positives = 78/215 (36%), Gaps = 39/215 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--------VCHRDLKLEN 52
Y G L++ + + SG+++ H + HRDLK +N
Sbjct: 85 THYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 53 TLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL------LRHEYD 101
L+ + + I D G + ++ L VGT Y+APEVL +
Sbjct: 144 ILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 102 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQY------------SVP 148
+ D+W+ G+ L+ + ++ K F + S + ++P
Sbjct: 202 KR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 149 DT---NPISQECRDLISRIFVADPAARITIPEIMK 180
+ +P L+ + +P+AR+T I K
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+FSE++ ++ Q++ G+ Y H+ V HRDLK N ++ LKI DFG ++
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH---- 175
Query: 78 SQPKST--VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----- 129
+ + T V T Y APEV+L Y+ + D+WS G + ML G F+ D
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234
Query: 130 ---------PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADP 169
+F + + + Y S+P T S + DL+ ++ D
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294
Query: 170 AARITIPEIMKHQWF 184
R+T + + H +F
Sbjct: 295 DKRLTAAQALTHPFF 309
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 55/234 (23%), Positives = 82/234 (35%), Gaps = 62/234 (26%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA------ 60
++ I G F D R Q+ V++ H+ ++ H DLK EN L S
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 61 -----------PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVW 108
P +K+ DFG S+ + ST V T Y APEV+L + DVW
Sbjct: 163 KIKRDERTLINPDIKVVDFG---SATYDDEHHSTLVSTRHYRAPEVILALGWSQPC-DVW 218
Query: 109 SCGVTLYVMLVG--------------------GYP-------------FED-----PDEP 130
S G L +G G F +
Sbjct: 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
Query: 131 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184
R + ++ + + + DLI ++ DPA RIT+ E +KH +F
Sbjct: 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 35/201 (17%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
I + ++D +F Q++ G+ Y H+ + HRDLK N ++ LKI DFG +
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED--CELKILDFGLA 179
Query: 72 KSSVLHSQPKST--VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 128
+ + + T V T Y APE++L Y+ + D+WS G + +L G F D
Sbjct: 180 RH----TADEMTGYVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTD 234
Query: 129 E--------------PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLISR 163
+ K I + Y S+ + + DL+ +
Sbjct: 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 294
Query: 164 IFVADPAARITIPEIMKHQWF 184
+ V D RIT + + H +F
Sbjct: 295 MLVLDSDKRITAAQALAHAYF 315
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 41/204 (20%)
Query: 18 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77
+ + Q++ G+ + H+ + HRDLK N ++ LKI DFG ++++
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTS 180
Query: 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 120
V T Y APEV+L Y + D+WS G + M+ G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239
Query: 121 ---GYPFED-----------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160
G P + F K +L S + + RDL
Sbjct: 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS-EHNKLKASQARDL 298
Query: 161 ISRIFVADPAARITIPEIMKHQWF 184
+S++ V D + RI++ E ++H +
Sbjct: 299 LSKMLVIDASKRISVDEALQHPYI 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 45/204 (22%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79
+ + Q++ G+ + H+ + HRDLK N ++ LKI DFG +++ +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTS 217
Query: 80 PKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 120
T V T Y APEV+L Y + D+WS G + M+
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 121 ---GYPFED-----------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160
G P + F K L S + + + RDL
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL-KASQARDL 335
Query: 161 ISRIFVADPAARITIPEIMKHQWF 184
+S++ V DPA RI++ + ++H +
Sbjct: 336 LSKMLVIDPAKRISVDDALQHPYI 359
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 53/232 (22%), Positives = 76/232 (32%), Gaps = 65/232 (28%)
Query: 19 FSEDEARFFFQQLISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76
S + R F QQ+ + + + + + H DLK EN LL +KI DFG SS
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQ 210
Query: 77 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------- 120
Q + + Y +PEVLL YD I D+WS G L M G
Sbjct: 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
Query: 121 -----------------------------GYPFEDPDEPK-----DFRKTIQRILSVQYS 146
+ + + K + + IL V+
Sbjct: 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329
Query: 147 VPDTNPISQECR---------DLISRIFVADPAARITIPEIMKHQWFLKNLP 189
P + DLI R+ DP RI ++H +F K
Sbjct: 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 42/215 (19%), Positives = 81/215 (37%), Gaps = 39/215 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLEN 52
+Y G LF+ + N + + SG+++ H + HRDLK +N
Sbjct: 119 SDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 53 TLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL-----LRH-EYD 101
L+ + I D G + + + P VGT Y+APEVL ++H E
Sbjct: 178 ILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 102 GKIADVWSCGVTLYVMLVGGYPFEDPDEPK----DFRKTIQRILSVQYSV---------- 147
+ AD+++ G+ + + ++ + D + + ++ V
Sbjct: 236 KR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 148 --PDTNPISQECRDLISRIFVADPAARITIPEIMK 180
+ + ++ + A+ AAR+T I K
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
++ S D +F Q++ G+ Y H+ V HRDLK N LL+ + LKICDFG +
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLA 175
Query: 72 KSSVLHSQPKST----VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFED 126
+ + V T Y APE++L Y I D+WS G L ML F
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPG 234
Query: 127 PDE--------------PKDFRKTIQRILSVQY--SVPDTNPI---------SQECRDLI 161
++ I + + Y S+P N + + DL+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 294
Query: 162 SRIFVADPAARITIPEIMKHQWF 184
++ +P RI + + + H +
Sbjct: 295 DKMLTFNPHKRIEVEQALAHPYL 317
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 37/214 (17%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--------VCHRDLKLEN 52
+Y G L++ + + +SG+ + H + HRDLK +N
Sbjct: 114 TDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 53 TLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDG 102
L+ + I D G + ++ + P + VGT Y+ PEVL H
Sbjct: 173 ILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 103 KIADVWSCGVTLYVMLVGGYPFEDPDE---PKDFRKTIQRILSVQYSV------------ 147
+AD++S G+ L+ + +E P +
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 148 -PDTNPISQECRDLISRIFVADPAARITIPEIMK 180
++ ++ L++ + +PA+R+T + K
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 47/214 (21%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG-- 69
R+ + S+D ++F Q + V H V HRDLK N L++ + LK+CDFG
Sbjct: 102 RVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLA 159
Query: 70 --YSKSSVLHSQPKST-------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLV 119
+S+ +S+P V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFL 218
Query: 120 G--------------------GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI------ 153
G P D D + + S+P
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIK---SLPMYPAAPLEKMF 275
Query: 154 ---SQECRDLISRIFVADPAARITIPEIMKHQWF 184
+ + DL+ R+ V DPA RIT E ++H +
Sbjct: 276 PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 51/242 (21%), Positives = 83/242 (34%), Gaps = 70/242 (28%)
Query: 9 LFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA------ 60
L+E I F ++ + + +++ ++Y M + H DLK EN LLD
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 61 -----------------PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 102
+K+ DFG + S + + T Y APEV+L +D
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKSDYHGSIINTRQYRAPEVILNLGWDV 238
Query: 103 KIADVWSCGVTLYVMLVG--------------------GYP---------------FEDP 127
D+WS G L + G + +
Sbjct: 239 SS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 128 DEPK----DFRKTIQRILSVQYSVPDTNPISQEC-RDLISRIFVADPAARITIPEIMKHQ 182
DE K + +I I V+ +P I E D + I DP R + E++KH+
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357
Query: 183 WF 184
+
Sbjct: 358 FL 359
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 48/237 (20%), Positives = 79/237 (33%), Gaps = 67/237 (28%)
Query: 12 RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71
+ A ++ QLI + Y H+ + HRD+K N LL+ +K+ DFG S
Sbjct: 99 AVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE--CHVKVADFGLS 156
Query: 72 KSSVLHSQPKST----------------------VGTPAYIAPEVLL-RHEYDGKIADVW 108
+S V + + V T Y APE+LL +Y I D+W
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMW 215
Query: 109 SCGVTLYVMLVG--------------------GYPFED------------------PDEP 130
S G L +L G +P +
Sbjct: 216 SLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVE 275
Query: 131 KDFRKTIQRILSVQYSVPDTNP---ISQECRDLISRIFVADPAARITIPEIMKHQWF 184
+ + NP ++E DL+ ++ +P RI+ + +KH +
Sbjct: 276 IRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 9e-16
Identities = 46/244 (18%), Positives = 77/244 (31%), Gaps = 50/244 (20%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLE 51
MEY G L + + + + + G++Y H + HRDL
Sbjct: 91 MEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 52 NTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVL------L 96
N L+ I DFG S + S VGT Y+APEVL
Sbjct: 150 NVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 97 RHEYDGKIADVWSCGVTLYVML-----------VGGY--PFEDPDEPKDFRKTIQRILSV 143
E K D+++ G+ + + V Y F+ + +Q ++S
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR 267
Query: 144 QY---SVPDTNPISQECRDLISRIFV----ADPAARITIPEIMKHQWFLKNLPADLVDEK 196
+ P+ + + D AR+T + + L K
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER---MAELMMIWERNK 324
Query: 197 TMSS 200
++S
Sbjct: 325 SVSP 328
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 44/242 (18%), Positives = 74/242 (30%), Gaps = 80/242 (33%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79
+E+ + L+ G ++ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKD 184
Query: 80 PKSTVGTPA-----------------------YIAPEVLL-RHEYDGKIADVWSCGVTLY 115
Y APE++L + Y I D+WS G
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFA 243
Query: 116 VMLVG------------------------GYPFEDPDEPKDFRKTIQRILSV-------- 143
+L K R + I ++
Sbjct: 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD 303
Query: 144 ----------QY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQ 182
+Y P PI S + +L+ + +P RITI + + H
Sbjct: 304 LKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHP 363
Query: 183 WF 184
+
Sbjct: 364 YL 365
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-15
Identities = 33/148 (22%), Positives = 58/148 (39%), Gaps = 22/148 (14%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ----------VCHRDLKL 50
+ G L + + A S +E + + G++Y H + HRD+K
Sbjct: 101 TAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 51 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVL-----LRHEYDG 102
+N LL + I DFG + T VGT Y+APEVL + +
Sbjct: 160 KNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 103 KIADVWSCGVTLYVMLVGGYPFEDPDEP 130
+ D+++ G+ L+ + + P +
Sbjct: 218 R-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 26/173 (15%), Positives = 42/173 (24%), Gaps = 32/173 (18%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E+ GG L E S A Q L + H V + S
Sbjct: 110 AEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV--SID 165
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+ + PA + D+ G +LY +LV
Sbjct: 166 GDVV-------------------LAYPATMPDA--------NPQDDIRGIGASLYALLVN 198
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAAR 172
+P + + D + I + + +R D R
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 47/250 (18%), Positives = 75/250 (30%), Gaps = 88/250 (35%)
Query: 20 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79
+E + L+ GV Y H+ + HRDLK N L++ +K+CDFG +++
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPEN 211
Query: 80 PKSTVGTPA----------------------------YIAPEVLLR-HEYDGKIADVWSC 110
S + Y APE++L Y I DVWS
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSI 270
Query: 111 G---------------------------VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 143
G + + + R + I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 144 ------------------QY--SVPDTNPI---------SQECRDLISRIFVADPAARIT 174
+Y P S + L+ R+ V +P RIT
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 175 IPEIMKHQWF 184
I E + H +F
Sbjct: 391 INECLAHPFF 400
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 42/265 (15%), Positives = 72/265 (27%), Gaps = 93/265 (35%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD------------ 56
+ N + QQ++ G+ Y H ++ H D+K EN LL
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 57 -----------------------------------GSPAPRLKICDFGYSKSSVLHSQPK 81
+ ++KI D G + +H
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFT 251
Query: 82 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE--DPDEPKDFRKTIQR 139
+ T Y + EVL+ Y+ AD+WS + + G Y FE +E I
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
Query: 140 ILSV----------------QYSVPDTNPIS------------------------QECRD 159
I+ + ++ + D
Sbjct: 311 IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 160 LISRIFVADPAARITIPEIMKHQWF 184
+ + P R T E ++H W
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWL 395
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 34/133 (25%), Positives = 50/133 (37%), Gaps = 12/133 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME GG+ + R +G+ Y + HRDL N L+
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTL 114
LKI DFG S+ + G + APE L Y + +DVWS G+ L
Sbjct: 251 V--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILL 305
Query: 115 Y-VMLVGGYPFED 126
+ +G P+ +
Sbjct: 306 WETFSLGASPYPN 318
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L + + + R + + Q+ G+ Y + HRDL N L+ +
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV-ENE 181
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTL 114
R+KI DFG +K + + V P APE L ++ +DVWS GV L
Sbjct: 182 N-RVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 238
Query: 115 Y 115
Y
Sbjct: 239 Y 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L + + + R + + Q+ G+ Y + HRDL N L+ +
Sbjct: 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV-ENE 150
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTL 114
R+KI DFG +K + + V P APE L ++ +DVWS GV L
Sbjct: 151 N-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVL 207
Query: 115 Y 115
Y
Sbjct: 208 Y 208
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 8/131 (6%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ + G L + R CN S + Q+ S + Y HR+L N L+ +
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN 354
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHEYDGKIADVWSCGVTLY- 115
+K+ DFG S+ + APE L +++ K +DVW+ GV L+
Sbjct: 355 HL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWE 411
Query: 116 VMLVGGYPFED 126
+ G P+
Sbjct: 412 IATYGMSPYPG 422
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 35/134 (26%), Positives = 51/134 (38%), Gaps = 13/134 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E A G L +R+ + G F + Q+ G+ Y + + HRDL N LL +
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL-ATR 157
Query: 60 APRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVT 113
+KI DFG + L APE L + +D W GVT
Sbjct: 158 D-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVT 213
Query: 114 LY-VMLVGGYPFED 126
L+ + G P+
Sbjct: 214 LWEMFTYGQEPWIG 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-10
Identities = 39/152 (25%), Positives = 60/152 (39%), Gaps = 13/152 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
MEY G L + + + R + Q+ G+ Y + + HRDL N L+ S
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV-ESE 163
Query: 60 APRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLLRHEYDGKIADVWSCGVT 113
A +KI DFG +K +L V P APE L + + + +DVWS GV
Sbjct: 164 A-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVV 219
Query: 114 LY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144
LY + E + + ++
Sbjct: 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 36/132 (27%), Positives = 58/132 (43%), Gaps = 10/132 (7%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ + G L + R CN S + Q+ S + Y HRDL N L+ +
Sbjct: 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG S+ + + G P + APE L +++ K +DVW+ GV L+
Sbjct: 148 HL--VKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLW 203
Query: 116 -VMLVGGYPFED 126
+ G P+
Sbjct: 204 EIATYGMSPYPG 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+ G L + + + + Q+ G++Y ++ HRDL N L+ +P
Sbjct: 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV-KTP 153
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLRHEYDGKIADVWSCGVTLY- 115
+KI DFG +K + G P ++A E +L Y + +DVWS GVT++
Sbjct: 154 Q-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 211
Query: 116 VMLVGGYPFED 126
+M G P++
Sbjct: 212 LMTFGSKPYDG 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 14/132 (10%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY + G L + R D F + + Y HRDL N L+
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
K+ DFG +K + + + APE L ++ K +DVWS G+ L+
Sbjct: 326 NV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 377
Query: 116 -VMLVGGYPFED 126
+ G P+
Sbjct: 378 EIYSFGRVPYPR 389
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 12/122 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME+ G L E + N + + + + Q+ G+ Y + Q HRDL N L+ S
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-ESE 162
Query: 60 APRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APEVLLRHEYDGKIADVWSCGVT 113
++KI DFG +K + + + TV APE L++ ++ +DVWS GVT
Sbjct: 163 H-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVT 218
Query: 114 LY 115
L+
Sbjct: 219 LH 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 33/132 (25%), Positives = 50/132 (37%), Gaps = 14/132 (10%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY + G L + R D F + + Y HRDL N L+ S
Sbjct: 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV--S 151
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
K+ DFG +K + + + APE L ++ K +DVWS G+ L+
Sbjct: 152 EDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 205
Query: 116 -VMLVGGYPFED 126
+ G P+
Sbjct: 206 EIYSFGRVPYPR 217
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-09
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 34 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 90
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 91 APEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
APE L K +D++S GV L ++ G
Sbjct: 203 APEALRGEITP-K-SDIYSFGVVLLEIITG 230
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 37/133 (27%), Positives = 54/133 (40%), Gaps = 12/133 (9%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME A G L + + + Q+ G+ Y HRDL N LL +
Sbjct: 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL-VTQH 154
Query: 61 PRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRHEYDGKIADVWSCGVTL 114
KI DFG SK L + K+ P + APE + +++ K +DVWS GV +
Sbjct: 155 -YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLM 210
Query: 115 Y-VMLVGGYPFED 126
+ G P+
Sbjct: 211 WEAFSYGQKPYRG 223
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-09
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 11/133 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY G L F R + G+F+ + + + +G+ Y + HRDL N L+D +
Sbjct: 129 TEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187
Query: 59 PAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTL 114
K+ DFG S+ +T G I APE + + +DVWS GV +
Sbjct: 188 LV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVM 244
Query: 115 Y-VMLVGGYPFED 126
+ V+ G P+ +
Sbjct: 245 WEVLAYGERPYWN 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 34/131 (25%), Positives = 51/131 (38%), Gaps = 8/131 (6%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY S G L F + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHEYDGKIADVWSCGVTLY- 115
K+ DFG ++ + APE L + K +DVWS G+ L
Sbjct: 317 LV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 373
Query: 116 VMLVGGYPFED 126
+ G P+
Sbjct: 374 LTTKGRVPYPG 384
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 34/131 (25%), Positives = 51/131 (38%), Gaps = 8/131 (6%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY S G L F + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 399
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHEYDGKIADVWSCGVTLY- 115
K+ DFG ++ + APE L + K +DVWS G+ L
Sbjct: 400 LV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 456
Query: 116 VMLVGGYPFED 126
+ G P+
Sbjct: 457 LTTKGRVPYPG 467
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 32/132 (24%), Positives = 59/132 (44%), Gaps = 10/132 (7%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY G L F + + + + ++ Q+ G+++ HRDL+ N L+ +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
+ KI DFG ++ + ++ + G I APE + + K +DVWS G+ L
Sbjct: 146 LS--CKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLT 201
Query: 116 -VMLVGGYPFED 126
++ G P+
Sbjct: 202 EIVTHGRIPYPG 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 11/132 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ G L + R G F+ + + G++Y V HRDL N L+ +
Sbjct: 82 TEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN 140
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG ++ VL Q S+ GT + +PEV Y K +DVWS GV ++
Sbjct: 141 QV--IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMW 196
Query: 116 -VMLVGGYPFED 126
V G P+E+
Sbjct: 197 EVFSEGKIPYEN 208
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 40/120 (33%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G L + + + F QQ+ G++Y HA HRDL N LL +
Sbjct: 114 MEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL-DNDR 171
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY 115
+KI DFG +K+ V V APE L +++ +DVWS GVTLY
Sbjct: 172 -LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 12/133 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+Y G L + + + G + Q+ G+ Y + HR+L N LL SP
Sbjct: 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL-KSP 151
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTL 114
+ ++++ DFG + +L K + + A A E + +Y + +DVWS GVT+
Sbjct: 152 S-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTV 207
Query: 115 Y-VMLVGGYPFED 126
+ +M G P+
Sbjct: 208 WELMTFGAEPYAG 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 37/134 (27%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME A GG L + + Q+ G+ Y HRDL N LL +
Sbjct: 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL-VNR 146
Query: 60 APRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRHEYDGKIADVWSCGVT 113
KI DFG SK L + + P + APE + ++ + +DVWS GVT
Sbjct: 147 H-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVT 202
Query: 114 LY-VMLVGGYPFED 126
++ + G P++
Sbjct: 203 MWEALSYGQKPYKK 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+ G L + + + + Q+ G++Y ++ HRDL N L+ +P
Sbjct: 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV-KTP 153
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLRHEYDGKIADVWSCGVTLY- 115
+KI DFG +K + G P ++A E +L Y + +DVWS GVT++
Sbjct: 154 Q-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 211
Query: 116 VMLVGGYPFED 126
+M G P++
Sbjct: 212 LMTFGSKPYDG 222
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 37/90 (41%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 34 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 90
G+ Y H + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 91 APEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
PE ++ K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVLCA 237
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 13/134 (9%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME A GG L + + Q+ G+ Y HR+L N LL +
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL-VNR 472
Query: 60 APRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVT 113
KI DFG SK L + + + APE + ++ + +DVWS GVT
Sbjct: 473 H-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVT 528
Query: 114 LY-VMLVGGYPFED 126
++ + G P++
Sbjct: 529 MWEALSYGQKPYKK 542
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 11/133 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY G L F R G FS + + + +G+ Y M HRDL N L++ +
Sbjct: 125 TEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183
Query: 59 PAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTL 114
K+ DFG S+ + +T G I APE + ++ +DVWS G+ +
Sbjct: 184 LV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVM 240
Query: 115 Y-VMLVGGYPFED 126
+ VM G P+ +
Sbjct: 241 WEVMTYGERPYWE 253
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 15/135 (11%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY G L F R + +F+ + + + SG+ Y M HRDL N L++ +
Sbjct: 125 TEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183
Query: 59 PAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYDGKIADVWSCGV 112
K+ DFG + VL P +T G I +PE + ++ +DVWS G+
Sbjct: 184 LV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGI 238
Query: 113 TLY-VMLVGGYPFED 126
L+ VM G P+ +
Sbjct: 239 VLWEVMSYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 39/132 (29%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY S G L + R + + + G+++ + Q HRDL N L+D
Sbjct: 82 TEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD 140
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG ++ VL Q S+VGT + APEV +Y K +DVW+ G+ ++
Sbjct: 141 LC--VKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMW 196
Query: 116 -VMLVGGYPFED 126
V +G P++
Sbjct: 197 EVFSLGKMPYDL 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 10/132 (7%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ + G L F + + + F Q+ G+++ HRDL+ N L+ S
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
KI DFG ++ + ++ + G I APE + + K +DVWS G+ L
Sbjct: 321 LV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLM 376
Query: 116 -VMLVGGYPFED 126
++ G P+
Sbjct: 377 EIVTYGRIPYPG 388
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 11/119 (9%)
Query: 27 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 86
+ Q+ G+ + + + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 87 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 139
A + APE + Y + +DVWS GV L+ + +G P+ ++F + ++
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-08
Identities = 32/138 (23%), Positives = 51/138 (36%), Gaps = 17/138 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLENT 53
+E +GG+L + + L+ G Y HRD+ N
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212
Query: 54 LLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADV 107
LL R+ KI DFG ++ ++ G A + PE + + K D
Sbjct: 213 LLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDT 269
Query: 108 WSCGVTLY-VMLVGGYPF 124
WS GV L+ + +G P+
Sbjct: 270 WSFGVLLWEIFSLGYMPY 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 17/138 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLENT 53
ME +GG+L + + L+ G Y HRD+ N
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171
Query: 54 LLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADV 107
LL R+ KI DFG ++ ++ G A + PE + + K D
Sbjct: 172 LLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDT 228
Query: 108 WSCGVTLY-VMLVGGYPF 124
WS GV L+ + +G P+
Sbjct: 229 WSFGVLLWEIFSLGYMPY 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 23/139 (16%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLE 51
+ + G+L F A R E+ Q L+ G+ Y + HRDL
Sbjct: 110 LPFMKHGDLHAFLL---ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIAD 106
N +L + + DFG S+ ++S G + + A E L + Y +D
Sbjct: 167 NCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SD 221
Query: 107 VWSCGVTLY-VMLVGGYPF 124
VW+ GVT++ +M G P+
Sbjct: 222 VWAFGVTMWEIMTRGQTPY 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 32/132 (24%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME + GEL + + QL + ++Y + + HRD+ N L+ +
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 528
Query: 60 APRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG S+ + K++ G P ++APE + + +DVW GV ++
Sbjct: 529 C--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMW 583
Query: 116 -VMLVGGYPFED 126
+++ G PF+
Sbjct: 584 EILMHGVKPFQG 595
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 11/132 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY + G L + R RF + + + + Y + Q HRDL N L++
Sbjct: 98 TEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG S+ VL + S+VG+ + PEVL+ ++ K +D+W+ GV ++
Sbjct: 157 GV--VKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMW 212
Query: 116 -VMLVGGYPFED 126
+ +G P+E
Sbjct: 213 EIYSLGKMPYER 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 36/147 (24%), Positives = 57/147 (38%), Gaps = 29/147 (19%)
Query: 1 MEYASGGEL-----------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQ 42
EY G+L + +DE + L+S G+++ +
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165
Query: 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLR 97
HRDL N LL KICDFG ++ + + V A + APE +
Sbjct: 166 CIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFN 221
Query: 98 HEYDGKIADVWSCGVTLY-VMLVGGYP 123
Y + +DVWS G+ L+ + +G P
Sbjct: 222 CVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 32/132 (24%), Positives = 58/132 (43%), Gaps = 11/132 (8%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
ME + GEL F + + QL + ++Y + + HRD+ N L+ +
Sbjct: 94 MELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN 152
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHEYDGKIADVWSCGVTLY 115
+K+ DFG S+ + S P ++APE + + +DVW GV ++
Sbjct: 153 DC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMW 208
Query: 116 -VMLVGGYPFED 126
+++ G PF+
Sbjct: 209 EILMHGVKPFQG 220
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 34/139 (24%), Positives = 52/139 (37%), Gaps = 23/139 (16%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCHRDLKLE 51
+ + G+L + R Q L+ G+ Y HRDL
Sbjct: 120 LPFMKYGDLHTYLLYS---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIAD 106
N +L + + DFG SK ++S G A + A E L Y K +D
Sbjct: 177 NCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SD 231
Query: 107 VWSCGVTLY-VMLVGGYPF 124
VW+ GVT++ + G P+
Sbjct: 232 VWAFGVTMWEIATRGMTPY 250
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 31/92 (33%), Positives = 41/92 (44%), Gaps = 20/92 (21%)
Query: 34 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----G 85
G++Y H ++ HRD+K N LLD + DFG +K L + V G
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRG 197
Query: 86 TPAYIAPEVLLRHEYDGKI---ADVWSCGVTL 114
T +IAPE L GK DV+ GV L
Sbjct: 198 TIGHIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 9/131 (6%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME GEL + N + Q+ ++Y ++ HRD+ + N L+
Sbjct: 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE 150
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIADVWSCGVTLY- 115
+K+ DFG S+ + T I +PE + + +DVW V ++
Sbjct: 151 C--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWE 206
Query: 116 VMLVGGYPFED 126
++ G PF
Sbjct: 207 ILSFGKQPFFW 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 32/143 (22%), Positives = 56/143 (39%), Gaps = 25/143 (17%)
Query: 1 MEYASGGELFE-------RICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVCHR 46
EY G+L + F+ + + L+ G+++ + HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 47 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYD 101
D+ N LL + KI DFG ++ + + V A + APE + Y
Sbjct: 189 DVAARNVLL--TNGHVAKIGDFGLARD--IMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244
Query: 102 GKIADVWSCGVTLY-VMLVGGYP 123
+ +DVWS G+ L+ + +G P
Sbjct: 245 VQ-SDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 39/219 (17%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVC 44
+EYAS G L + E + F+ L+S G+ Y + +
Sbjct: 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N L+ + +KI DFG ++ +++ T + APE L
Sbjct: 226 HRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRV 281
Query: 100 YDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156
Y + +DVWS GV ++ + +GG YP +E K R+ P E
Sbjct: 282 YTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-----DKPANCT--NE 333
Query: 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 195
++ + A P+ R T ++ L + +E
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQL---VEDLDRILTLTTNE 369
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 27/146 (18%)
Query: 1 MEYASGGELFE---------RICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVC 44
EY G+L + I G+ + + Q++ SG+ Y +
Sbjct: 96 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV 155
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N L+ +KI DFG S+ ++S VG + PE ++ +
Sbjct: 156 HRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRK 211
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYPF 124
+ + +DVWS GV L+ + G P+
Sbjct: 212 FTTE-SDVWSFGVILWEIFTYGKQPW 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 25/139 (17%), Positives = 49/139 (35%), Gaps = 21/139 (15%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ G L + + N + +QL + + + + H ++ +N LL
Sbjct: 91 QEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 59 PAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI----ADVW 108
+ K+ D G S + + + + ++ PE + + K D W
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPECIE----NPKNLNLATDKW 202
Query: 109 SCGVTLY-VMLVGGYPFED 126
S G TL+ + G P
Sbjct: 203 SFGTTLWEICSGGDKPLSA 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 27/145 (18%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVC 44
+EYAS G L + E + F+ L+S G+ Y + +
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N L+ + +KI DFG ++ +++ T + APE L
Sbjct: 180 HRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYP 123
Y + +DVWS GV ++ + +GG P
Sbjct: 236 YTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 12/132 (9%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ + + + HRDL N +LD
Sbjct: 170 LPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVT 113
+K+ DFG ++ T A + A E L ++ K +DVWS GV
Sbjct: 229 FT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVL 285
Query: 114 LY-VMLVGGYPF 124
L+ +M G P+
Sbjct: 286 LWELMTRGAPPY 297
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 39/145 (26%), Positives = 59/145 (40%), Gaps = 27/145 (18%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVC 44
+EYAS G L + E + + L+S G+ Y + +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N L+ + +KI DFG ++ +H T + APE L
Sbjct: 214 HRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYP 123
Y + +DVWS GV L+ + +GG P
Sbjct: 270 YTHQ-SDVWSFGVLLWEIFTLGGSP 293
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 39/145 (26%), Positives = 55/145 (37%), Gaps = 30/145 (20%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVC 44
+EYA G L E + + QQL+ G+ Y Q
Sbjct: 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 164
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N L+ + KI DFG S+ ++ T + A E L
Sbjct: 165 HRDLAARNILVGENYV--AKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSV 217
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYP 123
Y +DVWS GV L+ ++ +GG P
Sbjct: 218 YTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 14/133 (10%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ Y + + HRDL N +LD
Sbjct: 106 LPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHEYDGKIADVWSCGV 112
+K+ DFG ++ + + S ++A E L ++ K +DVWS GV
Sbjct: 165 FT--VKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGV 220
Query: 113 TLY-VMLVGGYPF 124
L+ +M G P+
Sbjct: 221 LLWELMTRGAPPY 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 34/146 (23%), Positives = 55/146 (37%), Gaps = 27/146 (18%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLIS-------GVSYCHAMQVC 44
+E+ G L + + LI G+ + + +
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
HRDL N LL +KICDFG ++ ++ P A + APE +
Sbjct: 171 HRDLAARNILLSEKNV--VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRV 226
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYPF 124
Y + +DVWS GV L+ + +G P+
Sbjct: 227 YTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-06
Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSP 59
+E+ GG E++ S A+ QL + ++ +++ HRDL N LL +
Sbjct: 141 LEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199
Query: 60 APRLKICDFGYS 71
+L G S
Sbjct: 200 LKKLHYTLNGKS 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 26/145 (17%)
Query: 1 MEYASGGELFE--------RICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVCH 45
EY G+L AG QL+ +G+ Y + H
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181
Query: 46 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEY 100
RDL N L+ +KI DFG S+ ++S VG + PE +L ++
Sbjct: 182 RDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 101 DGKIADVWSCGVTLY-VMLVGGYPF 124
+ +DVWS GV L+ + G P+
Sbjct: 238 TTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 37/128 (28%), Positives = 55/128 (42%), Gaps = 18/128 (14%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKIC 66
+LF C+ + S Q+I+ V + H+ HRD+K +N L+ G A ++ I
Sbjct: 91 DLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
Query: 67 DFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLY 115
DFG +K S+ H + K+ GT Y + L E D D+ S G L
Sbjct: 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRD----DLESLGYVLM 204
Query: 116 VMLVGGYP 123
L G P
Sbjct: 205 YFLRGSLP 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-06
Identities = 30/140 (21%), Positives = 56/140 (40%), Gaps = 21/140 (15%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEAR--------FFFQQLISGVSYCHAMQVCHRDLKL 50
ME + G+L + R + ++ G++Y +A + HRDL
Sbjct: 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166
Query: 51 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIA 105
N ++ + +KI DFG ++ ++ G + +PE L + +
Sbjct: 167 RNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-S 221
Query: 106 DVWSCGVTLY-VMLVGGYPF 124
DVWS GV L+ + + P+
Sbjct: 222 DVWSFGVVLWEIATLAEQPY 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 28/146 (19%), Positives = 55/146 (37%), Gaps = 27/146 (18%)
Query: 1 MEYASGGEL---------FERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQVC 44
Y S G+L + + ++ + +G+ Y + V
Sbjct: 91 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV 150
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHE 99
H+DL N L+ +KI D G + +++ + + + APE ++ +
Sbjct: 151 HKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLGNSLLPIRWMAPEAIMYGK 206
Query: 100 YDGKIADVWSCGVTLY-VMLVGGYPF 124
+ +D+WS GV L+ V G P+
Sbjct: 207 FSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 18/108 (16%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---S 78
Q+++ V H + +RD+K +N L+ + A + + DFG K + H
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 79 QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 123
+ K+ GT Y++ L E D D+ + G L G P
Sbjct: 174 EKKNLSGTARYMSINTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 36/132 (27%), Positives = 58/132 (43%), Gaps = 12/132 (9%)
Query: 1 MEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
+ Y G+L F R + + F Q+ G+ Y + HRDL N +LD S
Sbjct: 102 LPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160
Query: 59 PAPRLKICDFGYSK---SSVLHSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVT 113
+K+ DFG ++ +S + P + A E L + + K +DVWS GV
Sbjct: 161 FT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVL 217
Query: 114 LY-VMLVGGYPF 124
L+ ++ G P+
Sbjct: 218 LWELLTRGAPPY 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 18/108 (16%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---S 78
QLIS + Y H+ + +RD+K EN L+ ++ DF +K + H
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 79 QPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 123
+ KS GT Y++ L E D D+ + G L G P
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 38/152 (25%), Positives = 54/152 (35%), Gaps = 34/152 (22%)
Query: 1 MEYASGGEL----------------FERICNAGRFSEDEARFFFQQLIS-------GVSY 37
EY G+L ED F+ L+ G+ +
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 38 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 92
HRDL N L+ +KICDFG ++ + S V A + AP
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD--IMSDSNYVVRGNARLPVKWMAP 243
Query: 93 EVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 123
E L Y K +DVWS G+ L+ + +G P
Sbjct: 244 ESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 41/154 (26%), Positives = 61/154 (39%), Gaps = 35/154 (22%)
Query: 1 MEYASGGEL-----------------FERICNAGRFSEDEARFFFQQLIS-------GVS 36
+EYA G L ++ DE LIS G+
Sbjct: 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 37 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 91
Y M++ HRDL N L+ +KI DFG S+ ++ + + I A
Sbjct: 165 YLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYEEDSYVKRSQGRIPVKWMA 220
Query: 92 PEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
E L H Y + +DVWS GV L+ ++ +GG P+
Sbjct: 221 IESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 8e-05
Identities = 41/285 (14%), Positives = 81/285 (28%), Gaps = 78/285 (27%)
Query: 15 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74
N + E Q ++ ++ + D S +L+I
Sbjct: 188 NLKNCNSPETVLEMLQ-----------KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 75 VLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVW--SC---------GVTLYVMLVGG 121
+L S+P Y L L + + K + + SC VT ++
Sbjct: 237 LLKSKP--------Y--ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 122 YPFE--------DPDEPKD-FRKTI-QRILSVQYSVPDTNP-----ISQECRDLISRIFV 166
PDE K K + R + V TNP I++ RD ++
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-- 344
Query: 167 ADPAARITIPEIMKH-QWFLKNLPADLVDEKTMSSQYEE----PDQPMQSVDVIMQIIAE 221
D + ++ + L L + ++ P S + ++
Sbjct: 345 -DNWKHVNCDKLTTIIESSLNVL-----EPAEYRKMFDRLSVFPP----SAHIPTILL-- 392
Query: 222 ASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIY 266
S+ + + + M ++ L S ++ I
Sbjct: 393 -SL-------IWFDVIKSDVM--VVVNKLHKYSLVEKQPKESTIS 427
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 35/154 (22%)
Query: 1 MEYASGGEL-----------------FERICNAGRFSEDEARFFFQQLI-------SGVS 36
EY + G+L + A S + + +G++
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188
Query: 37 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 91
Y + HRDL N L+ +KI DFG S++ ++S I
Sbjct: 189 YLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYSADYYKADGNDAIPIRWMP 244
Query: 92 PEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 124
PE + + Y + +DVW+ GV L+ + G P+
Sbjct: 245 PESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 18/128 (14%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKIC 66
+LF C+ +FS Q+IS + Y H+ HRD+K +N L+ G + I
Sbjct: 93 DLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 150
Query: 67 DFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLRHEY---DGKIADVWSCGVTLY 115
DFG +K + H + K+ GT Y + L E D D+ S G L
Sbjct: 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD----DLESLGYVLM 206
Query: 116 VMLVGGYP 123
+G P
Sbjct: 207 YFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 13/91 (14%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 8 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67
+ SE +L+ + + H + H ++ EN +D ++ +
Sbjct: 146 SALDV-SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 68 FGYSK---SSVLH-----SQPKSTVGTPAYI 90
+G++ S H G +I
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 11/43 (25%), Positives = 21/43 (48%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 10/43 (23%), Positives = 22/43 (51%)
Query: 30 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.82 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.66 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.89 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 94.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 91.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.05 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 88.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 85.7 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 85.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 85.54 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 84.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 84.35 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 84.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 83.4 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 82.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.12 |
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=376.92 Aligned_cols=267 Identities=83% Similarity=1.344 Sum_probs=174.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.+++||+|||+|+........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 79999999999999888999999999999999999999999999999999999998777667999999999865555555
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
...+||+.|+|||++.+..++++++|||||||++|+|++|+.||.+......+.+.++.+....+..+....+++.+.+|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 66789999999999988888777689999999999999999999887766667777777777777777777799999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCCcccchhhhcccCCCCCCCCCCHHHHHHHHHHhCCCCCCCcCccccccCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL 240 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
|.+||+.||.+|||+.++++||||.+..+..........+.+..+.++.++++.+.+.+.++..+............++.
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNL 334 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC---------------
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhcccccc
Confidence 99999999999999999999999998887777666666677778888899999999999999998876655555555554
Q ss_pred CCCCccccccccccccccCCCCcccccC
Q 024363 241 DMDDDDMDDLDSESELDIDSSGEIIYAL 268 (268)
Q Consensus 241 ~~~~~d~d~~~~~~~~d~~~~g~~~~~~ 268 (268)
+.| ++++++|++++.|.|++|+|+||+
T Consensus 335 d~d-~~~~~~d~~~~~d~d~~g~~~~~~ 361 (361)
T 3uc3_A 335 DLD-DDMDDFDSESEIDIDSSGEIVYAL 361 (361)
T ss_dssp ----------------------------
T ss_pred ccc-cccccccchhhhccCCCCcEEecC
Confidence 444 344456677889999999999995
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=348.30 Aligned_cols=181 Identities=46% Similarity=0.791 Sum_probs=146.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||| +|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCeecCCCCcc
Confidence 7999 679999999999999999999999999999999999999999999999997665 4999999999876555556
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+||+.|||||++.+..|++.++||||+||++|+|++|+.||.+.+... ..+.+....+.+| ..+|+++++|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~l 242 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNISNGVYTLP--KFLSPGAAGL 242 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC--TTSCHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHH
Confidence 678999999999999988887766999999999999999999998765433 3333444444444 3489999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|.+||+.||.+|||+.|+++||||+...+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 999999999999999999999999766543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=349.42 Aligned_cols=177 Identities=34% Similarity=0.638 Sum_probs=151.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.... ...
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC-----CC
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEecccccceeccCCCcc
Confidence 89999999999999999999999999999999999999999999999999999997665 499999999985433 334
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+. .+......+| ..+|+++++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~ 255 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MILKAKLGMP--QFLSPEAQS 255 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHH----HHHcCCCCCC--CcCCHHHHH
Confidence 566789999999999998888766 999999999999999999998876544333 3344444444 448999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
||.+||+.||.+||| ++|+++||||+.
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999999998 589999999954
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=351.11 Aligned_cols=183 Identities=30% Similarity=0.533 Sum_probs=154.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+ +++++.+++.++.||+.||+|||++|||||||||+|||++.++ ++||+|||+|+..... ..
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCCCc
Confidence 899999999999876 5799999999999999999999999999999999999997665 4999999999864433 34
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+..+... .....+.+..+|+++++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SCCCCSCGGGSCHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCCccccCCHHHHH
Confidence 567789999999999988888665 99999999999999999999887654444333221 12233344558999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
||.+||+.||.+|||+.|+|+||||++..++
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 9999999999999999999999999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=349.65 Aligned_cols=181 Identities=31% Similarity=0.593 Sum_probs=154.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---~ 77 (268)
||||+||+|.++|.+.+.++|.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.... .
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceecCCCCCc
Confidence 89999999999999999999999999999999999999999999999999999997665 499999999985432 2
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
....+.+||+.|||||++.+..|+.+ +||||+||++|+|++|+.||.+.+.... +..+....+.+|. .+|+++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~ 261 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPE--KFFPKA 261 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT--TCCHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--ccCHHH
Confidence 23456789999999999998888655 9999999999999999999988765443 3344445555544 489999
Q ss_pred HHHHHHccccCCCCCCCHHH------HhcccccCCCCCCc
Q 024363 158 RDLISRIFVADPAARITIPE------IMKHQWFLKNLPAD 191 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e------~l~h~~~~~~~~~~ 191 (268)
++||.+||++||.+|||+.| +++||||.. ..+.
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~-idw~ 300 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES-VTWE 300 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT-CCCT
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC-CCHH
Confidence 99999999999999999987 689999953 4443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=341.64 Aligned_cols=179 Identities=23% Similarity=0.434 Sum_probs=148.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++.. .+.+||+|||+|+... ..
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~~-~~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-AS 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGCC-TT
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeCC-CC
Confidence 799999999999999999999999999999999999999999 9999999999999642 2359999999997532 23
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
...+.+||+.|||||++.+ .|+.+ +|||||||++|+|++|+.||.+......+... +.........+..++++++
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCCHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH---HHcCCCCCCCCccCCHHHH
Confidence 3456789999999999865 56655 99999999999999999999877665443332 2222221222344789999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+||.+||+.||.+|||+.++|+||||++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=350.74 Aligned_cols=183 Identities=30% Similarity=0.533 Sum_probs=154.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.. +++++.+++.++.||+.||+|||++|||||||||+|||++.++ ++||+|||+|+..... ..
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSSCCC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCCCcc
Confidence 899999999999865 5799999999999999999999999999999999999997665 4999999999864433 34
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+..+... .....+....+|+++++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSCTTSSCHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCcccccCCHHHHH
Confidence 567789999999999998888665 99999999999999999999887654444332221 12233445568999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
||.+||+.||.+|||+.|+|+||||++..+.
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 9999999999999999999999999876443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=349.55 Aligned_cols=182 Identities=28% Similarity=0.503 Sum_probs=152.5
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.++|... ..++|.+++.++.||+.||+|||++|||||||||+|||++.++ ++||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeecCCc
Confidence 8999999999999754 3579999999999999999999999999999999999997665 49999999998643321
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
...+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+.++. ...+ .+.+..+|+++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~----~~~~-~~~~~~~s~~~ 253 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKII----SGSF-PPVSLHYSYDL 253 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HTCC-CCCCTTSCHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH----cCCC-CCCCccCCHHH
Confidence 2245679999999999998888665 999999999999999999998876554444333 3322 23345589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++||.+||+.||.+|||+.|+|+||||++....
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~ 286 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence 999999999999999999999999999875443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=340.99 Aligned_cols=181 Identities=26% Similarity=0.394 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.++|++.+.+++.+++.++.||+.||+|||++|||||||||+|||++.++. ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcc
Confidence 899999999999999999999999999999999999999999999999999999976542 49999999997543221
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC-CCCCCC
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV-PDTNPI 153 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 153 (268)
.....+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+......++... .... ..+..+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~ 282 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----PPPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----CCGGGGSCTTS
T ss_pred cceecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----CCCchhcCccC
Confidence 1234579999999999998888766 99999999999999999999887665544444332 2111 223458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHH-------------hcccccCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEI-------------MKHQWFLKN 187 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~-------------l~h~~~~~~ 187 (268)
|+.+.+||.+||++||.+|||+.|+ ++|||+.+.
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999999999999999999997 568888653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=337.87 Aligned_cols=185 Identities=25% Similarity=0.410 Sum_probs=154.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 138 mE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~ 214 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAE 214 (398)
T ss_dssp EECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC------
T ss_pred EeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCccc
Confidence 79996 689999999999999999999999999999999999999999999999976654 99999999975422
Q ss_pred -CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc---------
Q 024363 77 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------- 146 (268)
Q Consensus 77 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 146 (268)
.....+.+||+.|||||++.+..+.+.++||||+||++|+|++|++||.+.+....+..++.........
T Consensus 215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~ 294 (398)
T 4b99_A 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294 (398)
T ss_dssp -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 2334567899999999999887766666999999999999999999999888776666655443222110
Q ss_pred -------CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 147 -------VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 147 -------~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+. ...+|+++.+||.+||++||.+|||+.|+|+||||++..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 111 123689999999999999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=334.86 Aligned_cols=182 Identities=27% Similarity=0.469 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.....
T Consensus 99 mE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence 7999999999998 4599999999999999999999999999999999999997542 35999999999642211
Q ss_pred --------------------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH
Q 024363 78 --------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 131 (268)
Q Consensus 78 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 131 (268)
....+.+||++|||||++.+..+++.++||||+||++|+|++|+.||...+...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 122345799999999999887655566999999999999999999997665443
Q ss_pred HHHHHHHHHhc-----------------------------------cc--------------ccCCCCCCCCHHHHHHHH
Q 024363 132 DFRKTIQRILS-----------------------------------VQ--------------YSVPDTNPISQECRDLIS 162 (268)
Q Consensus 132 ~~~~~~~~~~~-----------------------------------~~--------------~~~~~~~~~s~~~~~li~ 162 (268)
.....+..+.. .. ...+.+..+|+++++||+
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 32222211110 00 011223458899999999
Q ss_pred HccccCCCCCCCHHHHhcccccCC
Q 024363 163 RIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 163 ~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+||++||.+|+|++|+|+||||+.
T Consensus 335 ~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999963
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=353.45 Aligned_cols=195 Identities=29% Similarity=0.480 Sum_probs=158.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.++|.+.+.|+|..++.++.||+.||+|||++|||||||||+|||++.++ ++||+|||+|+.... ...
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~~-~~~ 347 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKP 347 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS-CCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecCC-CCC
Confidence 89999999999999999999999999999999999999999999999999999997665 499999999985433 334
Q ss_pred CCCcCCCCcccchhhccC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.+.+||+.|||||++.+. .|+ .++|||||||++|+|++|++||.+.+... ...+...+......+| ..+|+++++
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p--~~~S~~a~d 423 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELP--DSFSPELRS 423 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCC--ccCCHHHHH
Confidence 677999999999999754 554 45999999999999999999997644322 2234445555554444 448999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCCCCCCcccchhhhcccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYE 203 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~~~~~~~~~~~~~~~~~~ 203 (268)
||.+||+.||.+|++ ++++++||||+ ...+.....+...+++.
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~-~idW~~l~~~~~~pP~~ 471 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR-SLDWQMVFLQKYPPPLI 471 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT-TCCHHHHHTTCSCCSCC
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCcccc-CCCHHHHHcCCCCcCcc
Confidence 999999999999998 79999999995 34454443333333333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=318.62 Aligned_cols=179 Identities=21% Similarity=0.358 Sum_probs=141.4
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
||||+||+|.++|... +++++.++..++.||+.||+|||+++||||||||+|||++.++. +||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCc
Confidence 7999999999999764 57999999999999999999999999999999999999987654 99999999985432
Q ss_pred CCCCCCCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
.....+.+||+.|||||++.+. .|+.+ +|||||||++|||+||+.||.+.+....+...+............+..+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 2233456899999999999643 35444 9999999999999999999998776555444433221111111223458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
|+++.+||.+||+.||.+|||+.+++.+.
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 89999999999999999999999887653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.05 Aligned_cols=182 Identities=32% Similarity=0.579 Sum_probs=156.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|+++|.+ .+.|++.+++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+.......
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 799999999999964 4689999999999999999999999999999999999999876556799999999987655555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
....+||+.|||||++.+..|..+ +|||||||++|+|++|+.||.+.+....+. .+....+.++ .+..+|+++
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLR----NVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCSGGGTTSCHHH
T ss_pred eeeeEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHhCCCCCCcccccCCCHHH
Confidence 566789999999999998888655 999999999999999999999877654433 3334433332 335689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++||.+||+.||.+|||+.|+|+||||+..
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=315.17 Aligned_cols=176 Identities=21% Similarity=0.354 Sum_probs=133.7
Q ss_pred CCCCCCCchhHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRF---SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l---~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++.+.+.+ ++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 94 mE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQD 171 (299)
T ss_dssp EECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCCCC------
T ss_pred EecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEEEccCccceecCCC
Confidence 7999999999999877654 4567899999999999999999999999999999997665 4999999999754322
Q ss_pred C-------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 024363 78 S-------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144 (268)
Q Consensus 78 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (268)
. ..++.+||+.|||||++.+..|+.+ +|||||||++|||++ ||.... .....+..+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~~~~~~~~~~ 244 (299)
T 4g31_A 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVRTLTDVRNLK 244 (299)
T ss_dssp --------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHHHHHHHHTTC
T ss_pred ccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHHHHHHHhcCC
Confidence 1 1234579999999999998888765 999999999999996 775422 1222333333222
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+ .+.....++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 245 ~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 245 F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 1 1112235677899999999999999999999999999964
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=317.02 Aligned_cols=174 Identities=22% Similarity=0.412 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.++|++. ..+++.++..++.||+.||+|||+++||||||||+|||++.++. +|
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vK 225 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VK 225 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC--EE
Confidence 7999999999999753 34899999999999999999999999999999999999977654 99
Q ss_pred EeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+|+....... ..+..||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+......+.+.+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~- 303 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 303 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc-
Confidence 999999986433322 234579999999999998888766 999999999999998 99999987655544443332
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 304 ---g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 304 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 23344455589999999999999999999999999987
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=309.75 Aligned_cols=172 Identities=23% Similarity=0.376 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEee
Q 024363 1 MEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 67 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~D 67 (268)
||||+||+|.++|.+. ..+++.+++.++.||+.||+|||+++||||||||+|||++.++. +||+|
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~D 171 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGD 171 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEECC
Confidence 7999999999999764 36999999999999999999999999999999999999977654 99999
Q ss_pred cCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 68 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 68 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
||+|+...... ......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+....... +...
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~~ 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQG 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHHT
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcC
Confidence 99997432221 2234569999999999998888766 999999999999998 8999998775443333 2222
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+.+..+|+++.+||.+||+.||++|||+.+++.
T Consensus 247 -~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 247 -RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223444568999999999999999999999999953
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=310.56 Aligned_cols=173 Identities=21% Similarity=0.373 Sum_probs=138.7
Q ss_pred CCCCCCCchhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEE
Q 024363 1 MEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 65 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl 65 (268)
||||+||+|.+++.+. +++++.++..++.||+.||+|||+++||||||||+|||++.++. +||
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki 199 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKI 199 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EEE
Confidence 7999999999999753 35999999999999999999999999999999999999987654 999
Q ss_pred eecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHh
Q 024363 66 CDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRIL 141 (268)
Q Consensus 66 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~ 141 (268)
+|||+|+..... .......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+....+..+.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~---- 274 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT---- 274 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH----
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH----
Confidence 999999854322 22345679999999999998888766 999999999999998 899998877644333322
Q ss_pred cccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 142 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 142 ~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
. ....+.+..+|+++.+||.+||+.||.+|||+.+++.+
T Consensus 275 ~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 Q-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp H-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred c-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2 22344455689999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=306.99 Aligned_cols=173 Identities=20% Similarity=0.339 Sum_probs=145.3
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.++|... ..+++.++..++.||+.||+|||+++||||||||+|||++.++. +|
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~K 185 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VK 185 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--EE
Confidence 7999999999999653 35899999999999999999999999999999999999976654 99
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+|+..... .......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+..... ..+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~----~~i 260 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----EMI 260 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHH----HHH
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHH----HHH
Confidence 9999999853322 23445689999999999998888766 999999999999998 89999887654332 222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.. ....+.+..+|..+.+||.+||+.||.+|||+.+++++
T Consensus 261 ~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 23345556689999999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.48 Aligned_cols=198 Identities=28% Similarity=0.554 Sum_probs=157.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (268)
||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+... ....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeeecccCCCc
Confidence 79999999999999989999999999999999999999999999999999999997665 49999999998532 3344
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH-----HHHHHHHHhcccccCCCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-----FRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~s 154 (268)
..+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .....+.+......+|. .+|
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 286 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 286 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred cccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence 556789999999999998887655 9999999999999999999975432111 11233344444444443 489
Q ss_pred HHHHHHHHHccccCCCCCCCH------HHHhcccccCCCCCCcccchhhhcccCCC
Q 024363 155 QECRDLISRIFVADPAARITI------PEIMKHQWFLKNLPADLVDEKTMSSQYEE 204 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~------~e~l~h~~~~~~~~~~~~~~~~~~~~~~~ 204 (268)
.++++||++||+.||.+||++ .++++||||.. ..+.....+...+++.+
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~-i~w~~l~~~~~~pp~~p 341 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN-VDWDMMEQKQVVPPFKP 341 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT-CCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC-CCHHHHHcCCCCCCCcC
Confidence 999999999999999999984 89999999953 44544444444444443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=300.63 Aligned_cols=180 Identities=41% Similarity=0.766 Sum_probs=156.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcc
Confidence 799999999999998899999999999999999999999999999999999999976654 999999999865555555
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
...+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.... ...+....+..|. .+|+++.+|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~l 244 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRGKYRIPF--YMSTDCENL 244 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHH
Confidence 6778999999999999888876679999999999999999999987764333 3334444444443 389999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
|.+||..||.+|||+.++++||||....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.15 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=197.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+|+.......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 79999999999999888999999999999999999999999999999999999997543 34599999999986555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~ 157 (268)
....+||+.|+|||++.+ .++.+ +||||+||++|+|++|..||.+......+..+ ....+. .+.+..+|+.+
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKV----EKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHTCCCCCSGGGTTSCHHH
T ss_pred ccccCCCcCeeCHHHHcc-cCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCCchhcccCCHHH
Confidence 566789999999999864 46554 99999999999999999999887664443333 223222 23345689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCC--------cccchhhhcccCCCC--------------CCCCCCHHHH
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA--------DLVDEKTMSSQYEEP--------------DQPMQSVDVI 215 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~--------~~~~~~~~~~~~~~~--------------~~~~~~~~~~ 215 (268)
.+||.+||+.||.+|||+.++|+||||++.... ...........+... .........+
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l 348 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKEL 348 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHH
Confidence 999999999999999999999999999652110 000000011111111 1133456778
Q ss_pred HHHHHHhCCCCCCCcCccccccCCC----------CCCCccccccccccccccCCCCccccc
Q 024363 216 MQIIAEASIPAVGTHGLNCYMTDNL----------DMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+.|...+.+..|..+.+++..... +....+.+..+.+...|.|++|+|++.
T Consensus 349 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~ 410 (494)
T 3lij_A 349 TDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYS 410 (494)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred HHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHH
Confidence 8999999999999999988855321 112234555666777899999999873
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=305.83 Aligned_cols=177 Identities=34% Similarity=0.623 Sum_probs=147.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCC----
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceeecccCCcc
Confidence 79999999999999989999999999999999999999999999999999999997665 499999999985332 233
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+......+|. .++.++.+
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~ 253 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFE----AILNDEVVYPT--WLHEDATG 253 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHH
Confidence 456689999999999988777655 999999999999999999998876544333 33444444443 48999999
Q ss_pred HHHHccccCCCCCCCH------HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI------PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~------~e~l~h~~~~~ 186 (268)
||++||+.||.+||++ .++++||||..
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 9999999999999998 89999999964
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=299.17 Aligned_cols=177 Identities=38% Similarity=0.714 Sum_probs=151.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence 79999999999999888999999999999999999999999999999999999997665 499999999985332 233
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...... .+......+| ..+++++.+
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~ 234 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP--RTLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHH
Confidence 456789999999999988877655 999999999999999999998766543333 3333333444 348999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
||.+||+.||.+|| ++.++++||||..
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999999999 8999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=297.73 Aligned_cols=193 Identities=34% Similarity=0.624 Sum_probs=157.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCcc
Confidence 79999999999999888999999999999999999999999999999999999997665 499999999985332 233
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ +.+......+| ..+|.++.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~ 250 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYP--KSMSKEAVA 250 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHH
T ss_pred cccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHH
Confidence 456689999999999988877655 99999999999999999999876654433 33334444444 348999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCCCCCCcccchhhhcccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYE 203 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~~~~~~~~~~~~~~~~~~ 203 (268)
||.+||..||.+||+ +.++++||||.. ..+.....+...+++.
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~-~~w~~l~~~~~~~p~~ 298 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY-IDWEKLERKEIQPPYK 298 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT-CCHHHHHTTCSCCSCC
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC-CCHHHHHhCCCCCCcC
Confidence 999999999999994 699999999953 4444333333444443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.20 Aligned_cols=263 Identities=31% Similarity=0.504 Sum_probs=193.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+|+.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 79999999999999888999999999999999999999999999999999999996432 34699999999986655555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+......+..+... ......+.+..+|+++++
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--KYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCSCSGGGGGSCHHHHH
T ss_pred cCCCcCCCCCCCHHHhCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcccCCCCHHHHH
Confidence 567789999999999875 3544 499999999999999999999887654433332221 112233444568999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCCCccc--chhhh------cccCCCC--------------CCCCCCHHHHHH
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLPADLV--DEKTM------SSQYEEP--------------DQPMQSVDVIMQ 217 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~~--~~~~~------~~~~~~~--------------~~~~~~~~~~~~ 217 (268)
||.+||+.||.+|||+.++|+||||++....... ..... ..++... .........+.+
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~ 335 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTE 335 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHH
Confidence 9999999999999999999999999765432210 00000 0000000 012345577889
Q ss_pred HHHHhCCCCCCCcCccccccCC--------CCC--------CCccccccccccccccCCCCccccc
Q 024363 218 IIAEASIPAVGTHGLNCYMTDN--------LDM--------DDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~--------~~~--------~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.|...+.+.+|..+.+++.... ... ...+.+..+.+...|.|++|+|++.
T Consensus 336 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~ 401 (486)
T 3mwu_A 336 IFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYS 401 (486)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHH
T ss_pred HHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHH
Confidence 9999999999999988873210 000 1124445556677788888888763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.49 Aligned_cols=261 Identities=30% Similarity=0.497 Sum_probs=199.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC-CCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+|+.......
T Consensus 125 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 204 (504)
T 3q5i_A 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204 (504)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc
Confidence 799999999999998889999999999999999999999999999999999999976543 3599999999986555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~ 157 (268)
.....||+.|+|||++.+ .++.+ +||||+||++|+|++|..||.+.+....+.. +....+.+ +.+..+|+++
T Consensus 205 ~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~ 278 (504)
T 3q5i_A 205 LRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFNDWKNISDEA 278 (504)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHH
T ss_pred cccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCccccCCCCHHH
Confidence 567789999999999864 46554 9999999999999999999988765443333 32333222 2234589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCCccc-chh------hhcccCCCC--------------CCCCCCHHHHH
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV-DEK------TMSSQYEEP--------------DQPMQSVDVIM 216 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~~-~~~------~~~~~~~~~--------------~~~~~~~~~~~ 216 (268)
++||.+||+.||.+|||+.++|+||||++....... ... .....+... ..+......+.
T Consensus 279 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~ 358 (504)
T 3q5i_A 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELT 358 (504)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHH
Confidence 999999999999999999999999999765433211 100 001111111 11334567788
Q ss_pred HHHHHhCCCCCCCcCccccccCC----------CCCCCccccccccccccccCCCCccccc
Q 024363 217 QIIAEASIPAVGTHGLNCYMTDN----------LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+.|...+.+..|..+.+++.... ......+.+..+.+...|.|++|+|++.
T Consensus 359 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~ 419 (504)
T 3q5i_A 359 DIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYS 419 (504)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred HHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHH
Confidence 99999999999999998865311 0123344566667778899999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=299.37 Aligned_cols=177 Identities=38% Similarity=0.695 Sum_probs=151.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.... ...
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCCc
Confidence 79999999999999888999999999999999999999999999999999999997665 499999999975432 233
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+......++ ..++.++.+
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~ 247 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIRMDNPFYP--RWLEKEAKD 247 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHH
T ss_pred ccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHhCCCCCC--cccCHHHHH
Confidence 456789999999999988877655 999999999999999999998776544333 3333333333 348999999
Q ss_pred HHHHccccCCCCCCCHH-HHhcccccCC
Q 024363 160 LISRIFVADPAARITIP-EIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~-e~l~h~~~~~ 186 (268)
||.+||..||.+||++. ++++||||..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999998 9999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=296.16 Aligned_cols=181 Identities=30% Similarity=0.565 Sum_probs=149.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++... ....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCCc
Confidence 79999999999999888999999999999999999999999999999999999997665 49999999997533 2233
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhcccccCCCCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ......+.+......+| ..++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~s 243 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLS 243 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--TTSC
T ss_pred ccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--CCCC
Confidence 456689999999999988877655 999999999999999999997532211 11222333444444444 3489
Q ss_pred HHHHHHHHHccccCCCCCCCH------HHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARITI------PEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~------~e~l~h~~~~~ 186 (268)
.++++||.+||+.||.+||++ .++++||||..
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999999985 89999999953
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=300.46 Aligned_cols=181 Identities=33% Similarity=0.603 Sum_probs=153.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC--CCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~ 173 (361)
T 2yab_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (361)
T ss_dssp EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence 799999999999988889999999999999999999999999999999999999975542 259999999998655555
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+. .+....+.++ .+..+|..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 174 EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTSCHH
T ss_pred ccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCchhccCCCHH
Confidence 5567789999999999988777655 999999999999999999998876544333 3333333332 12458999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+++||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.71 Aligned_cols=175 Identities=35% Similarity=0.673 Sum_probs=150.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++... ...
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Ccc
Confidence 79999999999999988999999999999999999999999999999999999997655 49999999997533 233
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+......+| ..++.++.+|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~l 233 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFP--PFFNEDVKDL 233 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHH
Confidence 45689999999999988877665 899999999999999999998766544333 3333444444 3489999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
|.+||..||.+|| +++++++||||..
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999999 8999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.80 Aligned_cols=261 Identities=30% Similarity=0.501 Sum_probs=192.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 6999999999999999999999999999999999999999999999999999999542 345699999999876544444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--cCCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~ 157 (268)
....+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||.+.+....+.. +....+ ..+.+..+|+.+
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCSGGGGGSCHHH
T ss_pred cccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCCcccccCCHHH
Confidence 455679999999999876 45554 9999999999999999999988765443333 323322 233445689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCCcc------cchh-hhcccCCC--------------CCCCCCCHHHHH
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADL------VDEK-TMSSQYEE--------------PDQPMQSVDVIM 216 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~~~------~~~~-~~~~~~~~--------------~~~~~~~~~~~~ 216 (268)
++||.+||+.+|.+|||+.++|+||||+....... .... ....++.. ..........+.
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~ 338 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT 338 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence 99999999999999999999999999975332110 0000 00000000 000223455788
Q ss_pred HHHHHhCCCCCCCcCcccccc----C--CCCCCCc-------cccccccccccccCCCCccccc
Q 024363 217 QIIAEASIPAVGTHGLNCYMT----D--NLDMDDD-------DMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~-------d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+.|...+.+.+|..+.+++.. - ....... +.+..+.+...|.|++|+|++.
T Consensus 339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~ 402 (484)
T 3nyv_A 339 AIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYS 402 (484)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHH
T ss_pred HHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHH
Confidence 899999999999999888722 1 1111111 4455566777799999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.34 Aligned_cols=177 Identities=34% Similarity=0.604 Sum_probs=150.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++... ....
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCCc
Confidence 79999999999999988999999999999999999999999999999999999997665 49999999997532 2334
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.+ +......++ ..++..+++
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~~~~~~--~~~~~~~~~ 268 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLK--PNITNSARH 268 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH----HHHSCCCCC--SSSCHHHHH
T ss_pred cccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcccCCC--CCCCHHHHH
Confidence 556789999999999988877655 9999999999999999999987665444333 333333333 348999999
Q ss_pred HHHHccccCCCCCCCH----HHHhcccccCC
Q 024363 160 LISRIFVADPAARITI----PEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~----~e~l~h~~~~~ 186 (268)
||.+||+.||.+||++ .++++||||..
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999986 69999999954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=316.80 Aligned_cols=192 Identities=33% Similarity=0.616 Sum_probs=158.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC-CCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~-~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+... ....
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTCC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCcc
Confidence 79999999999999989999999999999999999999999999999999999997665 49999999998532 2334
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+.+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+... +.+.+......+|. .++.++.+
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~ 571 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAVA 571 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHH
Confidence 456789999999999988888655 999999999999999999998876543 33444455444443 48999999
Q ss_pred HHHHccccCCCCCCCH-----HHHhcccccCCCCCCcccchhhhcccC
Q 024363 160 LISRIFVADPAARITI-----PEIMKHQWFLKNLPADLVDEKTMSSQY 202 (268)
Q Consensus 160 li~~~l~~dp~~R~s~-----~e~l~h~~~~~~~~~~~~~~~~~~~~~ 202 (268)
||++||+.||.+||++ .++++||||.. ..+.....+...+++
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~-i~w~~l~~~~~~pp~ 618 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY-IDWEKLERKEIQPPY 618 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS-CCHHHHTTTCSCCSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccC-CCHHHHHhCCCCCCC
Confidence 9999999999999997 99999999954 444443333333333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=295.96 Aligned_cols=180 Identities=36% Similarity=0.587 Sum_probs=150.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+......
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSEE
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEeeccCCcc
Confidence 799999999999876 4799999999999999999999999999999999999997665 49999999997543322
Q ss_pred CCCCCcCCCCcccchhhccCc----cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
...+.+||+.|+|||++.+.. ++ .++|||||||++|+|++|+.||.+.+....+.+++.... ...+|....+|
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~s 301 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDIS 301 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCCC
T ss_pred cccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCccccc
Confidence 234678999999999997654 43 459999999999999999999998776555554443322 23445555699
Q ss_pred HHHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
.++++||.+||..+|.+ |++++++++||||+.
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 99999999999999988 999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=299.37 Aligned_cols=181 Identities=37% Similarity=0.687 Sum_probs=152.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 7999999999999999999999999999999999999999999999999999999754 33569999999997644332
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.. +....+. .+....+|++
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhCCCCCCccccccCCHH
Confidence 2345689999999999988777665 9999999999999999999988765443333 3333333 2334568999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+||.+||+.||.+|||+.++|+||||..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.77 Aligned_cols=177 Identities=41% Similarity=0.712 Sum_probs=149.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence 7999999999999988899999999999999999999998 9999999999999997665 499999999975332 23
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ .+......+| ..+++++.
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~ 377 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFP--RTLGPEAK 377 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHH
T ss_pred ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHH
Confidence 3456789999999999988877665 999999999999999999998776543333 2333333333 34899999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+||.+||..||.+|| ++.++++||||..
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999999 9999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=295.98 Aligned_cols=182 Identities=26% Similarity=0.484 Sum_probs=152.1
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 7999999999999765 479999999999999999999999999999999999999865456799999999976544444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+ ....+.++ ....+|.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENI----MNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCCCHHHHTTSCHHH
T ss_pred cccccCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH----HcCCCCCChhhhccCCHHH
Confidence 455679999999999987766554 99999999999999999999887654443333 33333222 123589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+||.+||..||.+|||+.++++||||.+.
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=295.59 Aligned_cols=181 Identities=48% Similarity=0.805 Sum_probs=152.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||| +|+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEeccceeccCCccc
Confidence 7999 789999999889999999999999999999999999999999999999997665 4999999999866555555
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+...... ...+....+ ..+..+|+.+.+|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~--~~p~~~s~~~~~l 238 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKVNSCVY--VMPDFLSPGAQSL 238 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BCCCCSSCC--CCCTTSCHHHHHH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCC--CCcccCCHHHHHH
Confidence 6778999999999998888766679999999999999999999987543221 111112222 2234489999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|.+||..||.+|||+.++++||||....+.
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=294.61 Aligned_cols=180 Identities=24% Similarity=0.464 Sum_probs=150.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTCCB
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceeeeccCCCce
Confidence 79999999999999988999999999999999999999999999999999999997665 4999999999865555556
Q ss_pred CCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 81 KSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
...+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||....... .......+.......+ ..++..+
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~~ 247 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQEM 247 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred eccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHHH
Confidence 67789999999999864 335444 899999999999999999997644322 2233333333333333 4489999
Q ss_pred HHHHHHccccCCCCCCC-HHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARIT-IPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s-~~e~l~h~~~~~ 186 (268)
.+||.+||+.||.+||+ +.++++||||..
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999998 999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.03 Aligned_cols=182 Identities=34% Similarity=0.632 Sum_probs=152.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 172 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172 (326)
T ss_dssp EECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence 79999999999998888999999999999999999999999999999999999997654 2259999999998655444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..+ .......+ ....++..
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANV----SAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HHTCCCCCHHHHTTSCHH
T ss_pred ccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----HhcCCCcCccccccCCHH
Confidence 5566789999999999987777655 89999999999999999999876654433332 22222222 12447899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+.+||.+||..||.+|||+.++++||||...
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.93 Aligned_cols=181 Identities=34% Similarity=0.672 Sum_probs=153.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 79999999999998888999999999999999999999999999999999999997643 34699999999986655555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+....+..+ ....+++++
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTGGGGSCHHH
T ss_pred cccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHH
Confidence 556789999999999988777665 999999999999999999998766543333 2333333332 234589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+||.+||..||.+|||+.++++||||..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=291.61 Aligned_cols=175 Identities=34% Similarity=0.642 Sum_probs=150.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.... ..
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~~--~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CB
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceeccC--Cc
Confidence 79999999999999888999999999999999999999999999999999999997665 499999999975432 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+......+| ..++.++.+|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~l 268 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHH
Confidence 45689999999999988877655 99999999999999999999876654333 33333433343 3489999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
|.+||+.||.+||+ +.++++||||..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999998 999999999963
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=300.98 Aligned_cols=187 Identities=36% Similarity=0.625 Sum_probs=144.6
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 79999999999998754 599999999999999999999999999999999999997632 456999999999865544
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~ 155 (268)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.............+....+.. +....++.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 44566789999999999988777665 9999999999999999999976543221111112222233333 33356899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999997643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=283.37 Aligned_cols=182 Identities=27% Similarity=0.491 Sum_probs=150.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+. .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccc
Confidence 7999999999999764 6999999999999999999999999999999999999976654 999999998754332 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+............ ........+..++..+.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHH
Confidence 345689999999999988887665 9999999999999999999987765443333222 122223334458999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||+.||.+|||+.++++||||+...+
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 999999999999999999999999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.19 Aligned_cols=183 Identities=27% Similarity=0.375 Sum_probs=144.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
||||+ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 90 ~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCCCC
T ss_pred ecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCcccccccccccc
Confidence 68998 599998876 5899999999999999999999999999999999999997665 499999999974322
Q ss_pred ------------------CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 024363 77 ------------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 138 (268)
Q Consensus 77 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 138 (268)
.......+||++|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11223457999999999998744444559999999999999999999998877666555543
Q ss_pred HHhcccc-----------------------------------------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHH
Q 024363 139 RILSVQY-----------------------------------------SVPDTNPISQECRDLISRIFVADPAARITIPE 177 (268)
Q Consensus 139 ~~~~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e 177 (268)
.+..... .......+++++.+||.+||+.||.+|||+.+
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 2211100 00111247899999999999999999999999
Q ss_pred HhcccccCCC
Q 024363 178 IMKHQWFLKN 187 (268)
Q Consensus 178 ~l~h~~~~~~ 187 (268)
+|+||||..-
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.49 Aligned_cols=183 Identities=25% Similarity=0.369 Sum_probs=150.8
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 98 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~ 174 (308)
T 3g33_A 98 FEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQM 174 (308)
T ss_dssp EECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCSCTTTSTTCC
T ss_pred ehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCccccccCCCc
Confidence 68897 599999987654 99999999999999999999999999999999999997665 49999999998765555
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cCC---------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP--------- 148 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------- 148 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........++......... .++
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T 3g33_A 175 ALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253 (308)
T ss_dssp CSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG
T ss_pred ccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 5566789999999999988887666 89999999999999999999987776665555543321110 000
Q ss_pred -----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 149 -----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 149 -----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....++..+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012478999999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=301.87 Aligned_cols=181 Identities=44% Similarity=0.797 Sum_probs=156.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence 799999999999988889999999999999999999999999999999999999976654 999999999865544455
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+........+ +....+..| ..+++++.+|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~----i~~~~~~~p--~~~s~~~~~L 246 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTP--QYLNPSVISL 246 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH----HHTTCCCCC--TTCCHHHHHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH----HhcCCcCCC--ccCCHHHHHH
Confidence 6678999999999998887766679999999999999999999988766544333 333333333 3488999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
|.+||+.||.+|||+.++++||||.+..+
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 99999999999999999999999987544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.58 Aligned_cols=177 Identities=34% Similarity=0.616 Sum_probs=146.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~ 177 (327)
T 3a62_A 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTV 177 (327)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccCCcc
Confidence 79999999999999888999999999999999999999999999999999999997655 4999999998753322 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+......+ +.......+ ..++.++.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~p--~~~~~~~~~ 250 (327)
T 3a62_A 178 THTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDK----ILKCKLNLP--PYLTQEARD 250 (327)
T ss_dssp -CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCC--TTSCHHHHH
T ss_pred ccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCC--CCCCHHHHH
Confidence 345679999999999988777655 8999999999999999999987765443333 333333333 348999999
Q ss_pred HHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 160 LISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
||.+||..||.+|| ++.++++||||..
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999 8999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=295.49 Aligned_cols=182 Identities=29% Similarity=0.534 Sum_probs=152.2
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 79999999999997654 79999999999999999999999999999999999999865556799999999986544444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+.. +....+. ......+++++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHH
T ss_pred eeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHH
Confidence 445679999999999988777555 8999999999999999999988665433333 2222222 22334589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+||.+||..||.+|||+.++++||||...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=306.04 Aligned_cols=181 Identities=30% Similarity=0.500 Sum_probs=151.5
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCc
Confidence 799999999999987554 99999999999999999999999999999999999997655 49999999998655444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+...+......++ ..+|+++.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~ 417 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQAR 417 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHH
Confidence 4456789999999999988877665 89999999999999999999876532222233333333333333 45899999
Q ss_pred HHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
+||.+||+.||.+|| ++.++++||||..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999 7999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.92 Aligned_cols=181 Identities=29% Similarity=0.584 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+.......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCC
Confidence 799999999999987 57899999999999999999999999999999999999997665 499999999975433222
Q ss_pred --CCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC-C
Q 024363 80 --PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-N 151 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 151 (268)
....+||+.|+|||++. ...++. ++|||||||++|+|++|+.||.+.+....+.+++..... ..+|.. .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~ 307 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--FQFPTQVT 307 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCSSCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCC-cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--ccCCcccc
Confidence 23468999999999987 344544 499999999999999999999987765555554433221 223322 4
Q ss_pred CCCHHHHHHHHHccccCCCC--CCCHHHHhcccccCC
Q 024363 152 PISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK 186 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~--R~s~~e~l~h~~~~~ 186 (268)
.+|+++++||++||..+|.+ |++++++++||||..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 48999999999999988888 999999999999964
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.03 Aligned_cols=177 Identities=22% Similarity=0.266 Sum_probs=130.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~--------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++++ .++++..+..++.|++.||+|||++ +||||||||+|||++.++. +||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCc
Confidence 799999999999976 4699999999999999999999987 9999999999999977654 9999999997
Q ss_pred CCCCCC-----CCCCCcCCCCcccchhhccC------ccCCcccchhhhhHHHHHHHhCCCCCCCCCC----------hH
Q 024363 73 SSVLHS-----QPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------PK 131 (268)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~ 131 (268)
...... .....+||+.|||||++.+. .++ .++|||||||++|||++|+.||..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~-~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccC-hhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 533221 22346799999999999754 233 348999999999999999776542211 10
Q ss_pred -HHHHHHHHHhcccccCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 132 -DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 132 -~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
........+.....+.+.+ ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1112222222222222111 1133578899999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=288.72 Aligned_cols=184 Identities=39% Similarity=0.669 Sum_probs=152.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---~ 77 (268)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcc
Confidence 79999999999998888899999999999999999999999999999999999997655 499999999974321 1
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........... .........+....++..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHH
Confidence 2234568999999999998877756669999999999999999999987665432222 1222222333345589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.+||.+||..||.+|||+.++++||||.+...
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=286.70 Aligned_cols=184 Identities=37% Similarity=0.642 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 799999999999988888999999999999999999999999999999999999975 2345699999999986554444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ...+....... +....++.++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cccccCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHH
Confidence 456789999999999988777655 99999999999999999999876654422 22233333222 2335689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+||.+||..||.+|||+.++++||||....
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999997654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.09 Aligned_cols=184 Identities=28% Similarity=0.416 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 136 ~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 136 LEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENG 212 (458)
T ss_dssp ECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTC
T ss_pred Eeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCcccc
Confidence 68885 699999998889999999999999999999999999999999999999976654 9999999997543211
Q ss_pred --------------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-----------CC
Q 024363 79 --------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-----------GG 121 (268)
Q Consensus 79 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-----------g~ 121 (268)
.....+||++|+|||++......+.++|||||||++|||++ |+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 23445789999999987544433455999999999999998 67
Q ss_pred CCCCCCCC--------------------hHHHHHHHHHHhcccc-----------------cC---------CCCCCCCH
Q 024363 122 YPFEDPDE--------------------PKDFRKTIQRILSVQY-----------------SV---------PDTNPISQ 155 (268)
Q Consensus 122 ~pf~~~~~--------------------~~~~~~~~~~~~~~~~-----------------~~---------~~~~~~s~ 155 (268)
++|.+... ..++..++ .+..... .. .....+++
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CSCC--------------------CHHHHHHHHHHH-HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHHHHH-HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 77766431 11111111 1111000 00 01234689
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++.+||.+||+.||.+|||++|+|+||||....
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 999999999999999999999999999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=287.15 Aligned_cols=184 Identities=35% Similarity=0.607 Sum_probs=150.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~- 77 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.... .+.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 79999999999999988999999999999999999999999999999999999985432 235999999999754332
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~ 155 (268)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+... .....+...+....+..+ .+..+|.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCH
Confidence 23445689999999999987767555 8999999999999999999986422 112233344444443332 2356899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++.+||.+||..||.+|||+.++++||||..
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999999999999954
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=300.70 Aligned_cols=181 Identities=32% Similarity=0.520 Sum_probs=150.2
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKA 341 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccC
Confidence 7999999999999764 3699999999999999999999999999999999999997665 499999999975443
Q ss_pred CCC-CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+.+.+.......| ..+|.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~ 418 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSP 418 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCH
T ss_pred CCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCH
Confidence 332 334589999999999988877665 99999999999999999999876433222334444444444444 45899
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
.+.+||.+||+.||.+||+ +.++++||||..
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 589999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=292.06 Aligned_cols=181 Identities=32% Similarity=0.592 Sum_probs=151.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+..+..+.+||+|||+++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 7999999999998654 469999999999999999999999999999999999999654455699999999986555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+.++.. ..+..+ ....+++++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA----CRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCSCSGGGTTSCHHH
T ss_pred cccccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----ccCCCChhhhccCCHHH
Confidence 556689999999999987766555 8999999999999999999988776554444333 222222 224589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+||.+||+.||.+|||+.++++||||..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=276.26 Aligned_cols=185 Identities=33% Similarity=0.647 Sum_probs=154.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC-CCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +.+||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 799999999999998889999999999999999999999999999999999999975442 4599999999976555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+... ......+....+++++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--cccCCchhhcccCHHHHH
Confidence 556789999999999988777655 89999999999999999999877654433332221 112223334568999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||+.||.+|||+.++++||||....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.65 Aligned_cols=182 Identities=27% Similarity=0.431 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+........
T Consensus 146 ~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 220 (464)
T 3ttj_A 146 MELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMM 220 (464)
T ss_dssp EECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC
T ss_pred EeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCccc
Confidence 689987 5667664 35999999999999999999999999999999999999976654 999999999876555556
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (268)
...+||++|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...++.+++..+.....
T Consensus 221 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~ 299 (464)
T 3ttj_A 221 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299 (464)
T ss_dssp ----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHT
T ss_pred CCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhh
Confidence 67889999999999998888766 99999999999999999999988876666665543321100
Q ss_pred cCCCCCC---------------------CCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 SVPDTNP---------------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ~~~~~~~---------------------~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+.... .++++++||.+||+.||.+|||++|+|+||||....
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000000 156799999999999999999999999999997543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.77 Aligned_cols=180 Identities=29% Similarity=0.551 Sum_probs=146.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGT 217 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSC
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCCc
Confidence 7999999999999875 4799999999999999999999999999999999999997665 499999999975433322
Q ss_pred --CCCCcCCCCcccchhhcc-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC-
Q 024363 80 --PKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD- 149 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 149 (268)
....+||+.|+|||++.. ..++. ++|||||||++|+|++|+.||.+.+....+.+++..... ...|.
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~ 294 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP-ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--LSLPLV 294 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCCh-HHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--cCCCcc
Confidence 234689999999999973 34544 499999999999999999999887765554444432111 22232
Q ss_pred CCCCCHHHHHHHHHccccCCCCC---CCHHHHhcccccCC
Q 024363 150 TNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFLK 186 (268)
Q Consensus 150 ~~~~s~~~~~li~~~l~~dp~~R---~s~~e~l~h~~~~~ 186 (268)
...+|.++++||++||. +|.+| ++++++++||||..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 24589999999999999 99998 58999999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.70 Aligned_cols=184 Identities=24% Similarity=0.442 Sum_probs=142.1
Q ss_pred CCCCCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||.| +|.+.+ ...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.... ..
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccc
Confidence 799987 555555 44678999999999999999999999999999999999999976654 99999999975432 23
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhccccc-----------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYS----------- 146 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~----------- 146 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|..||........ ...+..........
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345567999999999998766445559999999999999998877554444333 33333222111100
Q ss_pred ------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 147 ------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 147 ------------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
......++..+++||.+||+.||.+|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01112478999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=281.86 Aligned_cols=181 Identities=34% Similarity=0.617 Sum_probs=151.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC--CCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~ 173 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (321)
T ss_dssp ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence 799999999999998889999999999999999999999999999999999999976552 159999999997655554
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC--CCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+........ .+.......+. ...++..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 174 EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTCCHH
T ss_pred cccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccccChhhhcccCHH
Confidence 5566789999999999987777655 899999999999999999998766543332 22232222221 2347899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 999999999999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=280.39 Aligned_cols=187 Identities=32% Similarity=0.546 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC-CCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 799999999999998889999999999999999999999999999999999999976543 34999999998753221
Q ss_pred ------CCCCCCcCCCCcccchhhcc-----CccCCcccchhhhhHHHHHHHhCCCCCCCCCChH-----------HHHH
Q 024363 78 ------SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRK 135 (268)
Q Consensus 78 ------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------~~~~ 135 (268)
.......||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+..... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 11234569999999999875 345444 899999999999999999998754311 1122
Q ss_pred HHHHHhcccccCCC--CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 136 TIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 136 ~~~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
....+.......+. ...++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 23333333333332 134889999999999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=289.08 Aligned_cols=185 Identities=26% Similarity=0.357 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~ 185 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDT 185 (432)
T ss_dssp EECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC------
T ss_pred EecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCcccccccccc
Confidence 68887 49999999888899999999999999999999999999999999999997665 49999999997543221
Q ss_pred ---------------------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhC-----------CCCCCC
Q 024363 79 ---------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-----------GYPFED 126 (268)
Q Consensus 79 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-----------~~pf~~ 126 (268)
.....+||++|+|||++......+.++|||||||++|+|++| +++|.+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g 265 (432)
T 3n9x_A 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265 (432)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCC
T ss_pred cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCC
Confidence 235678999999999975544345559999999999999984 444444
Q ss_pred CCC-----------------hHHHHHHHHHHh--------------------cccccCC-----CCCCCCHHHHHHHHHc
Q 024363 127 PDE-----------------PKDFRKTIQRIL--------------------SVQYSVP-----DTNPISQECRDLISRI 164 (268)
Q Consensus 127 ~~~-----------------~~~~~~~~~~~~--------------------~~~~~~~-----~~~~~s~~~~~li~~~ 164 (268)
... ..++..++..+. ......+ ....+++++.+||.+|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 345 (432)
T 3n9x_A 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESM 345 (432)
T ss_dssp SCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred ccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 321 111111111110 0001111 0134799999999999
Q ss_pred cccCCCCCCCHHHHhcccccCCCC
Q 024363 165 FVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 165 l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
|+.||.+|||+.++|+||||..-.
T Consensus 346 L~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 346 LKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp SCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred hcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999997643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.04 Aligned_cols=183 Identities=26% Similarity=0.437 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||+| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCceecCCCcc
Confidence 789985 888888764 4599999999999999999999999999999999999997665 4999999999754322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc-CC---------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VP--------- 148 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--------- 148 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... ++
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 33456789999999999775444455999999999999999999999877766655554433221100 00
Q ss_pred --------------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 149 --------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 149 --------------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 01236789999999999999999999999999999965
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=285.66 Aligned_cols=182 Identities=32% Similarity=0.578 Sum_probs=148.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++..... .
T Consensus 138 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~ 215 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETE 215 (355)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGG
T ss_pred eecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeecccCCCC
Confidence 79999999999999888999999999999999999999999999999999999997655 4999999998743221 2
Q ss_pred CCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+...... .+..++..+
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 293 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 293 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--CCcccCHHH
Confidence 223457999999999997532 23445899999999999999999997654433333444444443333 334589999
Q ss_pred HHHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
.+||.+||..||.+|| ++.++++||||..
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999999999 9999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=275.65 Aligned_cols=183 Identities=27% Similarity=0.440 Sum_probs=143.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCcccc
Confidence 689986 999999764 6799999999999999999999999999999999999997665 4999999998643322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY------------- 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 145 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345578999999999976553445599999999999999999999987766555554443221110
Q ss_pred -cCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 146 -SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 146 -~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
..+ ....++.++.+||.+||+.||.+|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000 11347899999999999999999999999999999965
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=279.41 Aligned_cols=179 Identities=39% Similarity=0.651 Sum_probs=146.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++ ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 117 ~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 193 (298)
T 2zv2_A 117 FELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDAL 193 (298)
T ss_dssp EECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECSSSSCE
T ss_pred EecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--CEEEecCCCcccccccccc
Confidence 7999999998765 446799999999999999999999999999999999999997665 4999999999754332 22
Q ss_pred CCCCcCCCCcccchhhccCcc--CCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....||+.|+|||++.+... .+.++|||||||++|+|++|+.||....... ....+.......+....+++++
T Consensus 194 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l 269 (298)
T 2zv2_A 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC----LHSKIKSQALEFPDQPDIAEDL 269 (298)
T ss_dssp ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSSSCCCHHH
T ss_pred ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH----HHHHHhcccCCCCCccccCHHH
Confidence 345679999999999876542 3555899999999999999999998765322 2223333444455556689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+||.+||+.||.+|||+.++++||||++
T Consensus 270 ~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 270 KDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999999953
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=284.24 Aligned_cols=186 Identities=37% Similarity=0.611 Sum_probs=133.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 79999999999999999999999999999999999999999999999999999997544 225999999999753332 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH---HHHHHHHHHhcccccCCC--CCCC
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQYSVPD--TNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~ 153 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... .....+..+....+..+. +..+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp -------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 3345678999999999988777655 899999999999999999997654321 122344444444433322 1347
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|+++++||.+||..||.+|||+.++++||||...
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=285.79 Aligned_cols=185 Identities=22% Similarity=0.405 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC--
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-- 76 (268)
||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+.....
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence 7999999999999875 6799999999999999999999999999999999999997655 499999998753211
Q ss_pred ------CCCCCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----
Q 024363 77 ------HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----- 143 (268)
Q Consensus 77 ------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----- 143 (268)
........||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+..........+......
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 122334579999999999987 455554 999999999999999999998876655443332211100
Q ss_pred -----------------------------------cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 144 -----------------------------------QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 144 -----------------------------------~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
....+....+++.+.+||.+||+.||.+|||+.++|+||||.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 001122344789999999999999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=284.94 Aligned_cols=179 Identities=35% Similarity=0.634 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.........
T Consensus 179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~~~~~~ 256 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKL 256 (365)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTCCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccCCCccc
Confidence 79999999999999888999999999999999999999999999999999999997655 4999999998765555555
Q ss_pred CCCcCCCCcccchhhccC------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCC
Q 024363 81 KSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNP 152 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 152 (268)
....||+.|+|||++.+. .++. ++|||||||++|+|++|+.||...........+ ....... +.+..
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 257 RELCGTPGYLAPEILKCSMDETHPGYGK-EVDLWACGVILFTLLAGSPPFWHRRQILMLRMI----MEGQYQFSSPEWDD 331 (365)
T ss_dssp CCCCSCGGGCCHHHHHHTTCTTSCCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHTCCCCCHHHHSS
T ss_pred ccCCCCCCccChhhccccccccCcCCCc-hhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhCCCCCCCccccc
Confidence 667899999999998642 3444 489999999999999999999876544333322 2222222 22245
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++..+.+||.+||..||.+|||+.++++||||.+
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 7899999999999999999999999999999963
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.48 Aligned_cols=186 Identities=27% Similarity=0.373 Sum_probs=147.3
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+|+... .
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~ 254 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--Q 254 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--C
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--C
Confidence 68996 59999997654 4999999999999999999999999999999999999987665559999999996432 3
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY------------- 145 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 145 (268)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..++........
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~ 333 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFV 333 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHB
T ss_pred cccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhcc
Confidence 3456789999999999988887665 99999999999999999999988766655544432111000
Q ss_pred ---cC-----------------------------CC--------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 146 ---SV-----------------------------PD--------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 146 ---~~-----------------------------~~--------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
.. +. ....++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~ 413 (429)
T 3kvw_A 334 SSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413 (429)
T ss_dssp CTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC
T ss_pred CCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhc
Confidence 00 00 012378899999999999999999999999999998
Q ss_pred CCCCC
Q 024363 186 KNLPA 190 (268)
Q Consensus 186 ~~~~~ 190 (268)
+..+.
T Consensus 414 ~~~~~ 418 (429)
T 3kvw_A 414 RRLPK 418 (429)
T ss_dssp -----
T ss_pred cCCCC
Confidence 76544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=273.92 Aligned_cols=180 Identities=31% Similarity=0.598 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-CCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-~~~~~kl~Dfg~a~~~~ 75 (268)
||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.. ..+.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 799999999999854 3679999999999999999999999999999999999999642 24569999999997655
Q ss_pred CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc-CCCCCCCC
Q 024363 76 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPIS 154 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s 154 (268)
.........||+.|+|||++.+ .++ .++|||||||++|+|++|+.||.+......... ....... ......++
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLT 252 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCC--CCCC
T ss_pred CcccCcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hccCCcccccccCcCC
Confidence 5444566789999999999864 454 458999999999999999999987664332222 1111111 12234478
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+.+||.+||+.||.+|||+.++++||||++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.71 Aligned_cols=175 Identities=30% Similarity=0.503 Sum_probs=149.1
Q ss_pred CCCCCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg-~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~ 185 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKL 185 (335)
T ss_dssp EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECCCCCc
Confidence 6888776 9999999988999999999999999999999999999999999999997655 499999999986555554
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... .... ....+..++.++.+
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~--~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEA--AIHPPYLVSKELMS 253 (335)
T ss_dssp BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTT--CCCCSSCCCHHHHH
T ss_pred eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhh--ccCCCcccCHHHHH
Confidence 55677999999999998887766669999999999999999999975321 1111 22233448999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||..||.+|||+.++++||||.+...
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 999999999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=277.01 Aligned_cols=185 Identities=24% Similarity=0.469 Sum_probs=147.6
Q ss_pred CCCCCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAF 158 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEET
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceec
Confidence 68998 5999998653 3599999999999999999999999999999999999997665 4999999999754
Q ss_pred CCC-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------
Q 024363 75 VLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-------- 145 (268)
Q Consensus 75 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 145 (268)
... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 322 23345679999999999976543345599999999999999999999987766555544433211100
Q ss_pred --------------------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 --------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 --------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.......++.++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0001124789999999999999999999999999999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=275.31 Aligned_cols=182 Identities=38% Similarity=0.681 Sum_probs=150.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++.. +..+.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 799999999999998889999999999999999999999999999999999999932 2234599999999976555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC--CCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~ 157 (268)
.....||+.|+|||++.+. ++. ++|||||||++|+|++|+.||........... +.......+. ...+++.+
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHH
T ss_pred hhccCCCCCccChHHhccc-CCc-hhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHH
Confidence 5667899999999998654 544 48999999999999999999988765443333 2222222221 12478999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+||.+||+.||.+|||+.++++||||++..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999997543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=282.13 Aligned_cols=184 Identities=32% Similarity=0.536 Sum_probs=147.6
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||||.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++... .+.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 799999999999854 36799999999999999999999999999999999999997521 346999999999865554
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+... ......+....++..+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQLA 264 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHH
T ss_pred cccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHHH
Confidence 44556789999999999988777665 89999999999999999999887655444333222 2222333445689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+||.+||+.||.+|||+.++++||||+..
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.12 Aligned_cols=182 Identities=43% Similarity=0.787 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC----
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCcce
Confidence 69999999999999888999999999999999999999999999999999999997655 4999999998765544444
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||......... ..+....... +..++..+.++
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~--~~~~~~~l~~l 241 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF----KKIRGGVFYI--PEYLNRSVATL 241 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCC--CTTSCHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHhhcCcccC--chhcCHHHHHH
Confidence 56679999999999987766556699999999999999999999876543322 2222222222 33478999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
|.+||+.||.+|||+.++++||||++..+.
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.61 Aligned_cols=185 Identities=25% Similarity=0.371 Sum_probs=148.1
Q ss_pred CCCCCCCchhHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc-CCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+++.+.... ...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|||+|+....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccC
Confidence 6899875443322 2366899999999999999999999999999999999999997 344 599999999986655
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------c--
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------Q-- 144 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~-- 144 (268)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++...... .
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 5556677899999999999776534455999999999999999999999887766666555432111 0
Q ss_pred -ccCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 -YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 -~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..++ ....+++++.+||.+||+.||.+|||+.++++||||..-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0111 122378999999999999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=284.36 Aligned_cols=180 Identities=32% Similarity=0.624 Sum_probs=146.3
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~ 75 (268)
||||+||+|.+.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 7999999999888542 3599999999999999999999999999999999999997543 3459999999997544
Q ss_pred CCC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCC
Q 024363 76 LHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNP 152 (268)
Q Consensus 76 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 152 (268)
... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. .. ....+....+..+ ....
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-~~----~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ER----LFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-HH----HHHHHHHTCCCCCHHHHTT
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-HH----HHHHHHcCCCCCCcccccc
Confidence 332 2345689999999999988777655 999999999999999999998743 22 2223333332222 1245
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++.++.+||.+||..||.+|||+.++++||||..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=277.44 Aligned_cols=184 Identities=25% Similarity=0.459 Sum_probs=141.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC-----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCcc
Confidence 789985 999998765 4599999999999999999999999999999999999997665 4999999998754322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cC----------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV---------- 147 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~---------- 147 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......... .+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2345578999999999987444445599999999999999999999987765555444433221110 00
Q ss_pred ----C---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 148 ----P---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 148 ----~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+ ....+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0 112478999999999999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=282.68 Aligned_cols=182 Identities=26% Similarity=0.412 Sum_probs=147.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 109 ~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~--~~ 182 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQADS--EM 182 (367)
T ss_dssp EECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCS--SC
T ss_pred EecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeeccccccc--cc
Confidence 6899 8899999876 6799999999999999999999999999999999999997665 499999999975432 34
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (268)
...++|++|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..++........
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 262 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence 56789999999999987333344599999999999999999999987766655554432211100
Q ss_pred ---------cC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 ---------SV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ---------~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.+ ......++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00 01234689999999999999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=276.50 Aligned_cols=181 Identities=29% Similarity=0.545 Sum_probs=148.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCccc
Confidence 799999999998854 5799999999999999999999999999999999999997655 4999999998754332 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+ ... ..........+++.+.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDS--PPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHS--SCCCCTTGGGSCHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcC--CCCCcCccccCCHHHHH
Confidence 345689999999999988777665 89999999999999999999876654332222 111 11122233447899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||+.||.+|||+.++++||||.+..
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.94 Aligned_cols=186 Identities=30% Similarity=0.423 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC---CCCEEEeecCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVL- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~---~~~~kl~Dfg~a~~~~~- 76 (268)
||||+| +|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||+++....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 689985 9999999988999999999999999999999999999999999999995422 33599999999875332
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc----------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS---------- 146 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 146 (268)
........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+........++..........
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 2233456789999999999875544455999999999999999999999877666655554432211100
Q ss_pred ----CCCC----------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 147 ----VPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 147 ----~~~~----------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+.. ..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0000 1167999999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=291.40 Aligned_cols=182 Identities=36% Similarity=0.634 Sum_probs=141.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++..+ ...+||+|||+|+.......
T Consensus 218 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~ 297 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297 (419)
T ss_dssp EECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCcc
Confidence 79999999999998888999999999999999999999999999999999999996543 34599999999987655555
Q ss_pred CCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s 154 (268)
.....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||........+...+. ....... ....++
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~ 373 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWAEVS 373 (419)
T ss_dssp -------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHHTTSC
T ss_pred ccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhhcccC
Confidence 566789999999999853 334 3458999999999999999999987654433332222 2222111 123478
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 374 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 99999999999999999999999999999954
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=273.86 Aligned_cols=185 Identities=24% Similarity=0.383 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCcccc
Confidence 79999999999998888999999999999999999999999999999999999997655 4999999999754322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (268)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+....... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3456799999999999764444455999999999999999999998877655444333221110 0
Q ss_pred ccCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 ~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
...+. ...++..+.+||.+||..||.+|||+.++++||||..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 13478999999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=276.73 Aligned_cols=174 Identities=21% Similarity=0.269 Sum_probs=137.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||| +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCC
Confidence 6899 66999988764 46999999999999999999999999999999999999976654 99999999876555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.. .+. .+............+++++.+
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGGE---GWQ----QLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSHH---HHH----HHTTTCCCHHHHTTSCHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCcc---HHH----HHhccCCCcccccCCCHHHHH
Confidence 556679999999999875 55554 999999999999999977765422 111 122211111122347899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
||.+||+.||.+|||+.++++||||++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.07 Aligned_cols=184 Identities=25% Similarity=0.422 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.. .+.+||+|||+|+....
T Consensus 117 ~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~ 194 (383)
T 3eb0_A 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIP 194 (383)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETT-TTEEEECCCTTCEECCT
T ss_pred EecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCC-CCcEEEEECCCCcccCC
Confidence 799985 7766664 46789999999999999999999999999999999999999732 23599999999986655
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
........||+.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..++.......
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 274 (383)
T 3eb0_A 195 SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT 274 (383)
T ss_dssp TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-
T ss_pred CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc
Confidence 55566778999999999998765334559999999999999999999998877666665554322110
Q ss_pred -ccCC----------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 -YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 -~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
..++ .+..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp -CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 0111 12347899999999999999999999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=286.13 Aligned_cols=185 Identities=26% Similarity=0.438 Sum_probs=148.4
Q ss_pred CCCCCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ +.+||+|||+++....
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCT
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhccc
Confidence 689986 6666654 356799999999999999999999999999999999999998543 2489999999986555
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 143 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (268)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.+++..+...
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 5555667899999999999775433445999999999999999999999887766666555432111
Q ss_pred cccCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 ~~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+.++. ...++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111111 23468999999999999999999999999999999653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=281.34 Aligned_cols=181 Identities=26% Similarity=0.446 Sum_probs=143.5
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC--------------------
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-------------------- 58 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-------------------- 58 (268)
|||| ||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 7999 899999998754 59999999999999999999999999999999999999751
Q ss_pred ---CCCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHH
Q 024363 59 ---PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 135 (268)
Q Consensus 59 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 135 (268)
..+.+||+|||+|+... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp EEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 24569999999997532 23346689999999999998887766 8999999999999999999987665444333
Q ss_pred HHHHHhccc----------------------ccCCCC------------------CCCCHHHHHHHHHccccCCCCCCCH
Q 024363 136 TIQRILSVQ----------------------YSVPDT------------------NPISQECRDLISRIFVADPAARITI 175 (268)
Q Consensus 136 ~~~~~~~~~----------------------~~~~~~------------------~~~s~~~~~li~~~l~~dp~~R~s~ 175 (268)
+........ ..++.. ...++.+.+||.+||+.||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 222111000 001110 0124778899999999999999999
Q ss_pred HHHhcccccC
Q 024363 176 PEIMKHQWFL 185 (268)
Q Consensus 176 ~e~l~h~~~~ 185 (268)
.++|+||||+
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=269.61 Aligned_cols=177 Identities=35% Similarity=0.671 Sum_probs=146.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-RR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-cc
Confidence 799999999999998889999999999999999999999999999999999999976654 999999998643322 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... .+.......+ ..++..+.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~l 237 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVEFTFP--DFVTEGARDL 237 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHHH
T ss_pred cccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHH----HHHhCCCCCC--CcCCHHHHHH
Confidence 45679999999999987776655 899999999999999999998766443322 2223333333 3488999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|.+||..+|.+|||+.++++||||...
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.76 Aligned_cols=185 Identities=35% Similarity=0.608 Sum_probs=125.8
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+||+++.++ .+.+||+|||+++....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 79999999999998754 699999999999999999999999999999999999997533 34599999999975432
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--cCCCCCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~ 155 (268)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+..... ..+....++.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp --------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 23345678999999999977777655 89999999999999999999766543322222222222222 2233356899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+.+||.+||..||.+|||+.++++||||.+.
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=276.76 Aligned_cols=180 Identities=25% Similarity=0.409 Sum_probs=142.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|| +.+|+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC------
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccccc
Confidence 67 567899999999999999999999999999999999999999999999999963 349999999997643322
Q ss_pred -CCCCCcCCCCcccchhhcc-----------CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 79 -QPKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||........ .+.........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~ 239 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 239 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHH---HHHHHhcCCcc
Confidence 2235679999999999864 334 4448999999999999999999987554322 22333333333
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
...+...+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 444445788999999999999999999999999999997543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=282.78 Aligned_cols=182 Identities=27% Similarity=0.453 Sum_probs=135.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 109 ~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~ 183 (371)
T 2xrw_A 109 MELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMM 183 (371)
T ss_dssp EECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC----------
T ss_pred EEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeeccccccccccc
Confidence 689985 7888885 4699999999999999999999999999999999999997665 4999999999865544445
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------c
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------Y 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~ 145 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++....... .
T Consensus 184 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 262 (371)
T 2xrw_A 184 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262 (371)
T ss_dssp ------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHH
T ss_pred CCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHh
Confidence 56789999999999988777665 8999999999999999999998776555444432211000 0
Q ss_pred cCCCCC---------------------CCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 SVPDTN---------------------PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ~~~~~~---------------------~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+... ..+.++++||.+||+.||.+|||+.++++||||....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp SSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000000 0156899999999999999999999999999997544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=276.92 Aligned_cols=186 Identities=26% Similarity=0.405 Sum_probs=145.3
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC----
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---- 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~---- 75 (268)
||||.| +|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 103 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~ 179 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKN 179 (351)
T ss_dssp EECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCCCSS
T ss_pred EeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhccccccccc
Confidence 689986 777777654 5799999999999999999999999999999999999997665 49999999987432
Q ss_pred -CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC-CCCC--
Q 024363 76 -LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV-PDTN-- 151 (268)
Q Consensus 76 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 151 (268)
.........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+........... +...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 259 (351)
T 3mi9_A 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259 (351)
T ss_dssp SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 122334567899999999997755444559999999999999999999998776555444433222211110 0000
Q ss_pred -----------------------CCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 152 -----------------------PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 152 -----------------------~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
..++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 02678999999999999999999999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=274.49 Aligned_cols=183 Identities=22% Similarity=0.425 Sum_probs=144.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++........
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC-CEEEEEeCCCceEcCCCCcc
Confidence 69999999998874 499999999999999999999999999999999999997554 25999999999865555555
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------ccc-----
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------VQY----- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~----- 145 (268)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||............+..... ...
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 66789999999999987444445599999999999999999999655443322211111110 000
Q ss_pred -----------------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 -----------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 -----------------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.......+++++.+||.+||+.||.+|||+.++|+||||+.-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 001112278999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=269.91 Aligned_cols=177 Identities=35% Similarity=0.681 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAPS-LRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEECSS-SCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEecccccccCcc-ccc
Confidence 79999999999999888999999999999999999999999999999999999997655 499999999864332 223
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||......... ..+.......+ ..++..+.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l 242 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKDL 242 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHH
T ss_pred ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHHH
Confidence 45679999999999988777655 89999999999999999999876643332 23333333333 4489999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|.+||..||.+|||+.++++||||...
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=281.23 Aligned_cols=181 Identities=24% Similarity=0.389 Sum_probs=144.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|| |.+|+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCcc
Confidence 67 567899999999889999999999999999999999999999999999999953 359999999998643322
Q ss_pred -CCCCCcCCCCcccchhhccC----------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC
Q 024363 79 -QPKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 147 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (268)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||....... ..+..+.......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccC
Confidence 23456799999999998652 123445999999999999999999998765432 2233344444444
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+.+...+.++.+||.+||..||.+|||+.++++||||....
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 44445689999999999999999999999999999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=269.34 Aligned_cols=184 Identities=39% Similarity=0.671 Sum_probs=150.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||++||+|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcch
Confidence 69999999999998778899999999999999999999999999999999999997655 4999999998643221
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||............ ........+....++..+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHH
Confidence 22345679999999999987776555699999999999999999999876543322221 122222223334589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.+||.+||+.||.+|||+.++++||||.+...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 99999999999999999999999999976543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.70 Aligned_cols=182 Identities=25% Similarity=0.434 Sum_probs=133.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 113 ~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~~--~~ 186 (367)
T 2fst_X 113 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTAD--EM 186 (367)
T ss_dssp EECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC-------------
T ss_pred eccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeeccccccccc--cC
Confidence 5777 6899998865 6799999999999999999999999999999999999997665 499999999975432 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 144 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (268)
...+||++|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++.......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 266 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence 4568999999999998743334559999999999999999999998876665555443221110
Q ss_pred ---ccCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 145 ---YSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 145 ---~~~~~------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
...+. ....++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00000 123688999999999999999999999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=280.88 Aligned_cols=183 Identities=30% Similarity=0.393 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH--~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||.| +|.+++... +.+++..++.++.|++.||.||| +.||+||||||+|||++.+..+.+||+|||+|+...
T Consensus 135 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~- 212 (382)
T 2vx3_A 135 FEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG- 212 (382)
T ss_dssp EECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred EecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc-
Confidence 689965 999999765 46999999999999999999999 579999999999999976555679999999997543
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+........
T Consensus 213 -~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (382)
T 2vx3_A 213 -QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290 (382)
T ss_dssp -CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHH
T ss_pred -cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHH
Confidence 23456789999999999988877655 9999999999999999999998776665555544321110
Q ss_pred ---------c------------cCCCCCC-------------------------CCHHHHHHHHHccccCCCCCCCHHHH
Q 024363 145 ---------Y------------SVPDTNP-------------------------ISQECRDLISRIFVADPAARITIPEI 178 (268)
Q Consensus 145 ---------~------------~~~~~~~-------------------------~s~~~~~li~~~l~~dp~~R~s~~e~ 178 (268)
+ ..+.... .+.++.+||.+||+.||.+|||+.++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~ 370 (382)
T 2vx3_A 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA 370 (382)
T ss_dssp HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHH
Confidence 0 0000000 01478999999999999999999999
Q ss_pred hcccccCCC
Q 024363 179 MKHQWFLKN 187 (268)
Q Consensus 179 l~h~~~~~~ 187 (268)
|+||||++.
T Consensus 371 L~hp~f~~~ 379 (382)
T 2vx3_A 371 LQHSFFKKT 379 (382)
T ss_dssp TTSGGGCC-
T ss_pred hcCcccccC
Confidence 999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.86 Aligned_cols=179 Identities=23% Similarity=0.443 Sum_probs=145.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| ++||||||+||+++. ..+.+||+|||++..... .
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~kl~Dfg~~~~~~~-~ 185 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRA-S 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGGCCT-T
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCEEEeeCCCcccccc-c
Confidence 699999999999998889999999999999999999999999 999999999999962 223599999999864322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+ .++. ++|||||||++|+|++|+.||............+ .............++++.
T Consensus 186 ~~~~~~~t~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCCGGGGGCCCHHHH
T ss_pred ccccccCCcCcCCHHHHhc-cCCC-cchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH---hccCCccccCCCCCHHHH
Confidence 2345679999999998864 4544 4999999999999999999998866654433322 222112222334678999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+||.+||..||.+|||+.++++||||+.
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.99 Aligned_cols=181 Identities=33% Similarity=0.587 Sum_probs=150.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+...+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++.........
T Consensus 103 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 180 (298)
T 1phk_A 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKL 180 (298)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCB
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCccc
Confidence 699999999999998889999999999999999999999999999999999999976654 999999999765544455
Q ss_pred CCCcCCCCcccchhhc------cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCC
Q 024363 81 KSTVGTPAYIAPEVLL------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNP 152 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 152 (268)
....||+.|+|||++. ...++ .++|||||||++|+|++|+.||...........+ ....... +....
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----MSGNYQFGSPEWDD 255 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHTCCCCCTTTGGG
T ss_pred ccccCCccccCHHHhccccccccccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH----hcCCcccCcccccc
Confidence 5678999999999985 23343 4489999999999999999999876654333322 2222222 23345
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++..+.+||.+||+.||.+|||+.++++||||.+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 889999999999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.54 Aligned_cols=181 Identities=31% Similarity=0.452 Sum_probs=144.8
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-----------------CC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------------AP 61 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-----------------~~ 61 (268)
|||| +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++... .+
T Consensus 96 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~ 174 (339)
T 1z57_A 96 FELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174 (339)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCC
T ss_pred EcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCC
Confidence 6899 889999998765 689999999999999999999999999999999999997643 44
Q ss_pred CEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 024363 62 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 141 (268)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 141 (268)
.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....... +....
T Consensus 175 ~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~~~~~ 250 (339)
T 1z57_A 175 DIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAM-MERIL 250 (339)
T ss_dssp CEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH-HHHHH
T ss_pred CceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHh
Confidence 69999999987532 23345689999999999988777665 8999999999999999999987765443322 22221
Q ss_pred cccc------------------c---------------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 142 SVQY------------------S---------------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 142 ~~~~------------------~---------------------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
.... . .......++.+.+||.+||..||.+|||+.++++||
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHP 330 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCH
Confidence 1100 0 001112357899999999999999999999999999
Q ss_pred ccCC
Q 024363 183 WFLK 186 (268)
Q Consensus 183 ~~~~ 186 (268)
||..
T Consensus 331 ~f~~ 334 (339)
T 1z57_A 331 FFDL 334 (339)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 9964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=272.18 Aligned_cols=184 Identities=37% Similarity=0.620 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++...+.+++..++.++.|++.||.|||++|++||||||+||++.. +..+.+||+|||+++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence 799999999999988889999999999999999999999999999999999999932 23345999999998753322 2
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+.... .....+....++..+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY--YEFESPFWDDISESAKD 240 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC--CCCCTTTTTTSCHHHHH
T ss_pred cccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCccccccCCHHHHH
Confidence 234569999999999987776554 999999999999999999998766543333322211 11122334568999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||..||.+|||+.++++||||....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=268.29 Aligned_cols=179 Identities=32% Similarity=0.614 Sum_probs=125.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCC
Confidence 6999999999999875 6799999999999999999999999999999999999997655 4999999998754322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ......... .+..++.++.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ 240 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYE--MPSFLSIEAK 240 (278)
T ss_dssp ------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCC--CCTTSCHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccC--CccccCHHHH
Confidence 2345679999999999987766555 89999999999999999999876543322 222222222 2344889999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+||.+||..||.+|||+.++++||||.+..
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 999999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=271.88 Aligned_cols=180 Identities=35% Similarity=0.594 Sum_probs=151.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||.||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCccc
Confidence 79999999999998888999999999999999999999999999999999999997655 4999999998754322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... +.......+ ..++..+.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~ 270 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKNEYSIP--KHINPVAAS 270 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCC--TTSCHHHHH
T ss_pred ccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HhcCCCCCC--ccCCHHHHH
Confidence 345679999999999988777655 8999999999999999999987654433322 223333333 348899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||+.||.+|||+.++++||||.....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.56 Aligned_cols=184 Identities=26% Similarity=0.376 Sum_probs=148.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||+| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCcc
Confidence 689986 898888664 4699999999999999999999999999999999999997665 4999999999764332 3
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-cCCC--------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD-------- 149 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------- 149 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..+......... .++.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 3455689999999999976554455599999999999999999999888766666555544322111 1110
Q ss_pred -------------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 150 -------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 150 -------------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
...++.++.+||.+||..||.+|||+.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13467999999999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=274.92 Aligned_cols=185 Identities=26% Similarity=0.426 Sum_probs=147.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 109 ~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 109 QDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDH 184 (364)
T ss_dssp EECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCB
T ss_pred EcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCc
Confidence 688875 99999865 57999999999999999999999999999999999999976654 9999999997543221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----------
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------- 145 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 145 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 2345689999999999766553345599999999999999999999988776665554432211100
Q ss_pred -----cCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 146 -----SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 146 -----~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
..+ ....+++++.+||.+||+.||.+|||+.++++||||.+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 001 01347899999999999999999999999999999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=268.38 Aligned_cols=184 Identities=26% Similarity=0.368 Sum_probs=150.7
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 98 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~ 174 (326)
T 1blx_A 98 FEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQM 174 (326)
T ss_dssp EECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCCCCCGGG
T ss_pred EecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCcccccccCCC
Confidence 68998 59999998753 499999999999999999999999999999999999997665 49999999997654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccC----------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSV---------- 147 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~---------- 147 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........++....... ..+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 1blx_A 175 ALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253 (326)
T ss_dssp GGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred CccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhh
Confidence 4456789999999999988777655 8999999999999999999998776655555544321110 000
Q ss_pred ----------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 148 ----------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 148 ----------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.....++..+.+||.+||..||.+|||+.++++||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 01234789999999999999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=274.14 Aligned_cols=187 Identities=22% Similarity=0.382 Sum_probs=140.1
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 113 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 189 (362)
T 3pg1_A 113 TELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADAN 189 (362)
T ss_dssp EECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC---------
T ss_pred EccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCcccccccccc
Confidence 68998 5888888754 46999999999999999999999999999999999999976554 99999999986555555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------- 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 144 (268)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+........
T Consensus 190 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 269 (362)
T 3pg1_A 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269 (362)
T ss_dssp ------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHH
T ss_pred cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHH
Confidence 56678999999999998744344559999999999999999999998776555544443221110
Q ss_pred -----ccCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 145 -----YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 145 -----~~~~------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
...+ ....+++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp TTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0000 113368899999999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=278.48 Aligned_cols=183 Identities=30% Similarity=0.516 Sum_probs=145.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++. +||+|||+++.... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-cc
Confidence 79999999999999888999999999999999999999996 9999999999999976654 99999999864322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHH-------------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR------------------------- 134 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------------------------- 134 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 345679999999999988777655 899999999999999999998755332111
Q ss_pred -------------HHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 135 -------------KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 135 -------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.....+............++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 11111222211122223478999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=270.00 Aligned_cols=181 Identities=35% Similarity=0.639 Sum_probs=146.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC--CCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++ ...+||+|||+++......
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~ 166 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence 69999999999998888999999999999999999999999999999999999997654 2359999999997654444
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......... +.......+ ....++..
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTCCCCCHHHHTTCCHH
T ss_pred cccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHH----hHhcccCCcchhcccCCHH
Confidence 4456679999999999987777655 8999999999999999999987665433222 222222221 12347899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+||.+||..||.+|||+.++++||||..
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=279.99 Aligned_cols=184 Identities=29% Similarity=0.524 Sum_probs=143.7
Q ss_pred CCCCCCCchhHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 024363 1 MEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYCHA 40 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~~~~qil~~L~~LH~ 40 (268)
||||+||+|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 799999999998842 1124688899999999999999999
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-----CCCCCCcCCCCcccchhhcc--CccCCcccchhhhhHH
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVT 113 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i 113 (268)
+||+||||||+||+++.++...+||+|||+++..... .......||+.|+|||++.+ ..++ .++|||||||+
T Consensus 187 ~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~i 265 (345)
T 3hko_A 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG-PKCDAWSAGVL 265 (345)
T ss_dssp TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC-THHHHHHHHHH
T ss_pred CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC-cHHHHHHHHHH
Confidence 9999999999999998766556999999998743221 12345679999999999975 3444 45999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 114 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+|+|++|+.||.+.........+..... ....+....+++.+.+||.+||..+|.+|||+.++++||||...
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhccc--ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999988776554444333211 11222333478999999999999999999999999999999653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=265.91 Aligned_cols=180 Identities=35% Similarity=0.585 Sum_probs=150.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++...+.+++.+++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++..... ..
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCccc
Confidence 69999999999998888999999999999999999999999999999999999997655 4999999998754322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+....... +..++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~ 244 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSI--PKHINPVAAS 244 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCC--CTTSCHHHHH
T ss_pred cccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhhccCCC--ccccCHHHHH
Confidence 344679999999999987777655 89999999999999999999876643332 2233333333 3458899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||+.||.+|||+.++++||||.....
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 999999999999999999999999976543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=279.87 Aligned_cols=187 Identities=25% Similarity=0.363 Sum_probs=135.4
Q ss_pred CCCCCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC--CCCCCEEEeecC
Q 024363 1 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFG 69 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~--~~~~~~kl~Dfg 69 (268)
||||.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 689975 888888532 24999999999999999999999999999999999999943 223469999999
Q ss_pred CCCCCCCC----CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---------HHHHHH
Q 024363 70 YSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKT 136 (268)
Q Consensus 70 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~ 136 (268)
+|+..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.... ..+..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99754322 22345679999999999987654456699999999999999999999765432 233333
Q ss_pred HHHHhccccc-C-------------------------------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 137 IQRILSVQYS-V-------------------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 137 ~~~~~~~~~~-~-------------------------------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+..+...... + ......+..+.+||.+||+.||.+|||+.++|+||||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 2221111000 0 0011236789999999999999999999999999999
Q ss_pred CCCC
Q 024363 185 LKNL 188 (268)
Q Consensus 185 ~~~~ 188 (268)
....
T Consensus 338 ~~~~ 341 (405)
T 3rgf_A 338 LEDP 341 (405)
T ss_dssp TSSS
T ss_pred ccCC
Confidence 7653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.51 Aligned_cols=169 Identities=15% Similarity=0.137 Sum_probs=135.9
Q ss_pred CCCCCCCchhHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e-------~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||| +|+|.+++.+.+.+++ ..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 179 ~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~ 255 (377)
T 3byv_A 179 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVR 255 (377)
T ss_dssp EECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCGGGCEE
T ss_pred Eecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEechhhee
Confidence 6899 6799999987666666 88888999999999999999999999999999997665 599999999975
Q ss_pred CCCCCCCCCCcCCCCcccchhhccC-----------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 024363 74 SVLHSQPKSTVGTPAYIAPEVLLRH-----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 142 (268)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 142 (268)
... ......| +.|+|||++.+. .++. ++|||||||++|+|++|+.||.+.......
T Consensus 256 ~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DvwSlG~il~elltg~~Pf~~~~~~~~~--------- 322 (377)
T 3byv_A 256 DGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF-SFDAWALGLVIYWIWCADLPITKDAALGGS--------- 322 (377)
T ss_dssp TTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH-HHHHHHHHHHHHHHHHSSCCC------CCS---------
T ss_pred cCC--cccCCCC-cCccChhhhcccccccccccccccCCh-hhhHHHHHHHHHHHHHCCCCCcccccccch---------
Confidence 322 2345567 999999999876 5654 499999999999999999999764432111
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.........+++++.+||.+||..||.+|||+.++++||||..
T Consensus 323 -~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 323 -EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp -GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred -hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 1111223458999999999999999999999999999999953
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.69 Aligned_cols=185 Identities=24% Similarity=0.374 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qil~~L~~LH--~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||.|+ |...+ .....+++..++.++.|++.||.||| ++||+||||||+|||++.. .+.+||+|||+++..
T Consensus 105 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 105 MEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKL 182 (360)
T ss_dssp EECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT-TTEEEECCCTTCBCC
T ss_pred eeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC-CCcEEEeeCCCceec
Confidence 6899874 44433 35667999999999999999999999 9999999999999999752 235999999999876
Q ss_pred CCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------- 145 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 145 (268)
..........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence 65555566789999999999976654445599999999999999999999987766655555443211100
Q ss_pred ----c-------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 146 ----S-------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 146 ----~-------------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
. .......+.++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 01112256899999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=266.55 Aligned_cols=176 Identities=24% Similarity=0.347 Sum_probs=139.5
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-----------------
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP----------------- 59 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~----------------- 59 (268)
||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 7999999999999764 6799999999999999999999999999999999999997432
Q ss_pred CCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 024363 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 139 (268)
Q Consensus 60 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 139 (268)
...+||+|||+++.... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+.... ....
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~---- 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE---- 239 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH----
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH----
Confidence 33589999999875432 2345699999999999876444455999999999999999988775432 1221
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 140 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+..... ...+..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222211 22234589999999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=282.53 Aligned_cols=180 Identities=17% Similarity=0.162 Sum_probs=138.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~------~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
||||+ |+|.+++... ..+++..+ ..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 167 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DFG~a~~ 243 (371)
T 3q60_A 167 MPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSALWK 243 (371)
T ss_dssp ECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS--CEEECCGGGEEE
T ss_pred ecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC--CEEEEecceeee
Confidence 79999 7999999764 34555555 57779999999999999999999999999997665 499999999975
Q ss_pred CCCCCCCCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHH--HH-HHHHHhcccccCC
Q 024363 74 SVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--RK-TIQRILSVQYSVP 148 (268)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~ 148 (268)
... ......+|+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+....... .. ............+
T Consensus 244 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (371)
T 3q60_A 244 VGT--RGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG 320 (371)
T ss_dssp TTC--EEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCT
T ss_pred cCC--CccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchh
Confidence 422 1225567899999999976 4565 4499999999999999999999876432100 00 0000111223334
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 321 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 321 SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 44568999999999999999999999999999999954
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=273.76 Aligned_cols=181 Identities=22% Similarity=0.372 Sum_probs=142.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC---------
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccc
Confidence 799999999999998889999999999999999999999999999999999999976654 999999999754322
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+................. .......++.+
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 249 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGLSAD 249 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTCCHH
T ss_pred cccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCCCHH
Confidence 12234569999999999988777655 899999999999999999998776544333322211110 11112348899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.+||.+||..||.+||++.+++.|+|+..
T Consensus 250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 250 LDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=266.33 Aligned_cols=179 Identities=25% Similarity=0.394 Sum_probs=132.8
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||+| +|.+++.. .+.+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccc
Confidence 689985 88777653 56899999999999999999999998 999999999999997655 49999999997655
Q ss_pred CCCCCCCCcCCCCcccchhh----ccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 76 LHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
.........||+.|+|||++ .+..+ +.++|||||||++|+|++|+.||.......... ..............
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPAD 237 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTT
T ss_pred ccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccc
Confidence 55455556899999999997 33344 445899999999999999999998654433221 12222222222234
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 58999999999999999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.01 Aligned_cols=184 Identities=25% Similarity=0.437 Sum_probs=145.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||.|++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCccc
Confidence 79999999999888888899999999999999999999999999999999999997665 4999999999754332 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q 144 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 144 (268)
.....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........++...... .
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3456799999999999876444555999999999999999999998877665554443321110 0
Q ss_pred ccCCC----------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
...+. ...++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 11111 1247899999999999999999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=269.15 Aligned_cols=186 Identities=28% Similarity=0.421 Sum_probs=140.2
Q ss_pred CCCCCCCchhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~ 169 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSA 169 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchh
Confidence 699999999999964 45699999999999999999999999999999999999997655 49999999876
Q ss_pred CCCCC------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-
Q 024363 73 SSVLH------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY- 145 (268)
Q Consensus 73 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 145 (268)
..... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 43221 11234579999999999876332344599999999999999999999887665443332221111000
Q ss_pred ---cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 ---SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ---~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.......++..+.+||.+||..||.+|||+.++++||||.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0112245789999999999999999999999999999997644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=270.78 Aligned_cols=181 Identities=27% Similarity=0.405 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+. |+|.+++ ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ...
T Consensus 126 ~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~--~~~ 198 (371)
T 4exu_A 126 MPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD--AEM 198 (371)
T ss_dssp EECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC---------
T ss_pred Ecccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc--cCc
Confidence 68887 5888877 345999999999999999999999999999999999999976654 9999999997543 223
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (268)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++........
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 278 (371)
T 4exu_A 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278 (371)
T ss_dssp -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence 45678999999999987333344599999999999999999999887765555444332211100
Q ss_pred ----cCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 ----SVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ----~~~------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+ ....+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 000 0134689999999999999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=274.19 Aligned_cols=182 Identities=35% Similarity=0.633 Sum_probs=145.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 172 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172 (322)
T ss_dssp EECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH
T ss_pred EecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc
Confidence 79999999999998888999999999999999999999999999999999999997544 33599999999875433222
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCC
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS 154 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s 154 (268)
.....||+.|+|||++. ...++ .++|||||||++|+|++|..||........+...+.. ...... ....++
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 248 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVS 248 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHHTTSC
T ss_pred cccccCCcCccCchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhhhhcC
Confidence 23456999999999974 23444 4499999999999999999999876544333322221 111111 123478
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
..+.+||.+||..||.+|||+.++++||||..
T Consensus 249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 99999999999999999999999999999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.23 Aligned_cols=180 Identities=40% Similarity=0.687 Sum_probs=149.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++..+ ...+||+|||+++.......
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 69999999999998888999999999999999999999999999999999999997543 34699999999876554444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--cCCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~ 157 (268)
.....||+.|+|||++.+. ++. ++|||||||++|+|++|+.||.+........ .+..... ..+....++.++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-YDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-CCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGTTSCHHH
T ss_pred cccccCcccccChHHhcCC-CCC-chhhHhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCchhhhhcCHHH
Confidence 4556789999999998754 544 4899999999999999999998766443322 2222222 223335689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+||.+||..+|.+|||+.++++||||.+
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 99999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.10 Aligned_cols=181 Identities=21% Similarity=0.391 Sum_probs=142.3
Q ss_pred CCCCCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc--CCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~--~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+. .+..+.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 799999999999976443 99999999999999999999999999999999999982 1223349999999998665
Q ss_pred CCCCCCCCcCCCCcccchhhc--------cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--
Q 024363 76 LHSQPKSTVGTPAYIAPEVLL--------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-- 145 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 145 (268)
.........||+.|+|||++. +..++.+ +|||||||++|+|++|+.||............+..+.....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 555556678999999999986 3445444 89999999999999999999765544433334443332211
Q ss_pred -----------------cCCCCC----CCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 146 -----------------SVPDTN----PISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 146 -----------------~~~~~~----~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
..+... .++..+.+||.+||+.||.+|||+.|+++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111111 2346788999999999999999999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=271.61 Aligned_cols=182 Identities=27% Similarity=0.390 Sum_probs=142.2
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-----------------CCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----------------PAP 61 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-----------------~~~ 61 (268)
|||| +|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.. ..+
T Consensus 101 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 179 (355)
T 2eu9_A 101 FELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179 (355)
T ss_dssp EECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC
T ss_pred Eecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCC
Confidence 6899 56777777654 369999999999999999999999999999999999999432 234
Q ss_pred CEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 024363 62 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 141 (268)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 141 (268)
.+||+|||+++... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............. ..
T Consensus 180 ~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~ 255 (355)
T 2eu9_A 180 SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK-IL 255 (355)
T ss_dssp CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HH
T ss_pred cEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-Hc
Confidence 69999999997532 23345689999999999988777665 8999999999999999999987765444332222 21
Q ss_pred cccc---------------------------------------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 142 SVQY---------------------------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 142 ~~~~---------------------------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
.... ........+.++.+||.+||..||.+|||+.++++||
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 335 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1100 0001111245889999999999999999999999999
Q ss_pred ccCCC
Q 024363 183 WFLKN 187 (268)
Q Consensus 183 ~~~~~ 187 (268)
||...
T Consensus 336 ~f~~~ 340 (355)
T 2eu9_A 336 FFAGL 340 (355)
T ss_dssp GGGGC
T ss_pred hhcCC
Confidence 99754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=277.54 Aligned_cols=180 Identities=25% Similarity=0.400 Sum_probs=138.6
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCC------------------
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP------------------ 59 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~------------------ 59 (268)
|||| +|+|.+.+.+. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 124 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~ 202 (397)
T 1wak_A 124 FEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202 (397)
T ss_dssp ECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-------
T ss_pred Eecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCC
Confidence 6999 55776776554 5699999999999999999999999 999999999999997553
Q ss_pred -----------------------------CCCEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhh
Q 024363 60 -----------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 110 (268)
Q Consensus 60 -----------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 110 (268)
...+||+|||+|+.... ......||+.|+|||++.+..++.+ +|||||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Diwsl 279 (397)
T 1wak_A 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTP-ADIWST 279 (397)
T ss_dssp --------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTH-HHHHHH
T ss_pred CCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcH-HHHHHH
Confidence 12599999999975432 2345689999999999988877665 899999
Q ss_pred hHHHHHHHhCCCCCCCCCCh------HHHHHHHHHHhccc---------cc----------------------------C
Q 024363 111 GVTLYVMLVGGYPFEDPDEP------KDFRKTIQRILSVQ---------YS----------------------------V 147 (268)
Q Consensus 111 G~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~---------~~----------------------------~ 147 (268)
||++|+|++|+.||...+.. .....+.. ..... +. .
T Consensus 280 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
T 1wak_A 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358 (397)
T ss_dssp HHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTS
T ss_pred HHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhc
Confidence 99999999999999765432 11211111 11110 00 0
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
......+..+.+||.+||+.||.+|||+.++|+||||.
T Consensus 359 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00112346789999999999999999999999999995
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=267.81 Aligned_cols=180 Identities=27% Similarity=0.443 Sum_probs=139.8
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCTTTC------
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCcCceecCcCc
Confidence 7999999999999764 5799999999999999999999999999999999999997655 4999999998754322
Q ss_pred CCCCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 78 SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.......||+.|+|||++. +..++.+ +|||||||++|+|++|..||........... +............
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKK 258 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCSC
T ss_pred cccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCccc
Confidence 2234557999999999986 3445444 8999999999999999999987664333222 2222222223345
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++..+.+||.+||..||.+||++.++++||||...
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 89999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.31 Aligned_cols=179 Identities=28% Similarity=0.434 Sum_probs=145.6
Q ss_pred CCCCCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||. |+|.+++. ..+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---
Confidence 69998 58888885 456799999999999999999999999999999999999998665 499999999975432
Q ss_pred CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....||+.|+|||++. ...++.+ +|||||||++|+|++|+.||.+.........+. ...........++..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEY 281 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCCCCCCTTSCHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCCCCCCHH
Confidence 24567999999999985 3445544 899999999999999999998776544333322 222222233458999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
+.+||.+||+.||.+|||+.++++||||....+.
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999999999765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=269.96 Aligned_cols=176 Identities=19% Similarity=0.309 Sum_probs=138.0
Q ss_pred CCCCCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++.+... .++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 140 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQD 217 (332)
T ss_dssp EECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC
T ss_pred EEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccc
Confidence 799999999999987654 56677999999999999999999999999999999997665 4999999998754332
Q ss_pred -------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 024363 78 -------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144 (268)
Q Consensus 78 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (268)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+. .............
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~ 290 (332)
T 3qd2_B 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLK 290 (332)
T ss_dssp --------------CCCSCC-CGGGSCHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTC
T ss_pred hhhccccccccccccccccCCCcCccChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccC
Confidence 12344579999999999988777655 899999999999999876642 1122222222221
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.. ......++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 291 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 291 FP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred CC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11 111225688999999999999999999999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=273.13 Aligned_cols=185 Identities=23% Similarity=0.375 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCC----CCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP----APRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~----~~~~kl~Dfg~a~~ 73 (268)
|||+ ||+|.+++.+ .+.+++..++.++.||+.||.|||++ ||+||||||+|||++..+ .+.+||+|||+++.
T Consensus 109 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~ 187 (373)
T 1q8y_A 109 FEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187 (373)
T ss_dssp ECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred EecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence 6899 8899999976 34599999999999999999999998 999999999999995322 23599999999975
Q ss_pred CCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh------HHHHHHHHHHhccc---
Q 024363 74 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------KDFRKTIQRILSVQ--- 144 (268)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--- 144 (268)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..++.......
T Consensus 188 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 264 (373)
T 1q8y_A 188 YDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 264 (373)
T ss_dssp TTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred cCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHH
Confidence 432 2345689999999999988877655 89999999999999999999865421 12222221110000
Q ss_pred ---------------------------------ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 145 ---------------------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 145 ---------------------------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.....+..++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 265 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 000111224578899999999999999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=267.84 Aligned_cols=184 Identities=29% Similarity=0.420 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||+. |+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC-----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEeccccccccccccc
Confidence 68997 599999876 5799999999999999999999999999999999999997655 49999999987433211
Q ss_pred ---------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----
Q 024363 79 ---------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----- 144 (268)
Q Consensus 79 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 144 (268)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 123357899999999987644445559999999999999999999988765544433322211100
Q ss_pred ---------------ccCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 145 ---------------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 145 ---------------~~~~------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
...+ ....+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0134789999999999999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=267.61 Aligned_cols=175 Identities=36% Similarity=0.557 Sum_probs=145.4
Q ss_pred CCCCCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++.... ..
T Consensus 127 ~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~kL~Dfg~~~~~~~-~~ 204 (320)
T 3a99_A 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKD-TV 204 (320)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TTEEEECCCTTCEECCS-SC
T ss_pred EEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC-CCCEEEeeCcccccccc-cc
Confidence 578876 8999999988899999999999999999999999999999999999999732 23599999999875432 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... . ...... .....+++++.+
T Consensus 205 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~--~~~~~~~~~~~~ 272 (320)
T 3a99_A 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQV--FFRQRVSSECQH 272 (320)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCC--CCSSCCCHHHHH
T ss_pred ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccc--cccccCCHHHHH
Confidence 3456799999999999877776666899999999999999999997531 1 111112 223448999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
||.+||..||.+|||+.++++||||.....
T Consensus 273 li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 999999999999999999999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=271.07 Aligned_cols=181 Identities=28% Similarity=0.501 Sum_probs=148.3
Q ss_pred CCCCCCCchhHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~------l~~--~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
||||+||+|.++ +.+ ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++ .+||+|||++
T Consensus 122 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~ 199 (348)
T 2pml_X 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGES 199 (348)
T ss_dssp EECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS--CEEECCCTTC
T ss_pred EeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC--cEEEeccccc
Confidence 799999999998 655 5779999999999999999999999 9999999999999997665 4999999998
Q ss_pred CCCCCCCCCCCCcCCCCcccchhhccC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 72 KSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 72 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
+..... ......||+.|+|||++.+. .++..++|||||||++|+|++|+.||........ ....+.......+..
T Consensus 200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~i~~~~~~~~~~ 275 (348)
T 2pml_X 200 EYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---LFNNIRTKNIEYPLD 275 (348)
T ss_dssp EECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---HHHHHTSCCCCCCCS
T ss_pred cccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCcCCccc
Confidence 754322 33556799999999999876 5555359999999999999999999987766332 222333333333321
Q ss_pred -----------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 151 -----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 151 -----------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 4588999999999999999999999999999999654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.18 Aligned_cols=184 Identities=27% Similarity=0.447 Sum_probs=149.4
Q ss_pred CCCCCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||+||+|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhcc
Confidence 69999999999997 466899999999999999999999999999999999999997665 4999999998653322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ . .........+..++..+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-P--TNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-H--HSCCCCCSSGGGSCHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-h--cCCCcccCCcccCCHHHH
Confidence 2345679999999999988777666 89999999999999999999876543322211 1 111122223344789999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
+||.+||..||.+|||+.++++||||......
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 99999999999999999999999999765433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=264.55 Aligned_cols=181 Identities=26% Similarity=0.391 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.... ..
T Consensus 108 ~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~--~~ 180 (353)
T 3coi_A 108 MPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHADA--EM 180 (353)
T ss_dssp EECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC-------
T ss_pred ecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCCC--Cc
Confidence 68887 59988773 3599999999999999999999999999999999999997665 499999999975432 23
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------- 143 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 143 (268)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.......
T Consensus 181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 3coi_A 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260 (353)
T ss_dssp ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHH
T ss_pred cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHH
Confidence 456789999999998873333445999999999999999999998877655444433321100
Q ss_pred -------cccC-CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 144 -------QYSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 144 -------~~~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
...+ .....+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0001 11234789999999999999999999999999999997543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.82 Aligned_cols=173 Identities=27% Similarity=0.435 Sum_probs=134.9
Q ss_pred CCCCCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||+||+|.+++.+.+. +++..++.++.||+.||+|||++| |+||||||+||+++.++ .+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcccc
Confidence 799999999999987654 999999999999999999999999 99999999999997665 49999999997533
Q ss_pred CC-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 76 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 76 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......... +.........+..++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAA----VGFKCKRLEIPRNLN 265 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHHSCCCCCCCTTSC
T ss_pred ccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCCCCCCCccCC
Confidence 22 22345679999999999988877665 8999999999999999999987765433222 211222334445589
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+.+||.+||..+|.+|||+.++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=261.29 Aligned_cols=181 Identities=33% Similarity=0.563 Sum_probs=145.2
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||.+| |.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFA 163 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECCTTC
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccCccc
Confidence 6899986 7777765 45799999999999999999999999999999999999997665 4999999998754321
Q ss_pred --CCCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 78 --SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 78 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+...... ...+....... +..++
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~~~--~~~~~ 237 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----FENIGKGSYAI--PGDCG 237 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHCCCCC--CSSSC
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HHHHhcCCCCC--CCccC
Confidence 2223456999999999987633 234458999999999999999999987654332 22333333333 34488
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
..+.+||.+||..||.+|||+.++++||||.+..+.
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=259.65 Aligned_cols=179 Identities=28% Similarity=0.455 Sum_probs=135.7
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~ 171 (303)
T 1zy4_A 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLD 171 (303)
T ss_dssp EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCCSCTTC---
T ss_pred EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcchhhcccccc
Confidence 69999999999998644 689999999999999999999999999999999999997655 4999999998754321
Q ss_pred -------------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 024363 78 -------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 144 (268)
Q Consensus 78 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 144 (268)
.......||+.|+|||++.+....+.++|||||||++|+|++ ||..... .......+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~~~~~~~~~~ 245 (303)
T 1zy4_A 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVNILKKLRSVS 245 (303)
T ss_dssp ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHHHHHHHHSTT
T ss_pred hhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHHHHHhccccc
Confidence 122445799999999999865433455999999999999998 5543222 122333333333
Q ss_pred ccCC--CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 YSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 ~~~~--~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
...+ .....+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3222 234467889999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=259.41 Aligned_cols=183 Identities=29% Similarity=0.460 Sum_probs=142.4
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.. .+.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCEESCC-
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeecccccccCCC
Confidence 69999999999997642 46799999999999999999999999999999999999752 235999999998754322
Q ss_pred -CCCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||............. .... .....+..++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~ 253 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFK--VHPEIPESMSA 253 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHC--CCCCCCTTSCH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cccc--ccccccccCCH
Confidence 2234567999999999987643 12445899999999999999999997654433211111 1111 22223345899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++.+||.+||+.||.+|||+.++++||||...
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=263.97 Aligned_cols=182 Identities=21% Similarity=0.363 Sum_probs=135.8
Q ss_pred CCCCCCCchhHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVADFGLSRKI 187 (323)
T ss_dssp EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC----
T ss_pred EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEeeccccccc
Confidence 68999999999996532 599999999999999999999999999999999999997665 4999999999754
Q ss_pred CCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
.... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+. . ....+.+
T Consensus 188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~ 261 (323)
T 3qup_A 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----G-GNRLKQP 261 (323)
T ss_dssp -------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCC
T ss_pred cccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----c-CCCCCCC
Confidence 3322 2233457889999999988777655 999999999999999 999998877655433322 1 1223344
Q ss_pred CCCCHHHHHHHHHccccCCCCCCC-------HHHHhcccccCCCCCC
Q 024363 151 NPISQECRDLISRIFVADPAARIT-------IPEIMKHQWFLKNLPA 190 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s-------~~e~l~h~~~~~~~~~ 190 (268)
..++..+.+||.+||..||.+||| +++++.|||+....+.
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 558999999999999999999999 7888999999765443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=260.97 Aligned_cols=180 Identities=25% Similarity=0.398 Sum_probs=141.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++......
T Consensus 107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence 57 567899999999889999999999999999999999999999999999999964 359999999997543322
Q ss_pred -CCCCCcCCCCcccchhhccC----------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC
Q 024363 79 -QPKSTVGTPAYIAPEVLLRH----------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 147 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (268)
......||+.|+|||++.+. ...+.++|||||||++|+|++|+.||........ .+..........
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 259 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 259 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhccccc
Confidence 12345799999999998652 1234458999999999999999999987654322 223333333333
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..+...+..+.+||.+||..||.+|||+.++++||||...
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 4444578999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.18 Aligned_cols=180 Identities=34% Similarity=0.455 Sum_probs=139.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++ ++||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCcccccccccc
Confidence 79999999999999888999999999999999999999999999999999999997665 49999999997543322
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........+.+..... .........+++.+.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NVTTDVRKDIPQSLS 245 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CHHHHSCTTSCHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-CcchhcccCCCHHHH
Confidence 2234579999999999988777655 89999999999999999999887654433332221110 001112345889999
Q ss_pred HHHHHccccCCCCCCCHHHHhccccc
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
++|.+||..||.+||+..+.+.+.|.
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999965555555553
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=266.49 Aligned_cols=173 Identities=24% Similarity=0.381 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~k 243 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMK 243 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC--CEE
Confidence 79999999999997653 489999999999999999999999999999999999997665 499
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+..+
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~---- 318 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL---- 318 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999743322 22334567889999999988777655 999999999999999 99999887654433221
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
......+.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 319 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 -KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp -HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222333445589999999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=259.78 Aligned_cols=178 Identities=29% Similarity=0.496 Sum_probs=146.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+ +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...... ..
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccc
Confidence 699999999998854 6799999999999999999999999999999999999997655 4999999998654332 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... +... ........++..+.+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKN-NPPTLEGNYSKPLKE 249 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHS-CCCCCCSSCCHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcC-CCCCCccccCHHHHH
Confidence 345679999999999988777665 8999999999999999999987654332221 1111 112233458899999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
||.+||..||.+|||+.++++||||...
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999999999654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=267.68 Aligned_cols=178 Identities=15% Similarity=0.190 Sum_probs=139.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||| ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++....+.+||+|||+++......
T Consensus 131 ~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~ 209 (364)
T 3op5_A 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209 (364)
T ss_dssp EECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGC
T ss_pred EeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCc
Confidence 7999 99999999775 67999999999999999999999999999999999999984445569999999996432221
Q ss_pred -------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----c
Q 024363 79 -------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----S 146 (268)
Q Consensus 79 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~ 146 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+................... .
T Consensus 210 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T 3op5_A 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288 (364)
T ss_dssp CCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHH
T ss_pred ccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHH
Confidence 1234459999999999988777555 99999999999999999999864333322221111111000 0
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
......++.++.+||..||..+|.+||++.++++
T Consensus 289 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 289 CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1112347899999999999999999999998876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=261.47 Aligned_cols=173 Identities=33% Similarity=0.578 Sum_probs=144.1
Q ss_pred CCC-CCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc-CCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy-~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~-~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||| +.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+|||+++.....
T Consensus 117 ~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~- 193 (312)
T 2iwi_A 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDE- 193 (312)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccC-
Confidence 467 78999999999888999999999999999999999999999999999999997 443 5999999998754332
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..+...++|||||||++|+|++|+.||.... . +....... ...++..+.
T Consensus 194 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~--~~~~~~~~~ 261 (312)
T 2iwi_A 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHF--PAHVSPDCC 261 (312)
T ss_dssp CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCC--CTTSCHHHH
T ss_pred cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCC--cccCCHHHH
Confidence 33456799999999999877776655999999999999999999997521 1 11222222 344899999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+||.+||..+|.+|||+.++++||||....
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999999999999999997643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.82 Aligned_cols=184 Identities=29% Similarity=0.455 Sum_probs=143.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||+. |+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+||+++..+ +.+||+|||+++.....
T Consensus 101 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~ 177 (320)
T 2i6l_A 101 QEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSH 177 (320)
T ss_dssp EECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC------
T ss_pred eeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCccc
Confidence 68998 599998854 6799999999999999999999999999999999999997432 35999999999754321
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 143 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 143 (268)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (320)
T 2i6l_A 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257 (320)
T ss_dssp --CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSC
T ss_pred ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCc
Confidence 223445689999999998764444555999999999999999999999877655444433321100
Q ss_pred -----cccCC------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 -----QYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 -----~~~~~------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
....+ ....++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 258 VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 00000 113478999999999999999999999999999999653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=262.95 Aligned_cols=182 Identities=25% Similarity=0.431 Sum_probs=142.4
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCcccccccc
Confidence 699999999999875 56799999999999999999999999999999999999997655 499999998753111 11
Q ss_pred CCCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......||+.|+|||++. +..++. ++|||||||++|+|++|..||.............. ........+..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 248 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKW 248 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGS
T ss_pred ccccccCChhhcCCeeeccccCCCCCCch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCcccc
Confidence 223457999999999984 344444 48999999999999999999987665443332221 111122233457
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
+..+.+||.+||..||.+|||+.++++||||....
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 89999999999999999999999999999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=268.00 Aligned_cols=156 Identities=22% Similarity=0.433 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchhh
Q 024363 19 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 95 (268)
Q Consensus 19 l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 95 (268)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCCceeEChhhh
Confidence 89999999999999999999999999999999999997655 49999999997543222 23345689999999999
Q ss_pred ccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCC
Q 024363 96 LRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174 (268)
Q Consensus 96 ~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 174 (268)
.+..++.+ +|||||||++|+|++ |..||.+......+...+.. ....+.+..+++++.++|.+||..||.+|||
T Consensus 268 ~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 268 FDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp HHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 88777655 999999999999998 99999887765544443332 2223334458899999999999999999999
Q ss_pred HHHHhcc
Q 024363 175 IPEIMKH 181 (268)
Q Consensus 175 ~~e~l~h 181 (268)
+.++++|
T Consensus 343 ~~ell~~ 349 (359)
T 3vhe_A 343 FSELVEH 349 (359)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=268.80 Aligned_cols=180 Identities=18% Similarity=0.314 Sum_probs=145.7
Q ss_pred CCCCCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 79999999999997643 599999999999999999999999999999999999997543 2349999999986
Q ss_pred CCC---CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 73 SSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 73 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
... .........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ .+.. ....+
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~----~i~~-~~~~~ 306 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTS-GGRMD 306 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHT-TCCCC
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCC
Confidence 321 1223345678999999999988777655 999999999999998 999998766533222 2222 22233
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+..++..+.+||.+||+.+|.+|||+.+++++.++..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 34558999999999999999999999999999987743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=264.80 Aligned_cols=178 Identities=13% Similarity=0.169 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||| ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+++......
T Consensus 137 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 215 (352)
T 2jii_A 137 LPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215 (352)
T ss_dssp EECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGG
T ss_pred ecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCC
Confidence 7999 99999999876 78999999999999999999999999999999999999987653359999999997533221
Q ss_pred --------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhcccccCCC
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDFRKTIQRILSVQYSVPD 149 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~ 149 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .....................
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (352)
T 2jii_A 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG 294 (352)
T ss_dssp CCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC
T ss_pred ccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh
Confidence 1234579999999999988776555 999999999999999999998765 333344333333322222211
Q ss_pred ----CCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 150 ----TNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 150 ----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...++..+.+||.+||..||.+|||+.++++
T Consensus 295 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1246899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=264.65 Aligned_cols=173 Identities=25% Similarity=0.400 Sum_probs=142.2
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~k 231 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMK 231 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC--cEE
Confidence 79999999999998754 499999999999999999999999999999999999997665 499
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....... . .+
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~-~---~~ 306 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF-K---LL 306 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-H---HH
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H---HH
Confidence 9999999754332 22344567889999999988777655 899999999999999 99999876643322 2 22
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
........+..++.++.+||.+||+.+|.+|||+.+++++
T Consensus 307 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 307 -KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222333445589999999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.41 Aligned_cols=173 Identities=25% Similarity=0.409 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eEE
Confidence 79999999999997654 699999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 024363 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+|||+++............+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+....... ..+ ..
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~-~~ 256 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKL-PQ 256 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHG-GG
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHHH----HHh-hc
Confidence 999999875444444455567899999999987777655 899999999999998 99999876643322 222 22
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+..+++.+.+||.+||..+|.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23334455689999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.25 Aligned_cols=179 Identities=17% Similarity=0.200 Sum_probs=140.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
|||| ||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+.+||+|||+++......
T Consensus 131 ~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~ 209 (345)
T 2v62_A 131 MERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209 (345)
T ss_dssp EECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC
T ss_pred Eecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccccc
Confidence 7999 9999999988779999999999999999999999999999999999999987765579999999996432211
Q ss_pred ------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhcccc----cC
Q 024363 79 ------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDFRKTIQRILSVQY----SV 147 (268)
Q Consensus 79 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~----~~ 147 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.. ................. ..
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (345)
T 2v62_A 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW 288 (345)
T ss_dssp CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH
T ss_pred ccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh
Confidence 1134579999999999987766555 999999999999999999996532 22222222222111100 01
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.....++.++.+||.+||..||.+|||+.++++.
T Consensus 289 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 289 APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1122488999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=255.52 Aligned_cols=178 Identities=18% Similarity=0.209 Sum_probs=139.0
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC---CCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~---~~~~kl~Dfg~a~~~~~ 76 (268)
|||+ ||+|.+++...+ ++++..++.++.||+.||+|||++||+||||||+||+++.++ ...+||+|||+++....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 6899 999999998754 599999999999999999999999999999999999996543 23499999999875333
Q ss_pred CC--------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH---HHHHHHHHHhcccc
Q 024363 77 HS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQY 145 (268)
Q Consensus 77 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 145 (268)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... .+..+.........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 21 2345679999999999988777554 999999999999999999998754322 12222211111111
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
......+++++.+||.+||..+|.+||++.++++.
T Consensus 243 -~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 -RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11123488999999999999999999999998863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.26 Aligned_cols=178 Identities=22% Similarity=0.390 Sum_probs=133.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
||||.||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC----------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccc
Confidence 699999999999954 45699999999999999999999999999999999999998665 499999999874332
Q ss_pred CCCCCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 77 HSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
........||+.|+|||++. +..++ .++|||||||++|+|++|+.||.+..........+...............+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred cccccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 22234457999999999986 33443 348999999999999999999988777665554443322111111123357
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++.+.+||.+||..+|.+|||+.++++.
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 8999999999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.60 Aligned_cols=179 Identities=30% Similarity=0.478 Sum_probs=142.5
Q ss_pred CCCCCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qil~~L~~LH~~~-----ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
||||+||+|.+++.+. ..+++..++.++.|++.||.|||++| ++||||||+||+++.++ .+||+|||++
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~~ 163 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA 163 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCchh
Confidence 7999999999999653 34999999999999999999999999 99999999999997655 4999999998
Q ss_pred CCCCCCCC-CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 72 KSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 72 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
+....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+..... .+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~-~~~~ 237 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKF-RRIP 237 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCC-CCCC
T ss_pred eeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHH----HHHhhccc-ccCC
Confidence 64322211 123468999999999988777654 89999999999999999999876543322 22222222 1233
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
..++.++.++|.+||..||.+|||+.++++|+|+...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 4589999999999999999999999999999999654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.40 Aligned_cols=173 Identities=18% Similarity=0.308 Sum_probs=140.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||.||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGGGSCCCTT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCcccccCcccc
Confidence 6899999999999774 5799999999999999999999999999999999999997655 49999999997543322
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-L----EKGERLAQPQICTI 244 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-H----HTTCBCCCCTTBCT
T ss_pred cccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-H----HcCCCCCCCCcCcH
Confidence 2234567889999999987777655 999999999999999 9999987665433221 1 12223334445788
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++.++|.+||..||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=263.86 Aligned_cols=179 Identities=25% Similarity=0.409 Sum_probs=122.4
Q ss_pred CCCCCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||.| +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceec
Confidence 699986 88888763 56799999999999999999999999 999999999999997665 4999999999865
Q ss_pred CCCCCCCCCcCCCCcccchhhc----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-ccC--
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSV-- 147 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~-- 147 (268)
..........||+.|+|||++. +..++.+ +|||||||++|+|++|+.||....... ..+..+.... ...
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSN 252 (327)
T ss_dssp -----------------------------CCSH-HHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCC
Confidence 5444444557999999999983 4445544 899999999999999999998654321 1111111111 111
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.....++..+.+||.+||..||.+|||+.++++||||..
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 112348899999999999999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=259.05 Aligned_cols=172 Identities=23% Similarity=0.365 Sum_probs=139.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence 7999999999999754 5799999999999999999999999999999999999997655 49999999997543321
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... + ......+.+..++
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~ 280 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----V-EEGYRLPAPMGCP 280 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----H-HTTCCCCCCTTCC
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----H-HcCCCCCCCCCcC
Confidence 1223346788999999987777655 899999999999999 9999987765433322 2 2223445556689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+||.+||..||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=258.81 Aligned_cols=178 Identities=24% Similarity=0.366 Sum_probs=135.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH--------~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||+||+|.++++ ...+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||+|+
T Consensus 85 ~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~ 161 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAV 161 (301)
T ss_dssp ECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred hhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCee
Confidence 79999999999994 457999999999999999999999 99999999999999997665 49999999986
Q ss_pred CCCCCC-----CCCCCcCCCCcccchhhccCccC-----CcccchhhhhHHHHHHHhC----------CCCCCCCCChHH
Q 024363 73 SSVLHS-----QPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDPDEPKD 132 (268)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~el~~g----------~~pf~~~~~~~~ 132 (268)
...... ......||+.|+|||++.+.... +.++|||||||++|+|++| ..||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 432221 12345799999999999765321 1348999999999999999 888865433221
Q ss_pred HHHHHHHHhcccccCCCC------CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 133 FRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+..........+.. ...+..+.+||.+||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 122222222221111111 1245789999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.82 Aligned_cols=175 Identities=24% Similarity=0.412 Sum_probs=144.0
Q ss_pred CCCCCCCchhHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 024363 1 MEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~ 57 (268)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC
Confidence 79999999999997653 3799999999999999999999999999999999999976
Q ss_pred CCCCCEEEeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHH
Q 024363 58 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 133 (268)
Q Consensus 58 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 133 (268)
++ .+||+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+
T Consensus 208 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 208 GK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp TT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 65 499999999975433222 233457889999999987777655 899999999999998 99999887765544
Q ss_pred HHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 134 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
...+.. ....+.+..+++.+.+||.+||..||.+|||+.++++|.
T Consensus 285 ~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 285 YKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 443332 233344455899999999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=254.54 Aligned_cols=173 Identities=21% Similarity=0.338 Sum_probs=132.9
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence 79999999999997654 699999999999999999999999999999999999998665 49999999997543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+. . ....+.+..+++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~----~-~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----N-GERLPMPPNCPPT 245 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCCTTCCHH
T ss_pred cccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH----c-CCCCCCCCCCCHH
Confidence 1233457789999999987777655 899999999999996 999998876654433222 1 1223344568999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||..||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=253.65 Aligned_cols=177 Identities=20% Similarity=0.252 Sum_probs=138.1
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+ ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 6899 8999999974 567999999999999999999999999999999999999941 122359999999987533322
Q ss_pred --------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhcccccC
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSV 147 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 147 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..+..........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred cccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 1245679999999999988776555 89999999999999999999864322 2223322222211110
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 012347899999999999999999999999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=255.22 Aligned_cols=180 Identities=24% Similarity=0.411 Sum_probs=133.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~-~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||+ ++.+..+... .+.+++..++.++.||+.||.|||++ |++||||||+||+++.++ .+||+|||+++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCc
Confidence 6899 5566555543 56899999999999999999999996 999999999999997655 49999999997654444
Q ss_pred CCCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......||+.|+|||++. ...++ .++|||||||++|+|++|+.||............+ ........+....+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH--HHSCCCCCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH--hccCCCCCCccCCC
Confidence 445567999999999985 33444 44899999999999999999998755433222211 11222233444458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
+.++.+||.+||..||.+|||+.++++||||.+
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999999999999999999999999999999964
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=254.13 Aligned_cols=178 Identities=21% Similarity=0.309 Sum_probs=138.3
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------
T ss_pred EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcc
Confidence 79999999999997754 5999999999999999999999999999999999999976654 9999999997543321
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHhccc
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------KDFRKTIQRILSVQ 144 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~ 144 (268)
......+++.|+|||++.+..++.+ +|||||||++|+|++|..||...... ..............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred eeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 1233457778999999988777655 89999999999999999998643211 11111122222333
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
...+.+..+++++.+||.+||..||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 3455566689999999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=250.77 Aligned_cols=173 Identities=21% Similarity=0.358 Sum_probs=141.4
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhh
Confidence 79999999999997754 599999999999999999999999999999999999997665 49999999987433222
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... +.. ......+...++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQ-GHRLYRPHLASDT 233 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTSCHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHc-CCCCCCCCcChHH
Confidence 1233456778999999988777666 899999999999999 9999987765443322 211 2223334447899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||+.+|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.72 Aligned_cols=173 Identities=21% Similarity=0.352 Sum_probs=141.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+|+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCcc
Confidence 589999999999976 467999999999999999999999999999999999999976654 99999999874332221
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+....... . ........+.+..++.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-S----ILEKGERLPQPPICTI 246 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-H----HHHTTCCCCCCTTBCH
T ss_pred cccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-H----HHHcCCCCCCCccCCH
Confidence 233456889999999988777655 999999999999999 99999876654322 2 2222233445556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+++.+||+.+|.+|||+.+++.+
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=250.76 Aligned_cols=174 Identities=29% Similarity=0.456 Sum_probs=137.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEEcCC------CCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGS------PAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~---ivHrdlkp~Nili~~~------~~~~~kl~Dfg~a 71 (268)
||||+||+|.+++. .+.+++..++.++.|++.||.|||++| |+||||||+||+++.. ..+.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 79999999998884 568999999999999999999999999 8999999999999752 1346999999999
Q ss_pred CCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCC
Q 024363 72 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 151 (268)
Q Consensus 72 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (268)
+...... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...........+.+.
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 164 REWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALPIPS 237 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCCCCT
T ss_pred ccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCCCCc
Confidence 7543322 235679999999999987776555 8999999999999999999987665332 222333344445556
Q ss_pred CCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 152 PISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 152 ~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+++.+.++|.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 689999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=253.72 Aligned_cols=174 Identities=24% Similarity=0.357 Sum_probs=144.4
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDG 176 (284)
T ss_dssp ECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCS
T ss_pred EeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccc
Confidence 7999999999999754 67999999999999999999999999999999999999976654 9999999987655554
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||... ......+.... ....++..+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~ 245 (284)
T 2a19_B 177 KRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI----ISDIFDKKEK 245 (284)
T ss_dssp CCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC----CCTTSCHHHH
T ss_pred cccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc----ccccCCHHHH
Confidence 5556679999999999988777655 89999999999999999887421 11222222211 2234789999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+||.+||..||.+|||+.++++|++..+.
T Consensus 246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 246 TLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999887554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.10 Aligned_cols=174 Identities=25% Similarity=0.424 Sum_probs=143.9
Q ss_pred CCCCCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC
Q 024363 1 MEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~ 62 (268)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~ 183 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--I 183 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT--E
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC--C
Confidence 69999999999997654 489999999999999999999999999999999999997665 4
Q ss_pred EEEeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 024363 63 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ 138 (268)
Q Consensus 63 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~ 138 (268)
+||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+..........+.
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 262 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc
Confidence 99999999875443322 234457889999999987776655 899999999999998 9999988776555444433
Q ss_pred HHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 139 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 139 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
. ......+..++..+.+||.+||..||.+|||+.+++++
T Consensus 263 ~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3 22333345589999999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.44 Aligned_cols=182 Identities=28% Similarity=0.423 Sum_probs=130.7
Q ss_pred CCCCCCCchhHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC-----------CCCC
Q 024363 1 MEYASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----------PAPR 62 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l-------~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~-----------~~~~ 62 (268)
||||. |+|.+++...+.. ++..++.++.||+.||+|||++||+||||||+|||++.. ....
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 79996 5999999876543 333467899999999999999999999999999999753 2346
Q ss_pred EEEeecCCCCCCCCCC-----CCCCCcCCCCcccchhhcc-------CccCCcccchhhhhHHHHHHHh-CCCCCCCCCC
Q 024363 63 LKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE 129 (268)
Q Consensus 63 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~ 129 (268)
+||+|||+++...... ......||+.|+|||++.+ ..+ +.++|||||||++|+|++ |+.||.....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 9999999997543322 1234579999999999975 334 445999999999999999 9999976544
Q ss_pred hHHHHHHHHHHhcccc-cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 130 PKDFRKTIQRILSVQY-SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 130 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.. ..++........ .......++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 32 122222111110 01111124588999999999999999999999999999953
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=255.70 Aligned_cols=173 Identities=26% Similarity=0.422 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 024363 1 MEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~ 56 (268)
||||+||+|.+++.+... +++.+++.++.||+.||.|||++||+||||||+||+++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc
Confidence 699999999999987543 89999999999999999999999999999999999998
Q ss_pred CCCCCCEEEeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHH
Q 024363 57 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 132 (268)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 132 (268)
.++. +||+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......
T Consensus 185 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 185 EGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp TTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6654 9999999987433221 2234467889999999988777655 899999999999999 9999988765443
Q ss_pred HHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
... + ......+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNL-L----KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHH-H----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-h----hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322 1 1222233445589999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=251.37 Aligned_cols=173 Identities=21% Similarity=0.407 Sum_probs=141.6
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEecccccccccccccc
Confidence 799999999999975 45699999999999999999999999999999999999997655 4999999998743322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... +.. ......+..++..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTH 235 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHH
T ss_pred ccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----Hhc-CccCCCCCcCCHH
Confidence 12344567889999999987777655 899999999999999 9999987665433222 222 2233344558999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||..+|.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.58 Aligned_cols=175 Identities=21% Similarity=0.259 Sum_probs=138.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE---cCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili---~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||| ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccC
Confidence 6899 9999999974 5679999999999999999999999999999999999999 4444 499999999875333
Q ss_pred CC--------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhcccc
Q 024363 77 HS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQY 145 (268)
Q Consensus 77 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 145 (268)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ...............
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 21 2235679999999999988777555 89999999999999999999875432 222222222211111
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
......+++.+.+||.+||+.+|.+|||+.++++
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0011347899999999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=269.63 Aligned_cols=180 Identities=25% Similarity=0.401 Sum_probs=133.2
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC---CCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~---~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++..++||+|||+|+....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 68997 59999997654 4677778899999999999999999999999999999953 3344588999999975433
Q ss_pred C----CCCCCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc-C
Q 024363 77 H----SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS-V 147 (268)
Q Consensus 77 ~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 147 (268)
. .......||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||....... .. .. ....... .
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~-~~--~~~~~~~~~ 250 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-AN-IL--LGACSLDCL 250 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HH-HH--TTCCCCTTS
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HH-HH--hccCCcccc
Confidence 2 22345679999999999974 333 334899999999999999 899996544322 11 11 1111111 1
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
......+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 111224567899999999999999999999999999953
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=259.03 Aligned_cols=178 Identities=22% Similarity=0.386 Sum_probs=135.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~--------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++.+. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus 114 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a~ 190 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 190 (337)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred EeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCce
Confidence 7999999999999664 799999999999999999999999 999999999999997665 49999999986
Q ss_pred CCCCCCC-----CCCCcCCCCcccchhhccCccCCc-----ccchhhhhHHHHHHHhC----------CCCCCCCCChHH
Q 024363 73 SSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVG----------GYPFEDPDEPKD 132 (268)
Q Consensus 73 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~el~~g----------~~pf~~~~~~~~ 132 (268)
....... .....||+.|+|||++.+..+... ++|||||||++|+|++| ..||........
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 4332221 235679999999999977655433 37999999999999999 677765432221
Q ss_pred HHHHHHHHhcc-cccCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 133 FRKTIQRILSV-QYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 133 ~~~~~~~~~~~-~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+...... ......+ ..++..+.+||.+||+.||.+|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11222222211 1111111 1356779999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.64 Aligned_cols=171 Identities=21% Similarity=0.296 Sum_probs=140.5
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++| ++||||||+||+++.++. ++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--- 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--- 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee---
Confidence 69999999999998765 4899999999999999999999999 999999999999976654 88888887653
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCc--ccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGK--IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.......||+.|+|||++.+..+... ++|||||||++|+|++|+.||.+......... ........+.+..++
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 163 -FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGIS 237 (271)
T ss_dssp -TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTCC
T ss_pred -ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCCC
Confidence 22245678999999999987655442 48999999999999999999987765443332 222333334445689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.++|.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=258.05 Aligned_cols=173 Identities=25% Similarity=0.363 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.. .+.+++.+++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccc
Confidence 799999999999987 567999999999999999999999999999999999999976554 99999999874322211
Q ss_pred ---------------CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhcc
Q 024363 80 ---------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSV 143 (268)
Q Consensus 80 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 143 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 125579999999999988777665 8999999999999999999865332110 0000001111
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+..+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 ---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1112347889999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=250.40 Aligned_cols=173 Identities=20% Similarity=0.362 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||.||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEcccccccccccccc
Confidence 799999999999976 56799999999999999999999999999999999999997655 4999999998743222
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||...........+ .. ......+...++.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 249 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----AQ-GLRLYRPHLASEK 249 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HT-TCCCCCCTTCCHH
T ss_pred ccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHH----hc-ccCCCCCCcCCHH
Confidence 12234457889999999987777555 899999999999998 99999877654333222 21 2223334457899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+||.+||..+|.+|||+.++++|
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=248.39 Aligned_cols=175 Identities=25% Similarity=0.384 Sum_probs=140.1
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCC---CCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPA---PRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~---~~~kl~Dfg~a~~~ 74 (268)
||||+||+|.+++.+. ..+++..++.++.|++.||+|||++| |+||||||+||+++.++. ..+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 7999999999988654 47999999999999999999999999 999999999999965432 23899999999743
Q ss_pred CCCCCCCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.. ......||+.|+|||++.. ..++ .++|||||||++|+|++|+.||......... ..............+..
T Consensus 180 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~ 254 (287)
T 4f0f_A 180 VH--SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPTIPED 254 (287)
T ss_dssp SS--CEECCCCCCTTSCGGGSSCSSCEEC-HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCCCCTT
T ss_pred cc--cccccCCCccccCchhhccCCCCcC-chhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCCCCcc
Confidence 32 2345679999999999843 3343 4489999999999999999999876554321 12222233333444556
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=257.00 Aligned_cols=174 Identities=22% Similarity=0.412 Sum_probs=143.0
Q ss_pred CCCCCCCchhHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~k 188 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVK 188 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEE
Confidence 699999999999987554 89999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+..
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~- 266 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 266 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc-
Confidence 999999975433222 234467889999999988777655 899999999999998 99999887655444333322
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 267 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 267 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12233344588999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=266.66 Aligned_cols=170 Identities=23% Similarity=0.381 Sum_probs=140.0
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCccccccc-
Confidence 799999999999987554 79999999999999999999999999999999999997655 4999999999743322
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.........+ ......+.+..+++.+
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAV 415 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-----HTTCCCCCCTTCCHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHH
Confidence 233467889999999988777655 899999999999998 99999887655433222 1223444556689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+||.+||..||.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=250.08 Aligned_cols=173 Identities=20% Similarity=0.292 Sum_probs=139.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.||+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence 6899999999999764 4699999999999999999999999999999999999997665 49999999987543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||............. .....+.+..+++.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCPPV 242 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-----HTCCCCCCTTCCHH
T ss_pred cccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-----cCCCCCCCCCCCHH
Confidence 2234457889999999987777554 899999999999998 999998766544332221 11233444558999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||..+|.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.50 Aligned_cols=176 Identities=22% Similarity=0.262 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC---CCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~---~~~kl~Dfg~a~~~~~ 76 (268)
|||| ||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 7999 9999999986 468999999999999999999999999999999999999975442 2299999999975332
Q ss_pred CC--------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 77 HS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 77 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ...+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATP 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSC
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCC
Confidence 22 1245689999999999988777555 8999999999999999999987543322 122222211111111
Q ss_pred C---CCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 149 D---TNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 149 ~---~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
. ...++ ++.++|.+||..+|.+||++.++++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 11134 9999999999999999999988776
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=267.05 Aligned_cols=172 Identities=23% Similarity=0.371 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCc
Confidence 7999999999999754 3799999999999999999999999999999999999997655 4999999999754321
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.......+|+.|+|||++....++.+ +|||||||++|+|++ |+.||.+.........+. .....+.+..+++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----RGYRMPRPENCPE 412 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----HTCCCCCCTTSCH
T ss_pred eeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCH
Confidence 11233456789999999987777655 999999999999999 999998876544333222 2234455566899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||..||.+|||+.+++.
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=262.26 Aligned_cols=172 Identities=22% Similarity=0.366 Sum_probs=139.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVY 268 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCce
Confidence 7999999999999765 4699999999999999999999999999999999999997655 49999999987432211
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....... . ........+.+..++.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTR-E----FVEKGGRLPCPELCPD 342 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-H----HHHTTCCCCCCTTCCH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCCCCCCCCCCCH
Confidence 1122345778999999987777655 899999999999998 99999876653322 1 2222334455556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||..||.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=257.36 Aligned_cols=173 Identities=23% Similarity=0.331 Sum_probs=139.6
Q ss_pred CCCCCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 024363 1 MEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~ 56 (268)
||||+||+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+||+++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 7999999999999763 5799999999999999999999999999999999999997
Q ss_pred CCCCCCEEEeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHH
Q 024363 57 GSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD 132 (268)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 132 (268)
.++ .+||+|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......
T Consensus 209 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 209 ENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp GGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 655 4999999998643221 22334568999999999987777655 999999999999999 9999987665332
Q ss_pred HHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.. .+.... ..+.+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 286 ~~----~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IY----YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HH----HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----HHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 22 222222 123344588999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.24 Aligned_cols=172 Identities=23% Similarity=0.287 Sum_probs=139.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 173 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSE
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCCc
Confidence 69999999999999988899999999999999999999999999999999999998665 499999999875432221
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+....... . .+.. ....+.+..++.
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~---~~~~-~~~~~~~~~~~~ 247 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-A---MLEK-GERMGCPAGCPR 247 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-H---HHHT-TCCCCCCTTCCH
T ss_pred ccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-H---HHHc-CCCCCCCCCCCH
Confidence 223346789999999987776555 899999999999999 99999876653322 2 1211 222333455899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.++|.+||..||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=252.59 Aligned_cols=172 Identities=17% Similarity=0.189 Sum_probs=135.0
Q ss_pred CCCCCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC------CEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~------~~kl~Dfg~a~~ 73 (268)
||||.||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|||++.++.. .+||+|||+++.
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~ 170 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170 (289)
T ss_dssp EECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTT
T ss_pred EECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccc
Confidence 799999999999987654 9999999999999999999999999999999999999765431 289999999864
Q ss_pred CCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 74 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 74 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+............. ...... +...
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~--~~~~ 241 (289)
T 4fvq_A 171 VLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQL--PAPK 241 (289)
T ss_dssp TSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCC--CCCS
T ss_pred ccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCC--CCCC
Confidence 322 1234689999999999874444555999999999999999655444433333222222 122222 3336
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++.+||.+||+.||.+|||+.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.74 Aligned_cols=178 Identities=20% Similarity=0.240 Sum_probs=134.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------QVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~----------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
||||+||+|.+++.+ +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTT
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCc
Confidence 799999999999976 4699999999999999999999999 999999999999997655 499999999
Q ss_pred CCCCCCC---CCCCCCcCCCCcccchhhccCc----cCCcccchhhhhHHHHHHHhCCCCCCCCCChH------------
Q 024363 71 SKSSVLH---SQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------------ 131 (268)
Q Consensus 71 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------ 131 (268)
++..... .......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.....
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9643322 2234467999999999997631 12234799999999999999999997643211
Q ss_pred HHHHHHHHHhcccccCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 132 DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
................... ...+..+.+||.+||+.||.+|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0111111111111111111 1124569999999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.62 Aligned_cols=176 Identities=23% Similarity=0.361 Sum_probs=140.6
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 104 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCC
T ss_pred EEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccCCCc
Confidence 799999999999954 56799999999999999999999999999999999999997665 49999999987543332
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----------ChHHHHHHHHHHhccc
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------EPKDFRKTIQRILSVQ 144 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~~~~~~~~~~~~~ 144 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.|+.... ......... ......
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 259 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLKEG 259 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHHTT
T ss_pred ceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHhcc
Confidence 2344568889999999988777655 899999999999999998864321 111112222 222333
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 344555668999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.28 Aligned_cols=173 Identities=20% Similarity=0.344 Sum_probs=137.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC---------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCccc
Confidence 689999999999976 457999999999999999999999999999999999999976654 99999999975433222
Q ss_pred ---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 80 ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 80 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ . .......+.+..++.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~----~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS-I----LEKGERLPQPPICTI 246 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-H----HHTTCCCCCCTTBCH
T ss_pred cccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-H----HHcCCCCCCCccCCH
Confidence 233456889999999988777655 899999999999999 999998776544322 1 222233445556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++.+||.+||..||.+|||+.++++.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.27 Aligned_cols=173 Identities=21% Similarity=0.326 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~------~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADFGLSKKI 197 (313)
T ss_dssp EECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSCSCC---
T ss_pred EecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeecCcceec
Confidence 68999999999994 235699999999999999999999999999999999999997665 4999999998754
Q ss_pred CCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 75 VLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 75 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
... .......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........... . ....+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~ 271 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----H-GHRLKQP 271 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----T-TCCCCCB
T ss_pred ccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----c-CCCCCCC
Confidence 322 12234457889999999987777655 899999999999999 899998876654433222 1 1223334
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+++.+.+||.+||..+|.+|||+.+++.+
T Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 272 EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5588999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.64 Aligned_cols=172 Identities=20% Similarity=0.362 Sum_probs=131.1
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCc
Confidence 79999999999998754 699999999999999999999999999999999999997655 499999999975433211
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... .......+.+..++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-----i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-----VDEGYRLPPPMDCP 276 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-----HHTTEECCCCTTCB
T ss_pred cceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCcccc
Confidence 122345778999999988777655 899999999999998 9999987765432222 22233444555688
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
..+.+||.+||+.+|.+||++.++++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=249.58 Aligned_cols=174 Identities=24% Similarity=0.339 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+ .+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence 699999999999965 35699999999999999999999999999999999999997665 49999999987543221
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... +.. ....+.+..++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~ 239 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECP 239 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCCCTTCC
T ss_pred eeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----Hhc-CCcCCCCCCcC
Confidence 2233457899999999987777655 899999999999998 9999988766443322 222 12223345589
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
+.+.++|.+||..+|.+||++.+++++.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=253.44 Aligned_cols=173 Identities=24% Similarity=0.397 Sum_probs=140.7
Q ss_pred CCCCCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~k 197 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMK 197 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC--CEE
Confidence 69999999999998654 389999999999999999999999999999999999997655 499
Q ss_pred EeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +..
T Consensus 198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~- 274 (334)
T 2pvf_A 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKE- 274 (334)
T ss_dssp ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHH-
T ss_pred EccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH-Hhc-
Confidence 99999987533221 2234467889999999987777655 899999999999999 9999987664332222 211
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+..++..+.++|.+||..+|.+|||+.+++++
T Consensus 275 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 275 ---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12233345589999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=256.41 Aligned_cols=178 Identities=23% Similarity=0.360 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCS
T ss_pred EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCc
Confidence 799999999999976 456999999999999999999999999999999999999976654 9999999987543222
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH----------HHHHHHHHhcccc
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD----------FRKTIQRILSVQY 145 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------~~~~~~~~~~~~~ 145 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+........
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred cceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 2334568889999999988777555 8999999999999999999865332110 0111222223333
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 445556689999999999999999999999999765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.77 Aligned_cols=174 Identities=24% Similarity=0.383 Sum_probs=141.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
|||+.+|+|.+++.+. +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CC
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccccc
Confidence 6899999999999764 5799999999999999999999999999999999999997665 49999999987543322
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+..... ....+.......+....++
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTTCC
T ss_pred chhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCCCCCcCcC
Confidence 1234467889999999987777555 899999999999999 999998776533 2333334444455556689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.++|.+||..+|.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=267.43 Aligned_cols=166 Identities=15% Similarity=0.157 Sum_probs=134.0
Q ss_pred CCCchhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 5 SGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 5 ~gg~L~~~l~~-------~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~~~~ 264 (413)
T 3dzo_A 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS 264 (413)
T ss_dssp CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTEE
T ss_pred hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeecCCc
Confidence 45799888841 334788899999999999999999999999999999999977665 999999998754332
Q ss_pred CCCCCCcCCCCcccchhh----------ccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC
Q 024363 78 SQPKSTVGTPAYIAPEVL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 147 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 147 (268)
....+| +.|+|||++ ....++. ++|||||||++|+|++|+.||........ ....+
T Consensus 265 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~~----------~~~~~ 330 (413)
T 3dzo_A 265 --AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF-AFDTWTLGLAIYWIWCADLPNTDDAALGG----------SEWIF 330 (413)
T ss_dssp --ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH-HHHHHHHHHHHHHHHHSSCCCCTTGGGSC----------SGGGG
T ss_pred --cccCCC-CceeCchhhhccccccccccCcCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchhhh----------HHHHH
Confidence 345677 999999999 3334544 49999999999999999999986543221 11112
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.....+|+.+.+||.+||..||.+||++.++++||||..
T Consensus 331 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 331 RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 233458899999999999999999999999999999954
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=256.23 Aligned_cols=174 Identities=22% Similarity=0.385 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEe
Q 024363 1 MEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~ 66 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~ 206 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VAKIG 206 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EEEBC
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eEEEC
Confidence 7999999999999653 4689999999999999999999999999999999999997665 49999
Q ss_pred ecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 024363 67 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS 142 (268)
Q Consensus 67 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 142 (268)
|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+..
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--- 282 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD--- 282 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH---
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc---
Confidence 9999975433221 234567889999999987777655 899999999999998 99999887665544443332
Q ss_pred ccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 143 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 143 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 283 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 -GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 23333444578999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=258.27 Aligned_cols=173 Identities=21% Similarity=0.315 Sum_probs=132.1
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence 7999999999999764 4589999999999999999999999999999999999997655 49999999997532221
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |.+||...........+ ... .....+..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~-~~~~~p~~~ 321 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG-RRLLQPEYC 321 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTT-CCCCCCTTC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcC-CCCCCCCCC
Confidence 1233457889999999987777655 999999999999999 77888776554332221 111 223334458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+..+.++|.+||..+|.+|||+.+++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=256.12 Aligned_cols=183 Identities=22% Similarity=0.307 Sum_probs=132.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~---------~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
||||+||+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~a 167 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLS 167 (336)
T ss_dssp ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTTC
T ss_pred EecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccce
Confidence 7999999999999664 459999999999999999999999 999999999999997655 4999999999
Q ss_pred CCCCCC---------CCCCCCcCCCCcccchhhccC-------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH---
Q 024363 72 KSSVLH---------SQPKSTVGTPAYIAPEVLLRH-------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--- 132 (268)
Q Consensus 72 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--- 132 (268)
+..... .......||+.|+|||++.+. .+ +.++|||||||++|+|++|..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 743221 122345799999999999762 33 3448999999999999999776643221100
Q ss_pred ----------HHHHHHHHhccc-c--cCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHh------cccccCCC
Q 024363 133 ----------FRKTIQRILSVQ-Y--SVPD----TNPISQECRDLISRIFVADPAARITIPEIM------KHQWFLKN 187 (268)
Q Consensus 133 ----------~~~~~~~~~~~~-~--~~~~----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l------~h~~~~~~ 187 (268)
....+....... . .++. ...+++.+.+||.+||..||.+|||+.+++ .++|-+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 001111111111 1 1111 111345899999999999999999999995 45665444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.31 Aligned_cols=180 Identities=18% Similarity=0.314 Sum_probs=143.8
Q ss_pred CCCCCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 79999999999998753 499999999999999999999999999999999999997443 3359999999986
Q ss_pred CCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCC
Q 024363 73 SSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP 148 (268)
Q Consensus 73 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 148 (268)
..... .......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||......... ..+... ....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~-~~~~ 265 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----EFVTSG-GRMD 265 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTT-CCCC
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHH----HHHhcC-CCCC
Confidence 32211 22334568999999999987777555 999999999999998 99999876543322 222222 2233
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 149 ~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+..++..+.+||.+||..||.+||++.++++|.|+..
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 34458999999999999999999999999999988743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=251.73 Aligned_cols=173 Identities=20% Similarity=0.318 Sum_probs=140.3
Q ss_pred CCCCCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Dfg~ 184 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGM 184 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCTTC
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcCcc
Confidence 7999999999999653 4579999999999999999999999999999999999997655 499999999
Q ss_pred CCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +.... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-~ 258 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG-L 258 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC-C
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHH----HHcCC-c
Confidence 87533221 1234467899999999987777555 899999999999999 8999987665333222 22221 2
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+..++..+.+||.+||..||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23345589999999999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=251.90 Aligned_cols=173 Identities=21% Similarity=0.364 Sum_probs=136.3
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhccccc
Confidence 7999999999999764 6799999999999999999999999999999999999997655 49999999987543221
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+....... ..+. .....+.+..++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~-~~~~~~~~~~~~ 276 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAIN-DGFRLPTPMDCP 276 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHH-TTCCCCCCTTCB
T ss_pred cccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHH-CCCcCCCcccCC
Confidence 1123346789999999987777655 899999999999998 99999876653322 2222 223344455689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.++|.+||..+|.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=248.94 Aligned_cols=174 Identities=31% Similarity=0.509 Sum_probs=134.4
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 74 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~---~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~ 74 (268)
||||+||+|.+++...+ .+++..++.++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||+++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccc
Confidence 79999999999998765 37899999999999999999999 89999999999999976543 3799999998753
Q ss_pred CCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 75 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 75 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....... .....+....++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCC
T ss_pred cc--ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccC
Confidence 32 2234569999999999988777655 8999999999999999999986543321 1111111 122233345589
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=246.26 Aligned_cols=174 Identities=25% Similarity=0.370 Sum_probs=138.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
|||+.||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence 689999999999977 45699999999999999999999999999999999999997655 499999999974322
Q ss_pred --CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 77 --HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 77 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
........+|+.|+|||++.+..++.+ +|||||||++|+|++|..|+............+. .....+.+..++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccch
Confidence 122344568899999999988777655 8999999999999995555444333333322222 222334455589
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+||.+||..+|.+|||+.++++.
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=244.87 Aligned_cols=173 Identities=21% Similarity=0.404 Sum_probs=140.8
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
|||++||+|.+++.+. +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC--CEEEcccccccccccccc
Confidence 7999999999999765 5699999999999999999999999999999999999997655 4999999998753221
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... +.. ......+..++..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTH 233 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHH
T ss_pred cccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----Hhc-CCcCCCCccCcHH
Confidence 12234567889999999987776554 999999999999999 8999987665433222 222 2223334457899
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.++|.+||..+|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=246.42 Aligned_cols=170 Identities=22% Similarity=0.379 Sum_probs=134.7
Q ss_pred CCCCCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+. +++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeecccccccccc-
Confidence 699999999999976543 89999999999999999999999999999999999997655 4999999998753322
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
.....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... + ......+.+..+++.+
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----V-EKGYKMDAPDGCPPAV 243 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----H-TTTCCCCCCTTCCHHH
T ss_pred -ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-hcCCCCCCcccCCHHH
Confidence 234467899999999987777555 899999999999998 9999987665433222 2 2222334445689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q 024363 158 RDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=258.79 Aligned_cols=180 Identities=22% Similarity=0.271 Sum_probs=137.2
Q ss_pred CCCCCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccc
Confidence 69999999999986543 599999999999999999999999999999999999997655 499999999874322
Q ss_pred C---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHH--HH-HHHHHhcccc-----
Q 024363 77 H---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--RK-TIQRILSVQY----- 145 (268)
Q Consensus 77 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~----- 145 (268)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....... .. ..........
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 1 12234568999999999988777655 89999999999999999999765432211 00 0111111110
Q ss_pred ---cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 146 ---SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 146 ---~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
........+..+.+++.+||+.||.+|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 00111224567899999999999999999999998743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=258.57 Aligned_cols=169 Identities=16% Similarity=0.203 Sum_probs=132.6
Q ss_pred CCCCCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC---------CCCCCEEEe
Q 024363 1 MEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---------SPAPRLKIC 66 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~---------~~~~~~kl~ 66 (268)
||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++. ...+.+||+
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 799999999999974 467999999999999999999999999999999999999976 113459999
Q ss_pred ecCCCCCCC---CCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 024363 67 DFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 67 Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|||+|+... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ...
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~---------~~~ 295 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE---------CKP 295 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE---------EEE
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc---------eee
Confidence 999996422 2223355679999999999998887665 999999999999999999996543210 000
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+. ....++.+.+++.+||+.+|.+|++..+.+.
T Consensus 296 ~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 296 EGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred chhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 01111 1135688999999999999999976544444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=246.28 Aligned_cols=172 Identities=21% Similarity=0.349 Sum_probs=140.1
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCcc
Confidence 69999999999996543 799999999999999999999999999999999999997655 49999999987543222
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... +. .......+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LE-RGYRMVRPDNCPE 237 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HH-TTCCCCCCTTCCH
T ss_pred cccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hh-cccCCCCcccccH
Confidence 2234457889999999987777555 899999999999999 9999987665433222 21 2223334456899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||..+|.+|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=250.08 Aligned_cols=174 Identities=24% Similarity=0.332 Sum_probs=131.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence 69999999999999888999999999999999999999999999999999999997665 49999999987543321
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... .....+..... ........++..+.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP--RPSTVRPGIPVAFD 266 (309)
T ss_dssp ------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC--CGGGTSTTCCTHHH
T ss_pred cccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC--CccccCCCCCHHHH
Confidence 2235579999999999987777655 89999999999999999999875432 22222211111 11122345889999
Q ss_pred HHHHHccccCCCCCC-CHHHHhc
Q 024363 159 DLISRIFVADPAARI-TIPEIMK 180 (268)
Q Consensus 159 ~li~~~l~~dp~~R~-s~~e~l~ 180 (268)
++|.+||..||.+|| ++.++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 7888775
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=265.39 Aligned_cols=180 Identities=22% Similarity=0.398 Sum_probs=138.3
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc--CCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~--~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||+||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||+. .++.+.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 79999999999997543 399999999999999999999999999999999999982 1233349999999998655
Q ss_pred CCCCCCCCcCCCCcccchhhcc--------CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--
Q 024363 76 LHSQPKSTVGTPAYIAPEVLLR--------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-- 145 (268)
Q Consensus 76 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 145 (268)
.........||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||............+..+.....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 5555556789999999999865 3343 4489999999999999999999754433322333333332211
Q ss_pred -----------------cCCCCCC----CCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 146 -----------------SVPDTNP----ISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 146 -----------------~~~~~~~----~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.... ++..+.++|.+||..||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1111122 34678899999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=246.32 Aligned_cols=172 Identities=21% Similarity=0.318 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||.||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccch
Confidence 699999999999976 45699999999999999999999999999999999999997655 4999999999754322
Q ss_pred ---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 78 ---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 78 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
.......+|+.|+|||++.+..++.+ +|||||||++|+|++ |.+||.+........... .. .....+..+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~ 257 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QG-RRLLQPEYC 257 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----TT-CCCCCCTTC
T ss_pred hccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----cC-CCCCCCccC
Confidence 12334567889999999987777655 899999999999999 666776655443322221 11 122334457
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+..+.++|.+||..+|.+|||+.++++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.34 Aligned_cols=165 Identities=35% Similarity=0.634 Sum_probs=126.0
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++... .+.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 79999999999998754 699999999999999999999999999999999999998632 3469999999886321
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC--CCCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~ 155 (268)
+..++. ++|||||||++|+|++|+.||.+.............+.......+. ...+++
T Consensus 172 -------------------~~~~~~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 172 -------------------GEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp -------------------TCGGGG-HHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred -------------------cccCCc-hhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 123333 4899999999999999999997654322111000111111111111 134789
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 99999999999999999999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=250.42 Aligned_cols=176 Identities=27% Similarity=0.377 Sum_probs=140.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCTTCSE
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCccccccccccccc
Confidence 7999999999998664 599999999999999999999999999999999999997665 49999999987543322
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCCh----------HHHHHHHHHHhccccc
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP----------KDFRKTIQRILSVQYS 146 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~ 146 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ......+.........
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 2334568889999999988777655 89999999999999999999653211 1111122223333344
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5556668999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=262.77 Aligned_cols=172 Identities=23% Similarity=0.361 Sum_probs=137.6
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 334 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCc
Confidence 799999999999964 35699999999999999999999999999999999999997655 49999999997543221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..++.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPE 408 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTSCH
T ss_pred eecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCH
Confidence 1223456789999999987777655 999999999999999 9999988765433222 2 22334455566899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||..+|.+|||+.+++.
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=273.04 Aligned_cols=172 Identities=23% Similarity=0.288 Sum_probs=139.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccc
Confidence 79999999999999888999999999999999999999999999999999999998665 49999999987433221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..++.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i-~~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----L-EKGERMGCPAGCPR 599 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCH
Confidence 1233456789999999988777655 999999999999998 9999988765432222 2 12223344455899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
++.+||.+||..||.+||++.++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=246.93 Aligned_cols=172 Identities=22% Similarity=0.369 Sum_probs=141.1
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCc
Confidence 6999999999999864 4599999999999999999999999999999999999997655 49999999987543322
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... + ......+.+..+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L----EKDYRMERPEGCPE 239 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCH
T ss_pred cccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H----hccCCCCCCCCCCH
Confidence 1233457889999999987777555 899999999999999 9999987765433222 2 22233444556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||..||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=262.64 Aligned_cols=177 Identities=20% Similarity=0.249 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
|||| ||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+. +..+.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 7899 8999999975 567999999999999999999999999999999999999941 123359999999997543322
Q ss_pred --------CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhcccccC
Q 024363 79 --------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSV 147 (268)
Q Consensus 79 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 147 (268)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... +.++......... .
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~ 238 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-E 238 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-H
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-H
Confidence 1235679999999999988777655 8999999999999999999987654322 2222222111110 0
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.....++.++.+||.+||..+|.+||++.++++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111347899999999999999999999987765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=264.43 Aligned_cols=172 Identities=22% Similarity=0.367 Sum_probs=142.0
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCc
Confidence 7999999999999864 4599999999999999999999999999999999999997655 49999999997543221
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... .......+.+..++.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPE 446 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCH
Confidence 1233456789999999988777655 899999999999999 9999988765443222 222334445556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||+.||.+|||+.++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.43 Aligned_cols=174 Identities=21% Similarity=0.315 Sum_probs=135.7
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--- 76 (268)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++|++||||||+||+++ + +.+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~--~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N--GKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC-------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C--CCEEEeecCCccccccccc
Confidence 79999999999997654 699999999999999999999999999999999999997 3 3599999999864321
Q ss_pred ---CCCCCCCcCCCCcccchhhccC--------ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 024363 77 ---HSQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 145 (268)
Q Consensus 77 ---~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 145 (268)
........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.......... .+.....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~ 260 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMGTGMK 260 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHHTTCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhccCCC
Confidence 1222344689999999998752 122445899999999999999999998766543322 2222222
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.......++.++.++|.+||..+|.+|||+.++++.
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 222233478899999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.51 Aligned_cols=172 Identities=24% Similarity=0.337 Sum_probs=138.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDS 491 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC----
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCc
Confidence 7999999999999654 4699999999999999999999999999999999999998665 499999999986432221
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.....+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+......... +. .....+.+..++
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IE-QGKRMECPPECP 565 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HH-TTCCCCCCTTCC
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCC
Confidence 122345789999999987777655 899999999999998 9999998776543322 22 222344445689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+++.+||.+||..+|.+||++.++++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.79 Aligned_cols=177 Identities=22% Similarity=0.324 Sum_probs=140.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSSCS
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcccccc
Confidence 7999999999999875 4699999999999999999999999999999999999997665 499999999875433221
Q ss_pred ----CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhccc
Q 024363 80 ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKTIQRILSVQ 144 (268)
Q Consensus 80 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~ 144 (268)
.....+++.|+|||++.+..++.+ +|||||||++|+|++|..||..... .......+.......
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 233457888999999987777555 8999999999999999998864211 011111122222333
Q ss_pred ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 145 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 145 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
...+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 344555668999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=245.10 Aligned_cols=176 Identities=27% Similarity=0.413 Sum_probs=130.4
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
|||+.||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence 699999999999864 46699999999999999999999999999999999999997655 499999999875433
Q ss_pred CC-CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 77 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 77 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.. ......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ......+....+.......++.
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCH--HHHHHHHHTTCSCCCCTTTSCH
T ss_pred CCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhH--HHHHHHhhcccCCCCcccccCH
Confidence 22 2334579999999999987777655 899999999999999999997654321 1222223333222222345899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++.+||.+||..||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=249.40 Aligned_cols=180 Identities=21% Similarity=0.259 Sum_probs=136.6
Q ss_pred CCCCCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qil~~L~~LH~~---~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
||||.||+|.+++.... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccc
Confidence 69999999999997643 499999999999999999999999 999999999999997655 499999999975
Q ss_pred CCCCC--CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCC----CChHHHHHHHHHHhcccc--
Q 024363 74 SVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQY-- 145 (268)
Q Consensus 74 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~-- 145 (268)
..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||... .........+........
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 43222 2234569999999999987777555 89999999999999999999521 111111111111111100
Q ss_pred -------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 146 -------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 146 -------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
........+..+.+++.+||+.||.+|||+.++++|..
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00111113478999999999999999999999999854
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=272.65 Aligned_cols=185 Identities=27% Similarity=0.416 Sum_probs=143.6
Q ss_pred CCCCCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC-CCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~-~~~kl~Dfg~a~~~~~ 76 (268)
||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++. ..+||+|||+++....
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 79999999999998754 6999999999999999999999999999999999999986543 2389999999987655
Q ss_pred CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHH-----HHH-----hccccc
Q 024363 77 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-----QRI-----LSVQYS 146 (268)
Q Consensus 77 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-----~~~-----~~~~~~ 146 (268)
........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+...+ ... ......
T Consensus 177 ~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~ 255 (676)
T 3qa8_A 177 GELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255 (676)
T ss_dssp CCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCC
T ss_pred ccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccc
Confidence 555566789999999999988777666 899999999999999999997653322111000 000 000111
Q ss_pred ----CCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 ----VPD----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 ----~~~----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+. ...++..+.+||.+||..||.+|||+.+++.||||..
T Consensus 256 ~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 256 FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 111 1225688999999999999999999999999999954
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.26 Aligned_cols=176 Identities=26% Similarity=0.439 Sum_probs=136.5
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~ 76 (268)
||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACI 186 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhccc
Confidence 689999999999975 467999999999999999999999999999999999999976554 99999998864322
Q ss_pred CCCC----------CCCcCCCCcccchhhccCc---cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 024363 77 HSQP----------KSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 77 ~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
.... ....||+.|+|||++.+.. ++ .++|||||||++|+|++|+.||........ ........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID-ERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQN 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC-THHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHHHHC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCC-chhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHHhhc
Confidence 1110 1235799999999987543 34 448999999999999999999953110000 01111122
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
....+....++..+.+||.+||..||.+|||+.+++++-
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 334455566899999999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.36 Aligned_cols=177 Identities=25% Similarity=0.339 Sum_probs=136.7
Q ss_pred CCCCCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccc
Confidence 689999999999974 34699999999999999999999999999999999999997655 4999999998753322
Q ss_pred C---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------c
Q 024363 78 S---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------S 146 (268)
Q Consensus 78 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 146 (268)
. ......||+.|+|||++.+ .++. ++|||||||++|+|++|..||...........+...+..... .
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECT-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcC-CCCc-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 1 1234579999999999865 3544 489999999999999999999876543322222222211110 0
Q ss_pred -CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 147 -VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 147 -~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.......+..+.+++.+||..+|.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01112245778999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.01 Aligned_cols=178 Identities=22% Similarity=0.280 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH--------~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||+||+|.+++.+ ..+++..++.++.|++.||.||| ++||+||||||+||+++.++ .+||+|||+++
T Consensus 119 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~ 195 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 195 (342)
T ss_dssp ECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred EeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCce
Confidence 799999999999976 47999999999999999999999 89999999999999997665 49999999986
Q ss_pred CCCCCC-----CCCCCcCCCCcccchhhccCccC-----CcccchhhhhHHHHHHHhC----------CCCCCCCCChHH
Q 024363 73 SSVLHS-----QPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDPDEPKD 132 (268)
Q Consensus 73 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~el~~g----------~~pf~~~~~~~~ 132 (268)
...... ......||+.|+|||++.+.... +.++|||||||++|+|++| ..||........
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 275 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence 533322 23456799999999998765221 1458999999999999999 788876532211
Q ss_pred -HHHHHHHHhcccccCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 133 -FRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 133 -~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.......+.........+ ...+..+.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 111222222222211111 1234679999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.35 Aligned_cols=171 Identities=29% Similarity=0.494 Sum_probs=119.9
Q ss_pred CCCCCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCC
Q 024363 1 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 75 (268)
Q Consensus 1 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~ 75 (268)
||||. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 ~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTIS 189 (337)
T ss_dssp EECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTTCBCCS
T ss_pred EEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCccceecc
Confidence 68896 699998864 567999999999999999999999999 99999999999997655 49999999997543
Q ss_pred CCCC-------------CCCCcCCCCcccchhhc---cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 024363 76 LHSQ-------------PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 139 (268)
Q Consensus 76 ~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 139 (268)
.... .....||+.|+|||++. +..++ .++|||||||++|+|++|+.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~-------- 260 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLR-------- 260 (337)
T ss_dssp SCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHH--------
Confidence 3221 11456999999999983 34444 45999999999999999999997644321
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 140 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 140 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
+.......+.....+..+.+||.+||+.||.+|||+.++++|..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 12223334445557889999999999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.69 Aligned_cols=173 Identities=23% Similarity=0.362 Sum_probs=141.8
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||.||+|.+++.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCc
Confidence 799999999999964 35699999999999999999999999999999999999997655 4999999999754321
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
.......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..++.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPE 491 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCH
T ss_pred eecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCH
Confidence 11233457789999999987777655 999999999999999 9999987765433222 2 22334455556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+||.+||..||.+|||+.+++..
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=264.15 Aligned_cols=173 Identities=21% Similarity=0.332 Sum_probs=139.0
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence 79999999999998654 699999999999999999999999999999999999998665 499999999976433222
Q ss_pred --CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 80 --PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 80 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+. . ....+.+..+++.
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~----~-~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----N-GERLPMPPNCPPT 620 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----H-TCCCCCCTTCCHH
T ss_pred eeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----c-CCCCCCCccccHH
Confidence 223457789999999987777655 899999999999997 999998876544333222 1 1223344558999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+||.+||..||.+|||+.++++.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.51 Aligned_cols=170 Identities=15% Similarity=0.197 Sum_probs=129.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCC------------------C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPA------------------P 61 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH-~~~ivHrdlkp~Nili~~~~~------------------~ 61 (268)
||||+||+|.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+|||++.++. .
T Consensus 141 ~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~ 219 (336)
T 2vuw_A 141 LEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219 (336)
T ss_dssp EEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTE
T ss_pred EEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCc
Confidence 799999987777744 67999999999999999999999 999999999999999987641 1
Q ss_pred CEEEeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHH-HHHHHhCCCCCCCCCChHHHHHHHHHH
Q 024363 62 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT-LYVMLVGGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 62 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~ 140 (268)
.+||+|||+|+.... ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+.. ........+
T Consensus 220 ~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~ 290 (336)
T 2vuw_A 220 QVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKM 290 (336)
T ss_dssp EEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHH
T ss_pred eEEEeeccccEecCC----CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhh
Confidence 599999999975432 2458999999999998665 455999998777 777888999984311 001122222
Q ss_pred hc-ccccCCC----CCCCCHHHHHHHHHccccCCCCCCCHHHHh-cccccC
Q 024363 141 LS-VQYSVPD----TNPISQECRDLISRIFVADPAARITIPEIM-KHQWFL 185 (268)
Q Consensus 141 ~~-~~~~~~~----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l-~h~~~~ 185 (268)
.. ....... ...+|+++++||++||+.| |+.++| +||||+
T Consensus 291 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 21 1111111 1236789999999999976 999999 999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=258.11 Aligned_cols=163 Identities=24% Similarity=0.289 Sum_probs=129.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 163 ~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~--- 234 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF--- 234 (681)
T ss_dssp EECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC---
T ss_pred EEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC---
Confidence 799999999988755 79999999999999999999999999999999999999753 5999999999754322
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... ..........++.+.+|
T Consensus 235 ~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDSYGRL 300 (681)
T ss_dssp SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHHHHHH
T ss_pred CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHHHHHH
Confidence 4567999999999987543 455999999999999999998886522100 00000001146789999
Q ss_pred HHHccccCCCCCCCHHHHhcccccC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
|.+||..||.+||+..+++.|+|+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999988873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=213.70 Aligned_cols=148 Identities=16% Similarity=0.120 Sum_probs=111.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.++ ..+.++..++.||+.||+|||++||+||||||+|||++.++. +||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC-----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc-----------
Confidence 7999999999999543 466788999999999999999999999999999999986654 8987543
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccC--CCCCCCCHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECR 158 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~ 158 (268)
|++| + +.++|||||||++|+|++|+.||.+.+....+....+ ........ .....+++.+.
T Consensus 175 --------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 --------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-DTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp --------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-CTTSCBCCHHHHCTTSCHHHH
T ss_pred --------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-HhccCCCChhhcccCCCHHHH
Confidence 3332 2 3448999999999999999999987654221000000 00000000 11234889999
Q ss_pred HHHHHccccCCCCCCCHHHHhcc
Q 024363 159 DLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+||.+||+.||.+| |+.++++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-29 Score=230.46 Aligned_cols=114 Identities=16% Similarity=0.172 Sum_probs=82.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.++|.+.+++++. .++.||+.||+|||++|||||||||+|||++.++ ++||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCCcc
Confidence 8999999999999999999876 4789999999999999999999999999997665 4999999999864433 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 121 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 121 (268)
..+.+||+.|||||++.+.. ... +|+||+|++++.+.++.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~~~-~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-SWN-GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCceechhhccHHHhCCCC-CCc-ccccccccchhhhcccc
Confidence 45568999999999997643 333 89999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-22 Score=181.35 Aligned_cols=112 Identities=25% Similarity=0.246 Sum_probs=93.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~- 79 (268)
||||+||+|.+++.+ +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence 799999999999865 6789999999999999999999999999999976 599999999986433211
Q ss_pred -------CCCCcCCCCcccchhhcc--CccCCcccchhhhhHHHHHHHhCCCCCC
Q 024363 80 -------PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE 125 (268)
Q Consensus 80 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~ 125 (268)
..+..||+.|||||++.. ..|... +|+||..+-..+.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 134579999999999976 556555 899999888888877776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-17 Score=139.89 Aligned_cols=74 Identities=22% Similarity=0.218 Sum_probs=62.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ + +.+||+|||+|+
T Consensus 179 mE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~--~~vkl~DFG~a~-------- 240 (282)
T 1zar_A 179 MELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E--EGIWIIDFPQSV-------- 240 (282)
T ss_dssp EECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T--TEEEECCCTTCE--------
T ss_pred EEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C--CcEEEEECCCCe--------
Confidence 79999999987 41 234567999999999999999999999999999998 4 459999999986
Q ss_pred CCCcCCCCcccchhhc
Q 024363 81 KSTVGTPAYIAPEVLL 96 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~ 96 (268)
.+..++|||.+.
T Consensus 241 ----~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 ----EVGEEGWREILE 252 (282)
T ss_dssp ----ETTSTTHHHHHH
T ss_pred ----ECCCCCHHHHHH
Confidence 345678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.1e-14 Score=115.01 Aligned_cols=66 Identities=20% Similarity=0.262 Sum_probs=54.7
Q ss_pred CCCCCC-C----chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~g-g----~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH-~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
||||.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 147 mE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 147 MEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp EECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEE
T ss_pred EEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECccccc
Confidence 799942 4 67665432 346678899999999999999 999999999999999975 499999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=7.3e-12 Score=108.75 Aligned_cols=66 Identities=15% Similarity=0.096 Sum_probs=53.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCC--------CEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--------RLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~--------~~kl~Dfg~a~ 72 (268)
|||++|++|..+. ....+..++.||+.+|.+||++|||||||||.|||++.++.+ .+.|+||+.+.
T Consensus 190 ME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 190 MSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 8999999986542 223456788999999999999999999999999999766532 27899998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.2e-07 Score=79.87 Aligned_cols=119 Identities=18% Similarity=0.173 Sum_probs=77.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------- 40 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~---------------------------------------- 40 (268)
|||++|.+|..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 56799988876443 357888888899999999999986
Q ss_pred ------------------cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC---CCCC---cCC---------C
Q 024363 41 ------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST---VGT---------P 87 (268)
Q Consensus 41 ------------------~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~---~gt---------~ 87 (268)
..++|+|++|.||+++.+....+.|.||+.+........ .... .+. .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 136999999999999864222478999998753221100 0000 000 0
Q ss_pred Cccc-chhhccCccCCcccchhhhhHHHHHHHhCCCCC
Q 024363 88 AYIA-PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124 (268)
Q Consensus 88 ~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 124 (268)
.... |+....... ..+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~---~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRM---KEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHH---HHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHH---HHHHHHHHHHHHHHHcCCHHH
Confidence 1111 222221111 148999999999999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.22 E-value=9e-07 Score=76.16 Aligned_cols=70 Identities=21% Similarity=0.409 Sum_probs=56.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------- 40 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~---------------------------------------- 40 (268)
|||++|..|.+. ....+++.+...++.+++..|..||+
T Consensus 120 me~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 789999888542 12347888999999999999999997
Q ss_pred ------------------cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 ------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ------------------~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|++|.||+++.++...+.|.||+.+.
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999976543335899999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=8.5e-07 Score=72.74 Aligned_cols=64 Identities=20% Similarity=0.198 Sum_probs=49.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------------------------------------- 40 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~---------------------------------------- 40 (268)
|||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 7999999997653 1223345778899999999998
Q ss_pred -------------------cCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 41 -------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 41 -------------------~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
..++|+|++|.||+++.+. .+.|.||+.+
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a 211 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRS 211 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTC
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhc
Confidence 4589999999999996432 2569999865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.00 E-value=8.9e-05 Score=58.68 Aligned_cols=122 Identities=16% Similarity=0.106 Sum_probs=74.3
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCCCCCc
Q 024363 7 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 84 (268)
Q Consensus 7 g~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 84 (268)
-||.++|+. +.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|. |...+ +.+ ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence 368888864 6789999999999999999877622 22223344568999977765 55442 111 01
Q ss_pred CCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHc
Q 024363 85 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164 (268)
Q Consensus 85 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 164 (268)
....+.|||... ... ..+.=|||||+++|..+-=..| ......+|+.+-.||..|
T Consensus 99 ~~~~~~~pe~~~-~~~-te~~~IysLG~tLY~ALDygL~-----------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQC-METEVIESLGIIIYKALDYGLK-----------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS-SSS-CHHHHHHHHHHHHHHHHTTTCC-----------------------TTEEECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc-ccc-hHHHHHHHHHHHHHHHhhcCCC-----------------------cccchhhCHHHHHHHHHH
Confidence 233455787652 112 2235799999999998852111 111233899999999998
Q ss_pred ccc
Q 024363 165 FVA 167 (268)
Q Consensus 165 l~~ 167 (268)
..-
T Consensus 154 t~~ 156 (229)
T 2yle_A 154 ANT 156 (229)
T ss_dssp TTC
T ss_pred Hhc
Confidence 755
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.00 E-value=1.7e-06 Score=70.46 Aligned_cols=28 Identities=25% Similarity=0.258 Sum_probs=22.8
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
++|+|++|.||+++.+. .+.|.|||.+.
T Consensus 186 l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999996542 25699999763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0013 Score=55.15 Aligned_cols=30 Identities=30% Similarity=0.395 Sum_probs=22.9
Q ss_pred CeecCCCCCcEEEcCC-CCCCE-EEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGS-PAPRL-KICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~-~~~~~-kl~Dfg~a~ 72 (268)
++|+|++|.||+++.+ ..+.+ .|.||+.+.
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 5999999999999751 12234 799999765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0065 Score=51.07 Aligned_cols=29 Identities=28% Similarity=0.476 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
.+++|+|+++.||+++.++ .+.|.||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~--~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE--QIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGG--CEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCC--cEEEEehhhc
Confidence 5799999999999996443 3899999865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0087 Score=48.68 Aligned_cols=28 Identities=29% Similarity=0.444 Sum_probs=22.2
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
++|+|+.+.||+++..+ .+-|.||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~--~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGK--LIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence 78999999999997543 25699998663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0041 Score=52.94 Aligned_cols=30 Identities=13% Similarity=0.168 Sum_probs=23.8
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|+.|.||+++. ...+.|.||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~--~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRD--FQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEET--TEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeC--CcEEEEEcccccc
Confidence 46899999999999973 2236899998664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.019 Score=50.09 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=26.0
Q ss_pred HHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 39 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 39 H~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
+...++|+|++|.|||++.++ +++.||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccc
Confidence 456799999999999997543 8999998775
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.27 E-value=0.035 Score=38.09 Aligned_cols=62 Identities=16% Similarity=0.149 Sum_probs=48.0
Q ss_pred CCCCCCHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 206 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+......+++.|...+.+..|..+.+++.... ......+.+..+...+.|.|++|+|+|.
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~ 92 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFE 92 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHH
Confidence 3455678889999999999999999998876532 2223445666777889999999999984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.60 E-value=0.055 Score=45.09 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=23.6
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+++.||+++.+. .+.|.||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence 4699999999999997542 24799998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.20 E-value=0.12 Score=43.17 Aligned_cols=28 Identities=18% Similarity=0.170 Sum_probs=23.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|+++.||+++ + .+.|.||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D---GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S---SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C---CCEEEECCCCC
Confidence 4589999999999997 3 48999998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=91.66 E-value=0.074 Score=44.60 Aligned_cols=32 Identities=31% Similarity=0.414 Sum_probs=25.4
Q ss_pred cCCeecCCCCCcEEEcCCC--CCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~--~~~~kl~Dfg~a~ 72 (268)
..++|+|+.+.||+++.+. .+.+.|.||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4699999999999997531 1358999999775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.56 E-value=0.3 Score=41.53 Aligned_cols=29 Identities=34% Similarity=0.652 Sum_probs=23.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.+++|+|+++.||+++.+ .+.|.||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~---~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNK---CLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC----CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCC---cEEEEEecCCC
Confidence 359999999999999643 28999998664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.05 E-value=0.24 Score=42.57 Aligned_cols=30 Identities=20% Similarity=0.237 Sum_probs=24.4
Q ss_pred HcCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 40 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 40 ~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
...++|+|+.|.||+++.+ .+++.||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~---~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH---ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS---CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC---CeEEEeCcccc
Confidence 3579999999999999654 28999997654
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=88.93 E-value=0.24 Score=34.42 Aligned_cols=60 Identities=5% Similarity=-0.180 Sum_probs=46.6
Q ss_pred CCCCHHHHHHHHHHhCCCCCCCcCccccccCCCCCCCccccccccccccccCCCCccccc
Q 024363 208 PMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.......+.+.|...+.+..|..+.+++..-.......+++..+...+.|.|++|+|+|.
T Consensus 17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~ 76 (110)
T 1iq3_A 17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLP 76 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence 345678899999999999999998887766543333445666777888899999999973
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.84 E-value=0.26 Score=41.60 Aligned_cols=30 Identities=23% Similarity=0.461 Sum_probs=24.5
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
..++|+|+.+.||+++.++ .+.|.||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGG--CEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCC--eEEEEECCCCe
Confidence 4699999999999997543 38999998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=85.70 E-value=0.33 Score=42.46 Aligned_cols=17 Identities=41% Similarity=0.686 Sum_probs=14.7
Q ss_pred CCeecCCCCCcEEEcCC
Q 024363 42 QVCHRDLKLENTLLDGS 58 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~ 58 (268)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999764
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=85.66 E-value=0.61 Score=35.13 Aligned_cols=56 Identities=18% Similarity=0.061 Sum_probs=41.1
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+.+...|...+.+..|..+.+++..-. ......+++.++...+.| |++|+|+|.
T Consensus 82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~ 139 (176)
T 2lhi_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQ 139 (176)
T ss_dssp HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHH
Confidence 34668889999999999999998876532 222334555666677778 999999984
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=85.54 E-value=0.56 Score=41.41 Aligned_cols=15 Identities=33% Similarity=0.519 Sum_probs=14.0
Q ss_pred CCeecCCCCCcEEEc
Q 024363 42 QVCHRDLKLENTLLD 56 (268)
Q Consensus 42 ~ivHrdlkp~Nili~ 56 (268)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999997
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=84.91 E-value=0.11 Score=35.05 Aligned_cols=57 Identities=11% Similarity=-0.169 Sum_probs=42.1
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCCCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
....+.+.|...+.+..|..+.+++..-.......+++..+.....|.|++|+|+|.
T Consensus 8 ~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~ 64 (95)
T 1c07_A 8 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKD 64 (95)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETT
T ss_pred HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHH
Confidence 456788899999999999888877665332223345556667788899999999974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=84.35 E-value=0.48 Score=38.97 Aligned_cols=28 Identities=39% Similarity=0.519 Sum_probs=22.5
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++|+|+.|.||+.+ ++ .+.+.||..+.
T Consensus 174 ~l~HgDl~~~Nil~~-~~--~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDT-GE--RMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEEC-SS--CEEECCCTTCE
T ss_pred eeeccCCCcCCEEEC-CC--CEEEEeccccc
Confidence 489999999999953 33 38999998764
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.12 E-value=0.083 Score=37.63 Aligned_cols=56 Identities=13% Similarity=0.073 Sum_probs=41.2
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC-------CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.++.+...|...+.. .|+.+..++..-. .....++.+..+...+.|.||+|+|+|.
T Consensus 13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~ 75 (121)
T 4drw_A 13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQ 75 (121)
T ss_dssp HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence 456777888888877 6888887776533 2233456667778889999999999973
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=83.40 E-value=0.62 Score=40.03 Aligned_cols=31 Identities=39% Similarity=0.609 Sum_probs=24.4
Q ss_pred CCeecCCCCCcEEEcCC--CCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~--~~~~~kl~Dfg~a~ 72 (268)
.++|+|+.+.||+++.+ ..+.+.+.||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 59999999999999765 12358999998664
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=82.84 E-value=0.19 Score=34.25 Aligned_cols=56 Identities=11% Similarity=-0.171 Sum_probs=41.4
Q ss_pred HHHHHHHHHHhCCCCCCCcCccccccCCCCCCCccccccccccccccCCCCccccc
Q 024363 212 VDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
...+.+.|...+.+..|..+.+++..-.......+++..+.....|.|++|+|+|.
T Consensus 10 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D~d~dG~i~~~ 65 (99)
T 1qjt_A 10 NPVYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQ 65 (99)
T ss_dssp CTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHH
Confidence 34577888999999999988877765332223345666777788899999999974
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.12 E-value=0.99 Score=38.90 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.5
Q ss_pred CeecCCCCCcEEEcC----CCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~----~~~~~~kl~Dfg~a~ 72 (268)
++|+|+.+.||++.. +....+++.||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999943 223459999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 268 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-57
Identities = 74/192 (38%), Positives = 105/192 (54%), Gaps = 8/192 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EY SGGELF+RI E +A+ FF QL++GV Y H + + HRD+K EN LLD
Sbjct: 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-- 139
Query: 61 PRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
LKI DFG + +++ + GT Y+APE+L R E+ + DVWSCG+ L M
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
L G P+ D+P D + + + I L+ +I V +P+ARITIP+
Sbjct: 200 LAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256
Query: 178 IMKHQWFLKNLP 189
I K +W+ K L
Sbjct: 257 IKKDRWYNKPLK 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-56
Identities = 65/187 (34%), Positives = 104/187 (55%), Gaps = 10/187 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+EYA G ++ + +F E + +L + +SYCH+ +V HRD+K EN LL +
Sbjct: 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-- 142
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG+S + S+ + GT Y+ PE++ +D K D+WS GV Y LVG
Sbjct: 143 GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 200
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
PFE +++T +RI V+++ PD +++ RDLISR+ +P+ R + E+++
Sbjct: 201 KPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLREVLE 254
Query: 181 HQWFLKN 187
H W N
Sbjct: 255 HPWITAN 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 1e-54
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E+ SGGELF+RI + SE E + +Q G+ + H + H D+K EN + +
Sbjct: 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 164
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
A +KI DFG + K T T + APE++ R D+W+ GV YV+L
Sbjct: 165 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLS 223
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPE 177
G PF D+ +T+Q + + + +S E +D I + +P R+T+ +
Sbjct: 224 GLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 211
++H W + + + SS+Y + Q ++
Sbjct: 280 ALEHPWLKGDHSN--LTSRIPSSRYNKIRQKIKE 311
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 9e-54
Identities = 60/189 (31%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ GELF+ + SE E R + L+ + H + + HRDLK EN LLD
Sbjct: 89 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-- 146
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLY 115
+K+ DFG+S + + GTP+Y+APE++ D GK D+WS GV +Y
Sbjct: 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
+L G PF + R + + Q+ P+ + S +DL+SR V P R T
Sbjct: 207 TLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
Query: 176 PEIMKHQWF 184
E + H +F
Sbjct: 265 EEALAHPFF 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 1e-53
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 9/214 (4%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ SGGELFE++ + + SEDEA + +Q+ G+ + H H DLK EN +
Sbjct: 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 161
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ LK+ DFG + K T GT + APEV D+WS GV Y++L
Sbjct: 162 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLS 220
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPE 177
G PF ++ +T++ + S +++ D+ IS++ +D I ++ +ADP R+TI +
Sbjct: 221 GLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 211
++H W A D + SS+Y + +++
Sbjct: 277 ALEHPWL-TPGNAPGRDSQIPSSRYTKIRDSIKT 309
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-53
Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 10/231 (4%)
Query: 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ SG ++FERI +A +E E + Q+ + + H+ + H D++ EN +
Sbjct: 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+ +KI +FG ++ + P Y APEV D+WS G +YV+L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLS 198
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPE 177
G PF ++ I+ I++ +Y+ + IS E D + R+ V + +R+T E
Sbjct: 199 GINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVG 228
++H W + + V K + + + +++ A I G
Sbjct: 255 ALQHPWLKQKIER--VSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 6/226 (2%)
Query: 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG- 57
ME GGELF RI + G F+E EA + + + Y H++ + HRD+K EN L
Sbjct: 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 147
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
P LK+ DFG++K + H+ + TP Y+APEVL +YD D+WS GV +Y++
Sbjct: 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYIL 206
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITI 175
L G PF RI QY P+ +S+E + LI + +P R+TI
Sbjct: 207 LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 221
E M H W +++ T E+ ++ + + +A
Sbjct: 267 TEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALAT 312
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 7e-51
Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 8/207 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M+ SGGELF+RI G ++E +A Q++ V Y H + + HRDLK EN L
Sbjct: 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE 145
Query: 61 P-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
++ I DFG SK S + GTP Y+APEVL + Y D WS GV Y++L
Sbjct: 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLC 204
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIPE 177
G PF D ++ K ++IL +Y IS +D I + DP R T +
Sbjct: 205 GYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260
Query: 178 IMKHQWFLKNLPADLVDEKTMSSQYEE 204
++H W + D +++S Q ++
Sbjct: 261 ALQHPWIAGDTALDKNIHQSVSEQIKK 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-50
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 9/186 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGS 58
E + G L + R + +Q++ G+ + H + HRDLK +N + G
Sbjct: 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG- 149
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P +KI D G + S K+ +GTP ++APE+ +YD DV++ G+ + M
Sbjct: 150 PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCMLEMA 206
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
YP+ + +R+ S E +++I + R +I ++
Sbjct: 207 TSEYPYSECQNAAQI---YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 179 MKHQWF 184
+ H +F
Sbjct: 264 LNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-50
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G + E E + G++Y H+ + HRD+K N LL
Sbjct: 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-- 151
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVM 117
+K+ DFG + + + S VGTP ++APEV+L +YDGK DVWS G+T +
Sbjct: 152 GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIEL 207
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
P + + + I + + S+ R+ + P R T
Sbjct: 208 AERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263
Query: 178 IMKHQWFLKNLPADLVDE 195
++KH++ L+ P ++ +
Sbjct: 264 LLKHRFVLRERPPTVIMD 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-49
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ YA GEL + I G F E RF+ +++S + Y H + HRDLK EN LL+
Sbjct: 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM- 145
Query: 61 PRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
++I DFG +K S+ VGT Y++PE+L +D+W+ G +Y +
Sbjct: 146 -HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQL 203
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
+ G PF +E Q+I+ ++Y P+ + RDL+ ++ V D R+ E
Sbjct: 204 VAGLPPFRAGNEY----LIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEE 257
Query: 178 IMKHQW-----FLKNLPADLVDEKT 197
+ + F +++ + + ++T
Sbjct: 258 MEGYGPLKAHPFFESVTWENLHQQT 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 43/242 (17%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSP 59
ME+ GG L + + AGR E +I G++Y + HRD+K N L++
Sbjct: 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR- 141
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+CDFG S ++ S S VGT +Y++PE L Y + +D+WS G++L M V
Sbjct: 142 -GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAV 198
Query: 120 GGYPFEDPDE--------------------------------------PKDFRKTIQRIL 141
G YP PD P + + I+
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 142 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 201
+ + S E +D +++ + +PA R + ++M H + ++ ++ + S
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCST 318
Query: 202 YE 203
Sbjct: 319 IG 320
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-49
Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 1 MEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E+ +GG + + R +E + + +Q + ++Y H ++ HRDLK N L
Sbjct: 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD- 146
Query: 60 APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTL 114
+K+ DFG S + Q + + +GTP ++APEV++ + ADVWS G+TL
Sbjct: 147 -GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
M P + + + K + S ++ + S +D + + + AR T
Sbjct: 206 IEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT 262
Query: 175 IPEIMKHQWFLKNLPADL 192
++++H + + +
Sbjct: 263 TSQLLQHPFVTVDSNKPI 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-48
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG L + + E + ++ + + + H+ QV HRD+K +N LL
Sbjct: 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG- 153
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+K+ DFG+ +ST VGTP ++APEV+ R Y K D+WS G+ M+
Sbjct: 154 -SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIE 211
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G P+ + + + + + +S RD ++R D R + E++
Sbjct: 212 GEPPYLNENPLRALYLIATNG---TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
Query: 180 KHQWFLKNLPADLVDEKTMSSQ 201
+HQ+ P + +++
Sbjct: 269 QHQFLKIAKPLSSLTPLIAAAK 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-47
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 18/193 (9%)
Query: 1 MEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLE 51
MEY GG+L I + E+ QL + CH V HRDLK
Sbjct: 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143
Query: 52 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSC 110
N LDG +K+ DFG ++ + TP Y++PE + R Y+ K +D+WS
Sbjct: 144 NVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSL 200
Query: 111 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA 170
G LY + PF + ++ +I ++ S E ++I+R+
Sbjct: 201 GCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIPYR-YSDELNEIITRMLNLKDY 255
Query: 171 ARITIPEIMKHQW 183
R ++ EI+++
Sbjct: 256 HRPSVEEILENPL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-47
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GS 58
+E +GGELF+ + +E+EA F +Q+++GV Y H++Q+ H DLK EN +L
Sbjct: 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
P PR+KI DFG + ++ K+ GTP ++APE++ AD+WS GV Y++L
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILL 210
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLISRIFVADPAARITIP 176
G PF + + T+ + +V Y D S +D I R+ V DP R+TI
Sbjct: 211 SGASPFLGDTKQE----TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
Query: 177 EIMKHQWFLKNLPADLVDEKTMSSQYEEP 205
+ ++H W ++ +SS + P
Sbjct: 267 DSLQHPWI-----KPKDTQQALSSAWSHP 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-46
Identities = 63/185 (34%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 1 MEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+E +LF+ I G E+ AR FF Q++ V +CH V HRD+K EN L+D +
Sbjct: 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LK+ DFG + + GT Y PE + H Y G+ A VWS G+ LY M+
Sbjct: 148 -GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 179
G PFE +E I+ Q +S EC+ LI P+ R T EI
Sbjct: 206 GDIPFEHDEE----------IIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQ 253
Query: 180 KHQWF 184
H W
Sbjct: 254 NHPWM 258
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-45
Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 12/204 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY +GG+L I + +F A F+ ++I G+ + H+ + +RDLKL+N LLD
Sbjct: 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-- 139
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K ++L +T GTP YIAPE+LL +Y+ D WS GV LY ML+
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLI 198
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP-EI 178
G PF DE + I P + +E +DL+ ++FV +P R+ + +I
Sbjct: 199 GQSPFHGQDEE----ELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDI 252
Query: 179 MKHQWFLKNLPADLVDEKTMSSQY 202
+H F + + + ++ K + +
Sbjct: 253 RQHPLF-REINWEELERKEIDPPF 275
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-45
Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 9/196 (4%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
++ G L+ + +F + +Q G+ Y HA + HRDLK N L
Sbjct: 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141
Query: 60 APRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTL 114
+KI DFG + Q + G+ ++APEV+ + + +DV++ G+ L
Sbjct: 142 --TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
Y ++ G P+ + + + R + + + L++ R
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 175 IPEIMKH-QWFLKNLP 189
P+I+ + ++LP
Sbjct: 260 FPQILASIELLARSLP 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 4e-43
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ +GG+L + G FSE + RF+ ++I G+ + H V +RDLK N LLD
Sbjct: 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--EH 143
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
++I D G + +P ++VGT Y+APEVL + AD +S G L+ +L G
Sbjct: 144 GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP---- 176
PF + KD + + L++ +PD+ S E R L+ + D R+
Sbjct: 203 HSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 177 -EIMKHQWFLKNLPADLVDEKTMSSQY 202
E+ + +F ++L +V +
Sbjct: 260 QEVKESPFF-RSLDWQMVFLQKYPPPL 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (352), Expect = 8e-41
Identities = 36/185 (19%), Positives = 71/185 (38%), Gaps = 5/185 (2%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEY G L + + G + A +++ H + HRD+K N ++ + A
Sbjct: 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 149
Query: 61 PRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
++ + S +Q + +GT Y++PE D + +DV+S G LY +L
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVL 208
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
G PF + ++ + + +S + ++ + +P R
Sbjct: 209 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEG--LSADLDAVVLKALAKNPENRYQTAAE 266
Query: 179 MKHQW 183
M+
Sbjct: 267 MRADL 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 54/247 (21%), Positives = 90/247 (36%), Gaps = 29/247 (11%)
Query: 1 MEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57
++Y + + QL ++Y H+ +CHRD+K +N LLD
Sbjct: 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157
Query: 58 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
A K+CDFG +K V S + + Y APE++ DVWS G L +
Sbjct: 158 DTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILS-------------VQYSVPDTNP----------IS 154
L+G F + I+ + + ++ P
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 276
Query: 155 QECRDLISRIFVADPAARITIPEIMKHQWF--LKNLPADLVDEKTMSSQYEEPDQPMQSV 212
E L SR+ P AR+T E H +F L++ L + + + + Q + S
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
Query: 213 DVIMQII 219
+ I+
Sbjct: 337 PPLATIL 343
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (352), Expect = 2e-40
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M+Y GGELF + + RF A+F+ ++ + Y H+ + +RDLK EN LLD +
Sbjct: 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-- 140
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+KI DFG++K + + GTP YIAPEV+ Y+ D WS G+ +Y ML G
Sbjct: 141 GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAG 197
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TI 175
PF D + KT ++IL+ + P +++ +DL+SR+ D + R+
Sbjct: 198 YTPFYDSNT----MKTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGT 251
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSSQYEEP 205
++ H WF K + + + + + + YE P
Sbjct: 252 EDVKNHPWF-KEVVWEKLLSRNIETPYEPP 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 2e-39
Identities = 41/216 (18%), Positives = 87/216 (40%), Gaps = 36/216 (16%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E+ + + + ++ + RF+ +++ + YCH+M + HRD+K N ++D
Sbjct: 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID-HEH 166
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
+L++ D+G ++ + V + + PE+L+ ++ D+WS G L M+
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQY--------------------------------SVP 148
PF + D I ++L +
Sbjct: 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 286
Query: 149 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 184
+ + +S E D + ++ D +R+T E M+H +F
Sbjct: 287 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-39
Identities = 39/183 (21%), Positives = 69/183 (37%), Gaps = 11/183 (6%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY + G L + + + GR D F + + Y HRDL N L+
Sbjct: 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 139
Query: 59 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 118
K+ DFG +K S + + APE L ++ K +DVWS G+ L+ +
Sbjct: 140 --NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIY 194
Query: 119 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 178
G KD +++ Y + + +++ + D A R + ++
Sbjct: 195 SFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250
Query: 179 MKH 181
+
Sbjct: 251 REQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-39
Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
MEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+KLEN +LD
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-- 141
Query: 61 PRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
+KI DFG K + K+ GTP Y+APEVL ++Y D W GV +Y M+
Sbjct: 142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMC 200
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF + D + + IL + P T +S E + L++ + DP R+
Sbjct: 201 GRLPFYNQDH----ERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQY 202
E+M+H++F ++ V +K + +
Sbjct: 255 AKEVMEHRFF-LSINWQDVVQKKLLPPF 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 26/213 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ N+ + + + + G+ Y H + HRDLK N LLD +
Sbjct: 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-- 136
Query: 61 PRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LK+ DFG +KS + V T Y APE+L G D+W+ G L +L+
Sbjct: 137 GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----------------------NPISQEC 157
+ + + + + + +
Sbjct: 197 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256
Query: 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190
DLI +F+ +P ARIT + +K ++F N P
Sbjct: 257 LDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-38
Identities = 48/224 (21%), Positives = 80/224 (35%), Gaps = 34/224 (15%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ +F+ E + Q L++G+ Y H ++ HRD+K N L+
Sbjct: 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-- 153
Query: 61 PRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
LK+ DFG ++ + ++ + V T Y PE+LL G D+W G +
Sbjct: 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-------------------------- 149
M + E Q S+ V
Sbjct: 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 150 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPADL 192
DLI ++ V DPA RI + + H +F + +P+DL
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-37
Identities = 48/206 (23%), Positives = 76/206 (36%), Gaps = 25/206 (12%)
Query: 1 MEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ + + + QL+ G+ + H+ +V HRDLK +N L+ S
Sbjct: 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS- 152
Query: 60 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
++K+ DFG ++ S V T Y APEVLL+ Y D+WS G M
Sbjct: 153 -GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFR 210
Query: 120 GGYPFEDPDEPKDFRKTIQRIL---------------------SVQYSVPDTNPISQECR 158
F + K + I S Q I + +
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK 270
Query: 159 DLISRIFVADPAARITIPEIMKHQWF 184
DL+ + +PA RI+ + H +F
Sbjct: 271 DLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-37
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 9/208 (4%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++Y +GGELF + RF+E E + + +++ + + H + + +RD+KLEN LLD +
Sbjct: 108 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 167
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKIADVWSCGVTLYVMLV 119
L + + GT Y+AP+++ + K D WS GV +Y +L
Sbjct: 168 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----T 174
G PF E + +RIL + P +S +DLI R+ + DP R+
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRD 285
Query: 175 IPEIMKHQWFLKNLPADLVDEKTMSSQY 202
EI +H +F + + D + K + + +
Sbjct: 286 ADEIKEHLFF-QKINWDDLAAKKVPAPF 312
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-37
Identities = 55/251 (21%), Positives = 97/251 (38%), Gaps = 35/251 (13%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ + G +L++ + S D +F Q++ G+ Y H+ V HRDLK N LL+ +
Sbjct: 89 VTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC- 146
Query: 61 PRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
LKICDFG ++ V T Y APE++L + K D+WS G L
Sbjct: 147 -DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 117 MLVGGYPFEDPDEPKDFRKTIQ----------------RILSVQYSVPDTNP-------- 152
ML F + + + S+P N
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 153 -ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE-EPDQPMQ 210
+ DL+ ++ +P RI + + + H + + D DE + ++ + +
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY--YDPSDEPIAEAPFKFDMELDDL 323
Query: 211 SVDVIMQIIAE 221
+ + ++I E
Sbjct: 324 PKEKLKELIFE 334
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-36
Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 33/246 (13%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
M + G ++ + ED +F Q++ G+ Y HA + HRDLK N ++
Sbjct: 102 MPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-- 157
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG ++ S+ V T Y APEV+L + D+WS G + M+ G
Sbjct: 158 CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 121 GYPFEDPDE--------------PKDFRKTIQRILSVQY--SVPDTNP---------ISQ 155
F+ D P +F + +Q + Y +P+ S
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVI 215
+L+ ++ V D R+T E + H +F ++L D DE + + D +++D
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLH-DTEDEPQVQKYDDSFDDVDRTLDEW 333
Query: 216 MQIIAE 221
++ +
Sbjct: 334 KRVTYK 339
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-36
Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 13/195 (6%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME A G L + + + Q+ G+ Y HRDL N LL
Sbjct: 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV--TQ 143
Query: 61 PRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
KI DFG SK+ + + APE + +++ K +DVWS GV ++
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWE 202
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
G + + +++ + +E DL++ + D R
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 177 EI--MKHQWFLKNLP 189
+ ++ +
Sbjct: 259 AVELRLRNYYYDVVN 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 2e-36
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 7 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 66
GE+F + GRFSE ARF+ Q++ Y H++ + +RDLK EN L+D +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ--GYIQVT 183
Query: 67 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 126
DFG++K + + GTP +APE++L Y+ D W+ GV +Y M G PF
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFA 240
Query: 127 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEIMKH 181
+ ++I+S + P S + +DL+ + D R + +I H
Sbjct: 241 DQP----IQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
Query: 182 QWFLKNLPADLVDEKTMSSQY 202
+WF + ++ + + +
Sbjct: 295 KWF-ATTDWIAIYQRKVEAPF 314
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-36
Identities = 40/185 (21%), Positives = 67/185 (36%), Gaps = 9/185 (4%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E A G L +R+ + G F + Q+ G+ Y + + HRDL N LL
Sbjct: 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR- 147
Query: 60 APRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+KI DFG + + H + P L+ +D W GVTL+
Sbjct: 148 -DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
M G P + + + +I +P Q+ +++ + + P R T
Sbjct: 207 MFTYGQE---PWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 177 EIMKH 181
+
Sbjct: 264 ALRDF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-36
Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 15/192 (7%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME A GG L + + Q+ G+ Y HRDL N LL
Sbjct: 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 146
Query: 60 APRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
+ I DFG SK ++ + + APE + ++ + +DVWS GVT++
Sbjct: 147 YAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMW 203
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
L G P + + + I + + E L+S ++ R
Sbjct: 204 EALSYGQK---PYKKMKGPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDF 259
Query: 176 PEI---MKHQWF 184
+ M+ ++
Sbjct: 260 LTVEQRMRACYY 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-36
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 13/195 (6%)
Query: 1 MEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY S G L + + + Q+ SG++Y M HRDL+ N L+ +
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 149
Query: 59 PAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
K+ DFG ++ ++ + + APE L + K +DVWS G+ L
Sbjct: 150 --LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTE 206
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
+ G ++ ++R Y +P + DL+ + + +P R T
Sbjct: 207 LTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 262
Query: 177 EIMK--HQWFLKNLP 189
+ +F P
Sbjct: 263 YLQAFLEDYFTSTEP 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (310), Expect = 2e-34
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E+ G A+ F QL++G++YCH +V HRDLK +N L++
Sbjct: 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-- 136
Query: 61 PRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LKI DFG +++ + + + + T Y AP+VL+ + D+WS G M+
Sbjct: 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 120 GGYPFEDPDEPKDFRKTIQRILSVQ-------YSVPDTNP----------------ISQE 156
G F E + + + + +P +P + +
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 157 CRDLISRIFVADPAARITIPEIMKHQWF 184
DL+S++ DP RIT + ++H +F
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-34
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
E+ G + + F QL+ G+ +CH+ V HRDLK +N L++ +
Sbjct: 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-- 137
Query: 61 PRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 119
LK+ +FG +++ + + S V T Y P+VL + D+WS G +
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 120 GGYPFEDPDEPKDFRKTIQRIL--------SVQYSVPDTNP----------------ISQ 155
G P ++ D K I R+L +PD P ++
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 189
RDL+ + +P RI+ E ++H +F P
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-34
Identities = 42/197 (21%), Positives = 71/197 (36%), Gaps = 23/197 (11%)
Query: 1 MEYASGGELFERI----------------CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 44
+EYA G L + + A S + F + G+ Y Q
Sbjct: 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 149
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 104
HRDL N L+ + KI DFG S+ ++ + ++A E L Y
Sbjct: 150 HRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN- 206
Query: 105 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 164
+DVWS GV L+ ++ G + + + + Y + E DL+ +
Sbjct: 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----GYRLEKPLNCDDEVYDLMRQC 262
Query: 165 FVADPAARITIPEIMKH 181
+ P R + +I+
Sbjct: 263 WREKPYERPSFAQILVS 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-34
Identities = 38/207 (18%), Positives = 71/207 (34%), Gaps = 32/207 (15%)
Query: 1 MEYASGGELFERI-----------------------CNAGRFSEDEARFFFQQLISGVSY 37
EY G+L + + + ++ F Q+ G+ +
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 38 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEV 94
HRDL N L+ +KICDFG ++ S + + ++APE
Sbjct: 180 LEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 95 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154
L Y K +DVWS G+ L+ + G P +++ + + +
Sbjct: 238 LFEGIYTIK-SDVWSYGILLWEIFSLGVN---PYPGIPVDANFYKLIQNGFKMDQPFYAT 293
Query: 155 QECRDLISRIFVADPAARITIPEIMKH 181
+E ++ + D R + P +
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-34
Identities = 38/193 (19%), Positives = 75/193 (38%), Gaps = 11/193 (5%)
Query: 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+ G L + + + + Q+ G++Y ++ HRDL N L+
Sbjct: 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP- 147
Query: 60 APRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+KI DFG +K + + ++A E +L Y + +DVWS GVT++
Sbjct: 148 -QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 205
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
++ G D + I IL +P + + ++ + ++ D +R
Sbjct: 206 LMTFGSKPYDGIPASE----ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFR 261
Query: 177 EIMKHQWFLKNLP 189
E++ + P
Sbjct: 262 ELIIEFSKMARDP 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-34
Identities = 37/184 (20%), Positives = 72/184 (39%), Gaps = 10/184 (5%)
Query: 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
EY + G L + RF + + + + Y + Q HRDL N L++
Sbjct: 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137
Query: 60 APRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG S+ + S + PEVL+ ++ K +D+W+ GV ++ +
Sbjct: 138 --VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEI 194
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
G P E +T + I + + S++ ++ + R T
Sbjct: 195 YSLGKM---PYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 250
Query: 178 IMKH 181
++ +
Sbjct: 251 LLSN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-34
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 26/203 (12%)
Query: 6 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 65
+ F + + QL+ G+++CH+ +V HRDLK +N L++ +K+
Sbjct: 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKL 143
Query: 66 CDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 124
DFG +++ + + + V T Y APE+LL +Y D+WS G M+ F
Sbjct: 144 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203
Query: 125 EDPDEPKDFRKTIQ-------RILSVQYSVPDTNP----------------ISQECRDLI 161
E + + + S+PD P + ++ R L+
Sbjct: 204 PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL 263
Query: 162 SRIFVADPAARITIPEIMKHQWF 184
S++ DP RI+ + H +F
Sbjct: 264 SQMLHYDPNKRISAKAALAHPFF 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-33
Identities = 39/184 (21%), Positives = 75/184 (40%), Gaps = 10/184 (5%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
ME + GEL + + QL + ++Y + + HRD+ N L+ +
Sbjct: 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN- 144
Query: 60 APRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG S+ + K++ ++APE + + +DVW GV ++ +
Sbjct: 145 -DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEI 202
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
L+ G P + I RI + + +P L+++ + DP+ R E
Sbjct: 203 LMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258
Query: 178 IMKH 181
+
Sbjct: 259 LKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 4e-33
Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 13/202 (6%)
Query: 1 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
E+ + G L + + R S + Q+ S + Y HRDL N L+ +
Sbjct: 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 151
Query: 59 PAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
+K+ DFG S+ + ++ + APE L +++ K +DVW+ GV L+
Sbjct: 152 --HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWE 208
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
+ G + + +++ Y + ++ +L+ + +P+ R +
Sbjct: 209 IATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
Query: 177 EIMK--HQWFLKNLPADLVDEK 196
EI + F ++ +D V+++
Sbjct: 265 EIHQAFETMFQESSISDEVEKE 286
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 5e-33
Identities = 40/206 (19%), Positives = 73/206 (35%), Gaps = 17/206 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSP 59
ME + +FS Q+IS + Y H+ HRD+K +N L+ G
Sbjct: 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 141
Query: 60 APRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 111
+ I DFG +K + + + K+ GT Y + L E + D+ S G
Sbjct: 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLG 200
Query: 112 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD---TNPISQECRDLISRIFVAD 168
L +G P++ +K +RI + S P E ++
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259
Query: 169 PAARIT---IPEIMKHQWFLKNLPAD 191
+ + ++ ++ + + D
Sbjct: 260 FDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 5e-33
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 14/188 (7%)
Query: 1 MEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ G L N G+F+ + + + +G+ Y M HRDL N L++ +
Sbjct: 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN- 164
Query: 60 APRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 113
K+ DFG S+ S ++ + APE + ++ +DVWS G+
Sbjct: 165 -LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIV 222
Query: 114 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 173
++ ++ G +D I++ Y +P L+ + D R
Sbjct: 223 MWEVMSYGERPYWDMTNQDVINAIEQ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRP 278
Query: 174 TIPEIMKH 181
+I+
Sbjct: 279 KFGQIVNT 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-33
Identities = 36/190 (18%), Positives = 70/190 (36%), Gaps = 13/190 (6%)
Query: 1 MEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 58
EY G L + + + + + ++ Q+ G+++ HRDL+ N L+
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-- 143
Query: 59 PAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 116
KI DFG ++ + + APE + + K +DVWS G+ L
Sbjct: 144 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTE 202
Query: 117 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 176
++ G + + ++R Y + + +E L+ + P R T
Sbjct: 203 IVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFD 258
Query: 177 EIMK--HQWF 184
+ +F
Sbjct: 259 YLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-32
Identities = 35/184 (19%), Positives = 68/184 (36%), Gaps = 10/184 (5%)
Query: 1 MEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
E+ G L + G F+ + + G++Y V HRDL N L+ +
Sbjct: 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138
Query: 60 APRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM 117
+K+ DFG ++ ++ T + +PEV Y K +DVWS GV ++ +
Sbjct: 139 --VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEV 195
Query: 118 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 177
G + + + I + + S +++ + P R
Sbjct: 196 FSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSR 251
Query: 178 IMKH 181
+++
Sbjct: 252 LLRQ 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-32
Identities = 34/201 (16%), Positives = 71/201 (35%), Gaps = 16/201 (7%)
Query: 1 MEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
+ Y G+L + + F Q+ G+ + + + HRDL N +LD
Sbjct: 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 167
Query: 60 APRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 114
+K+ DFG ++ ++A E L ++ K +DVWS GV L
Sbjct: 168 --TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLL 224
Query: 115 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 174
+ ++ G P D + + + +++ + + R +
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 280
Query: 175 IPEIMKHQWFLKNLPADLVDE 195
E++ + + + + E
Sbjct: 281 FSELVSR---ISAIFSTFIGE 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-32
Identities = 48/246 (19%), Positives = 89/246 (36%), Gaps = 31/246 (12%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
+ G I + ++D +F Q++ G+ Y H+ + HRDLK N ++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN--ED 157
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG ++ + V T Y APE++L + + D+WS G + +L G
Sbjct: 158 CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 121 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------------------------ISQ 155
F D + ++ + + + +
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275
Query: 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVI 215
DL+ ++ V D RIT + + H +F + D DE + + +D
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVADPYDQSFESRDLLIDEW 333
Query: 216 MQIIAE 221
+ +
Sbjct: 334 KSLTYD 339
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 4e-32
Identities = 42/207 (20%), Positives = 75/207 (36%), Gaps = 34/207 (16%)
Query: 1 MEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVS 36
EY + G+L E + + S E +Q+ +G++
Sbjct: 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154
Query: 37 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 93
Y + HRDL N L+ + +KI DFG S+ S+ + + ++ PE
Sbjct: 155 YLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212
Query: 94 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153
+ + Y + +DVW+ GV L+ + G P + I + N
Sbjct: 213 SIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACPEN-C 267
Query: 154 SQECRDLISRIFVADPAARITIPEIMK 180
E +L+ + PA R + I +
Sbjct: 268 PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-30
Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 15/205 (7%)
Query: 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 59
EY G L + + G FS + + + +G+ Y M HRDL N L++ +
Sbjct: 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN- 146
Query: 60 APRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 115
K+ DFG S+ + APE + ++ +DVWS G+ ++
Sbjct: 147 -LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMW 204
Query: 116 VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI 175
++ G + K I + +P L+ + + + A R
Sbjct: 205 EVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 260
Query: 176 PEIMKHQWFLKNLPADLVDEKTMSS 200
+I+ L P L KT++
Sbjct: 261 ADIVSILDKLIRAPDSL---KTLAD 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (281), Expect = 3e-30
Identities = 32/194 (16%), Positives = 65/194 (33%), Gaps = 16/194 (8%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
++ +FS +Q+++ V H + +RD+K +N L+ +
Sbjct: 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS 139
Query: 61 P---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 109
+ + DFG K + + + K+ GT Y++ L E + D+ +
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEA 198
Query: 110 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP---ISQECRDLISRIFV 166
G L G P++ + +K +RI + S P +E +
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELCAGFPEEFYKYMHYARN 257
Query: 167 ADPAARITIPEIMK 180
A +
Sbjct: 258 LAFDATPDYDYLQG 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-29
Identities = 39/200 (19%), Positives = 74/200 (37%), Gaps = 25/200 (12%)
Query: 1 MEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVC 44
+E+ G L + + + + + Q+ G+ + + +
Sbjct: 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 156
Query: 45 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYD 101
HRDL N LL +KICDFG ++ + + ++APE + Y
Sbjct: 157 HRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 102 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 161
+ +DVWS GV L+ + G P + R L + + + E +
Sbjct: 215 IQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 270
Query: 162 SRIFVADPAARITIPEIMKH 181
+ +P+ R T E+++H
Sbjct: 271 LDCWHGEPSQRPTFSELVEH 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-29
Identities = 40/201 (19%), Positives = 71/201 (35%), Gaps = 27/201 (13%)
Query: 1 MEYASGGELFERIC------------------NAGRFSEDEARFFFQQLISGVSYCHAMQ 42
EY G+L + + ++ F Q+ G+++ +
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165
Query: 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHE 99
HRDL N LL KICDFG ++ S ++APE +
Sbjct: 166 CIHRDLAARNILLTHG--RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223
Query: 100 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159
Y + +DVWS G+ L+ + G +++ + + E D
Sbjct: 224 YTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---KFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 160 LISRIFVADPAARITIPEIMK 180
++ + ADP R T +I++
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 8e-29
Identities = 36/198 (18%), Positives = 72/198 (36%), Gaps = 22/198 (11%)
Query: 1 MEYASGGELFERI----------------CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 44
+EYAS G L E + + S + Q+ G+ Y + +
Sbjct: 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157
Query: 45 HRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 103
HRDL N L+ ++ + + + ++APE L Y +
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217
Query: 104 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 163
+DVWS GV L+ + G ++ K ++ + + + + E ++
Sbjct: 218 -SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE----GHRMDKPSNCTNELYMMMRD 272
Query: 164 IFVADPAARITIPEIMKH 181
+ A P+ R T ++++
Sbjct: 273 CWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 51/255 (20%), Positives = 96/255 (37%), Gaps = 42/255 (16%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 60
ME + + Q++ G+ + H+ + HRDLK N ++
Sbjct: 101 MELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC- 156
Query: 61 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 120
LKI DFG ++++ V T Y APEV+L Y + D+WS G + M+
Sbjct: 157 -TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRH 214
Query: 121 GYPFEDPDEPKDFRKTIQRILS-----------------------VQYSVPDTNP----- 152
F D + K I+++ + + P P
Sbjct: 215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP 274
Query: 153 --------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEE 204
+ + RDL+S++ V DPA RI++ + ++H + V+ ++
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 334
Query: 205 PDQPMQSVDVIMQII 219
D+ +++ ++I
Sbjct: 335 LDEREHTIEEWKELI 349
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-27
Identities = 44/214 (20%), Positives = 79/214 (36%), Gaps = 37/214 (17%)
Query: 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLEN 52
+Y G LF+ + N + + SG+++ H + HRDLK +N
Sbjct: 80 SDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
Query: 53 TLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDG 102
L+ + I D G S + + P VGT Y+APEVL ++H
Sbjct: 139 ILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 103 KIADVWSCGVTLYVMLVGGYPFE---------------DPDEPKDFRKTIQRILSVQY-S 146
K AD+++ G+ + + DP + + ++ L +
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256
Query: 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 180
+ + ++ + A+ AAR+T I K
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 8e-26
Identities = 40/228 (17%), Positives = 77/228 (33%), Gaps = 46/228 (20%)
Query: 9 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKI 65
+ + +QL+ G+ Y H + H D+K EN L++ SP ++I
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 66 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 125
+ +++ T Y +PEVLL + AD+WS ++ ++ G + FE
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 230
Query: 126 DPDEPKDFRK--TIQRILSVQYSVPD---------------------------------- 149
+ + I +I+ + +P
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 150 ------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 191
+ ++E D +S + DP R ++ H W L +
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-25
Identities = 34/194 (17%), Positives = 74/194 (38%), Gaps = 20/194 (10%)
Query: 1 MEYASGGELFERICNAGRF----------SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 50
ME + G+L + + S + ++ G++Y +A + HRDL
Sbjct: 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161
Query: 51 ENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 107
N ++ +KI DFG ++ + + + + +++PE L + DV
Sbjct: 162 RNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DV 218
Query: 108 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 167
WS GV L+ + P + + ++ ++ + + +L+ +
Sbjct: 219 WSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQY 274
Query: 168 DPAARITIPEIMKH 181
+P R + EI+
Sbjct: 275 NPKMRPSFLEIISS 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 16/104 (15%), Positives = 29/104 (27%), Gaps = 14/104 (13%)
Query: 10 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 69
R + ++ V+ + + H DL N L+ + I DF
Sbjct: 91 LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP 147
Query: 70 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK----IADVWS 109
SV + + +V Y + D+ S
Sbjct: 148 ---QSVEVGEEGW----REILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.36 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 90.97 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 90.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 90.51 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 89.87 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 89.0 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 88.86 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 87.06 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 86.4 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 86.07 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 85.3 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 84.9 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 83.91 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 83.7 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 83.67 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 82.91 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 82.87 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 82.69 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 82.6 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 82.6 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 82.55 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 81.8 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 80.58 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=337.51 Aligned_cols=184 Identities=39% Similarity=0.668 Sum_probs=154.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC---C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---~ 77 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... .
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcc
Confidence 799999999999988889999999999999999999999999999999999999976654 99999999975332 2
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
....+.+||+.|||||++.+..+++.++||||+||++|+|++|+.||............. .......+....+|+++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTCTTSTTGGGSCHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCCCCCCccccCCHHH
Confidence 234567899999999999888887776999999999999999999998765543322222 22222233345589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLP 189 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~ 189 (268)
.+||.+||+.||.+|||++|+++||||++.++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=329.97 Aligned_cols=176 Identities=35% Similarity=0.661 Sum_probs=152.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 799999999999999899999999999999999999999999999999999999976654 99999999975433 234
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+.... ...+......+| ..+|+++++|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFP--DFVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCC--TTSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC--ccCCHHHHHH
Confidence 55689999999999998887655 8999999999999999999987664333 333444444444 3489999999
Q ss_pred HHHccccCCCCCCCHHHHhcccccCC
Q 024363 161 ISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
|.+||+.||.+|||+.|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=333.21 Aligned_cols=182 Identities=37% Similarity=0.669 Sum_probs=143.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC-CCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~-~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||++.. +..+.+||+|||+|+.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 899999999999999999999999999999999999999999999999999999964 2345699999999987655555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc--CCCCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~ 157 (268)
..+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+....... ..+...... .+....+|+++
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHH
Confidence 567789999999999998888665 99999999999999999999876654433 333333333 33445689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+||.+||+.||.+|||+.|+++||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=326.86 Aligned_cols=181 Identities=27% Similarity=0.471 Sum_probs=152.0
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+..... ..
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccccc
Confidence 799999999998765 5799999999999999999999999999999999999997665 4999999999864332 33
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+... .....+.+..+|+++++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRD 248 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGSCHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccCCHHHHH
Confidence 456689999999999998888665 99999999999999999999887655444333322 22233444558999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||+.||.+|||+.|+|+||||+...
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999996543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=329.67 Aligned_cols=177 Identities=38% Similarity=0.703 Sum_probs=153.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~~ 79 (268)
||||+||+|.+++.+.+.++|..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence 79999999999999999999999999999999999999999999999999999997665 499999999986443 334
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
....+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+.... .+.+......+| ..+|+++++
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~d 234 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFP--RTLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHH----HHHHhcCCCCCC--ccCCHHHHH
Confidence 456789999999999999888665 9999999999999999999998775433 333444444444 448999999
Q ss_pred HHHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 160 LISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
||.+||++||.+|++ +.++++||||..
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 999999999999994 899999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=321.24 Aligned_cols=178 Identities=24% Similarity=0.442 Sum_probs=147.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~--ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.. .+.+||+|||+|+.... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~~~-~ 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRA-S 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGCCT-T
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceeccC-C
Confidence 799999999999999899999999999999999999999999 9999999999999632 23599999999975322 2
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 158 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 158 (268)
...+.+||+.|||||++.+ .++.+ +|||||||++|+|++|+.||.+......+.+ .+.........+..+++++.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHH
T ss_pred ccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HHHcCCCCcccCccCCHHHH
Confidence 3346689999999999865 46554 9999999999999999999987766544333 22222222222344789999
Q ss_pred HHHHHccccCCCCCCCHHHHhcccccC
Q 024363 159 DLISRIFVADPAARITIPEIMKHQWFL 185 (268)
Q Consensus 159 ~li~~~l~~dp~~R~s~~e~l~h~~~~ 185 (268)
+||.+||+.||++|||+.|+++||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999994
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-48 Score=334.22 Aligned_cols=182 Identities=32% Similarity=0.580 Sum_probs=154.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+.......
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 799999999999954 5679999999999999999999999999999999999999765556799999999986655555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
..+..||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.. +....+..+ ....+|+++
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHH
T ss_pred cceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHH
Confidence 566789999999999998888655 9999999999999999999987765444433 333333322 224589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++||.+||+.||.+|||+.|+|+||||+..
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=323.98 Aligned_cols=177 Identities=32% Similarity=0.600 Sum_probs=148.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcc
Confidence 799999999999999999999999999999999999999999999999999999976654 999999999754322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.... ...+....+.+| ..+|+++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~ 237 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLI----FQKIIKLEYDFP--EKFFPKA 237 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCC--TTCCHHH
T ss_pred cccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHH----HHHHHcCCCCCC--ccCCHHH
Confidence 23345689999999999988887655 9999999999999999999987665433 334445544444 3489999
Q ss_pred HHHHHHccccCCCCCCCHHH------HhcccccCC
Q 024363 158 RDLISRIFVADPAARITIPE------IMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e------~l~h~~~~~ 186 (268)
++||.+||+.||.+|||++| +++||||..
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999987 688999954
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=330.35 Aligned_cols=182 Identities=30% Similarity=0.513 Sum_probs=145.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ++||+|||+|+.... ..
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~-~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HT
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccCC-Cc
Confidence 7999999999999998999999999999999999999997 5999999999999997665 499999999985332 23
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHH------------------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK------------------------ 135 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------------------------ 135 (268)
..+.+||+.|+|||++.+..|+.+ +||||+||++|||++|+.||.+.+.......
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 356789999999999999888766 8999999999999999999987654322110
Q ss_pred --------------HHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 136 --------------TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 136 --------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
....+............+|.++.+||.+||+.||.+|||++|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000111111111111236899999999999999999999999999999965
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=325.44 Aligned_cols=182 Identities=34% Similarity=0.637 Sum_probs=155.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCC--CCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~--~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. ..+||+|||+|+......
T Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~ 171 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171 (293)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence 799999999999999889999999999999999999999999999999999999976543 359999999998765555
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQE 156 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~ 156 (268)
...+..||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+. .+.......+ .+..+|..
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTSCHH
T ss_pred cccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHH----HHHhcCCCCCchhcCCCCHH
Confidence 5667789999999999988777655 999999999999999999998876544333 3333333322 22458999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
+++||++||+.||.+|||++++++||||+..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=334.09 Aligned_cols=187 Identities=35% Similarity=0.617 Sum_probs=154.7
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~ 77 (268)
||||+||+|.++|.+. .+|++.+++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 7999999999999874 3699999999999999999999999999999999999997533 456999999999876666
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC--CCCCH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQ 155 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~ 155 (268)
.......||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+.......+...+....+.+|.. ..+|+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCH
T ss_pred CccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCH
Confidence 66677889999999999988888665 9999999999999999999987665544444444444444444432 34799
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus 247 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999999999999999997653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-48 Score=332.01 Aligned_cols=182 Identities=29% Similarity=0.530 Sum_probs=155.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++.+. .++++.+++.++.||+.||.|||++||+||||||+|||++....+++||+|||+|+.......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 8999999999988654 469999999999999999999999999999999999999865666799999999987665555
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCC--CCCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~ 157 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.. +....+.++ ....+|+++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHH
T ss_pred eeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHH
Confidence 566789999999999988888665 9999999999999999999988776544333 333333332 335689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-47 Score=328.77 Aligned_cols=180 Identities=29% Similarity=0.465 Sum_probs=150.2
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-~~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-SCC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-Ccc
Confidence 799999999999999999999999999999999999999999999999999999976654 99999999985433 334
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
....||+.|+|||++......+.++|||||||++|+|++|+.||.+...... ..+.......... .+..+|+++++|
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~s~~~~~l 239 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVE--LPDSFSPELRSL 239 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCC--CCSSSCHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCC--CCCCCCHHHHHH
Confidence 5678999999999997554334459999999999999999999987654332 2233333333333 334589999999
Q ss_pred HHHccccCCCCCCC-----HHHHhcccccCC
Q 024363 161 ISRIFVADPAARIT-----IPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~s-----~~e~l~h~~~~~ 186 (268)
|.+||+.||.+||| ++++++||||+.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 99999999999999 799999999954
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=322.02 Aligned_cols=181 Identities=25% Similarity=0.440 Sum_probs=148.9
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~ 78 (268)
||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcc
Confidence 899999999999865 557999999999999999999999999999999999999976654 999999998643221 2
Q ss_pred CCCCCcCCCCcccchhhc-----cCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 79 QPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
...+..||+.|+|||++. ...|+. ++|||||||++|+|++|+.||.+.+....+.++... .....+.+..+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~-k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~ 241 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRW 241 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTT-HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGS
T ss_pred cccccccccccCCHHHHhhcccCCCCCCh-hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccC
Confidence 234568999999999985 233444 499999999999999999999988776655443332 11223334558
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
|+++++||.+||+.||.+|||+.|+++||||+..
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=322.63 Aligned_cols=180 Identities=28% Similarity=0.412 Sum_probs=150.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---C
Confidence 799999999888888889999999999999999999999999999999999999986654 99999999975432 3
Q ss_pred CCCcCCCCcccchhhcc---CccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 81 KSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
....||+.|||||++.+ ..|+.+ +|||||||++|+|++|+.||.+.+....+.++ ............+|+++
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYF 243 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCSCTTSCHHH
T ss_pred CccccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhCCCCCCCCCCCCHHH
Confidence 45689999999999864 235544 99999999999999999999887654443333 23333333345589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
++||.+||+.||.+|||++++|+||||.+..+.
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 999999999999999999999999999775543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-46 Score=318.24 Aligned_cols=175 Identities=35% Similarity=0.667 Sum_probs=151.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECSS--CB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEecc--cc
Confidence 79999999999999999999999999999999999999999999999999999997655 499999999976432 33
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+..... ..+.......| ..+|+++.++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CCCCHHHHHH
Confidence 56789999999999988888765 89999999999999999999887654433 33444444443 4489999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
|.+||..||.+|+ |++++++||||+.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 9999999999996 8999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-47 Score=315.35 Aligned_cols=182 Identities=32% Similarity=0.559 Sum_probs=152.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||+||+|.++|...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+........
T Consensus 89 mE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~ 166 (277)
T d1phka_ 89 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKL 166 (277)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCB
T ss_pred EEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCCce
Confidence 799999999999999999999999999999999999999999999999999999976654 999999999876555555
Q ss_pred CCCcCCCCcccchhhccCc-----cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 81 KSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
....||+.|+|||++.+.. ..+.++||||+||++|+|++|+.||.+.+.......+... ...+..+....+|+
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~ 244 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSD 244 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCH
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCCcccccCCH
Confidence 6678999999999986421 2244589999999999999999999987754443333322 11222333446899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
++++||.+||+.||.+|||+.|+++||||++
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 9999999999999999999999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=314.47 Aligned_cols=176 Identities=31% Similarity=0.470 Sum_probs=137.7
Q ss_pred CCCCCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 1 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 1 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qil~~L~~LH~~~-----ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeeccce
Confidence 799999999999864 467999999999999999999999987 99999999999997665 4999999999
Q ss_pred CCCCCC-CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC
Q 024363 72 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 150 (268)
Q Consensus 72 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (268)
+..... .......||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+...... +.+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~i~~~~~~-~~~ 235 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFR-RIP 235 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCC-CCC
Confidence 754332 23456789999999999988887655 99999999999999999999876654332 233333222 233
Q ss_pred CCCCHHHHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 151 NPISQECRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 151 ~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
..+|+++.+||.+||+.||.+|||+.|+++|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4589999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-46 Score=321.96 Aligned_cols=175 Identities=34% Similarity=0.642 Sum_probs=150.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|..++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.++ ++||+|||+|+.... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECSS--CB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeeccc--cc
Confidence 69999999999999999999999999999999999999999999999999999997665 499999999986432 33
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 160 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 160 (268)
.+..||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ ..+.......+ ..+|+++.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~l 268 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHH----HHHhcCCCCCC--ccCCHHHHHH
Confidence 56789999999999998888655 99999999999999999999876644333 33334433333 4589999999
Q ss_pred HHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 161 ISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 161 i~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
|++||+.||.+|+ |++++++||||+.
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999999995 8999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=323.36 Aligned_cols=182 Identities=26% Similarity=0.500 Sum_probs=155.4
Q ss_pred CCCCCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.++|.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 79999999999997665 79999999999999999999999999999999999999876666799999999986555444
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCC--CCCCCHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQEC 157 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~ 157 (268)
.....+|+.|+|||.+.+..++.+ +||||+||++|+|++|+.||.+.+....+..+ ....+.++. +..+|+++
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENI----MNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCCCHHHHTTSCHHH
T ss_pred ccccccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCCChhhccCCCHHH
Confidence 556789999999999988877655 99999999999999999999887765444443 333333322 23589999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 158 RDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
++||.+||+.||.+|||+.|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=318.14 Aligned_cols=177 Identities=38% Similarity=0.693 Sum_probs=151.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++..+ ++||+|||+|+..... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhccccccc
Confidence 79999999999999999999999999999999999999999999999999999997655 4999999999854433 33
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+ +.......| ..+|+++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~~p--~~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYP--RWLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCC--TTSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCC--ccCCHHHHH
Confidence 445689999999999998888765 9999999999999999999988765443333 333333333 348999999
Q ss_pred HHHHccccCCCCCCCHH-HHhcccccCC
Q 024363 160 LISRIFVADPAARITIP-EIMKHQWFLK 186 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~-e~l~h~~~~~ 186 (268)
||.+||+.||.+|||+. ++++||||++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999995 8999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=312.30 Aligned_cols=185 Identities=24% Similarity=0.348 Sum_probs=151.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
||||.||++..++.....+++.+++.++.||+.||+|||++||+||||||+|||++..+ .+||+|||+|+..... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~--~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC--ccccccCccccccCCCccc
Confidence 79999998887777778899999999999999999999999999999999999997655 4999999999764433 33
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc-------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS------------- 146 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 146 (268)
....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+.++..........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 4566899999999999776555566999999999999999999999887766665555433221100
Q ss_pred ---CCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 147 ---VPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 147 ---~~~------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.+. ...+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 000 12468999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=307.14 Aligned_cols=174 Identities=36% Similarity=0.575 Sum_probs=147.0
Q ss_pred CCCCCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
|||+.| ++|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.... ..
T Consensus 88 ~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~-~~ 165 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKD-TV 165 (273)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCS-SC
T ss_pred EEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceeccc-cc
Confidence 688876 68899998889999999999999999999999999999999999999997543 3599999999975432 33
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 159 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 159 (268)
..+..||+.|+|||++.+..+.++++||||+||++|+|++|+.||.+.+ . +......+ +..+|+++++
T Consensus 166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~----i~~~~~~~--~~~~s~~~~~ 233 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVFF--RQRVSSECQH 233 (273)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCCC--SSCCCHHHHH
T ss_pred ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H----HhhcccCC--CCCCCHHHHH
Confidence 4567899999999999888777777899999999999999999997522 1 22222333 3458999999
Q ss_pred HHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 160 LISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 160 li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
||.+||+.||.+|||++|+++||||++..
T Consensus 234 li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999997643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=307.20 Aligned_cols=183 Identities=25% Similarity=0.339 Sum_probs=151.7
Q ss_pred CCCCCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||.||.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++..+. +||+|||+++.......
T Consensus 94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~ 171 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA 171 (305)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGG
T ss_pred EEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhccccc
Confidence 68999988755544 3456999999999999999999999999999999999999976554 99999999987665556
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-c------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S------------ 146 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------------ 146 (268)
.....||+.|+|||++.+..|+.+ +||||+||++|+|++|+.||.+.+....+.+++........ .
T Consensus 172 ~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred CCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 677889999999999998888766 99999999999999999999988776666555543221110 0
Q ss_pred --------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 --------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 --------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
......+++.+++||.+||++||.+|||+.|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0112347899999999999999999999999999999964
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=304.59 Aligned_cols=179 Identities=22% Similarity=0.355 Sum_probs=142.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++... +++++..+..++.||++||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCC
Confidence 7999999999999764 56999999999999999999999999999999999999987654 999999999754322
Q ss_pred -CCCCCCcCCCCcccchhhccC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 153 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (268)
....+..||+.|||||++.+. .|+ .++|||||||++|||++|+.||.+.+........+............+..+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred cccccccccCcccCCHHHHhcccCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 233456799999999998643 344 458999999999999999999998877665554444322221111233458
Q ss_pred CHHHHHHHHHccccCCCCCCCHHHHhccc
Q 024363 154 SQECRDLISRIFVADPAARITIPEIMKHQ 182 (268)
Q Consensus 154 s~~~~~li~~~l~~dp~~R~s~~e~l~h~ 182 (268)
|+++.+||.+||..||.+|||+.+++++.
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 89999999999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=308.19 Aligned_cols=174 Identities=24% Similarity=0.411 Sum_probs=146.2
Q ss_pred CCCCCCCchhHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcC
Q 024363 1 MEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 57 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-----------------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~ 57 (268)
||||+||+|.++|.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc
Confidence 7999999999999764 24899999999999999999999999999999999999986
Q ss_pred CCCCCEEEeecCCCCCCCCCCC---CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHH
Q 024363 58 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF 133 (268)
Q Consensus 58 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 133 (268)
++ .+||+|||+|+....... ..+..||+.|||||++.+..++.+ +|||||||++|||++ |+.||.+.+....+
T Consensus 200 ~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 200 GK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp TT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 65 499999999986443332 234568999999999988887655 999999999999997 89999887765554
Q ss_pred HHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 134 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+++ ....+.+.+..+|+++++||.+||+.||++|||+++|++|
T Consensus 277 ~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 277 YKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 3344555566689999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=299.16 Aligned_cols=176 Identities=22% Similarity=0.301 Sum_probs=144.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC--
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-- 78 (268)
||||+||+|.+++.+...+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccc
Confidence 799999999999999999999999999999999999999999999999999999986654 9999999997533222
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+..... ..+. .....+.+..+|+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~----~~i~-~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLE-KGERMGCPAGCPR 237 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTCCCCCCTTCCH
T ss_pred cccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCcccCH
Confidence 2234578999999999988887665 999999999999997 89999887654322 2222 2233444556899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHh---ccccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIM---KHQWF 184 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l---~h~~~ 184 (268)
++.+||.+||+.||.+|||+.+++ +|+|+
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999999999984 55554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=304.32 Aligned_cols=186 Identities=26% Similarity=0.385 Sum_probs=148.8
Q ss_pred CCCCCCCchhHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC
Q 024363 1 MEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 77 (268)
Q Consensus 1 mEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~ 77 (268)
||||++|.+..+. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence 7999876443332 34667999999999999999999999999999999999999976542 4999999999876666
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------c
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------------Q 144 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~ 144 (268)
....+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||...+....+.++....... .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 666778999999999998765544555999999999999999999998877666555544321110 0
Q ss_pred ccC----------CCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 YSV----------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 ~~~----------~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
... .....+++++.+||.+||..||.+|||+.|+|+||||.+-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 1123478999999999999999999999999999999653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=296.86 Aligned_cols=184 Identities=24% Similarity=0.405 Sum_probs=147.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~-~~ 78 (268)
||||.|+.+...... .+.+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcc
Confidence 799987555433333 45699999999999999999999999999999999999997665 499999999975433 23
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccc------------
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS------------ 146 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 146 (268)
......||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+....+.++..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 44566899999999999888777777999999999999999999999877666555554432211100
Q ss_pred --CCC---------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 --VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 --~~~---------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
.+. ...+|.++.+||++||+.||.+|||+.|+++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 000 1246899999999999999999999999999999964
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-43 Score=295.99 Aligned_cols=184 Identities=26% Similarity=0.398 Sum_probs=146.3
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-~~ 79 (268)
|||+.|+.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|...... ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccc
Confidence 689998888877777889999999999999999999999999999999999999977654 999999998753322 22
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-------c------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-------S------ 146 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~------ 146 (268)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+....+.++......... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 345579999999999987766666699999999999999999999887766555554433211110 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 147 ----------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 147 ----------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
......+++.+.+||++||+.||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0012346899999999999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=299.32 Aligned_cols=174 Identities=21% Similarity=0.389 Sum_probs=138.6
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~K 174 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VK 174 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc--EE
Confidence 7999999999999753 34899999999999999999999999999999999999976654 99
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+|+..... .......||+.|+|||++.+..++.+ +|||||||++|||++| .+||.+......+...+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~- 252 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 252 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-
Confidence 9999999753322 22345679999999999988877655 9999999999999986 5688877665554444332
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
....+.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 253 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 253 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23334445589999999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=300.65 Aligned_cols=187 Identities=27% Similarity=0.432 Sum_probs=147.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
|||+.||+|.+++.. +++++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGGCB
T ss_pred EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCCcc
Confidence 467889999999975 4799999999999999999999999999999999999997655 4999999998743222
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------ 144 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 144 (268)
......+||+.|+|||++......+.++||||+||++|+|++|+.||.+.+................
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 2245567999999999986655555669999999999999999999987765444433322111110
Q ss_pred ----ccCC---------CCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCCCC
Q 024363 145 ----YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 190 (268)
Q Consensus 145 ----~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~~~ 190 (268)
...+ ....+|+++++||.+||+.||.+|||+.++|+||||.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0010 123478899999999999999999999999999999765443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=299.55 Aligned_cols=182 Identities=32% Similarity=0.576 Sum_probs=152.5
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC--CC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~--~~ 78 (268)
||||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 108 ~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~~~~~~ 185 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETE 185 (322)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCGGGGG
T ss_pred eecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhcccccc
Confidence 79999999999999999999999999999999999999999999999999999997665 499999999874322 22
Q ss_pred CCCCCcCCCCcccchhhccCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
...+..|++.|+|||.+.+.. +.+.++|||||||++|+|++|+.||.+.........+.......... .+..+|+++
T Consensus 186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~~ 263 (322)
T d1vzoa_ 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263 (322)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC--CcccCCHHH
Confidence 345568999999999997643 33445999999999999999999998877666555555555444333 334589999
Q ss_pred HHHHHHccccCCCCCC-----CHHHHhcccccCC
Q 024363 158 RDLISRIFVADPAARI-----TIPEIMKHQWFLK 186 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~-----s~~e~l~h~~~~~ 186 (268)
.+||.+||++||.+|| |++|+++||||++
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5899999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.8e-43 Score=298.43 Aligned_cols=182 Identities=23% Similarity=0.438 Sum_probs=146.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.+|+|..+. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 7999999997753 57999999999999999999999999999999999999975442 4899999999876665666
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------c----
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------Q---- 144 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------~---- 144 (268)
...++|+.|+|||++.+....+.++||||+||++|+|++|+.||............+...... .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 778899999999998876654556999999999999999999998766544322222221110 0
Q ss_pred ----------------ccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCC
Q 024363 145 ----------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 186 (268)
Q Consensus 145 ----------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~ 186 (268)
...+....+|+++.+||++||+.||.+|||++|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 001112337899999999999999999999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=294.49 Aligned_cols=176 Identities=24% Similarity=0.360 Sum_probs=145.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS 164 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence 799999999999865 457999999999999999999999999999999999999987654 999999999754322
Q ss_pred --CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 78 --SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 78 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
.......||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+...... .+. .....+.+..+|
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~-~~~~~~~p~~~~ 238 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIE-QGKRMECPPECP 238 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHH-TTCCCCCCTTCC
T ss_pred ccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCC
Confidence 22334568999999999988887665 999999999999998 999999877644322 222 223344455689
Q ss_pred HHHHHHHHHccccCCCCCCCHHHH---hccccc
Q 024363 155 QECRDLISRIFVADPAARITIPEI---MKHQWF 184 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~---l~h~~~ 184 (268)
+++.+||.+||+.+|.+|||+.++ |+|+|+
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999999877 567766
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-43 Score=294.81 Aligned_cols=173 Identities=21% Similarity=0.369 Sum_probs=134.9
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~ 79 (268)
||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence 7999999999988774 56999999999999999999999999999999999999976654 99999999975432221
Q ss_pred ------CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCC
Q 024363 80 ------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 152 (268)
Q Consensus 80 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (268)
.....||+.|||||++.+..++.+ +|||||||++|||++ |+.||.+........ .+ ......+.+..
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~----~i-~~~~~~~~~~~ 257 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AI-EQDYRLPPPMD 257 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HH-HTTCCCCCCTT
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCcc
Confidence 122457899999999988777655 899999999999998 899998876543322 22 22344555666
Q ss_pred CCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 153 ISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 153 ~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
++..+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=294.80 Aligned_cols=185 Identities=25% Similarity=0.344 Sum_probs=145.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCC----
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~---- 76 (268)
||||.+|.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 96 ~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC----
T ss_pred EeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeeccccccc
Confidence 689998888766666778999999999999999999999999999999999999976654 99999999964322
Q ss_pred -CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCC-----
Q 024363 77 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----- 150 (268)
Q Consensus 77 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 150 (268)
.....+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.+............
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 22334567999999999998764444559999999999999999999988766555444333332211110000
Q ss_pred ---------------------CCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 151 ---------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 151 ---------------------~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0136788999999999999999999999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=289.56 Aligned_cols=178 Identities=20% Similarity=0.288 Sum_probs=143.1
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||++|+|.+++.. ..++++.+++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCc
Confidence 799999999998754 336999999999999999999999999999999999999976654 999999999854332
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......||+.|+|||++.+..++.+ +|||||||++|||+||..|+........... .+. .....+.+..++++
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHH-TTCCCCCCTTCCHH
T ss_pred cccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---HHH-hcCCCCCcccChHH
Confidence 23345679999999999988777655 9999999999999996555444333333222 222 22344445568999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc--ccccC
Q 024363 157 CRDLISRIFVADPAARITIPEIMK--HQWFL 185 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~--h~~~~ 185 (268)
+.+||.+||+.||.+|||+.++++ |+||.
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999998 77874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.8e-43 Score=292.99 Aligned_cols=179 Identities=22% Similarity=0.381 Sum_probs=137.6
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC---
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~--- 77 (268)
||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||.++.....
T Consensus 90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-----
T ss_pred EECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcccccc
Confidence 799999999999999999999999999999999999999999999999999999977665 999999987643222
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+.+..... ........+|++
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--PPSARHEGLSAD 244 (277)
T ss_dssp -----------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CGGGTSSSCCHH
T ss_pred ccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC--CCchhccCCCHH
Confidence 23345679999999999988777655 99999999999999999999887665444443322111 111233458999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhccccc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKHQWF 184 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h~~~ 184 (268)
+.+||.+||+.||.+||+..+.+.|+|.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 9999999999999999944444445554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=285.79 Aligned_cols=173 Identities=21% Similarity=0.405 Sum_probs=132.2
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCc
Confidence 7999999999998764 56899999999999999999999999999999999999987654 9999999997543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|||+++ .+||...+. ..+...+. . ....+.+..++++
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~---~-~~~~~~p~~~~~~ 230 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDIS---T-GFRLYKPRLASTH 230 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHH---H-TCCCCCCTTSCHH
T ss_pred eeecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHH---h-cCCCCCccccCHH
Confidence 2234578999999999998888655 9999999999999995 556655443 32222222 1 2333445558999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+||.+||+.||.+|||++++++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=292.72 Aligned_cols=181 Identities=27% Similarity=0.431 Sum_probs=145.7
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
|||| |++|..++ +.+++++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||+|+... ...
T Consensus 102 ~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~--~~~ 175 (346)
T d1cm8a_ 102 MPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD--SEM 175 (346)
T ss_dssp EECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC--SSC
T ss_pred Eecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC--Ccc
Confidence 6899 56777665 4568999999999999999999999999999999999999976654 9999999997543 334
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 144 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (268)
+..+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+...........
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
T d1cm8a_ 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255 (346)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh
Confidence 5678999999999998766656669999999999999999999988765554433332211100
Q ss_pred -----cc----CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 145 -----YS----VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 145 -----~~----~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
.. ......+++++.+||.+||..||.+|||+.|+|+||||+.-
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 01123478999999999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-42 Score=288.95 Aligned_cols=173 Identities=21% Similarity=0.316 Sum_probs=142.7
Q ss_pred CCCCCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCCC
Confidence 7999999999999764 5689999999999999999999999999999999999997665 49999999998643322
Q ss_pred C--CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 Q--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
. .....||+.|+|||++.+..++.+ +|||||||++|||++|..||..........+.+ ......+.+..+|++
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEK 244 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHH
T ss_pred ceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHH
Confidence 2 233458999999999988888655 999999999999999777765555544433333 333445555668999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q 024363 157 CRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+.+||.+||+.||.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=284.54 Aligned_cols=186 Identities=25% Similarity=0.405 Sum_probs=150.4
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-C
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 79 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~-~ 79 (268)
|||+.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++..+ .+||+|||.|+...... .
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSCCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccCCCcc
Confidence 58999999999999999999999999999999999999999999999999999997655 49999999998654433 3
Q ss_pred CCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------------
Q 024363 80 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-------------- 145 (268)
Q Consensus 80 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 145 (268)
.....+++.|+|||++....+.+.++||||+||++|+|++|+.||............+........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 345568889999999987766566699999999999999999997666555544433333222110
Q ss_pred ----------cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 ----------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ----------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
.......+++.+.+||++||+.||.+|||++|+|+||||++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0111234689999999999999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=294.58 Aligned_cols=183 Identities=25% Similarity=0.429 Sum_probs=146.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++. +|++|||+|.... ...
T Consensus 101 ~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--~~~ 175 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--DEM 175 (348)
T ss_dssp EEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--GGG
T ss_pred EEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--ccc
Confidence 578899999998854 57999999999999999999999999999999999999976654 9999999987543 233
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------- 145 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 145 (268)
.+..||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 56789999999999887776666699999999999999999999987765555444433221110
Q ss_pred ----cCCC------CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 146 ----SVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 146 ----~~~~------~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
..+. ...+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000 134789999999999999999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=284.56 Aligned_cols=180 Identities=22% Similarity=0.336 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~- 77 (268)
||||+||+|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|+.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 167 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCC
Confidence 799999999988854 457999999999999999999999999999999999999987654 999999999754322
Q ss_pred -CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......||+.|+|||++....++.+ +|||||||++|||++|..||............+. .....+.+..+|++
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~----~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----RGYRMPCPPECPES 242 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTCCCCCCTTSCHH
T ss_pred ceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCCCCCcccCHH
Confidence 22344679999999999988888655 9999999999999997666555444433333222 22344556668999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc--ccccCCC
Q 024363 157 CRDLISRIFVADPAARITIPEIMK--HQWFLKN 187 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~--h~~~~~~ 187 (268)
+++||.+||+.||++|||+++++. ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999987 8888654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=292.76 Aligned_cols=182 Identities=26% Similarity=0.424 Sum_probs=136.1
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 80 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~~~ 80 (268)
||||.||.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +|++|||+++........
T Consensus 101 ~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~ 175 (355)
T d2b1pa1 101 MELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMM 175 (355)
T ss_dssp EECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC----------
T ss_pred EeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccccccc
Confidence 799987555 444 457999999999999999999999999999999999999976654 999999999877666666
Q ss_pred CCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 024363 81 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------- 144 (268)
Q Consensus 81 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 144 (268)
...+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+......+++.......
T Consensus 176 ~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_dssp -----CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence 77789999999999988877666 9999999999999999999988776555544443322110
Q ss_pred --ccC--------------CC----CCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCCC
Q 024363 145 --YSV--------------PD----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 188 (268)
Q Consensus 145 --~~~--------------~~----~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~~ 188 (268)
... +. ....|+++.+||++||..||++|||++|||+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 00 011357899999999999999999999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=284.16 Aligned_cols=173 Identities=21% Similarity=0.332 Sum_probs=135.2
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCC--
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~-- 77 (268)
||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence 799999999998765 457999999999999999999999999999999999999987664 999999999854322
Q ss_pred CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 78 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 78 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
.......||+.|+|||++.+..++.+ +|||||||++|||++ |.+||.+.+......++. . ....+.+..+|++
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~----~-~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----N-GERLPMPPNCPPT 237 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCCTTCCHH
T ss_pred eeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH----c-CCCCCCCCCCCHH
Confidence 22344568999999999988887655 999999999999998 899998877655443322 2 2234455668999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+||.+||+.||.+|||+.++++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=279.03 Aligned_cols=173 Identities=20% Similarity=0.368 Sum_probs=144.6
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||++|+|..++.. ...+++..++.++.|+++||+|||++||+||||||+||+++.++ .+||+|||+|+......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC--CEEECCCSSCCBCSSSSC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC--cEEECcchhheeccCCCc
Confidence 799999999999765 46799999999999999999999999999999999999997655 49999999997543322
Q ss_pred -CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHH
Q 024363 79 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 156 (268)
Q Consensus 79 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 156 (268)
......||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+...... .+.. ....+.+...+++
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~ 229 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQ-GLRLYRPHLASEK 229 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHHT-TCCCCCCTTCCHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHH----HHHh-CCCCCCcccccHH
Confidence 2334578999999999998888655 999999999999998 899998877544332 2222 3344555668999
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcc
Q 024363 157 CRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 157 ~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+.+||.+||+.||++|||+.++++|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=279.16 Aligned_cols=173 Identities=21% Similarity=0.329 Sum_probs=135.7
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||.+|+|.+++.+. +.+++.++..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCCc
Confidence 6999999999988654 57999999999999999999999999999999999999987654 9999999997543221
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+..++.+ +|||||||++|||++|..||........+.+.+ ....+.+.+..++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i----~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGFRLPTPMDCPS 240 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCCCCCTTCBH
T ss_pred cceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHH----hccCCCCCchhhHH
Confidence 1223468999999999988887665 999999999999999666655444443333222 23344555666899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=278.75 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CC
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccCCC
Confidence 799999999988765 457999999999999999999999999999999999999987654 9999999998543322
Q ss_pred ---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......|++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+.... +..+.......+.+..+|
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCCCCCTTCC
T ss_pred cceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHH----HHHHHhCCCCCCCccccc
Confidence 2233457889999999988777655 899999999999998 8999987765443 344445555566667799
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
+++.+||.+||..||++|||+.++++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=278.69 Aligned_cols=172 Identities=26% Similarity=0.418 Sum_probs=143.3
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.++|... ..+++.+++.++.||+.||+|||+++||||||||+|||++.++. +|
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~k 175 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MK 175 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC--eE
Confidence 7999999999999754 35899999999999999999999999999999999999977665 99
Q ss_pred EeecCCCCCCCCC---CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024363 65 ICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI 140 (268)
Q Consensus 65 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~ 140 (268)
|+|||+++..... .......||+.|+|||++.+..|+.+ +|||||||++|+|++ |.+||.+.+....+ . .
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~----~ 249 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF-K----L 249 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-H----H
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHHH-H----H
Confidence 9999999854332 23345678999999999988888655 999999999999998 78888776643322 2 2
Q ss_pred hcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 141 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 141 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.......+.+..+|+++.+||.+||+.||++|||+.++++
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2233444555668999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=281.71 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=142.8
Q ss_pred CCCCCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEE
Q 024363 1 MEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 64 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~k 64 (268)
||||+||+|.++|++. ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++. +|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eE
Confidence 7999999999999754 57999999999999999999999999999999999999977654 99
Q ss_pred EeecCCCCCCCCCCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhcc
Q 024363 65 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSV 143 (268)
Q Consensus 65 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~ 143 (268)
|+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+... +...+. .
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~-~ 241 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP-Q 241 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG-G
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHH-h
Confidence 999999986655555556679999999999988888655 89999999999999965 5676655433 222222 2
Q ss_pred cccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 144 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 144 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..+.+.+..+++++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33445556689999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=283.40 Aligned_cols=175 Identities=19% Similarity=0.328 Sum_probs=141.7
Q ss_pred CCCCCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccccc
Confidence 589999999998866 457999999999999999999999999999999999999987654 9999999997543322
Q ss_pred --CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCH
Q 024363 79 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 155 (268)
Q Consensus 79 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 155 (268)
......||+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+..... ..+. .....+.+..+++
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~----~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQPPICTI 240 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHH----HTCCCCCCTTBCH
T ss_pred cccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH----cCCCCCCCcccCH
Confidence 2233468999999999988887655 999999999999998 78899876654432 2222 2234455566899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcccc
Q 024363 156 ECRDLISRIFVADPAARITIPEIMKHQW 183 (268)
Q Consensus 156 ~~~~li~~~l~~dp~~R~s~~e~l~h~~ 183 (268)
++.+||.+||+.||.+|||+.+++.|..
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999999843
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=271.40 Aligned_cols=171 Identities=21% Similarity=0.371 Sum_probs=136.4
Q ss_pred CCCCCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC
Q 024363 1 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~ 78 (268)
||||+||+|.+++.+.+ .+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS-- 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--
Confidence 79999999999996543 5999999999999999999999999999999999999977654 99999999975332
Q ss_pred CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCCHHH
Q 024363 79 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 157 (268)
Q Consensus 79 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 157 (268)
......+|+.|+|||++.+..++.+ +|||||||++|||++ |++||........... + ....+.+.+..+++++
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----V-EKGYKMDAPDGCPPAV 229 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----H-TTTCCCCCCTTCCHHH
T ss_pred CCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----H-HcCCCCCCCccCCHHH
Confidence 2345578999999999988777655 999999999999998 7888887665443322 2 2233445555689999
Q ss_pred HHHHHHccccCCCCCCCHHHHhcc
Q 024363 158 RDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 158 ~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+||++||..||.+|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-40 Score=275.84 Aligned_cols=172 Identities=23% Similarity=0.343 Sum_probs=138.6
Q ss_pred CCCCCCCchhHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEc
Q 024363 1 MEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 56 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~ 56 (268)
||||++|+|.+++.... .+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld 174 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 174 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEEC
Confidence 68999999999996532 389999999999999999999999999999999999997
Q ss_pred CCCCCCEEEeecCCCCCCCC---CCCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC-CCCCCCCChHH
Q 024363 57 GSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKD 132 (268)
Q Consensus 57 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~ 132 (268)
.++. +||+|||+|+.... .....+..||+.|+|||++.+..++.+ +|||||||++|||++|. +||.+....+.
T Consensus 175 ~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 175 ENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp GGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 6654 99999999874322 223345678999999999998888755 99999999999999985 67777655433
Q ss_pred HHHHHHHHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 133 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
. ..+.... ..+.+..+++++.+||.+||+.+|.+|||+.++++
T Consensus 252 ~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 I----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp H----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 2233322 33345568999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=274.63 Aligned_cols=173 Identities=25% Similarity=0.425 Sum_probs=142.7
Q ss_pred CCCCCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCC
Q 024363 1 MEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 62 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~ 62 (268)
||||+||+|.+++.+.. .+++..++.++.||+.||+|||++++|||||||+||+++.++.
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~-- 183 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-- 183 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc--
Confidence 79999999999997643 5899999999999999999999999999999999999976654
Q ss_pred EEEeecCCCCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 024363 63 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ 138 (268)
Q Consensus 63 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~ 138 (268)
+|++|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|||++ |.+||.+......+.+++.
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999998643322 2234578999999999987777655 999999999999998 6666766665454444443
Q ss_pred HHhcccccCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 139 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 139 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
.......+..+|..+.+||.+||+.||.+|||+.++++
T Consensus 263 ----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 ----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33344445568999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-39 Score=272.04 Aligned_cols=185 Identities=19% Similarity=0.228 Sum_probs=137.8
Q ss_pred CCCCCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCC-CCCEEEeecCCCCCCCCC-
Q 024363 1 MEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH- 77 (268)
Q Consensus 1 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~-~~~~kl~Dfg~a~~~~~~- 77 (268)
||||.| +|...+ ...+.+++..++.++.|++.||+|||++||+||||||+|||++..+ ...+||+|||+|+.....
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 688855 665555 4566899999999999999999999999999999999999986432 345999999999753322
Q ss_pred -------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHH---HhcccccC
Q 024363 78 -------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR---ILSVQYSV 147 (268)
Q Consensus 78 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 147 (268)
....+..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............+. ...... .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-H
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-h
Confidence 12345679999999999988877655 99999999999999999999876554333222111 111111 0
Q ss_pred CCCCCCCHHHHHHHHHccccCCCCCCCHH---HHhcccccCCCC
Q 024363 148 PDTNPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKNL 188 (268)
Q Consensus 148 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~---e~l~h~~~~~~~ 188 (268)
.....+|+++.+||.+||+.+|.+||++. ++|+|+|.....
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 11234889999999999999999999986 557787765443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-39 Score=271.06 Aligned_cols=174 Identities=21% Similarity=0.307 Sum_probs=138.6
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCCCCCCC-
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 78 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~~~~~~- 78 (268)
||||+||+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++. +||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccc
Confidence 7999999999998754 45888999999999999999999999999999999999976654 9999999997543322
Q ss_pred ----CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccccCCCCCCCC
Q 024363 79 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 154 (268)
Q Consensus 79 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 154 (268)
......||+.|+|||++....++.+ +|||||||++|||++|..||........+. ..+... ...+.+..++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~---~~i~~g-~~~~~p~~~~ 260 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQG-RRLLQPEYCP 260 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CH---HHHHTT-CCCCCCTTCC
T ss_pred ccceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcC-CCCCCcccCc
Confidence 2233568999999999988777655 899999999999999887776544332222 222222 2334445588
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 155 QECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 155 ~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
+++.+||.+||+.||.+|||+.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=270.30 Aligned_cols=173 Identities=20% Similarity=0.307 Sum_probs=140.7
Q ss_pred CCCCCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCC
Q 024363 1 MEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 70 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~ 70 (268)
||||.+|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGl 179 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGM 179 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTC
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeeccc
Confidence 7999999999998642 24789999999999999999999999999999999999976654 99999999
Q ss_pred CCCCCCCC---CCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhccccc
Q 024363 71 SKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYS 146 (268)
Q Consensus 71 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 146 (268)
|+...... ......||+.|+|||.+.+..++.+ +|||||||++|||++|. .||.+.+....+.. +... ..
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~~~-~~ 253 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEG-GL 253 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTT-CC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhC-CC
Confidence 97543222 2334568999999999988887655 89999999999999984 77776655433322 2222 23
Q ss_pred CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 147 VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 147 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
.+.+..+++.+.+||.+||+.+|.+|||+.+++++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44455689999999999999999999999999984
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-37 Score=258.69 Aligned_cols=177 Identities=18% Similarity=0.190 Sum_probs=137.0
Q ss_pred CCCCCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCC---CCCCEEEeecCCCCCCCC
Q 024363 1 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVL 76 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~---~~~~~kl~Dfg~a~~~~~ 76 (268)
|||| ||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.. ..+.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 6898 68999999764 479999999999999999999999999999999999999742 245699999999975322
Q ss_pred C--------CCCCCCcCCCCcccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChHHHH---HHHHHHhcccc
Q 024363 77 H--------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR---KTIQRILSVQY 145 (268)
Q Consensus 77 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 145 (268)
. ....+.+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+........ ++.........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 1 22345679999999999988877655 999999999999999999998655433221 11111111111
Q ss_pred cCCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhc
Q 024363 146 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK 180 (268)
Q Consensus 146 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~ 180 (268)
......+|+++.+++..|+..+|.+||+++.+.+
T Consensus 238 -~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 -RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0112347899999999999999999999876643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-38 Score=263.72 Aligned_cols=178 Identities=21% Similarity=0.239 Sum_probs=130.9
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~--------~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
||||++|+|.++|++. ++++.+++.++.|++.||+|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCccc
Confidence 7999999999999764 69999999999999999999996 5999999999999997665 49999999987
Q ss_pred CCCCC-----CCCCCCcCCCCcccchhhccCcc-----CCcccchhhhhHHHHHHHhCCCCCCCCCCh-----------H
Q 024363 73 SSVLH-----SQPKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------K 131 (268)
Q Consensus 73 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------~ 131 (268)
..... .......||+.|+|||++.+... .+.++|||||||++|||++|..||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 53222 12345689999999999875421 133489999999999999998877432210 0
Q ss_pred HHHHHHHHHhcccccCCCC-----CCCCHHHHHHHHHccccCCCCCCCHHHHhcc
Q 024363 132 DFRKTIQRILSVQYSVPDT-----NPISQECRDLISRIFVADPAARITIPEIMKH 181 (268)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h 181 (268)
..............+.+.+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111222222222211111 1123468999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-36 Score=258.58 Aligned_cols=169 Identities=24% Similarity=0.417 Sum_probs=127.0
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEcCCCCC----CEEEeecCCCCCCCCCCCCCCCcCCCCc
Q 024363 15 NAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP----RLKICDFGYSKSSVLHSQPKSTVGTPAY 89 (268)
Q Consensus 15 ~~~~l~e~~~~~~~~qil~~L~~LH~-~~ivHrdlkp~Nili~~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 89 (268)
....+++..++.++.||+.||+|||+ .||+||||||+|||++..+.. .+|++|||.|+.... .....+||+.|
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y 195 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREY 195 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGG
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccc
Confidence 34579999999999999999999998 899999999999999754432 389999999875432 33567899999
Q ss_pred ccchhhccCccCCcccchhhhhHHHHHHHhCCCCCCCCCChH------HHHHHHHHHhcc--------------------
Q 024363 90 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------DFRKTIQRILSV-------------------- 143 (268)
Q Consensus 90 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~-------------------- 143 (268)
+|||++.+..++.+ +||||+||++++|++|+.||....... .....+. .+..
T Consensus 196 ~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~ 273 (362)
T d1q8ya_ 196 RSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRG 273 (362)
T ss_dssp CCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--
T ss_pred cChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH-HhCCCCHHHhhcccccccccccch
Confidence 99999998888765 899999999999999999997543211 1111111 1000
Q ss_pred -ccc----------------CCCCCCCCHHHHHHHHHccccCCCCCCCHHHHhcccccCCC
Q 024363 144 -QYS----------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 187 (268)
Q Consensus 144 -~~~----------------~~~~~~~s~~~~~li~~~l~~dp~~R~s~~e~l~h~~~~~~ 187 (268)
... .......++++++||.+||.+||.+|||++|+|+||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 000 00111235789999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.62 E-value=4.6e-17 Score=126.96 Aligned_cols=63 Identities=24% Similarity=0.302 Sum_probs=53.8
Q ss_pred CCCCCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEcCCCCCCEEEeecCCCCC
Q 024363 1 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 73 (268)
Q Consensus 1 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qil~~L~~LH~~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~~ 73 (268)
|||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++.++ ++|+|||+|+.
T Consensus 89 me~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~ 151 (191)
T d1zara2 89 MELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVE 151 (191)
T ss_dssp EECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEE
T ss_pred EEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCccc
Confidence 6888876653 256677788999999999999999999999999999998543 89999999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.71 E-value=0.027 Score=46.70 Aligned_cols=28 Identities=18% Similarity=0.239 Sum_probs=23.6
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++|+|+.|.|||++.+. ++|.||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 589999999999997543 8999997664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.49 E-value=0.01 Score=47.55 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=24.3
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.|+||+|+.+.||+++.+. ..-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc--ceeEecccccc
Confidence 5799999999999997543 25799998663
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.36 E-value=0.075 Score=42.58 Aligned_cols=28 Identities=18% Similarity=0.158 Sum_probs=22.2
Q ss_pred cCCeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 41 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 41 ~~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
.++||+|+.|.|||++. + ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~-~---~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G---PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS-S---EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC-C---ceEEechhcc
Confidence 35899999999999963 2 4589998664
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.97 E-value=0.024 Score=33.46 Aligned_cols=54 Identities=17% Similarity=0.121 Sum_probs=42.5
Q ss_pred HHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 214 VIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+.+.|...+.+..|..+..++.... ......+.+........|.|++|+|+|.
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~ 57 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK 57 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence 56788889999999999987776632 3344566777788899999999999983
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=90.73 E-value=0.05 Score=41.83 Aligned_cols=28 Identities=25% Similarity=0.284 Sum_probs=22.1
Q ss_pred CeecCCCCCcEEEcCCCCCCEEEeecCCCC
Q 024363 43 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 72 (268)
Q Consensus 43 ivHrdlkp~Nili~~~~~~~~kl~Dfg~a~ 72 (268)
++|+|+.|.||+++.++ .+-|.||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred EEEeeccCcceeecCCc--eEEEeechhcc
Confidence 79999999999997543 24599998653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=90.51 E-value=0.045 Score=41.89 Aligned_cols=28 Identities=25% Similarity=0.253 Sum_probs=22.4
Q ss_pred CCeecCCCCCcEEEcCCCCCCEEEeecCCC
Q 024363 42 QVCHRDLKLENTLLDGSPAPRLKICDFGYS 71 (268)
Q Consensus 42 ~ivHrdlkp~Nili~~~~~~~~kl~Dfg~a 71 (268)
.++|+|+.|.||+++.+. .+-|.||+.+
T Consensus 176 ~liHgD~~~~Nvl~~~~~--~~~iID~~~~ 203 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGR--FSGFIDCGRL 203 (255)
T ss_dssp EEECSSCCGGGEEEETTE--EEEECCCTTC
T ss_pred eEEeCCCCCcceEEeCCc--eEEEEEchhc
Confidence 389999999999997543 2569999865
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=89.87 E-value=0.077 Score=33.14 Aligned_cols=57 Identities=14% Similarity=0.025 Sum_probs=45.4
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.-+.+.+.|...+.+..|..+..++.... ......+.+..+...+.|.|++|+|+|.
T Consensus 13 ~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~ 71 (81)
T d1fi5a_ 13 TEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYD 71 (81)
T ss_dssp CHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHH
T ss_pred CHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHH
Confidence 45678999999999999999998876632 3334456677778889999999999984
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=89.00 E-value=0.023 Score=35.77 Aligned_cols=57 Identities=12% Similarity=0.038 Sum_probs=44.0
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCCCC-CCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDM-DDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+..+.++|...+.+..|..+..++....... ...+++..+...+.|.||+|+|+|.
T Consensus 4 e~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~ 61 (81)
T d2opoa1 4 DIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFD 61 (81)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 45678899999999999999997776532111 2455677788899999999999973
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.86 E-value=0.052 Score=33.43 Aligned_cols=58 Identities=14% Similarity=-0.008 Sum_probs=46.1
Q ss_pred CCHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 210 QSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+-+.++..|...+.+..|..+..++.... ......+.+..+...+.|.|++|+|+|.
T Consensus 6 ~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~ 65 (75)
T d1jc2a_ 6 KSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFD 65 (75)
T ss_dssp CCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHH
T ss_pred CcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHH
Confidence 355778999999999999999997776632 3345556677888899999999999984
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.06 E-value=0.063 Score=31.97 Aligned_cols=55 Identities=18% Similarity=0.100 Sum_probs=42.6
Q ss_pred HHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 213 DVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+.++..|...+....|..+.+++.... ......+.+......+.|.|++|+|+|.
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~ 59 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYE 59 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence 567889999999999999988776632 2233455666777888999999999983
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=86.40 E-value=0.15 Score=33.85 Aligned_cols=57 Identities=12% Similarity=-0.021 Sum_probs=42.6
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccC-----CCCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTD-----NLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+.+.++..|...+.+..|..+.+++..- .......+.+..+...+.|.|++|+|+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~ 100 (109)
T d5pala_ 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD 100 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHH
T ss_pred CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHH
Confidence 3467889999999999999999887541 11223345556677888899999999983
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=86.07 E-value=0.07 Score=32.11 Aligned_cols=55 Identities=15% Similarity=0.077 Sum_probs=41.6
Q ss_pred HHHHHHHHHhCCCCCCCcCccccccCCCC---CCCccccccccccccccCCCCccccc
Q 024363 213 DVIMQIIAEASIPAVGTHGLNCYMTDNLD---MDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+.+...|...+.+..|..+..++...... ....+.+..+.....|.||+|+|+|.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~ 59 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIP 59 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence 35778899999999999998887763322 22356666777888999999999973
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=85.30 E-value=0.16 Score=33.72 Aligned_cols=57 Identities=16% Similarity=0.027 Sum_probs=42.1
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCC-----CCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNL-----DMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+.+++.|...+.+..|..+.+++..-.. .....+.+..+.....|.||+|+|+|.
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~ 100 (109)
T d1pvaa_ 39 SANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGID 100 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred CHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHH
Confidence 346788999999999999999988754321 122345556667778899999999973
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=84.90 E-value=0.097 Score=31.88 Aligned_cols=57 Identities=18% Similarity=0.135 Sum_probs=45.6
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+..++..|...+.+..|..+..++.... ....-.+++........|.|++|+|+|.
T Consensus 6 ei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~ 64 (73)
T d2pq3a1 6 QIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 64 (73)
T ss_dssp HHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHH
T ss_pred HHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 46778899999999999999998776643 3344556777788889999999999974
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=83.91 E-value=0.077 Score=31.74 Aligned_cols=53 Identities=15% Similarity=0.136 Sum_probs=39.2
Q ss_pred HHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 215 IMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
+++.|...+.+..|..+..++.... ......+++........|.|++|+|+|.
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~ 57 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNAD 57 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHH
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHH
Confidence 4577888888888888887766532 2334456677778888899999999873
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=83.70 E-value=0.071 Score=32.87 Aligned_cols=57 Identities=16% Similarity=0.041 Sum_probs=43.2
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+.+++.|...+.+..|..+..++..-. ......+.+..+...+.|.|++|+|+|.
T Consensus 7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~ 65 (77)
T d1oqpa_ 7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDED 65 (77)
T ss_dssp HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHH
T ss_pred HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence 34678899999999999999987776632 2223345566677888899999999983
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=83.67 E-value=0.078 Score=32.67 Aligned_cols=57 Identities=16% Similarity=0.174 Sum_probs=44.9
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+..++..|...+.+..|..+..++.... ......+.+..+.....|.+++|+|+|.
T Consensus 8 qi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~ 66 (77)
T d1f54a_ 8 QIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFS 66 (77)
T ss_dssp HHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHH
T ss_pred HHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 45678899999999999999987776632 3334456677778899999999999973
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=82.91 E-value=0.17 Score=30.90 Aligned_cols=58 Identities=10% Similarity=-0.019 Sum_probs=36.0
Q ss_pred CCHHHHHHHHHHhCCC--CCCCcCccccccCC----CCCCCccccccccccccccCCCCccccc
Q 024363 210 QSVDVIMQIIAEASIP--AVGTHGLNCYMTDN----LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
++.+.+.++|...+.. ..|..+.+++..-. .....++.+..+...+.|.|++|+|+|.
T Consensus 2 ~s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~ 65 (76)
T d1qx2a_ 2 KSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFE 65 (76)
T ss_dssp CCHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHH
T ss_pred cCHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHH
Confidence 3556677777765332 34667666654421 1222234456677889999999999984
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=82.87 E-value=0.18 Score=31.47 Aligned_cols=57 Identities=14% Similarity=0.064 Sum_probs=43.1
Q ss_pred CHHHHHHHHHHhCCCC-CCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPA-VGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+..+++.|...+.+. .|..+..++.... ......+.+..+...+.|.|++|+|+|.
T Consensus 13 q~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~ 72 (82)
T d1wrka1 13 QKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFD 72 (82)
T ss_dssp HHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHH
T ss_pred HHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 4567788888888884 6888887766632 3344567778888999999999999974
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=82.69 E-value=0.12 Score=32.24 Aligned_cols=57 Identities=16% Similarity=0.035 Sum_probs=44.0
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
.+..++..|...+.+..|..+..++..-. ......+.+..+...+.|.|++|+|+|.
T Consensus 12 ~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~ 70 (81)
T d1avsa_ 12 MIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFE 70 (81)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHH
T ss_pred HHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 34567888999999999999987766522 3344456677788899999999999984
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=82.60 E-value=0.18 Score=33.27 Aligned_cols=57 Identities=12% Similarity=-0.048 Sum_probs=43.8
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCC-----CCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNL-----DMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+.++++|...+.+..|..+.+++..-.. ....++.+..+.....|.|++|+|+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~ 100 (108)
T d1rroa_ 39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGAD 100 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHH
T ss_pred CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 556788999999999999999988754321 122345666777888899999999974
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=82.60 E-value=0.21 Score=32.87 Aligned_cols=57 Identities=14% Similarity=-0.059 Sum_probs=43.2
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCC-----CCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNL-----DMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..+.++..|...+.+..|..+.+++..-.. .....+++..+...+.|.|++|+|+|.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~ 99 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVD 99 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHH
Confidence 456789999999999999999988765321 122345566677788899999999973
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.55 E-value=0.071 Score=34.47 Aligned_cols=57 Identities=11% Similarity=-0.169 Sum_probs=43.0
Q ss_pred CHHHHHHHHHHhCCCCCCCcCccccccCCCCCCCccccccccccccccCCCCccccc
Q 024363 211 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
......++|...+.+..|..+.++...-.......+.+-.......|.|++|+|++.
T Consensus 8 e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~ 64 (95)
T d1c07a_ 8 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKD 64 (95)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETT
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeEcHH
Confidence 445677899999999999998877766443344455566677888899999999873
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=81.80 E-value=0.053 Score=34.50 Aligned_cols=55 Identities=18% Similarity=0.160 Sum_probs=43.1
Q ss_pred HHHHHHHHHhCCCCCCCcCccccccCC--CCCCCccccccccccccccCCCCccccc
Q 024363 213 DVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
..++..|...+.+..|..+..++.... ......+.+..+...+.|.|++|+|+|.
T Consensus 23 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~ 79 (87)
T d1s6ja_ 23 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYG 79 (87)
T ss_dssp TTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHH
Confidence 447788999999999999988776632 3344556677888899999999999973
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=80.58 E-value=0.47 Score=29.06 Aligned_cols=58 Identities=14% Similarity=0.026 Sum_probs=35.7
Q ss_pred CCHHHHHHHHHHhCC--CCCCCcCccccccC----CCCCCCccccccccccccccCCCCccccc
Q 024363 210 QSVDVIMQIIAEASI--PAVGTHGLNCYMTD----NLDMDDDDMDDLDSESELDIDSSGEIIYA 267 (268)
Q Consensus 210 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~d~d~~~~~~~~d~~~~g~~~~~ 267 (268)
...+.+..+|...+. ...|+.+..++..- ......++.+.++...+.|.|++|+|+|.
T Consensus 4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~ 67 (78)
T d1cb1a_ 4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFE 67 (78)
T ss_dssp CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHH
T ss_pred hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence 355667777776533 22355666554331 12222345567778899999999999984
|